[go: up one dir, main page]

EP2697214A1 - Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants - Google Patents

Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants

Info

Publication number
EP2697214A1
EP2697214A1 EP12710948.6A EP12710948A EP2697214A1 EP 2697214 A1 EP2697214 A1 EP 2697214A1 EP 12710948 A EP12710948 A EP 12710948A EP 2697214 A1 EP2697214 A1 EP 2697214A1
Authority
EP
European Patent Office
Prior art keywords
alkyl
aryl
alkoxy
alkylaminocarbonyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12710948.6A
Other languages
German (de)
French (fr)
Inventor
Jens Frackenpohl
Thomas Müller
Ines Heinemann
Pascal VON KOSKULL-DÖRING
Christopher Hugh Rosinger
Isolde HÄUSER-HAHN
Martin Jeffrey Hills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Priority to EP12710948.6A priority Critical patent/EP2697214A1/en
Publication of EP2697214A1 publication Critical patent/EP2697214A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-oxygen bonds
    • A01N33/24—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-oxygen bonds only one oxygen atom attached to the nitrogen atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/06—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical at least one of the bonds to hetero atoms is to nitrogen
    • A01N35/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical at least one of the bonds to hetero atoms is to nitrogen containing a carbon-to-nitrogen double bond
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing within the same carbon skeleton a carboxylic group or a thio analogue, or a derivative thereof, and a carbon atom having only two bonds to hetero atoms with at the most one bond to halogen, e.g. keto-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04—Sulfonic acids; Derivatives thereof
    • A01N41/06—Sulfonic acid amides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/08—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/10—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with sulfur as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A01N43/26—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings
    • A01N43/28—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A01N43/26—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings
    • A01N43/28—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3
    • A01N43/30—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3 with two oxygen atoms in positions 1,3, condensed with a carbocyclic ring
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Definitions

  • the invention relates to substituted vinyl and alkynylcyclohexenols, processes for their preparation and their use for increasing the stress tolerance in
  • Plants against abiotic stress to enhance plant growth and / or increase plant yield.
  • Abscisic acid derivatives with 3-methyl substituent can be used to increase the tolerance of plants to low temperatures (cf.
  • Pharmaceutical agents can be used to regulate the transport of calcium (see EP240257).
  • Germination behavior of lettuce is in Agric. Biol. Chem. 1986, 50, 1097. 2 - [(E) -2- (1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid is also disclosed in Biosci. Biotech. Biochem. 1992, 56, 624.
  • abiotic stress eg cold, heat, drought, salt, flooding
  • signal transduction chains eg transcription factors, kinases, phosphatases
  • the signal chain genes of the abiotic stress reaction include transcription factors of classes DREB and CBF (Jaglo-Ottosen et al., 1998, Science 280: 104-106).
  • the response to salt stress involves phosphatases of the ATPK and MP2C types.
  • ROS Detoxify oxygen species
  • HSF Heat Shock Factors
  • HSP Heat Shock Proteins
  • osmolytes e.g. Glycine betaine or its biochemical precursors, e.g. Choline derivatives have been observed (Chen et al., 2000, Plant Cell Environ 23: 609-618, Bergmann et al., DE4103253). Also, the effect of antioxidants such as Naphtole and
  • PARP poly-ADP-ribose polymerases
  • PARG poly (ADP-ribose) glycohydrolases
  • the object of the present invention was therefore to provide further compounds which increase the tolerance to abiotic stress in plants, in particular effect and / or enhance plant growth
  • the present invention accordingly provides substituted vinyl and alkynylcyclohexenols of the general formula (I) or salts thereof,
  • groups R 6 to R 21 and A 1 to A 12 are each as defined below and wherein the arrow represents a bond to the respective group [XY], Alkoxyalkyl, hydroxyalkyl, alkylamino, sulphonylamino, alkoxy, haloalkyl, haloalkoxyalkyl, represents hydrogen, alkyl, nitroalkyl, hydroxyalkyl, haloalkyl, alkylamino,
  • R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring, R 3 and R 4 independently of one another represent alkoxy, alkoxyalkoxy, cycloalkylalkoxy,
  • R 5 is hydrogen, alkyl, alkenyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl,
  • R 6 and R 7 independently of one another represent hydrogen, nitro, amino, cyano,
  • Cycloalkylaminocarbonyl cyanoalkylaminocarbonyl, alkenylaminocarbonyl, alkynylaminocarbonyl, alkylamino, alkylthio, haloalkylthio, hydrothio,
  • Aminosulfonyl aminoalkylsulfonyl, aminohaloalkylsulfonyl,
  • Alkylaminosulfonyl bisalkylaminosulfonyl, cycloalkylaminosulfonyl,
  • a 1 , A 2 , A 3 are the same or different and are independently N
  • a 1 and A 2 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
  • a 2 and A 3 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
  • R 8 , R 14 , R 15 and R 21 are each independently hydrogen, nitro, amino, hydroxy, hydrothio, thiocyanato, isothiocyanato, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, arylalkoxy, heteroaryl, haloalkyl,
  • Halocycloalkyl alkoxy, haloalkoxy, aryloxy, heteroaryloxy, cycloalkyloxy, cycloalkylalkoxy, hydroxyalkyl, alkoxyalkyl, aryloxyalkyl, heteroaryloxyalkyl, alkenylaminocarbonyl, alkylamino, alkylthio, haloalkylthio, bisalkylamino, cycloalkylamino, alkylcarbonylamino, cycloalkylcarbonylamino, formylamino, haloalkylcarbonylamino, alkoxycarbonylamino, alkylaminocarbonylamino, (alkyl-) aminocarbonylamino, alkylsulfonylamino, cycloalkylsulfonylamino, arylsulfonylamino, hetarylsulfonylamino, sulfonyl
  • Alkylaminocarbonylheterocyclyl bis-alkylaminocarbonylheterocyclyl
  • R 9 and R 10 independently of one another represent hydrogen, halogen, alkyl, alkoxy,
  • a 4 , A 5 are the same or different and are each independently NR 11 ,
  • Oxygen, sulfur or the group CR 11 but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groupings NR 11 and CR 11 each have the same or different meanings as defined below,
  • R 11 is hydrogen, alkyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, alkenyloxycarbonyl, alkoxycarbonylalkyl, alkylaminocarbonylalkyl, arylaminocarbonylalkyl, aryloxyalkyl, arylalkyl, heteroarylalkyl, haloalkyl,
  • R 12 and R 13 independently of one another represent hydrogen, halogen, alkyl, alkoxy,
  • a 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N-alkyl, alkoxycarbonyl-N, N-aryl, N-heteroaryl, N-heterocyclyl,
  • Heterocycle are present, and wherein no 0 or S atoms are adjacent to each other, and wherein R 15 in the group CR 15 each have the same or different meanings as defined above, and R 16 and R 17 are independently hydrogen, halogen, Alkyl, alkoxy,
  • a 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
  • R 18 is hydrogen, alkyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, allyloxycarbonyl, aryloxyalkyl, arylalkyl, haloalkyl, aryl,
  • a 11 is N or the group CR 21 and wherein R 21 in the group C-R 21 has the meaning defined above
  • a 12 is NR 18 or the group C (R 19 ) R 20 and wherein R 19 and R 20 in the group C (R 19 ) R 20 have the meaning as defined below,
  • R 19 and R 20 independently of one another represent hydrogen, halogen, alkyl, alkoxy,
  • the compounds of formula (I) can form salts. Salt formation can be effected by the action of a base on those compounds of the formula (I) which carry an acidic hydrogen atom, for example in the case where R 1 contains a COOH group or a sulfonamide group -NHSO 2 -.
  • suitable bases are organic amines, such as trialkylamines, morpholine, piperidine or pyridine, and ammonium, alkali metal or alkaline earth metal hydroxides, carbonates and
  • bicarbonates in particular sodium and potassium hydroxide, sodium and potassium carbonate and sodium and potassium bicarbonate.
  • These salts are compounds in which the acidic hydrogen is replaced by a cation suitable for agriculture, for example metal salts, in particular
  • Alkali metal salts or alkaline earth metal salts especially sodium and potassium salts, or ammonium salts, salts with organic amines or quaternary
  • alkyl, aryl, aralkyl or alkylaryl in particular alkyl, aryl, aralkyl or alkylaryl.
  • alkylsulfonium and alkylsulfoxonium salts such as (C 1 -C 4 ) -trialkylsulfonium and (C 1 -C 4 ) -trialkylsulfoxonium salts.
  • R 1 is (Ci-C 8) alkyl, (C 2 -C 8) alkenyl, (C 2 -C 8) -alkynyl, (C 2 -C 8) alkenyl (Ci-C 8) - alkyl , (C 2 -C 8) alkynyl (Ci-C 8) alkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, hydroxy (Ci-Cs) alkyl, (C -Cs) -alkylamino, sulfonylamino, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy- (C 1 -C 8 ) -alkyl,
  • R 2 is hydrogen, (C 1 -C 5) -alkyl, nitro (C 1 -C 8 ) -alkyl, hydroxy (C 1 -C 8 ) -alkyl,
  • Cycloalkoxyimino distr (C3-C8) -cycloalkyl (Ci-C8) -alkoximinooeuvre, aryl (Ci-C8) -alkoxyimino distr or a 5-7-membered heterocyclic ring, which may optionally be further substituted, form hydrogen, (Ci -C 8) alkyl, (C 2 -C 8) alkenyl, (C2-C8) alkenyl (Ci-C 8) alkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, (C 1 -C 8 ) -alkylcarbonyl, arylcarbonyl,
  • a 1 , A 2 , A 3 are the same or different and are independently N
  • a 1 and A 2 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
  • R 8 , R 14 , R 15 and R 21 independently of one another each represent hydrogen, nitro, amino, hydroxyl, hydrothio, thiocyanato, isothiocyanato, halogen, (C 1 -C 8 ) -alkyl, (C 3 -C 8 ) -cycloalkyl, ( C 2 -C 8) alkenyl, (C 2 -C 8) alkynyl, aryl, aryl (Ci-C 8) alkyl, aryl (Ci-C 8) alkoxy, heteroaryl, (Ci-Cs) haloalkyl, (Ci-Cs) halocycloalkyl, (Ci-C 8) alkoxy,
  • R 9 and R 10 independently of one another represent hydrogen, halogen, (C 1 -C 8 ) -alkyl, (C 1 -C 6 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl, Aryl- (C 1 -C 6) -alkyl or together with the atom to which they are attached form a carbonyl group,
  • a 4 , A 5 are the same or different and are each independently NR 11 ,
  • Oxygen, sulfur or the group CR 11 but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groupings NR 11 and CR 11 each have the same or different meanings as defined below,
  • R 11 is hydrogen, (C 1 -C 8 ) -alkyl, (C 2 -C 8 ) -alkenyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, ( C 1 -C 8) -alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 8) -cycloalkylcarbonyl, (C 1 -C 8) -alkoxycarbonyl, (C 2 -C 8) -alkenyloxycarbonyl, (C 1 -C 6) -alkoxycarbonyl- (C 1 -C 6) -alkyl , (C 1 -C 6) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, arylaminocarbonyl- (C 1 -C 6) -alkyl
  • R 12 and R 13 independently of one another represent hydrogen, halogen, (C 1 -C 8) -alkyl,
  • a 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N- (C 1 -C 6) -alkyl, (C 1 -C 8 ) -alkoxycarbonyl-N, (Ci -C 8) alkoxy- (Ci-C 8) -alkyl- N, N-aryl, N-heteroaryl, N-heterocyclyl, N-arylsulfonyl, (Ci-Cs) alkylsulfonyl N, (C3-C8) - Cycloalkyls
  • (C 1 -C 6) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 8 ) -alkyl or together with the atom to which they are attached are each a carbonyl group, NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
  • a 12 is NR 18 or the moiety C (R 19 ) R 20 and where R 19 and R 20 in the moiety C (R 19 ) R 20 are as defined below,
  • R 19 and R 20 independently of one another represent hydrogen, halogen, (C 1 -C 5) -alkyl,
  • R 1 is (Ci-C7) alkyl, (C 2 -C 7) alkenyl, (C 2 -C 7) -alkynyl, (C 2 -C 7) alkenyl (Ci-C7) - alkyl , (C 2 -C 7) alkynyl (Ci-C7) alkyl, (Ci-C7) alkoxy (Ci-C7) alkyl, hydroxy (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkylamino, sulfonylamino, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy- (C 1 -C 4 -alkyl) 7 ) ) -alkyl,
  • R 2 is hydrogen, (C 1 -C 7 ) -alkyl, nitro (C 1 -C 7 ) -alkyl, hydroxy- (C 1 -C 7 ) -alkyl,
  • R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
  • R 3 and R 4 are each independently (Ci-C7) alkoxy, (Ci-C7) alkoxy (Ci-C7) - alkoxy, (C 3 -C 7) -cycloalkyl- (Ci-C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkoxy, (C 1 -C 7 ) -
  • R 5 represents hydrogen, (Ci-C7) alkyl, (C 2 -C 7) alkenyl, (C 2 -C 7) alkenyl (Ci-C7) alkyl, (Ci-C7) - Alkoxy- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkylcarbonyl, arylcarbonyl,
  • a 1 , A 2 , A 3 are the same or different and are independently N
  • a 1 and A 2 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
  • a 2 and A 3 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
  • R 8 , R 14 , R 15 and R 21 independently of one another each represent hydrogen, nitro, amino, hydroxyl, hydrothio, thiocyanato, isothiocyanato, halogen, (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkyl, ( C 2 -C 7) alkenyl, (C 2 -C 7) alkynyl, aryl, aryl (Ci-C7) alkyl, aryl (Ci-C7) alkoxy, heteroaryl, (Ci-C 7 ) -haloalkyl, (Ci-C 7) halocycloalkyl, (Ci-C7) alkoxy, (Ci-C7) haloalkoxy, aryloxy, heteroaryloxy, (C3-C7) - cycloalkyloxy, (C3-C7) -Cycloalkyl- (Ci-C 7 ) -alk
  • Arylsulfonylamino, Hetarylsulfonylamino, sulfonyl (Ci-C 7) -haloalkylamino, amino (Ci-C7) alkylsulfonyl, amino (Ci-C 7) haloalkylsulfonyl, (C 7) - alkylaminosulfonyl, bis (C -C 7) alkylaminosulfonyl, (C3-C7) - Cycloalkylaminosulfonyl, (Ci-C 7) -Haloalkylaminosulfonyl, arylaminosulfonyl, aryl- (Ci-C7) alkylaminosulfonyl, (Ci-C7) alkylsulphonyl, (C 3 -C 7) - cycloalkylsulfonyl, arylsulfonyl, (Ci-C 7) al
  • R 9 and R 10 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, heteroaryl, Aryl- (C 1 -C 7 ) -alkyl or together with the atom to which they are attached form a carbonyl group,
  • a 4 , A 5 are the same or different and are each independently NR 11 ,
  • R 11 represents hydrogen, (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkenyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy- (C 1 -C 7 ) -alkyl, (Ci-C 7) alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C3-C7) cycloalkylcarbonyl, (C 7) alkoxycarbonyl, (C2-C7) alkenyloxycarbonyl, (C 7) alkoxycarbonyl (C -C 7) alkyl, (Ci-C 7) alkylaminocarbonyl (Ci-C7) - alky
  • R 12 and R 13 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl,
  • a 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxycarbonyl-N, ( C 1 -C 4 ) -alkoxy- (C 1 -C 7 ) -alkyl-N, N-aryl, N-heteroaryl, N-heterocyclyl, arylsulfonyl-N, (C 1 -C 7 ) -alkylsulfonyl-N, (C 3 -C 7 ) -cycloalkylsulfonyl-N or the group CR 15 , wherein a maximum of two 0 or S atoms are present in the heterocycle, and wherein no 0 or S atoms are adjacent to each other, and wherein R 15 in the group CR 15 each has the same or different meanings according to the above definition and
  • R 16 and R 17 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl,
  • a 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
  • R 18 is hydrogen, (Ci-C7) alkyl, (C 2 -C 7) alkenyl (Ci-C7) alkyl, (Ci-C7) alkoxy (Ci-C7) alkyl , (C 1 -C 7 ) -alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 7 ) Cycloalkylcarbonyl, (C 1 -C 7 ) -alkoxycarbonyl, (C 2 -C 7 ) -alloxycarbonyl, aryloxy- (C 1 -C 7 ) -alkyl, aryl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -haloalkyl, aryl stands,
  • a 11 is N or the group CR 21 and R 21 in the grouping C-R 21 has the meaning given above,
  • a 12 is NR 18 or the moiety C (R 19 ) R 20 and where R 19 and R 20 in the moiety C (R 19 ) R 20 are as defined below,
  • R 19 and R 20 independently of one another represent hydrogen, halogen, (C 1 -C 7) -alkyl,
  • R 1 is (Ci-Ce) alkyl, (C 2 -C 6) alkenyl, (C 2 -C 6) -alkynyl, (C2 -Ce) alkenyl (Ci-Ce) - alkyl, (C2 -C 6) alkynyl (Ci-C 6) alkyl, (Ci-C6) alkoxy (Ci-C 6) alkyl, hydroxy (Ci-Ce) alkyl, (Ci-Ce) - Alkoxy, (C 1 -C 6 ) -haloalkyl,
  • R 2 is hydrogen, (C 1 -C 6 ) -alkyl, hydroxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl,
  • (C 1 -C 6 ) -alkoxy tris - [(C 1 -C 6 ) -alkylsilyl] - (C 1 -C 6 ) -alkyl, cyano- (C 1 -C 6 ) -alkyl, aryl- (C 1 -C 6 ) -alkyl, ( C 1 -C 6 -alkoxycarbonyl- (C 1 -C 6 ) -alkyl,
  • R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
  • R 3 and R 4 independently of one another are methoxy, ethoxy, n-propoxy, isopropoxy, n-butyloxy, iso-butyloxy or, together with the atom to which they are bonded, an oxo group, hydroxyimino group, (C 1 -C 6) Alkoxyimino group, (C 3 -C 6) -cycloalkoxyimino group, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkoximino group, (C 1 -C 6) -alkenyloxy-imino group or a 5-7-membered heterocyclic ring, e.g. B. a 1, 3-Dioxolanyl-, 1, 3-dioxanyl, 1, 3-dithiolanyl, 1, 3-dithianyl, optionally further by (Ci-Ce) -
  • R 5 is hydrogen, tert-butyldimethylsilyl, trimethylsilyl, triethylsilyl, tri (iso-propyl) silyl, tri (n-propyl) silyl, dimethyl (phenyl) silyl, tert-butyldiphenylsilyl, diethylisopropylsilyl, isopropyldimethylsilyl, tert. Hexyldimethylsilyl, 2- (trimethylsilyl) ethoxymethyl, 2- (trimethylsilyl) ethyl,
  • R 6 and R 7 independently of one another represent hydrogen, nitro, amino, cyano,
  • a 1 , A 2 , A 3 are the same or different and are independently N
  • a 1 and A 2 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 bis Form a 6-membered ring
  • a 2 and A 3 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring
  • R 8 , R 14 , R 15 and R 21 are each independently hydrogen, nitro, amino, hydroxy, hydrothio, thiocyanato, isothiocyanato, fluorine, chlorine, bromine, iodine, (Ci-C 6 ) alkyl, (C 3 -C 6) -cycloalkyl, (C 2 -C 6) alkenyl, (C 2 -C 6) alkynyl, ary
  • Alkylaminocarbonylheterocyclyl (C 3 -C 6) -cycloalkylaminocarbonylheterocyclyl, aryl- (C 1 -C 6) -alkylaminocarbonylheterocyclyl, (C 2 -C 6) -
  • R 9 and R 10 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
  • a 4 , A 5 are the same or different and are each independently NR 11 ,
  • Heteroaryl- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, and R 13 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
  • a 6 , A 7 , A 8 , A 9 are identical or different and independently of one another represent 0, S, N, NH, N- (C 1 -C 6 ) - Alkyl, (C 1 -C 6 ) -alkoxycarbonyl-N, (C 1 -C 6 ) -alkoxy- (C 1 -C 6 ) -alkyl-N, N-aryl, N-heteroaryl, N-heterocyclyl, arylsulfonyl-N, ( Ci-Ce) alkylsul
  • a 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
  • R 18 is hydrogen, (C 1 -C 6) -alkyl, (C 2 -C 6) -alkenyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkoxy- (C 1 -C 6) -alkyl, (C 1 -C 6 ) -alkyl C 6 ) -alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 6 ) -cycloalkylcarbonyl, (C 1 -C 6 ) -alkoxycarbonyl, (C 2 -C 6 ) -alloxycarbonyl, aryloxy- (C 1 -C 6 ) -alkyl, aryl- (C 1 -C 6 -cycloalkylcarbonyl) ) -alkyl, (C 1 -C 6 ) -haloalkyl, aryl,
  • a 11 is N or the group CR 21 and R 21 in the grouping C-R 21 has the meaning given above,
  • a 12 is NR 18 or the moiety C (R 19 ) R 20 and where R 19 and R 20 in the moiety C (R 19 ) R 20 are as defined below,
  • R 19 and R 20 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
  • [xY] 1 and [XY] 2 stands for the carbocyclic and heterocyclic moieties Q-1 to Q-4
  • R 1 is methyl, ethyl, n -propyl, n -butyl, iso -butyl, iso -propyl, n -pentyl, n -hexyl, iso-pentyl, cyclopropyl, cyclobutyl, cyclopentyl, 2,2,3,3,3 Pentafluoropropyl, 3,3,2, 2-tetrafluoropropyl, 4,4,4-trifluorobutyl, 1-fluoroethyl, 2-fluoroethyl,
  • R 2 is hydrogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl,
  • R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
  • R 3 and R 4 independently of one another are methoxy, ethoxy or, together with the atom to which they are attached, an oxo group, hydroxyimino group, methoxyimino group, ethoxyimino group, n-propoxyimino group, isopropoxyimino group, n-butyloxyimino group, isobutoxyimine inoè, Cylcopropyloxyim inoadmiadmi, Cylcobutyloxyim inooli,
  • Cylcopropylmethoxyimino group, allyloxyimino group or a 5-7- membered heterocyclic ring e.g. B. a 1, 3-dioxolanyl, 1, 3-Dioxanylring, which optionally further by (Ci-C6) alkyl, (C1-C6) - alkoxycarbonyl, (C3-C6) -cycloalkyl, spiro- (C3-C6 ) -Cycloalkyl, spiro-oxetanyl may be substituted, for hydrogen, tert-butyldimethylsilyl, trimethylsilyl, triethylsilyl, tri (iso-propyl) silyl, tri (n-propyl) silyl, dimethyl (phenyl) silyl, tert Is -butyldiphenylsilyl, diethylisopropylsilyl, isopropyldi
  • Ethylcarbonylamino iso -propylcarbonylamino, n-propylcarbonylamino, n-butylcarbonylamino, tert-butylcarbonylamino, cyclopropylcarbonylamino,
  • a 1 , A 2 , A 3 are the same or different and are independently N
  • a 1 and A 2 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 bis Form a 6-membered ring
  • a 2 and A 3 when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted Form 5 to 6-membered ring,
  • R 14 , R 15 and R 21 independently of one another each represent hydrogen, nitro, amino, hydroxyl, hydrothio, fluorine, chlorine, bromine, iodine, (C 1 -C 5 ) -alkyl, (C 3 -C 6 ) -cycloalkyl, (C 2 -C 5) alkenyl, (C 2 -C 5) alkynyl, aryl, aryl (Ci-C 5) alkyl, aryl (Ci-C 5) alkoxy, heteroaryl, (Ci-C 5) Haloalkyl, (C 1 -C 6 ) -halocycloalkyl, (C 1 -C 5 ) -alkoxy, (C 1 -C 5 ) -haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 6 ) -cycloalkyloxy, (C 3 -C 5 ) -cycloalkyl- ( C 1 -
  • Alkylaminocarbonylheterocyclyl (C 3 -C 6) -cycloalkylaminocarbonylheterocyclyl, aryl- (C 1 -C 5) -alkylaminocarbonylheterocyclyl, (C 2 -C 5) -
  • R 9 and R 10 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, trifluoromethyl, difluoromethyl, 2,2,2-trifluoroethyl, 2,2- Difluor
  • a 4 , A 5 are the same or different and are each independently NR 11 ,
  • Oxygen, sulfur or the group CR 11 but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groupings NR 11 and CR 11 each have the same or different meanings as defined below,
  • R 11 is hydrogen, methyl, ethyl, n-propyl, isopropyl, allyl, methoxymethyl, methylcarbonyl, ethylcarbonyl, isopropylphenyl, n-propylcarbonyl,
  • R 12 and R 13 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
  • a 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N-methyl, N-ethyl, N-isopropyl, Nn-propyl, methoxycarbonyl-N,
  • Ethoxycarbonyl-N iso-propyloxycarbonyl-N, tert-butyloxycarbonyl-N, N-phenyl, N-tetrahydropyranyl, phenylsulfonyl-N, p-methylphenylsulfonyl-N,
  • Methylsulfonyl-N iso-propylsulfonyl-N, cyclopropylsulfonyl-N,
  • Methoxymethyl-N or the group CR 15 wherein a maximum of two 0 or S atoms are present in the heterocycle, and wherein no 0 or S atoms are adjacent to each other, and wherein R 15 in the grouping C-R 15 each same or different meanings according to the
  • R 16 and R 17 independently of one another are hydrogen, fluorine, methyl, ethyl, methoxy, ethoxy, trifluoromethyl, trifluoromethoxy, phenyl or together with the atom to which they are attached form a carbonyl group,
  • a 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
  • R 18 represents hydrogen, methyl, ethyl, n-propyl, isopropyl, allyl, methoxymethyl, methylcarbonyl, ethylcarbonyl, isopropyloxycarbonyl, phenylcarbonyl, cyclopropylcarbonyl, methoxycarbonyl, ethoxycarbonyl, isopropyloxycarbonyl, tert-butyloxycarbonyl, allyloxycarbonyl, phenoxymethyl, Benzyl, trifluoromethyl, difluoromethyl, 2,2,2-trifluoromethyl, 2,2-difluoroethyl, optionally substituted phenyl,
  • a 11 is N or the group CR 21 and R 21 in the grouping C-R 21 has the meaning given above,
  • a 12 is NR 18 or the moiety C (R 19 ) R 20 and wherein R 19 and R 20 in the Group C (R 19 ) R 20 have the meaning as defined below,
  • R 19 and R 20 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
  • Residue definitions apply both to the end products of the formula (I) and also correspondingly to the starting or each preparation required for the preparation
  • R 1 is (Ci-Ce) alkyl, (C 2 -C 8) alkenyl, (C 2 -C 8) -alkynyl, (C 2 -C 8) alkenyl (Ci-C 8) - alkyl, (C 2 -C 8) alkynyl (Ci-C 8) alkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, hydroxy (Ci-Cs) alkyl, (Ci- C 8 ) -alkylamino, sulfonylamino, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy- (C 1 -C 8 ) -alkyl,
  • R 2 is hydrogen, (C 1 -C 5) -alkyl, nitro (C 1 -C 8 ) -alkyl, hydroxy (C 1 -C 8 ) -alkyl,
  • R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
  • R 3 and R 4 are each independently (Ci-Cs) alkoxy, (Ci-C 8) alkoxy (Ci-C 8) - alkoxy, (C 3 -C 8) -cycloalkyl- (Ci-C 8) -alkoxy, (Ci-Cs) -haloalkoxy, (Ci-C 8 ) - alkylthio, (Ci-Cs) haloalkylthio or together with the atom to which they are attached, an oxo group, hydroxyimino group, (Ci-C 8 ) Alkoxyimino group, (C 3 -C 8 ) -cycloalkoxyimino group, (C 3 -C 8 ) -cycloalkyl- (C 1 -C 8 ) -alkoximino group, aryl- (C 1 -C 8 ) -alkoxyimino group or a 5-7 membered heterocyclic ring , which may
  • X is chloro, bromo, iodo, (C 1 -C 9) -haloalkylsulfonyloxy, (C 1 -C 9) -alkylsulfonyloxy.
  • Haloalkoxy amino, alkylamino, alkylcarbonylamino, dialkylamino or
  • cycloalkylsulfonyl alone or as part of a chemical group - is optionally substituted Cycloalkylsulfonyl, preferably having 3 to 6 carbon atoms such as cyclopropylsulfonyl, cyclobutylsulfonyl, cyclopentylsulfonyl or cyclohexylsulfonyl.
  • alkylsulfonyl alone or as part of a chemical group - represents straight-chain or branched alkylsulfonyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, for example methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl and tert-butylsulfonyl.
  • heteroarylsulfonyl is optionally substituted
  • substituted polycyclic heteroarylsulfonyl here in particular optionally substituted quinolinylsulfonyl, for example substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, alkyl, haloalkyl, haloalkoxy, amino, alkylamino,
  • Alkylcarbonylamino, dialkylamino or alkoxy groups Alkylcarbonylamino, dialkylamino or alkoxy groups.
  • alkylthio alone or as part of a chemical group - represents straight-chain or branched S-alkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as, for example, methylthio, ethylthio, n-propylthio, isopropylthio, n- Butylthio, isobutylthio, sec-butylthio and tert-butylthio.
  • Alkenylthio represents an alkenyl radical bonded via a sulfur atom
  • alkynylthio represents an alkynyl radical bonded via a sulfur atom
  • cycloalkylthio represents a cycloalkyl radical bonded via a sulfur atom
  • cycloalkenylthio represents a cycloalkenyl radical bonded via a sulfur atom
  • Alkoxy means an alkyl radical bonded via an oxygen atom
  • alkenyloxy represents an alkynyl radical bonded via an oxygen atom
  • alkynyloxy means an alkynyl radical bonded via an oxygen atom
  • cycloalkyloxy denotes a cycloalkyl radical bonded via an oxygen atom
  • cycloalkenyloxy denotes a cycloalkenyl radical bonded via an oxygen atom.
  • aryl means an optionally substituted mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring C atoms, for example phenyl, naphthyl, anthryl, phenanthrenyl, and the like, preferably phenyl.
  • optionally substituted aryl also includes polycyclic systems, such as tetrahydronaphthyl, indenyl, indanyl, fluorenyl, biphenylyl, the binding site being on the aromatic system.
  • Aryl is also generally known from the term “optionally substituted phenyl ".
  • the heterocyclyl or the heterocyclic ring optionally
  • cyclic systems such as 8-azabicyclo [3.2.1] octanyl, 8-azabicyclo [2.2.2] octanyl or 1-azabicyclo [2.2.1] heptyl.
  • 8-azabicyclo [3.2.1] octanyl 8-azabicyclo [2.2.2] octanyl or 1-azabicyclo [2.2.1] heptyl.
  • optionally substituted heterocydyl also includes spirocyclic systems such as 1-oxa-5-aza-spiro [2.3] hexyl.
  • the heterocyclic ring preferably contains 3 to 9 ring atoms, in particular 3 to 6 ring atoms, and one or more, preferably 1 to 4, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, 0, and S, but not two oxygen atoms should be directly adjacent, such as with a heteroatom from the group N, 0 and S 1 - or 2- or 3-pyrrolidinyl, 3,4-dihydro-2H-pyrrole-2 or 3 -yl, 2,3-dihydro-1H-pyrrole-1 - or 2- or 3- or 4- or 5-yl; 2,5-dihydro-1H-pyrrol-1 - or 2- or 3-yl, 1- or 2- or 3- or 4-piperidinyl; 2,3,4,5-tetrahydropyridine-2- or 3- or 4-
  • Heterocycles are, for example, 1- or 2-aziridinyl, oxiranyl, thiiranyl, 1- or 2- or 3-azetidinyl, 2- or 3-oxetanyl, 2- or 3-thietanyl, 1,3-dioxetan-2-yl.
  • Further examples of “heterocyclyl” are a partially or fully hydrogenated
  • heterocyclic radical having two heteroatoms from the group consisting of N, O and S such as 1- or 2- or 3- or 4-pyrazolidinyl; 4,5-dihydro-3H-pyrazole-3 or 4 or 5-yl; 4,5-dihydro-1H-pyrazole-1 - or 3- or 4- or 5-yl; 2,3-dihydro-1H-pyrazole-1 - or 2- or 3- or 4- or 5-yl; 1 or 2 or 3 or 4 imidazolidinyl; 2,3-dihydro-1H-imidazole-1 - or 2- or 3- or 4-yl; 2,5-dihydro-1H-imidazole-1 - or 2- or 4- or 5-yl; 4,5-dihydro-1H-imidazole-1 - or 2- or 4- or 5-yl; Hexahydropyridazine-1 - or 2- or 3- or 4-yl; 1,2,3,4-tetrahydropyridazine-1 - or 2- or 3- or 4- or 5- or 6-
  • 6-yl 5,6-dihydro-2H-1,3-oxazine-2- or 4- or 5- or 6-yl; 5,6-dihydro-4H-1, 3-oxazine-2 or 4 or 5 or 6-yl; 2H-1, 3-oxazine-2- or 4- or 5- or 6-yl; 6H-1,3-oxazine-2- or 4- or 5- or 6-yl; 4H-1, 3-oxazine-2 or 4 or 5 or 6-yl; Morpholine-2- or 3- or 4-yl; 3,4-dihydro-2H-1,4-oxazine-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1, 4-oxazine-2 or 3 or 5 or 6-yl; 2H-1,4-oxazine-2- or 3- or 5- or 6-yl; 4H-1,4-oxazine-2 or 3-yl; 1, 2-Oxazepan-2 or 3 or
  • 6- or 7-yl 1,3-oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-tetrahydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 4,5,6,7-tetrahydro-1,3,10-oxazepine-2- or 4- or 5- or 6- or 7-yl; 2,3-dihydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-dihydro-1,3-oxa
  • heterocyclyl are a partially or fully hydrogenated heterocyclic radical having 3 heteroatoms from the group N, O and S, such as, for example, 1, 4,2-dioxazolidin-2 or 3 or 5-yl; 1, 4,2-dioxazol-3 or 5-yl; 1,2,2-dioxazinane-2- or -3- or 5- or 6-yl; 5,6-dihydro-1,2,2,2-dioxazine-3- or 5- or 6-yl; 1,2,2-dioxazine-3- or 5- or 6-yl; 1, 4,2-dioxazepan-2 or 3 or 5 or 6 or 7-yl; 6,7-dihydro-5H-1,2,2-dioxazepine-3 or 5 or 6 or 7-yl; 2,3-dihydro-7H-1, 4,2-dioxazepin-2 or 3 or 5 or 6 or
  • Suitable substituents for a substituted heterocyclic radical are the substituents mentioned below, in addition to oxo and thioxo.
  • the oxo group as a substituent on a ring C atom then means, for example, a carbonyl group in the heterocyclic ring.
  • lactones and lactams are preferably also included.
  • the oxo group may also be attached to the hetero ring atoms, which may exist in different oxidation states, e.g. in the case of N and S, for example, the divalent groups N (O), S (O) (also SO for short) and S (O) 2 (also SO2 for short) occur and form in the heterocyclic ring.
  • N and S for example, the divalent groups N (O), S (O) (also SO for short) and S (O) 2 (also SO2 for short) occur and form in the heterocyclic ring.
  • -N (O) and -S (O) groups both enantiomers
  • heteroaryl and “hetaryl” stand for
  • heteroaromatic compounds ie completely unsaturated aromatic heterocyclic compounds, preferably for 5- to 7-membered rings having 1 to 4, preferably 1 or 2 identical or different heteroatoms, preferably O, S or N.
  • Heteroaryls according to the invention are for example 1 H-pyrrole-1 yl; 1H-pyrrol-2-yl; 1H-pyrrol-3-yl; Furan-2-yl; Furan-3-yl; Thien-2-yl; Thien-3-yl, 1H-imidazol-1-yl; 1 H -imidazol-2-yl; 1 H -imidazol-4-yl; 1 H -imidazol-5-yl; 1H-pyrazole-1-yl; 1H-pyrazol-3-yl; 1H-pyrazol-4-yl; 1 H-pyrazol-5-yl, 1 H-1, 2,3-triazol-1-yl, 1 H-1, 2,3-triazol-4-yl, 1 H
  • Heteroaryl groups can furthermore be substituted by one or more, identical or
  • quinolines e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl
  • Isoquinolines e.g., isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl, isoquinolin-8-yl
  • quinoxaline quinazoline
  • cinnoline 1,5-naphthyridine; 1,6-naphthyridine; 1,7-naphthyridine
  • heteroaryl are also 5- or 6-membered benzo-fused rings from the group 1H-indol-1-yl, 1H-indol-2-yl, 1H-indol-3-yl, 1H-indole-4 yl, 1H-indol-5-yl, 1H-indol-6-yl, 1H-indol-7-yl, 1-benzofuran-2-yl, 1-benzofuran-3-yl, 1-benzofuran-4 -yl, 1-benzofuran-5-yl, 1 -
  • halogen means, for example, fluorine, chlorine, bromine or iodine.
  • halogen means, for example, a fluorine, chlorine, bromine or iodine atom.
  • alkyl means a straight-chain or branched one
  • substituents are halogen, alkoxy, haloalkoxy, cyano, alkylthio, haloalkylthio, amino or nitro groups, particularly preferred are methoxy, methyl, fluoroalkyl, cyano, nitro, fluoro, chloro, bromo or iodo.
  • monohaloalkyl such as, for example, CH 2 CH 2 Cl, CH 2 CH 2 Br, CH 3 CH 3, CH 2 Cl, CH 2 F
  • perhaloalkyl such as CCI 3 , CCIF 2 , CFCl 2 , CF 2 CCIF 2 , CF 2 CC
  • Haloalkoxy is eg OCF 3 , OCHF 2 , OCH 2 F, OCF 2 CF 3 , OCH 2 CF 3 and OCH 2 CH 2 Cl; The same applies to haloalkenyl and other halogen-substituted radicals.
  • (C 1 -C 4 ) -alkyl given here by way of example means a
  • Carbon atoms corresponding to the range for C atoms, ie, the radicals include methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl or tert-butyl.
  • General alkyl radicals having a larger specified range of carbon atoms eg. B. "(Ci-C6) -alkyl”, accordingly also include straight-chain or branched alkyl radicals having a larger number of carbon atoms, ie according to Example, the alkyl radicals having 5 and 6 carbon atoms.
  • the lower carbon skeletons for example having 1 to 6 carbon atoms or in unsaturated groups having 2 to 6 carbon atoms, are preferred.
  • Alkyl radicals including in the assembled radicals such as alkoxy, haloalkyl, etc., mean, for example, methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i -Hexyl and 1, 3-dimethylbutyl, heptyls, such as n-heptyl, 1-methylhexyl and 1, 4-dimethylpentyl; Alkenyl and Aikinyireste have the meaning of the alkyl radicals corresponding possible unsaturated radicals, wherein at least one double bond or triple bond is included.
  • radicals having a double bond or triple bond Preference is given to radicals having a double bond or triple bond.
  • alkenyl also includes straight-chain or branched open-chain hydrocarbon radicals having more than one double bond, such as 1,3-butadienyl and 1,4-pentadienyl, but also allenyl or cumulenyl radicals having one or more cumulative double bonds, such as for example, allenyl (1,2-propadienyl), 1,2-butadienyl and 1,2,3-pentatrienyl.
  • Alkenyl is, for example, vinyl, which may be substituted by further alkyl radicals, for example, prop-1-en-1-yl, But-1-en-1-yl, allyl, 1-methyl-prop-2-en-1-yl, 2-methyl-prop-2-en-1-yl, but-2-en-1-yl, 1-methylbut-3-en-1-yl and 1-methylbut-2-en-1-yl, 2-methyl-prop-1 -ene-1-yl,
  • alkynyl in particular also includes straight-chain or branched open-chain hydrocarbon radicals having more than one triple bond or else having one or more triple bonds and one or more
  • C 2 -C 6) -alkynyl is, for example, ethynyl, propargyl, 1-methyl-prop-2-yn-1-yl, 2-butynyl, 2-pentynyl or 2-hexynyl, preferably propargyl, but-2-yn-1 - yl,
  • cycloalkyl means a carbocyclic saturated ring system preferably having 3-8 ring C atoms, eg, cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl
  • substituents are included, with substituents also having a
  • alkylidene group such as methylidene
  • polycyclic aliphatic systems are also included, such as bicyclo [1, 1] -butan-1-yl, bicyclo [1, 1] -butan-2-yl, bicyclo [2.1.0] pentane -1 -yl, bicyclo [2.1.0] pentan-2-yl, bicyclo [2.1.0] pentan-5-yl, bicyclo [2.2.1] hept-2-yl (norbornyl), bicyclo [2.2.2] octan-2-yl, adamantan-1-yl and adamantan-2-yl.
  • (C3-C7) cycloalkyl means a shorthand notation for cycloalkyl having from three to seven carbon atoms corresponding to the range of C atoms.
  • spirocyclic aliphatic systems are also included, such as spiro [2.2] pent-1-yl, spiro [2.3] hex-1-yl,
  • Cycloalkenyl means a carbocyclic, non-aromatic, partial
  • unsaturated ring system having preferably 4-8 C atoms, e.g. 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1 -
  • Cycloalkenylrest As an alkylidene group such as methylidene, are included.
  • alkylidene group such as methylidene
  • substituted cycloalkyl the explanations for substituted cycloalkyl apply correspondingly.
  • Cycloalkylidene means carbocyclic radical bonded via a double bond.
  • stannyl stands for a further substituted radical containing a tin atom
  • “Germanyl” is analogous to a further substituted radical which is a
  • Zeroconyl represents a further substituted radical containing a zirconium atom.
  • Hafnyl represents a further substituted radical containing a hafnium atom.
  • Boryl represents a further substituted radical containing a lead atom.
  • Borolanyl represents a further substituted radical containing a lead atom.
  • Plumbanyl represents a further substituted radical containing a lead atom.
  • Hydrargyl represents a further substituted radical containing a mercury atom
  • Alanyl represents a further substituted radical containing an aluminum atom.
  • Magnnesyl represents a further substituted radical containing a
  • the compounds of the general formula (I) can exist as stereoisomers.
  • the possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, Z and E isomers, are all encompassed by the formula (I). If, for example, one or more alkenyl groups are present, diastereomers (Z and E isomers) can occur. For example, if one or more asymmetric carbon atoms are present, enantiomers and diastereomers may occur.
  • Stereoisomers can be obtained from the resulting mixtures in the preparation by conventional separation methods. The chromatographic separation can be used both on an analytical scale to determine the enantiomeric excess and the
  • Diastereomerenüberschusses as well as on a preparative scale for the production of test samples for biological testing done.
  • Stereoisomers can be selectively prepared by using stereoselective reactions using optically active starting materials and / or auxiliaries.
  • the invention thus also relates to all stereoisomers which comprises the general formula (I), but are not specified with their specific stereoform, and their
  • the further substituted vinyl and alkynylcyclohexenols of the general formula (I) according to the invention can be prepared starting from known processes.
  • the known and structurally related plant natural substance abscisic acid can be obtained on various synthetic routes (compare Hanson et al.
  • the further substituted 1,4-dioxaspiro [4.5] dec-6-ene-8-one can then be added either directly with a lithium acetylide
  • Ethylenediamine complex in a suitable polar aprotic solvent eg., Tetrahydrofuran
  • a suitable polar aprotic solvent eg., Tetrahydrofuran
  • LDA lithium diisopropylamide
  • a suitable polar aprotic solvent eg. B. tetrahydrofuran
  • Trialkylammonium fluoride eg, tetrabutylammonium fluoride
  • a suitable carbonate base e.g. Potassium carbonate
  • a polar protic solvent eg methanol
  • dec-6-en-8-ol The relevant substituted 8-ethynyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol can be obtained by reaction with a suitable silyltrifluoromethanesulfonate reagent
  • a suitable base eg 2,6-lutidine
  • a suitable polar aprotic solvent eg dichloromethane
  • 8-ethynyl-1,4-dioxaspiro [4.5] dec-6-ene -8-yl) oxysilane be transferred.
  • propanediol propanediol
  • the corresponding substituted 9-ethynyl-1, 5-dioxaspiro [5.5] undec-7-en-9-ols can be used in analogous reactions as key intermediates for those described below
  • Alkanediols can be used for the introduction of protective groups.
  • the more substituted 7,9-dimethyl-1,4-dioxaspiro [4.5] deca-6,9-dien-8-one may also be substituted by
  • the substituted 5-ethynyl-4,6-dimethylspiro [bicyclo [4.1.0] hept-3-ene-2,2'- [1,3] dioxolane] -5-ol in question can be prepared by reaction with a suitable
  • Silyl trifluoromethanesulfonate reagent using a suitable base (e.g., 2,6-lutidine) in a suitable polar aprotic solvent (e.g.
  • Arylethynyl, 1-hetarylethynyl, and 1-heterocycloylethynylcyclohex-2-en-1-ols 1 (a) - l (d) transition metal-catalyzed coupling with suitable substituted aryl, cycloalkenyl or heteroaryl halides (see J. Chem. Res. (S), 2003, 426; J. Chem. Soc, Perkin Trans. 1 2001, 47; Synth. Catal. 2005, 347, 872; Synlett 2010, 150; Org. Lett., 2008, 10, 1569; Helv. Chim. Acta 2009, 92, 826, Can. J. Chem. 1993, 71, 983). using a suitable substituted aryl, cycloalkenyl or heteroaryl halides (see J. Chem. Res. (S), 2003, 426; J. Chem. Soc, Perkin Trans. 1 2001, 47; Synth. Catal. 2005
  • Transition metal catalyst system e.g., (bis (triphenylphosphine) palladium dichloride, palladium II) acetate together with triphenylphosphine or bis (Cycloacta-1, 5- dienyl) lridiumchlorid in combination with a bidentate ligand such as 2,2 '- bis (diphenylphosphino) -1, 1-binaphthyl or 1, 4-bis- (diphenylphosphino) butane) and an appropriate copper (I) halide (eg., copper (l) iodide) in a suitable solvent mixture of an amine and a polar aprotic solvent (eg diisopropylamine and toluene or triethylamine and tetrahydrofuran) (Scheme 3).
  • a bidentate ligand such as 2,2 '- bis (diphenylphosphino) -1, 1-binaphthyl or
  • the substituted 1-arylethynyl, 1-hetarylethynyl and 1-heterocycloylethynylcyclohex-2-en-1-ols (a) -l (d) of the invention may also be prepared by reaction of a suitable substituted cyclohexenone with corresponding substituted aryl, Hetaryl or heterocyclyl alkynes can be prepared using a suitable base (e.g., lithium diisopropylamide or n-butyllithium) in a suitable polar aprotic solvent (e.g., tetrahydrofuran) (Scheme 3).
  • a suitable base e.g., lithium diisopropylamide or n-butyllithium
  • a suitable polar aprotic solvent e.g., tetrahydrofuran
  • the substituted (E) -configured 1-arylvinyl- and 1-hetarylvinylcyclohex-2-en-1-ols (e) and 1 (f) according to the invention can be prepared by reduction of the
  • borohydride reagents eg sodium borohydride
  • a suitable polar protic solvent eg.
  • aryl or hetaryl halide in a suitable solvent (eg tetrahydrofuran or ⁇ , ⁇ -dimethylformamide) using suitable transition metal catalysts (eg bis (triphenylphosphine) palladium dicyanide, tetrakis (triphenylphosphine) palladium or bis (triphenylphosphine) palladium
  • a suitable solvent eg tetrahydrofuran or ⁇ , ⁇ -dimethylformamide
  • transition metal catalysts eg bis (triphenylphosphine) palladium dicyanide, tetrakis (triphenylphosphine) palladium or bis (triphenylphosphine) palladium
  • the subject substituted (E) - [M] -1-vinylcyclohex-2-en-1-ols may be reacted with a suitable halogenating agent (e.g., N-bromosuccinimide, N-iodosuccinimide or iodine) in a suitable polar aprotic Solvent (eg dichloromethane) are converted into the corresponding substituted (E) -1-halovinyl-cyclohex-2-en-1-ols II according to the invention, which are then by coupling with an appropriately substituted aryl or Hetarylboronklad
  • Solvent mixture eg dioxane, water and sat.
  • transition metal catalysts e.g., tetrakis (triphenylphosphine) palladium, tris (cyclohexyl) phosphine, [1,1-bis (diphenylphosphino) ferrocene] palladium dichloride, tris
  • reaction mixture was stirred for a further 3 hours at 100.degree. After cooling to room temperature, water and ethyl acetate were added. The aqueous phase was extracted several times thoroughly with ethyl acetate, and the combined organic phases were then dried over magnesium sulfate, filtered and concentrated
  • Lithium acetylide-ethylenediamine complex (6.28 g, 57.96 mmol, 85% content) in abs. Tetrahydrofuran (70 ml) was added. The reaction solution was stirred for 4 h after the addition at room temperature, then treated with water and concentrated under reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase repeatedly with dichloromethane extracted. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure.
  • En-8-ol 160 mg, 0.41 mmol was dissolved under argon in a round bottom flask in acetone (5 ml) and concentrated with 5 drops of conc. Hydrochloric acid added. The resulting
  • Methyl 2 - [(E) -2- (8-hydroxy-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-yl) vinyl] -6 - Methyl benzoate was then dissolved under argon in a round bottom flask in acetone (5 ml) and treated with 5 drops of 10% hydrochloric acid. The resulting
  • Acetylmethylenetriphenylphosphorane (12.91 g, 40.57 mmol) was dissolved in a mixture of diethyl ether (30 ml) and dichloromethane (10 ml), stirred for 5 min with 1,1,1-trifluoroacetone (5.00 g, 44.62 mmol) and allowed to stand for 40 h at
  • 2,6-dimethyl-6- (trifluoromethyl) cyclohex-2-ene-1,4-dione 300 mg, 17% of theory was obtained in the form of a colorless oil.
  • 2,6-Dimethyl-6- (trifluoromethyl) cyclohex-2-ene-1,4-dione 520 mg, 2.52 mmol was dissolved under argon in 2,3-butanediol (4 ml) and with trimethyl orthoformate (0.83 ml, 7.57 mmol) and p-toluenesulfonic acid (30 mg, 0.18 mmol). The resulting reaction mixture was stirred at 50 ° C for 6 hours. After this
  • Tetrahydrofuran (3 ml) was dissolved under argon and added dropwise to a solution of a lithium acetylide-ethylenediamine complex (376 mg, 3.27 mmol, 80% content) in abs. Tetrahydrofuran (5 ml) was added. The reaction solution was stirred for 4 h after the addition at room temperature, then treated with water and subs concentrated reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure.
  • the reaction mixture was stirred for 3 hours at room temperature and then washed with
  • Trimethylsulfoxonium iodide (1.46 g, 6.63 mmol) in N, N-dimethylformamide (5 mL) under argon.
  • the resulting reaction mixture was stirred for 20 minutes at room temperature and then treated with water and methyl tert-butyl ether.
  • the aqueous phase extracted several times with methyl tert-butyl ether, and the combined organic phases were washed with sat.
  • Washed sodium bicarbonate solution dried over magnesium sulfate, filtered and concentrated under reduced pressure.
  • Tetrahydrofuran (3 ml) was dissolved and added dropwise to a solution of a lithium acetylide-ethylenediamine complex (383 mg, 3.74 mmol, 90% content) in abs. Tetrahydrofuran (7 ml) was added. The reaction solution was after completed
  • Tetrahydrofuran (8 ml) was dissolved. The reaction solution was cooled to -78 ° C, with a solution of n-butyllithium in abs. Tetrahydrofuran (1.18 ml) was added and stirred at -78 ° C for 30 minutes. This was followed by the addition of a solution of 5-ethynyl-4,4 ', 5', 6-tetramethylspiro- [bicyclo [4.1.0] hept-3-ene-2,2'- [1,3] dioxolane] -5 -ol (300 mg, 1 .34 mmol) in abs. Tetrahydrofuran (2 ml).
  • the resulting reaction mixture was stirred for 10 minutes at -78 ° C, slowly warmed to 0 ° C and stirred for 2 h at 0 ° C and treated with water.
  • the aqueous phase was extracted several times with dichloromethane.
  • the combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure.
  • dec-6-en-8-ol (260 mg, 0.79 mmol) was dissolved under argon in a round bottom flask in acetone (5 ml) and treated with 5 drops of 10% hydrochloric acid. The resulting
  • Toluene sulfonic acid (1 .22 g, 7.08 mmol) was added. The resulting reaction mixture was stirred at 50 ° C for 7 hours. After cooling to room temperature, the addition of water and toluene and the multiple extraction of the aqueous phase with toluene. The combined organic phases were over
  • Lithium acetylide-ethylenediamine complex (6.28 g, 57.96 mmol, 85% content) in abs. Tetrahydrofuran (70 ml) was added. The reaction solution was stirred for 4 h after the addition at room temperature, then treated with water and concentrated under reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure.
  • Tetrahydrofuran (1 ml) and diisopropylamine (1.29 ml, 9.2 mmol) were added.
  • Ethyl acetate / heptane gradient was ethyl 2 - [(8-hydroxy-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-yl) ethynyl] cyclopent -1 -ene-1-carboxylate (139 mg, 39% of theory) in the form of a colorless oil.
  • Tetrakis (triphenylphosphine) palladium (0) (231 mg, 0.20 mmol) was placed under argon in a heated round bottom flask and washed with abs. Tetrahydrofuran (25 ml) and 8-ethynyl-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (1 .0 g, 3.99 mmol) were added. After stirring for 5 minutes at room temperature, the addition was made of tributyltin hydride (1.29 mL, 4.79 mmol). The resulting reaction mixture was stirred for 1 h at room temperature and then treated with water. The aqueous phase was extracted several times thoroughly with dichloromethane and the combined organic phases were then dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final
  • Tetrahydrofuran (5 ml) was dissolved and added dropwise to a solution of a Lithiumacetylid-ethylenediamine complex (507 mg, 4.95 mmol, 90% content) in abs. Tetrahydrofuran (10 ml) was added. The reaction solution was stirred for 4 h after the addition at room temperature, then treated with water and concentrated under reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure.
  • Tetrakis (triphenylphosphine) palladium (0) (231 mg, 0.20 mmol) was placed under argon in a heated round bottom flask and washed with abs. Tetrahydrofuran (25 ml) and 8-ethynyl-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (1 .0 g, 3.99 mmol) were added. After stirring for 5 minutes at room temperature, tributyltin hydride (1.29 ml, 4.79 mmol) was added. The resulting reaction mixture was stirred for 1 h at room temperature and then treated with water. The aqueous phase was extracted several times thoroughly with dichloromethane and the combined organic phases were then dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final
  • SiEt 3 o : Q-1.7 R 2 R 5 R 3 R 4 XY Q

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to substituted vinyl and alkinyl cyclohexenols of general formula (I) and the salts thereof, in which the radicals R1, R2, R3, R4, R5, [X-Y] and Q have the definitions specified in the description, to methods for the production thereof and the use thereof for enhancing stress tolerance in plants against abiotic stress and/or for increasing plant yield.

Description

Substituierte Vinyl- und Alkinyl-cyclohexenole als Wirkstoffe gegen abiotischen Pflanzenstress  Substituted vinyl and alkynyl cyclohexenols as active ingredients against abiotic plant stress
Beschreibung description
Die Erfindung betrifft substituierte Vinyl- und Alkinyl-cyclohexenole, Verfahren zu deren Herstellung und ihre Verwendung zur Steigerung der Stresstoleranz in The invention relates to substituted vinyl and alkynylcyclohexenols, processes for their preparation and their use for increasing the stress tolerance in
Pflanzen gegenüber abiotischem Stress, zur Stärkung des Pflanzenwachstums und/oder zur Erhöhung des Pflanzenertrags. Plants against abiotic stress, to enhance plant growth and / or increase plant yield.
Es ist bekannt, dass bestimmte 5-(1 ,2-Epoxy-2,6,6-trimethylcyclohexyl)-3- methylpenta-2,4-diensäuren und ihre Derivate Eigenschaften besitzen, die den Pflanzenwuchs beeinflussen (vgl. NL681 1769). Der wuchsbeeinflussende Effekt bestimmter 1 ,2-Epoxyanaloga von Abscisinsäure auf Reissetzlinge wird außerdem in Agr. Biol. Chem. 1969, 33, 1357 und Agr. Biol. Chem. 1970, 34, 1393 beschrieben. Die Verwendung von substituierten 5-Cyclohex-2-en-1 -ylpenta-2,4-dienyl- und 5- Cyclohex-2-en-1 -ylpent-2-en-4-inyl-olen, -thioethern und am inen als Inhibitoren der Epoxycarotenoiddioxygenase und als Keimungsinhibitoren wird in US2010/0160166 beschrieben. Die Herstellung von bestimmten Abscisinsäurederivaten mit 3- Methylsubstituent in der 2,4-Pentadiensäureeinheit und ihre Verwendung zur Beeinflussung der Keimung und des Pflanzenwuchses wird in US5518995 und EP0371882 beschrieben. Es ist weiter bekannt, dass bestimmte It is known that certain 5- (1,2-epoxy-2,6,6-trimethylcyclohexyl) -3-methylpenta-2,4-dienoic acids and their derivatives possess properties which influence plant growth (see NL681 1769). The growth-influencing effect of certain 1,2-epoxy analogues of abscisic acid on rice seedlings is also reported in Agr. Biol. Chem. 1969, 33, 1357 and Agr. Biol. Chem. 1970, 34, 1393. The use of substituted 5-cyclohex-2-en-1 -ylpenta-2,4-dienyl and 5-cyclohex-2-en-1-yl-pent-2-en-4-ynyl-ols, -thioethers and amines as inhibitors of Epoxycarotenoiddioxygenase and as germination inhibitors is described in US2010 / 0160166. The preparation of certain abcisic acid derivatives having 3-methyl substituent in the 2,4-pentadienoic acid unit and their use for influencing germination and plant growth is described in US5518995 and EP0371882. It is further known that certain
Abscisinsäurederivate mit 3-Methylsubstituent zur Erhöhung der Toleranz von Pflanzen gegenüber niedrigen Temperaturen verwendet werden können (vgl.  Abscisic acid derivatives with 3-methyl substituent can be used to increase the tolerance of plants to low temperatures (cf.
W094/15467). Die Erhöhung der Ausbeute an Sojabohnensamen durch W094 / 15467). Increasing the yield of soybean seeds by
Verwendung eines Gemisches aus Abscisinsäure und einem geeigneten Dünger wird in US4581057 beschrieben. Use of a mixture of abscisic acid and a suitable fertilizer is described in US4581057.
Es ist ebenfalls bekannt, daß 5-(Cyclohex-2-en-1 -yl)-3-methylpenta-2,4- diensäurederivate mit ungesättigten Substituenten an Position C6 der 5-Cyclohex-2- en-1 -yl-Einheit den Wasserhaushalt und die Keimung von Pflanzen beeinflussen können (vgl. W097/23441 ). Weiterhin sind Trifluormethyl-, Alkyl- und It is also known that 5- (cyclohex-2-en-1-yl) -3-methylpenta-2,4-dienoic acid derivatives having unsaturated substituents at position C6 of the 5-cyclohex-2-en-1-yl moiety Water balance and germination of plants influence can (see W097 / 23441). Furthermore, trifluoromethyl, alkyl and
Methoxymethyl-Substituenten an Position C6 der 5-Cyclohex-2-en-1 -yl-Einheit in 5- (Cyclohex-2-en-1 -yl)-3-methylpenta-2,4-diensäuren beschrieben (vgl. Biosci. Methoxymethyl substituents at position C6 of 5-cyclohex-2-en-1-yl-unit in 5- (cyclohex-2-en-1-yl) -3-methylpenta-2,4-dienoic acids described (see Biosci.
Biotech. Biochem. 1994, 58, 707; Biosci. Biotech. Biochem. 1995, 59, 699; Biotech. Biochem. 1994, 58, 707; Biosci. Biotech. Biochem. 1995, 59, 699;
Phytochem. 1995, 38, 561 ; Bioorg. Med. Chem. Lett. 1995, 5, 275). Bicyclische Tetralon-basierte 3-Methylpenta-2,4-diensäurederivate sind in WO2005108345 beschrieben. Phytochem. 1995, 38, 561; Bioorg. Med. Chem. Lett. 1995, 5, 275). Bicyclic tetralone-based 3-methylpenta-2,4-dienoic acid derivatives are described in WO2005108345.
Es ist außerdem bekannt, dass Abscisinsäure und ihre Derivate als It is also known that abscisic acid and its derivatives as
pharmazeutische Wirkstoffe zur Regulierung des Calciumtransports eingesetzt werden können (vgl. EP240257). Pharmaceutical agents can be used to regulate the transport of calcium (see EP240257).
Die Herstellung von 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]benzoesäure, dem analogen Methylester Methyl-2-[(E)-2-(1 -hydroxy-2,6,6- trimethyl-4-oxocyclohex-2-en-1 -yl)vinyl]benzoat sowie den entsprechenden The preparation of 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid, the analogous methyl ester methyl-2 - [( E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoate and the corresponding
Hydroxymethyl- und Aldehydvorstufen und deren Wirkung auf das Hydroxymethyl and aldehyde precursors and their effect on the
Keimungsverhalten von Salatkeimen ist in Agric. Biol. Chem. 1986, 50, 1097 beschrieben. 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]benzoesäure wird ebenfalls in Biosci. Biotech. Biochem. 1992, 56, 624 beschrieben. Germination behavior of lettuce is in Agric. Biol. Chem. 1986, 50, 1097. 2 - [(E) -2- (1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid is also disclosed in Biosci. Biotech. Biochem. 1992, 56, 624.
Es ist bekannt, dass Pflanzen auf natürliche Stressbedingungen, wie beispielsweise Kälte, Hitze, Trockenstress (Stress verursacht durch Trockenheit und/oder It is known that plants are susceptible to natural stress conditions such as cold, heat, drought stress (stress caused by dryness and / or
Wassermangel), Verwundung, Pathogenbefall (Viren, Bakterien, Pilze, Insekten) etc. aber auch auf Herbizide mit spezifischen oder unspezifischen Abwehrmechanismen reagieren können [Pflanzenbiochemie, S. 393-462 , Spektrum Akademischer Verlag, Heidelberg, Berlin, Oxford, Hans W. Heidt, 1996.; Biochemistry and Molecular Biology of Plants, S. 1 102-1203, American Society of Plant Physiologists, Rockville, Maryland, eds. Buchanan, Gruissem, Jones, 2000]. Lack of water), wounding, pathogen infestation (viruses, bacteria, fungi, insects) etc. but also can react to herbicides with specific or nonspecific defense mechanisms [Plant Biochemistry, pp. 393-462, Spektrum Akademischer Verlag, Heidelberg, Berlin, Oxford, Hans W. Heidt, 1996; Biochemistry and Molecular Biology of Plants, p. 1 102-1203, American Society of Plant Physiologists, Rockville, Maryland, eds. Buchanan, Gruissem, Jones, 2000].
In Pflanzen sind zahlreiche Proteine und die sie codierenden Gene bekannt, die an Abwehrreaktionen gegen abiotischen Stress (z.B. Kälte, Hitze, Trockenheit, Salz, Überflutung) beteiligt sind. Diese gehören teilweise zu Signaltransduktionsketten (z.B. Transkriptionsfaktoren, Kinasen, Phosphatasen) oder bewirken eine physiologische Antwort der Pflanzenzelle (z.B. lonentransport, Entgiftung reaktiver Sauerstoff-Spezies). Zu den Signalkettengenen der abiotischen Stressreaktion gehören u.a. Transkriptionsfaktoren der Klassen DREB und CBF (Jaglo-Ottosen et al., 1998, Science 280: 104-106). An der Reaktion auf Salzstress sind Phosphatasen vom Typ ATPK und MP2C beteiligt. Ferner wird bei Salzstress häufig die In plants numerous proteins and their coding genes are known, which are involved in defense reactions against abiotic stress (eg cold, heat, drought, salt, flooding). These belong partly to signal transduction chains (eg transcription factors, kinases, phosphatases) or cause a physiological response of the plant cell (eg ion transport, detoxification of reactive oxygen species). The signal chain genes of the abiotic stress reaction include transcription factors of classes DREB and CBF (Jaglo-Ottosen et al., 1998, Science 280: 104-106). The response to salt stress involves phosphatases of the ATPK and MP2C types. Furthermore, in Salzstress often the
Biosynthese von Osmolyten wie Prolin oder Sucrose aktiviert. Beteiligt sind hier z.B. die Sucrose-Synthase und Prolin-Transporter (Hasegawa et al., 2000, Annu Rev Plant Physiol Plant Mol Biol 51 : 463-499). Die Stressabwehr der Pflanzen gegen Kälte und Trockenheit benutzt z.T. die gleichen molekularen Mechanismen. Bekannt ist die Akkumulation von sogenannten Late Embryogenesis Abundant Proteins (LEA- Proteine), zu denen als wichtige Klasse die Dehydrine gehören (Ingram and Bartels, 1996, Annu Rev Plant Physiol Plant Mol Biol 47: 277-403, Close, 1997, Physiol Plant 100: 291 -296). Es handelt sich dabei um Chaperone, die Vesikel, Proteine und Membranstrukturen in gestressten Pflanzen stabilisieren (Bray, 1993, Plant Physiol 103: 1035-1040). Außerdem erfolgt häufig eine Induktion von Aldehyd- Deydrogenasen, welche die bei oxidativem Stress entstehenden reaktiven Biosynthesis of osmolytes such as proline or sucrose activated. Involved here are e.g. the sucrose synthase and proline transporters (Hasegawa et al., 2000, Annu Rev Plant Physiol Plant Mol Biol 51: 463-499). The stress defense of the plants against cold and drought uses z.T. the same molecular mechanisms. The accumulation of so-called Late Embryogenesis Abundant Proteins (LEA proteins), which include dehydrins as an important class, is known (Ingram and Bartels, 1996, Annu Rev Plant Physiol Plant Mol Biol 47: 277-403, Close, 1997, Physiol Plant 100: 291-296). These are chaperones that stabilize vesicles, proteins and membrane structures in stressed plants (Bray, 1993, Plant Physiol 103: 1035-1040). In addition, induction of aldehyde dehydrogenases often occurs, which are reactive oxidative stress
Sauerstoff-Spezies (ROS) entgiften (Kirch et al., 2005, Plant Mol Biol 57: 315-332). Heat Shock Faktoren (HSF) und Heat Shock Proteine (HSP) werden bei Hitzestress aktiviert und spielen hier als Chaperone eine ähnliche Rolle wie die Dehydrine bei Kälte- und Trockenstress (Yu et al., 2005, Mol Cells 19: 328-333). Detoxify oxygen species (ROS) (Kirch et al., 2005, Plant Mol Biol 57: 315-332). Heat Shock Factors (HSF) and Heat Shock Proteins (HSP) are activated by heat stress and act as chaperones in a similar role to dehydrins in cold and dry stress (Yu et al., 2005, Mol Cells 19: 328-333).
Eine Reihe von pflanzenendogenen Signalstoffen, die in die Stresstoleranz bzw. die Pathogenabwehr involviert sind, sind bereits bekannt. Zu nennen sind hier A number of plant endogenous signaling substances involved in stress tolerance and pathogen defense are already known. To call here are
beispielsweise Salicylsäure, Benzoesäure, Jasmonsäure oder Ethylen [Biochemistry and Molecular Biology of Plants, S. 850-929, American Society of Plant for example, salicylic acid, benzoic acid, jasmonic acid or ethylene [Biochemistry and Molecular Biology of Plants, p. 850-929, American Society of Plant
Physiologists, Rockville, Maryland, eds. Buchanan, Gruissem, Jones, 2000]. Einige dieser Substanzen oder deren stabile synthetische Derivate und abgeleitete Physiologists, Rockville, Maryland, eds. Buchanan, Gruissem, Jones, 2000]. Some of these substances or their stable synthetic derivatives and derived
Strukturen sind auch bei externer Applikation auf Pflanzen oder Saatgutbeizung wirksam und aktivieren Abwehrreaktionen, die eine erhöhte Stress- bzw. Structures are also effective in external application to plants or seed dressing and activate defense reactions that increased stress or
Pathogentoleranz der Pflanze zur Folge haben [Sembdner, and Parthier, 1993, Ann. Rev. Plant Physiol. Plant Mol. Biol. 44: 569-589]. Es ist weiter bekannt, dass chemische Substanzen die Toleranz von Pflanzen gegen abiotischen Stress erhöhen können. Derartige Substanzen werden dabei entweder durch Saatgut-Beizung, durch Blattspritzung oder durch Bodenbehandung appliziert. So wird eine Erhöhung der abiotischen Stresstoleranz von Kulturpflanzen durch Behandlung mit Elicitoren der System ic Acquired Resistance (SAR) oder Pathogen tolerance of the plant [Sembdner, and Parthier, 1993, Ann. Rev. Plant Physiol. Plant Mol. Biol. 44: 569-589]. It is also known that chemical substances can increase the tolerance of plants to abiotic stress. Such substances are applied either by seed dressing, by foliar spraying or by soil treatment. Thus, an increase in the abiotic stress tolerance of crops by treatment with elicitors of System ic Acquired Resistance (SAR) or
Abscisinsäure-Derivaten beschrieben (Schading and Wei, WO200028055; Churchill et al., 1998, Plant Growth Regul 25: 35-45). Desweiteren wurden Effekte von Abscisic acid derivatives (Schading and Wei, WO200028055, Churchill et al., 1998, Plant Growth Regul 25: 35-45). Furthermore, effects of
Wachstumsregulatoren auf die Stresstoleranz von Kulturpflanzen beschrieben (Morrison and Andrews, 1992, J Plant Growth Regul 1 1 : 1 13-1 17, RD-259027). In diesem Zusammenhang ist ebenfalls bekannt, dass ein wachstumsregulierendes Naphthylsulfonamid (4-Brom-N-(pyridin-2-ylmethyl)naphthalin-1 -Sulfonamid) die Keimung von Pflanzensamen in der gleichen Weise wie Abscisinsäure beeinflusst (Park et al. Science 2009, 324, 1068-1071 ). Außerdem ist bekannt, dass ein weiteres Naphthylsulfonamid, N-(6-aminohexyl)-5-chlornaphthalin-1 -Sulfonamid, den Calcium-Spiegel in Pflanzen beeinflusst, die einem Kälteschock ausgesetzt wurden (Cholewa et al. Can. J. Botany 1997, 75, 375-382). Growth regulators on the stress tolerance of crops described (Morrison and Andrews, 1992, J Plant Growth Regul 1 1: 1 13-1 17, RD-259027). In this connection, it is also known that a growth-regulating naphthylsulfonamide (4-bromo-N- (pyridin-2-ylmethyl) naphthalene-1-sulfonamide) influences the germination of plant seeds in the same way as abscisic acid (Park et al., Science 2009, 324, 1068-1071). In addition, it is known that another naphthylsulfonamide, N- (6-aminohexyl) -5-chloronaphthalene-1-sulfonamide, affects calcium levels in plants that have been cold shocked (Cholewa et al., Can. J. Botany 1997, Vol. 75, 375-382).
Auch bei Anwendung von Fungiziden, insbesondere aus der Gruppe der Strobilurine oder der Succinat Dehydrogenase Inhibitoren werden ähnliche Effekte beobachtet, die häufig auch mit einer Ertragssteigerung einhergehen (Draber et al., DE3534948, Bartlett et al., 2002, Pest Manag Sei 60: 309). Es ist ebenfalls bekannt, dass das Herbizid Glyphosat in niedriger Dosierung das Wachstum einiger Pflanzenarten stimuliert (Cedergreen, Env. Pollution 2008, 156, 1099). Similar effects are observed even when using fungicides, in particular from the group of strobilurins or succinate dehydrogenase inhibitors, which are often accompanied by an increase in yield (Draber et al., DE3534948, Bartlett et al., 2002, Pest Management, 60: 309 ). It is also known that the low dose herbicide glyphosate stimulates the growth of some plant species (Cedergreen, Env. Pollution 2008, 156, 1099).
Bei osmotischem Stress ist eine Schutzwirkung durch Applikation von Osmolyten wie z.B. Glycinbetain oder deren biochemischen Vorstufen, z.B. Cholin-Derivate beobachtet worden (Chen et al., 2000, Plant Cell Environ 23: 609-618, Bergmann et al., DE4103253). Auch die Wirkung von Antioxidantien wie z.B Naphtole und At osmotic stress, a protective effect is provided by the application of osmolytes, e.g. Glycine betaine or its biochemical precursors, e.g. Choline derivatives have been observed (Chen et al., 2000, Plant Cell Environ 23: 609-618, Bergmann et al., DE4103253). Also, the effect of antioxidants such as Naphtole and
Xanthine zur Erhöhung der abiotischen Stresstoleranz in Pflanzen wurde bereits beschrieben (Bergmann et al., DD277832, Bergmann et al., DD277835). Die molekularen Ursachen der Anti-Stress-Wirkung dieser Substanzen sind jedoch weitgehend unbekannt. Xanthines for increasing the abiotic stress tolerance in plants has already been described (Bergmann et al., DD277832, Bergmann et al., DD277835). The However, the molecular causes of the anti-stress effects of these substances are largely unknown.
Es ist weiter bekannt, dass die Toleranz von Pflanzen gegenüber abiotischem Stress durch eine Modifikation der Aktivität von endogenen Poly-ADP-ribose Polymerasen (PARP) oder Poly-(ADP-ribose) glycohydrolasen (PARG) erhöht werden kann (de Block et al., The Plant Journal, 2004, 41 , 95; Levine et al., FEBS Lett. 1998, 440, 1 ; WO0004173; WO04090140). Somit ist bekannt, dass Pflanzen über mehrere endogene Reaktionsmechanismen verfügen, die eine wirksame Abwehr gegenüber verschiedensten Schadorganismen und/oder natürlichem abiotischem Stress bewirken können. It is further known that the tolerance of plants to abiotic stress can be increased by a modification of the activity of endogenous poly-ADP-ribose polymerases (PARP) or poly (ADP-ribose) glycohydrolases (PARG) (de Block et al. , The Plant Journal, 2004, 41, 95; Levine et al., FEBS Lett. 1998, 440, 1, WO0004173, WO04090140). Thus, it is known that plants have several endogenous reaction mechanisms that can effectively prevent various harmful organisms and / or natural abiotic stress.
Da sich die ökologischen und ökonomischen Anforderungen an moderne As the environmental and economic demands on modern
Pflanzenbehandlungsmittel laufend erhöhen, beispielsweise was Toxizität, Continuously increase plant protection products, for example, toxicity,
Selektivität, Aufwandmenge, Rückstandsbildung und günstige Herstellbarkeit angeht, besteht die ständige Aufgabe, neue Pflanzenbehandlungsmittel zu entwickeln, die zumindest in Teilbereichen Vorteile gegenüber den bekannten aufweisen. As regards selectivity, application rate, formation of residues and favorable manufacturability, there is the constant task of developing new plant treatment agents which, at least in some areas, have advantages over the known ones.
Daher bestand die Aufgabe der vorliegenden Erfindung darin, weitere Verbindungen bereitzustellen, die die Toleranz gegenüber abiotischem Stress in Pflanzen erhöhen, insbesondere eine Stärkung des Pflanzenwachstums bewirken und/oder zur The object of the present invention was therefore to provide further compounds which increase the tolerance to abiotic stress in plants, in particular effect and / or enhance plant growth
Erhöhung des Pflanzenertrags beitragen. Increase in crop yield contribute.
Gegenstand der vorliegenden Erfindung sind demnach substituierte Vinyl- und Alkinyl-cyclohexenole der allgemeinen Formel (I) oder deren Salze, The present invention accordingly provides substituted vinyl and alkynylcyclohexenols of the general formula (I) or salts thereof,
(I)(I)
wobei in which
[X-Y] für die Gruppierungen [X-Y] for the groupings
[X-Y]1 [χ-γ [x-Y]3 und [x-Y]4 ste ht [XY] 1 [χ-γ [XY] 3 and [XY] 4 ste ht
Q für die carbocyclischen und heterocyclischen Gruppierungen Q-1 bis Q-4 Q for the carbocyclic and heterocyclic moieties Q-1 to Q-4
steht, wobei die Gruppierungen R6 bis R21 und A1 bis A12 jeweils die Bedeutung gemäß der nachstehenden Definitionen haben und wobei der Pfeil für eine Bindung zur jeweiligen Gruppierung [X-Y] steht, für Alkyl, Alkenyl, Alkinyl, Alkenylalkyl, Alkinylalkyl, Alkoxyalkyl, Hydroxyalkyl, Alkylamino, Sulfonylamino, Alkoxy, Haloalkyl, Haloalkoxyalkyl steht, für Wasserstoff, Alkyl, Nitroalkyl, Hydroxyalkyl, Haloalkyl, Alkylamino, where the groups R 6 to R 21 and A 1 to A 12 are each as defined below and wherein the arrow represents a bond to the respective group [XY], Alkoxyalkyl, hydroxyalkyl, alkylamino, sulphonylamino, alkoxy, haloalkyl, haloalkoxyalkyl, represents hydrogen, alkyl, nitroalkyl, hydroxyalkyl, haloalkyl, alkylamino,
Sulfonylamino, Alkoxy, Trialkylsilylalkyl, Cyanoalkyl, Arylalkyl,  Sulfonylamino, alkoxy, trialkylsilylalkyl, cyanoalkyl, arylalkyl,
Alkoxycarbonylalkyl, Haloalkoxycarbonylalkyl, Alkylthioalkyl, Arylthioalkyl steht,  Alkoxycarbonylalkyl, haloalkoxycarbonylalkyl, alkylthioalkyl, arylthioalkyl,
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden, R3 und R4 unabhängig voneinander für Alkoxy, Alkoxyalkoxy, Cycloalkylalkoxy,R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring, R 3 and R 4 independently of one another represent alkoxy, alkoxyalkoxy, cycloalkylalkoxy,
Haloalkoxy, Alkylthio, Haloalkylthio stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, Haloalkoxy, alkylthio, haloalkylthio or, together with the atom to which they are attached, an oxo group, hydroxyimino group,
Alkoxyiminogruppe, Cycloalkoxyiminogruppe, Cycloalkylalkoximinogruppe, , Alkenyloximinogruppe, Aryl-(Ci-C8)-alkoxyiminogruppe oder einen 5-7- gliedrigen heterocyclischen Ring, der gegebenenfalls weiter substituiert sein kann, bilden  Alkoxyimino group, cycloalkoxyimino group, cycloalkylalkoximino group, alkenyloxyimino group, aryl- (C 1 -C 8) -alkoxyimino group or a 5-7 membered heterocyclic ring, which may optionally be further substituted
R5 für Wasserstoff, Alkyl, Alkenyl, Alkenylalkyl, Alkoxyalkyl, Alkylcarbonyl, R 5 is hydrogen, alkyl, alkenyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl,
Arylcarbonyl, Heteroarylcarbonyl, Cycloalkylcarbonyl, Alkoxycarbonyl, Allyloxycarbonyl, Aryloxyalkyl, Arylalkyl, Alkoxyalkoxy alkyl, Alkylthioalkyl, Trialkylsilyl, Alkyl(Bis-alkyl)silyl, Alkyl(Bis-Aryl)silyl, Aryl(Bis-alkyl)silyl,  Arylcarbonyl, heteroarylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, allyloxycarbonyl, aryloxyalkyl, arylalkyl, alkoxyalkoxyalkyl, alkylthioalkyl, trialkylsilyl, alkyl (bis-alkyl) silyl, alkyl (bis-aryl) silyl, aryl (bis-alkyl) silyl,
Cycloalkyl(Bis-alkyl)silyl, Halo(Bis-alkyl)silyl, Trialkylsilylalkoxyalkyl steht,  Cycloalkyl (bis-alkyl) silyl, halo (bis-alkyl) silyl, trialkylsilylalkoxyalkyl,
R6 und R7 unabhängig voneinander für Wasserstoff, Nitro, Amino, Cyano, R 6 and R 7 independently of one another represent hydrogen, nitro, amino, cyano,
Thiocyanato, Isothiocyanato, Halogen, Alkyl, Cycloalkyl, Alkenyl, Alkinyl, Aryl, Arylalkyl, Alkenylalkyl, Alkinylalkyl, Arylalkoxy, Heteroaryl, Alkoxyalkyl, Hydroxyalkyl, Haloalkyl, Halocycloalkyl, Alkoxy, Haloalkoxy, Aryloxy,  Thiocyanato, isothiocyanato, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, alkenylalkyl, alkynylalkyl, arylalkoxy, heteroaryl, alkoxyalkyl, hydroxyalkyl, haloalkyl, halocycloalkyl, alkoxy, haloalkoxy, aryloxy,
Heteroaryloxy, Cycloalkyloxy, Hydroxy, Cycloalkylalkoxy, Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, Alkylaminocarbonyl,  Heteroaryloxy, cycloalkyloxy, hydroxy, cycloalkylalkoxy, alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, alkylaminocarbonyl,
Cycloalkylaminocarbonyl, Cyanoalkylaminocarbonyl, Alkenylaminocarbonyl, Alkinylaminocarbonyl, Alkylamino, Alkylthio, Haloalkylthio, Hydrothio,  Cycloalkylaminocarbonyl, cyanoalkylaminocarbonyl, alkenylaminocarbonyl, alkynylaminocarbonyl, alkylamino, alkylthio, haloalkylthio, hydrothio,
Bisalkylamino, Cycloalkylamino, Alkylcarbonylamino,  Bisalkylamino, cycloalkylamino, alkylcarbonylamino,
Cycloalkylcarbonylamino, Formylamino, Haloalkylcarbonylamino,  Cycloalkylcarbonylamino, formylamino, haloalkylcarbonylamino,
Alkoxycarbonylamino, Alkylaminocarbonylamino, Alkyl(Alkyl- )aminocarbonylamino, Alkylsulfonylamino, Cycloalkylsulfonylamino,  Alkoxycarbonylamino, alkylaminocarbonylamino, alkyl (alkyl) aminocarbonylamino, alkylsulfonylamino, cycloalkylsulfonylamino,
Arylsulfonylamino, Hetarylsulfonylamino, Sulfonylhaloalkylamino,  Arylsulfonylamino, hetarylsulfonylamino, sulfonylhaloalkylamino,
Aminosulfonyl, Aminoalkylsulfonyl, Aminohaloalkylsulfonyl,  Aminosulfonyl, aminoalkylsulfonyl, aminohaloalkylsulfonyl,
Alkylaminosulfonyl, Bisalkylaminosulfonyl, Cycloalkylaminosulfonyl,  Alkylaminosulfonyl, bisalkylaminosulfonyl, cycloalkylaminosulfonyl,
Haloalkylaminosulfonyl, Arylaminosulfonyl, Arylalkylaminosulfonyl,  Haloalkylaminosulfonyl, arylaminosulfonyl, arylalkylaminosulfonyl,
Alkylsulfonyl, Cycloalkylsulfonyl, Arylsulfonyl, Alkylsulfinyl, Cycloalkylsulfinyl, Arylsulfinyl, N,S-Dialkylsulfonimidoyl, S-Alkylsulfonimidoyl, Alkylsulfonyl, cycloalkylsulfonyl, arylsulfonyl, alkylsulfinyl, cycloalkylsulfinyl, Arylsulfinyl, N, S-dialkylsulfonimidoyl, S-alkylsulfonimidoyl,
Alkylsulfonylaminocarbonyl, Cycloalkylsulfonylaminocarbonyl,  Alkylsulfonylaminocarbonyl, cycloalkylsulfonylaminocarbonyl,
Cycloalkylaminosulfonyl, Arylalkylcarbonylamino,  Cycloalkylaminosulfonyl, arylalkylcarbonylamino,
Cycloalkylalkylcarbonylamino, Heteroarylcarbonylamino,  Cycloalkylalkylcarbonylamino, heteroarylcarbonylamino,
Alkoxyalkylcarbonylamino, Hydroxyalkylcarbonylamino, Trialkylsilyl stehen,  Alkoxyalkylcarbonylamino, hydroxyalkylcarbonylamino, trialkylsilyl,
A1, A2, A3 gleich oder verschieden sind und unabhängig voneinander für N A 1 , A 2 , A 3 are the same or different and are independently N
(Stickstoff) oder die Gruppierung C-R8 stehen, wobei jedoch in keinem Fall mehr als zwei N-Atome benachbart sind, und wobei R8 in der Gruppierung C- R8 jeweils gleiche oder verschiedene Bedeutungen gemäß der (Nitrogen) or the group CR 8 , but in no case more than two N atoms are adjacent, and wherein R 8 in the group C-R 8 each have the same or different meanings according to the
nachstehenden Definition hat und  has the following definition and
A1 und A2, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, A 1 and A 2 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
A2 und A3, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, A 2 and A 3 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
R8, R14, R15 und R21 unabhängig voneinander jeweils für Wasserstoff, Nitro, Amino, Hydroxy, Hydrothio, Thiocyanato, Isothiocyanato, Halogen, Alkyl, Cycloalkyl, Alkenyl, Alkinyl, Aryl, Arylalkyl, Arylalkoxy, Heteroaryl, Haloalkyl, R 8 , R 14 , R 15 and R 21 are each independently hydrogen, nitro, amino, hydroxy, hydrothio, thiocyanato, isothiocyanato, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, arylalkoxy, heteroaryl, haloalkyl,
Halocycloalkyl, Alkoxy, Haloalkoxy, Aryloxy, Heteroaryloxy, Cycloalkyloxy, Cycloalkylalkoxy, Hydroxyalkyl, Alkoxyalkyl, Aryloxyalkyl, Heteroaryloxyalkyl, Alkenylaminocarbonyl, Alkylamino, Alkylthio, Haloalkylthio, Bisalkylamino, Cycloalkylamino, Alkylcarbonylamino, Cycloalkylcarbonylamino, Formylamino, Haloalkylcarbonylamino, Alkoxycarbonylamino, Alkylaminocarbonylamino, (Alkyl-)aminocarbonylamino, Alkylsulfonylamino, Cycloalkylsulfonylamino, Arylsulfonylamino, Hetarylsulfonylamino, Sulfonylhaloalkylamino, Aminoalkylsulfonyl, Aminohaloalkylsulfonyl, Alkylaminosulfonyl, Halocycloalkyl, alkoxy, haloalkoxy, aryloxy, heteroaryloxy, cycloalkyloxy, cycloalkylalkoxy, hydroxyalkyl, alkoxyalkyl, aryloxyalkyl, heteroaryloxyalkyl, alkenylaminocarbonyl, alkylamino, alkylthio, haloalkylthio, bisalkylamino, cycloalkylamino, alkylcarbonylamino, cycloalkylcarbonylamino, formylamino, haloalkylcarbonylamino, alkoxycarbonylamino, alkylaminocarbonylamino, (alkyl-) aminocarbonylamino, alkylsulfonylamino, cycloalkylsulfonylamino, arylsulfonylamino, hetarylsulfonylamino, sulfonylhaloalkylamino, Aminoalkylsulfonyl, aminohaloalkylsulfonyl, alkylaminosulfonyl,
Bisalkylaminosulfonyl, Cycloalkylaminosulfonyl, Haloalkylaminosulfonyl, Arylaminosulfonyl, Arylalkylaminosulfonyl, Alkylsulfonyl, Cycloalkylsulfonyl, Arylsulfonyl, Alkylsulfinyl, Cycloalkylsulfinyl, Arylsulfinyl, N,S- Dialkylsulfonimidoyl, S-Alkylsulfonimidoyl, Alkylsulfonylam inocarbonyl, Cycloalkylsulfonylaminocarbonyl, Cycloalkylaminosulfonyl, Bisalkylaminosulfonyl, cycloalkylaminosulfonyl, haloalkylaminosulfonyl, arylaminosulfonyl, arylalkylaminosulfonyl, alkylsulfonyl, cycloalkylsulfonyl, arylsulfonyl, alkylsulfinyl, cycloalkylsulfinyl, arylsulfinyl, N, S-dialkylsulfonimidoyl, S-alkylsulfonimidoyl, alkylsulfonylamino inocarbonyl, cycloalkylsulfonylaminocarbonyl, cycloalkylaminosulfonyl,
Arylalkylcarbonylamino, Cycloalkylalkylcarbonylamino, Arylalkylcarbonylamino, cycloalkylalkylcarbonylamino,
Heteroarylcarbonylamino, Alkoxyalkylcarbonylamino, Heteroarylcarbonylamino, alkoxyalkylcarbonylamino,
Hydroxyalkylcarbonylamino, Cyano, Cyanoalkyl, Hydroxycarbonyl, Hydroxyalkylcarbonylamino, cyano, cyanoalkyl, hydroxycarbonyl,
Alkoxycarbonyl, Cycloalkoxycarbonyl, Cycloalkylalkoxycarbonyl, Alkoxycarbonyl, cycloalkoxycarbonyl, cycloalkylalkoxycarbonyl,
Aryloxycarbonyl, Arylalkoxycarbonyl, Am inocarbonyl, Alkylam inocarbonyl, Bisalkylaminocarbonyl, Alkyl(Alkoxy)am inocarbonyl, Cycloalkylaminocarbonyl, Arylalkylaminocarbonyl, Heteroarylalkylaminocarbonyl, Aryloxycarbonyl, arylalkoxycarbonyl, aminocarbonyl, alkylam inocarbonyl, bisalkylaminocarbonyl, alkyl (alkoxy) on inocarbonyl, cycloalkylaminocarbonyl, arylalkylaminocarbonyl, heteroarylalkylaminocarbonyl,
Cyanoalkylam inocarbonyl, Haloalkylaminocarbonyl, Cyanoalkylam inocarbonyl, haloalkylaminocarbonyl,
Alkinylalkylaminocarbonyl, Alkoxycarbonylam inocarbonyl, Alkynylalkylaminocarbonyl, alkoxycarbonylam inocarbonyl,
Arylalkoxycarbonylaminocarbonyl, Hydroxycarbonylalkyl, Alkoxycarbonylalkyl, Cycloalkoxycarbonylalkyl, Cycloalkylalkoxycarbonylalkyl, Arylalkoxycarbonylaminocarbonyl, hydroxycarbonylalkyl, alkoxycarbonylalkyl, cycloalkoxycarbonylalkyl, cycloalkylalkoxycarbonylalkyl,
Alkylam inocarbonylalkyl, Aminocarbonylalkyl, Bisalkylaminocarbonylalkyl, Cycloalkylam inocarbonylalkyl, Arylalkylam inocarbonylalkyl, Alkylam inocarbonylalkyl, aminocarbonylalkyl, bisalkylaminocarbonylalkyl, cycloalkylam inocarbonylalkyl, arylalkylam inocarbonylalkyl,
Heteroarylalkylam inocarbonylalkyl, Cyanoalkylam inocarbonylalkyl, Heteroarylalkylam inocarbonylalkyl, cyanoalkylam inocarbonylalkyl,
Haloalkylaminocarbonylalkyl, Alkinylalkylaminocarbonylalkyl, Haloalkylaminocarbonylalkyl, alkynylalkylaminocarbonylalkyl,
Cycloalkylalkylaminocarbonylalkyl, Cycloalkylalkylaminocarbonylalkyl,
Alkoxycarbonylam inocarbonylalkyl, Arylalkoxycarbonylam inocarbonylalkyl, Alkoxycarbonylalkylam inocarbonyl, Hydroxycarbonylalkylam inocarbonyl, Am inocarbonylalkylam inocarbonyl, Alkylam inocarbonylalkylam inocarbonyl, Cycloalkylam inocarbonylalkylam inocarbonyl, Cycloalkylalkylam inocarbonyl , Cycloalkylalkylam inocarbonylalkyl, Alkenyloxycarbonyl,  Alkoxycarbonylam inocarbonylalkyl, arylalkoxycarbonylam inocarbonylalkyl, alkoxycarbonylalkylam inocarbonyl, hydroxycarbonylalkylam inocarbonyl, aminocarbonylalkylam inocarbonyl, alkylam inocarbonylalkylam inocarbonyl, cycloalkylam inocarbonylalkylam inocarbonyl, cycloalkylalkylam inocarbonyl, cycloalkylalkylam inocarbonylalkyl, alkenyloxycarbonyl,
Alkenyloxycarbonylalkyl, Alkenylaminocarbonyl, Alkenylalkylaminocarbonyl, Alkenylam inocarbonylalkyl, Alkenylalkylam inocarbonylalkyl, Alkylcarbonyl, Cycloalkylcarbonyl, Formyl, Hydroxyiminomethyl, Aminoiminomethyl, Alkenyloxycarbonylalkyl, alkenylaminocarbonyl, alkenylalkylaminocarbonyl, alkenylamino-carbonylalkyl, alkenylalkylamino-carbonylalkyl, alkylcarbonyl, cycloalkylcarbonyl, formyl, hydroxyiminomethyl, aminoiminomethyl,
Alkoxyiminomethyl, Alkylaminoiminomethyl, Dialkylaminoiminomethyl, Alkoxyiminomethyl, alkylaminoiminomethyl, dialkylaminoiminomethyl,
Cycloalkoxyiminomethyl, Cycloalkylalkoximinomethyl, Aryloximinomethyl, Arylalkoxyiminomethyl, Arylalkylaminoiminomethyl, Alkenyloxyiminomethyl, Arylaminoiminomethyl, Arylsulfonylaminoiminomethyl, Heteroarylalkyl, Heterocyclylalkyl, Hydroxycarbonylheterocyclyl, Alkoxycarbonylheterocyclyl, Alkenyloxycarbonylheterocyclyl, Alkenylalkoxycarbonylheterocyclyl, Cycloalkoxyiminomethyl, cycloalkylalkoximinomethyl, aryloximinomethyl, Arylalkoxyiminomethyl, arylalkylaminoiminomethyl, alkenyloxyiminomethyl, arylaminoiminomethyl, arylsulfonylaminoiminomethyl, heteroarylalkyl, heterocyclylalkyl, hydroxycarbonylheterocyclyl, alkoxycarbonylheterocyclyl, alkenyloxycarbonylheterocyclyl, alkenylalkoxycarbonylheterocyclyl,
Arylalkoxycarbonylheterocyclyl, Cycloalkoxycarbonylheterocyclyl,  Arylalkoxycarbonylheterocyclyl, cycloalkoxycarbonylheterocyclyl,
Cycloalkylalkoxycarbonylheterocyclyl, Aminocarbonylheterocyclyl,  Cycloalkylalkoxycarbonylheterocyclyl, aminocarbonylheterocyclyl,
Alkylaminocarbonylheterocyclyl, Bis-Alkylaminocarbonylheterocyclyl,  Alkylaminocarbonylheterocyclyl, bis-alkylaminocarbonylheterocyclyl,
Cycloalkylaminocarbonylheterocyclyl, Arylalkylaminocarbonylheterocyclyl, Alkenylaminocarbonylheterocyclyl, Hydroxycarbonylheterocyclylalkyl, Alkoxycarbonylheterocyclylalkyl, Hydroxycarbonylcycloalkylalkyl,  Cycloalkylaminocarbonylheterocyclyl, arylalkylaminocarbonylheterocyclyl, alkenylaminocarbonylheterocyclyl, hydroxycarbonylheterocyclylalkyl, alkoxycarbonylheterocyclylalkyl, hydroxycarbonylcycloalkylalkyl,
Alkoxycarbonylcycloalkylalkyl stehen,  Alkoxycarbonylcycloalkylalkyl,
R9 und R10 unabhängig voneinander für Wasserstoff, Halogen, Alkyl, Alkoxy, R 9 and R 10 independently of one another represent hydrogen, halogen, alkyl, alkoxy,
Haloalkyl, Haloalkoxy, Aryl, Heteroaryl, Arylalkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden,  Haloalkyl, haloalkoxy, aryl, heteroaryl, arylalkyl or together with the atom to which they are attached form a carbonyl group,
A4, A5 gleich oder verschieden sind und unabhängig voneinander für N-R11, A 4 , A 5 are the same or different and are each independently NR 11 ,
Sauerstoff, Schwefel oder die Gruppierung C-R11 stehen, wobei jedoch in keinem Fall mehr als ein Sauerstoffatom im Heterocyclus enthalten ist, und wobei R11 in den Gruppierungen N-R11 und C-R11 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, Oxygen, sulfur or the group CR 11 , but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groupings NR 11 and CR 11 each have the same or different meanings as defined below,
R11 für Wasserstoff, Alkyl, Alkenylalkyl, Alkoxyalkyl, Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, Cycloalkylcarbonyl, Alkoxycarbonyl, Alkenyloxycarbonyl, Alkoxycarbonylalkyl, Alkylaminocarbonylalkyl, Arylaminocarbonylalkyl, Aryloxyalkyl, Arylalkyl, Heteroarylalkyl, Haloalkyl steht, R 11 is hydrogen, alkyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, alkenyloxycarbonyl, alkoxycarbonylalkyl, alkylaminocarbonylalkyl, arylaminocarbonylalkyl, aryloxyalkyl, arylalkyl, heteroarylalkyl, haloalkyl,
R12 und R13 unabhängig voneinander für Wasserstoff, Halogen, Alkyl, Alkoxy, R 12 and R 13 independently of one another represent hydrogen, halogen, alkyl, alkoxy,
Haloalkyl, Haloalkoxy, Aryl, Heteroaryl, Arylalkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, A6, A7, A8, A9 gleich oder verschieden sind und unabhängig voneinander für 0, S, N, NH, N-Alkyl, Alkoxycarbonyl-N, N-Aryl, N-Heteroaryl, N-Heterocyclyl, Haloalkyl, haloalkoxy, aryl, heteroaryl, arylalkyl or together with the atom to which they are attached form a carbonyl group, A 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N-alkyl, alkoxycarbonyl-N, N-aryl, N-heteroaryl, N-heterocyclyl,
Alkoxyalkyl-N, Arylsulfonyl-N, Alkylsulfonyl-N, Cycloalkylsulfonyl-N oder die Gruppierung C-R15 stehen, wobei maximal zwei 0- oder S-Atome im Alkoxyalkyl-N, arylsulfonyl-N, alkylsulfonyl-N, cycloalkylsulfonyl-N or the group CR 15 , wherein a maximum of two 0 or S atoms in the
Heterocyclus vorhanden sind sind, und wobei keine 0- oder S-Atome benachbart zueinander sind, und wobei R15 in der Gruppierung C-R15 jeweils gleiche oder verschiedene Bedeutungen gemäß der vorstehenden Definition hat und R16 und R17 unabhängig voneinander für Wasserstoff, Halogen, Alkyl, Alkoxy, Heterocycle are present, and wherein no 0 or S atoms are adjacent to each other, and wherein R 15 in the group CR 15 each have the same or different meanings as defined above, and R 16 and R 17 are independently hydrogen, halogen, Alkyl, alkoxy,
Haloalkyl, Haloalkoxy, Aryl, Heteroaryl, Arylalkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden,  Haloalkyl, haloalkoxy, aryl, heteroaryl, arylalkyl or together with the atom to which they are attached form a carbonyl group,
A10 für N-R18, Sauerstoff oder die Gruppierung C-R18 steht und wobei R18 in den Gruppierungen N-R18 und C-R18 jeweils gleiche oder verschiedene A 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
Bedeutungen gemäß der nachstehenden Definition hat,  Has meanings as defined below,
R18 für Wasserstoff, Alkyl, Alkenylalkyl, Alkoxyalkyl, Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, Cycloalkylcarbonyl, Alkoxycarbonyl, Allyloxycarbonyl, Aryloxyalkyl, Arylalkyl, Haloalkyl, Aryl steht, R 18 is hydrogen, alkyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, allyloxycarbonyl, aryloxyalkyl, arylalkyl, haloalkyl, aryl,
A11 für N oder die Gruppierung C-R21 steht und wobei R21 in der Gruppierung C- R21 die Bedeutung gemäß der vorstehenden Definition hat, A12 für N-R18 oder die Gruppierung C(R19)R20 steht und wobei R19 und R20 in der Gruppierung C(R19)R20 die Bedeutung gemäß der nachstehenden Definition haben, A 11 is N or the group CR 21 and wherein R 21 in the group C-R 21 has the meaning defined above, A 12 is NR 18 or the group C (R 19 ) R 20 and wherein R 19 and R 20 in the group C (R 19 ) R 20 have the meaning as defined below,
R19 und R20 unabhängig voneinander für Wasserstoff, Halogen, Alkyl, Alkoxy, R 19 and R 20 independently of one another represent hydrogen, halogen, alkyl, alkoxy,
Haloalkyl, Haloalkoxy, Aryl, Heteroaryl, Arylalkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, mit Ausnahme von 4-Hydroxy-4-{(E)-2-[2-(hydroxymethyl)phenyl]vinyl}-3,5,5- trimethylcyclohex-2-en-1 -on, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en- 1 -yl)vinyl]benzaldehyd, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]benzoesäure und Methyl-2-[(E)-2-(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex- 2-en-1 -yl)vinyl]benzoat. Haloalkyl, haloalkoxy, aryl, heteroaryl, arylalkyl or together with the atom to which they are attached form a carbonyl group, with the exception of 4-hydroxy-4 - {(E) -2- [2- (hydroxymethyl) phenyl] vinyl} -3,5,5-trimethylcyclohex-2-en-1-one, 2 - [(E) - 2- (1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzaldehyde, 2 - [(E) -2- (1-hydroxy-2,6,6 -trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid and methyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-ene 1 -yl) vinyl] benzoate.
Die Verbindungen der Formel (I) können Salze bilden. Salzbildung kann durch Einwirkung einer Base auf solche Verbindungen der Formel (I) erfolgen, die ein acides Wasserstoffatom tragen, z.B. im Falle dass R1 eine COOH-Gruppe oder eine Sulfonamid-Gruppe -NHSO2- enthält. Geeignete Basen sind beispielsweise organische Amine , wie Trialkylamine, Morpholin, Piperidin oder Pyridin sowie Ammonium-, Alkali- oder Erdalkalimetallhydroxide, -carbonate und The compounds of formula (I) can form salts. Salt formation can be effected by the action of a base on those compounds of the formula (I) which carry an acidic hydrogen atom, for example in the case where R 1 contains a COOH group or a sulfonamide group -NHSO 2 -. Examples of suitable bases are organic amines, such as trialkylamines, morpholine, piperidine or pyridine, and ammonium, alkali metal or alkaline earth metal hydroxides, carbonates and
-hydrogencarbonate, insbesondere Natrium- und Kaliumhydroxid, Natrium- und Kaliumcarbonat und Natrium- und Kaliumhydrogencarbonat. Diese Salze sind Verbindungen, in denen der acide Wasserstoff durch ein für die Landwirtschaft geeignetes Kation ersetzt wird, beispielsweise Metallsalze, insbesondere bicarbonates, in particular sodium and potassium hydroxide, sodium and potassium carbonate and sodium and potassium bicarbonate. These salts are compounds in which the acidic hydrogen is replaced by a cation suitable for agriculture, for example metal salts, in particular
Alkalimetallsalze oder Erdalkalimetallsalze, insbesondere Natrium- und Kaliumsalze, oder auch Ammoniumsalze, Salze mit organischen Aminen oder quartäre Alkali metal salts or alkaline earth metal salts, especially sodium and potassium salts, or ammonium salts, salts with organic amines or quaternary
(quaternäre) Ammoniumsalze, zum Beispiel mit Kationen der Formel [NRR'R"R" ']+, worin R bis R' " jeweils unabhängig voneinander einen organischen Rest, (quaternary) ammonium salts, for example with cations of the formula [NRR ' R " R "' ] + , where R to R '"are each independently an organic radical,
insbesondere Alkyl, Aryl, Aralkyl oder Alkylaryl darstellen. Infrage kommen auch Alkylsulfonium- und Alkylsulfoxoniumsalze, wie (Ci-C4)-Trialkylsulfonium- und (C1- C4)-Trialkylsulfoxoniumsalze. Im Folgenden werden die erfindungsgemäßen und/oder erfindungsgemäß in particular alkyl, aryl, aralkyl or alkylaryl. Also suitable are alkylsulfonium and alkylsulfoxonium salts, such as (C 1 -C 4 ) -trialkylsulfonium and (C 1 -C 4 ) -trialkylsulfoxonium salts. The following are the inventive and / or inventive
verwendeten Verbindungen der Formel (I) und ihre Salze auch kurz als used compounds of formula (I) and their salts also briefly as
"Verbindungen der allgemeinen Formel (I)" bezeichnet. "Compounds of the general formula (I)" denotes.
Bevorzugt sind Verbindungen der allgemeinen Formel (I), worin Preference is given to compounds of the general formula (I) in which
[X-Y] für die Gruppierungen [XY] for the groupings
Q für die carbocyclischen und heterocyclischen Gruppierungen Q-1 bis Q-4 Q for the carbocyclic and heterocyclic moieties Q-1 to Q-4
steht, wobei die Gruppierungen R6 bis R21 und A1 bis A12 jeweils die wherein the groups R 6 to R 21 and A 1 to A 12 are each the
Bedeutung gemäß der nachstehenden Definitionen haben und wobei der Pfeil für eine Bindung zur jeweiligen Gruppierung [X-Y] steht,  Have meaning according to the definitions below and wherein the arrow represents a bond to the respective grouping [X-Y],
R1 für (Ci-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C2-C8)-Alkenyl-(Ci-C8)- alkyl, (C2-C8)-Alkinyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Hydroxy- (Ci-Cs)-alkyl, (Ci-Cs)-Alkylamino, Sulfonylamino, (Ci-Cs)-Alkoxy, (Ci-C8)- Haloalkyl, (Ci-C8)-Haloalkoxy-(Ci-C8)-alkyl steht, R 1 is (Ci-C 8) alkyl, (C 2 -C 8) alkenyl, (C 2 -C 8) -alkynyl, (C 2 -C 8) alkenyl (Ci-C 8) - alkyl , (C 2 -C 8) alkynyl (Ci-C 8) alkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, hydroxy (Ci-Cs) alkyl, (C -Cs) -alkylamino, sulfonylamino, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy- (C 1 -C 8 ) -alkyl,
R2 für Wasserstoff, (Ci-Cs)-Alkyl, Nitro-(Ci-C8)-alkyl, Hydroxy-(Ci-C8)-alkyl, R 2 is hydrogen, (C 1 -C 5) -alkyl, nitro (C 1 -C 8 ) -alkyl, hydroxy (C 1 -C 8 ) -alkyl,
(Ci-Cs)-Haloalkyl, (Ci-C8)-Alkylamino, Sulfonylamino, (Ci-Cs)-Alkoxy, Tris- [(Ci-Cs)-alkylsilyl]- (Ci-C8)-alkyl, Cyano-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkyl, (C 1 -C 5) -haloalkyl, (C 1 -C 8 ) -alkylamino, sulfonylamino, (C 1 -C 5) -alkoxy, tris [(C 1 -C 5) -alkylsilyl] - (C 1 -C 8 ) -alkyl, cyano- (C 1 -C 8 ) -alkyl, aryl- (C 1 -C 8 ) -alkyl,
(Ci-C8)-Alkoxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)-Haloalkoxycarbonyl-(Ci-C8)- alkyl, (Ci-C8)-Alkylthio-(Ci-C8)-alkyl, Arylthio-(Ci-C8)-alkyl steht, (Ci-C8) alkoxycarbonyl (Ci-C 8) alkyl, (Ci-C 8) -Haloalkoxycarbonyl- (Ci-C 8) - alkyl, (Ci-C8) alkylthio (Ci-C 8 ) -alkyl, arylthio (C 1 -C 8 ) -alkyl,
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden, R3 und R4 unabhängig voneinander für (Ci-C8)-Alkoxy, (Ci-C8)-Alkoxy-(Ci-C8)- alkoxy, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxy, (Ci-C8)-Haloalkoxy, (Ci-C8)- Alkylthio, (Ci-C8)-Haloalkylthio stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, (Ci-Cs)- Alkoxyiminogruppe, (Ci-C8)-alkenyloximinogruppe, (C3-Cs)-R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring, R 3 and R 4 independently of one another are (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkoxy, (C 3 -C 8 ) -cycloalkyl- (C 1 -C 8 ) -alkoxy, (Ci-C 8 ) -haloalkoxy, (Ci-C 8 ) - alkylthio, (Ci-C8) haloalkylthio or together with the atom to which they are attached, an oxo group, hydroxyimino group, (Ci-Cs) - alkoxyimino group , (Ci-C8) -alkenyloximino group, (C3-Cs) -
Cycloalkoxyiminogruppe, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoximinogruppe, Aryl- (Ci-C8)-alkoxyiminogruppe oder einen 5-7-gliedrigen heterocyclischen Ring, der gegebenenfalls weiter substituiert sein kann, bilden für Wasserstoff, (Ci-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkenyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, Arylcarbonyl, Cycloalkoxyiminogruppe, (C3-C8) -cycloalkyl (Ci-C8) -alkoximinogruppe, aryl (Ci-C8) -alkoxyiminogruppe or a 5-7-membered heterocyclic ring, which may optionally be further substituted, form hydrogen, (Ci -C 8) alkyl, (C 2 -C 8) alkenyl, (C2-C8) alkenyl (Ci-C 8) alkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, (C 1 -C 8 ) -alkylcarbonyl, arylcarbonyl,
Heteroarylcarbonyl, (C3-C8)-Cycloalkylcarbonyl, (Ci-C8)-Alkoxycarbonyl, (C2-C8)-Alkenyloxycarbonyl, Aryloxy-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkyl, (Ci-C8)- Alkoxy-(Ci-C8)-alkoxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylthio-(Ci-C8)-alkyl, Tris- [(Ci-C8)-alkyl]silyl, (Ci-C8)-Alkyl-Bis-[(Ci-C8)-alkyl]silyl, (Ci-C8)-Alkyl-bis- Arylsilyl, Aryl-bis-[(Ci-C8)-alkyl]silyl, (C3-C8)-Cycloalkyl-bis-[(Ci-C8)-alkyl]silyl, Halo-bis-[(Ci-C8)-alkyl]silyl, Tns-[(Ci-C8)-alkyl]silyl-(Ci-C8)-alkoxy-(Ci-C8)-alkyl steht, R6 und R7 unabhängig voneinander für Wasserstoff, Nitro, Amino, Cyano, Heteroarylcarbonyl, (C3-C8) cycloalkylcarbonyl, (Ci-C8) alkoxycarbonyl, (C 2 -C 8) alkenyloxycarbonyl, aryloxy- (Ci-C 8) alkyl, aryl (Ci-C8) alkyl, (Ci-C8) - alkoxy (Ci-C 8) alkoxy (Ci-C 8) alkyl, (Ci-C8) alkylthio (Ci-C8) alkyl, tris [(C -C 8) alkyl] silyl, (Ci-C 8) -alkyl, - bis [(Ci-C 8) alkyl] silyl, (Ci-C 8) -alkyl-bis- arylsilyl, aryl-bis- [ (C 1 -C 8 ) -alkyl] silyl, (C 3 -C 8 ) -cycloalkyl-bis - [(C 1 -C 8 ) -alkyl] silyl, halo-bis - [(C 1 -C 8 ) -alkyl] silyl, Tns - [(C 1 -C 8 ) -alkyl] silyl- (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, R 6 and R 7 independently of one another represent hydrogen, nitro, amino, cyano,
Thiocyanato, Isothiocyanato, Halogen, (Ci-C8)-Alkyl, (C3-C8)-Cycloalkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, Aryl, Aryl-(Ci-C8)-alkyl, (C2-C8)-Alkenyl- (Ci-C8)-alkyl, (C2-C8)-Alkinyl-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkoxy, Heteroaryl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Hydroxy-(Ci-C8)-alkyl, (Ci-C8)-Haloalkyl, (C3-C8)- Halocycloalkyl, (Ci-C8)-Alkoxy, (Ci-C8)-Haloalkoxy, Aryloxy, Heteroaryloxy,Thiocyanato, isothiocyanato, halogen, (Ci-C8) -alkyl, (C3-C8) -cycloalkyl, (C 2 -C 8 ) -alkenyl, (C 2 -C 8 ) -alkynyl, aryl, aryl- (Ci-C 8) -alkyl, (C 2 -C 8) alkenyl (Ci-C 8) alkyl, (C 2 -C 8) alkynyl (Ci-C 8) alkyl, aryl (Ci-C 8 ) alkoxy, heteroaryl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, hydroxy (Ci-C 8) alkyl, (Ci-C8) -haloalkyl, (C 3 -C 8 Halocycloalkyl, (C 1 -C 8) -alkoxy, (C 1 -C 8) -haloalkoxy, aryloxy, heteroaryloxy,
(C3-C8)-Cycloalkyloxy, Hydroxy, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxy, (Ci-C8)- Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (Ci-Cs)- Alkylaminocarbonyl, (C3-C8)-Cycloalkylaminocarbonyl, Cyano-(Ci-Cs)- alkylaminocarbonyl, (C2-C8)-Alkenylaminocarbonyl, (C2-Cs)- Alkinylaminocarbonyl, (Ci-C8)-Alkylamino, (Ci-C8)-Alkylthio, (Ci-C8)-(C 3 -C 8) cycloalkyloxy, hydroxy, (C3-C8) -cycloalkyl- (Ci-C8) alkoxy, (Ci-C8) - alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, (Ci-Cs) - alkylaminocarbonyl , (C 3 -C 8) -cycloalkylaminocarbonyl, cyano- (C 1 -C 8) -alkylaminocarbonyl, (C 2 -C 8 ) -alkenylaminocarbonyl, (C 2 -Cs) -alkynylaminocarbonyl, (C 1 -C 8 ) -alkylamino, (Ci-C 8 ) -Alkylthio, (Ci-C 8 ) -
Haloalkylthio, Hydrothio, Bis-(Ci-C8)-alkylamino, (C3-C8)-Cycloalkylamino, (Ci-C8)-Alkylcarbonylamino, (C3-C8)-Cycloalkylcarbonylamino, Formylamino, (Ci-C8)-Haloalkylcarbonylamino, (Ci-C8)-Alkoxycarbonylamino, (Ci-Cs)- Alkylaminocarbonylamino, (Ci-C8)-Alkyl-[(Ci-C8)-Alkyl]-aminocarbonylamino, (Ci-C8)-Alkylsulfonylamino, (C3-C8)-Cycloalkylsulfonylamino, Haloalkylthio, hydrothio, bis- (C 1 -C 8) -alkylamino, (C 3 -C 8) -cycloalkylamino, (C 1 -C 8) -alkylcarbonylamino, (C 3 -C 8) -cycloalkylcarbonylamino, formylamino, (Ci-C8) -haloalkylcarbonylamino, (Ci-C8) -alkoxycarbonylamino, (Ci-Cs) - alkylaminocarbonylamino, (Ci-C8) -alkyl - [(Ci-C8) -alkyl] -aminocarbonylamino, (Ci-C8) - Alkylsulfonylamino, (C 3 -C 8) -cycloalkylsulfonylamino,
Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl-(Ci-C8)-haloalkylamino, Aminosulfonyl, Amino-(Ci-C8)-alkylsulfonyl, Amino-(Ci-C8)-haloalkylsulfonyl, (Ci-C8)-Alkylaminosulfonyl, Bis-[(Ci-C8)-alkyl]aminosulfonyl, (C3-C8)- Cycloalkylaminosulfonyl, (Ci-C8)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-(Ci-C8)-alkylaminosulfonyl, (Ci-Ce)-Alkylsulfonyl, (C3-C8)- Cycloalkylsulfonyl, Arylsulfonyl, (Ci-Ce)-Alkylsulfinyl, (C3-C8)- Cycloalkylsulfinyl, Arylsulfinyl, N,S-Di-(Ci-C8)-alkylsulfonimidoyl, S-(Ci-Cs)- Alkylsulfonimidoyl, (Ci-C8)-Alkylsulfonylaminocarbonyl, (C3-C8)- Cycloalkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylaminosulfonyl, Aryl- (Ci-C8)-alkylcarbonylamino, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C8)-Alkoxy-(Ci-C8)-alkylcarbonylamino, Hydroxy-(Ci-C8)-alkylcarbonylamino, Tris-[(Ci-C8)-alkyl]silyl stehen, Arylsulfonylamino, hetarylsulfonylamino, sulfonyl- (C 1 -C 8) -haloalkylamino, aminosulfonyl, amino- (C 1 -C 8) -alkylsulfonyl, amino- (C 1 -C 8) -haloalkylsulfonyl, (C 1 -C 8) -alkylaminosulfonyl, bis - [(ci) C 8 ) alkyl] aminosulfonyl, (C 3 -C 8 ) -cycloalkylaminosulfonyl, (C 1 -C 8 ) -haloalkylaminosulfonyl, arylaminosulfonyl, aryl- (C 1 -C 8 ) -alkylaminosulfonyl, (C 1 -C 6 ) -alkylsulfonyl, (C 3 -C 8 ) - Cycloalkylsulfonyl, arylsulfonyl, (Ci-Ce) alkylsulfinyl, (C 3 -C 8 ) - cycloalkylsulfinyl, arylsulfinyl, N, S-di- (Ci-C 8 ) -alkylsulfonimidoyl, S- (Ci-Cs) - alkylsulfonimidoyl , (C 1 -C 8) -alkylsulfonylaminocarbonyl, (C 3 -C 8) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 8) -cycloalkylaminosulfonyl, aryl- (C 1 -C 8) -alkylcarbonylamino, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkylcarbonylamino , Heteroarylcarbonylamino, (C 1 -C 8) -alkoxy- (C 1 -C 8) -alkylcarbonylamino, hydroxy- (C 1 -C 8) -alkylcarbonylamino, tris - [(C 1 -C 8) -alkyl] silyl,
A1, A2, A3 gleich oder verschieden sind und unabhängig voneinander für N A 1 , A 2 , A 3 are the same or different and are independently N
(Stickstoff) oder die Gruppierung C-R8 stehen, wobei jedoch in keinem Fall mehr als zwei N-Atome benachbart sind, und wobei R8 in der Gruppierung C- R8 jeweils gleiche oder verschiedene Bedeutungen gemäß der (Nitrogen) or the group CR 8 , but in no case more than two N atoms are adjacent, and wherein R 8 in the group C-R 8 each have the same or different meanings according to the
nachstehenden Definition hat und  has the following definition and
A1 und A2, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, A 1 and A 2 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
A2 und A3, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, R8, R14, R15 und R21 unabhängig voneinander jeweils für Wasserstoff, Nitro, Amino, Hydroxy, Hydrothio, Thiocyanato, Isothiocyanato, Halogen, (Ci-C8)-Alkyl, (C3-C8)-Cycloalkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, Aryl, Aryl-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkoxy, Heteroaryl, (Ci-Cs)-Haloalkyl, (Ci-Cs)-Halocycloalkyl, (Ci-C8)-Alkoxy, (Ci-Cs)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C8)- Cycloalkyloxy, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxy, Hydroxy-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Aryloxy-(Ci-C8)-alkyl, Heteroaryloxy-(Ci-Cs)- alkyl, (C2-C8)-Alkenylaminocarbonyl, (Ci-Cs)-Alkylamino, (Ci-Cs)-Alkylthio, (Ci-Cs)-Haloalkylthio, Bis-[(Ci-C8)-alkyl]amino, (C3-C8)-Cycloalkylamino, (Ci-C8)-Alkylcarbonylamino, (C3-C8)-Cycloalkylcarbonylamino, Formylamino, (Ci-C8)-Haloalkylcarbonylamino, (Ci-Cs)-Alkoxycarbonylamino, (Ci-C8)- Alkylaminocarbonylamino, (Ci-C8)-Alkyl[(Ci-C8)-Alkyl]-aminocarbonylamino, (Ci-C8)-Alkylsulfonylamino, (C3-C8)-Cycloalkylsulfonylamino, A 2 and A 3 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form, R 8 , R 14 , R 15 and R 21 independently of one another each represent hydrogen, nitro, amino, hydroxyl, hydrothio, thiocyanato, isothiocyanato, halogen, (C 1 -C 8 ) -alkyl, (C 3 -C 8 ) -cycloalkyl, ( C 2 -C 8) alkenyl, (C 2 -C 8) alkynyl, aryl, aryl (Ci-C 8) alkyl, aryl (Ci-C 8) alkoxy, heteroaryl, (Ci-Cs) haloalkyl, (Ci-Cs) halocycloalkyl, (Ci-C 8) alkoxy, (Ci-Cs) haloalkoxy, aryloxy, heteroaryloxy, (C3-C8) - cycloalkyloxy, (C3-C8) cycloalkyl (C 1 -C 8 ) -alkoxy, hydroxy- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, aryloxy- (C 1 -C 8 ) -alkyl, heteroaryloxy - (C 1 -C 8 ) -alkyl, (C 2 -C 8 ) -alkenylaminocarbonyl, (C 1 -C 8 ) -alkylamino, (C 1 -C 8 ) -alkylthio, (C 1 -C 8 ) -haloalkylthio, bis - [(C 1 -C 8 ) alkyl] amino, (C 3 -C 8) cycloalkylamino, (Ci-C8) alkylcarbonylamino, (C3-C8) -Cycloalkylcarbonylamino, formylamino, (Ci-C 8) -Haloalkylcarbonylamino, (Ci-Cs) alkoxycarbonylamino, (Ci-C 8) - alkylaminocarbonylamino, (Ci-C 8) alkyl [(Ci-C 8) alkyl] -aminocarbonylamino, (Ci-C8) alkylsulfonylamino, (C3-C8) -Cy cloalkylsulfonylamino,
Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl-(Ci-C8)-haloalkylamino, Amino-(Ci-C8)-alkylsulfonyl, Amino-(Ci-C8)-haloalkylsulfonyl, (Ci-C8)- Alkylaminosulfonyl, Bis-(Ci-C8)-alkylaminosulfonyl, (C3-C8)- Cycloalkylaminosulfonyl, (Ci-Cs)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-(Ci-C8)-alkylaminosulfonyl, (Ci-Cs)-Alkylsulfonyl, (C3-C8)- Cycloalkylsulfonyl, Arylsulfonyl, (Ci-Cs)-Alkylsulfinyl, (C3-C8)- Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-(Ci-C8)-alkylsulfonimidoyl, S-(Ci-C8)- Alkylsulfonimidoyl, (Ci-C8)-Alkylsulfonylaminocarbonyl, (C3-C8)- Cycloalkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylaminosulfonyl, Aryl- (Ci-C8)-alkylcarbonylamino, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C8)-Alkoxy-(Ci-C8)-alkylcarbonylamino, Arylsulfonylamino, Hetarylsulfonylamino, sulfonyl (Ci-C 8) -haloalkylamino, amino (Ci-C8) alkylsulfonyl, amino (Ci-C 8) haloalkylsulfonyl, (Ci-C 8) - alkylaminosulfonyl, bis (C C8) -alkylaminosulfonyl, (C3-C8) - Cycloalkylaminosulfonyl, (Ci-Cs) -Haloalkylaminosulfonyl, arylaminosulfonyl, aryl (Ci-C8) -alkylaminosulfonyl, (Ci-Cs) alkylsulfonyl, (C 3 -C 8 ) - cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 8 ) -alkylsulfinyl, (C 3 -C 8 ) -cycloalkylsulfinyl, arylsulfinyl, N, S-bis (C 1 -C 8 ) -alkylsulfonimidoyl, S- (C 1 -C 8 ) - Alkylsulfonimidoyl, (Ci-C 8) -Alkylsulfonylaminocarbonyl, (C3-C8) - Cycloalkylsulfonylaminocarbonyl, (C3-C8) -Cycloalkylaminosulfonyl, aryl (Ci-C8) alkylcarbonylamino, (C3-C8) cycloalkyl (C 1 -C 8 ) -alkylcarbonylamino, heteroarylcarbonylamino, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkylcarbonylamino,
Hydroxy-(Ci-C8)-alkylcarbonylamino, Cyano, Cyano-(Ci-C8)-alkyl, Hydroxy- (C 1 -C 8 ) -alkylcarbonylamino, cyano, cyano- (C 1 -C 8 ) -alkyl,
Hydroxycarbonyl, (Ci-Cs)-Alkoxycarbonyl, (C3-C8)-Cycloalkoxycarbonyl, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxycarbonyl, Aryloxycarbonyl, Aryl-(Ci-Cs)- alkoxycarbonyl, Aminocarbonyl, (Ci-C8)-Alkylaminocarbonyl, Bis-(Ci-Cs)- alkylaminocarbonyl, (Ci-C8)-Alkyl[(Ci-C8)-Alkoxy]aminocarbonyl, (C3-C8)- Cycloalkylaminocarbonyl, Aryl-(Ci-C8)-alkylaminocarbonyl, Heteroaryl-(Ci-Cs)- alkylaminocarbonyl, Cyano-(Ci-C8)-alkylaminocarbonyl, (Ci-C8)- Haloalkylaminocarbonyl, (C2-C8)-Alkinyl-(Ci-C8)-alkylaminocarbonyl, (Ci-C8)- Alkoxycarbonylaminocarbonyl, Aryl-(Ci-C8)-alkoxycarbonylaminocarbonyl, Hydroxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxycarbonyl-(Ci-C8)-alkyl, (C3-C8)- Cycloalkoxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)-Cycloalkyl-(Ci-C8)-alkoxycarbonyl- (Ci-C8)-alkyl, (Ci-C8)-Alkylaminocarbonyl-(Ci-C8)-alkyl, Aminocarbonyl- (Ci-Cs)-alkyl, Bis-(Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (C3-C8)- Cycloalkylaminocarbonyl-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkylaminocarbonyl- (Ci-C8)-alkyl, Heteroaryl-(Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, Cyano- (Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (Ci-C8)-Haloalkylaminocarbonyl- (Ci-Cs)-alkyl, (C2-C8)-Alkinyl-(Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (Ci-C8)- Alkoxycarbonylaminocarbonyl-(Ci-C8)-alkyl, Aryl-(C-i-Cs)- alkoxycarbonylaminocarbonyl-(Ci-C8)-alkyl, Hydroxycarbonyl, (C 1 -C 8 ) -alkoxycarbonyl, (C 3 -C 8 ) -cycloalkoxycarbonyl, (C 3 -C 8 ) -cycloalkyl- (C 1 -C 8 ) -alkoxycarbonyl, aryloxycarbonyl, aryl- (C 1 -C 8 ) -alkoxycarbonyl, aminocarbonyl , (Ci-C 8) alkylaminocarbonyl, bis (Ci-Cs) - alkylaminocarbonyl, (Ci-C 8) alkyl [(Ci-C 8) alkoxy] aminocarbonyl, (C3-C8) - cycloalkylaminocarbonyl, aryl - (Ci-C 8) alkylaminocarbonyl, heteroaryl (Ci-Cs) - alkylaminocarbonyl, cyano (Ci-C 8) alkylaminocarbonyl, (Ci-C 8) - Haloalkylaminocarbonyl, (C2-C8) alkynyl ( C 1 -C 8 ) -alkylaminocarbonyl, (C 1 -C 8 ) - Alkoxycarbonylaminocarbonyl, aryl (Ci-C8) -alkoxycarbonylaminocarbonyl, hydroxycarbonyl- (Ci-C 8) alkyl, (Ci-C8) alkoxycarbonyl (Ci-C 8) alkyl, (C 3 -C 8) - cycloalkoxycarbonyl - (Ci-C 8 ) -alkyl, (Ci-C 8 ) -cycloalkyl- (Ci-C 8 ) -alkoxycarbonyl- (Ci-C 8 ) -alkyl, (Ci-C 8 ) -alkylaminocarbonyl- (Ci-C 8 ) -alkyl, aminocarbonyl (Ci-Cs) -alkyl, bis (Ci-C 8 ) -alkylaminocarbonyl (Ci-C 8 ) -alkyl, (C 3 -C 8 ) - Cycloalkylaminocarbonyl- (Ci-C 8 ) -alkyl, aryl- (C 1 -C 8 ) -alkylaminocarbonyl- (C 1 -C 8 ) -alkyl, heteroaryl- (C 1 -C 8 ) -alkylaminocarbonyl- (C 1 -C 8 ) -alkyl, cyano- (C 1 -C 4) -alkyl) 8) alkylaminocarbonyl (Ci-C8) alkyl, (Ci-C 8) -Haloalkylaminocarbonyl- (Ci-Cs) alkyl, (C2-C8) alkynyl (Ci-C8) alkylaminocarbonyl ( Ci-C 8) alkyl, (C 3 -C 8) -cycloalkyl- (Ci-C8) alkylaminocarbonyl (Ci-C8) alkyl, (Ci-C 8) - Alkoxycarbonylaminocarbonyl- (Ci-C 8 ) -alkyl, aryl- (C 1 -C 8 ) -alkoxycarbonylaminocarbonyl- (C 1 -C 8 ) -alkyl,
(Ci-C8)-Alkoxycarbonyl-(Ci-C8)-alkylaminocarbonyl, Hydroxycarbonyl-(Ci-C8)- alkylaminocarbonyl, Aminocarbonyl-(Ci-C8)-alkylaminocarbonyl, (Ci-C8)- Alkylaminocarbonyl-(Ci-C8)-alkylaminocarbonyl, (C3-C8)- Cycloalkylaminocarbonyl-(Ci-C8)-alkylaminocarbonyl, (C3-C8)-Cycloalkyl- (Ci-C8)-alkylaminocarbonyl, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylaminocarbonyl- (Ci-C8)-alkyl, (C2-C8)-Alkenyloxycarbonyl, (C2-C8)-Alkenyloxycarbonyl-(Ci-C8)- alkyl, (C2-C8)-Alkenylaminocarbonyl, (C2-C8)-Alkenyl-(Ci-C8)- alkylaminocarbonyl, (C2-C8)-Alkenylaminocarbonyl-(Ci-C8)-alkyl, (C2-C8)- Alkenyl-(Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (Ci-Cs)-Alkylcarbonyl, (Ci-C8) alkoxycarbonyl (Ci-C 8) alkylaminocarbonyl, hydroxycarbonyl (Ci-C8) - alkylaminocarbonyl, aminocarbonyl (Ci-C 8) alkylaminocarbonyl, (Ci-C8) - alkylaminocarbonyl ( Ci-C 8) alkylaminocarbonyl, (C3-C8) - cycloalkylaminocarbonyl (Ci-C 8) alkylaminocarbonyl, (C3-C8) -cycloalkyl- (Ci-C8) -alkylaminocarbonyl, (C3-C8) cycloalkyl (Ci-C8) alkylaminocarbonyl (Ci-C8) alkyl, (C2-C8) alkenyloxycarbonyl, (C2-C8) -Alkenyloxycarbonyl- (Ci-C 8) - alkyl, (C2 -C 8) -Alkenylaminocarbonyl, (C 2 -C 8) alkenyl (Ci-C8) - alkylaminocarbonyl, (C2-C8) -Alkenylaminocarbonyl- (Ci-C 8) alkyl, (C2-C8) Alkenyl- (C 1 -C 8 ) -alkylaminocarbonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylcarbonyl,
(C3-C8)-Cycloalkylcarbonyl, Formyl, Hydroxyiminomethyl, Aminoiminomethyl, (Ci-C8)-Alkoxyiminomethyl, (Ci-C8)-Alkylaminoiminomethyl, Bis-(Ci-Cs)- alkylaminoiminomethyl, (C3-C8)-Cycloalkoxyiminomethyl, (C3-C8)-Cycloalkyl- (Ci-C8)-alkoximinomethyl, Aryloximinomethyl, Aryl-(Ci-C8)-alkoxyiminomethyl, Aryl-(Ci-C8)-alkylaminoiminomethyl, (C2-C8)-Alkenyloxyiminomethyl, (C 3 -C 8 ) -cycloalkylcarbonyl, formyl, hydroxyiminomethyl, aminoiminomethyl, (C 1 -C 8 ) -alkoxyiminomethyl, (C 1 -C 8 ) -alkylaminoiminomethyl, bis (C 1 -C 8 ) -alkylaminoiminomethyl, (C 3 -C 8 ) - Cycloalkoxyiminomethyl, (C3-C8) -cycloalkyl- (Ci-C 8) -alkoximinomethyl, Aryloximinomethyl, aryl (Ci-C 8) alkoxyiminomethyl, aryl (Ci-C 8) -alkylaminoiminomethyl, (C2-C8) -Alkenyloxyiminomethyl,
Arylaminoiminomethyl, Arylsulfonylaminoiminomethyl, Heteroaryl-(Ci-Cs)- alkyl, Heterocyclyl-(Ci-C8)-alkyl, Hydroxycarbonylheterocyclyl, (Ci-C8)- Alkoxycarbonylheterocyclyl, (C2-C8)-Alkenyloxycarbonylheterocyclyl, (C2-C8)- Alkenyl-(Ci-C8)-alkoxycarbonylheterocyclyl, Aryl-(Ci-Cs)- alkoxycarbonylheterocyclyl, (C3-C8)-Cycloalkoxycarbonylheterocyclyl, (C3-C8)- Cycloalkyl-(Ci-C8)-alkoxycarbonylheterocyclyl, Aminocarbonylheterocyclyl, (Ci-C8)-Alkylaminocarbonylheterocyclyl, Bis-(Ci-C8)-Arylaminoiminomethyl, Arylsulfonylaminoiminomethyl, heteroaryl (Ci-Cs) - alkyl, heterocyclyl- (Ci-C 8) alkyl, Hydroxycarbonylheterocyclyl, (Ci-C 8) - Alkoxycarbonylheterocyclyl, (C2-C8) -Alkenyloxycarbonylheterocyclyl, (C2-C8 ) - alkenyl, (Ci-C 8) -alkoxycarbonylheterocyclyl, aryl (Ci-Cs) - alkoxycarbonylheterocyclyl, (C3-C8) -Cycloalkoxycarbonylheterocyclyl, (C3-C8) - cycloalkyl- (Ci-C 8) -alkoxycarbonylheterocyclyl, Aminocarbonylheterocyclyl, (C 1 -C 8) -Alkylaminocarbonylheterocyclyl, bis (C 1 -C 8) -
Alkylaminocarbonylheterocyclyl, (C3-C8)-Cycloalkylaminocarbonylheterocyclyl, Aryl-(Ci-C8)-alkylaminocarbonylheterocyclyl, (C2-C8)-Alkylaminocarbonylheterocyclyl, (C3-C8) -cycloalkylaminocarbonylheterocyclyl, aryl- (Ci-C8) -alkylaminocarbonylheterocyclyl, (C2-C8) -
Alkenylaminocarbonylheterocyclyl, Hydroxycarbonylheterocyclyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxycarbonylheterocyclyl-(Ci-C8)-alkyl, Hydroxycarbonyl-(C3-C8)- cycloalkyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxycarbonyl-(C3-C8)-cycloalkyl-(Ci-C8)- alkyl steht, Alkenylaminocarbonylheterocyclyl, hydroxycarbonylheterocyclyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxycarbonylheterocyclyl- (C 1 -C 8 ) -alkyl, hydroxycarbonyl- (C 3 -C 8 ) -cycloalkyl- (C 1 -C 8 ) -alkyl, C8) alkoxycarbonyl (C3-C8) cycloalkyl- (Ci-C 8) - alkyl;
R9 und R10 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C8)-Alkyl, (Ci-Ce)- Alkoxy, (Ci-C8)-Haloalkyl, (Ci-C8)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-Ce)- alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, R 9 and R 10 independently of one another represent hydrogen, halogen, (C 1 -C 8 ) -alkyl, (C 1 -C 6 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl, Aryl- (C 1 -C 6) -alkyl or together with the atom to which they are attached form a carbonyl group,
A4, A5 gleich oder verschieden sind und unabhängig voneinander für N-R11 , A 4 , A 5 are the same or different and are each independently NR 11 ,
Sauerstoff, Schwefel oder die Gruppierung C-R11 stehen, wobei jedoch in keinem Fall mehr als ein Sauerstoffatom im Heterocyclus enthalten ist, und wobei R11 in den Gruppierungen N-R11 und C-R11 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, Oxygen, sulfur or the group CR 11 , but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groupings NR 11 and CR 11 each have the same or different meanings as defined below,
R11 für Wasserstoff, (Ci-C8)-Alkyl, (C2-C8)-Alkenyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy- (Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C8)- Cycloalkylcarbonyl, (Ci-C8)-Alkoxycarbonyl, (C2-C8)-Alkenyloxycarbonyl, (Ci-C6)-Alkoxycarbonyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylaminocarbonyl-(Ci-C6)- alkyl, Arylaminocarbonyl-(Ci-C6)-alkyl, Aryloxyalkyl, Aryl-(Ci-C8)-alkyl, R 11 is hydrogen, (C 1 -C 8 ) -alkyl, (C 2 -C 8 ) -alkenyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, ( C 1 -C 8) -alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 8) -cycloalkylcarbonyl, (C 1 -C 8) -alkoxycarbonyl, (C 2 -C 8) -alkenyloxycarbonyl, (C 1 -C 6) -alkoxycarbonyl- (C 1 -C 6) -alkyl , (C 1 -C 6) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, arylaminocarbonyl- (C 1 -C 6) -alkyl, aryloxyalkyl, aryl- (C 1 -C 8) -alkyl,
Heteroaryl-(Ci-C8)-alkyl, (Ci-C8)-Haloalkyl steht, Heteroaryl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -haloalkyl,
R12 und R13 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C8)-Alkyl, R 12 and R 13 independently of one another represent hydrogen, halogen, (C 1 -C 8) -alkyl,
(Ci-C8)-Alkoxy, (Ci-C8)-Haloalkyl, (Ci-C8)-Haloalkoxy, Aryl, Heteroaryl, Aryl- (Ci-C8)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, A6, A7, A8, A9 gleich oder verschieden sind und unabhängig voneinander für 0, S, N, NH, N-(Ci-Ce)-Alkyl, (Ci-C8)-Alkoxycarbonyl-N, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl- N, N-Aryl, N-Heteroaryl, N-Heterocyclyl, Arylsulfonyl-N, (Ci-Cs)-Alkylsulfonyl- N, (C3-C8)-Cycloalkylsulfonyl-N oder die Gruppierung C-R15 stehen, wobei maximal zwei 0- oder S-Atome im Heterocyclus vorhanden sind sind, und wobei keine 0- oder S-Atome benachbart zueinander sind, und wobei R15 in der Gruppierung C-R15 jeweils gleiche oder verschiedene Bedeutungen gemäß der vorstehenden Definition hat und und R17 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C8)-Alkyl, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 8 ) -alkyl or together with the atom to which they are attached are bound to form a carbonyl group, A 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N- (C 1 -C 6) -alkyl, (C 1 -C 8 ) -alkoxycarbonyl-N, (Ci -C 8) alkoxy- (Ci-C 8) -alkyl- N, N-aryl, N-heteroaryl, N-heterocyclyl, N-arylsulfonyl, (Ci-Cs) alkylsulfonyl N, (C3-C8) - Cycloalkylsulfonyl-N or the group CR 15 , wherein a maximum of two 0 or S atoms in the heterocycle are present, and wherein no 0 or S atoms are adjacent to each other, and wherein R 15 in the group CR 15 are the same or has different meanings according to the above definition and R 17 is independently of one another hydrogen, halogen, (C 1 -C 8) -alkyl,
(Ci-Ce)-Alkoxy, (Ci-C8)-Haloalkyl, (Ci-C8)-Haloalkoxy, Aryl, Heteroaryl, Aryl- (Ci-C8)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, für N-R18, Sauerstoff oder die Gruppierung C-R18 steht und wobei R18 in den Gruppierungen N-R18 und C-R18 jeweils gleiche oder verschiedene (C 1 -C 6) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 8 ) -alkyl or together with the atom to which they are attached are each a carbonyl group, NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
Bedeutungen gemäß der nachstehenden Definition hat, für Wasserstoff, (Ci-C8)-Alkyl, (C2-C8)-Alkenyl-(Ci-C8)-alkyl, (Ci-Cs)-Alkoxy- (Ci-C8)-alkyl, (Ci-Cs)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C8) Cycloalkylcarbonyl, (Ci-Cs)-Alkoxycarbonyl, (C2-C8)-Allyloxycarbonyl, Aryloxy- (Ci-Cs)-alkyl, Aryl-(Ci-C8)-alkyl, (Ci-Cs)-Haloalkyl, Aryl steht, für N oder die Gruppierung C-R21 steht und wobei R21 in der Gruppierung C- R21 die Bedeutung gemäß der vorstehenden Definition hat, Has the meanings as defined below, is hydrogen, (Ci-C 8) -alkyl, (C2-C8) alkenyl (Ci-C 8) alkyl, (Ci-Cs) alkoxy (Ci-C 8 ) alkyl, (C 1 -C 8 ) alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 8 ) cycloalkylcarbonyl, (C 1 -C 8 ) -alkoxycarbonyl, (C 2 -C 8 ) -alloxycarbonyl, aryloxy- (C 1 -C 8 ) -alkyl , Aryl- (C 1 -C 8 ) -alkyl, (C 1 -C 5) -haloalkyl, aryl, N represents or the group CR 21 and where R 21 in the grouping C-R 21 has the meaning given above,
A12 für N-R18 oder die Gruppierung C(R19)R20 steht und wobei R19 und R20 in der Gruppierung C(R19)R20 die Bedeutung gemäß der nachstehenden Definition haben, A 12 is NR 18 or the moiety C (R 19 ) R 20 and where R 19 and R 20 in the moiety C (R 19 ) R 20 are as defined below,
R19 und R20 unabhängig voneinander für Wasserstoff, Halogen, (Ci-Cs)-Alkyl, R 19 and R 20 independently of one another represent hydrogen, halogen, (C 1 -C 5) -alkyl,
(Ci-Cs)-Alkoxy, (Ci-C8)-Haloalkyl, (Ci-Cs)-Haloalkoxy, Aryl, Heteroaryl, Aryl- (Ci-C8)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, mit Ausnahme von 4-Hydroxy-4-{(E)-2-[2-(hydroxymethyl)phenyl]vinyl}-3,5,5- trimethylcyclohex-2-en-1 -on, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en- 1 -yl)vinyl]benzaldehyd, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]benzoesäure und Methyl-2-[(E)-2-(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex- 2-en-1 -yl)vinyl]benzoat. (C 1 -C 5) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl, aryl (Ci-C8) -alkyl or together with the atom to which they are attached form a carbonyl group, with the exception of 4-hydroxy-4 - {(E) -2- [2- (hydroxymethyl) phenyl] vinyl} -3,5,5-trimethylcyclohex-2-en-1-one, 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl ) vinyl] benzaldehyde, 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid and methyl 2 - [(E ) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoate.
Besonders bevorzugt sind Verbindungen der allgemeinen Formel (I), worin Particular preference is given to compounds of the general formula (I) in which
[X-Y] für die Gruppierungen [X-Y] for the groupings
[X-Y]1 und [X-Y]2 steht, [XY] 1 and [XY] 2 ,
Q für die carbocyclischen und heterocyclischen Gruppierungen Q-1 bis Q-4 Q for the carbocyclic and heterocyclic moieties Q-1 to Q-4
Q-1 Q-2 Q-3 und Q-4 steht, wobei die Gruppierungen R6 bis R21 und A1 bis A12 jeweils die Q-1 Q-2 Q-3 and Q-4, wherein the groups R 6 to R 21 and A 1 to A 12 are each the
Bedeutung gemäß der nachstehenden Definitionen haben und wobei der Pfeil für eine Bindung zur jeweiligen Gruppierung [X-Y] steht,  Have meaning according to the definitions below and wherein the arrow represents a bond to the respective grouping [X-Y],
R1 für (Ci-C7)-Alkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, (C2-C7)-Alkenyl-(Ci-C7)- alkyl, (C2-C7)-Alkinyl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, Hydroxy- (Ci-C7)-alkyl, (Ci-C7)-Alkylamino, Sulfonylamino, (Ci-C7)-Alkoxy, (C1-C7)- Haloalkyl, (Ci-C7)-Haloalkoxy-(Ci-C7)-alkyl steht, R 1 is (Ci-C7) alkyl, (C 2 -C 7) alkenyl, (C 2 -C 7) -alkynyl, (C 2 -C 7) alkenyl (Ci-C7) - alkyl , (C 2 -C 7) alkynyl (Ci-C7) alkyl, (Ci-C7) alkoxy (Ci-C7) alkyl, hydroxy (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkylamino, sulfonylamino, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy- (C 1 -C 4 -alkyl) 7 ) -alkyl,
R2 für Wasserstoff, (Ci-C7)-Alkyl, Nitro-(Ci-C7)-alkyl, Hydroxy-(Ci-C7)-alkyl, R 2 is hydrogen, (C 1 -C 7 ) -alkyl, nitro (C 1 -C 7 ) -alkyl, hydroxy- (C 1 -C 7 ) -alkyl,
(Ci-C7)-Haloalkyl, (Ci-C7)-Alkylamino, Sulfonylamino, (Ci-C7)-Alkoxy, Tris-(C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -alkylamino, sulfonylamino, (C 1 -C 7 ) -alkoxy, tris-
[(Ci-C7)-alkylsilyl]- (Ci-C7)-alkyl, Cyano-(Ci-C7)-alkyl, Aryl-(Ci-C7)-alkyl, [(C 1 -C 7 ) -alkylsilyl] - (C 1 -C 7 ) -alkyl, cyano- (C 1 -C 7 ) -alkyl, aryl- (C 1 -C 7 ) -alkyl,
(Ci-C7)-Alkoxycarbonyl-(Ci-C7)-alkyl, (Ci-C7)-Haloalkoxycarbonyl-(Ci-C7)- alkyl, (Ci-C7)-Alkylthio-(Ci-C7)-alkyl, Arylthio-(Ci-C7)-alkyl steht, (Ci-C 7) alkoxycarbonyl (Ci-C7) alkyl, (Ci-C 7) -Haloalkoxycarbonyl- (Ci-C7) - alkyl, (Ci-C7) -alkylthio (Ci-C 7 ) -alkyl, arylthio (C 1 -C 7 ) -alkyl,
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden, R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
R3 und R4 unabhängig voneinander für (Ci-C7)-Alkoxy, (Ci-C7)-Alkoxy-(Ci-C7)- alkoxy, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoxy, (Ci-C7)-Haloalkoxy, (Ci-C7)-R 3 and R 4 are each independently (Ci-C7) alkoxy, (Ci-C7) alkoxy (Ci-C7) - alkoxy, (C 3 -C 7) -cycloalkyl- (Ci-C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkoxy, (C 1 -C 7 ) -
Alkylthio, (Ci-C7)-Haloalkylthio stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, (Ci-C7)- Alkoxyiminogruppe, (C3-C7)-Cycloalkoxyiminogruppe, (C3-C7)-Cycloalkyl- (Ci-C7)-alkoximinogruppe, (Ci-C7)-alkenyloximinogruppe, Aryl-(Ci-C7)- alkoxyiminogruppe oder einen 5-7-gliedrigen heterocyclischen Ring, der gegebenenfalls weiter substituiert sein kann, bilden Alkylthio, (Ci-C 7 ) haloalkylthio or together with the atom to which they are attached, an oxo group, hydroxyimino group, (Ci-C 7 ) - alkoxyimino group, (C3-C 7 ) -Cycloalkoxyiminogruppe, (C3-C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkoximino group, (C 1 -C 7 ) -alkenyloximino group, aryl- (C 1 -C 7 ) -alkoxyimino group or a 5-7-membered heterocyclic ring which may optionally be further substituted, form
R5 für Wasserstoff, (Ci-C7)-Alkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkenyl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, (Ci-C7)-Alkylcarbonyl, Arylcarbonyl, R 5 represents hydrogen, (Ci-C7) alkyl, (C 2 -C 7) alkenyl, (C 2 -C 7) alkenyl (Ci-C7) alkyl, (Ci-C7) - Alkoxy- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkylcarbonyl, arylcarbonyl,
Heteroarylcarbonyl, (C3-C7)-Cycloalkylcarbonyl, (Ci-C7)-Alkoxycarbonyl,Heteroarylcarbonyl, (C 3 -C 7 ) -cycloalkylcarbonyl, (C 1 -C 7 ) -alkoxycarbonyl,
(C2-C7)-Alkenyloxycarbonyl, Aryloxy-(Ci-C7)-alkyl, Aryl-(Ci-C7)-alkyl, (Ci-C7)- Alkoxy-(Ci-C7)-alkoxy-(Ci-C7)-alkyl, (Ci-C7)-Alkylthio-(Ci-C7)-alkyl, Tris- [(Ci-C7)-alkyl]silyl, (Ci-C7)-Alkyl-Bis-[(Ci-C7)-alkyl]silyl, (Ci-C7)-Alkyl-bis- Arylsilyl, Aryl-bis-[(Ci-C7)-alkyl]silyl, (C3-C7)-Cycloalkyl-bis-[(Ci-C7)-alkyl]silyl, Halo-bis-[(Ci-C7)-alkyl]silyl, Tris-[(Ci-C7)-alkyl]silyl-(Ci-C7)-alkoxy-(Ci-C7)-alkyl steht, und R7 unabhängig voneinander für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-C7)-Alkyl, (C3-C7)-Cycloalkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, Aryl, Aryl-(Ci-C7)-alkyl, (C2-C7)-Alkenyl- (Ci-C7)-alkyl, (C2-C7)-Alkinyl-(Ci-C7)-alkyl, Aryl-(Ci-C7)-alkoxy, Heteroaryl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, Hydroxy-(Ci-C7)-alkyl, (Ci-C7)-Haloalkyl, (C3-C7)- Halocycloalkyl, (Ci-C7)-Alkoxy, (Ci-C7)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C7)-Cycloalkyloxy, Hydroxy, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoxy, (C1-C7)- Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (C1-C7)- Alkylaminocarbonyl, (C3-C7)-Cycloalkylaminocarbonyl, Cyano-(Ci-C7)- alkylaminocarbonyl, (C2-C7)-Alkenylaminocarbonyl, (C2-C7)- Alkinylaminocarbonyl, (Ci-C7)-Alkylamino, (Ci-C7)-Alkylthio, (C1-C7)- Haloalkylthio, Hydrothio, Bis-(Ci-C7)-alkylamino, (C3-C7)-Cycloalkylamino, (Ci-C7)-Alkylcarbonylamino, (C3-C7)-Cycloalkylcarbonylamino, Formylamino, (Ci-C7)-Haloalkylcarbonylamino, (Ci-C7)-Alkoxycarbonylamino, (C1-C7)- Alkylaminocarbonylamino, (Ci-C7)-Alkyl-[(Ci-C7)-Alkyl]-aminocarbonylamino, (Ci-C7)-Alkylsulfonylamino, (C3-C7)-Cycloalkylsulfonylamino, (C 2 -C 7) alkenyloxycarbonyl, aryloxy- (Ci-C 7) alkyl, aryl (Ci-C7) alkyl, (Ci-C7) - alkoxy (Ci-C7) alkoxy (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkylthio (C 1 -C 7 ) -alkyl, tris [(C 1 -C 7 ) -alkyl] silyl, (C 1 -C 7 ) -alkyl bis - [(Ci-C 7) alkyl] silyl, (Ci-C7) alkyl-bis- arylsilyl, aryl-bis - [(Ci-C 7) alkyl] silyl, (C 3 -C 7) Cycloalkyl-bis - [(C 1 -C 7 ) -alkyl] silyl, halo-bis - [(C 1 -C 7 ) -alkyl] silyl, tris - [(C 1 -C 7 ) -alkyl] silyl- (ci) C 7 ) -alkoxy- (C 1 -C 7 ) -alkyl, and R 7 independently of one another represent hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkyl, (C 2 -C 7 ) -alkenyl, (C 2 -) C 7) alkynyl, aryl, aryl (Ci-C7) alkyl, (C 2 -C 7) alkenyl (Ci-C7) alkyl, (C2-C7) alkynyl (Ci-C 7 ) -alkyl, aryl- (Ci-C 7 ) -alkoxy, heteroaryl, (Ci-C7) -alkoxy- (Ci-C 7 ) -alkyl, hydroxy (Ci-C 7 ) -alkyl, (Ci-C 7) -haloalkyl, (C3-C7) - halocycloalkyl, (Ci-C7) alkoxy, (Ci-C7) haloalkoxy, aryloxy, heteroaryloxy, (C3-C7) cycloalkyloxy, hydroxy, (C3-C7) - Cycloalkyl- (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, (C 1 -C 7 ) -alkylaminocarbonyl, (C 3 -C 7 ) -cycloalkylaminocarbonyl, cyano- (C 1 -C 7 ) -alkylaminocarbonyl, ( C 2 -C 7 ) alkenylaminocarbonyl, (C 2 -C 7 ) -alkynylaminocarbonyl, (C 1 -C 7 ) -alkylamino, (C 1 -C 7 ) -alkylthio, (C 1 -C 7 ) -haloalkylthio, hydrothio, bis (C 1 -C 7 ) -alkylamino, (C3-C7) -cycloalkylamino, (Ci-C7) -alkylcarbonylamino, (C3-C7) -cycloalkylcarbonylamino, formylamino, (Ci-C7) -haloalkylcarbonylamino , (C 1 -C 7) -alkoxycarbonylamino, (C 1 -C 7) -alkylaminocarbonylamino, (C 1 -C 7) -alkyl- [(C 1 -C 7) -alkyl] -aminocarbonylamino, (C 1 -C 7) -alkylsulfonylamino, (C 3 -C 7) -Cycloalkylsulfonylamino,
Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl-(Ci-C7)-haloalkylamino, Aminosulfonyl, Amino-(Ci-C7)-alkylsulfonyl, Amino-(Ci-C7)-haloalkylsulfonyl, (Ci-C7)-Alkylaminosulfonyl, Bis-[(Ci-C7)-alkyl]aminosulfonyl, (C3-C7)- Cycloalkylaminosulfonyl, (Ci-C7)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-(Ci-C7)-alkylaminosulfonyl, (Ci-C7)-Alkylsulfonyl, (C3-C7)- Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C7)-Alkylsulfinyl, (C3-C7)- Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-[(Ci-C7)-alkyl]sulfonimidoyl, S-(Ci-C7)- Alkylsulfonimidoyl, (Ci-C7)-Alkylsulfonylaminocarbonyl, (C3-C7)- Cycloalkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylaminosulfonyl, Aryl- (Ci-C7)-alkylcarbonylamino, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C7)-Alkoxy-(Ci-C7)-alkylcarbonylamino, Arylsulfonylamino, hetarylsulfonylamino, sulfonyl- (C 1 -C 7) -haloalkylamino, aminosulfonyl, amino- (C 1 -C 7) -alkylsulfonyl, amino- (C 1 -C 7) -haloalkylsulfonyl, (C 1 -C 7) -alkylaminosulfonyl, bis - [(ci) C7) -alkyl] aminosulfonyl, (C3-C7) - Cycloalkylaminosulfonyl, (Ci-C7) -Haloalkylaminosulfonyl, arylaminosulfonyl, aryl- (Ci-C7) alkylaminosulfonyl, (Ci-C7) alkylsulfonyl, (C3-C7) Cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 7 ) -alkylsulfinyl, (C 3 -C 7 ) -cycloalkylsulfinyl, arylsulfinyl, N, S-bis - [(C 1 -C 7 ) -alkyl] sulfonimidoyl, S- (C 1 -C 7 ) Alkylsulfonimidoyl, (C 1 -C 7) -alkylsulfonylaminocarbonyl, (C 3 -C 7) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 7) -cycloalkylaminosulfonyl, aryl- (C 1 -C 7) -alkylcarbonylamino, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) alkylcarbonylamino, heteroarylcarbonylamino, (C 1 -C 7) -alkoxy- (C 1 -C 7) -alkylcarbonylamino,
Hydroxy-(Ci-C7)-alkylcarbonylamino, Tris-[(Ci-C7)-alkyl]silyl stehen,  Hydroxy- (C 1 -C 7) -alkylcarbonylamino, tris - [(C 1 -C 7) -alkyl] silyl,
A1 , A2, A3 gleich oder verschieden sind und unabhängig voneinander für N A 1 , A 2 , A 3 are the same or different and are independently N
(Stickstoff) oder die Gruppierung C-R8 stehen, wobei jedoch in keinem Fall mehr als zwei N-Atome benachbart sind, und wobei R8 in der Gruppierung C- R8 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat und (Nitrogen) or the group CR 8 , but in no case more than two N atoms are adjacent, and wherein R 8 in the grouping C- R 8 has the same or different meanings as defined below, and
A1 und A2, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, A 1 and A 2 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
A2 und A3, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, A 2 and A 3 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
R8, R14, R15 und R21 unabhängig voneinander jeweils für Wasserstoff, Nitro, Amino, Hydroxy, Hydrothio, Thiocyanato, Isothiocyanato, Halogen, (Ci-C7)-Alkyl, (C3-C7)-Cycloalkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, Aryl, Aryl-(Ci-C7)-alkyl, Aryl-(Ci-C7)-alkoxy, Heteroaryl, (Ci-C7)-Haloalkyl, (Ci-C7)-Halocycloalkyl, (Ci-C7)-Alkoxy, (Ci-C7)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C7)- Cycloalkyloxy, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoxy, Hydroxy-(Ci-C7)-alkyl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, Aryloxy-(Ci-C7)-alkyl, Heteroaryloxy-(Ci-C7)- alkyl, (C2-C7)-Alkenylaminocarbonyl, (Ci-C7)-Alkylamino, (Ci-C7)-Alkylthio, (Ci-C7)-Haloalkylthio, Bis-[(Ci-C7)-alkyl]amino, (C3-C7)-Cycloalkylamino, (Ci-C7)-Alkylcarbonylamino, (C3-C7)-Cycloalkylcarbonylamino, Formylamino, (Ci-C7)-Haloalkylcarbonylamino, (Ci-C7)-Alkoxycarbonylamino, (Ci-C7)- Alkylaminocarbonylamino, (Ci-C7)-Alkyl[(Ci-C7)-Alkyl]-aminocarbonylamino, (Ci-C7)-Alkylsulfonylamino, (C3-C7)-Cycloalkylsulfonylamino, R 8 , R 14 , R 15 and R 21 independently of one another each represent hydrogen, nitro, amino, hydroxyl, hydrothio, thiocyanato, isothiocyanato, halogen, (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkyl, ( C 2 -C 7) alkenyl, (C 2 -C 7) alkynyl, aryl, aryl (Ci-C7) alkyl, aryl (Ci-C7) alkoxy, heteroaryl, (Ci-C 7 ) -haloalkyl, (Ci-C 7) halocycloalkyl, (Ci-C7) alkoxy, (Ci-C7) haloalkoxy, aryloxy, heteroaryloxy, (C3-C7) - cycloalkyloxy, (C3-C 7) -Cycloalkyl- (Ci-C 7 ) -alkoxy, hydroxy (Ci-C 7 ) -alkyl, (Ci-C 7 ) -alkoxy- (Ci-C 7 ) -alkyl, aryloxy- (Ci-C 7 ) - alkyl, heteroaryloxy- (Ci-C7) - alkyl, (C2-C7) -Alkenylaminocarbonyl, (Ci-C7) alkylamino, (Ci-C7) -alkylthio, (Ci-C 7) haloalkylthio, bis - [(Ci-C 7) alkyl] amino, (C 3 -C 7) cycloalkylamino, (Ci-C7) alkylcarbonylamino, (C3-C 7) -Cycloalkylcarbonylamino, formylamino, (Ci-C7) - Haloalkylcarbonylamino, (Ci-C 7) alkoxycarbonylamino, (Ci-C7) - alkylaminocarbonylamino, (Ci-C 7) alkyl [(Ci-C 7) alkyl] -aminocarbonylamino, (Ci-C 7) -Alkylsulfonylami no, (C 3 -C 7 ) -cycloalkylsulfonylamino,
Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl-(Ci-C7)-haloalkylamino, Amino-(Ci-C7)-alkylsulfonyl, Amino-(Ci-C7)-haloalkylsulfonyl, (Ci-C7)- Alkylaminosulfonyl, Bis-(Ci-C7)-alkylaminosulfonyl, (C3-C7)- Cycloalkylaminosulfonyl, (Ci-C7)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-(Ci-C7)-alkylaminosulfonyl, (Ci-C7)-Alkylsulfonyl, (C3-C7)- Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C7)-Alkylsulfinyl, (C3-C7)- Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-(Ci-C7)-alkylsulfonimidoyl, S-(Ci-Cy)- Alkylsulfonimidoyl, (Ci-C7)-Alkylsulfonylaminocarbonyl, (C3-C7)- Cycloalkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylaminosulfonyl, Aryl- (Ci-C7)-alkylcarbonylamino, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C7)-Alkoxy-(Ci-C7)-alkylcarbonylamino, Arylsulfonylamino, Hetarylsulfonylamino, sulfonyl (Ci-C 7) -haloalkylamino, amino (Ci-C7) alkylsulfonyl, amino (Ci-C 7) haloalkylsulfonyl, (C 7) - alkylaminosulfonyl, bis (C -C 7) alkylaminosulfonyl, (C3-C7) - Cycloalkylaminosulfonyl, (Ci-C 7) -Haloalkylaminosulfonyl, arylaminosulfonyl, aryl- (Ci-C7) alkylaminosulfonyl, (Ci-C7) alkylsulphonyl, (C 3 -C 7) - cycloalkylsulfonyl, arylsulfonyl, (Ci-C 7) alkylsulfinyl, (C 3 -C 7) - Cycloalkylsulfinyl, arylsulfinyl, N, S-bis (C 1 -C 7 ) -alkylsulfonimidoyl, S- (C 1 -C 6 ) -alkylsulfonimidoyl, (C 1 -C 7 ) -alkylsulfonylaminocarbonyl, (C 3 -C 7 ) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 7 ) Cycloalkylaminosulfonyl, aryl- (C 1 -C 7) -alkylcarbonylamino, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkylcarbonylamino, heteroarylcarbonylamino, (C 1 -C 7) -alkoxy- (C 1 -C 7) -alkylcarbonylamino,
Hydroxy-(Ci-C7)-alkylcarbonylamino, Cyano, Cyano-(Ci-C7)-alkyl, Hydroxy- (C 1 -C 7) -alkylcarbonylamino, cyano, cyano- (C 1 -C 7) -alkyl,
Hydroxycarbonyl, (Ci-C7)-Alkoxycarbonyl, (C3-C7)-Cycloalkoxycarbonyl, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoxycarbonyl, Aryloxycarbonyl, Aryl-(Ci-C7)- alkoxycarbonyl, Aminocarbonyl, (Ci-C7)-Alkylaminocarbonyl, Bis-(Ci-C7)- alkylaminocarbonyl, (Ci-C7)-Alkyl[(Ci-C7)-Alkoxy]aminocarbonyl, (C3-C7)- Cycloalkylaminocarbonyl, Aryl-(Ci-C7)-alkylaminocarbonyl, Heteroaryl-(Ci-C7)- alkylaminocarbonyl, Cyano-(Ci-C7)-alkylaminocarbonyl, (C1-C7)- Haloalkylaminocarbonyl, (C2-C7)-Alkinyl-(Ci-C7)-alkylaminocarbonyl, (C1-C7)- Alkoxycarbonylaminocarbonyl, Aryl-(Ci-C7)-alkoxycarbonylaminocarbonyl, Hydroxycarbonyl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxycarbonyl-(Ci-C7)-alkyl, (C3-C7)- Cycloalkoxycarbonyl-(Ci-C7)-alkyl, (Ci-C7)-Cycloalkyl-(Ci-C7)-alkoxycarbonyl- (Ci-C7)-alkyl, (Ci-C7)-Alkylaminocarbonyl-(Ci-C7)-alkyl, Aminocarbonyl- (Ci-C7)-alkyl, Bis-(Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (C3-C7)- Cycloalkylaminocarbonyl-(Ci-C7)-alkyl, Aryl-(Ci-C7)-alkylaminocarbonyl- (Ci-C7)-alkyl, Heteroaryl-(Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, Cyano- (Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (Ci-C7)-Haloalkylaminocarbonyl- (Ci-C7)-alkyl, (C2-C7)-Alkinyl-(Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (C1-C7)- Alkoxycarbonylaminocarbonyl-(Ci-C7)-alkyl, Aryl-(Ci-C7)- alkoxycarbonylaminocarbonyl-(Ci-C7)-alkyl, Hydroxycarbonyl, (C 1 -C 7) -alkoxycarbonyl, (C 3 -C 7) -cycloalkoxycarbonyl, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkoxycarbonyl, aryloxycarbonyl, aryl- (C 1 -C 7) -alkoxycarbonyl, aminocarbonyl, (Ci -C 7) -alkylaminocarbonyl, bis- (C 1 -C 7) -alkylaminocarbonyl, (C 1 -C 7) -alkyl [(C 1 -C 7) -alkoxy] -aminocarbonyl, (C 3 -C 7) -cycloalkylaminocarbonyl, aryl- (C 1 -C 7) - alkylaminocarbonyl, heteroaryl- (C 1 -C 7) -alkylaminocarbonyl, cyano- (C 1 -C 7) -alkylaminocarbonyl, (C 1 -C 7) -haloalkylaminocarbonyl, (C 2 -C 7) -alkynyl- (C 1 -C 7) -alkylaminocarbonyl, (C 1 -C 7 ) - alkoxycarbonylaminocarbonyl, aryl- (C 1 -C 7 ) -alkoxycarbonylaminocarbonyl, hydroxycarbonyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxycarbonyl- (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkoxycarbonyl- (C 1 -C 7) -alkyl, (C 1 -C 7) -cycloalkyl- (C 1 -C 7) -alkoxycarbonyl- (C 1 -C 7) -alkyl, (C 1 -C 7) -alkylaminocarbonyl- (C 1 -C 7) -alkyl, aminocarbonyl- (C 1 -C 7 ) -alkyl, bis (C 1 -C 7 ) -alkylaminocarbonyl (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkylaminocarbonyl- (C 1 -C 7 ) -alkyl, aryl- (C 1 -C 7 ) -alkyl ) -alkylaminocarbonyl- (C 1 -C 7) -alkyl, heteroaryl- (C 1 -C 7) -alkylamino carbonyl- (C 1 -C 7 ) -alkyl, cyano- (C 1 -C 7 ) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -haloalkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) Alkynyl (C 1 -C 7 ) -alkylaminocarbonyl (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkylaminocarbonyl (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) Alkoxycarbonylaminocarbonyl- (C 1 -C 7) -alkyl, aryl- (C 1 -C 7) -alkoxycarbonylaminocarbonyl- (C 1 -C 7) -alkyl,
(Ci-C7)-Alkoxycarbonyl-(Ci-C7)-alkylaminocarbonyl, Hydroxycarbonyl-(Ci-C7)- alkylaminocarbonyl, Aminocarbonyl-(Ci-C7)-alkylaminocarbonyl, (C1-C7)- Alkylaminocarbonyl-(Ci-C7)-alkylaminocarbonyl, (C3-C7)- Cycloalkylaminocarbonyl-(Ci-C7)-alkylaminocarbonyl, (C3-C7)-Cycloalkyl- (Ci-C7)-alkylaminocarbonyl, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylaminocarbonyl- (Ci-C7)-alkyl, (C2-C7)-Alkenyloxycarbonyl, (C2-C7)-Alkenyloxycarbonyl-(Ci-C7)- alkyl, (C2-C7)-Alkenylaminocarbonyl, (C2-C7)-Alkenyl-(Ci-C7)- alkylaminocarbonyl, (C2-C7)-Alkenylaminocarbonyl-(Ci-C7)-alkyl, (C2-C7)- Alkenyl-(Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (Ci-C7)-Alkylcarbonyl, (C3-C7)-Cycloalkylcarbonyl, Formyl, Hydroxyiminomethyl, Aminoiminomethyl, (Ci-C7)-Alkoxyiminomethyl, (Ci-C7)-Alkylaminoiminomethyl, Bis-(Ci-C7)- alkylaminoiminomethyl, (C3-C7)-Cycloalkoxyiminomethyl, (C3-C7)-Cycloalkyl-(C 1 -C 7) -alkoxycarbonyl- (C 1 -C 7) -alkylaminocarbonyl, hydroxycarbonyl- (C 1 -C 7) -alkylaminocarbonyl, aminocarbonyl- (C 1 -C 7) -alkylaminocarbonyl, (C 1 -C 7) -alkylaminocarbonyl- (C 1 -C 7) - alkylaminocarbonyl, (C 3 -C 7) -cycloalkylaminocarbonyl- (C 1 -C 7) -alkylaminocarbonyl, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkylaminocarbonyl, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkenyloxycarbonyl, (C 2 -C 7 ) -alkenyloxycarbonyl- (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkenylaminocarbonyl, (C 2 -C 7 ) -alkenyl- Ci-C 7 ) - alkylaminocarbonyl, (C 2 -C 7) -alkenylaminocarbonyl- (C 1 -C 7) -alkyl, (C 2 -C 7) -alkenyl- (C 1 -C 7) -alkylaminocarbonyl- (C 1 -C 7) -alkyl, (C 1 -C 7) -alkylcarbonyl, (C 3 -C 7) -cycloalkylcarbonyl, formyl, hydroxyiminomethyl, aminoiminomethyl, (C 1 -C 7) -alkoxyiminomethyl, (C 1 -C 7) -alkylaminoiminomethyl, bis (C 1 -C 7) -alkylaminoiminomethyl, (C 3 -C 7) -cycloalkoxyiminomethyl, (C3 C7) cycloalkyl
(Ci-C7)-alkoximinomethyl, Aryloximinomethyl, Aryl-(Ci-C7)-alkoxyiminomethyl, Aryl-(Ci-C7)-alkylaminoiminomethyl, (C2-C7)-Alkenyloxyiminomethyl, (C 1 -C 7) -alkoximinomethyl, aryloximinomethyl, aryl- (C 1 -C 7) -alkoxyiminomethyl, aryl- (C 1 -C 7) -alkylaminoiminomethyl, (C 2 -C 7) -alkenyloxyiminomethyl,
Arylaminoiminomethyl, Arylsulfonylaminoiminomethyl, Heteroaryl-(Ci-C7)- alkyl, Heterocyclyl-(Ci-C7)-alkyl, Hydroxycarbonylheterocyclyl, (C1-C7)- Alkoxycarbonylheterocyclyl, (C2-C7)-Alkenyloxycarbonylheterocyclyl, (C2-C7)- Arylaminoiminomethyl, arylsulfonylaminoiminomethyl, heteroaryl- (C 1 -C 7) -alkyl, heterocyclyl- (C 1 -C 7) -alkyl, hydroxycarbonylheterocyclyl, (C 1 -C 7) -alkoxycarbonylheterocyclyl, (C 2 -C 7) -alkenyloxycarbonylheterocyclyl, (C 2 -C 7) -
Alkenyl-(Ci-C7)-alkoxycarbonylheterocyclyl, Aryl-(Ci-C7)- alkoxycarbonylheterocyclyl, (C3-C7)-Cycloalkoxycarbonylheterocyclyl, (C3-C7)- Cycloalkyl-(Ci-C7)-alkoxycarbonylheterocyclyl, Aminocarbonylheterocyclyl, (Ci-C7)-Alkylaminocarbonylheterocyclyl, Bis-(Ci-C7)- Alkylaminocarbonylheterocyclyl, (C3-C7)-Cycloalkylaminocarbonylheterocyclyl,Alkenyl- (Ci-C7) -alkoxycarbonylheterocyclyl, aryl- (Ci-C7) -alkoxycarbonylheterocyclyl, (C3-C7) -cycloalkoxycarbonylheterocyclyl, (C3-C7) -cycloalkyl- (Ci-C7) -alkoxycarbonylheterocyclyl, aminocarbonylheterocyclyl, (Ci-C7 ) -Alkylaminocarbonylheterocyclyl, bis (C 1 -C 7) -alkylaminocarbonylheterocyclyl, (C 3 -C 7) -cycloalkylaminocarbonylheterocyclyl,
Aryl-(Ci-C7)-alkylaminocarbonylheterocyclyl, (C2-C7)-Aryl- (Ci-C7) -alkylaminocarbonylheterocyclyl, (C2-C7) -
Alkenylaminocarbonylheterocyclyl, Hydroxycarbonylheterocyclyl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxycarbonylheterocyclyl-(Ci-C7)-alkyl, Hydroxycarbonyl-(C3-C7)- cycloalkyl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxycarbonyl-(C3-C7)-cycloalkyl-(Ci-C7)- alkyl steht, Alkenylaminocarbonylheterocyclyl, hydroxycarbonylheterocyclyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxycarbonylheterocyclyl- (C 1 -C 7 ) -alkyl, hydroxycarbonyl- (C 3 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkyl, (C 1 -C 4 ) -alkyl C7) -alkoxycarbonyl- (C3-C7) -cycloalkyl- (C 1 -C 7 ) -alkyl,
R9 und R10 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C7)-Alkyl, (C1-C7)- Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C7)- alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, R 9 and R 10 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, heteroaryl, Aryl- (C 1 -C 7 ) -alkyl or together with the atom to which they are attached form a carbonyl group,
A4, A5 gleich oder verschieden sind und unabhängig voneinander für N-R11, A 4 , A 5 are the same or different and are each independently NR 11 ,
Sauerstoff, Schwefel oder die Gruppierung C-R11 stehen, wobei jedoch in keinem Fall mehr als ein Sauerstoffatom im Heterocyclus enthalten ist, und wobei R11 in den Gruppierungen N-R11 und C-R11 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, R11 für Wasserstoff, (Ci-C7)-Alkyl, (C2-C7)-Alkenyl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxy- (Ci-C7)-alkyl, (Ci-C7)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C7) Cycloalkylcarbonyl, (Ci-C7)-Alkoxycarbonyl, (C2-C7)-Alkenyloxycarbonyl, (Ci-C7)-Alkoxycarbonyl-(Ci-C7)-alkyl, (Ci-C7)-Alkylaminocarbonyl-(Ci-C7)- alkyl, Arylaminocarbonyl-(Ci-C7)-alkyl, Aryloxyalkyl, Aryl-(Ci-C7)-alkyl, Heteroaryl-(Ci-C7)-alkyl, (Ci-C7)-Haloalkyl steht, Oxygen, sulfur or the group CR 11 , but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groupings NR 11 and CR 11 each have the same or different meanings as defined below, R 11 represents hydrogen, (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkenyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy- (C 1 -C 7 ) -alkyl, (Ci-C 7) alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C3-C7) cycloalkylcarbonyl, (C 7) alkoxycarbonyl, (C2-C7) alkenyloxycarbonyl, (C 7) alkoxycarbonyl (C -C 7) alkyl, (Ci-C 7) alkylaminocarbonyl (Ci-C7) - alkyl, arylaminocarbonyl (Ci-C7) alkyl, aryloxyalkyl, aryl (Ci-C7) alkyl, heteroaryl (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -haloalkyl,
R12 und R13 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C7)-Alkyl, R 12 and R 13 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl,
(Ci-C7)-Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy, Aryl, Heteroaryl, Aryl- (Ci-C7)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 7 ) -alkyl or together with the atom to which they are bound to form a carbonyl group,
A6, A7, A8, A9 gleich oder verschieden sind und unabhängig voneinander für 0, S, N, NH, N-(Ci-C7)-Alkyl, (Ci-C7)-Alkoxycarbonyl-N, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl- N, N-Aryl, N-Heteroaryl, N-Heterocyclyl, Arylsulfonyl-N, (Ci-C7)-Alkylsulfonyl- N, (C3-C7)-Cycloalkylsulfonyl-N oder die Gruppierung C-R15 stehen, wobei maximal zwei 0- oder S-Atome im Heterocyclus vorhanden sind sind, und wobei keine 0- oder S-Atome benachbart zueinander sind, und wobei R15 in der Gruppierung C-R15 jeweils gleiche oder verschiedene Bedeutungen gemäß der vorstehenden Definition hat und A 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxycarbonyl-N, ( C 1 -C 4 ) -alkoxy- (C 1 -C 7 ) -alkyl-N, N-aryl, N-heteroaryl, N-heterocyclyl, arylsulfonyl-N, (C 1 -C 7 ) -alkylsulfonyl-N, (C 3 -C 7 ) -cycloalkylsulfonyl-N or the group CR 15 , wherein a maximum of two 0 or S atoms are present in the heterocycle, and wherein no 0 or S atoms are adjacent to each other, and wherein R 15 in the group CR 15 each has the same or different meanings according to the above definition and
R16 und R17 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C7)-Alkyl, R 16 and R 17 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl,
(Ci-C7)-Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy, Aryl, Heteroaryl, Aryl- (Ci-C7)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 7 ) -alkyl or together with the atom to which they are bound to form a carbonyl group,
A10 für N-R18, Sauerstoff oder die Gruppierung C-R18 steht und wobei R18 in den Gruppierungen N-R18 und C-R18 jeweils gleiche oder verschiedene A 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
Bedeutungen gemäß der nachstehenden Definition hat,  Has meanings as defined below,
R18 für Wasserstoff, (Ci-C7)-Alkyl, (C2-C7)-Alkenyl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxy- (Ci-C7)-alkyl, (Ci-C7)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C7) Cycloalkylcarbonyl, (Ci-C7)-Alkoxycarbonyl, (C2-C7)-Allyloxycarbonyl, Aryloxy- (Ci-C7)-alkyl, Aryl-(Ci-C7)-alkyl, (Ci-C7)-Haloalkyl, Aryl steht, R 18 is hydrogen, (Ci-C7) alkyl, (C 2 -C 7) alkenyl (Ci-C7) alkyl, (Ci-C7) alkoxy (Ci-C7) alkyl , (C 1 -C 7 ) -alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 7 ) Cycloalkylcarbonyl, (C 1 -C 7 ) -alkoxycarbonyl, (C 2 -C 7 ) -alloxycarbonyl, aryloxy- (C 1 -C 7 ) -alkyl, aryl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -haloalkyl, aryl stands,
A11 für N oder die Gruppierung C-R21 steht und wobei R21 in der Gruppierung C- R21 die Bedeutung gemäß der vorstehenden Definition hat, A 11 is N or the group CR 21 and R 21 in the grouping C-R 21 has the meaning given above,
A12 für N-R18 oder die Gruppierung C(R19)R20 steht und wobei R19 und R20 in der Gruppierung C(R19)R20 die Bedeutung gemäß der nachstehenden Definition haben, A 12 is NR 18 or the moiety C (R 19 ) R 20 and where R 19 and R 20 in the moiety C (R 19 ) R 20 are as defined below,
R19 und R20 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C7)-Alkyl, R 19 and R 20 independently of one another represent hydrogen, halogen, (C 1 -C 7) -alkyl,
(Ci-C7)-Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy, Aryl, Heteroaryl, Aryl- (Ci-C7)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, mit Ausnahme von 4-Hydroxy-4-{(E)-2-[2-(hydroxymethyl)phenyl]vinyl}-3,5,5- trimethylcyclohex-2-en-1 -on, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en- 1 -yl)vinyl]benzaldehyd, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]benzoesäure und Methyl-2-[(E)-2-(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex- 2-en-1 -yl)vinyl]benzoat. (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 7 ) -alkyl or together with the atom to which They are bonded to form a carbonyl group, with the exception of 4-hydroxy-4 - {(E) -2- [2- (hydroxymethyl) phenyl] vinyl} -3,5,5-trimethylcyclohex-2-en-1-one , 2 - [(E) -2- (1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzaldehyde, 2 - [(E) -2- (1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid and methyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl 4-oxocyclohex-2-en-1-yl) vinyl] benzoate.
Ganz besonders bevorzugt sind Verbindungen der allgemeinen Formel (I), worin Very particular preference is given to compounds of the general formula (I) in which
[X-Y] für die Gruppierungen [X-Y] for the groupings
[x-Y]1 und [X-Y]2 steht, [xY] 1 and [XY] 2 ,
Q für die carbocyclischen und heterocyclischen Gruppierungen Q-1 bis Q-4 Q for the carbocyclic and heterocyclic moieties Q-1 to Q-4
steht, wobei die Gruppierungen R6 bis R21 und A1 bis A12 jeweils die wherein the groups R 6 to R 21 and A 1 to A 12 are each the
Bedeutung gemäß der nachstehenden Definitionen haben und wobei der Pfeil für eine Bindung zur jeweiligen Gruppierung [X-Y] steht,  Have meaning according to the definitions below and wherein the arrow represents a bond to the respective grouping [X-Y],
R1 für (Ci-Ce)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C2-Ce)-Alkenyl-(Ci-Ce)- alkyl, (C2-C6)-Alkinyl-(Ci-C6)-alkyl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl, Hydroxy- (Ci-Ce)-alkyl, (Ci-Ce)-Alkoxy, (Ci-C6)-Haloalkyl steht, R 1 is (Ci-Ce) alkyl, (C 2 -C 6) alkenyl, (C 2 -C 6) -alkynyl, (C2 -Ce) alkenyl (Ci-Ce) - alkyl, (C2 -C 6) alkynyl (Ci-C 6) alkyl, (Ci-C6) alkoxy (Ci-C 6) alkyl, hydroxy (Ci-Ce) alkyl, (Ci-Ce) - Alkoxy, (C 1 -C 6 ) -haloalkyl,
R2 für Wasserstoff, (Ci-Ce)-Alkyl, Hydroxy-(Ci-C6)-alkyl, (Ci-C6)-Haloalkyl, R 2 is hydrogen, (C 1 -C 6 ) -alkyl, hydroxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl,
(Ci-Ce)-Alkoxy, Tris-[(Ci-Ce)-alkylsilyl]-(Ci-Ce)-alkyl, Cyano-(Ci-C6)-alkyl, Aryl- (Ci-Ce)-alkyl, (Ci-C6)-Alkoxycarbonyl-(Ci-C6)-alkyl steht, (C 1 -C 6 ) -alkoxy, tris - [(C 1 -C 6 ) -alkylsilyl] - (C 1 -C 6 ) -alkyl, cyano- (C 1 -C 6 ) -alkyl, aryl- (C 1 -C 6 ) -alkyl, ( C 1 -C 6 -alkoxycarbonyl- (C 1 -C 6 ) -alkyl,
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden, R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
R3 und R4 unabhängig voneinander für Methoxy, Ethoxy, n-Propoxy, iso-Propoxy, n- Butyloxy, iso-Butyloxy stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, (C1-C6)- Alkoxyiminogruppe, (C3-C6)-Cycloalkoxyiminogruppe, (C3-C6)-Cycloalkyl- (Ci-C6)-alkoximinogruppe, (Ci-C6)-alkenyloximinogruppe oder einen 5-7- gliedrigen heterocyclischen Ring, z. B. einen 1 ,3-Dioxolanyl-, 1 ,3-Dioxanyl-, 1 ,3-Dithiolanyl-, 1 ,3-Dithianylring, der gegebenenfalls weiter durch (C-i-Ce)-R 3 and R 4 independently of one another are methoxy, ethoxy, n-propoxy, isopropoxy, n-butyloxy, iso-butyloxy or, together with the atom to which they are bonded, an oxo group, hydroxyimino group, (C 1 -C 6) Alkoxyimino group, (C 3 -C 6) -cycloalkoxyimino group, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkoximino group, (C 1 -C 6) -alkenyloxy-imino group or a 5-7-membered heterocyclic ring, e.g. B. a 1, 3-Dioxolanyl-, 1, 3-dioxanyl, 1, 3-dithiolanyl, 1, 3-dithianyl, optionally further by (Ci-Ce) -
Alkyl, (Ci-Ce)-Alkoxycarbonyl, (C3-C6)-Cycloalkyl, spiro-(C3-C6)-Cycloalkyl, spiro-Oxetanyl substituiert sein kann, bilden, R5 für Wasserstoff, tert.-Butyldimethylsilyl, Trimethylsilyl, Triethylsilyl, Tri-(iso- Propyl)silyl, Tri-(n-Propyl)silyl, Dimethyl(phenyl)silyl, tert.-Butyldiphenylsilyl, Diethylisopropylsilyl, Isopropyldimethylsilyl, tert.-Hexyldimethylsilyl, 2- (Trimethylsilyl)ethoxymethyl, 2-(Trimethylsilyl)ethyl steht, Alkyl, (C 1 -C 6 ) -alkoxycarbonyl, (C 3 -C 6 ) -cycloalkyl, spiro (C 3 -C 6 ) -cycloalkyl, spiro-oxetanyl may be substituted, R 5 is hydrogen, tert-butyldimethylsilyl, trimethylsilyl, triethylsilyl, tri (iso-propyl) silyl, tri (n-propyl) silyl, dimethyl (phenyl) silyl, tert-butyldiphenylsilyl, diethylisopropylsilyl, isopropyldimethylsilyl, tert. Hexyldimethylsilyl, 2- (trimethylsilyl) ethoxymethyl, 2- (trimethylsilyl) ethyl,
R6 und R7 unabhängig voneinander für Wasserstoff, Nitro, Amino, Cyano, R 6 and R 7 independently of one another represent hydrogen, nitro, amino, cyano,
Thiocyanato, Isothiocyanato, Fluor, Chlor, Brom, lod, (Ci-C6)-Alkyl, (C3-Ce)- Cycloalkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, Aryl, Aryl-(Ci-C6)-alkyl, (C2-C6)- Alkenyl-(Ci-C6)-alkyl, (C2-C6)-Alkinyl-(Ci-C6)-alkyl, Aryl-(Ci-C6)-alkoxy, Heteroaryl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl, Hydroxy-(Ci-C6)-alkyl, (Ci-C6)- Haloalkyl, (C3-C6)-Halocycloalkyl, (Ci-C6)-Alkoxy, (Ci-C6)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C6)-Cycloalkyloxy, Hydroxy, (C3-C6)-Cycloalkyl-(Ci-C6)- alkoxy, (Ci-C6)-Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (C1-C6)- Alkylaminocarbonyl, (C3-C6)-Cycloalkylaminocarbonyl, Cyano-(Ci-Ce)- alkylaminocarbonyl, (C2-C6)-Alkenylaminocarbonyl, (C2-C6)- Alkinylaminocarbonyl, (Ci-C6)-Alkylamino, (Ci-C6)-Alkylthio, (C1-C6)- Haloalkylthio, Hydrothio, Bis-(Ci-C6)-alkylamino, (C3-C6)-Cycloalkylamino, (Ci-C6)-Alkylcarbonylamino, (C3-C6)-Cycloalkylcarbonylamino, Formylamino, (Ci-C6)-Haloalkylcarbonylamino, (Ci-C6)-Alkoxycarbonylamino, (C1-C6)- Alkylaminocarbonylamino, (Ci-C6)-Alkyl-[(Ci-C6)-Alkyl]-aminocarbonylamino, (Ci-C6)-Alkylsulfonylamino, (C3-C6)-Cycloalkylsulfonylamino, Thiocyanato, isothiocyanato, fluorine, chlorine, bromine, iodine, (C 1 -C 6 ) -alkyl, (C 3 -C 6 ) -cycloalkyl, (C 2 -C 6 ) -alkenyl, (C 2 -C 6 ) -alkynyl, aryl, aryl (Ci-C 6) alkyl, (C 2 -C 6) - alkenyl, (Ci-C 6) alkyl, (C2-C6) alkynyl (Ci-C 6) alkyl, aryl (C 1 -C 6 ) -alkoxy, heteroaryl, (C 1 -C 6 ) -alkoxy- (C 1 -C 6 ) -alkyl, hydroxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, ( C 3 -C 6) halocycloalkyl, (Ci-C 6) alkoxy, (Ci-C 6) haloalkoxy, aryloxy, heteroaryloxy, (C3-C6) cycloalkyloxy, hydroxy, (C3-C6) -cycloalkyl- ( C 1 -C 6) -alkoxy, (C 1 -C 6) -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, (C 1 -C 6) -alkylaminocarbonyl, (C 3 -C 6) -cycloalkylaminocarbonyl, cyano- (C 1 -C 6) -alkylaminocarbonyl, (C 2 -C 6) Alkenylaminocarbonyl, (C 2 -C 6) -alkynylaminocarbonyl, (C 1 -C 6) -alkylamino, (C 1 -C 6) -alkylthio, (C 1 -C 6) -haloalkylthio, hydrothio, bis (C 1 -C 6) -alkylamino, (C 3 -C 6) -alkylamino, C6) -cycloalkylamino, (C 1 -C 6) -alkylcarbonylamino, (C 3 -C 6) -cycloalkylcarbonylamino, formylamino, (C 1 -C 6) -haloalkylcarbonylamino, (C 1 -C 6) -alkoxycarbonylamino, (C 1 -C 6) -alkylamino carbonylamino, (C 1 -C 6) -alkyl - [(C 1 -C 6) -alkyl] -aminocarbonylamino, (C 1 -C 6) -alkylsulfonylamino, (C 3 -C 6) -cycloalkylsulfonylamino,
Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl-(Ci-C6)-haloalkylamino, Aminosulfonyl, Amino-(Ci-C6)-alkylsulfonyl, Amino-(Ci-C6)-haloalkylsulfonyl, (Ci-C6)-Alkylaminosulfonyl, Bis-[(Ci-C6)-alkyl]aminosulfonyl, (C3-C6)- Cycloalkylaminosulfonyl, (Ci-C6)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-(Ci-C6)-alkylaminosulfonyl, (Ci-C6)-Alkylsulfonyl, (C3-C6)- Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C6)-Alkylsulfinyl, (C3-C6)- Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-[(Ci-C6)-alkyl]sulfonimidoyl, S-(Ci-Ce)- Alkylsulfonimidoyl, (Ci-C6)-Alkylsulfonylaminocarbonyl, (C3-C6)- Cycloalkylsulfonylaminocarbonyl, (C3-C6)-Cycloalkylaminosulfonyl, Aryl- (Ci-C6)-alkylcarbonylamino, (C3-C6)-Cycloalkyl-(Ci-C6)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C6)-Alkoxy-(Ci-C6)-alkylcarbonylamino, Hydroxy-(Ci-C6)-alkylcarbonylamino, Tris-[(Ci-C6)-alkyl]silyl stehen, Arylsulfonylamino, hetarylsulfonylamino, sulfonyl- (C 1 -C 6) -haloalkylamino, aminosulfonyl, amino- (C 1 -C 6) -alkylsulfonyl, amino- (C 1 -C 6) -haloalkylsulfonyl, (C 1 -C 6) -alkylaminosulfonyl, bis - [(ci) C6) alkyl] aminosulfonyl, (C3-C6) - Cycloalkylaminosulfonyl, (Ci-C6) -Haloalkylaminosulfonyl, arylaminosulfonyl, aryl (Ci-C6) alkylaminosulfonyl, (Ci-C 6) alkylsulfonyl, (C 3 -C 6) - cycloalkylsulfonyl, arylsulfonyl, (Ci-C 6) alkylsulfinyl, (C 3 -C 6) - cycloalkylsulfinyl, arylsulfinyl, N, S-bis - [(Ci-C6) alkyl] sulfonimidoyl, S- (Ci -Ce) - alkylsulfonimidoyl, (C 1 -C 6) -alkylsulfonylaminocarbonyl, (C 3 -C 6) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 6) -cycloalkylaminosulfonyl, aryl- (C 1 -C 6) -alkylcarbonylamino, (C 3 -C 6) -cycloalkyl- (Ci C6) alkylcarbonylamino, Heteroarylcarbonylamino, (C 1 -C 6) -alkoxy- (C 1 -C 6) -alkylcarbonylamino, hydroxy- (C 1 -C 6) -alkylcarbonylamino, tris - [(C 1 -C 6) -alkyl] silyl,
A1, A2, A3 gleich oder verschieden sind und unabhängig voneinander für N A 1 , A 2 , A 3 are the same or different and are independently N
(Stickstoff) oder die Gruppierung C-R8 stehen, wobei jedoch in keinem Fall mehr als zwei N-Atome benachbart sind, und wobei R8 in der Gruppierung C- R8 jeweils gleiche oder verschiedene Bedeutungen gemäß der (Nitrogen) or the group CR 8 , but in no case more than two N atoms are adjacent, and wherein R 8 in the group C-R 8 each have the same or different meanings according to the
nachstehenden Definition hat und A1 und A2, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, A2 und A3, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, R8, R14, R15 und R21 unabhängig voneinander jeweils für Wasserstoff, Nitro, Amino, Hydroxy, Hydrothio, Thiocyanato, Isothiocyanato, Fluor, Chlor, Brom, lod, (Ci-C6)-Alkyl, (C3-C6)-Cycloalkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, Aryl, Aryl- (Ci-C6)-alkyl, Aryl-(Ci-C6)-alkoxy, Heteroaryl, (Ci-C6)-Haloalkyl, (Ci-C6)- Halocycloalkyl, (Ci-C6)-Alkoxy, (Ci-C6)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C6)-Cycloalkyloxy, (C3-C6)-Cycloalkyl-(Ci-C6)-alkoxy, Hydroxy-(Ci-Ce)- alkyl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl, Aryloxy-(Ci-C6)-alkyl, Heteroaryloxy- (Ci-C6)-alkyl, (C2-C6)-Alkenylaminocarbonyl, (Ci-C6)-Alkylamino, (C1-C6)- Alkylthio, (Ci-C6)-Haloalkylthio, Bis-[(Ci-C6)-alkyl]amino, (C3-C6)- Cycloalkylamino, (Ci-C6)-Alkylcarbonylamino, (C3-C6)- Cycloalkylcarbonylamino, Formylamino, (Ci-C6)-Haloalkylcarbonylamino,has the following definition and A 1 and A 2 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 bis Form a 6-membered ring, A 2 and A 3 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring, R 8 , R 14 , R 15 and R 21 are each independently hydrogen, nitro, amino, hydroxy, hydrothio, thiocyanato, isothiocyanato, fluorine, chlorine, bromine, iodine, (Ci-C 6 ) alkyl, (C 3 -C 6) -cycloalkyl, (C 2 -C 6) alkenyl, (C 2 -C 6) alkynyl, aryl, aryl (Ci-C 6) alkyl, aryl ( C 1 -C 6 ) -alkoxy, heteroaryl, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -halocycloalkyl, (Ci-C6) alkoxy, (Ci-C6) haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 6) cycloalkyloxy, (C3-C6) cycloalkyl (Ci-C 6) alkoxy, hydroxy (C 1 -C 6) -alkyl, (C 1 -C 6) -alkoxy- (C 1 -C 6) -alkyl, aryloxy- (C 1 -C 6) -alkyl, heteroaryloxy- (C 1 -C 6) -alkyl, (C 2 -C 6) - alkenylaminocarbonyl, (Ci-C6) alkylamino, (C1-C6) - alkylthio, (Ci-C 6) haloalkylthio, bis - [(Ci-C 6) alkyl] amino, (C 3 -C 6) - cycloalkylamino , (C 1 -C 6) -alkylcarbonylamino, (C 3 -C 6) -cycloalkylcarbonylamino, formylamino, (C 1 -C 6) -haloalkylcarbonylamino,
(Ci-C6)-Alkoxycarbonylamino, (Ci-C6)-Alkylaminocarbonylamino, (C1-C6)- Alkyl[(Ci-C6)-Alkyl]-aminocarbonylamino, (Ci-C6)-Alkylsulfonylamino, (C3-C6)- Cycloalkylsulfonylamino, Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl- (Ci-C6)-haloalkylamino, Amino-(Ci-C6)-alkylsulfonyl, Amino-(Ci-C6)- haloalkylsulfonyl, (Ci-C6)-Alkylaminosulfonyl, Bis-(Ci-C6)-alkylaminosulfonyl, (C3-C6)-Cycloalkylaminosulfonyl, (Ci-C6)-Haloalkylaminosulfonyl, (C 1 -C 6) -alkoxycarbonylamino, (C 1 -C 6) -alkylaminocarbonylamino, (C 1 -C 6) -alkyl [(C 1 -C 6) -alkyl] -aminocarbonylamino, (C 1 -C 6) -alkylsulfonylamino, (C 3 -C 6) - Cycloalkylsulfonylamino, arylsulfonylamino, hetarylsulfonylamino, sulfonyl- (C 1 -C 6) -haloalkylamino, amino- (C 1 -C 6) -alkylsulfonyl, amino- (C 1 -C 6) -haloalkylsulfonyl, (C 1 -C 6) -alkylaminosulfonyl, bis (C 1 -C 6) ) -alkylaminosulfonyl, (C 3 -C 6) -cycloalkylaminosulfonyl, (C 1 -C 6) -haloalkylaminosulfonyl,
Arylaminosulfonyl, Aryl-(Ci-C6)-alkylaminosulfonyl, (Ci-C6)-Alkylsulfonyl, (C3-C6)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-Ce)-Alkylsulfinyl, (C3-C6)- Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-(Ci-C6)-alkylsulfonimidoyl, S-(Ci-Ce)- Alkylsulfonimidoyl, (Ci-C6)-Alkylsulfonylaminocarbonyl, (C3-C6)- Cycloalkylsulfonylaminocarbonyl, (C3-C6)-Cycloalkylaminosulfonyl, Aryl- (Ci-C6)-alkylcarbonylamino, (C3-C6)-Cycloalkyl-(Ci-C6)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C6)-Alkoxy-(Ci-C6)-alkylcarbonylamino, Arylaminosulfonyl, aryl (Ci-C6) alkylaminosulfonyl, (Ci-C6) alkylsulfonyl, (C 3 -C 6) cycloalkylsulfonyl, arylsulfonyl, (Ci-Ce) alkylsulfinyl, (C 3 -C 6) - cycloalkylsulfinyl, Arylsulfinyl, N, S-bis- (C 1 -C 6) -alkylsulfonimidoyl, S- (C 1 -C 6) -alkylsulfonimidoyl, (C 1 -C 6) -alkylsulfonylaminocarbonyl, (C 3 -C 6) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 6) -cycloalkylaminosulfonyl, Aryl- (C 1 -C 6) -alkylcarbonylamino, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkylcarbonylamino, heteroarylcarbonylamino, (C 1 -C 6) -alkoxy- (C 1 -C 6) -alkylcarbonylamino,
Hydroxy-(Ci-C6)-alkylcarbonylamino, Cyano, Cyano-(Ci-C6)-alkyl, Hydroxy- (C 1 -C 6) -alkylcarbonylamino, cyano, cyano- (C 1 -C 6) -alkyl,
Hydroxycarbonyl, (Ci-C6)-Alkoxycarbonyl, (C3-C6)-Cycloalkoxycarbonyl, (C3-C6)-Cycloalkyl-(Ci-C6)-alkoxycarbonyl, Aryloxycarbonyl, Aryl-(Ci-Ce)- alkoxycarbonyl, Aminocarbonyl, (Ci-C6)-Alkylaminocarbonyl, Bis-(Ci-Ce)- alkylaminocarbonyl, (Ci-C6)-Alkyl[(Ci-C6)-Alkoxy]aminocarbonyl, (C3-C6)- Cycloalkylaminocarbonyl, Aryl-(Ci-C6)-alkylaminocarbonyl, Heteroaryl-(Ci-C6)- alkylaminocarbonyl, Cyano-(Ci-C6)-alkylaminocarbonyl, (C1-C6)- Haloalkylaminocarbonyl, (C2-C6)-Alkinyl-(Ci-C6)-alkylaminocarbonyl, (C1-C6)- Alkoxycarbonylaminocarbonyl, Aryl-(Ci-C6)-alkoxycarbonylaminocarbonyl, Hydroxycarbonyl-(Ci-C6)-alkyl, (Ci-C6)-Alkoxycarbonyl-(C-i-C6)-alkyl, (C3-C6)- Cycloalkoxycarbonyl-(Ci-C6)-alkyl, (Ci-C6)-Cycloalkyl-(Ci-C6)-alkoxycarbonyl- (Ci-C6)-alkyl, (Ci-C6)-Alkylaminocarbonyl-(Ci-C6)-alkyl, Aminocarbonyl- (Ci-Ce)-alkyl, Bis-(Ci-C6)-alkylaminocarbonyl-(Ci-C6)-alkyl, (C3-C6)- Cycloalkylaminocarbonyl-(Ci-C6)-alkyl, Aryl-(Ci-C6)-alkylaminocarbonyl- (Ci-C6)-alkyl, Heteroaryl-(Ci-C6)-alkylaminocarbonyl-(Ci-C6)-alkyl, Cyano- (Ci-C6)-alkylaminocarbonyl-(Ci-C6)-alkyl, (Ci-C6)-Haloalkylaminocarbonyl- (Ci-Ce)-alkyl, (C2-Ce)-Alkinyl-(Ci-Ce)-alkylaminocarbonyl-(Ci-Ce)-alkyl, (C3-Ce)-Cycloalkyl-(Ci-Ce)-alkylaminocarbonyl-(Ci-Ce)-alkyl, (Ci-C6)- Alkoxycarbonylaminocarbonyl-(Ci-C6)-alkyl, Aryl-(Ci-Ce)- alkoxycarbonylaminocarbonyl-(Ci-C6)-alkyl, (Ci-C6)-Alkoxycarbonyl-(Ci-C6)-alkylaminocarbonyl, Hydroxycarbonyl-(Ci-C6)- alkylaminocarbonyl, Aminocarbonyl-(Ci-C6)-alkylaminocarbonyl, (C1-C6)- Alkylaminocarbonyl-(Ci-C6)-alkylaminocarbonyl, (C3-C6)- Cycloalkylaminocarbonyl-(Ci-C6)-alkylaminocarbonyl, (C3-C6)-Cycloalkyl- (Ci-C6)-alkylaminocarbonyl, (C3-C6)-Cycloalkyl-(Ci-C6)-alkylaminocarbonyl- (Ci-C6)-alkyl, (C2-C6)-Alkenyloxycarbonyl, (C2-C6)-Alkenyloxycarbonyl-(Ci-C6)- alkyl, (C2-C6)-Alkenylaminocarbonyl, (C2-C6)-Alkenyl-(Ci-C6)- alkylaminocarbonyl, (C2-C6)-Alkenylaminocarbonyl-(Ci-C6)-alkyl, (C2-C6)- Alkenyl-(Ci-C6)-alkylaminocarbonyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylcarbonyl, (C3-C6)-Cycloalkylcarbonyl, Formyl, Hydroxyiminomethyl, Aminoiminomethyl, (Ci-C6)-Alkoxyiminomethyl, (Ci-C6)-Alkylaminoiminomethyl, Bis-(Ci-Ce)- alkylaminoiminomethyl, (C3-C6)-Cycloalkoxyiminomethyl, (C3-C6)-Cycloalkyl- (Ci-C6)-alkoximinomethyl, Aryloximinomethyl, Aryl-(Ci-C6)-alkoxyiminomethyl, Aryl-(Ci-C6)-alkylaminoiminomethyl, (C2-C6)-Alkenyloxyiminomethyl, Hydroxycarbonyl, (C 1 -C 6) -alkoxycarbonyl, (C 3 -C 6) -cycloalkoxycarbonyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkoxycarbonyl, aryloxycarbonyl, aryl- (C 1 -C 6) -alkoxycarbonyl, aminocarbonyl, (Ci -C 6) -alkylaminocarbonyl, bis- (C 1 -C 6) -alkylaminocarbonyl, (C 1 -C 6) -alkyl [(C 1 -C 6) -alkoxy] -aminocarbonyl, (C 3 -C 6) -cycloalkylaminocarbonyl, aryl- (C 1 -C 6) - alkylaminocarbonyl, heteroaryl- (C 1 -C 6) -alkylaminocarbonyl, cyano- (C 1 -C 6) -alkylaminocarbonyl, (C 1 -C 6) -haloalkylaminocarbonyl, (C 2 -C 6) -alkynyl- (C 1 -C 6) -alkylaminocarbonyl, (C 1 -C 6 ) - alkoxycarbonylaminocarbonyl, aryl- (C 1 -C 6) -alkoxycarbonylaminocarbonyl, hydroxycarbonyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkoxycarbonyl- (C 1 -C 6) -alkyl, (C 3 -C 6) -cycloalkoxycarbonyl- (Ci -C 6) -alkyl, (C 1 -C 6) -cycloalkyl- (C 1 -C 6) -alkoxycarbonyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, aminocarbonyl- (Ci -Ce) alkyl, bis (Ci-C 6 ) -alkylaminocarbonyl (Ci-C 6 ) alkyl, (C 3 -C 6 ) - cycloalkylaminocarbonyl (Ci-C6) alkyl, aryl (Ci-C6 ) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, heteroaryl- (C 1 -C 6) -alkylamino carbonyl- (C 1 -C 6) -alkyl, cyano- (C 1 -C 6) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -haloalkylaminocarbonyl- (C 1 -C 6) -alkyl, (C 2 -C 6) - Alkynyl (C 1 -C 6 ) -alkylaminocarbonyl (C 1 -C 6 ) -alkyl, (C 3 -C 6 ) -cycloalkyl- (C 1 -C 6 ) -alkylaminocarbonyl- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkoxycarbonylaminocarbonyl (C 1 -C 6) -alkyl, aryl- (C 1 -C 6) -alkoxycarbonylaminocarbonyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkoxycarbonyl- (C 1 -C 6) -alkylaminocarbonyl, hydroxycarbonyl- (C 1 -C 6) -alkylaminocarbonyl, aminocarbonyl- (C 1 -C 6) -alkylaminocarbonyl, (C 1 -C 6) -alkylaminocarbonyl- (C 1 -C 6) - alkylaminocarbonyl, (C 3 -C 6) -cycloalkylaminocarbonyl- (C 1 -C 6) -alkylaminocarbonyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkylaminocarbonyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, (C 2 -C 6) -alkenyloxycarbonyl, (C 2 -C 6) -alkenyloxycarbonyl- (C 1 -C 6) -alkyl, (C 2 -C 6) -alkenylaminocarbonyl, (C 2 -C 6) -alkenyl- (Ci -C 6) - alkylaminocarbonyl, (C 2 -C 6) -alkenylaminocarbonyl- (C 1 -C 6) -alkyl, (C 2 -C 6) -alkenyl- (C 1 -C 6) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, (C 1 -C 6) ) -Alkylcarbonyl, (C 3 -C 6) -cycloalkylcarbonyl, formyl, hydroxyiminomethyl, aminoiminomethyl, (C 1 -C 6) -alkoxyiminomethyl, (C 1 -C 6) -alkylaminoiminomethyl, bis (C 1 -C 6) -alkylaminoiminomethyl, (C 3 -C 6) - Cycloalkoxyiminomethyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkoximinomethyl, aryloximinomethyl, aryl- (C 1 -C 6) -alkoxyiminomethyl, aryl- (C 1 -C 6) -alkylaminoiminomethyl, (C 2 -C 6) -alkenyloxyiminomethyl,
Arylaminoiminomethyl, Arylsulfonylaminoiminomethyl, Heteroaryl-(Ci-C6)- alkyl, Heterocyclyl-(Ci-C6)-alkyl, Hydroxycarbonylheterocyclyl, (C1-C6)- Alkoxycarbonylheterocyclyl, (C2-C6)-Alkenyloxycarbonylheterocyclyl, (C2-C6)- Alkenyl-(Ci-C6)-alkoxycarbonylheterocyclyl, Aryl-(Ci-Ce)- alkoxycarbonylheterocyclyl, (C3-C6)-Cycloalkoxycarbonylheterocyclyl, (C3-C6)- Cycloalkyl-(Ci-C6)-alkoxycarbonylheterocyclyl, Aminocarbonylheterocyclyl, (Ci-C6)-Alkylaminocarbonylheterocyclyl, Bis-(Ci-Ce)- Arylaminoiminomethyl, arylsulfonylaminoiminomethyl, heteroaryl- (C 1 -C 6) -alkyl, heterocyclyl- (C 1 -C 6) -alkyl, hydroxycarbonylheterocyclyl, (C 1 -C 6) -alkoxycarbonylheterocyclyl, (C 2 -C 6) -alkenyloxycarbonylheterocyclyl, (C 2 -C 6) -alkenyl- (C 1 -C 6) -alkoxycarbonylheterocyclyl, aryl- (C 1 -C 6) -alkoxycarbonylheterocyclyl, (C 3 -C 6) -cycloalkoxycarbonylheterocyclyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkoxycarbonylheterocyclyl, aminocarbonylheterocyclyl, (C 1 -C 6) - Alkylaminocarbonylheterocyclyl, bis (Ci-Ce) -
Alkylaminocarbonylheterocyclyl, (C3-C6)-Cycloalkylaminocarbonylheterocyclyl, Aryl-(Ci-C6)-alkylaminocarbonylheterocyclyl, (C2-C6)-Alkylaminocarbonylheterocyclyl, (C 3 -C 6) -cycloalkylaminocarbonylheterocyclyl, aryl- (C 1 -C 6) -alkylaminocarbonylheterocyclyl, (C 2 -C 6) -
Alkenylaminocarbonylheterocyclyl, Hydroxycarbonylheterocyclyl-(Ci-C6)-alkyl, (Ci-C6)-Alkoxycarbonylheterocyclyl-(Ci-C6)-alkyl, Hydroxycarbonyl-(C3-C6)- cycloalkyl-(Ci-C6)-alkyl, (Ci-C6)-Alkoxycarbonyl-(C3-C6)-cycloalkyl-(Ci-C6)- alkyl stehen, Alkenylaminocarbonylheterocyclyl, hydroxycarbonylheterocyclyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkoxycarbonylheterocyclyl- (C 1 -C 6) -alkyl, hydroxycarbonyl- (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkyl, (C 1 -C 6) ) Alkoxycarbonyl- (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkyl,
R9 und R10 unabhängig voneinander für Wasserstoff, Fluor, Chlor, Brom, lod, R 9 and R 10 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
(Ci-Ce)-Alkyl, (Ci-Ce)-Alkoxy, (Ci-C6)-Haloalkyl, (Ci-C6)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C6)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, A4, A5 gleich oder verschieden sind und unabhängig voneinander für N-R11, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkoxy, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 6 ) -alkyl or together form a carbonyl group with the atom to which they are attached, A 4 , A 5 are the same or different and are each independently NR 11 ,
Sauerstoff, Schwefel oder die Gruppierung C-R11 stehen, wobei jedoch in keinem Fall mehr als ein Sauerstoffatom im Heterocyclus enthalten ist, und wobei R11 in den Gruppierungen N-R11 und C-R11 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, für Wasserstoff, (Ci-Ce)-Alkyl, (C2-C6)-Alkenyl-(Ci-C6)-alkyl, (Ci-Ce)-Alkoxy- (Ci-C6)-alkyl, (Ci-C6)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C6)- Cycloalkylcarbonyl, (Ci-C6)-Alkoxycarbonyl, (C2-C6)-Alkenyloxycarbonyl, Oxygen, sulfur or the group CR 11 , but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groupings NR 11 and CR 11 each have the same or different meanings as defined below, for hydrogen, (C 1 -C 6 ) -alkyl, (C 2 -C 6 ) -alkenyl- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkoxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkylcarbonyl, Arylcarbonyl, heteroarylcarbonyl, (C 3 -C 6) -cycloalkylcarbonyl, (C 1 -C 6) -alkoxycarbonyl, (C 2 -C 6) -alkenyloxycarbonyl,
(Ci-C6)-Alkoxycarbonyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylaminocarbonyl-(Ci-C6)- alkyl, Arylaminocarbonyl-(Ci-C6)-alkyl, Aryloxyalkyl, Aryl-(Ci-C6)-alkyl,  (C 1 -C 6) -alkoxycarbonyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, arylaminocarbonyl- (C 1 -C 6) -alkyl, aryloxyalkyl, aryl- (C 1 -C 6) ) alkyl,
Heteroaryl-(Ci-C6)-alkyl, (Ci-C6)-Haloalkyl steht, und R13 unabhängig voneinander für Wasserstoff, Fluor, Chlor, Brom, lod, Heteroaryl- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, and R 13 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
(Ci-Ce)-Alkyl, (Ci-Ce)-Alkoxy, (Ci-C6)-Haloalkyl, (Ci-C6)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C6)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, A6, A7, A8, A9 gleich oder verschieden sind und unabhängig voneinander für 0, S, N, NH, N-(Ci-C6)-Alkyl, (Ci-C6)-Alkoxycarbonyl-N, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl- N, N-Aryl, N-Heteroaryl, N-Heterocyclyl, Arylsulfonyl-N, (Ci-Ce)-Alkylsulfonyl- N, (C3-C6)-Cycloalkylsulfonyl-N oder die Gruppierung C-R15 stehen, wobei maximal zwei 0- oder S-Atome im Heterocyclus vorhanden sind sind, und wobei keine 0- oder S-Atome benachbart zueinander sind, und wobei R15 in der Gruppierung C-R15 jeweils gleiche oder verschiedene Bedeutungen gemäß der vorstehenden Definition hat und und R17 unabhängig voneinander für Wasserstoff, Fluor, Chlor, Brom, lod, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkoxy, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 6 ) -alkyl or together with the atom to which they are attached form a carbonyl group, A 6 , A 7 , A 8 , A 9 are identical or different and independently of one another represent 0, S, N, NH, N- (C 1 -C 6 ) - Alkyl, (C 1 -C 6 ) -alkoxycarbonyl-N, (C 1 -C 6 ) -alkoxy- (C 1 -C 6 ) -alkyl-N, N-aryl, N-heteroaryl, N-heterocyclyl, arylsulfonyl-N, ( Ci-Ce) alkylsulfonyl N, (C3-C6) cycloalkylsulfonyl-N or the group CR 15 communicate with a maximum of two 0 or S atoms in the heterocycle are present, and wherein any 0- or S-atoms adjacent to each other, and wherein R 15 in the group CR 15 has the same or different meanings as defined above and R 17 is independently hydrogen, fluorine, chlorine, bromine, iodine,
(Ci-Ce)-Alkyl, (Ci-Ce)-Alkoxy, (Ci-C6)-Haloalkyl, (Ci-C6)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C6)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, A10 für N-R18, Sauerstoff oder die Gruppierung C-R18 steht und wobei R18 in den Gruppierungen N-R18 und C-R18 jeweils gleiche oder verschiedene (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkoxy, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 6 ) -alkyl or together form a carbonyl group with the atom to which they are attached, A 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
Bedeutungen gemäß der nachstehenden Definition hat,  Has meanings as defined below,
R18 für Wasserstoff, (Ci-Ce)-Alkyl, (C2-Ce)-Alkenyl-(Ci-Ce)-alkyl, (Ci-C6)-Alkoxy- (Ci-C6)-alkyl, (Ci-C6)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C6)- Cycloalkylcarbonyl, (Ci-C6)-Alkoxycarbonyl, (C2-C6)-Allyloxycarbonyl, Aryloxy- (Ci-Ce)-alkyl, Aryl-(Ci-C6)-alkyl, (Ci-C6)-Haloalkyl, Aryl steht, R 18 is hydrogen, (C 1 -C 6) -alkyl, (C 2 -C 6) -alkenyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkoxy- (C 1 -C 6) -alkyl, (C 1 -C 6 ) -alkyl C 6 ) -alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 6 ) -cycloalkylcarbonyl, (C 1 -C 6 ) -alkoxycarbonyl, (C 2 -C 6 ) -alloxycarbonyl, aryloxy- (C 1 -C 6 ) -alkyl, aryl- (C 1 -C 6 -cycloalkylcarbonyl) ) -alkyl, (C 1 -C 6 ) -haloalkyl, aryl,
A11 für N oder die Gruppierung C-R21 steht und wobei R21 in der Gruppierung C- R21 die Bedeutung gemäß der vorstehenden Definition hat, A 11 is N or the group CR 21 and R 21 in the grouping C-R 21 has the meaning given above,
A12 für N-R18 oder die Gruppierung C(R19)R20 steht und wobei R19 und R20 in der Gruppierung C(R19)R20 die Bedeutung gemäß der nachstehenden Definition haben, A 12 is NR 18 or the moiety C (R 19 ) R 20 and where R 19 and R 20 in the moiety C (R 19 ) R 20 are as defined below,
R19 und R20 unabhängig voneinander für Wasserstoff, Fluor, Chlor, Brom, lod, R 19 and R 20 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
(Ci-Ce)-Alkyl, (Ci-Ce)-Alkoxy, (Ci-C6)-Haloalkyl, (Ci-C6)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C6)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, und Q weiterhin für eine der in der folgenden Tabelle beschriebenen Gruppierungen Q-1 .1 bis Q-4.10 steht (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkoxy, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -haloalkoxy, aryl, heteroaryl, aryl- (C 1 -C 6 ) -alkyl or together with the atom to which they are attached form a carbonyl group, and Q furthermore represents one of the groupings Q-1 .1 to Q-4.10 described in the following table
0 0
Q-1 .1 Q-1 .2 Q-1 .3 Q-1 .4 Q-1 .5 Q-1 .6 Q-1 .1 Q-1 .2 Q-1 .3 Q-1 .4 Q-1 .5 Q-1 .6
F  F
F F
Q-1.19 Q-1.20 Q-1.21 Q-1.22 Q-1.23 Q-1.24  Q-1.19 Q-1.20 Q-1.21 Q-1.22 Q-1.23 Q-1.24
Cl Cl
Cl Cl
Q-1.25 Q-1.26 Q-1.27 Q-1.28 Q-1.29 Q-1.30  Q-1.25 Q-1.26 Q-1.27 Q-1.28 Q-1.29 Q-1.30
Q-1.31 Q-1.32 Q-1.33 Q-1.34 Q-1.35 Q-1.36 Q-1.31 Q-1.32 Q-1.33 Q-1.34 Q-1.35 Q-1.36
^^^^ ^^^^ ^^^^^^^^
Q-1.37 Q-1.38 Q-1.39 Q-1.40 Q-1.41 Q-1.42 0^^ Q-1.37 Q-1.38 Q-1.39 Q-1.40 Q-1.41 Q-1.42 0 ^^
H H CF3 HH CF 3
H  H
Q-1.43 Q-1.44 Q-1.45 Q-1.46 Q-1.47 Q-1.48  Q-1.43 Q-1.44 Q-1.45 Q-1.46 Q-1.47 Q-1.48
CF3 CF 3
Q-1.49 Q-1.50 Q-1.51 Q-1.52 Q-1.53 Q-1.54 Q-1.49 Q-1.50 Q-1.51 Q-1.52 Q-1.53 Q-1.54
Q-1.85 Q-1.86 1 Q-1.87 Q-1.88 Q-1.89 Q-1.90  Q-1.85 Q-1.86 1 Q-1.87 Q-1.88 Q-1.89 Q-1.90
0 0
o o o O  o o o O
Q-1.91 Q-1.92 Q-1.93 Q-1.94 Q-1.95 Q-1.96 Q-1.91 Q-1.92 Q-1.93 Q-1.94 Q-1.95 Q-1.96
ΗΝ^ ^ΝΗ ΗΝ ^ ^ ΝΗ
^^^^  ^^^^
Η Η  Η Η
Q-1.133 Q-1.134 Q-1.135 Q-1.136 Q-1.137 Q-1.138  Q-1,133 Q-1,134 Q-1,135 Q-1,136 Q-1,137 Q-1,138
ΗΝ07 Η Η ΗΝ 07 Η Η
Q-1.139 Q-1.140 Q-1.141 Q-1.142 Q-1.143 Q-1.144  Q-1,139 Q-1,140 Q-1,141 Q-1,142 Q-1,143 Q-1,144
Q-1.163 Q-1.164 Q-1.165 Q-1.166 Q-1.167 Q-1.168 Q-1,163 Q-1,164 Q-1,165 Q-1,166 Q-1,167 Q-1,168
Cl  Cl
Q-1.211 Q-1.212 Q-1.213 Q-1.214 Q-1.215 Q-1.216 Q-1.211 Q-1.212 Q-1.213 Q-1.214 Q-1.215 Q-1.216
CN  CN
Brbr
CN CN
Q-1.217 Q-1.218 Q-1.219 Q-1.220 Q-1.221 Q-1.222 Q-1.217 Q-1.218 Q-1.219 Q-1.220 Q-1.221 Q-1.222
Q-3.13 Q-3.14 Q-3.15 Q-3.16 Q-3.17 Q-3.18  Q-3.13 Q-3.14 Q-3.15 Q-3.16 Q-3.17 Q-3.18
^0 ^ 0
Q-3.19 Q-3.20 Q-3.21 Q-3.22 Q-3.23 Q-3.24  Q-3.19 Q-3.20 Q-3.21 Q-3.22 Q-3.23 Q-3.24
::p :: p
o 0 0  o 0 0
/  /
Q-3.25 Q-3.26 Q-3.27 Q-3.28 Q-3.29 Q-3.30  Q-3.25 Q-3.26 Q-3.27 Q-3.28 Q-3.29 Q-3.30
mit Ausnahme von 4-Hydroxy-4-{(E)-2-[2-(hydroxymethyl)phenyl]vinyl}-3,5,5- trimethylcyclohex-2-en-1 -on, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en- 1 -yl)vinyl]benzaldehyd, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]benzoesäure, Methyl-2-[(E)-2-(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en- 1 -yl)vinyl]benzoat. with the exception of 4-hydroxy-4 - {(E) -2- [2- (hydroxymethyl) phenyl] vinyl} -3,5,5-trimethylcyclohex-2-en-1-one, 2 - [(E) - 2- (1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzaldehyde, 2 - [(E) -2- (1-hydroxy-2,6,6 -trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid, methyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-ene - 1 -yl) vinyl] benzoate.
Im Speziellen bevorzugt sind Verbindungen der allgemeinen Formel (I), worin Especially preferred are compounds of general formula (I) wherein
[X-Y] für die Gruppierungen [X-Y] for the groupings
[x-Y]1 und [X-Y]2 steht, für die carbocyclischen und heterocyclischen Gruppierungen Q-1 bis Q-4 [xY] 1 and [XY] 2 stands for the carbocyclic and heterocyclic moieties Q-1 to Q-4
Q-1 Q-2 Q-3 und Q-4 steht, wobei die Gruppierungen R6 bis R21 und A1 bis A12 jeweils die Q-1 Q-2 Q-3 and Q-4, wherein the groups R 6 to R 21 and A 1 to A 12 are each the
Bedeutung gemäß der nachstehenden Definitionen haben und wobei der Pfeil für eine Bindung zur jeweiligen Gruppierung [X-Y] steht,  Have meaning according to the definitions below and wherein the arrow represents a bond to the respective grouping [X-Y],
R1 für Methyl, Ethyl, n-Propyl, n-Butyl, iso-Butyl, iso-Propyl, n-Pentyl, n-Hexyl, iso-Pentyl, Cyclopropyl, Cyclobutyl, Cyclopentyl, 2,2,3,3,3-Pentafluorpropyl, 3,3,2, 2-Tetrafluorpropyl, 4,4,4-Trifluorbutyl, 1 -Fluorethyl, 2-Fluorethyl, R 1 is methyl, ethyl, n -propyl, n -butyl, iso -butyl, iso -propyl, n -pentyl, n -hexyl, iso-pentyl, cyclopropyl, cyclobutyl, cyclopentyl, 2,2,3,3,3 Pentafluoropropyl, 3,3,2, 2-tetrafluoropropyl, 4,4,4-trifluorobutyl, 1-fluoroethyl, 2-fluoroethyl,
Fluormethyl, Difluormethyl, Trifluormethyl, Pentafluorethyl, Heptafluor-n- propyl, Heptafluor-iso-propyl, Chlordifluormethyl, 2,2-Difluorethyl, 2,2,2- Trifluorethyl, 1 , 1 ,2,2-Tetrafluorethyl, 1 ,2,2,2-Tetrafluorethyl, 1 ,2,2,3,3,3- Hexafluorpropyl, 1 -Methyl-2,2,2-trifluorethyl, 1 -Chlor-2,2,2-trifluorethyl, 1 ,2,2,3,3,4,4,4-octafluorbutyl, 1 -Fluor-1 -methyl-ethyl, n-Propoxydifluormethyl, Methoxydifluormethyl, Ethoxydifluormethyl steht,  Fluoromethyl, difluoromethyl, trifluoromethyl, pentafluoroethyl, heptafluoro-n-propyl, heptafluoro-isopropyl, chlorodifluoromethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1, 1, 2,2-tetrafluoroethyl, 1, 2, 2,2-tetrafluoroethyl, 1, 2,2,3,3,3-hexafluoropropyl, 1-methyl-2,2,2-trifluoroethyl, 1-chloro-2,2,2-trifluoroethyl, 1, 2,2, 3,3,4,4,4-octafluorobutyl, 1-fluoro-1-methyl-ethyl, n-propoxydifluoromethyl, methoxydifluoromethyl, ethoxydifluoromethyl,
R2 für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl steht, R 2 is hydrogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl,
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden, R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
R3 und R4 unabhängig voneinander für Methoxy, Ethoxy stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, Methoxyiminogruppe, Ethoxyiminogruppe, n-Propoxyiminogruppe, iso- Propoxyim inogruppe, n-Butyloxyim inogruppe, iso-Butyloxyim inogruppe, Cylcopropyloxyim inogruppe, Cylcobutyloxyim inogruppe, R 3 and R 4 independently of one another are methoxy, ethoxy or, together with the atom to which they are attached, an oxo group, hydroxyimino group, methoxyimino group, ethoxyimino group, n-propoxyimino group, isopropoxyimino group, n-butyloxyimino group, isobutoxyimine inogruppe, Cylcopropyloxyim inogruppe, Cylcobutyloxyim inogruppe,
Cylcopentyloxyim inogruppe, Cylcohexyloxyim inogruppe,  Cylcopentyloxyimine group, Cylcohexyloxyim inogruppe,
Cylcopropylmethoxyim inogruppe, Allyloxyim inogruppe oder einen 5-7- gliedrigen heterocyclischen Ring, z. B. einen 1 ,3-Dioxolanyl-, 1 ,3- Dioxanylring, der gegebenenfalls weiter durch (Ci-C6)-Alkyl, (C1-C6)- Alkoxycarbonyl, (C3-C6)-Cycloalkyl, spiro-(C3-C6)-Cycloalkyl, spiro-Oxetanyl substituiert sein kann, bilden, für Wasserstoff, tert.-Butyldimethylsilyl, Trimethylsilyl, Triethylsilyl, Tri-(iso- Propyl)silyl, Tri-(n-Propyl)silyl, Dimethyl(phenyl)silyl, tert.-Butyldiphenylsilyl, Diethylisopropylsilyl, Isopropyldimethylsilyl, tert.-Hexyldimethylsilyl steht, R6 und R7 unabhängig voneinander für Wasserstoff, Nitro, Amino, Cyano, Fluor, Chlor, Brom, lod, Methyl, Ethyl, n-Propyl, iso-Propyl, n-Butyl, iso-Butyl, tert. Butyl, Cyclopropyl, Cyclobutyl, Methoxy, Ethoxy, n-Propyloxy, iso-Propyloxy, gegebenenfalls substituiertes Phenyl, Ethinyl, Aryl, Benzyl, Allyl, Phenoxy, Heteroaryl, Methoxymethyl, Ethoxymethyl, Ethoxyethyl, Methoxyethyl, Cylcopropylmethoxyimino group, allyloxyimino group or a 5-7- membered heterocyclic ring, e.g. B. a 1, 3-dioxolanyl, 1, 3-Dioxanylring, which optionally further by (Ci-C6) alkyl, (C1-C6) - alkoxycarbonyl, (C3-C6) -cycloalkyl, spiro- (C3-C6 ) -Cycloalkyl, spiro-oxetanyl may be substituted, for hydrogen, tert-butyldimethylsilyl, trimethylsilyl, triethylsilyl, tri (iso-propyl) silyl, tri (n-propyl) silyl, dimethyl (phenyl) silyl, tert Is -butyldiphenylsilyl, diethylisopropylsilyl, isopropyldimethylsilyl, tert-hexyldimethylsilyl, R 6 and R 7 are independently of one another hydrogen, nitro, amino, cyano, fluorine, chlorine, bromine, iodine, methyl, ethyl, n-propyl, isopropyl, n-butyl, iso-butyl, tert. Butyl, cyclopropyl, cyclobutyl, methoxy, ethoxy, n-propyloxy, isopropoxy, optionally substituted phenyl, ethynyl, aryl, benzyl, allyl, phenoxy, heteroaryl, methoxymethyl, ethoxymethyl, ethoxyethyl, methoxyethyl,
Hydroxymethyl, Trifluormethyl, Difluormethyl, Chlordifluormethyl,  Hydroxymethyl, trifluoromethyl, difluoromethyl, chlorodifluoromethyl,
Trifluormethoxy, Difluormethoxy, Heteroaryloxy, Hydroxy,  Trifluoromethoxy, difluoromethoxy, heteroaryloxy, hydroxy,
Cyclopropylmethoxy, Methoxycarbonyl, Ethoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, Methylaminocarbonyl, Ethylaminocarbonyl, n- Propylaminocarbonyl, iso-Propylaminocarbonyl, Cyclopropylaminocarbonyl, Cyanomethylaminocarbonyl, Allylaminocarbonyl, Ethinylmethylaminocarbonyl, Cyclopropylmethoxy, methoxycarbonyl, ethoxycarbonyl, hydroxycarbonyl, aminocarbonyl, methylaminocarbonyl, ethylaminocarbonyl, n-propylaminocarbonyl, isopropylaminocarbonyl, cyclopropylaminocarbonyl, cyanomethylaminocarbonyl, allylaminocarbonyl, ethynylmethylaminocarbonyl,
Methylamino, Ethylamino, n-Propylamino, iso-Propylamino, Methylthio, Ethylthio, Trifluormethylthio, Hydrothio, Dimethylamino, Diethylamino, Methylamino, ethylamino, n-propylamino, iso-propylamino, methylthio, ethylthio, trifluoromethylthio, hydrothio, dimethylamino, diethylamino,
Cyclopropylamino, Cyclobutylamino, Methylcarbonylamino,  Cyclopropylamino, cyclobutylamino, methylcarbonylamino,
Ethylcarbonylamino, iso-Propylcarbonylamino, n-Propylcarbonylamino, n- Butylcarbonylamino, tert.-Butylcarbonylamino, Cyclopropylcarbonylamino, Ethylcarbonylamino, iso -propylcarbonylamino, n-propylcarbonylamino, n-butylcarbonylamino, tert-butylcarbonylamino, cyclopropylcarbonylamino,
Cyclobutylcarbonylamino, Cyclopentylcarbonylamino, Cyclobutylcarbonylamino, cyclopentylcarbonylamino,
Cyclohexylcarbonylamino, Formylamino, Trifluormethylcarbonylamino, Methoxycarbonylam ino, Ethoxycarbonylam ino, iso-Propoxycarbonylam ino, tert. -Butyloxycarbonylam ino, Methylam inocarbonylam ino,  Cyclohexylcarbonylamino, formylamino, Trifluoromethylcarbonylamino, Methoxycarbonylam ino, Ethoxycarbonylam ino, iso-Propoxycarbonylam ino, tert. Butyloxycarbonylamino, methylam inocarbonylam ino,
Ethylaminocarbonylamino, Dimethylaminocarbonylamino,  Ethylaminocarbonylamino, dimethylaminocarbonylamino,
Diethylaminocarbonylamino, Methyl(ethyl)aminocarbonylamino,  Diethylaminocarbonylamino, methyl (ethyl) aminocarbonylamino,
Methylsulfonylamino, Ethylsulfonylamino, iso-Propylsulfonylamino, n- Propylsulfonylamino, Cyclopropylsulfonylamino, Phenylsulfonylamino, p- Methylphenylsulfonylamino, p-Chlorphenylsulfonylamino, Sulfonyl-(Ci-Ce)- haloalkylamino, Aminosulfonyl, Methylami nosulfonyl, Ethylaminosulfonyl, Dimethylaminosulfonyl, Trifluormethylaminosulfonyl, Phenylaminosulfonyl, Benzylaminosulfonyl, Benzylcarbonylamino, Methylsulfonylamino, ethylsulfonylamino, iso-propylsulfonylamino, n- Propylsulfonylamino, cyclopropylsulfonylamino, phenylsulfonylamino, p-methylphenylsulfonylamino, p-chlorophenylsulfonylamino, sulfonyl- (Ci-Ce) -haloalkylamino, aminosulfonyl, methylaminosulfonyl, ethylaminosulfonyl, dimethylaminosulfonyl, trifluoromethylaminosulfonyl, phenylaminosulfonyl, benzylaminosulfonyl, benzylcarbonylamino,
Cyclopropylmethylcarbonylamino, Methoxymethylcarbonylamino,  Cyclopropylmethylcarbonylamino, methoxymethylcarbonylamino,
Trimethylsilyl stehen,  Are trimethylsilyl,
A1, A2, A3 gleich oder verschieden sind und unabhängig voneinander für N A 1 , A 2 , A 3 are the same or different and are independently N
(Stickstoff) oder die Gruppierung C-R8 stehen, wobei jedoch in keinem Fall mehr als zwei N-Atome benachbart sind, und wobei R8 in der Gruppierung C- R8 jeweils gleiche oder verschiedene Bedeutungen gemäß der (Nitrogen) or the group CR 8 , but in no case more than two N atoms are adjacent, and wherein R 8 in the group C-R 8 each have the same or different meanings according to the
nachstehenden Definition hat und A1 und A2, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, A2 und A3, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6-gliedrigen Ring bilden, has the following definition and A 1 and A 2 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 bis Form a 6-membered ring, A 2 and A 3 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted Form 5 to 6-membered ring,
R14, R15 und R21 unabhängig voneinander jeweils Wasserstoff, Nitro, Amino, Hydroxy, Hydrothio, Fluor, Chlor, Brom, lod, (Ci-C5)-Alkyl, (C3-C6)-Cycloalkyl, (C2-C5)-Alkenyl, (C2-C5)-Alkinyl, Aryl, Aryl-(Ci-C5)-alkyl, Aryl-(Ci-C5)-alkoxy, Heteroaryl, (Ci-C5)-Haloalkyl, (Ci-C6)-Halocycloalkyl, (Ci-C5)-Alkoxy, (C1-C5)- Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C6)-Cycloalkyloxy, (C3-C5)-Cycloalkyl- (Ci-C5)-alkoxy, Hydroxy-(Ci-C5)-alkyl, (Ci-C5)-Alkoxy-(Ci-C5)-alkyl, Aryloxy- (Ci-C5)-alkyl, Heteroaryloxy-(Ci-C5)-alkyl, (C2-C5)-Alkenylaminocarbonyl, (Ci-C5)-Alkylamino, (Ci-C5)-Alkylthio, (Ci-C5)-Haloalkylthio, Bis-[(Ci-C5)- alkyl]amino, (C3-C6)-Cycloalkylamino, (Ci-C5)-Alkylcarbonylamino, (C3-C6)- Cycloalkylcarbonylamino, Formylamino, (Ci-C5)-Haloalkylcarbonylamino, (Ci-C5)-Alkoxycarbonylamino, (Ci-C5)-Alkylaminocarbonylamino, (C1-C5)- Alkyl[(Ci-C5)-Alkyl]-aminocarbonylamino, (Ci-C5)-Alkylsulfonylamino, (C3-C6)- Cycloalkylsulfonylamino, Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl- (Ci-C5)-haloalkylamino, Amino-(Ci-C5)-alkylsulfonyl, Amino-(Ci-C5)- haloalkylsulfonyl, (Ci-C5)-Alkylaminosulfonyl, Bis-(Ci-C5)-alkylaminosulfonyl, (C3-C6)-Cycloalkylaminosulfonyl, (Ci-C5)-Haloalkylaminosulfonyl, R 14 , R 15 and R 21 independently of one another each represent hydrogen, nitro, amino, hydroxyl, hydrothio, fluorine, chlorine, bromine, iodine, (C 1 -C 5 ) -alkyl, (C 3 -C 6 ) -cycloalkyl, (C 2 -C 5) alkenyl, (C 2 -C 5) alkynyl, aryl, aryl (Ci-C 5) alkyl, aryl (Ci-C 5) alkoxy, heteroaryl, (Ci-C 5) Haloalkyl, (C 1 -C 6 ) -halocycloalkyl, (C 1 -C 5 ) -alkoxy, (C 1 -C 5 ) -haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 6 ) -cycloalkyloxy, (C 3 -C 5 ) -cycloalkyl- ( C 1 -C 5 ) -alkoxy, hydroxy- (C 1 -C 5 ) -alkyl, (C 1 -C 5 ) -alkoxy- (C 1 -C 5 ) -alkyl, aryloxy- (C 1 -C 5 ) -alkyl, heteroaryloxy- (C 1 -C 4) -alkyl, Ci-C5) alkyl, (C2-C5) -Alkenylaminocarbonyl, (Ci-C5) alkylamino, (Ci-C 5) alkylthio, (Ci-C 5) haloalkylthio, bis - [(Ci-C 5 ) - alkyl] amino, (C 3 -C 6) -cycloalkylamino, (C 1 -C 5) -alkylcarbonylamino, (C 3 -C 6) -cycloalkylcarbonylamino, formylamino, (C 1 -C 5) -haloalkylcarbonylamino, (C 1 -C 5) -alkoxycarbonylamino, (C 1 -C 5) ) -Alkylaminocarbonylamino, (C 1 -C 5) -alkyl [(C 1 -C 5) -alkyl] -aminocarbonylamino, (C 1 -C 5) -alkylsulfonylamino, (C 3 -C 6) -cycloalkylsulfonylamino, arylsulfonylamino, hetarylsulfonylamino, sulfonyl- (C 1 -C 5) -haloalkylamino, amino- (C 1 -C 5) -alkylsulfonyl, amino- (C 1 -C 5) -haloalkylsulfonyl, (C 1 -C 5) -alkylaminosulfonyl, bis (C 1 -C 5) -alkylaminosulfonyl, (C 3 -C 6) -cycloalkylaminosulfonyl, ( Ci-C5) -Haloalkylaminosulfonyl,
Arylaminosulfonyl, Aryl-(Ci-C5)-alkylaminosulfonyl, (Ci-C6)-Alkylsulfonyl, (C3-C5)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C5)-Alkylsulfinyl, (C3-C6)- Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-(Ci-C5)-alkylsulfonimidoyl, S-(Ci-Cs)- Alkylsulfonimidoyl, (Ci-C5)-Alkylsulfonylaminocarbonyl, (C3-C6)- Cycloalkylsulfonylaminocarbonyl, (C3-C6)-Cycloalkylaminosulfonyl, Aryl- (Ci-C5)-alkylcarbonylamino, (C3-C6)-Cycloalkyl-(Ci-C5)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C5)-Alkoxy-(Ci-C5)-alkylcarbonylamino, Arylaminosulfonyl, aryl- (C 1 -C 5 ) -alkylaminosulfonyl, (C 1 -C 6 ) -alkylsulfonyl, (C 3 -C 5 ) -cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 5 ) -alkylsulfinyl, (C 3 -C 6 ) -cycloalkylsulfinyl , Arylsulfinyl, N, S-bis- (C 1 -C 5) -alkylsulfonimidoyl, S- (C 1 -C 8) -alkylsulfonimidoyl, (C 1 -C 5) -alkylsulfonylaminocarbonyl, (C 3 -C 6) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 6) -cycloalkylaminosulfonyl , Aryl- (C 1 -C 5) -alkylcarbonylamino, (C 3 -C 6) -cycloalkyl- (C 1 -C 5) -alkylcarbonylamino, heteroarylcarbonylamino, (C 1 -C 5) -alkoxy- (C 1 -C 5) -alkylcarbonylamino,
Hydroxy-(Ci-C5)-alkylcarbonylamino, Cyano, Cyano-(Ci-C5)-alkyl, Hydroxy- (C 1 -C 5) -alkylcarbonylamino, cyano, cyano- (C 1 -C 5) -alkyl,
Hydroxycarbonyl, (Ci-C5)-Alkoxycarbonyl, (C3-C6)-Cycloalkoxycarbonyl, (C3-C6)-Cycloalkyl-(Ci-C5)-alkoxycarbonyl, Aryloxycarbonyl, Aryl-(Ci-Cs)- alkoxycarbonyl, Aminocarbonyl, (Ci-C5)-Alkylaminocarbonyl, Bis-(Ci-Cs)- alkylaminocarbonyl, (Ci-C5)-Alkyl[(Ci-C5)-Alkoxy]aminocarbonyl, (C3-C6)- Cycloalkylaminocarbonyl, Aryl-(Ci-C5)-alkylaminocarbonyl, Heteroaryl-(Ci-C5)- alkylaminocarbonyl, Cyano-(Ci-C5)-alkylaminocarbonyl, (C1-C5)- Haloalkylaminocarbonyl, (C2-C5)-Alkinyl-(Ci-C5)-alkylaminocarbonyl, (C1-C5)- Alkoxycarbonylaminocarbonyl, Aryl-(Ci-C5)-alkoxycarbonylaminocarbonyl, Hydroxycarbonyl-(Ci-C5)-alkyl, (Ci-C5)-Alkoxycarbonyl-(Ci-C5)-alkyl, (C3-C6)- Cycloalkoxycarbonyl-(Ci-C5)-alkyl, (Ci-C6)-Cycloalkyl-(Ci-C5)-alkoxycarbonyl- (Ci-C5)-alkyl, (Ci-C5)-Alkylaminocarbonyl-(Ci-C5)-alkyl, Aminocarbonyl- (Ci-C5)-alkyl, Bis-(Ci-C5)-alkylaminocarbonyl-(Ci-C5)-alkyl, (C3-C6)- Cycloalkylaminocarbonyl-(Ci-C5)-alkyl, Aryl-(Ci-C5)-alkylaminocarbonyl- (Ci-C5)-alkyl, Heteroaryl-(Ci-C5)-alkylaminocarbonyl-(Ci-C5)-alkyl, Cyano- (Ci-C5)-alkylaminocarbonyl-(Ci-C5)-alkyl, (Ci-C5)-Haloalkylaminocarbonyl- (Ci-C5)-alkyl, (C2-C5)-Alkinyl-(Ci-C5)-alkylaminocarbonyl-(Ci-C5)-alkyl, (C3-Ce)-Cycloalkyl-(Ci-C5)-alkylaminocarbonyl-(Ci-C5)-alkyl, (C1-C5)- Alkoxycarbonylaminocarbonyl-(Ci-C5)-alkyl, Aryl-(Ci-Cs)- alkoxycarbonylaminocarbonyl-(Ci-C5)-alkyl, Hydroxycarbonyl, (C 1 -C 5) -alkoxycarbonyl, (C 3 -C 6) -cycloalkoxycarbonyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 5) -alkoxycarbonyl, aryloxycarbonyl, aryl- (C 1 -C 8) -alkoxycarbonyl, aminocarbonyl, (Ci -C 5) -alkylaminocarbonyl, bis- (C 1 -C 8) -alkylaminocarbonyl, (C 1 -C 5) -alkyl [(C 1 -C 5) -alkoxy] -aminocarbonyl, (C 3 -C 6) -cycloalkylaminocarbonyl, aryl- (C 1 -C 5) - alkylaminocarbonyl, heteroaryl- (C 1 -C 5) -alkylaminocarbonyl, cyano- (C 1 -C 5) -alkylaminocarbonyl, (C 1 -C 5) -haloalkylaminocarbonyl, (C 2 -C 5) -alkynyl- (C 1 -C 5) -alkylaminocarbonyl, (C 1 -C 5 ) - alkoxycarbonylaminocarbonyl, aryl- (C 1 -C 5) -alkoxycarbonylaminocarbonyl, hydroxycarbonyl- (C 1 -C 5) -alkyl, (C 1 -C 5) -alkoxycarbonyl- (C 1 -C 5) -alkyl, (C 3 -C 6) -cycloalkoxycarbonyl- (Ci -C 5) -alkyl, (C 1 -C 6) -cycloalkyl- (C 1 -C 5) -alkoxycarbonyl- (C 1 -C 5) -alkyl, (C 1 -C 5) -alkylaminocarbonyl- (C 1 -C 5) -alkyl, aminocarbonyl- (Ci -C 5) alkyl, bis (C 5) alkylaminocarbonyl (Ci-C 5) alkyl, (C 3 -C 6) - cycloalkylaminocarbonyl (Ci-C5) alkyl, aryl (Ci- C5) -alkylaminocarbonyl- (C 1 -C 5) -alkyl, heteroaryl- (C 1 -C 5) -alkylamines nocarbonyl- (C 1 -C 5 ) -alkyl, cyano- (C 1 -C 5 ) -alkylaminocarbonyl- (C 1 -C 5 ) -alkyl, (C 1 -C 5 ) -haloalkylaminocarbonyl- (C 1 -C 5 ) -alkyl, (C 2 -C 5 ) Alkynyl (C 1 -C 5 ) -alkylaminocarbonyl (C 1 -C 5 ) -alkyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 5) -alkylaminocarbonyl- (C 1 -C 5) -alkyl, (C 1 -C 5) -alkoxycarbonylaminocarbonyl- (C 1 -C 5) -alkyl, aryl- (C 1 -C 5) -alkoxycarbonylaminocarbonyl- (Ci-C5) alkyl,
(Ci-C5)-Alkoxycarbonyl-(Ci-C5)-alkylaminocarbonyl, Hydroxycarbonyl-(Ci-C5)- alkylaminocarbonyl, Aminocarbonyl-(Ci-C5)-alkylaminocarbonyl, (C1-C5)- Alkylaminocarbonyl-(Ci-C5)-alkylaminocarbonyl, (C3-C6)- Cycloalkylaminocarbonyl-(Ci-C5)-alkylaminocarbonyl, (C3-C6)-Cycloalkyl- (Ci-C5)-alkylaminocarbonyl, (C3-C5)-Cycloalkyl-(Ci-C5)-alkylaminocarbonyl- (Ci-C5)-alkyl, (C2-C5)-Alkenyloxycarbonyl, (C2-C5)-Alkenyloxycarbonyl-(Ci-C5)- alkyl, (C2-C5)-Alkenylaminocarbonyl, (C2-C5)-Alkenyl-(Ci-C5)- alkylaminocarbonyl, (C2-C5)-Alkenylaminocarbonyl-(Ci-C5)-alkyl, (C2-C5)- Alkenyl-(Ci-C5)-alkylaminocarbonyl-(Ci-C5)-alkyl, (Ci-C5)-Alkylcarbonyl, (C3-C6)-Cycloalkylcarbonyl, Formyl, Hydroxyiminomethyl, Aminoiminomethyl, (Ci-C5)-Alkoxyiminomethyl, (Ci-C5)-Alkylaminoiminomethyl, Bis-(Ci-Cs)- alkylaminoiminomethyl, (C3-C6)-Cycloalkoxyiminomethyl, (C3-C6)-Cycloalkyl- (Ci-C5)-alkoximinomethyl, Aryloximinomethyl, Aryl-(Ci-C5)-alkoxyiminomethyl, Aryl-(Ci-C5)-alkylaminoiminomethyl, (C2-C5)-Alkenyloxyiminomethyl,  (C 1 -C 5) -alkoxycarbonyl- (C 1 -C 5) -alkylaminocarbonyl, hydroxycarbonyl- (C 1 -C 5) -alkylaminocarbonyl, aminocarbonyl- (C 1 -C 5) -alkylaminocarbonyl, (C 1 -C 5) -alkylaminocarbonyl- (C 1 -C 5) - alkylaminocarbonyl, (C 3 -C 6) -cycloalkylaminocarbonyl- (C 1 -C 5) -alkylaminocarbonyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 5) -alkylaminocarbonyl, (C 3 -C 5) -cycloalkyl- (C 1 -C 5) -alkylaminocarbonyl- (C 1 -C 5) -alkyl, (C 2 -C 5) -alkenyloxycarbonyl, (C 2 -C 5) -alkenyloxycarbonyl- (C 1 -C 5) -alkyl, (C 2 -C 5) -alkenylaminocarbonyl, (C 2 -C 5) -alkenyl- (Ci -C 5) - alkylaminocarbonyl, (C 2 -C 5) -alkenylaminocarbonyl- (C 1 -C 5) -alkyl, (C 2 -C 5) -alkenyl- (C 1 -C 5) -alkylaminocarbonyl- (C 1 -C 5) -alkyl, (C 1 -C 5) -alkylaminocarbonyl; ) -Alkylcarbonyl, (C 3 -C 6) -cycloalkylcarbonyl, formyl, hydroxyiminomethyl, aminoiminomethyl, (C 1 -C 5) -alkoxyiminomethyl, (C 1 -C 5) -alkylaminoiminomethyl, bis (C 1 -C 5) -alkylaminoiminomethyl, (C 3 -C 6) - Cycloalkoxyiminomethyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 5) -alkoximinomethyl, aryloximinomethyl, aryl- (C 1 -C 5) -alkoxyiminomethyl, aryl- (C 1 -C 5) -alkylaminoiminomethyl, (C 2 -C 5) -alkenyloxyiminomethyl,
Arylaminoiminomethyl, Arylsulfonylaminoiminomethyl, Heteroaryl-(Ci-C5)- alkyl, Heterocyclyl-(Ci-C5)-alkyl, Hydroxycarbonylheterocyclyl, (C1-C5)- Alkoxycarbonylheterocyclyl, (C2-C5)-Alkenyloxycarbonylheterocyclyl, (C2-C5)- Alkenyl-(Ci-C5)-alkoxycarbonylheterocyclyl, Aryl-(Ci-Cs)- alkoxycarbonylheterocyclyl, (C3-C6)-Cycloalkoxycarbonylheterocyclyl, (C3-C6)- Cycloalkyl-(Ci-C5)-alkoxycarbonylheterocyclyl, Aminocarbonylheterocyclyl, (Ci-C5)-Alkylaminocarbonylheterocyclyl, Bis-(Ci-Cs)-Arylaminoiminomethyl, arylsulfonylaminoiminomethyl, heteroaryl- (C 1 -C 5) -alkyl, heterocyclyl- (C 1 -C 5) -alkyl, hydroxycarbonylheterocyclyl, (C 1 -C 5) -alkoxycarbonylheterocyclyl, (C 2 -C 5) -alkenyloxycarbonylheterocyclyl, (C 2 -C 5) -alkenyl- (C 1 -C 5) -alkoxycarbonylheterocyclyl, aryl- (C 1 -C 5) -alkoxycarbonylheterocyclyl, (C 3 -C 6) -cycloalkoxycarbonylheterocyclyl, (C 3 -C 6) -cycloalkyl- (C 1 -C 5) -alkoxycarbonylheterocyclyl, aminocarbonylheterocyclyl, (C 1 -C 5) - Alkylaminocarbonylheterocyclyl, bis (Ci-Cs) -
Alkylaminocarbonylheterocyclyl, (C3-C6)-Cycloalkylaminocarbonylheterocyclyl, Aryl-(Ci-C5)-alkylaminocarbonylheterocyclyl, (C2-C5)-Alkylaminocarbonylheterocyclyl, (C 3 -C 6) -cycloalkylaminocarbonylheterocyclyl, aryl- (C 1 -C 5) -alkylaminocarbonylheterocyclyl, (C 2 -C 5) -
Alkenylaminocarbonylheterocyclyl, Hydroxycarbonylheterocyclyl-(Ci-C5)-alkyl, (Ci-C5)-Alkoxycarbonylheterocyclyl-(Ci-C5)-alkyl, Hydroxycarbonyl-(C3-C5)- cycloalkyl-(Ci-C5)-alkyl, (Ci-C5)-Alkoxycarbonyl-(C3-C5)-cycloalkyl-(Ci-C5)- alkyl steht, R9 und R10 unabhängig voneinander für Wasserstoff, Fluor, Chlor, Brom, lod, Methyl, Ethyl, n-Propyl, iso-Propyl, Methoxy, Ethoxy, Trifluormethyl, Difluormethyl, 2,2,2-Trifluorethyl, 2,2-Difluorethyl, Trifluormethoxy, Difluormethoxy, Phenyl, Pyridyl, Benzyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, Alkenylaminocarbonylheterocyclyl, hydroxycarbonylheterocyclyl- (C 1 -C 5) -alkyl, (C 1 -C 5) -alkoxycarbonyl-heterocyclyl- (C 1 -C 5) -alkyl, hydroxycarbonyl- (C 3 -C 5) -cycloalkyl- (C 1 -C 5) -alkyl, (C 1 -C 5) -alkyl ) Alkoxycarbonyl- (C 3 -C 5) -cycloalkyl- (C 1 -C 5) -alkyl, R 9 and R 10 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, trifluoromethyl, difluoromethyl, 2,2,2-trifluoroethyl, 2,2- Difluoroethyl, trifluoromethoxy, difluoromethoxy, phenyl, pyridyl, benzyl or together with the atom to which they are attached form a carbonyl group,
A4, A5 gleich oder verschieden sind und unabhängig voneinander für N-R11, A 4 , A 5 are the same or different and are each independently NR 11 ,
Sauerstoff, Schwefel oder die Gruppierung C-R11 stehen, wobei jedoch in keinem Fall mehr als ein Sauerstoffatom im Heterocyclus enthalten ist, und wobei R11 in den Gruppierungen N-R11 und C-R11 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, Oxygen, sulfur or the group CR 11 , but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groupings NR 11 and CR 11 each have the same or different meanings as defined below,
R11 für Wasserstoff, Methyl, Ethyl, n-Propyl, iso-Propyl, Allyl, Methoxymethyl, Methylcarbonyl, Ethylcarbonyl, iso-Propylcarbonyl, n-Propylcarbonyl, R 11 is hydrogen, methyl, ethyl, n-propyl, isopropyl, allyl, methoxymethyl, methylcarbonyl, ethylcarbonyl, isopropylphenyl, n-propylcarbonyl,
Phenylcarbonyl, p-Chlorphenylcarbonyl, Cyclopropylcarbonyl,  Phenylcarbonyl, p-chlorophenylcarbonyl, cyclopropylcarbonyl,
Methoxycarbonyl, Ethoxycarbonyl, n-Propyloxycarbonyl, iso- Propyloxycarbonyl, tert.-Butyloxycarbonyl, Allyloxycarbonyl, Phenoxymethyl, Benzyl, Trifluormethyl, Difluormethyl, 2,2,2-Trifluorethyl, 2,2-Difluorethyl, Methoxycarbonylmethyl, Ethoxycarbonylmethyl, iso-Propyloxycarbonylmethyl, tert.-Butyloxycarbonylmethyl, Methoxycarbonyl(dimethyl)methyl,  Methoxycarbonyl, ethoxycarbonyl, n-propyloxycarbonyl, iso-propyloxycarbonyl, tert-butyloxycarbonyl, allyloxycarbonyl, phenoxymethyl, benzyl, trifluoromethyl, difluoromethyl, 2,2,2-trifluoroethyl, 2,2-difluoroethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, isopropyloxycarbonylmethyl, tert Butyloxycarbonylmethyl, methoxycarbonyl (dimethyl) methyl,
Ethoxycarbonyl(dimethyl)methyl, iso-Propyloxycarbonyl(dimethyl)methyl, tert.- Butyloxycarbonyl(dimethyl)methyl, Methylaminocarbonylmethyl,  Ethoxycarbonyl (dimethyl) methyl, iso-propyloxycarbonyl (dimethyl) methyl, tert-butyloxycarbonyl (dimethyl) methyl, methylaminocarbonylmethyl,
Methylaminocarbonyl(dimethyl)methyl, Phenylaminocarbonylmethyl,  Methylaminocarbonyl (dimethyl) methyl, phenylaminocarbonylmethyl,
Phenylaminocarbonyl(dimethyl)methyl, 3,5-Difluorhenylaminocarbonylmethyl, 3,5-Difluorphenylaminocarbonyl(dimethyl)methyl steht,  Phenylaminocarbonyl (dimethyl) methyl, 3,5-difluorhenylaminocarbonylmethyl, 3,5-difluorophenylaminocarbonyl (dimethyl) methyl,
R12 und R13 unabhängig voneinander für Wasserstoff, Fluor, Chlor, Brom, lod, R 12 and R 13 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
Methyl, Ethyl, iso-Propyl, n-Propyl, Methoxy, Ethoxy, Trifluormethyl,  Methyl, ethyl, iso-propyl, n-propyl, methoxy, ethoxy, trifluoromethyl,
Difluormethyl, Trifluormethoxy, Phenyl, p-Chlorphenyl, p-Methylphenyl, p- Trifluormethylphenyl, 2-Pyridyl, 3-Pyridyl, 4-Pyridyl, Benzyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, A6, A7, A8, A9 gleich oder verschieden sind und unabhängig voneinander für 0, S, N, NH, N-Methyl, N-Ethyl, N-iso-Propyl, N-n-Propyl, Methoxycarbonyl-N, Difluoromethyl, trifluoromethoxy, phenyl, p-chlorophenyl, p-methylphenyl, p-trifluoromethylphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, benzyl or together with the atom to which they are attached form a carbonyl group, A 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N-methyl, N-ethyl, N-isopropyl, Nn-propyl, methoxycarbonyl-N,
Ethoxycarbonyl-N, iso-Propyloxycarbonyl-N, tert.-Butyloxycarbonyl-N, N- Phenyl, N-Tetrahydropyranyl, Phenylsulfonyl-N, p-Methylphenylsulfonyl-N, Ethoxycarbonyl-N, iso-propyloxycarbonyl-N, tert-butyloxycarbonyl-N, N-phenyl, N-tetrahydropyranyl, phenylsulfonyl-N, p-methylphenylsulfonyl-N,
Methylsulfonyl-N, iso-Propylsulfonyl-N, Cyclopropylsulfonyl-N, Methylsulfonyl-N, iso-propylsulfonyl-N, cyclopropylsulfonyl-N,
Methoxymethyl-N oder die Gruppierung C-R15 stehen, wobei maximal zwei 0- oder S-Atome im Heterocyclus vorhanden sind sind, und wobei keine 0- oder S-Atome benachbart zueinander sind, und wobei R15 in der Gruppierung C- R15 jeweils gleiche oder verschiedene Bedeutungen gemäß der Methoxymethyl-N or the group CR 15 , wherein a maximum of two 0 or S atoms are present in the heterocycle, and wherein no 0 or S atoms are adjacent to each other, and wherein R 15 in the grouping C-R 15 each same or different meanings according to the
obenstehenden Definition hat und  has above definition and
R16 und R17 unabhängig voneinander für Wasserstoff, Fluor, Methyl, Ethyl, Methoxy, Ethoxy, Trifluormethyl, Trifluormethoxy, Phenyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, R 16 and R 17 independently of one another are hydrogen, fluorine, methyl, ethyl, methoxy, ethoxy, trifluoromethyl, trifluoromethoxy, phenyl or together with the atom to which they are attached form a carbonyl group,
A10 für N-R18, Sauerstoff oder die Gruppierung C-R18 steht und wobei R18 in den Gruppierungen N-R18 und C-R18 jeweils gleiche oder verschiedene A 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or different
Bedeutungen gemäß der nachstehenden Definition hat,  Has meanings as defined below,
R18 für Wasserstoff, Methyl, Ethyl, n-Propyl, iso-Propyl, Allyl, Methoxymethyl, Methylcarbonyl, Ethylcarbonyl, iso-Propyloxycarbonyl, Phenylcarbonyl, Cyclopropylcarbonyl, Methoxycarbonyl, Ethoxycarbonyl, iso- Propyloxycarbonyl, tert.-Butyloxycarbonyl, Allyloxycarbonyl, Phenoxymethyl, Benzyl, Trifluormethyl, Difluormethyl, 2,2, 2-Trif I uorethy 1 , 2,2-Difluorethyl, gegebenenfalls substituiertes Phenyl steht, R 18 represents hydrogen, methyl, ethyl, n-propyl, isopropyl, allyl, methoxymethyl, methylcarbonyl, ethylcarbonyl, isopropyloxycarbonyl, phenylcarbonyl, cyclopropylcarbonyl, methoxycarbonyl, ethoxycarbonyl, isopropyloxycarbonyl, tert-butyloxycarbonyl, allyloxycarbonyl, phenoxymethyl, Benzyl, trifluoromethyl, difluoromethyl, 2,2,2-trifluoromethyl, 2,2-difluoroethyl, optionally substituted phenyl,
A11 für N oder die Gruppierung C-R21 steht und wobei R21 in der Gruppierung C- R21 die Bedeutung gemäß der vorstehenden Definition hat, A 11 is N or the group CR 21 and R 21 in the grouping C-R 21 has the meaning given above,
A12 für N-R18 oder die Gruppierung C(R19)R20 steht und wobei R19 und R20 in der Gruppierung C(R19)R20 die Bedeutung gemäß der nachstehenden Definition haben, A 12 is NR 18 or the moiety C (R 19 ) R 20 and wherein R 19 and R 20 in the Group C (R 19 ) R 20 have the meaning as defined below,
R19 und R20 unabhängig voneinander für Wasserstoff, Fluor, Chlor, Brom, lod, R 19 and R 20 independently of one another represent hydrogen, fluorine, chlorine, bromine, iodine,
Methyl, Ethyl, n-Propyl, iso-Propyl, n-Butyl,  Methyl, ethyl, n-propyl, iso-propyl, n-butyl,
Methoxy, Ethoxy, Trifluormethyl, Difluormethyl, 2,2-Difluorethyl, 2,2,2- Trifluorethyl, Trifluormethoxy, gegebenenfalls substituiertes Phenyl, 2-Pyridyl, 3-Pyridyl, 4-Pyridyl, Benzyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, und Q weiterhin für eine der in der vorstehend genannten Tabelle beschriebenen Gruppierungen Q-1 .1 bis Q-4.10 steht mit Ausnahme von 4-Hydroxy-4-{(E)-2-[2-(hydroxymethyl)phenyl]vinyl}-3,5,5- trimethylcyclohex-2-en-1 -on, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en- 1 -yl)vinyl]benzaldehyd, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]benzoesäure, Methyl-2-[(E)-2-(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en- 1 -yl)vinyl]benzoat. Die oben aufgeführten allgemeinen oder in Vorzugsbereichen aufgeführten  Methoxy, ethoxy, trifluoromethyl, difluoromethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, trifluoromethoxy, optionally substituted phenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, benzyl, or together with the atom to which and Q is furthermore one of the groupings Q-1 .1 to Q-4.10 described in the table above, with the exception of 4-hydroxy-4 - {(E) -2- [2-] (hydroxymethyl) phenyl] vinyl} -3,5,5-trimethylcyclohex-2-en-1-one, 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohexanol) 2-en-1-yl) vinyl] benzaldehyde, 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid, Methyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoate. The general or preferred ones listed above
Restedefinitionen gelten sowohl für die Endprodukte der Formel (I) als auch entsprechend für die jeweils zur Herstellung benötigten Ausgans- oder Residue definitions apply both to the end products of the formula (I) and also correspondingly to the starting or each preparation required for the preparation
Zwischenprodukte. Intermediates.
Diese Restedefinitionen können untereinander, also auch zwischen den  These remainder definitions can be used among each other, ie between the
angegebenen bevorzugten Bereichen beliebig kombiniert werden. specified preferred ranges are arbitrarily combined.
Ebenfalls noch nicht bekannt und somit weiterer Teil der Erfindung sind Also not yet known and thus further part of the invention
Verbindungen der Formel (II) oder deren Salze, Compounds of the formula (II) or salts thereof,
die als Zwischenprodukte zur Herstellung der erfindungsgemäßen Verbindungen der allgemeinen Formel (I) dienen, worin which serve as intermediates for the preparation of the compounds of general formula (I) according to the invention, in which
R1 für (Ci-Ce)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C2-C8)-Alkenyl-(Ci-C8)- alkyl, (C2-C8)-Alkinyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Hydroxy- (Ci-Cs)-alkyl, (Ci-C8)-Alkylamino, Sulfonylamino, (Ci-Cs)-Alkoxy, (Ci-C8)- Haloalkyl, (Ci-C8)-Haloalkoxy-(Ci-C8)-alkyl steht, R 1 is (Ci-Ce) alkyl, (C 2 -C 8) alkenyl, (C 2 -C 8) -alkynyl, (C 2 -C 8) alkenyl (Ci-C 8) - alkyl, (C 2 -C 8) alkynyl (Ci-C 8) alkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, hydroxy (Ci-Cs) alkyl, (Ci- C 8 ) -alkylamino, sulfonylamino, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy- (C 1 -C 8 ) -alkyl,
R2 für Wasserstoff, (Ci-Cs)-Alkyl, Nitro-(Ci-C8)-alkyl, Hydroxy-(Ci-C8)-alkyl, R 2 is hydrogen, (C 1 -C 5) -alkyl, nitro (C 1 -C 8 ) -alkyl, hydroxy (C 1 -C 8 ) -alkyl,
(Ci-Cs)-Haloalkyl, (Ci-C8)-Alkylamino, Sulfonylamino, (Ci-Cs)-Alkoxy, Tris- [(Ci-Cs)-alkylsilyl]- (Ci-C8)-alkyl, Cyano-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkyl, (C 1 -C 5) -haloalkyl, (C 1 -C 8 ) -alkylamino, sulfonylamino, (C 1 -C 5) -alkoxy, tris [(C 1 -C 5) -alkylsilyl] - (C 1 -C 8 ) -alkyl, cyano- (C 1 -C 8 ) -alkyl, aryl- (C 1 -C 8 ) -alkyl,
(Ci-C8)-Alkoxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)-Haloalkoxycarbonyl-(Ci-C8)- alkyl, (Ci-C8)-Alkylthio-(Ci-C8)-alkyl, Arylthio-(Ci-C8)-alkyl steht, (Ci-C8) alkoxycarbonyl (Ci-C 8) alkyl, (Ci-C 8) -Haloalkoxycarbonyl- (Ci-C 8) - alkyl, (Ci-C8) alkylthio (Ci-C 8 ) -alkyl, arylthio (C 1 -C 8 ) -alkyl,
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden, R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
R3 und R4 unabhängig voneinander für (Ci-Cs)-Alkoxy, (Ci-C8)-Alkoxy-(Ci-C8)- alkoxy, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxy, (Ci-Cs)-Haloalkoxy, (Ci-C8)- Alkylthio, (Ci-Cs)-Haloalkylthio stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, (Ci-C8)- Alkoxyiminogruppe, (C3-C8)-Cycloalkoxyiminogruppe, (C3-C8)-Cycloalkyl- (Ci-C8)-alkoximinogruppe, Aryl-(Ci-C8)-alkoxyiminogruppe oder einen 5-7- gliedrigen heterocyclischen Ring, der gegebenenfalls weiter substituiert sein kann, bilden R5 für Wasserstoff, (Ci-Ce)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkenyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, (Ci-Cs)-Alkylcarbonyl, Arylcarbonyl, R 3 and R 4 are each independently (Ci-Cs) alkoxy, (Ci-C 8) alkoxy (Ci-C 8) - alkoxy, (C 3 -C 8) -cycloalkyl- (Ci-C 8) -alkoxy, (Ci-Cs) -haloalkoxy, (Ci-C 8 ) - alkylthio, (Ci-Cs) haloalkylthio or together with the atom to which they are attached, an oxo group, hydroxyimino group, (Ci-C 8 ) Alkoxyimino group, (C 3 -C 8 ) -cycloalkoxyimino group, (C 3 -C 8 ) -cycloalkyl- (C 1 -C 8 ) -alkoximino group, aryl- (C 1 -C 8 ) -alkoxyimino group or a 5-7 membered heterocyclic ring , which may optionally be further substituted, form R 5 is hydrogen, (C 1 -C 6) -alkyl, (C 2 -C 8 ) -alkenyl, (C 2 -C 8 ) -alkenyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy- ( C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylcarbonyl, arylcarbonyl,
Heteroarylcarbonyl, (C3-C8)-Cycloalkylcarbonyl, (Ci-Cs)-Alkoxycarbonyl, (C2-C8)-Alkenyloxycarbonyl, Aryloxy-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkyl, (Ci-C8)-Heteroarylcarbonyl, (C3-C8) cycloalkylcarbonyl, (Ci-Cs) -alkoxycarbonyl, (C 2 -C 8) alkenyloxycarbonyl, aryloxy- (Ci-C 8) alkyl, aryl (Ci-C 8) -alkyl , (Ci-C 8 ) -
Alkoxy-(Ci-C8)-alkoxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylthio-(Ci-C8)-alkyl, Tris- [(Ci-C8)-alkyl]silyl, (Ci-C8)-Alkyl-Bis-[(Ci-C8)-alkyl]silyl, (Ci-Cs)-Alkyl-bis- Arylsilyl, Aryl-bis-[(Ci-C8)-alkyl]silyl, (C3-C8)-Cycloalkyl-bis-[(Ci-C8)-alkyl]silyl, Halo-bis-[(Ci-C8)-alkyl]silyl, Tris-[(Ci-C8)-alkyl]silyl-(Ci-C8)-alkoxy-(Ci-C8)-alkyl steht, und Alkoxy- (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylthio (C 1 -C 8 ) -alkyl, tris- [(C 1 -C 8 ) -alkyl] silyl, (C 1 -C 8 ) -alkyl-bis - [(C 1 -C 8 ) -alkyl] silyl, (C 1 -C 8 ) -alkyl-bis-arylsilyl, aryl-bis - [(C 1 -C 8 ) -alkyl ] silyl, (C 3 -C 8) cycloalkyl-bis - [(Ci-C 8) alkyl] silyl, halo-bis - [(Ci-C 8) alkyl] silyl, tris - [(Ci-C 8 ) -alkyl] silyl- (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, and
X für Chlor, Brom, lod, (Ci-C9)-Haloalkylsulfonyloxy, (Ci-C9)-Alkylsulfonyloxy steht. Im Hinblick auf die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) werden die vorstehend und weiter unten verwendeten Bezeichnungen erläutert. X is chloro, bromo, iodo, (C 1 -C 9) -haloalkylsulfonyloxy, (C 1 -C 9) -alkylsulfonyloxy. With regard to the compounds of the general formula (I) according to the invention, the terms used above and below are explained.
Diese sind dem Fachmann geläufig und haben insbesondere die im Folgenden erläuterten Bedeutungen: Erfindungsgemäß steht "Arylsulfonyl" für gegebenenfalls substituiertes These are familiar to the person skilled in the art and in particular have the meanings explained below: According to the invention, "arylsulfonyl" is optionally substituted
Phenylsulfonyl oder gegebenenfalls substituiertes polycyclisches Arylsulfonyl, hier insbesondere gegebenenfalls substituiertes Naphthylsulfonyl, beispielsweise substituiert durch Fluor, Chlor, Brom, lod, Cyano, Nitro, Alkyl-, Haloalkyl-,  Phenylsulfonyl or optionally substituted polycyclic arylsulfonyl, here in particular optionally substituted naphthylsulfonyl, for example substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, alkyl, haloalkyl,
Haloalkoxy-, Amino-, Alkylamino-, Alkylcarbonylamino-, Dialkylamino- oder Haloalkoxy, amino, alkylamino, alkylcarbonylamino, dialkylamino or
Alkoxygruppen. Alkoxy groups.
Erfindungsgemäß steht "Cycloalkylsulfonyl" - in Alleinstellung oder als Bestandteil einer chemischen Gruppe - für gegebenenfalls substituiertes Cycloalkylsulfonyl, vorzugsweise mit 3 bis 6 Kohlenstoffatomen wie beispielsweise Cyclopropylsulfonyl, Cyclobutylsulfonyl, Cyclopentylsulfonyl oder Cyclohexylsulfonyl. According to the invention "cycloalkylsulfonyl" - alone or as part of a chemical group - is optionally substituted Cycloalkylsulfonyl, preferably having 3 to 6 carbon atoms such as cyclopropylsulfonyl, cyclobutylsulfonyl, cyclopentylsulfonyl or cyclohexylsulfonyl.
Erfindungsgemäß steht "Alkylsulfonyl" - in Alleinstellung oder als Bestandteil einer chemischen Gruppe - für geradkettiges oder verzweigtes Alkylsulfonyl, vorzugsweise mit 1 bis 8, oder mit 1 bis 6 Kohlenstoffatomen wie beispielsweise Methylsulfonyl, Ethylsulfonyl, n-Propylsulfonyl, Isopropylsulfonyl, n-Butylsulfonyl, Isobutylsulfonyl, sec-Butylsulfonyl und tert-Butylsulfonyl. According to the invention "alkylsulfonyl" - alone or as part of a chemical group - represents straight-chain or branched alkylsulfonyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, for example methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl and tert-butylsulfonyl.
Erfindungsgemäß steht "Heteroarylsulfonyl" für gegebenenfalls substituiertes According to the invention "heteroarylsulfonyl" is optionally substituted
Pyridylsulfonyl, Pyrimidinylsulfonyl, Pyrazinylsulfonyl oder gegebenenfalls Pyridylsulfonyl, pyrimidinylsulfonyl, pyrazinylsulfonyl or optionally
substituiertes polycyclisches Heteroarylsulfonyl, hier insbesondere gegebenenfalls substituiertes Chinolinylsulfonyl, beispielsweise substituiert durch Fluor, Chlor, Brom, lod, Cyano, Nitro, Alkyl-, Haloalkyl-, Haloalkoxy-, Amino-, Alkylamino-, substituted polycyclic heteroarylsulfonyl, here in particular optionally substituted quinolinylsulfonyl, for example substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, alkyl, haloalkyl, haloalkoxy, amino, alkylamino,
Alkylcarbonylamino-, Dialkylamino- oder Alkoxygruppen. Alkylcarbonylamino, dialkylamino or alkoxy groups.
Erfindungsgemäß steht "Alkylthio" - in Alleinstellung oder als Bestandteil einer chemischen Gruppe - für geradkettiges oder verzweigtes S-Alkyl, vorzugsweise mit 1 bis 8, oder mit 1 bis 6 Kohlenstoffatomen, wie beispielsweise Methylthio, Ethylthio, n- Propylthio, Isopropylthio, n-Butylthio, Isobutylthio, sec-Butylthio und tert-Butylthio. Alkenylthio bedeutet ein über ein Schwefelatom gebundenen Alkenylrest, Alkinylthio bedeutet ein über ein Schwefelatom gebundenen Alkinylrest, Cycloalkylthio bedeutet ein über ein Schwefelatom gebundenen Cycloalkylrest und Cycloalkenylthio bedeutet ein über ein Schwefelatom gebundenen Cycloalkenylrest. According to the invention, "alkylthio" - alone or as part of a chemical group - represents straight-chain or branched S-alkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as, for example, methylthio, ethylthio, n-propylthio, isopropylthio, n- Butylthio, isobutylthio, sec-butylthio and tert-butylthio. Alkenylthio represents an alkenyl radical bonded via a sulfur atom, alkynylthio represents an alkynyl radical bonded via a sulfur atom, cycloalkylthio represents a cycloalkyl radical bonded via a sulfur atom, and cycloalkenylthio represents a cycloalkenyl radical bonded via a sulfur atom.
„Alkoxy" bedeutet ein über ein Sauerstoffatom gebundenen Alkylrest, Alkenyloxy bedeutet ein über ein Sauerstoffatom gebundenen Alkenylrest, Alkinyloxy bedeutet ein über ein Sauerstoffatom gebundenen Alkinylrest, Cycloalkyloxy bedeutet ein über ein Sauerstoffatom gebundenen Cycloalkylrest und Cycloalkenyloxy bedeutet ein über ein Sauerstoffatom gebundenen Cycloalkenylrest. "Alkoxy" means an alkyl radical bonded via an oxygen atom, alkenyloxy represents an alkynyl radical bonded via an oxygen atom, alkynyloxy means an alkynyl radical bonded via an oxygen atom, cycloalkyloxy denotes a cycloalkyl radical bonded via an oxygen atom, and cycloalkenyloxy denotes a cycloalkenyl radical bonded via an oxygen atom.
Der Begriff„Aryl" bedeutet ein gegebenenfalls substituiertes mono-, bi- oder polycyclisches aromatisches System mit vorzugsweise 6 bis 14, insbesondere 6 bis 10 Ring-C-Atomen, beispielsweise Phenyl, Naphthyl, Anthryl, Phenanthrenyl, und ähnliches, vorzugsweise Phenyl. Vom Begriff„gegebenenfalls substituiertes Aryl" sind auch mehrcyclische Systeme, wie Tetrahydronaphtyl, Indenyl, Indanyl, Fluorenyl, Biphenylyl, umfasst, wobei die Bindungsstelle am aromatischen System ist. Von der Systematik her ist„Aryl" in der Regel auch von dem Begriff„gegebenenfalls substituiertes Phenyl" umfasst. The term "aryl" means an optionally substituted mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring C atoms, for example phenyl, naphthyl, anthryl, phenanthrenyl, and the like, preferably phenyl. The term "optionally substituted aryl" also includes polycyclic systems, such as tetrahydronaphthyl, indenyl, indanyl, fluorenyl, biphenylyl, the binding site being on the aromatic system. "Aryl" is also generally known from the term "optionally substituted phenyl ".
Ein heterocyclischer Rest (Heterocydyl) enthält mindestens einen heterocyclischen Ring (=carbocyclischer Ring, in dem mindestens ein C-Atom durch ein Heteroatom ersetzt ist, vorzugsweise durch ein Heteroatom aus der Gruppe N, 0, S, P) der gesättigt, ungesättigt, teilgesättigt oder heteroaromatisch ist und dabei unsubstituiert oder substituiert sein kann, wobei die Bindungsstelle an einem Ringatom lokalisiert ist. Ist der Heterocyclylrest oder der heterocyclische Ring gegebenenfalls A heterocyclic radical (heterocyclic) contains at least one heterocyclic ring (= carbocyclic ring in which at least one carbon atom is replaced by a heteroatom, preferably by a heteroatom from the group N, O, S, P) which is saturated, unsaturated, partially saturated or is heteroaromatic and may be unsubstituted or substituted, wherein the binding site is located on a ring atom. Is the heterocyclyl or the heterocyclic ring optionally
substituiert, kann er mit anderen carbocyclischen oder heterocyclischen Ringen annelliert sein. Im Falle von gegebenenfalls substituiertem Heterocydyl werden auch mehrcyclische Systeme umfaßt, wie beispielsweise 8-Aza-bicyclo[3.2.1 ]octanyl, 8- Aza-bicyclo[2.2.2]octanyl oder 1 -Aza-bicyclo[2.2.1 ]heptyl. Im Falle von substituted, it may be fused with other carbocyclic or heterocyclic rings. In the case of optionally substituted heterocyclic, more cyclic systems are also included, such as 8-azabicyclo [3.2.1] octanyl, 8-azabicyclo [2.2.2] octanyl or 1-azabicyclo [2.2.1] heptyl. In case of
gegebenenfalls substituiertem Heterocydyl werden auch spirocyclische Systeme umfaßt, wie beispielsweise 1 -Oxa-5-aza-spiro[2.3]hexyl. Wenn nicht anders definiert, enthält der heterocyclische Ring vorzugsweise 3 bis 9 Ringatome, insbesondere 3 bis 6 Ringatome, und ein oder mehrere, vorzugsweise 1 bis 4, insbesondere 1 , 2 oder 3 Heteroatome im heterocyclischen Ring, vorzugsweise aus der Gruppe N, 0, und S, wobei jedoch nicht zwei Sauerstoffatome direkt benachbart sein sollen, wie beispielsweise mit einem Heteroatom aus der Gruppe N, 0 und S 1 - oder 2- oder 3- Pyrrolidinyl, 3,4-Dihydro-2H-pyrrol-2- oder 3-yl, 2,3-Dihydro-1 H-pyrrol-1 - oder 2- oder 3- oder 4- oder 5-yl; 2,5-Dihydro-1 H-pyrrol-1 - oder 2- oder 3-yl, 1 - oder 2- oder 3- oder 4-Piperidinyl; 2,3,4,5-Tetrahydropyridin-2- oder 3- oder 4- oder 5-yl oder 6-yl; 1 ,2,3,6-Tetrahydropyridin-1 - oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1 ,2,3,4- Tetrahydropyridin-1 - oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1 ,4-Dihydropyridin-1 - oder 2- oder 3- oder 4-yl; 2,3-Dihydropyridin-2- oder 3- oder 4- oder 5- oder 6-yl; 2,5- Dihydropyridin-2- oder 3- oder 4- oder 5- oder 6-yl, 1 - oder 2- oder 3- oder 4- Azepanyl; 2,3,4,5-Tetrahydro-1 H-azepin-1 - oder 2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7-Tetrahydro-1 H-azepin-1 - oder 2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7-Tetrahydro-1 H-azepin-1 - oder 2- oder 3- oder 4-yl; 3,4,5,6- Tetrahydro-2H-azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-1 H- azepin-1 - oder 2- oder 3- oder 4-yl; 2,5-Dihydro-1 H-azepin-1 - oder -2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,7-Dihydro-1 H-azepin-1 - oder -2- oder 3- oder 4-yl; 2,3- Dihydro-1 H-azepin-1 - oder -2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 3,4-Dihydro- 2H-azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 3,6-Dihydro-2H-azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 5,6-Dihydro-2H-azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-3H-azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 1 H-Azepin-1 - oder -2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2H- Azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 3H-Azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4H-Azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl, 2- oder 3-Oxolanyl (= 2- oder 3-Tetrahydrofuranyl); 2,3-Dihydrofuran-2- oder 3- oder 4- oder 5-yl; 2,5-Dihydrofuran-2- oder 3-yl, 2- oder 3- oder 4-Oxanyl (= 2- oder 3- oder 4-Tetrahydropyranyl); 3,4-Dihydro-2H-pyran-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6- Dihydro-2H-pyran-2- oder 3-oder 4- oder 5- oder 6-yl; 2H-Pyran-2- oder 3- oder 4- oder 5- oder 6-yl; 4H-Pyran-2- oder 3- oder 4-yl, 2- oder 3- oder 4-Oxepanyl; 2,3,4,5- Tetrahydrooxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7- Tetrahydrooxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7- Tetrahydrooxepin-2- oder 3- oder 4-yl; 2,3-Dihydrooxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydrooxepin-2- oder 3- oder 4-yl; 2,5-Dihydrooxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; Oxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7- yl; 2- oder 3-Tetrahydrothiophenyl; 2,3-Dihydrothiophen-2- oder 3- oder 4- oder 5-yl; 2,5-Dihydrothiophen-2- oder 3-yl; Tetrahydro-2H-thiopyran-2- oder 3- oder 4-yl; 3,4- Dihydro-2H-thiopyran-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-2H- thiopyran-2- oder 3- oder 4- oder 5- oder 6-yl; 2H-Thiopyran-2- oder 3- oder 4- oder 5- oder 6-yl; 4H-Thiopyran-2- oder 3- oder 4-yl. Bevorzugte 3-Ring und 4-Ring-optionally substituted heterocydyl also includes spirocyclic systems such as 1-oxa-5-aza-spiro [2.3] hexyl. Unless defined otherwise, the heterocyclic ring preferably contains 3 to 9 ring atoms, in particular 3 to 6 ring atoms, and one or more, preferably 1 to 4, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, 0, and S, but not two oxygen atoms should be directly adjacent, such as with a heteroatom from the group N, 0 and S 1 - or 2- or 3-pyrrolidinyl, 3,4-dihydro-2H-pyrrole-2 or 3 -yl, 2,3-dihydro-1H-pyrrole-1 - or 2- or 3- or 4- or 5-yl; 2,5-dihydro-1H-pyrrol-1 - or 2- or 3-yl, 1- or 2- or 3- or 4-piperidinyl; 2,3,4,5-tetrahydropyridine-2- or 3- or 4- or 5-yl or 6-yl; 1, 2,3,6-tetrahydropyridine-1 - or 2- or 3- or 4- or 5- or 6-yl; 1, 2,3,4-tetrahydropyridine-1 - or 2- or 3- or 4- or 5- or 6-yl; 1,4-dihydropyridine-1 - or 2- or 3- or 4-yl; 2,3-dihydropyridine-2- or 3- or 4- or 5- or 6-yl; 2,5-dihydropyridine-2- or 3- or 4- or 5- or 6-yl, 1- or 2- or 3- or 4- azepanyl; 2,3,4,5-tetrahydro-1H-azepine-1 - or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1H-azepine-1 - or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1H-azepine-1 - or 2- or 3- or 4-yl; 3,4,5,6 Tetrahydro-2H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1H-azepine-1 - or 2- or 3- or 4-yl; 2,5-dihydro-1H-azepine-1 or -2 or 3 or 4 or 5 or 6 or 7-yl; 2,7-dihydro-1H-azepine-1 - or -2- or 3- or 4-yl; 2,3-dihydro-1H-azepine-1 or -2 or 3 or 4 or 5 or 6 or 7-yl; 3,4-dihydro-2H-azepine-2 or 3 or 4 or 5 or 6 or 7-yl; 3,6-dihydro-2H-azepine-2 or 3 or 4 or 5 or 6 or 7-yl; 5,6-dihydro-2H-azepine-2 or 3 or 4 or 5 or 6 or 7-yl; 4,5-dihydro-3H-azepine-2 or 3 or 4 or 5 or 6 or 7-yl; 1 H-azepine-1 or -2 or 3 or 4 or 5 or 6 or 7-yl; 2H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl; 3H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl; 4H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl, 2- or 3-oxolanyl (= 2- or 3-tetrahydrofuranyl); 2,3-dihydrofuran-2- or 3- or 4- or 5-yl; 2,5-dihydrofuran-2- or 3-yl, 2- or 3- or 4-oxanyl (= 2- or 3- or 4-tetrahydropyranyl); 3,4-dihydro-2H-pyran-2 or 3 or 4 or 5 or 6-yl; 3,6-dihydro-2H-pyran-2 or 3 or 4 or 5 or 6-yl; 2H-pyran-2- or 3- or 4- or 5- or 6-yl; 4H-pyran-2- or 3- or 4-yl, 2- or 3- or 4-oxepanyl; 2,3,4,5-tetrahydrooxepin-2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,4,7-tetrahydrooxepin-2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,6,7-tetrahydrooxepin-2 or 3 or 4-yl; 2,3-dihydrooxepin-2 or 3 or 4 or 5 or 6 or 7-yl; 4,5-dihydrooxepin-2 or 3 or 4-yl; 2,5-dihydrooxepin-2 or 3 or 4 or 5 or 6 or 7-yl; Oxepin-2 or 3 or 4 or 5 or 6 or 7 yl; 2- or 3-tetrahydrothiophenyl; 2,3-dihydrothiophene-2 or 3 or 4 or 5-yl; 2,5-dihydrothiophene-2 or 3-yl; Tetrahydro-2H-thiopyran-2- or 3- or 4-yl; 3,4-dihydro-2H-thiopyran-2 or 3 or 4 or 5 or 6-yl; 3,6-dihydro-2H-thiopyran-2 or 3 or 4 or 5 or 6-yl; 2H-thiopyran-2 or 3 or 4 or 5 or 6-yl; 4H-thiopyran-2- or 3- or 4-yl. Preferred 3-ring and 4-ring
Heterocyclen sind beispielsweise 1 - oder 2-Aziridinyl, Oxiranyl, Thiiranyl, 1 - oder 2- oder 3-Azetidinyl, 2- oder 3-Oxetanyl, 2- oder 3-Thietanyl, 1 ,3-Dioxetan-2-yl. Weitere Beispiele für "Heterocyclyl" sind ein partiell oder vollständig hydrierter Heterocycles are, for example, 1- or 2-aziridinyl, oxiranyl, thiiranyl, 1- or 2- or 3-azetidinyl, 2- or 3-oxetanyl, 2- or 3-thietanyl, 1,3-dioxetan-2-yl. Further examples of "heterocyclyl" are a partially or fully hydrogenated
heterocyclischer Rest mit zwei Heteroatomen aus der Gruppe N, O und S, wie beispielsweise 1 - oder 2- oder 3- oder 4-Pyrazolidinyl; 4,5-Dihydro-3H-pyrazol- 3- oder 4- oder 5-yl; 4,5-Dihydro-1 H-pyrazol-1 - oder 3- oder 4- oder 5-yl; 2,3-Dihydro- 1 H-pyrazol-1 - oder 2- oder 3- oder 4- oder 5-yl; 1 - oder 2- oder 3- oder 4- Imidazolidinyl; 2,3-Dihydro-1 H-imidazol-1 - oder 2- oder 3- oder 4-yl; 2,5-Dihydro-1 H- imidazol-1 - oder 2- oder 4- oder 5-yl; 4,5-Dihydro-1 H-imidazol-1 - oder 2- oder 4- oder 5-yl; Hexahydropyridazin-1 - oder 2- oder 3- oder 4-yl; 1 ,2,3,4- Tetrahydropyridazin-1 - oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1 ,2,3,6- Tetrahydropyridazin-1 - oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1 ,4,5,6- Tetrahydropyridazin-1 - oder 3- oder 4- oder 5- oder 6-yl; 3,4,5,6- Tetrahydropyridazin-3- oder 4- oder 5-yl; 4,5-Dihydropyridazin-3- oder 4-yl; 3,4- Dihydropyridazin-3- oder 4- oder 5- oder 6-yl; 3,6-Dihydropyridazin-3- oder 4-yl; 1 ,6- Dihydropyriazin-1 - oder 3- oder 4- oder 5- oder 6-yl; Hexahydropyrimidin-1 - oder 2- oder 3- oder 4-yl; 1 ,4,5,6-Tetrahydropyrimidin-l - oder 2- oder 4- oder 5- oder 6-yl; 1 ,2,5,6-Tetrahydropyrimidin-1 - oder 2- oder 4- oder 5- oder 6-yl; 1 ,2,3,4- Tetrahydropyrimidin-1 - oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1 ,6- Dihydropyrimidin-1 - oder 2- oder 4- oder 5- oder 6-yl; 1 ,2-Dihydropyrimidin-l - oder 2- oder 4- oder 5- oder 6-yl; 2,5-Dihydropyrimidin-2- oder 4- oder 5-yl; 4,5- Dihydropyrimidin- 4- oder 5- oder 6-yl; 1 ,4-Dihydropyrimidin-l - oder 2- oder 4- oder 5- oder 6-yl; 1 - oder 2- oder 3-Piperazinyl; 1 ,2,3,6-Tetrahydropyrazin-1 - oder 2- oderheterocyclic radical having two heteroatoms from the group consisting of N, O and S, such as 1- or 2- or 3- or 4-pyrazolidinyl; 4,5-dihydro-3H-pyrazole-3 or 4 or 5-yl; 4,5-dihydro-1H-pyrazole-1 - or 3- or 4- or 5-yl; 2,3-dihydro-1H-pyrazole-1 - or 2- or 3- or 4- or 5-yl; 1 or 2 or 3 or 4 imidazolidinyl; 2,3-dihydro-1H-imidazole-1 - or 2- or 3- or 4-yl; 2,5-dihydro-1H-imidazole-1 - or 2- or 4- or 5-yl; 4,5-dihydro-1H-imidazole-1 - or 2- or 4- or 5-yl; Hexahydropyridazine-1 - or 2- or 3- or 4-yl; 1,2,3,4-tetrahydropyridazine-1 - or 2- or 3- or 4- or 5- or 6-yl; 1, 2,3,6-tetrahydropyridazine-1 - or 2- or 3- or 4- or 5- or 6-yl; 1, 4,5,6-tetrahydropyridazine-1 - or 3- or 4- or 5- or 6-yl; 3,4,5,6-tetrahydropyridazine-3- or 4- or 5-yl; 4,5-dihydropyridazine-3 or 4-yl; 3,4-dihydropyridazine-3- or 4- or 5- or 6-yl; 3,6-dihydropyridazine-3 or 4-yl; 1,6-dihydropyriazine-1 - or 3- or 4- or 5- or 6-yl; Hexahydropyrimidine-1 - or 2- or 3- or 4-yl; 1, 4,5,6-tetrahydropyrimidine-1 - or 2- or 4- or 5- or 6-yl; 1, 2,5,6-tetrahydropyrimidine-1 - or 2- or 4- or 5- or 6-yl; 1, 2,3,4-tetrahydropyrimidine-1 - or 2- or 3- or 4- or 5- or 6-yl; 1,6-dihydropyrimidine-1 - or 2- or 4- or 5- or 6-yl; 1,2-dihydropyrimidine-1 - or 2- or 4- or 5- or 6-yl; 2,5-dihydropyrimidine-2- or 4- or 5-yl; 4,5-dihydropyrimidine-4- or 5- or 6-yl; 1,4-dihydropyrimidine-1 - or 2- or 4- or 5- or 6-yl; 1- or 2- or 3-piperazinyl; 1, 2,3,6-tetrahydropyrazine-1 - or 2- or
3- oder 5- oder 6-yl; 1 ,2,3,4-Tetrahydropyrazin-1 - oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1 ,2-Dihydropyrazin-1 - oder 2- oder 3- oder 5- oder 6-yl; 1 ,4- Dihydropyrazin-1 - oder 2- oder 3-yl; 2,3-Dihydropyrazin-2- oder 3- oder 5- oder 6-yl; 2,5-Dihydropyrazin-2- oder 3-yl; 1 ,3-Dioxolan-2- oder 4- oder 5-yl; 1 ,3-Dioxol-2- oder3- or 5- or 6-yl; 1,2,3,4-tetrahydropyrazine-1 - or 2- or 3- or 4- or 5- or 6-yl; 1,2-dihydropyrazine-1 - or 2- or 3- or 5- or 6-yl; 1,4-dihydropyrazine-1 - or 2- or 3-yl; 2,3-dihydropyrazine-2- or 3- or 5- or 6-yl; 2,5-dihydropyrazine-2 or 3-yl; 1,3-dioxolane-2- or 4- or 5-yl; 1, 3-dioxol-2 or
4- yl; 1 ,3-Dioxan-2- oder 4- oder 5-yl; 4H-1 ,3-Dioxin-2- oder 4- oder 5- oder 6-yl; 1 ,4- Dioxan-2- oder 3- oder 5- oder 6-yl; 2,3-Dihydro-1 ,4-dioxin-2- oder 3- oder 5- oder 6- yl; 1 ,4-Dioxin-2- oder 3-yl; 1 ,2-Dithiolan-3- oder 4-yl; 3H-1 ,2-Dithiol-3- oder 4- oder 5- yl; 1 ,3-Dithiolan-2- oder 4-yl; 1 ,3-Dithiol-2- oder 4-yl; 1 ,2-Dithian-3- oder 4-yl; 3,4- Dihydro-1 ,2-dithiin-3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-1 ,2-dithiin-3- oder 4-yl; 1 ,2-Dithiin-3- oder 4-yl; 1 ,3-Dithian-2- oder 4- oder 5-yl; 4H-1 ,3-Dithiin-2- oder 4- oder 5- oder 6-yl; lsoxazolidin-2- oder 3- oder 4- oder 5-yl; 2,3-Dihydroisoxazol-2- oder 3- oder 4- oder 5-yl; 2,5-Dihydroisoxazol-2- oder 3- oder 4- oder 5-yl; 4,5- Dihydroisoxazol-3- oder 4- oder 5-yl; 1 ,3-Oxazolidin-2- oder 3- oder 4- oder 5-yl; 2,3- Dihydro-1 ,3-oxazol-2- oder 3- oder 4- oder 5-yl; 2,5-Dihydro-1 ,3-oxazol-2- oder 4- oder 5-yl; 4,5-Dihydro-1 ,3-oxazol-2- oder 4- oder 5-yl; 1 ,2-Oxazinan-2- oder 3- oder 4- oder 5- oder 6-yl; 3,4-Dihydro-2H-1 ,2-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-2H-1 ,2-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-2H-1 ,2- oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-4H-1 ,2-oxazin-3- oder 4- oder 5- oder 6-yl; 2H-1 ,2-Oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 6H-1 ,2-Oxazin-4-yl; 1,3-dioxane-2- or 4- or 5-yl; 4H-1, 3-dioxin-2 or 4 or 5 or 6-yl; 1, 4-dioxane-2 or 3 or 5 or 6-yl; 2,3-dihydro-1,4-dioxin-2- or 3- or 5- or 6-yl; 1, 4-dioxin-2 or 3-yl; 1,2-dithiolan-3 or 4-yl; 3H-1,2-dithiol-3- or 4- or 5-yl; 1,3-dithiolan-2 or 4-yl; 1,3-dithiol-2- or 4-yl; 1,2-dithian-3 or 4-yl; 3,4-dihydro-1,2-dithiin-3- or 4- or 5- or 6-yl; 3,6-dihydro-1,2-dithiin-3 or 4-yl; 1,2-dithiin-3 or 4-yl; 1,3-dithian-2- or 4- or 5-yl; 4H-1, 3-dithiine-2 or 4 or 5 or 6-yl; Isoxazolidine-2 or 3 or 4 or 5-yl; 2,3-dihydroisoxazole-2 or 3 or 4 or 5-yl; 2,5-dihydroisoxazole-2 or 3 or 4 or 5-yl; 4,5-dihydroisoxazole-3 or 4 or 5-yl; 1,3-oxazolidine-2- or 3- or 4- or 5-yl; 2,3-dihydro-1,3-oxazol-2- or 3- or 4- or 5-yl; 2,5-dihydro-1,3-oxazol-2- or 4- or 5-yl; 4,5-dihydro-1,3-oxazol-2- or 4- or 5-yl; 1, 2-oxazinan-2 or 3 or 4 or 5 or 6-yl; 3,4-dihydro-2H-1,2-oxazine-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1, 2-oxazine-2 or 3 or 4 or 5 or 6-yl; 5,6-dihydro-2H-1, 2-oxazine-2 or 3 or 4 or 5 or 6-yl; 5,6-dihydro-4H-1,2-oxazine-3- or 4- or 5- or 6-yl; 2H-1, 2-oxazine-2 or 3 or 4 or 5 or 6-yl; 6H-1, 2-oxazine
3- oder 4- oder 5- oder 6-yl; 4H-1 ,2-Oxazin-3- oder 4- oder 5- oder 6-yl; 1 ,3- Oxazinan-2- oder 3- oder 4- oder 5- oder 6-yl; 3,4-Dihydro-2H-1 ,3-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-2H-1 ,3-oxazin-2- oder 3- oder 4- oder 5- oder3- or 4- or 5- or 6-yl; 4H-1, 2-oxazine-3 or 4 or 5 or 6-yl; 1, 3-oxazinan-2 or 3 or 4 or 5 or 6-yl; 3,4-dihydro-2H-1,3-oxazine-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1, 3-oxazine-2 or 3 or 4 or 5 or
6- yl; 5,6-Dihydro-2H-1 ,3-oxazin-2- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-4H-1 ,3- oxazin-2- oder 4- oder 5- oder 6-yl; 2H-1 ,3-Oxazin-2- oder 4- oder 5- oder 6-yl; 6H- 1 ,3-Oxazin-2- oder 4- oder 5- oder 6-yl; 4H-1 ,3-Oxazin-2- oder 4- oder 5- oder 6-yl; Morpholin-2- oder 3- oder 4-yl; 3,4-Dihydro-2H-1 ,4-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-2H-1 ,4-oxazin-2- oder 3- oder 5- oder 6-yl; 2H-1 ,4-oxazin-2- oder 3- oder 5- oder 6-yl; 4H-1 ,4-oxazin-2- oder 3-yl; 1 ,2-Oxazepan-2- oder 3- oder6-yl; 5,6-dihydro-2H-1,3-oxazine-2- or 4- or 5- or 6-yl; 5,6-dihydro-4H-1, 3-oxazine-2 or 4 or 5 or 6-yl; 2H-1, 3-oxazine-2- or 4- or 5- or 6-yl; 6H-1,3-oxazine-2- or 4- or 5- or 6-yl; 4H-1, 3-oxazine-2 or 4 or 5 or 6-yl; Morpholine-2- or 3- or 4-yl; 3,4-dihydro-2H-1,4-oxazine-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1, 4-oxazine-2 or 3 or 5 or 6-yl; 2H-1,4-oxazine-2- or 3- or 5- or 6-yl; 4H-1,4-oxazine-2 or 3-yl; 1, 2-Oxazepan-2 or 3 or
4- oder 5- oder 6- oder 7-yl; 2,3,4,5-Tetrahydro-1 ,2-oxazepin-2- oder 3- oder 4- oder4- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,2-oxazepine-2- or 3- or 4- or
5- oder 6- oder 7-yl; 2,3,4,7-Tetrahydro-1 ,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7-Tetrahydro-1 ,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or
7- yl; 2,5,6,7-Tetrahydro-1 ,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5,6,7-Tetrahydro-1 ,2-oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-7- yl; 2,5,6,7-tetrahydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5,6,7-tetrahydro-1,2-oxazepine-3- or 4- or 5- or 6- or 7-yl; 2,3-dihydro-
1 .2- oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,5-Dihydro-1 ,2-oxazepin- 2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,7-Dihydro-1 ,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-1 ,2-oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; 4,7-Dihydro-1 ,2-oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; 6,7-Dihydro-1 ,2- oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; 1 ,2-Oxazepin-3- oder 4- oder 5- oder1, 2-oxazepine-2 or 3 or 4 or 5 or 6 or 7-yl; 2,5-dihydro-1,2-oxazepine 2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,2-oxazepine-3- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,2-oxazepine-3- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1, 2-oxazepine-3 or 4 or 5 or 6 or 7-yl; 1, 2-oxazepine-3 or 4 or 5 or
6- oder 7-yl; 1 ,3-Oxazepan-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,5- Tetrahydro-1 ,3-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7- Tetrahydro-1 ,3-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7- Tetrahydro-1 ,3-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,5,6,7- Tetrahydro-1 ,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 4,5,6,7-Tetrahydro-1 ,3- oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-1 ,3-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,5-Dihydro-1 ,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 2,7-Dihydro-1 ,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-6- or 7-yl; 1,3-oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-tetrahydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 4,5,6,7-tetrahydro-1,3,10-oxazepine-2- or 4- or 5- or 6- or 7-yl; 2,3-dihydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 4,5-dihydro
1 .3- oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 4,7-Dihydro-1 ,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 6,7-Dihydro-1 ,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 1 ,3-Oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 1 ,4-Oxazepan-2- oder 3- oder 5- oder 6- oder 7-yl; 2,3,4,5-Tetrahydro-1 ,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7-Tetrahydro-1 ,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7-Tetrahydro-1 ,4-oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 1, 3-oxazepine-2 or 4 or 5 or 6 or 7-yl; 4,7-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,3-oxazepine-2 or 4 or 5 or 6 or 7-yl; 1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 1,4-oxazepan-2- or 3- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl;
2,5,6,7-Tetrahydro-1 ,4-oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 4,5,6,7- Tetrahydro-1 ,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3-Dihydro- 1 ,4-oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 2,5-Dihydro-1 ,4-oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 2,7-Dihydro-1 ,4-oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-1 ,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,7- Dihydro-1 ,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 6,7-Dihydro-1 ,4- oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 1 ,4-Oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; lsothiazolidin-2- oder 3- oder 4- oder 5-yl; 2,3-Dihydroisothiazol-2- oder2,5,6,7-tetrahydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 4,5,6,7-tetrahydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 2,5-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 2,7-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 4,5-dihydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1, 4-oxazepine-2 or 3 or 5 or 6 or 7-yl; 1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; isothiazolidine-2- or 3- or 4- or 5-yl; 2,3-dihydroisothiazole-2- or
3- oder 4- oder 5-yl; 2,5-Dihydroisothiazol-2- oder 3- oder 4- oder 5-yl; 4,5- Dihydroisothiazol-3- oder 4- oder 5-yl; 1 ,3-Thiazolidin-2- oder 3- oder 4- oder 5-yl; 2,3-Dihydro-1 ,3-thiazol-2- oder 3- oder 4- oder 5-yl; 2,5-Dihydro-1 ,3-thiazol-2- oder3- or 4- or 5-yl; 2,5-dihydroisothiazole-2 or 3 or 4 or 5-yl; 4,5-dihydroisothiazol-3 or 4 or 5-yl; 1,3-thiazolidine-2- or 3- or 4- or 5-yl; 2,3-dihydro-1, 3-thiazole-2 or 3 or 4 or 5-yl; 2,5-dihydro-1, 3-thiazole-2-or
4- oder 5-yl; 4,5-Dihydro-1 ,3-thiazol-2- oder 4- oder 5-yl; 1 ,3-Thiazinan-2- oder 3- oder 4- oder 5- oder 6-yl; 3,4-Dihydro-2H-1 ,3-thiazin-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-2H-1 ,3-thiazin-2- oder 3- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-2H- 1 ,3-thiazin-2- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-4H-1 ,3-thiazin-2- oder 4- oder 5- oder 6-yl; 2H-1 ,3-Thiazin-2- oder 4- oder 5- oder 6-yl; 6H-1 ,3-Thiazin-2- oder 4- oder4- or 5-yl; 4,5-dihydro-1,3-thiazole-2- or 4- or 5-yl; 1, 3-thiazinan-2 or 3 or 4 or 5 or 6-yl; 3,4-dihydro-2H-1, 3-thiazine-2 or 3 or 4 or 5 or 6-yl; 3,6-dihydro-2H-1, 3-thiazine-2 or 3 or 4 or 5 or 6-yl; 5,6-dihydro-2H-1, 3-thiazine-2 or 4 or 5 or 6-yl; 5,6-dihydro-4H-1, 3-thiazine-2 or 4 or 5 or 6-yl; 2H-1, 3-thiazine-2 or 4 or 5 or 6-yl; 6H-1, 3-thiazine-2 or 4 or
5- oder 6-yl; 4H-1 ,3-Thiazin-2- oder 4- oder 5- oder 6-yl. Weitere Beispiele für "Heterocyclyl" sind ein partiell oder vollständig hydrierter heterocyclischer Rest mit 3 Heteroatomen aus der Gruppe N, 0 und S, wie beispielsweise 1 ,4,2-Dioxazolidin-2- oder 3- oder 5-yl; 1 ,4,2-Dioxazol-3- oder 5-yl; 1 ,4,2-Dioxazinan-2- oder -3- oder 5- oder 6-yl; 5,6-Dihydro-1 ,4,2-dioxazin-3- oder 5- oder 6-yl; 1 ,4,2-Dioxazin-3- oder 5- oder 6-yl; 1 ,4,2-Dioxazepan-2- oder 3- oder 5- oder 6- oder 7-yl; 6,7-Dihydro-5H- 1 ,4,2-Dioxazepin-3- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-7H-1 ,4,2-Dioxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-5H-1 ,4,2-Dioxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 5H-1 ,4,2-Dioxazepin-3- oder 5- oder 6- oder 7-yl; 7H-1 ,4,2- Dioxazepin-3- oder 5- oder 6- oder 7-yl. 5- or 6-yl; 4H-1, 3-thiazine-2 or 4 or 5 or 6-yl. Further examples of "heterocyclyl" are a partially or fully hydrogenated heterocyclic radical having 3 heteroatoms from the group N, O and S, such as, for example, 1, 4,2-dioxazolidin-2 or 3 or 5-yl; 1, 4,2-dioxazol-3 or 5-yl; 1,2,2-dioxazinane-2- or -3- or 5- or 6-yl; 5,6-dihydro-1,2,2,2-dioxazine-3- or 5- or 6-yl; 1,2,2-dioxazine-3- or 5- or 6-yl; 1, 4,2-dioxazepan-2 or 3 or 5 or 6 or 7-yl; 6,7-dihydro-5H-1,2,2-dioxazepine-3 or 5 or 6 or 7-yl; 2,3-dihydro-7H-1, 4,2-dioxazepin-2 or 3 or 5 or 6 or 7-yl; 2,3-dihydro-5H-1, 4,2-dioxazepine-2 or 3 or 5 or 6 or 7-yl; 5H-1, 4,2-dioxazepine-3 or 5 or 6 or 7-yl; 7H-1, 4,2-dioxazepine-3 or 5 or 6 or 7-yl.
Wenn ein Grundkörper "durch einen oder mehrere Reste" aus einer Aufzählung von Resten (= Gruppe) oder einer generisch definierten Gruppe von Resten substituiert ist, so schließt dies jeweils die gleichzeitige Substitution durch mehrere gleiche und/oder strukturell unterschiedliche Reste ein. Handelt es sich es sich um einen teilweise oder vollständig gesättigten Stickstoff- Heterocyclus, so kann dieser sowohl über Kohlenstoff als auch über den Stickstoff mit dem Rest des Moleküls verknüpft sein. If a body "by one or more remains" from a list of Rests (= group) or a generically defined group of radicals is substituted, this includes the simultaneous substitution by a plurality of identical and / or structurally different radicals. If it is a partially or fully saturated nitrogen heterocycle, it may be linked to the rest of the molecule via both carbon and nitrogen.
Als Substituenten für einen substituierten heterocyclischen Rest kommen die weiter unten genannten Substituenten in Frage, zusätzlich auch Oxo und Thioxo. Die Oxogruppe als Substituent an einem Ring-C-Atom bedeutet dann beispielsweise eine Carbonylgruppe im heterocyclischen Ring. Dadurch sind vorzugsweise auch Lactone und Lactame umfasst. Die Oxogruppe kann auch an den Heteroringatomen, die in verschiedenen Oxidationsstufen existieren können, z.B. bei N und S, auftreten und bilden dann beispielsweise die divalenten Gruppen N(O) , S(O) (auch kurz SO) und S(O)2 (auch kurz SO2) im heterocyclischen Ring. Im Fall von -N(O)- und -S(O)-Gruppen sind jeweils beide Enantiomere umfasst. Suitable substituents for a substituted heterocyclic radical are the substituents mentioned below, in addition to oxo and thioxo. The oxo group as a substituent on a ring C atom then means, for example, a carbonyl group in the heterocyclic ring. As a result, lactones and lactams are preferably also included. The oxo group may also be attached to the hetero ring atoms, which may exist in different oxidation states, e.g. in the case of N and S, for example, the divalent groups N (O), S (O) (also SO for short) and S (O) 2 (also SO2 for short) occur and form in the heterocyclic ring. In the case of -N (O) and -S (O) groups, both enantiomers are included.
Erfindungsgemäß stehen die Ausdrücke„Heteroaryl" und„Hetaryl" für According to the invention, the terms "heteroaryl" and "hetaryl" stand for
heteroaromatische Verbindungen, d. h. vollständig ungesättigte aromatische heterocyclische Verbindungen, vorzugsweise für 5- bis 7-gliedrige Ringe mit 1 bis 4, vorzugsweise 1 oder 2 gleichen oder verschiedenen Heteroatomen, vorzugsweise O, S oder N. Erfindungsgemäße Heteroaryle sind beispielsweise 1 H-Pyrrol-1 -yl; 1 H- Pyrrol-2-yl; 1 H-Pyrrol-3-yl; Furan-2-yl; Furan-3-yl; Thien-2-yl; Thien-3-yl, 1 H- lmidazol-1 -yl; 1 H-lmidazol-2-yl; 1 H-lmidazol-4-yl; 1 H-lmidazol-5-yl; 1 H-Pyrazol-1 -yl; 1 H-Pyrazol-3-yl; 1 H-Pyrazol-4-yl; 1 H-Pyrazol-5-yl, 1 H-1 ,2,3-Triazol-1 -yl, 1 H-1 ,2,3- Triazol-4-yl, 1 H-1 ,2,3-Triazol-5-yl, 2H-1 ,2,3-Triazol-2-yl, 2H-1 ,2,3-Triazol-4-yl, 1 H- 1 ,2,4-Triazol-1 -yl, 1 H-1 ,2,4-Triazol-3-yl, 4H-1 ,2,4-Triazol-4-yl, 1 ,2,4-Oxadiazol-3-yl, 1 ,2,4-Oxadiazol-5-yl, 1 ,3,4-Oxadiazol-2-yl, 1 ,2,3-Oxadiazol-4-yl, 1 ,2,3-Oxadiazol-5- yl, 1 ,2,5-Oxadiazol-3-yl, Azepinyl, Pyridin-2-yl, Pyridin-3-yl, Pyridin-4-yl, Pyrazin-2-yl, Pyrazin-3-yl, Pyrimidin-2-yl, Pyrimidin-4-yl, Pyrimidin-5-yl, Pyridazin-3-yl, Pyridazin- 4-yl, 1 ,3,5-Triazin-2-yl, 1 ,2,4-Triazin-3-yl, 1 ,2,4-Triazin-5-yl, 1 ,2,4-Triazin-6-yl, 1 ,2,3- Triazin-4-yl, 1 ,2,3-Triazin-5-yl, 1 ,2,4-, 1 ,3,2-, 1 ,3,6- und 1 ,2,6-Oxazinyl, lsoxazol-3-yl, lsoxazol-4-yl, lsoxazol-5-yl, 1 ,3-Oxazol-2-yl, 1 ,3-Oxazol-4-yl, 1 ,3-Oxazol-5-yl, lsothiazol-3-yl, lsothiazol-4-yl, lsothiazol-5-yl, 1 ,3-Thiazol-2-yl, 1 ,3-Thiazol-4-yl, 1 ,3- Thiazol-5-yl, Oxepinyl, Thiepinyl, 1 ,2,4-Triazolonyl und 1 ,2,4-Diazepinyl, 2H-1 ,2,3,4- Tetrazol-5-yl, 1 H-1 ,2,3,4-Tetrazol-5-yl, 1 ,2,3,4-Oxatriazol-5-yl, 1 ,2,3,4-Thiatriazol-5- yl, 1 ,2,3,5-Oxatriazol-4-yl, 1 ,2,3,5-Thiatriazol-4-yl. Die erfindungsgemäßen heteroaromatic compounds, ie completely unsaturated aromatic heterocyclic compounds, preferably for 5- to 7-membered rings having 1 to 4, preferably 1 or 2 identical or different heteroatoms, preferably O, S or N. Heteroaryls according to the invention are for example 1 H-pyrrole-1 yl; 1H-pyrrol-2-yl; 1H-pyrrol-3-yl; Furan-2-yl; Furan-3-yl; Thien-2-yl; Thien-3-yl, 1H-imidazol-1-yl; 1 H -imidazol-2-yl; 1 H -imidazol-4-yl; 1 H -imidazol-5-yl; 1H-pyrazole-1-yl; 1H-pyrazol-3-yl; 1H-pyrazol-4-yl; 1 H-pyrazol-5-yl, 1 H-1, 2,3-triazol-1-yl, 1 H-1, 2,3-triazol-4-yl, 1 H-1, 2,3-triazole 5-yl, 2H-1, 2,3-triazol-2-yl, 2H-1, 2,3-triazol-4-yl, 1H-1, 2,4-triazol-1-yl, 1H- 1, 2,4-triazol-3-yl, 4H-1, 2,4-triazol-4-yl, 1, 2,4-oxadiazol-3-yl, 1, 2,4-oxadiazol-5-yl, 1, 3,4-oxadiazol-2-yl, 1, 2,3-oxadiazol-4-yl, 1,2,3-oxadiazol-5-yl, 1, 2,5-oxadiazol-3-yl, azepinyl, Pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrazine-2-yl, pyrazine-3-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyridazine 3-yl, pyridazin-4-yl, 1, 3,5-triazin-2-yl, 1, 2,4-triazin-3-yl, 1, 2,4-triazin-5-yl, 1, 2, 4-triazin-6-yl, 1, 2,3- Triazin-4-yl, 1, 2,3-triazin-5-yl, 1, 2,4-, 1, 3,2-, 1, 3,6- and 1, 2,6-oxazinyl, isoxazole-3 -yl, isoxazol-4-yl, isoxazol-5-yl, 1,3-oxazol-2-yl, 1,3-oxazol-4-yl, 1,3-oxazol-5-yl, isothiazol-3-yl , isothiazol-4-yl, isothiazol-5-yl, 1, 3-thiazol-2-yl, 1, 3-thiazol-4-yl, 1, 3-thiazol-5-yl, oxepinyl, thiepinyl, 1, 2 , 4-triazolonyl and 1, 2,4-diazepinyl, 2H-1,2,3,4-tetrazol-5-yl, 1H-1,2,3,4-tetrazol-5-yl, 1, 2, 3,4-Oxatriazol-5-yl, 1, 2,3,4-thiatriazol-5-yl, 1, 2,3,5-oxatriazol-4-yl, 1, 2,3,5-thiatriazole-4 yl. The invention
Heteroarylgruppen können ferner mit einem oder mehreren, gleichen oder Heteroaryl groups can furthermore be substituted by one or more, identical or
verschiedenen Resten substituiert sein. Sind zwei benachbarte Kohlenstoffatome Bestandteil eines weiteren aromatischen Rings, so handelt es sich um annellierte heteroaromatische Systeme, wie benzokondensierte oder mehrfach annellierte Heteroaromaten. Bevorzugt sind beispielsweise Chinoline (z. B. Chinolin-2-yl, Chinolin-3-yl, Chinolin-4-yl, Chinolin-5-yl, Chinolin-6-yl, Chinolin-7-yl, Chinolin-8-yl); Isochinoline (z. B. lsochinolin-1 -yl, lsochinolin-3-yl, lsochinolin-4-yl, lsochinolin-5-yl, lsochinolin-6-yl, lsochinolin-7-yl, lsochinolin-8-yl); Chinoxalin; Chinazolin; Cinnolin; 1 ,5-Naphthyridin; 1 ,6-Naphthyridin; 1 ,7-Naphthyridin; 1 ,8-Naphthyridin; 2,6- Naphthyridin; 2,7-Naphthyridin; Phthalazin; Pyridopyrazine; Pyridopyrimidine; be substituted by different radicals. If two adjacent carbon atoms are part of another aromatic ring, they are fused heteroaromatic systems, such as benzo-fused or multiply fused heteroaromatics. Preferred are, for example, quinolines (e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl ); Isoquinolines (e.g., isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl, isoquinolin-8-yl); quinoxaline; quinazoline; cinnoline; 1,5-naphthyridine; 1,6-naphthyridine; 1,7-naphthyridine; 1,8-naphthyridine; 2,6-naphthyridine; 2,7-naphthyridine; phthalazine; Pyridopyrazine; pyridopyrimidines;
Pyridopyridazine; Pteridine; Pyrimidopyrimidine. Beispiele für Heteroaryl sind auch 5- oder 6-gliedrige benzokondensierte Ringe aus der Gruppe 1 H-lndol-1 -yl, 1 H-lndol-2- yl, 1 H-lndol-3-yl, 1 H-lndol-4-yl, 1 H-lndol-5-yl, 1 H-lndol-6-yl, 1 H-lndol-7-yl, 1 - Benzofuran-2-yl, 1 -Benzofuran-3-yl, 1 -Benzofuran-4-yl, 1 -Benzofuran-5-yl, 1 -Pyridopyridazine; pteridines; Pyrimidopyrimidine. Examples of heteroaryl are also 5- or 6-membered benzo-fused rings from the group 1H-indol-1-yl, 1H-indol-2-yl, 1H-indol-3-yl, 1H-indole-4 yl, 1H-indol-5-yl, 1H-indol-6-yl, 1H-indol-7-yl, 1-benzofuran-2-yl, 1-benzofuran-3-yl, 1-benzofuran-4 -yl, 1-benzofuran-5-yl, 1 -
Benzofuran-6-yl, 1 -Benzofuran-7-yl, 1 -Benzothiophen-2-yl, 1 -Benzothiophen-3-yl, 1 - Benzothiophen-4-yl, 1 -Benzothiophen-5-yl, 1 -Benzothiophen-6-yl, 1 -Benzothiophen- 7-yl, 1 H-lndazol-1 -yl, 1 H-lndazol-3-yl, 1 H-lndazol-4-yl, 1 H-lndazol-5-yl, 1 H-lndazol-6- yl, 1 H-lndazol-7-yl, 2H-lndazol-2-yl, 2H-lndazol-3-yl, 2H-lndazol-4-yl, 2H-lndazol-5- yl, 2H-lndazol-6-yl, 2H-lndazol-7-yl, 2H-lsoindol-2-yl, 2H-lsoindol-1 -yl, 2H-lsoindol-3- yl, 2H-lsoindol-4-yl, 2H-lsoindol-5-yl, 2H-lsoindol-6-yl; 2H-lsoindol-7-yl, 1 H- Benzimidazol-1 -yl, 1 H-Benzimidazol-2-yl, 1 H-Benzimidazol-4-yl, 1 H-Benzimidazol-5- yl, 1 H-Benzimidazol-6-yl, 1 H-Benzimidazol-7-yl, 1 ,3-Benzoxazol-2-yl, 1 ,3- Benzoxazol-4-yl, 1 ,3-Benzoxazol-5-yl, 1 ,3-Benzoxazol-6-yl, 1 ,3-Benzoxazol-7-yl, 1 ,3- Benzthiazol-2-yl, 1 ,3-Benzthiazol-4-yl, 1 ,3-Benzthiazol-5-yl, 1 ,3-Benzthiazol-6-yl, 1 ,3- Benzthiazol-7-yl, 1 ,2-Benzisoxazol-3-yl, 1 ,2-Benzisoxazol-4-yl, 1 ,2-Benzisoxazol-5- yl, 1 ,2-Benzisoxazol-6-yl, 1 ,2-Benzisoxazol-7-yl, 1 ,2-Benzisothiazol-3-yl, 1 ,2- Benzisothiazol-4-yl, 1 ,2-Benzisothiazol-5-yl, 1 ,2-Benzisothiazol-6-yl, 1 ,2- Benzisothiazol-7-yl. Benzofuran-6-yl, 1-benzofuran-7-yl, 1-benzothiophene-2-yl, 1-benzothiophene-3-yl, 1-benzothiophene-4-yl, 1-benzothiophene-5-yl, 1-benzothiophene 6-yl, 1-benzothiophen-7-yl, 1H-indazol-1-yl, 1H-indazol-3-yl, 1H-indazol-4-yl, 1H-indazol-5-yl, 1H -lndazol-6-yl, 1H-indazol-7-yl, 2H-indazol-2-yl, 2H-indazol-3-yl, 2H-indazol-4-yl, 2H-indazol-5-yl, 2H- indazol-6-yl, 2H-indazol-7-yl, 2H-isoindol-2-yl, 2H-isoindol-1-yl, 2H-isoindol-3-yl, 2H-isoindol-4-yl, 2H-isoindole- 5-yl, 2H-isoindol-6-yl; 2H-isoindol-7-yl, 1H-benzimidazol-1-yl, 1H-benzimidazol-2-yl, 1H-benzimidazol-4-yl, 1H-benzimidazol-5-yl, 1H-benzimidazole-6 -yl, 1 H -benzimidazol-7-yl, 1, 3-benzoxazol-2-yl, 1,3-benzoxazol-4-yl, 1,3-benzoxazol-5-yl, 1,3-benzoxazole-6 yl, 1,3-benzoxazol-7-yl, 1,3-benzthiazol-2-yl, 1,3-benzthiazol-4-yl, 1,3-benzthiazol-5-yl, 1,3-benzthiazole-6 yl, 1, 3-benzthiazol-7-yl, 1,2-benzisoxazol-3-yl, 1,2-benzisoxazol-4-yl, 1,2-benzisoxazol-5-yl, 1,2-benzisoxazole-6 yl, 1,2-benzisoxazol-7-yl, 1,2-benzisothiazol-3-yl, 1, 2 Benzisothiazol-4-yl, 1,2-benzisothiazol-5-yl, 1,2-benzisothiazol-6-yl, 1,2-benzisothiazol-7-yl.
Die Bezeichnung "Halogen" bedeutet beispielsweise Fluor, Chlor, Brom oder lod. Wird die Bezeichnung für einen Rest verwendet, dann bedeutet "Halogen" beispielsweise ein Fluor-, Chlor-, Brom- oder lodatom. The term "halogen" means, for example, fluorine, chlorine, bromine or iodine. When the term for a group is used, "halogen" means, for example, a fluorine, chlorine, bromine or iodine atom.
Erfindungsgemäß bedeutet„Alkyl" einen geradkettigen oder verzweigten According to the invention, "alkyl" means a straight-chain or branched one
offenkettigen, gesättigten Kohlenwasserstoff rest, der gegebenenfalls ein- oder mehrfach substituiert ist. Bevorzugte Substituenten sind Halogenatome, Alkoxy-, Haloalkoxy-, Cyano-, Alkylthio, Haloalkylthio-, Amino- oder Nitrogruppen, besonders bevorzugt sind Methoxy, Methyl, Fluoralkyl, Cyano, Nitro, Fluor, Chlor, Brom oder lod. „Haloalkyl", ,,-alkenyl" und ,,-alkinyl" bedeuten durch gleiche oder verschiedene Halogenatome, teilweise oder vollständig substituiertes Alkyl, Alkenyl bzw. Alkinyl, z.B. Monohaloalkyl (= Monohalogenalkyl) wie z. B. CH2CH2CI, CH2CH2Br, CHCICH3, CH2CI, CH2F; Perhaloalkyl wie z. B. CCI3, CCIF2, CFCl2,CF2CCIF2, CF2CCIFCF3; Polyhaloalkyl wie z. B. CH2CHFCI, CF2CCIFH, CF2CBrFH, CH2CF3; Der Begriff Perhaloalkyl umfasst dabei auch den Begriff Perfluoralkyl. open-chain, saturated hydrocarbon radical which is optionally mono- or polysubstituted. Preferred substituents are halogen, alkoxy, haloalkoxy, cyano, alkylthio, haloalkylthio, amino or nitro groups, particularly preferred are methoxy, methyl, fluoroalkyl, cyano, nitro, fluoro, chloro, bromo or iodo. "Haloalkyl", "-alkenyl" and "-alkynyl" denote by identical or different halogen atoms, partially or completely substituted alkyl, alkenyl or alkynyl, for example monohaloalkyl (= monohaloalkyl) such as, for example, CH 2 CH 2 Cl, CH 2 CH 2 Br, CH 3 CH 3, CH 2 Cl, CH 2 F, perhaloalkyl such as CCI 3 , CCIF 2 , CFCl 2 , CF 2 CCIF 2 , CF 2 CCIFCF 3, polyhaloalkyl such as CH 2 CHFCI, CF 2 CCIFH, CF 2 CBrFH, CH 2 CF 3; also includes the term perfluoroalkyl.
Haloalkoxy ist z.B. OCF3, OCHF2, OCH2F, OCF2CF3, OCH2CF3 und OCH2CH2CI; Entsprechendes gilt für Haloalkenyl und andere durch Halogen substituierten Reste. Der hier beispielhaft genannte Ausdruck "(Ci-C4)-Alkyl" bedeutet eine Haloalkoxy is eg OCF 3 , OCHF 2 , OCH 2 F, OCF 2 CF 3 , OCH 2 CF 3 and OCH 2 CH 2 Cl; The same applies to haloalkenyl and other halogen-substituted radicals. The term "(C 1 -C 4 ) -alkyl" given here by way of example means a
Kurzschreibweise für geradkettiges oder verzweigtes Alkyl mit einem bis 4  Short notation for straight-chain or branched alkyl having one to four
Kohlenstoffatomen entsprechend der Bereichsangabe für C-Atome, d. h. umfasst die Reste Methyl, Ethyl, 1 -Propyl, 2-Propyl, 1 -Butyl, 2-Butyl, 2-Methylpropyl oder tert- Butyl. Allgemeine Alkylreste mit einem größeren angegebenen Bereich von C- Atomen, z. B. "(Ci-C6)-Alkyl", umfassen entsprechend auch geradkettige oder verzweigte Alkylreste mit einer größeren Zahl von C-Atomen, d. h. gemäß Beispiel auch die Alkylreste mit 5 und 6 C-Atomen. Wenn nicht speziell angegeben, sind bei den Kohlenwasserstoffresten wie Alkyl-, Alkenyl- und Alkinylresten, auch in zusammengesetzten Resten, die niederen Kohlenstoffgerüste, z.B. mit 1 bis 6 C-Atomen bzw. bei ungesättigten Gruppen mit 2 bis 6 C-Atomen, bevorzugt. Alkylreste, auch in den zusammengesetzten Resten wie Alkoxy, Haloalkyl usw., bedeuten z.B. Methyl, Ethyl, n- oder i-Propyl, n-, i-, t- oder 2-Butyl, Pentyle, Hexyle, wie n-Hexyl, i-Hexyl und 1 ,3-Dimethylbutyl, Heptyle, wie n-Heptyl, 1 -Methylhexyl und 1 ,4-Dimethylpentyl; Alkenyl- und Aikinyireste haben die Bedeutung der den Alkylresten entsprechenden möglichen ungesättigten Reste, wobei mindestens eine Doppelbindung bzw. Dreifachbindung enthalten ist. Carbon atoms corresponding to the range for C atoms, ie, the radicals include methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl or tert-butyl. General alkyl radicals having a larger specified range of carbon atoms, eg. B. "(Ci-C6) -alkyl", accordingly also include straight-chain or branched alkyl radicals having a larger number of carbon atoms, ie according to Example, the alkyl radicals having 5 and 6 carbon atoms. Unless specifically stated, in the hydrocarbon radicals such as alkyl, alkenyl and alkynyl, even in composite radicals, the lower carbon skeletons, for example having 1 to 6 carbon atoms or in unsaturated groups having 2 to 6 carbon atoms, are preferred. Alkyl radicals, including in the assembled radicals such as alkoxy, haloalkyl, etc., mean, for example, methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i -Hexyl and 1, 3-dimethylbutyl, heptyls, such as n-heptyl, 1-methylhexyl and 1, 4-dimethylpentyl; Alkenyl and Aikinyireste have the meaning of the alkyl radicals corresponding possible unsaturated radicals, wherein at least one double bond or triple bond is included.
Bevorzugt sind Reste mit einer Doppelbindung bzw. Dreifachbindung. Preference is given to radicals having a double bond or triple bond.
Der Begriff„Alkenyl" schließt insbesondere auch geradkettige oder verzweigte offenkettige Kohlenwasserstoffreste mit mehr als einer Doppelbindung ein, wie 1 ,3- Butadienyl und 1 ,4-Pentadienyl, aber auch Allenyl- oder Kumulenyl-reste mit einer bzw. mehreren kumulierten Doppelbindungen, wie beispielsweise Allenyl (1 ,2- Propadienyl), 1 ,2-Butadienyl und 1 ,2,3-Pentatrienyl. Alkenyl bedeutet z.B. Vinyl, welches ggf. durch weitere Alkylreste substituiert sein kann, z.B. Prop-1 -en-1 -yl, But- 1 -en-1 -yl, Allyl, 1 -Methyl-prop-2-en-1 -yl, 2-Methyl-prop-2-en-1 -yl, But-2-en-1 -yl, 1 - Methyl-but-3-en-1 -yl und 1 -Methyl-but-2-en-1 -yl, 2-Methyl-prop-1 -en-1 -yl, In particular, the term "alkenyl" also includes straight-chain or branched open-chain hydrocarbon radicals having more than one double bond, such as 1,3-butadienyl and 1,4-pentadienyl, but also allenyl or cumulenyl radicals having one or more cumulative double bonds, such as for example, allenyl (1,2-propadienyl), 1,2-butadienyl and 1,2,3-pentatrienyl.Alkenyl is, for example, vinyl, which may be substituted by further alkyl radicals, for example, prop-1-en-1-yl, But-1-en-1-yl, allyl, 1-methyl-prop-2-en-1-yl, 2-methyl-prop-2-en-1-yl, but-2-en-1-yl, 1-methylbut-3-en-1-yl and 1-methylbut-2-en-1-yl, 2-methyl-prop-1 -ene-1-yl,
1 -Methylprop-1 -en-1 -yl, 1 -Methylprop-2-en-1 -yl, 2-Methyl-prop-2-en-1 -yl, 1-methylprop-1 -ene-1-yl, 1-methylprop-2-en-1-yl, 2-methyl-prop-2-en-1-yl,
But-2-en-1 -yl, But-3-en-1 -yl, 1 -Methyl-but-3-en-1 -yl oder 1 -Methyl-but-2-en-1 -yl, Pentenyl, 2-Methylpentenyl oder Hexenyl. Der Begriff„Alkinyl" schließt insbesondere auch geradkettige oder verzweigte offenkettige Kohlenwasserstoffreste mit mehr als einer Dreifachbindung oder auch mit einer oder mehreren Dreifachbindungen und einer oder mehreren But-2-en-1-yl, but-3-en-1-yl, 1-methyl-but-3-en-1-yl or 1-methyl-but-2-en-1-yl, pentenyl, 2-methylpentenyl or hexenyl. The term "alkynyl" in particular also includes straight-chain or branched open-chain hydrocarbon radicals having more than one triple bond or else having one or more triple bonds and one or more
Doppelbindungen ein, wie beispielsweise 1 ,3-Butatrienyl bzw. 3-Penten-1 -in-1 -yl. (C2-C6)-Alkinyl bedeutet beispielsweise Ethinyl, Propargyl, 1 -Methyl-prop-2-in-1 -yl, 2-Butinyl, 2-Pentinyl oder 2-Hexinyl, vorzugsweise Propargyl, But-2-in-1 -yl, Double bonds, such as 1, 3-butatrienyl and 3-penten-1-yn-1-yl, respectively. (C 2 -C 6) -alkynyl is, for example, ethynyl, propargyl, 1-methyl-prop-2-yn-1-yl, 2-butynyl, 2-pentynyl or 2-hexynyl, preferably propargyl, but-2-yn-1 - yl,
But-3-in-1 -yl oder 1 -Methyl-but-3-in-1 -yl. Der Begriff„Cycloalkyl" bedeutet ein carbocyclisches, gesättigtes Ringsystem mit vorzugsweise 3-8 Ring-C-Atomen, z.B. Cyclopropyl, Cyclobutyl, Cyclopentyl oder Cyclohexyl. Im Falle von gegebenenfalls substituiertem Cycloalkyl werden cyclische Systeme mit Substituenten umfasst, wobei auch Substituenten mit einer But-3-yn-1-yl or 1-methyl-but-3-yn-1-yl. The term "cycloalkyl" means a carbocyclic saturated ring system preferably having 3-8 ring C atoms, eg, cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl In the case of optionally substituted cycloalkyl, cyclic systems having substituents are included, with substituents also having a
Doppelbindung am Cycloalkylrest, z. B. eine Alkylidengruppe wie Methyliden, umfasst sind. Im Falle von gegebenenfalls substituiertem Cycloalkyl werden auch mehrcyclische aliphatische Systeme umfaßt, wie beispielsweise Bicyclo[1 .1 .0]butan- 1 -yl, Bicyclo[1 .1 .0]butan-2-yl, Bicyclo[2.1.0]pentan-1 -yl, Bicyclo[2.1 .0]pentan-2-yl, Bicyclo[2.1 .0]pentan-5-yl, Bicyclo[2.2.1 ]hept-2-yl (Norbornyl), Bicyclo[2.2.2]octan-2- yl, Adamantan-1 -yl und Adamantan-2-yl. Der Ausdruck "(C3-C7)-Cycloalkyl" bedeutet eine Kurzschreibweise für Cycloalkyl mit drei bis 7 Kohlenstoffatomen entsprechend der Bereichsangabe für C-Atome. Double bond on the cycloalkyl, z. As an alkylidene group such as methylidene, are included. In the case of optionally substituted cycloalkyl, polycyclic aliphatic systems are also included, such as bicyclo [1, 1] -butan-1-yl, bicyclo [1, 1] -butan-2-yl, bicyclo [2.1.0] pentane -1 -yl, bicyclo [2.1.0] pentan-2-yl, bicyclo [2.1.0] pentan-5-yl, bicyclo [2.2.1] hept-2-yl (norbornyl), bicyclo [2.2.2] octan-2-yl, adamantan-1-yl and adamantan-2-yl. The term "(C3-C7) cycloalkyl" means a shorthand notation for cycloalkyl having from three to seven carbon atoms corresponding to the range of C atoms.
Im Falle von substituiertem Cycloalkyl werden auch spirocyclische aliphatische Systeme umfaßt, wie beispielsweise Spiro[2.2]pent-1 -yl, Spiro[2.3]hex-1 -yl, In the case of substituted cycloalkyl, spirocyclic aliphatic systems are also included, such as spiro [2.2] pent-1-yl, spiro [2.3] hex-1-yl,
Spiro[2.3]hex-4-yl, 3-Spiro[2.3]hex-5-yl. Spiro [2.3] hex-4-yl, 3-spiro [2.3] hex-5-yl.
„Cycloalkenyl" bedeutet ein carbocyclisches, nicht aromatisches, partiell "Cycloalkenyl" means a carbocyclic, non-aromatic, partial
ungesättigtes Ringsystem mit vorzugsweise 4-8 C-Atomen, z.B. 1 -Cyclobutenyl, 2- Cyclobutenyl, 1 -Cyclopentenyl, 2-Cyclopentenyl, 3-Cyclopentenyl, oder 1 -unsaturated ring system having preferably 4-8 C atoms, e.g. 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1 -
Cyclohexenyl, 2-Cyclohexenyl, 3-Cyclohexenyl, 1 ,3-Cyclohexadienyl oder 1 ,4- Cyclohexadienyl, wobei auch Substituenten mit einer Doppelbindung am Cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1, 3-cyclohexadienyl or 1, 4-cyclohexadienyl, wherein also substituents having a double bond on
Cycloalkenylrest, z. B. eine Alkylidengruppe wie Methyliden, umfasst sind. Im Falle von gegebenenfalls substituiertem Cycloalkenyl gelten die Erläuterungen für substituiertes Cycloalkyl entsprechend. Cycloalkenylrest, z. As an alkylidene group such as methylidene, are included. In the case of optionally substituted cycloalkenyl, the explanations for substituted cycloalkyl apply correspondingly.
Der Begriff„Alkyliden", z. B. auch in der Form (Ci-Cio)-Alkyliden, bedeutet den Rest eines geradkettigen oder verzweigten offenkettigen Kohlenwasserstoffrests, der über eine Zweifachbindung gebunden ist. Als Bindungsstelle für Alkyliden kommen naturgemäß nur Positionen am Grundkörper in Frage, an denen zwei H-Atome durch die Doppelbindung ersetzt werden können; Reste sind z. B. =CH2, =CH-CH3, =C(CH3)-CH3, =C(CH3)-C2H5 oder =C(C2H5)-C2H5. Cycloalkyliden bedeutet ein carbocyclischer Rest, der über eine Zweifachbindung gebunden ist. The term "alkylidene", for example also in the form of (C 1 -C 10) -alkylidene, means the radical of a straight-chain or branched open-chain hydrocarbon radical which is bonded via a double bond.As a binding site for alkylidene, only positions on the main body naturally occur Question in which two hydrogen atoms can be replaced by the double bond: radicals are eg = CH 2, = CH-CH 3 , = C (CH 3 ) -CH 3 , = C (CH 3 ) -C 2 H 5 or = C (C 2 H 5 ) -C 2 H 5. Cycloalkylidene means carbocyclic radical bonded via a double bond.
Der Begriff„Stannyl" steht für einen weiter substituierten Rest, der ein Zinn-Atom enthält;„Germanyl" steht analog für einen weiter substituierten Rest, der ein The term "stannyl" stands for a further substituted radical containing a tin atom, "Germanyl" is analogous to a further substituted radical which is a
Germanium-Atom enthält.„Zirconyl" steht für einen weiter substituierten Rest, der ein Zirconium-Atom enthält.„Hafnyl" steht für einen weiter substituierten Rest, der ein Hafnium-Atom enthält.„Boryl",„Borolanyl" und„Borinanyl" steht für weiter substituierte und gegebenenfalls cyclische Gruppen, die jeweils ein Bor-Atom enthalten.„Plumbanyl" steht für einen weiter substituierten Rest, der ein Blei-Atom enthält.„Hydrargyl" steht für einen weiter substituierten Rest, der ein Quecksilber- Atom enthält.„Alanyl" steht für einen weiter substituierten Rest, der ein Aluminium- Atom enthält.„Magnesyl" steht für einen weiter substituierten Rest, der ein "Zirconyl" represents a further substituted radical containing a zirconium atom. "Hafnyl" represents a further substituted radical containing a hafnium atom. "Boryl", "Borolanyl" and "Borinanyl". represents further substituted and optionally cyclic groups, each containing a boron atom. "Plumbanyl" represents a further substituted radical containing a lead atom. "Hydrargyl" represents a further substituted radical containing a mercury atom "Alanyl" represents a further substituted radical containing an aluminum atom. "Magnesyl" represents a further substituted radical containing a
Magnesium-Atom enthält.„Zinkyl" steht für einen weiter substituierten Rest, der ein Zink-Atom enthält. Contains magnesium atom. "Zincyl" represents a further substituted radical containing a zinc atom.
Die Verbindungen der allgemeinen Formel (I) können je nach Art und Verknüpfung der Substituenten als Stereoisomere vorliegen. Die durch ihre spezifische Raumform definierten möglichen Stereoisomere, wie Enantiomere, Diastereomere, Z- und E- Isomere sind alle von der Formel (I) umfasst. Sind beispielsweise eine oder mehrere Alkenylgruppen vorhanden, so können Diastereomere (Z- und E-Isomere) auftreten. Sind beispielsweise ein oder mehrere asymmetrische Kohlenstoffatome vorhanden, so können Enantiomere und Diastereomere auftreten. Stereoisomere lassen sich aus den bei der Herstellung anfallenden Gemischen nach üblichen Trennmethoden erhalten. Die chromatographische Trennung kann sowohl im analytischen Maßstab zur Feststellung des Enantiomerenüberschusses bzw. des Depending on the nature and linkage of the substituents, the compounds of the general formula (I) can exist as stereoisomers. The possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, Z and E isomers, are all encompassed by the formula (I). If, for example, one or more alkenyl groups are present, diastereomers (Z and E isomers) can occur. For example, if one or more asymmetric carbon atoms are present, enantiomers and diastereomers may occur. Stereoisomers can be obtained from the resulting mixtures in the preparation by conventional separation methods. The chromatographic separation can be used both on an analytical scale to determine the enantiomeric excess and the
Diastereomerenüberschusses, wie auch im präparativen Maßstab zur Herstellung von Prüfmustern für die biologische Ausprüfung erfolgen. Ebenso können  Diastereomerenüberschusses, as well as on a preparative scale for the production of test samples for biological testing done. Likewise
Stereoisomere durch Einsatz stereoselektiver Reaktionen unter Verwendung optisch aktiver Ausgangs- und/oder Hilfsstoffe selektiv hergestellt werden. Die Erfindung betrifft somit auch alle Stereoisomeren, die von der allgemeinen Formel (I) umfasst, jedoch nicht mit ihrer spezifischen Stereoform angegeben sind, sowie deren Stereoisomers can be selectively prepared by using stereoselective reactions using optically active starting materials and / or auxiliaries. The invention thus also relates to all stereoisomers which comprises the general formula (I), but are not specified with their specific stereoform, and their
Gemische. Synthese von substituierten Vinyl- und Alkinyl-cyclohexenole sowie deren Analoga Mixtures. Synthesis of substituted vinyl and alkynyl cyclohexenols and their analogs
Die erfindungsgemäßen weiter substituierten Vinyl- und Alkinylcyclohexenole der allgemeinen Formel (I) können ausgehend von bekannten Verfahren hergestellt werden. Der bekannte und strukturverwandte pflanzliche Naturstoff Abscisinsäure kann auf verschiedenen Syntheserouten erhalten werden (vgl. Hanson et al. J. The further substituted vinyl and alkynylcyclohexenols of the general formula (I) according to the invention can be prepared starting from known processes. The known and structurally related plant natural substance abscisic acid can be obtained on various synthetic routes (compare Hanson et al.
Chem. Res . (S), 2003, 426; Constantino et al. J. Org. Chem. 1986, 51 , 253; Chem. Res. (S), 2003, 426; Constantino et al. J. Org. Chem. 1986, 51, 253;
Constantino et al. 1989, 54, 681 ; Marsh et al. Org. Biomol. Chem. 2006, 4, 4186; WO94/15467). Einige der darin beschriebenen Verfahren zur Synthese von Vinyl- und Alkinylcyclohexenolgrundgerüsten wurden optimiert und durch alternative Syntheseschritte ersetzt. Die eingesetzten und untersuchten Syntheserouten gehen dabei von kommerziell erhältlichen oder leicht herstellbaren Cyclohexenonen, Heteroaryl- und Arylboronsäuren sowie Heteroaryl- und Arylhalogeniden aus. Constantino et al. 1989, 54, 681; Marsh et al. Org. Biomol. Chem. 2006, 4, 4186; WO94 / 15467). Some of the processes described therein for the synthesis of vinyl and alkynylcyclohexenol backbones have been optimized and replaced by alternative synthetic steps. The synthetic routes used and investigated are based on commercially available or easily prepared cyclohexenones, heteroaryl and arylboronic acids and heteroaryl and aryl halides.
Als ein Schlüsselintermediat für die Synthese der erfindungsgemäßen Verbindungen der allgemeinen Formel (I) wird ein entsprechend substituiertes und gegebenenfalls geschütztes 8-Ethinyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol hergestellt. Dazu wird ein entsprechend weiter substituiertes Cyclohex-2-en-1 ,4-dion mit einem gegebenenfalls substituierten Ethandiol unter Verwendung katalytischer Mengen an p- Toluolsulfonsäure oder mit p-Toluolsulfonsäure in einem Gemisch aus Dioxan und Trimethoxyameisensäureorthoester in das entsprechende weiter substituierte 1 ,4- Dioxaspiro[4.5]dec-6-en-8-on überführt (vgl. J. Org. Chem. 2009, 74, 2425; Org. Lett. 2001 , 3, 1649; J. Label Compd. Radiopharm. 2003, 46, 273). Es sind auch andere Alkohole und Alkandiole nutzbar. Das weiter substituierte 1 ,4-Dioxaspiro[4.5]dec-6- en-8-οη kann daran anschließend entweder direkt mit einem Lithiumacetylid-As a key intermediate for the synthesis of the compounds of the general formula (I) according to the invention, an appropriately substituted and optionally protected 8-ethynyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol is prepared. For this purpose, a correspondingly further substituted cyclohex-2-en-1, 4-dione with an optionally substituted ethanediol using catalytic amounts of p-toluenesulfonic acid or p-toluenesulfonic acid in a mixture of dioxane and Trimethoxyameisensäureorthoester in the corresponding further substituted 1, 4 Dioxaspiro [4.5] dec-6-en-8-one (see J. Org. Chem., 2009, 74, 2425; Org. Lett., 2001, 3, 1649, J. Label Compd., Radiopharm., 2003, 46 , 273). There are also other alcohols and alkanediols available. The further substituted 1,4-dioxaspiro [4.5] dec-6-ene-8-one can then be added either directly with a lithium acetylide
Ethylendiaminkomplex in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Tetrahydrofuran) oder in zwei Schritten durch Umsetzung mit Trimethylsilylacetylen und LDA (Lithiumdiisopropylamid) in einem Temperaturbereich von -78 °C bis 0 °C in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Tetrahydrofuran) und nachfolgende Abspaltung der Trimethylsilylgruppe mit Hilfe eines geeigneten Ethylenediamine complex in a suitable polar aprotic solvent (eg., Tetrahydrofuran) or in two steps by reaction with trimethylsilylacetylene and LDA (lithium diisopropylamide) in a temperature range of -78 ° C to 0 ° C in a suitable polar aprotic solvent (eg. B. tetrahydrofuran) and subsequent cleavage of the trimethylsilyl using a suitable
Trialkylammoniumfluorids (z. B. Tetrabutylammoniumfluorid) in einem polar- aprotischen Lösungsmittel oder mit einer geeigneten Carbonatbase (z. B. Kaliumcarbonat) in einem polar-protischen Lösungsmittel (z. B. Methanol) (vgl. J. Chem. Res. (S) 2003, 426) in das entsprechend substituierte 8-Ethinyl-1 ,4- dioxaspiro[4.5]dec-6-en-8-ol überführt werden (Schema 1 ). Trialkylammonium fluoride (eg, tetrabutylammonium fluoride) in a polar aprotic solvent or with a suitable carbonate base (e.g. Potassium carbonate) in a polar protic solvent (eg methanol) (see J. Chem. Res. (S) 2003, 426) into the correspondingly substituted 8-ethynyl-1,4-dioxaspiro [4.5] dec-6 -en-8-ol (Scheme 1).
Schema 1  Scheme 1
Das betreffende substituierte 8-Ethinyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol kann durch Umsetzung mit einem geeigneten Silyltrifluormethansulfonat-Reagenz unter The relevant substituted 8-ethynyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol can be obtained by reaction with a suitable silyltrifluoromethanesulfonate reagent
Verwendung einer geeigneten Base (z. B. 2,6-Lutidin) in einem geeigneten polar- aprotischen Lösungsmittel (z. B. Dichlormethan) in ein substituiertes (8-Ethinyl-1 ,4- dioxaspiro[4.5]dec-6-en-8-yl)oxysilan überführt werden. Durch Verwendung eines gegebenenfalls substituierten Propandiols im ersten Schritt können in analogen Umsetzungen die entsprechenden substituierten 9-Ethinyl-1 ,5-dioxaspiro[5.5]undec- 7-en-9-ole als Schlüsselintermediate für die im folgenden beschriebenen  Use of a suitable base (eg 2,6-lutidine) in a suitable polar aprotic solvent (eg dichloromethane) in a substituted (8-ethynyl-1,4-dioxaspiro [4.5] dec-6-ene -8-yl) oxysilane be transferred. By using an optionally substituted propanediol in the first step, the corresponding substituted 9-ethynyl-1, 5-dioxaspiro [5.5] undec-7-en-9-ols can be used in analogous reactions as key intermediates for those described below
Umsetzungen zu den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) dienen. In Schema 1 wird die oben beschriebene Synthesesequenz beispielhaft unter Verwendung von 2,3-Butandiol und 2,2-Dimethylpropandiol sowie  Reactions to the compounds of the general formula (I) are used. In Scheme 1, the above-described synthetic sequence is exemplified using 2,3-butanediol and 2,2-dimethylpropanediol as well
Triethylsilyltrifluormethansulfonat dargestellt.  Triethylsilyltrifluormethansulfonat shown.
Als ein weiteres beispielhaftes Intermediat für die Synthese der erfindungsgemäßen Verbindungen der allgemeinen Formel (I) wird ein entsprechend gegebenenfalls weiter substituiertes und gegebenenfalls geschütztes 5-Ethinyl-4,6- dimethylspiro[bicyclo[4.1.0]hept-3-en-2,2'-[1 ,3]dioxolan]-5-ol hergestellt. Dazu wird ein entsprechend weiter substituiertes 2,6-Dimethyl-1 ,4-benzochinon mit einem gegebenenfalls substituierten Ethandiol unter Verwendung katalytischer Mengen an p-Toluolsulfonsäure oder mit p-Toluolsulfonsäure in einem Gemisch aus Dioxan und Trimethoxyameisensäureorthoester in das entsprechende gegebenenfalls weiter substituierte 1 ,4-Dioxaspiro[4.5]deca-6,9-dien-8-on überführt (vgl. J. Org. Chem. 2009, 74, 2425; Org. Lett. 2001 , 3, 1649). Es sind auch andere Alkohole und As a further exemplary intermediate for the synthesis of the compounds of general formula (I) according to the invention, a correspondingly optionally further substituted and optionally protected 5-ethynyl-4,6- dimethylspiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolane] -5-ol. For this purpose, a correspondingly further substituted 2,6-dimethyl-1, 4-benzoquinone with an optionally substituted ethanediol using catalytic amounts of p-toluenesulfonic acid or p-toluenesulfonic acid in a mixture of dioxane and Trimethoxyameisensäureorthoester in the corresponding optionally further substituted 1, 4-Dioxaspiro [4.5] deca-6,9-dien-8-one (see J. Org. Chem., 2009, 74, 2425, Org. Lett., 2001, 3, 1649). There are also other alcohols and
Alkandiole für die Schutzgruppeneinführung nutzbar. Alternativ kann das weiter substituierte 7,9-Dimethyl-1 ,4-dioxaspiro[4.5]deca-6,9-dien-8-on auch durch Alkanediols can be used for the introduction of protective groups. Alternatively, the more substituted 7,9-dimethyl-1,4-dioxaspiro [4.5] deca-6,9-dien-8-one may also be substituted by
Umsetzung von 2,6-Dimethylphenol mit Diacetoxyiodobenzol und einem Reaction of 2,6-dimethylphenol with diacetoxyiodobenzene and a
entsprechenden Alkandiol erhalten werden (vgl. Org. Biomol. Chem. 2006, 4, 1400). Das so erhaltene gegebenenfalls weiter substituierte 1 ,4-dioxaspiro[4.5]deca-6,9- dien-8-οη wird im nächsten Schritt mit Trimethylsulfoxoniumiodid und Natriumhydrid oder einem anderen geeigneten Cyclopropanierungsreagenz in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Ν,Ν-Dimethylformamid oder Dimethylsulfoxid) in ein gegebenenfalls weiter substituiertes 4,6-Dimethyl-5H-spiro[bicyclo[4.1 .0]hept- 3-en-2,2'-[1 ,3]dioxolan]-5-on überführt, das daran anschließend entweder direkt mit einem Lithiumacetylid-Ethylendiaminkomplex in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Tetrahydrofuran) oder in zwei Schritten durch Umsetzung mit Trimethylsilylacetylen und LDA (Lithiumdiisopropylamid) in einem Temperaturbereich von -78 °C bis 0 °C in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Tetrahydrofuran) und nachfolgende Abspaltung der Trimethylsilylgruppe mit Hilfe eines geeigneten Trialkylammoniumfluorids (z. B. Tetrabutylammoniumfluorid) in einem polar-aprotischen Lösungsmittel oder mit einer geeigneten Carbonatbase (z. B. Kaliumcarbonat) in einem polar-protischen Lösungsmittel (z. B. Methanol) (vgl. J. Chem. Res. (S) 2003, 426) in das entsprechend substituierte 5-Ethinyl-4,6- dimethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]dioxolan]-5-ol überführt werden kann (Schema 2). Alternative Cyclopropanierungsmethoden zur Herstellung von substituierten 4,6-Dimethyl-5H-spiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]dioxolan]-5- onen sind z. B. in Synlett 2010, 266; Inorg. Chim. Acta 2009, 362, 3507; Synthesis 2008, 3279; Synthesis 2008, 1269; Tetrahedron 2006, 62, 1583; Synlett 2008, 521 ; Synlett 2003, 485; Tetrahedron Lett. 1997, 38, 2133 beschrieben. corresponding alkanediol are obtained (see Org Biomol Chem, 2006, 4, 1400). The optionally further substituted 1,4-dioxaspiro [4.5] deca-6,9-diene-8-oo thus obtained is treated in the next step with trimethylsulfoxonium iodide and sodium hydride or another suitable cyclopropanation reagent in a suitable polar aprotic solvent (eg. Ν, Ν-dimethylformamide or dimethyl sulfoxide) into an optionally further substituted 4,6-dimethyl-5H-spiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolane] -5- subsequently reacted either directly with a lithium acetylide-ethylenediamine complex in a suitable polar aprotic solvent (eg tetrahydrofuran) or in two steps by reaction with trimethylsilylacetylene and LDA (lithium diisopropylamide) in a temperature range from -78 ° C to 0 ° C in a suitable polar aprotic solvent (eg tetrahydrofuran) and subsequent cleavage of the trimethylsilyl group with the aid of a suitable trialkylammonium fluoride (eg tetrabutylammonium fluoride) in a p olar-aprotic solvent or with a suitable carbonate base (e.g. Potassium carbonate) in a polar protic solvent (eg methanol) (see J. Chem. Res. (S) 2003, 426) into the appropriately substituted 5-ethynyl-4,6-dimethylspiro [bicyclo [4.1 .0] hept-3-ene-2,2 '- [1,3] dioxolane] -5-ol can be converted (Scheme 2). Alternative cyclopropanation methods for the preparation of substituted 4,6-dimethyl-5H-spiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolan] -ions are e.g. In Synlett 2010, 266; Inorg. Chim. Acta 2009, 362, 3507; Synthesis 2008, 3279; Synthesis 2008, 1269; Tetrahedron 2006, 62, 1583; Synlett 2008, 521; Synlett 2003, 485; Tetrahedron Lett. 1997, 38, 2133.
Schema 2 Das betreffende substituierte 5-Ethinyl-4,6-dimethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'- [1 ,3]dioxolan]-5-ol kann durch Umsetzung mit einem geeigneten  The substituted 5-ethynyl-4,6-dimethylspiro [bicyclo [4.1.0] hept-3-ene-2,2'- [1,3] dioxolane] -5-ol in question can be prepared by reaction with a suitable
Silyltrifluormethansulfonat-Reagenz unter Verwendung einer geeigneten Base (z. B. 2,6-Lutidin) in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Silyl trifluoromethanesulfonate reagent using a suitable base (e.g., 2,6-lutidine) in a suitable polar aprotic solvent (e.g.
Dichlormethan) in ein substituiertes [(5-Ethinyl-4,6-dimethylspiro[bicyclo[4.1 .0]hept- 3-en-2,2'-[1 ,3]dioxolan]-5-yl)oxy](trimethyl)silan überführt werden. Durch Dichloromethane) to a substituted [(5-ethynyl-4,6-dimethylspiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3-dioxolan] -5-yl) oxy] (trimethyl ) silane are transferred. By
Verwendung eines gegebenenfalls substituierten Propandiols im ersten Schritt können in analogen Umsetzungen die entsprechenden substituierten 5-Ethinyl-4,6- dimethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]dioxan]-5-ole als  Use of an Optionally Substituted Propanediol in the First Step In analogous reactions, the corresponding substituted 5-ethynyl-4,6-dimethylspiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxane] - 5-ole as
Schlüsselintermediate für die im folgenden beschriebenen Umsetzungen zu den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) dienen. In Schema 2 wird die oben beschriebene Synthesesequenz beispielhaft unter Verwendung von Trimethylsulfoxoniumiodid, 2,3-Butandiol und Triethylsilyltrifluormethansulfonat dargestellt. Key intermediates for the reactions described below to the compounds of the general formula (I) are used. In Scheme 2, the above-described synthetic sequence is exemplified using trimethylsulfoxonium iodide, 2,3-butanediol and triethylsilyl trifluoromethanesulfonate.
Ausgehend von den obenen beschrieben und weiteren entsprechend substituierten 1 -Ethinyl-cyclohexen-1 -olen können die erfindungsgemäßen substituierten 1 - Starting from the above described and further correspondingly substituted 1-ethynylcyclohexene-1-ols, the substituted
Arylethinyl-, 1 -Hetarylethinyl-, und 1 -Heterocycloylethinyl-cyclohex-2-en-1 -ole 1(a)- l(d) durch Übergangsmetall-katalysierte Kupplung mit geeigneten substituierten Aryl- , Cycloalkenyl- oder Heteroarylhalogeniden (vgl. J. Chem. Res. (S), 2003, 426; J. Chem. Soc, Perkin Trans. 1 2001 , 47; Adv. Synth. Catal. 2005, 347, 872; Synlett 2010, 150; Org. Lett. 2008, 10, 1569; Helv. Chim. Acta 2009, 92, 826, Can. J. Chem. 1993, 71 , 983) unter Verwendung eines geeigneten Arylethynyl, 1-hetarylethynyl, and 1-heterocycloylethynylcyclohex-2-en-1-ols 1 (a) - l (d) transition metal-catalyzed coupling with suitable substituted aryl, cycloalkenyl or heteroaryl halides (see J. Chem. Res. (S), 2003, 426; J. Chem. Soc, Perkin Trans. 1 2001, 47; Synth. Catal. 2005, 347, 872; Synlett 2010, 150; Org. Lett., 2008, 10, 1569; Helv. Chim. Acta 2009, 92, 826, Can. J. Chem. 1993, 71, 983). using a suitable
Übergangsmetallkatalysatorsystems (z. B. Bis(Triphenylphosphin)palladiumdichlorid, Palladium(ll)acetat zusammen mit Triphenylphosphin oder Bis-(Cycloacta-1 ,5- dienyl)lridiumchlorid in Kombination mit einem bidentaten Liganden, z.B. 2,2'- Bis(diphenylphosphino)-1 , 1 '-binaphthyl oder 1 ,4-bis-(diphenylphosphino)butan) und eines geeigneten Kupfer(l)halogenids (z. B. Kupfer(l)iodid) in einem geeigneten Lösungsmittelgemisch aus einem Amin und einem polar aprotischen Lösungsmittel (z. B. Diisopropylamin und Toluol oder Triethylamin und Tetrahydrofuran) hergestellt werden (Schema 3). . Transition metal catalyst system (e.g., (bis (triphenylphosphine) palladium dichloride, palladium II) acetate together with triphenylphosphine or bis (Cycloacta-1, 5- dienyl) lridiumchlorid in combination with a bidentate ligand such as 2,2 '- bis (diphenylphosphino) -1, 1-binaphthyl or 1, 4-bis- (diphenylphosphino) butane) and an appropriate copper (I) halide (eg., copper (l) iodide) in a suitable solvent mixture of an amine and a polar aprotic solvent (eg diisopropylamine and toluene or triethylamine and tetrahydrofuran) (Scheme 3).
Schema 3 Alternativ können die erfindungsgemäßen substituierten 1 -Arylethinyl-, 1 - Hetarylethinyl- und 1 -Heterocycloylethinyl-cyclohex-2-en-1 -ole l(a)-l(d) auch durch Reaktion eines geeigneten substituierten Cyclohexenons mit entsprechenden substituierten Aryl-, Hetaryl- oder Heterocyclylalkinen unter Verwendung einer geeigneten Base (z. B. Lithiumdiisopropylamid oder n-Butyllithium) in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Tetrahydrofuran) hergestellt werden (Schema 3). Scheme 3 Alternatively, the substituted 1-arylethynyl, 1-hetarylethynyl and 1-heterocycloylethynylcyclohex-2-en-1-ols (a) -l (d) of the invention may also be prepared by reaction of a suitable substituted cyclohexenone with corresponding substituted aryl, Hetaryl or heterocyclyl alkynes can be prepared using a suitable base (e.g., lithium diisopropylamide or n-butyllithium) in a suitable polar aprotic solvent (e.g., tetrahydrofuran) (Scheme 3).
Schema 4  Scheme 4
Die erfindungsgemäßen substituierten (E)-konfigurierten 1 -Arylvinyl- und 1 - Hetarylvinyl-cyclohex-2-en-1 -ole l(e) und 1 (f) können durch Reduktion der The substituted (E) -configured 1-arylvinyl- and 1-hetarylvinylcyclohex-2-en-1-ols (e) and 1 (f) according to the invention can be prepared by reduction of the
Alkingruppe der entsprechenden erfindungsgemäßen 1 -Arylethinyl- und 1 - Hetarylethinyl-cyclohex-2-en-1 -ole l(a) und l(c) unter Verwendung geeigneter Aluminiumhydridreagenzien (z. B. Natrium-bis-(2-methoxyethoxy)-aluminiumhydrid oder Lithiumaluminiumhydrid) in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Tetrahydrofuran) (vgl. Org. Biomol. Chem. 2006, 4, 4186; Bioorg. Med. Chem. 2004, 12, 363-370; Tetrahedron 2003, 59, 9091 -9100; Org. Biomol. Chem. 2006, 4, 1400-1412; Synthesis 1977, 561 ; Tetrahedron Letters 1992, 33, 3477 und  Alkyne group of the corresponding 1-arylethynyl- and 1-hetarylethynylcyclohex-2-en-1-ols 1 (a) and 1 (c) according to the invention using suitable aluminum hydride reagents (for example sodium bis (2-methoxyethoxy) - aluminum hydride or lithium aluminum hydride) in a suitable polar aprotic solvent (for example tetrahydrofuran) (compare Org. Biomol. Chem. 2006, 4, 4186, Bioorg. Med. Chem. 2004, 12, 363-370, Tetrahedron 2003, 59, 9091-9100; Org. Biomol. Chem. 2006, 4, 1400-1412; Synthesis 1977, 561; Tetrahedron Letters 1992, 33, 3477 and
Tetrahedron Letters 1974, 1593), unter Einsatz von Borhydridreagenzien (z. B. Natriumborhydrid) in einem geeigneten polar-protischen Lösungsmittel (z. B.  Tetrahedron Letters 1974, 1593), using borohydride reagents (eg sodium borohydride) in a suitable polar protic solvent (eg.
Methanol) (vgl. Org. Lett. 2004, 6, 1785), unter Verwendung von Lithium gelöst in einem Gemisch aus Ethylamin und tert.-Butanol (z. B. Helvetica Chimica Acta 1986, 69, 368) oder unter Nutzung eines geeigneten Trialkoxysilans in Gegenwart eines geeigneten Übergangsmetallkatalysators (z. B. Tris-(acetonitril)ruthenium-1 ,2,3,4,5- pentamethylcyclopentadienylhexafluorophosphat oder Tris-(acetonitril)ruthenium- cyclopentadienylhexafluorophosphat; vgl. J. Am. Chem. Soc. 2002, 124, 7622; J. Am. Chem. Soc. 2005, 127, 17645) hergestellt werden (Schema 4). Eine weitere Variante zur Reduktion der Alkingruppe stellt die Umsetzung des betreffenden Alkins mit Zink in konz. Essigsäure oder mit Zink und einem passenden Ammoniumsalz in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Dichlormethan) dar (vgl. WO2006027243). In Abhängigkeit von den Reaktionsbedingungen können bei den Hydrierungen der Dreifachbindung als weitere Reaktionsprodukte auch die Lett., 2004, 6, 1785) using lithium dissolved in a mixture of ethylamine and tert-butanol (eg Helvetica Chimica Acta 1986, Vol. 69, 368) or using a suitable trialkoxysilane in the presence of a suitable transition metal catalyst (eg tris (acetonitrile) ruthenium-1,2,3,4,5-pentamethylcyclopentadienyl hexafluorophosphate or tris (acetonitrile) ruthenium cyclopentadienyl hexafluorophosphate; Chem. Soc., 2002, 124, 7622; J. Am. Chem. Soc., 2005, 127, 17645) (Scheme 4). Another variant for the reduction of the alkyne group is the reaction of the respective alkyne with zinc in conc. Acetic acid or with zinc and a suitable ammonium salt in a suitable polar aprotic solvent (eg dichloromethane) (see WO2006027243). Depending on the reaction conditions in the hydrogenations of the triple bond as further reaction products and the
entsprechenden erfindungsgemäßen (Z)-konfigurierten Analoga erhalten werden. Einen alternativen Zugang zu den erfindungsgemäßen substituierten (E)- konfigurierten 1 -Arylvinyl- und 1 -Hetarylvinyl-cyclohex-2-en-1 -olen l(e) bietet die Metall- oder Halbmetallhydrid-vermittelte Überführung der oben beschriebenen substituierten 1 -Ethinylcyclohex-2-en-1 -ole l(a) in einem geeigneten polar- aprotischen Lösungsmittel (z. B. Tetrahydrofuran oder Dichlormethan) in corresponding (Z) -configured analogs according to the invention are obtained. An alternative access to the substituted (E) -configured 1-arylvinyl- and 1-hetarylvinylcyclohex-2-en-1-ols (e) according to the invention is afforded by the metal- or semimetal hydride-mediated conversion of the above-described substituted 1-ethynylcyclohex -2-en-1-ol (a) in a suitable polar aprotic solvent (eg tetrahydrofuran or dichloromethane) in
entsprechende substituierte (E)-[M]-1 -Vinyl-cyclohex-2-en-1 -ole (vgl. Org. Lett. 2002, 4, 703; Angew. Int. Ed. 2006, 45, 2916), wobei [M] für eine weiter substituierte Metall- oder Halbmetallkomponente aus der Reihe Zinn, Germanium, Blei, Bor, Aluminium oder Zirconium steht (z. B. [M] = Tri-n-butylstannyl oder Bis- cyclopentadienylchlorzirconyl) (vgl. auch Org. Lett. 2010, 12, 1056; Org. Lett 2005, 7, 5191 , J. Am. Chem. Soc. 2010, 132, 10961 ; Tetrahedron 1994, 50, 5189;Angew. Chem. Int. Ed. 2000, 39, 1930). Die so erhaltenen substituierten (E)-[M]-1 -Vinyl- cyclohex-2-en-1 -ole können durch Kupplung mit einem entsprechenden corresponding substituted (E) - [M] -1-vinylcyclohex-2-en-1-ols (cf., Org. Lett., 2002, 4, 703; Angew. Int Ed., 2006, 45, 2916), wherein [M] represents a further substituted metal or semimetal component selected from tin, germanium, lead, boron, aluminum or zirconium (eg [M] = tri-n-butylstannyl or bis-cyclopentadienylchlorozirconyl) (compare also Org Lett., 2010, 12, 1056; Org. Lett 2005, 7, 5191, J. Am. Chem. Soc., 2010, 132, 10961; Tetrahedron 1994, 50, 5189; Angew. Chem. Int. Ed., 2000, 39 , 1930). The substituted (E) - [M] -1-vinylcyclohex-2-en-1-ols so obtained can be prepared by coupling with a corresponding
substituierten Aryl- oder Hetarylhalogenid in einem geeigneten Lösungsmittel (z. B. Tetrahydrofuran oder Ν,Ν-Dimethylformamid) unter Verwendung von geeigneten Übergangsmetallkatalysatoren (z. B. Bis-(triphenylphosphin)palladiumdicyanid, Tetrakis-(triphenylphosphin)palladium oder Bis-substituted aryl or hetaryl halide in a suitable solvent (eg tetrahydrofuran or Ν, Ν-dimethylformamide) using suitable transition metal catalysts (eg bis (triphenylphosphine) palladium dicyanide, tetrakis (triphenylphosphine) palladium or bis (triphenylphosphine) palladium
(triphenylphosphin)palladiumdichlorid) zu den erfindungsgemäßen substituierten, (E)-konfigurierten 1 -Arylvinyl- und 1 -Hetarylvinyl-cyclohex-2-en-1 -olen l(e) umgesetzt werden (Schema 5). (triphenylphosphine) palladium dichloride) to the substituted, (E) -configured 1-arylvinyl- and 1-hetarylvinyl-cyclohex-2-en-1-ols l (e) according to the invention are reacted (Scheme 5).
Schema 5 Scheme 5
Die betreffenden substituierten (E)-[M]-1 -Vinyl-cyclohex-2-en-1 -ole können mit einem geeigneten Halogenierungsmittel (z. B. N-Bromsuccinimid, N-Iodsuccinimid oder lod) in einem geeigneten polar-aprotischen Lösungsmittel (z. B. Dichlormethan) in die entsprechenden erfindungsgemäßen substituierten (E)-1 -Halovinyl-cyclohex-2- en-1 -ole II überführt werden, die dann durch Kupplung mit einer entsprechend substituierten Aryl- oder Hetarylboronsäure in einem geeigneten The subject substituted (E) - [M] -1-vinylcyclohex-2-en-1-ols may be reacted with a suitable halogenating agent (e.g., N-bromosuccinimide, N-iodosuccinimide or iodine) in a suitable polar aprotic Solvent (eg dichloromethane) are converted into the corresponding substituted (E) -1-halovinyl-cyclohex-2-en-1-ols II according to the invention, which are then by coupling with an appropriately substituted aryl or Hetarylboronsäure in a suitable
Lösungsmittelgemisch (z. B. Dioxan, Wasser und ges. Solvent mixture (eg dioxane, water and sat.
Natriumhydrogencarbonatlösung, Tetrahydrofuran und wässrige Sodium bicarbonate solution, tetrahydrofuran and aqueous
Kaliumcarbonatlösung oder Toluol und wäßrige Natriumcarbonatlösung) unter Verwendung von geeigneten Übergangsmetallkatalysatoren (z. B. Tetrakis- (triphenylphosphin)palladium, Tris-(cyclohexyl)phosphin, [1 , 1 - Bis(diphenylphosphino)ferrocen]palladiumdichlorid, Tris-Potassium carbonate solution or toluene and aqueous sodium carbonate solution) using suitable transition metal catalysts (e.g., tetrakis (triphenylphosphine) palladium, tris (cyclohexyl) phosphine, [1,1-bis (diphenylphosphino) ferrocene] palladium dichloride, tris
(dibenzylideneacetone)dipalladium(O)) zu den erfindungsgemäßen substituierten, (E)-konfigurierten 1 -Arylvinyl- und 1 -Hetarylvinyl-cyclohex-2-en-1 -olen l(e) umgesetzt werden (Schema 5). Die entsprechenden erfindungsgemäßen 1 -Hetaryl- und 1 - Heterocyclylvinyl-cyclohex-2-en-1 -ole l(f)-l(h) können in analogen Umsetzungen ausgehend von substituierten (E)-[M]-1 -Vinyl-cyclohex-2-en-1 -olen und (E)-1 - Halovinyl-cyclohex-2-en-1 -olen II hergestellt werden (Schema 6). (dibenzylideneacetone) dipalladium (O)) to the substituted, (E) -configured 1-arylvinyl- and 1-hetarylvinyl-cyclohex-2-en-1-ols (e) according to the invention (Scheme 5). The corresponding 1-hetaryl and 1-heterocyclyl-vinylcyclohex-2-en-1-ols (f) -l (h) according to the invention can be prepared in analogous reactions starting from substituted (E) - [M] -1-vinylcyclohex 2-en-1-ols and (E) -1-halovinylcyclohex-2-en-1-ols II (Scheme 6).
Schema 6  Scheme 6
Die Reduktion von erfindungsgemäßen substituierten 1 -Arylethinyl- und 1 - Hetarylethinyl-cyclohex-2-en-1 -olen l(a) und l(c) zu den erfindungsgemäßen substituierten (Z)-konfigurierten 1 -Arylvinyl- und 1 -Hetarylvinyl-cyclohex-2-en-1 -olen l(i)-l(j) läßt sich in Gegenwart eines Übergangsmetallkatalysators wie zum Beispiel Lindlars Katalysator mit Wasserstoff in einem geeigneten polar-aprotischen The reduction of substituted 1-arylethinyl- and 1-hetarylethynyl-cyclohex-2-en-1-ols l (a) and l (c) according to the invention to the substituted (Z) -configured 1-arylvinyl- and 1-hetarylvinyl invention cyclohex-2-en-1-ols l (i) -l (j) can be reacted with hydrogen in a suitable polar aprotic manner in the presence of a transition metal catalyst such as Lindlar's catalyst
Lösungsmittel (wie z. B. n-Butanol) durchführen (vgl. Tetrahedron 1987, 43, 4107; Tetrahedron 1983, 39, 2315; J. Org. Synth. 1983, 48, 4436 und J. Am. Chem. Soc. 1984, 106, 2735) (Schema 7). Solvent (such as n-butanol) (see Tetrahedron 1987, 43, 4107, Tetrahedron 1983, 39, 2315, J. Org. Synth., 1983, 48, 4436 and J. Am. Chem. Soc., 1984 , 106, 2735) (Scheme 7).
Schema 7 Ausgewählte detaillierte Synthesebeispiele für die erfindungsgemäßen Scheme 7 Selected detailed synthesis examples for the invention
Verbindungen der allgemeinen Formel (I) sind im Folgenden aufgeführt. Die angegebenen Beispielnummern entsprechen den in den nachstehenden Tabellen 1 bis 5 genannten Numerierungen. Die 1H-NMR-, 13C-NMR- und 19F-NMR- spektroskopischen Daten, die für die in den nachfolgenden Abschnitten Compounds of the general formula (I) are listed below. The given example numbers correspond to the numbers given in Tables 1 to 5 below. The 1 H NMR, 13 C NMR and 19 F NMR spectroscopic data for those in the following sections
beschriebenen chemischen Beispiele angegeben sind, (400 MHz bei 1H-NMR und 150 MHz bei 13C-NMR und 375 MHz bei 19F-NMR, Lösungsmittel CDCI3, CD3OD oder d6-DMSO, interner Standard: Tetramethylsilan δ = 0.00 ppm), wurden mit einem Gerät der Firma Bruker erhalten, und die bezeichneten Signale haben die nachfolgend aufgeführten Bedeutungen: br = breit(es); s = Singulett, d = Dublett, t = Triplett, dd = Doppeldublett, ddd = Dublett eines Doppeldubletts, m = Multiplett, q = Quartett, quint = Quintett, sext = Sextett, sept = Septett, dq = Doppelquartett, dt = Doppeltriplett. Bei Diastereomerengemischen werden entweder die jeweils signifikanten Signale beider Diastereomere oder das charakteristische Signal des Hauptdiastereomers angegeben. Die verwendeten Abkürzungen für chemische Gruppen haben die nachfolgenden Bedeutungen: Me = CH3, Et = CH2CH3, t-Hex = C(CH3)2CH(CH3)2, t-Bu = C(CH3)3, n-Bu = unverzweigtes Butyl, n-Pr = (400 MHz at 1 H-NMR and 150 MHz at 13 C-NMR and 375 MHz at 19 F-NMR, solvent CDCl 3 , CD3OD or d6-DMSO, internal standard: tetramethylsilane δ = 0.00 ppm) , were obtained with a Bruker device, and the designated signals have the meanings given below: br = broad (es); s = singlet, d = doublet, t = triplet, dd = double doublet, ddd = doublet of double doublet, m = multiplet, q = quartet, quint = quintet, sext = sextet, sept = septet, dq = double quartet, dt = double triplet. For diastereomeric mixtures, either the respective significant signals of both diastereomers or the characteristic signal of the main diastereomer are given. The abbreviations used for chemical groups have the following meanings: Me = CH3, Et = CH2CH3, t-Hex = C (CH 3) 2 CH (CH 3) 2, t-Bu = C (CH 3) 3, n-Bu = unbranched butyl, n-Pr =
unverzweigtes Propyl, c-Hex = Cyclohexyl.  unbranched propyl, c-hex = cyclohexyl.
Synthesebeispiele: Synthesis Examples:
No. 1.1 -75: 2,3,7,9,9-Pentamethyl-8-[(E)-2-(2-methylphenyl)vinyl]-1 ,4- dioxaspiro[4.5]dec-6-en-8-ol No. 1.1-75: 2,3,7,9,9-pentamethyl-8 - [(E) -2- (2-methylphenyl) -vinyl] -1,4-dioxaspiro [4.5] dec-6-en-8-ol
8-[(E)-2-lodvinyl]-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol (200 mg, 0.53 mmol) und 2-Methylphenylboronsäure (144 mg, 1 .06 mmol) wurden unter Argon in einem ausgeheizten Rundkolben in Dioxan (4 ml) gelöst, mit Tetrakis(triphenylphosphin)-palladium(0) (18 mg, 0.02 mmol) versetzt und die resultierende Reaktionslösung auf 100 °C erwärmt. Nach 15 Minuten Rühren bei 100 °C erfolgte die Zugabe von ges. Natriumhydrogencarbonatlösung, und das 8 - [(E) -2-iodovinyl] -2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (200mg, 0.53mmol) and 2 Methylphenylboronic acid (144 mg, 1.06 mmol) was added Dissolved argon in a heated round bottom flask in dioxane (4 ml), treated with tetrakis (triphenylphosphine) palladium (0) (18 mg, 0.02 mmol) and the resulting reaction solution heated to 100 ° C. After stirring for 15 minutes at 100 ° C, the addition of sat. Sodium bicarbonate solution, and that
Reaktionsgemisch wurde weitere 3 h bei 100 °C gerührt. Nach dem Abkühlen auf Raumtemperatur wurden Wasser und Ethylacetat zugegeben. Die wässrige Phase wurde mehrfach gründlich mit Ethylacetat extrahiert und die vereinigten organischen Phasen anschließend über Magnesiumsulfat getrocknet, filtriert und unter The reaction mixture was stirred for a further 3 hours at 100.degree. After cooling to room temperature, water and ethyl acetate were added. The aqueous phase was extracted several times thoroughly with ethyl acetate, and the combined organic phases were then dried over magnesium sulfate, filtered and concentrated
vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) konnte 2,3,7,9,9-Pentamethyl-8-[(E)-2-(2-methylphenyl)vinyl]-1 ,4-dioxaspiro[4.5]dec-6-en-8- ol (80 mg, 42 % der Theorie) in Form eines farblosen Feststoffs erhalten werden. 1H- NMR (400 MHz, CDCI3 δ, ppm) 7.38 (m, 1 H), 7.14 (m, 3H), 6.84 (d, 1 H), 6.06 (d, 1 H), 5.48 (s, 1 H), 4.21 (m, 1 H), 3.59 (m, 1 H), 2.36 (s, 3H), 2.04 (d, 1 H), 1 .92 (d, 1 H), 1 .73 (s, 3H), 1 .22 (m, 6H), 1 .12 (m, 3H), 0.99 (m, 3H). concentrated reduced pressure. Final purification by column chromatography of the resulting crude product (ethyl acetate / heptane gradient) gave 2,3,7,9,9-pentamethyl-8 - [(E) -2- (2-methylphenyl) vinyl] -1,4-dioxaspiro [ 4.5] dec-6-en-8-ol (80 mg, 42% of theory) in the form of a colorless solid. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.38 (m, 1H), 7.14 (m, 3H), 6.84 (d, 1H), 6.06 (d, 1H), 5.48 (s, 1 H), 4.21 (m, 1H), 3.59 (m, 1H), 2.36 (s, 3H), 2.04 (d, 1H), 1 .92 (d, 1H), 1 .73 (s, 3H), 1 .22 (m, 6H), 1 .12 (m, 3H), 0.99 (m, 3H).
No. 1.1 -76: 4-Hydroxy-3,5,5-trimethyl-4-[(E)-2-(2-methylphenyl)vinyl]cyclohex-2-en-1 - on No. 1.1-76: 4-hydroxy-3,5,5-trimethyl-4 - [(E) -2- (2-methylphenyl) vinyl] cyclohex-2-en-1-one
2,3,7,9,9-Pentamethyl-8-[(E)-2-(2-methylphenyl)vinyl]-1 ,4-dioxaspiro[4.5]dec-6-en-8- ol (80 mg, 0.23 mmol) wurde unter Argon in einem Rundkolben in Aceton (5 ml) gelöst und mit 5 Tropfen 10%iger Salzsäure versetzt. Die resultierende 2,3,7,9,9-pentamethyl-8 - [(E) -2- (2-methylphenyl) vinyl] -1,4-dioxaspiro [4.5] dec-6-en-8-ol (80mg, 0.23 mmol) was dissolved under argon in a round bottom flask in acetone (5 ml) and treated with 5 drops of 10% hydrochloric acid. The resulting
Reaktionslösung wurde 4 h lang bei Raumtemperatur gerührt und danach mitReaction solution was stirred for 4 h at room temperature and then with
Wasser versetzt. Nach dem Entfernen von Aceton unter vermindertem Druck wurde die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) 4-Hydroxy-3,5,5- trimethyl-4-[(E)-2-(2-methylphenyl)vinyl]cyclohex-2-en-1 -on (50 mg, 75 % der Theorie) in Form eines farblosen Feststoffes isoliert. 1H-NMR (400 MHz, CDC δ, ppm) 7.64 (d, 1 H), 7.53 (d, 1 H), 7.51 (dd, 1 H), 7.46 (dd, 1 H), 6.71 (d, 1 H), 6.16 (d, 1 H), 5.88 (s, 1 H), 2.61 (d, 1 H), 2.45 (d, 1 H), 2.38 (s, 3H), 2.33 (br. s, 1 H, OH), 2.16 (s, 3H), 1.29 (s, 3H), 1.16 (s, 3H). Water is added. After removal of acetone under reduced pressure, the aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatographic purification of the resulting crude product (ethyl acetate / heptane gradient) 4-hydroxy-3,5,5- trimethyl-4 - [(E) -2- (2-methylphenyl) vinyl] cyclohex-2-en-1-one (50 mg, 75% of theory) as a colorless solid. 1 H-NMR (400 MHz, CDC δ, ppm) 7.64 (d, 1H), 7.53 (d, 1H), 7.51 (dd, 1H), 7.46 (dd, 1H), 6.71 (d, 1 H), 6.16 (d, 1H), 5.88 (s, 1H), 2.61 (d, 1H), 2.45 (d, 1H), 2.38 (s, 3H), 2.33 (br. S, 1H , OH), 2.16 (s, 3H), 1.29 (s, 3H), 1.16 (s, 3H).
No. 1.1 -145: 2,3,7,9,9-Pentamethyl-8-{[2-(trifluormethyl)phenyl]ethinyl}-1 ,4- dioxaspiro[4.5]-dec-6-en-8-ol No. 1.1-145: 2,3,7,9,9-pentamethyl-8 - {[2- (trifluoromethyl) phenyl] ethynyl} -1,4-dioxaspiro [4.5] -dec-6-en-8-ol
2,2,6-Trimethyl-1 ,4-cyclohexandion (15.40 g, 101.19 mmol) wurde in einem 2,2,6-trimethyl-1,4-cyclohexanedione (15.40 g, 101.19 mmol) was dissolved in a
Rundkolben unter Argon in 2,3-Butandiol (90 ml) und abs. Toluol (90 ml) gelöst und mit Orthoameisensäuretrimethylester (33.21 ml, 303.56 mmol) sowie p- Toluolsulfonsäure (1 .22 g, 7.08 mmol) versetzt. Das resultierende Reaktionsgemisch wurde 7 h lang bei 50 °C gerührt. Nach dem Abkühlen auf Raumtemperatur erfolgte die Zugabe von Wasser und Toluol und die mehrfache Extraktion der wässrigen Phase mit Toluol. Die vereinigten organischen Phasen wurden über Round bottom flask under argon in 2,3-butanediol (90 ml) and abs. Toluene (90 ml) and triethyl orthoformate (33.21 ml, 303.56 mmol) and p-toluenesulfonic acid (1.22 g, 7.08 mmol) were added. The resulting reaction mixture was stirred at 50 ° C for 7 hours. After cooling to room temperature, the addition of water and toluene and the multiple extraction of the aqueous phase with toluene. The combined organic phases were over
Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Gradient Essigester/Heptan) wurde 2,3,7,9,9-Pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-on (20.01 g, 88 % der Theorie) erhalten. 2,3,7, 9,9-Pentamethyl-1 ,4-dioxaspiro[4.5]dec- 6-en-8-on (10.00 g, 44.58 mmol) wurde danach in einem Rundkolben unter Argon in abs. Tetrahydrofuran (50 ml) gelöst und tropfenweise zu einer Lösung eines Dried magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatographic purification of the resulting crude product (gradient ethyl acetate / heptane) was 2,3,7,9,9-pentamethyl-1, 4-dioxaspiro [4.5] dec-6-en-8-one (20.01 g, 88% of theory ) receive. 2,3,7,9,9-Pentamethyl-1,4-dioxaspiro [4.5] dec-6-ene-8-one (10.00 g, 44.58 mmol) was then dissolved in a round-bottomed flask under argon in abs. Tetrahydrofuran (50 ml) and added dropwise to a solution of a
Lithiumacetylid-Ethylendiaminkomplexes (6.28 g, 57.96 mmol, 85% Gehalt) in abs. Tetrahydrofuran (70 ml) gegeben. Die Reaktionslösung wurde nach erfolgter Zugabe 4 h lang bei Raumtemperatur gerührt, anschließend mit Wasser versetzt und unter vermindertem Druck eingeengt. Der verbleibende Rückstand wurde mit Wasser und Dichlormethan versetzt und die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch Lithium acetylide-ethylenediamine complex (6.28 g, 57.96 mmol, 85% content) in abs. Tetrahydrofuran (70 ml) was added. The reaction solution was stirred for 4 h after the addition at room temperature, then treated with water and concentrated under reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase repeatedly with dichloromethane extracted. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By
säulenchromatographische Reinigung des erhaltenen Rohproduktes (Gradient Essigester/Heptan) wurde 8-Ethinyl-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6- en-8-ol (10.02 g, 85 % der Theorie) als farbloser Feststoff isoliert. Anschließend wurden Kupfer(l)iodid (30 mg, 0.16 mmol) und column chromatographic purification of the resulting crude product (gradient ethyl acetate / heptane) was 8-ethynyl-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (10.02 g, 85 % of theory) as a colorless solid. Subsequently, copper (I) iodide (30 mg, 0.16 mmol) and
Bis(triphenylphosphin)palladium(ll)chlorid (84 mg, 0.12 mmol) unter Argon in einem ausgeheizten Rundkolben vorgelegt und mit abs. Toluol (4 ml) sowie 1 -lod-2- (trifluormethyl)benzol (239 mg, 0.88 mmol) versetzt. Nach 15 Min Rühren bei Raumtemperatur erfolgte die tropfenweise Zugabe einer Lösung von 8-Ethinyl- Provided bis (triphenylphosphine) palladium (II) chloride (84 mg, 0.12 mmol) under argon in a heated round bottom flask and with abs. Toluene (4 ml) and 1-ald-2- (trifluoromethyl) benzene (239 mg, 0.88 mmol) were added. After stirring for 15 min at room temperature, the dropwise addition of a solution of 8-ethynyl
2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol (200 mg, 0.80 mmol) in abs. Toluol (2 ml) und von Diisopropylamin (0.22 ml, 1 .60 mmol). Das resultierende Reaktionsgemisch wurde 5 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Die wässrige Phase wurde mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende 2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (200 mg, 0.80 mmol) in abs. Toluene (2 mL) and diisopropylamine (0.22 mL, 1.60 mmol). The resulting reaction mixture was stirred at room temperature for 5 hours and then water was added. The aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final
säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter column chromatographic purification of the resulting crude product (under
Verwendung eines Essigester/Heptan-Gradienten) wurde 2,3,7,9,9-Pentamethyl-8- {[2-(trifluormethyl)phenyl]ethinyl}-1 ,4-dioxaspiro[4.5]-dec-6-en-8-ol (160 mg, 48 % der Theorie) in Form eines farblosen Feststoffes isoliert. 1H-NMR (400 MHz, CDC δ, ppm) 7.63 (d, 1 H), 7.58 (d, 1 H), 7.48 (dd, 1 H), 7.40 (dd, 1 H), 5.55 (s, 1 H), 4.22 (m, 1 H), 3.61 (m, 1 H), 2.08 (d, 1 H), 1 .98 (s, 3H), 1 .91 (d, 1 H), 1 .23 (d, 3H), 1.21 (s, 3H), 1 .18 (d, 3H), 1 .15 (s, 3H). No. 1.1 -146: 4-Hydroxy-3,5,5-trimethyl-4-{[2-(trifluormethyl)phenyl]ethinyl}cyclohex-2- en-1 -οη Using an ethyl acetate / heptane gradient), 2,3,7,9,9-pentamethyl-8- {[2- (trifluoromethyl) phenyl] ethynyl} -1, 4-dioxaspiro [4.5] -dec-6-ene Isolated 8-ol (160 mg, 48% of theory) in the form of a colorless solid. 1 H-NMR (400 MHz, CDC δ, ppm) 7.63 (d, 1H), 7.58 (d, 1H), 7.48 (dd, 1H), 7.40 (dd, 1H), 5.55 (s, 1 H), 4.22 (m, 1H), 3.61 (m, 1H), 2.08 (d, 1H), 1 .98 (s, 3H), 1 .91 (d, 1H), 1 .23 ( d, 3H), 1.21 (s, 3H), 1 .18 (d, 3H), 1 .15 (s, 3H). No. 1.1-146: 4-hydroxy-3,5,5-trimethyl-4 - {[2- (trifluoromethyl) phenyl] ethynyl} cyclohex-2-ene-1-o
2,37,9,9-Pentamethyl-8-{[2-(tnfluormethyl)phenyl]ethinyl}-1 ,4-d 2,37,9,9-Pentamethyl-8 - {[2- (t -fluoromethyl) phenyl] ethynyl} -1, 4-d
en-8-ol (160 mg, 0.41 mmol) wurde unter Argon in einem Rundkolben in Aceton (5 ml) gelöst und mit 5 Tropfen konz. Salzsäure versetzt. Die resultierende En-8-ol (160 mg, 0.41 mmol) was dissolved under argon in a round bottom flask in acetone (5 ml) and concentrated with 5 drops of conc. Hydrochloric acid added. The resulting
Reaktionslösung wurde 4 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Nach dem Entfernen von Aceton unter vermindertem Druck wurde die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) wurde 4-Hydroxy-3,5,5- trimethyl-4-{[2-(trifluormethyl)phenyl]ethinyl}cyclohex-2-en-1 -on (90 mg, 65 % der Theorie) in Form eines farblosen Feststoffes isoliert. 1H-NMR (400 MHz, CDC δ, ppm) 7.69 (d, 1 H), 7.58 (d, 1 H), 7.52 (dd, 1 H), 7.47 (dd, 1 H), 5.90 (s, 1 H), 2.62 (d, 1 H), 2.47 (d, 1 H), 2.31 (br. s, 1 H, OH), 2.18 (s, 3H), 1 .29 (s, 3H), 1 .16 (s, 3H). No. 1.1 -632: Methyl-2-[(E)-2-(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]-6-methylbenzoat Reaction solution was stirred for 4 hours at room temperature and then treated with water. After removal of acetone under reduced pressure, the aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. Purification by column chromatography of the resulting crude product (ethyl acetate / heptane gradient) gave 4-hydroxy-3,5,5-trimethyl-4 - {[2- (trifluoromethyl) phenyl] ethynyl} cyclohex-2-en-1-one (90 mg, 65% of theory) in the form of a colorless solid. 1 H-NMR (400 MHz, CDC δ, ppm) 7.69 (d, 1H), 7.58 (d, 1H), 7.52 (dd, 1H), 7.47 (dd, 1H), 5.90 (s, 1 H), 2.62 (d, 1H), 2.47 (d, 1H), 2.31 (br s, 1H, OH), 2.18 (s, 3H), 1 .29 (s, 3H), 1 .16 (s, 3H). No. 1.1-632: Methyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] -6-methylbenzoate
2,3,7,9,9-Pentamethyl-8-[(E)-2-(tributylstannyl)vinyl]-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol (250 mg, 0.46 mmol) und 2-lod-6-methylbenzoesäuremethylester (128 mg, 0.46 mmol) wurden unter Argon in einem ausgeheizten Rundkolben in abs. N.N- Dimethylformamid (4 ml) gelöst, mit Dichlorbis(acetonitril)palladium(ll) (6 mg, 0.02 mmol) versetzt und 3 h lang bei Raumtemperatur gerührt. Nach der Zugabe von Kaliumfluorid-Lösung wurde das Reaktionsgemisch weiter über Nacht bei 2,3,7,9,9-Pentamethyl-8 - [(E) -2- (tributylstannyl) vinyl] -1,4-dioxaspiro [4.5] dec-6-en-8-ol (250mg, 0.46mmol ) and 2-iodo-6-methylbenzoic acid methyl ester (128 mg, 0.46 mmol) were dissolved under argon in a heated round bottom flask in abs. Dissolved N, N-dimethylformamide (4 mL), added dichloro-bis (acetonitrile) palladium (II) (6 mg, 0.02 mmol) and stirred at room temperature for 3 h. After the addition of potassium fluoride solution, the reaction was allowed to continue overnight
Raumtemperatur gerührt. Die wässrige Phase wurde anschließend mehrfach gründlich mit Diethylether extrahiert und die vereinigten organischen Phasen anschließend über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) konnte Methyl-2-[(E)-2- (8-hydroxy-2,37,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-yl)vinyl]-6- methylbenzoat in Form eines viskosen Öls erhalten werden. Methyl-2-[(E)-2-(8- hydroxy-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-yl)vinyl]-6- methylbenzoat wurde im Anschluß unter Argon in einem Rundkolben in Aceton (5 ml) gelöst und mit 5 Tropfen 10%iger Salzsäure versetzt. Die resultierende Room temperature stirred. The aqueous phase was then extracted several times thoroughly with diethyl ether and the combined organic phases were then dried over magnesium sulfate, filtered and concentrated under reduced pressure. Final purification by column chromatography of the resulting crude product (ethyl acetate / heptane gradient) gave methyl 2 - [(E) -2- (8-hydroxy-2,37,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-yl) vinyl] -6-methylbenzoate in the form of a viscous oil. Methyl 2 - [(E) -2- (8-hydroxy-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-yl) vinyl] -6 - Methyl benzoate was then dissolved under argon in a round bottom flask in acetone (5 ml) and treated with 5 drops of 10% hydrochloric acid. The resulting
Reaktionslösung wurde 4 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Nach dem Entfernen von Aceton unter vermindertem Druck wurde die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) wurde Methyl-2-[(E)-2- (1 -hydroxy-2,6,6-trimethyl-4-oxo-cyclohex-2-en-1 -yl)vinyl]-6-methylbenzoat (30 mg, 19 % der Theorie) in Form eines farblosen Feststoffes isoliert. 1H-NMR (400 MHz, CDCI3 6, ppm) 7.29 (m, 2H), 7.13 (d, 1 H), 6.70 (d, 1 H), 6.17 (d, 1 H), 5.96 (s, 1 H), 3.88 (s, 3H), 2.52 (d, 1 H), 2.33 (s, 3H), 2.30 (d, 1 H), 1 .95 (s, 3H), 1 .12 (s, 3H), 1.07 (s, 3H). Reaction solution was stirred for 4 hours at room temperature and then treated with water. After removal of acetone under reduced pressure, the aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. Purification by column chromatography of the resulting crude product (ethyl acetate / heptane gradient) gave methyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl) vinyl] -6-methylbenzoate (30 mg, 19% of theory) in the form of a colorless solid isolated. 1 H-NMR (400 MHz, CDCl 3 6, ppm) 7.29 (m, 2H), 7.13 (d, 1H), 6.70 (d, 1H), 6.17 (d, 1H), 5.96 (s, 1 H), 3.88 (s, 3H), 2.52 (d, 1H), 2.33 (s, 3H), 2.30 (d, 1H), 1 .95 (s, 3H), 1 .12 (s, 3H) , 1.07 (s, 3H).
No. 1.1 -1097: Ethyl-2-{[(4Z)-4-(ethoxyimino)-1 -hydroxy-2,6,6-trimethylcyclohex-2-en- 1 -yl]ethinyl}benzoat No. 1.1-1097: Ethyl 2 - {[(4Z) -4- (ethoxyimino) -1-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl] ethynyl} benzoate
Ethyl-2-[(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 -yl)ethinyl]benzoat (50 mg, 0.15 mmol), O-Ethylhydroxylaminhydrochlorid (18 mg, 0.18 mmol) und Ethyl 2 - [(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) ethynyl] benzoate (50 mg, 0.15 mmol), O-ethylhydroxylamine hydrochloride (18 mg, 0.18 mmol ) and
Natriumacetat (27 mg, 0.32 mmol) wurden in einem 1 : 1 -Gemisch aus Ethanol und Wasser (4 ml) gelöst und danach 4 h lang bei einer Temperatur von 60 °C gerührt. Nach dem Abkühlen auf Raumtemperatur wurde Ethanol unter vermindertem Druck entfernt und die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Sodium acetate (27 mg, 0.32 mmol) was dissolved in a 1: 1 mixture of ethanol and water (4 ml) and then stirred for 4 hours at a temperature of 60 ° C. After cooling to room temperature, ethanol was removed under reduced pressure and the aqueous phase extracted several times with dichloromethane. The The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatography
Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) konnte Ethyl-2-{[(4Z)-4-(ethoxyimino)-1 -hydroxy-2,6,6-trimethylcyclohex-2-en-1 - yl]ethinyl}benzoat (30 mg, 50 % der Theorie) in Form eines farblosen Feststoffes erhalten werden. 1H-NMR (400 MHz, CDCI3 δ, ppm) 7.93 (m, 1 H), 7.52 (m, 1 H), 7.47 (m, 1 H), 7.39 (m, 1 H), 6.64 / 5.99 (s, 1 H), 4.38 (q, 2H), 4.12 (q, 2H), 2.61 / 2.56 (br. s, 1 H, OH), 2.52 (d, 1 H), 2.38 (d, 1 H), 2.13 / 2.09 (s, 3H), 1 .39 (t, 3H), 1 .29 (t, 3H), 1 .24 (s, 3H), 1 .12 (s, 3H). Purification of the resulting crude product (ethyl acetate / heptane gradient) revealed ethyl 2 - {[(4Z) -4- (ethoxyimino) -1-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl] ethynyl} benzoate (30 mg, 50% of theory) in the form of a colorless solid. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.93 (m, 1H), 7.52 (m, 1H), 7.47 (m, 1H), 7.39 (m, 1H), 6.64 / 5.99 ( s, 1 H), 4.38 (q, 2H), 4.12 (q, 2H), 2.61 / 2.56 (br s, 1 H, OH), 2.52 (d, 1 H), 2.38 (d, 1 H), 2.13 / 2.09 (s, 3H), 1.39 (t, 3H), 1.29 (t, 3H), 1.24 (s, 3H), 1.12 (s, 3H).
No. 1.1 -1 105: Methyl-2-{[8-hydroxy-2,3,7,9-tetramethyl-9-(trifluormethyl)-1 ,4- dioxaspiro[4.5]dec-6-en-8-yl]ethinyl}benzoat No. 1.1-1 105: methyl 2 - {[8-hydroxy-2,3,7,9-tetramethyl-9- (trifluoromethyl) -1,4-dioxaspiro [4.5] dec-6-en-8-yl] ethynyl } benzoate
Acetylmethylentriphenylphosphoran (12.91 g, 40.57 mmol) wurde in einem Gemisch aus Diethylether (30 ml) und Dichlormethan (10 ml) gelöst, nach 5 Min Rühren mit 1 , 1 , 1 -Trifluoraceton (5.00 g, 44.62 mmol) versetzt und 40 h lang bei Acetylmethylenetriphenylphosphorane (12.91 g, 40.57 mmol) was dissolved in a mixture of diethyl ether (30 ml) and dichloromethane (10 ml), stirred for 5 min with 1,1,1-trifluoroacetone (5.00 g, 44.62 mmol) and allowed to stand for 40 h at
Raumtemperatur gerührt. Der entstandene Niederschlag wurde abfiltriert, der Filterkuchen mit Diethylether nachgewaschen und die vereinigten organischen Phasen vorsichtig unter leicht vermindertem Druck eingeengt. Die so erhaltene Rohlösung von (3Z)-5,5,5-Trifluor-4-methylpent-3-en-2-on wurde ohne weitere Reinigung im nächsten Reaktionsschritt eingesetzt und in Toluol (25 ml) Room temperature stirred. The resulting precipitate was filtered off, the filter cake washed with diethyl ether and the combined organic phases carefully concentrated under slightly reduced pressure. The crude solution of (3Z) -5,5,5-trifluoro-4-methylpent-3-en-2-one thus obtained was used without further purification in the next reaction step and dissolved in toluene (25 ml).
aufgenommen. Nach der Zugabe von Acetylessigsäureethylester (3.42 g, 26.29 mmol) und Kalium-tert.-butylat (0.88 g, 7.89 mmol) wurde das resultierende added. After the addition of ethyl acetylacetate (3.42 g, 26.29 mmol) and potassium tert-butoxide (0.88 g, 7.89 mmol), the resulting
Reaktionsgemisch 5 h lang unter Rückflußbedingungen gerührt. Nach dem Abkühlen auf Raumtemperatur wurde Wasser zugesetzt, 5 Minuten lang intensiv gerührt und die wässrige Phase danach mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) konnte 3,5-Dimethyl-5- (trifluormethyl)cyclohex-2-en-1 -on (1 .9 g, 38 % der Theorie) in Form eines farblosen Öles erhalten werden. 3,5-Dimethyl-5-(trifluormethyl)cyclohex-2-en-1 -on (1 .60 g, 8.33 mmol) wurde danach in abs. Toluol gelöst und mit Molybdatophosphorsäure- Hydrat (30 mg, 0.02 mmol), Kupfer(ll)sulfat-Pentahydrat (4 mg, 0.02 mmol) sowie Molybdän(VI)oxid (5 mg, 0.03 mmol) versetzt. Das resultierende Reaktionsgemisch wurde unter Einleitung von Luft unter Rückflußbedingungen 4 Tage lang gerührt. Nach dem Abkühlen auf Raumtemperatur wurde Wasser zugesetzt, 5 Minuten lang intensiv gerührt und die wässrige Phase danach mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch Reaction mixture stirred for 5 h under reflux conditions. After cooling to room temperature, water was added, stirred vigorously for 5 minutes and the aqueous phase was then extracted several times with dichloromethane. The United organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatography purification of the resulting crude product (ethyl acetate / heptane gradient) could 3,5-dimethyl-5- (trifluoromethyl) cyclohex-2-en-1 -one (1 .9 g, 38% of theory) in the form of a colorless oil to be obtained. 3,5-Dimethyl-5- (trifluoromethyl) cyclohex-2-en-1-one (1.60 g, 8.33 mmol) was then dissolved in abs. Toluene was dissolved and treated with Molybdatophosphorsäure- hydrate (30 mg, 0.02 mmol), copper (II) sulfate pentahydrate (4 mg, 0.02 mmol) and molybdenum (VI) oxide (5 mg, 0.03 mmol). The resulting reaction mixture was stirred with introduction of air under reflux conditions for 4 days. After cooling to room temperature, water was added, stirred vigorously for 5 minutes and the aqueous phase was then extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By
säulenchromatographische Reinigung des resultierenden Rohproduktes column chromatographic purification of the resulting crude product
(Essigester/Heptan-Gradient) konnte 2,6-Dimethyl-6-(trifluormethyl)cyclohex-2-en- 1 ,4-dion (300 mg, 17 % der Theorie) in Form eines farblosen Öles erhalten werden. 2,6-Dimethyl-6-(trifluormethyl)cyclohex-2-en-1 ,4-dion (520 mg, 2.52 mmol) wurde unter Argon in 2,3-Butandiol gelöst (4 ml) und mit Orthoameisensäuretrimethylester (0.83 ml, 7.57 mmol) sowie p-Toluolsulfonsäure (30 mg, 0.18 mmol) versetzt. Das resultierende Reaktionsgemisch wurde 6 h lang bei 50 °C gerührt. Nach dem (Ethyl acetate / heptane gradient), 2,6-dimethyl-6- (trifluoromethyl) cyclohex-2-ene-1,4-dione (300 mg, 17% of theory) was obtained in the form of a colorless oil. 2,6-Dimethyl-6- (trifluoromethyl) cyclohex-2-ene-1,4-dione (520 mg, 2.52 mmol) was dissolved under argon in 2,3-butanediol (4 ml) and with trimethyl orthoformate (0.83 ml, 7.57 mmol) and p-toluenesulfonic acid (30 mg, 0.18 mmol). The resulting reaction mixture was stirred at 50 ° C for 6 hours. After this
Abkühlen auf Raumtemperatur erfolgte die Zugabe von Wasser und Toluol und die mehrfache Extraktion der wässrigen Phase mit Toluol. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Gradient Essigester/Heptan) wurde 2,3,7,9-Tetramethyl-9- (trifluormethyl)-l ,4-dioxaspiro[4.5]dec-6-en-8-on (700 mg, 98 % der Theorie) erhalten. 2,3,7,9-Tetramethyl-9-(trifluormethyl)-1 ,4-dioxaspiro[4.5]dec-6-en-8-on (700 mg, 2.52 mmol) wurde danach in einem Rundkolben unter Argon in abs.  Cooling to room temperature, the addition of water and toluene and the multiple extraction of the aqueous phase with toluene. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. Purification by column chromatography of the resulting crude product (gradient ethyl acetate / heptane) gave 2,3,7,9-tetramethyl-9- (trifluoromethyl) -1,4-dioxaspiro [4.5] dec-6-en-8-one (700 mg, 98% of theory). 2,3,7,9-Tetramethyl-9- (trifluoromethyl) -1,4-dioxaspiro [4.5] dec-6-ene-8-one (700 mg, 2.52 mmol) was then dissolved in a round-bottom flask under argon in abs.
Tetrahydrofuran (3 ml) unter Argon gelöst und tropfenweise zu einer Lösung eines Lithiumacetylid-Ethylendiaminkomplexes (376 mg, 3.27 mmol, 80% Gehalt) in abs. Tetrahydrofuran (5 ml) gegeben. Die Reaktionslösung wurde nach erfolgter Zugabe 4 h lang bei Raumtemperatur gerührt, anschließend mit Wasser versetzt und unter vermindertem Druck eingeengt. Der verbleibende Rückstand wurde mit Wasser und Dichlormethan versetzt und die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch Tetrahydrofuran (3 ml) was dissolved under argon and added dropwise to a solution of a lithium acetylide-ethylenediamine complex (376 mg, 3.27 mmol, 80% content) in abs. Tetrahydrofuran (5 ml) was added. The reaction solution was stirred for 4 h after the addition at room temperature, then treated with water and subs concentrated reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By
säulenchromatographische Reinigung des erhaltenen Rohproduktes (Gradient Essigester/Heptan) wurde 8-Ethinyl-2,3,7,9-tetramethyl-9-(trifluormethyl)-1 ,4- dioxaspiro[4.5]dec-6-en-8-ol (550 mg, 68 % der Theorie) als farbloser Feststoff isoliert. Anschließend wurden Kupfer(l)iodid (16 mg, 0.09 mmol) und purification by column chromatography of the obtained crude product (gradient ethyl acetate / heptane) was 8-ethynyl-2,3,7,9-tetramethyl-9- (trifluoromethyl) -1,4-dioxaspiro [4.5] dec-6-en-8-ol ( 550 mg, 68% of theory) as a colorless solid. Subsequently, copper (I) iodide (16 mg, 0.09 mmol) and
Bis(triphenylphosphin)palladium(ll)chlorid (45 mg, 0.06 mmol) unter Argon in einem ausgeheizten Rundkolben vorgelegt und mit abs. Toluol (3 ml) sowie Methyl-2- iodbenzoat (1 12 mg, 0.43 mmol) versetzt. Nach 10 Min Rühren bei Raumtemperatur erfolgte die tropfenweise Zugabe einer Lösung von 8-Ethinyl-2,3,7,9-tetramethyl-9- (trifluormethyl)-l ,4-dioxaspiro[4.5]dec-6-en-8-ol (130 mg, 0.43 mmol) in abs. Toluol (2 ml) und von Diisopropylamin (0.12 ml, 0.85 mmol). Das resultierende Bis (triphenylphosphine) palladium (II) chloride (45 mg, 0.06 mmol) under argon in a heated round bottom flask and charged with abs. Toluene (3 ml) and methyl 2-iodobenzoate (1 12 mg, 0.43 mmol) were added. After stirring at room temperature for 10 min, the dropwise addition of a solution of 8-ethynyl-2,3,7,9-tetramethyl-9- (trifluoromethyl) -1,4-dioxaspiro [4.5] dec-6-en-8-ol was carried out (130 mg, 0.43 mmol) in abs. Toluene (2 mL) and diisopropylamine (0.12 mL, 0.85 mmol). The resulting
Reaktionsgemisch wurde 3 h lang bei Raumtemperatur gerührt und danach mitThe reaction mixture was stirred for 3 hours at room temperature and then washed with
Wasser versetzt. Die wässrige Phase wurde mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende Water is added. The aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final
säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter column chromatographic purification of the resulting crude product (under
Verwendung eines Essigester/Heptan-Gradienten) wurde Methyl-2-{[8-hydroxy-Using an ethyl acetate / heptane gradient), methyl 2 - {[8-hydroxy-
2,3,7,9-tetramethyl-9-(trifluormethyl)-1 ,4-dioxaspiro[4.5]dec-6-en-8-yl]ethinyl}benzoat (120 mg, 64 % der Theorie) in Form eines farblosen Öles isoliert. 1H-NMR (400 MHz, CDCIs δ, ppm) 7.95 (d, 1 H), 7.53 (d, 1 H), 7.48 (m, 1 H), 7.39 (m, 1 H), 5.51 / 5.42 (s, 1 H), 4.23 / 3.62 (m, 2H), 3.90 (s, 3H), 2.52 / 2.41 (d, 1 H), 2.32 / 2.28 (br. s, 1 H, OH), 2.17 / 2.08 (s, 3H), 1 .97 (m, 1 H), 1 .48 / 1 .39 (s, 3H), 1 .27 (m, 3H), 1 .17 (m, 3H). 2,3,7,9-tetramethyl-9- (trifluoromethyl) -1,4-dioxaspiro [4.5] dec-6-en-8-yl] ethynyl} benzoate (120 mg, 64% of theory) as a colorless Oil isolated. 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.95 (d, 1H), 7.53 (d, 1H), 7.48 (m, 1H), 7.39 (m, 1H), 5.51 / 5.42 (s , 1H), 4.23 / 3.62 (m, 2H), 3.90 (s, 3H), 2.52 / 2.41 (d, 1H), 2.32 / 2.28 (brs s, 1H, OH), 2.17 / 2.08 (s , 3H), 1 .97 (m, 1H), 1 .48 / 1 .39 (s, 3H), 1 .27 (m, 3H), 1 .17 (m, 3H).
1 .73 (s, 3H), 1.22 (m, 6H), 1 .12 (m, 3H), 0.99 (m, 3H). 1 .73 (s, 3H), 1.22 (m, 6H), 1 .12 (m, 3H), 0.99 (m, 3H).
No. 1.1 -1 106: 4-Hydroxy-3,5,5-trimethyl-4-[(E)-2-(2-methylphenyl)vinyl]cyclohex-2- en-1 -οη No. 1.1-1 106: 4-hydroxy-3,5,5-trimethyl-4 - [(E) -2- (2-methylphenyl) vinyl] cyclohex-2-ene-1-one
Methyl-2-{[8-hydroxy-2,37,9-tetramethyl-9-(tnfluormethyl)-1 ,4-dioxaspiro[4.5]dec-6- en-8-yl]ethinyl}benzoat (120 mg, 0.27 mmol) wurde unter Argon in einem Methyl 2 - {[8-hydroxy-2,37,9-tetramethyl-9- (t -fluoromethyl) -1,4-dioxaspiro [4.5] dec-6-en-8-yl] ethynyl} benzoate (120 mg, 0.27 mmol) was added under argon in a
Rundkolben in Aceton (5 ml) gelöst und mit 5 Tropfen 10%iger Salzsäure versetzt. Die resultierende Reaktionslösung wurde 4 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Nach dem Entfernen von Aceton unter vermindertem Druck wurde die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Dissolve round-bottomed flask in acetone (5 ml) and add 5 drops of 10% hydrochloric acid. The resulting reaction solution was stirred at room temperature for 4 hours and then water was added. After removal of acetone under reduced pressure, the aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatography
Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) 4- Methyl- 2-{[1 -hydroxy-2,6-dimethyl-4-oxo-6-(trifluormethyl)cyclohex-2-en-1 -yl]ethinyl}benzoat (50 mg, 49 % der Theorie) in Form eines farblosen Feststoffes isoliert. 1H-NMR (400 MHz, CDCIs δ, ppm) 8.00 (d, 1 H), 7.52 (m, 2H), 7.44 (m, 1 H), 5.97 / 5.96 (s, 1 H), 3.91 (s, 3H), 3.14 (br. s, 1 H, OH), 3.00 (d, 1 H), 2.76 (d, 1 H), 2.26 (s, 3H), 1 .55 (s, 3H). Purification of the resulting crude product (ethyl acetate / heptane gradient) 4-methyl-2 - {[1-hydroxy-2,6-dimethyl-4-oxo-6- (trifluoromethyl) cyclohex-2-en-1-yl] ethynyl} Benzoate (50 mg, 49% of theory) isolated in the form of a colorless solid. 1 H-NMR (400 MHz, CDCIs δ, ppm) 8.00 (d, 1H), 7.52 (m, 2H), 7.44 (m, 1H), 5.97 / 5.96 (s, 1H), 3.91 (s, 3H), 3.14 (br s, 1H, OH), 3.00 (d, 1H), 2.76 (d, 1H), 2.26 (s, 3H), 1.55 (s, 3H).
No. I.2-45: 5-[(5-Hydroxy-4,4',5',6-tetramethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]- dioxolan]-5-yl)ethinyl]-1 ,3-dimethylpyrimidin-2,4(1 H,3H)-dion No. I.2-45: 5 - [(5-Hydroxy-4,4 ', 5', 6-tetramethylspiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolane ] -5-yl) ethynyl] -1,3-dimethylpyrimidine-2,4 (1H, 3H) -dione
Dimethylbenzochinon (5.00 g, 36.72 mmol) wurde in einem Rundkolben unter Argon in 2,3-Butandiol (75 ml) gelöst und mit Orthoameisensäuretrimethylester (12.05 ml, 1 10.17 mmol) sowie p-Toluolsulfonsäure (0.44 g, 2.57 mmol) versetzt. Das resultierende Reaktionsgemisch wurde 6 h lang bei 60 °C gerührt. Nach dem Dimethylbenzoquinone (5.00 g, 36.72 mmol) was dissolved in a round bottom flask under argon in 2,3-butanediol (75 ml) and treated with trimethyl orthoformate (12.05 ml, 1 10.17 mmol) and p-toluenesulfonic acid (0.44 g, 2.57 mmol). The resulting reaction mixture was stirred at 60 ° C for 6 hours. After this
Abkühlen auf Raumtemperatur erfolgte die Zugabe von Wasser und Toluol und die mehrfache Extraktion der wässrigen Phase mit Toluol. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Gradient Essigester/Heptan) wurde 2,3,7,9-Tetramethyl-1 ,4- dioxaspiro[4.5]deca-6,9-dien-8-on (7.00 g, 92 % der Theorie) erhalten. 2,3,7,9- Tetramethyl-1 ,4-dioxaspiro[4.5]deca-6,9-dien-8-on (2.00 g, 5.76 mmol) wurde unter Argon in abs. N,N-Dimethylformamid (5 ml) gelöst und zu einer vorgerührten Cooling to room temperature, the addition of water and toluene and the multiple extraction of the aqueous phase with toluene. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatographic purification of the resulting crude product (gradient ethyl acetate / heptane) was 2,3,7,9-tetramethyl-1, 4-dioxaspiro [4.5] deca-6,9-dien-8-one (7.00 g, 92% of theory ) receive. 2,3,7,9-Tetramethyl-1,4-dioxaspiro [4.5] deca-6,9-dien-8-one (2.00 g, 5.76 mmol) was dissolved under argon in abs. Dissolved N, N-dimethylformamide (5 ml) and stirred to a
Reaktionsmischung aus Natriumhydrid (0.34 g, 60 % Gehalt, 8.64 mmol) undReaction mixture of sodium hydride (0.34 g, 60% content, 8.64 mmol) and
Trimethylsulfoxoniumiodid (1 .46 g, 6.63 mmol) in N,N-Dimethylformamid (5 ml) unter Argon gegeben. Das resultierende Reaktionsgemisch wurde 20 min lang bei Raumtemperatur gerührt und danach mit Wasser sowie Methyl-tert.-butylether versetzt. Die wässrige Phase mehrfach mit Methyl-tert.-butylether extrahiert, und die vereinigten organischen Phasen wurden im Anschluß mit ges. Trimethylsulfoxonium iodide (1.46 g, 6.63 mmol) in N, N-dimethylformamide (5 mL) under argon. The resulting reaction mixture was stirred for 20 minutes at room temperature and then treated with water and methyl tert-butyl ether. The aqueous phase extracted several times with methyl tert-butyl ether, and the combined organic phases were washed with sat.
Natriumhydrogencarbonatlösung gewaschen, über Magnesiumsulfat getrocknet, filtriert sowie unter vermindertem Druck eingeengt. Durch abschließende  Washed sodium bicarbonate solution, dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final
säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter column chromatographic purification of the resulting crude product (under
Verwendung eines Essigester/Heptan-Gradienten) wurde 4,4',5',6-Tetramethyl-5H- spiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]-dioxolan]-5-on (1 .00 g, 76 % der Theorie) in Form eines farblosen Öls isoliert. 4,4',5',6-Tetramethyl-5H-spiro[bicyclo[4.1 .0]hept-3- en-2,2'-[1 ,3]dioxolan]-5-on (640 mg, 2.88 mmol) wurde danach in einem Rundkolben unter Argon in abs. Tetrahydrofuran (3 ml) gelöst und tropfenweise zu einer Lösung eines Lithiumacetylid-Ethylendiaminkomplexes (383 mg, 3.74 mmol, 90% Gehalt) in abs. Tetrahydrofuran (7 ml) gegeben. Die Reaktionslösung wurde nach erfolgterUse of an ethyl acetate / heptane gradient) was 4,4 ', 5', 6-tetramethyl-5H-spiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] -dioxolane] -5-one (1 .00 g, 76% of theory) in the form of a colorless oil isolated. 4,4 ', 5', 6-tetramethyl-5H-spiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolan] -5-one (640 mg, 2.88 mmol ) was then in a round bottom flask under argon in abs. Tetrahydrofuran (3 ml) was dissolved and added dropwise to a solution of a lithium acetylide-ethylenediamine complex (383 mg, 3.74 mmol, 90% content) in abs. Tetrahydrofuran (7 ml) was added. The reaction solution was after completed
Zugabe 4 h lang bei Raumtemperatur gerührt, anschließend mit Wasser versetzt und unter vermindertem Druck eingeengt. Der verbleibende Rückstand wurde mit Wasser und Dichlormethan versetzt und die wässrige Phase mehrfach mit Stirred for 4 h at room temperature, then treated with water and concentrated under reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase with several times
Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Extracted dichloromethane. The combined organic phases were over
Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des erhaltenen Rohproduktes (Gradient Essigester/Heptan) wurde 5-Ethinyl-4,4',5',6-tetramethylspiro-[bicyclo[4.1 .0]hept-3- en-2,2'-[1 ,3]dioxolan]-5-ol (498 mg, 69 % der Theorie) als farbloser Feststoff isoliert. Anschließend wurden Kupfer(l)iodid (31 mg, 0.16 mmol) und Dried magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatographic purification of the resulting crude product (gradient ethyl acetate / heptane) was 5-ethynyl-4,4 ', 5', 6-tetramethylspiro- [bicyclo [4.1 .0] hept-3 en-2,2 '- [1,3-dioxolane] -5-ol (498 mg, 69% of theory) as a colorless solid. Subsequently, copper (I) iodide (31 mg, 0.16 mmol) and
Bis(triphenylphosphin)palladium(ll)chlorid (85 mg, 0.12 mmol) unter Argon in einem ausgeheizten Rundkolben vorgelegt und mit abs. Toluol (5 ml) sowie 5-lod-1 ,3- dimethyluracil (215 mg, 0.81 mmol) versetzt. Nach 10 Min Rühren bei Provided bis (triphenylphosphine) palladium (II) chloride (85 mg, 0.12 mmol) under argon in a heated round bottom flask and with abs. Toluene (5 ml) and 5-iodo-1,3-dimethyluracil (215 mg, 0.81 mmol) were added. After stirring for 10 min
Raumtemperatur erfolgte die tropfenweise Zugabe einer Lösung von 5-Ethinyl- 4,4',5',6-tetramethylspiro-[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]dioxolan]-5-ol (200 mg, 0.81 mmol) in abs. Toluol (2 ml) und von Diisopropylamin (0.23 ml, 1 .62 mmol). Das resultierende Reaktionsgemisch wurde 3 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Die wässrige Phase wurde mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter  Room temperature was added dropwise a solution of 5-ethynyl-4,4 ', 5', 6-tetramethylspiro- [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolane] - 5-ol (200 mg, 0.81 mmol) in abs. Toluene (2 mL) and diisopropylamine (0.23 mL, 1.62 mmol). The resulting reaction mixture was stirred at room temperature for 3 hours and then water was added. The aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final column chromatographic purification of the resulting crude product (under
Verwendung eines Essigester/Heptan-Gradienten) wurde 5-[(5-Hydroxy-4,4',5',6- tetramethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]-dioxolan]-5-yl)ethinyl]-1 ,3-dimethyl- pyrimidin-2,4(1 H,3H)-dion (300 mg, 92 % der Theorie) in Form eines farblosen Feststoffs isoliert. 1H-NMR (400 MHz, CDCI3 δ, ppm) 7.46 (s, 1 H), 5.41 / 5.29 (s, 1 H), 3.70 (m, 2H), 3.61 (s, 3H), 3.47 (s, 3H), 2.30 (br. s, 1 H, OH), 2.04 / 2.01 (s, 3H), 1 .92 / 1 .48 (m, 1 H), 1 .48 / 1 .46 (s, 3H), 1 .29-1.24 (m, 6H), 1 .18 / 0.62 (m, 2H). Use of an ethyl acetate / heptane gradient), 5 - [(5-hydroxy-4,4 ', 5', 6-tetramethylspiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1, 3 ] -dioxolan] -5-yl) ethynyl] -1,3-dimethylpyrimidine-2,4 (1H, 3H) -dione (300 mg, 92% of theory) as a colorless solid. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.46 (s, 1H), 5.41 / 5.29 (s, 1H), 3.70 (m, 2H), 3.61 (s, 3H), 3.47 (s, 3H), 2.30 (brs s, 1H, OH), 2.04 / 2.01 (s, 3H), 1 .92 / 1 .48 (m, 1H), 1 .48 / 1 .46 (s, 3H) , 1.29-1.24 (m, 6H), 1.18 / 0.62 (m, 2H).
No. I.2-46: 5-[(2-Hydroxy-1 ,3-dimethyl-5-oxobicyclo[4.1 .0]hept-3-en-2-yl)ethinyl]-1 ,3- dimethylpyrimidin-2,4(1 H,3H)-dion No. I.2-46: 5 - [(2-Hydroxy-1,3-dimethyl-5-oxobicyclo [4.1.0] hept-3-en-2-yl) ethynyl] -1,3-dimethylpyrimidine-2,4 (1H, 3H) -dione
5-[(5-Hydroxy-4,4',5',6-tetramethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]-dioxolan]-5- yl)-ethinyl]-1 ,3-dimethyl-pyrimidin-2,4(1 H,3H)-dion (300 mg, 0.78 mmol) wurde unter Argon in einem Rundkolben in Aceton (10 ml) gelöst und mit 5 Tropfen 10%iger Salzsäure versetzt. Die resultierende Reaktionslösung wurde 3 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Nach dem Entfernen von Aceton unter vermindertem Druck wurde die wässrige Phase mehrfach mit 5 - [(5-Hydroxy-4,4 ', 5', 6-tetramethylspiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3-dioxolan] -5-yl) -ethynyl] -1,3-dimethyl-pyrimidine-2,4 (1H, 3H) -dione (300mg, 0.78mmol) was dissolved under argon in a round bottom flask in acetone (10ml) and 10% 10 drops Hydrochloric acid added. The resulting reaction solution was added for 3 hours Room temperature stirred and then treated with water. After removal of acetone under reduced pressure, the aqueous phase was washed several times
Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Extracted dichloromethane. The combined organic phases were over
Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes Dried magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatographic purification of the resulting crude product
(Essigester/Heptan-Gradient) wurde 5-[(2-Hydroxy-1 ,3-dimethyl-5- oxobicyclo[4.1.0]hept-3-en-2-yl)ethinyl]-1 ,3-dimethylpyrimidin-2,4(1 H,3H)-dion (60 mg, 23 % der Theorie) in Form eines farblosen Öles isoliert. 1H-NMR (400 MHz, CDCIs δ, ppm) 7.53 / 7.43 (s, 1 H), 6.18 / 6.1 1 (s, 1 H), 3.48 / 3.46 (s, 3H), 3.36 / 3.35 (s, 3H), 2.63 / 1.92 (m, 1 H), 2.58 (m, 1 H), 2.50 (m, 1 H), 2.34 / 2.22 (s, 3H), 2.03 / 1 .99 (s, 3H). (Ethyl acetate / heptane gradient) was 5 - [(2-hydroxy-1,3-dimethyl-5-oxobicyclo [4.1.0] hept-3-en-2-yl) ethynyl] -1,3-dimethylpyrimidine-2 , 4 (1H, 3H) -dione (60 mg, 23% of theory) isolated as a colorless oil. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.53 / 7.43 (s, 1 H), 6.18 / 6.1 1 (s, 1 H), 3.48 / 3.46 (s, 3H), 3.36 / 3.35 (s, 3H ), 2.63 / 1.92 (m, 1H), 2.58 (m, 1H), 2.50 (m, 1H), 2.34 / 2.22 (s, 3H), 2.03 / 1.99 (s, 3H).
No. 1.3-121 : 2,3,7,9,9-Pentamethyl-8-[(1 -methyl-1 H-imidazol-5-yl)ethinyl]-1 ,4- dioxaspiro-[4.5]dec-6-en-8-ol No. 1.3-121: 2,3,7,9,9-Pentamethyl-8 - [(1-methyl-1H-imidazol-5-yl) -ethynyl] -1,4-dioxaspiro [4.5] dec-6-ene -8-ol
5-Ethinyl-1 methyl-1 H-imidazol (142 mg, 1 .34 mmol) wurde unter Argon in abs. 5-Ethynyl-1-methyl-1H-imidazole (142mg, 1 .34mmol) was added under argon in abs.
Tetrahydrofuran (8 ml) gelöst. Die Reaktionslösung wurde auf -78 °C eingekühlt, mit einer Lösung von n-Butyllithium in abs. Tetrahydrofuran (1.18 ml) versetzt und 30 Minuten lang bei -78 °C nachgerührt. Anschließend erfolgte die Zugabe einer Lösung von 5-Ethinyl-4,4',5',6-tetramethylspiro-[bicyclo[4.1 .0]hept-3-en-2,2'- [1 ,3]dioxolan]-5-ol (300 mg, 1 .34 mmol) in abs. Tetrahydrofuran (2 ml). Das resultierende Reaktionsgemisch wurde 10 Minuten lang bei -78 °C gerührt, langsam auf 0 °C erwärmt und 2 h lang bei 0 °C nachgerührt sowie mit Wasser versetzt. Die wässrige Phase wurde mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter Verwendung eines Essigester/Heptan-Gradienten) wurde 2,3,7,9,9-Pentamethyl-8-[(1 -methyl-1 H- imidazol-5-yl)ethinyl]-1 ,4-dioxaspiro-[4.5]dec-6-en-8-ol (260 mg, 59 % der Theorie) in Form eines farblosen Feststoffs isoliert. 1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (s, 1 H), 7.21 (s, 1 H), 5.42 (s, 1 H), 3.64 (s, 3H), 3.59 (m, 2H), 2.23 (br. s, 1 H, OH), 2.08 (d, 1 H), 1 .94 (s, 3H), 1 .87 (d, 1 H), 1 .25-1 .20 (m, 9H), 1 .14 (m, 3H). Tetrahydrofuran (8 ml) was dissolved. The reaction solution was cooled to -78 ° C, with a solution of n-butyllithium in abs. Tetrahydrofuran (1.18 ml) was added and stirred at -78 ° C for 30 minutes. This was followed by the addition of a solution of 5-ethynyl-4,4 ', 5', 6-tetramethylspiro- [bicyclo [4.1.0] hept-3-ene-2,2'- [1,3] dioxolane] -5 -ol (300 mg, 1 .34 mmol) in abs. Tetrahydrofuran (2 ml). The resulting reaction mixture was stirred for 10 minutes at -78 ° C, slowly warmed to 0 ° C and stirred for 2 h at 0 ° C and treated with water. The aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final column chromatographic purification of the resulting crude product (using a Ethyl acetate / heptane gradient) was 2,3,7,9,9-pentamethyl-8 - [(1-methyl-1H-imidazol-5-yl) ethynyl] -1,4-dioxaspiro [4.5] decyl Isolated 6-en-8-ol (260 mg, 59% of theory) in the form of a colorless solid. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.42 (s, 1H), 7.21 (s, 1H), 5.42 (s, 1H), 3.64 (s, 3H), 3.59 (m, 2H ), 2.23 (br s, 1H, OH), 2.08 (d, 1H), 1 .94 (s, 3H), 1 .87 (d, 1H), 1 .25-1 .20 (m , 9H), 1 .14 (m, 3H).
No. 1.3-122: 4-Hydroxy-3,5,5-trimethyl-4-[(1 -methyl-1 H-imidazol-5- yl)ethinyl]cyclohex-2-en-1 -on No. 1.3-122: 4-Hydroxy-3,5,5-trimethyl-4 - [(1-methyl-1H-imidazol-5-yl) -ethynyl] cyclohex-2-en-1-one
2,3,7,9,9-Pentamethyl-8-[(1 -methyl-1 H-imidazol-5-yl)ethinyl]-1 ,4-dioxaspiro-[4.5]dec- 6-en-8-ol (260 mg, 0.79 mmol) wurde unter Argon in einem Rundkolben in Aceton (5 ml) gelöst und mit 5 Tropfen 10%iger Salzsäure versetzt. Die resultierende 2,3,7,9,9-Pentamethyl-8 - [(1-methyl-1 H -imidazol-5-yl) -ethynyl] -1,4-dioxaspiro [4.5] dec-6-en-8-ol (260 mg, 0.79 mmol) was dissolved under argon in a round bottom flask in acetone (5 ml) and treated with 5 drops of 10% hydrochloric acid. The resulting
Reaktionslösung wurde 3 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Nach dem Entfernen von Aceton unter vermindertem Druck wurde die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) wurde 4-Hydroxy-3,5,5- trimethyl-4-[(1 -methyl-1 H-imidazol-5-yl)ethinyl]cyclohex-2-en-1 -on (150 mg, 70 % der Theorie) in Form eines farblosen Feststoffes isoliert. 1H-NMR (400 MHz, CDCI3 δ, ppm) 7.69 (s, 1 H), 7.22 (s, 1 H), 5.87 (s, 1 H), 3.71 (s, 3H), 3.31 (br. s, 1 H, OH), 2.55 (d, 1 H), 2.42 (d, 1 H), 2.19 (s, 3H), 1 .28 (s, 3H), 1 .13 (s, 3H); 13C-NMR (125 MHz, CDCI3 6, ppm) 200.6, 160.0, 140.3, 134.3, 126.5, 1 16.9, 97.0, 75.6, 61 .6, 43.1 , 33.1 , 32.7, 25.6, 23.8, 20.2. Reaction solution was stirred for 3 hours at room temperature and then treated with water. After removal of acetone under reduced pressure, the aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. Purification by column chromatography of the resulting crude product (ethyl acetate / heptane gradient) gave 4-hydroxy-3,5,5-trimethyl-4 - [(1-methyl-1H-imidazol-5-yl) -ethynyl] cyclohex-2-ene -1 -one (150 mg, 70% of theory) isolated as a colorless solid. 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.69 (s, 1H), 7.22 (s, 1H), 5.87 (s, 1H), 3.71 (s, 3H), 3.31 (br. S, 1H, OH), 2.55 (d, 1H), 2.42 (d, 1H), 2.19 (s, 3H), 1 .28 (s, 3H), 1 .13 (s, 3H); 13 C-NMR (125 MHz, CDCI 3 6, ppm) 200.6, 160.0, 140.3, 134.3, 126.5, 1 16.9, 97.0, 75.6, 61 .6, 43.1, 33.1, 32.7, 25.6, 23.8, 20.2.
No. I.4-25: Ethyl-2-[(8-hydroxy-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8- yl)ethinyl]cyclopent-1 -en-1 -carboxylat No. I.4-25: Ethyl 2 - [(8-hydroxy-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-yl) ethynyl] cyclopentene 1-en-1-carboxylate
2,2,6-Trimethyl-l ,4-cyclohexandion (15.40 g, 101.19 mmol) wurde in einem 2,2,6-Trimethyl-1,4-cyclohexanedione (15.40 g, 101.19 mmol) was dissolved in a
Rundkolben unter Argon in 2,3-Butandiol (90 ml) und abs. Toluol (90 ml) gelöst und mit Orthoameisensäuretrimethylester (33.21 ml, 303.56 mmol) sowie p-Round bottom flask under argon in 2,3-butanediol (90 ml) and abs. Toluene (90 ml) and triethyl orthoformate (33.21 ml, 303.56 mmol) and p-
Toluolsulfonsäure (1 .22 g, 7.08 mmol) versetzt. Das resultierende Reaktionsgemisch wurde 7 h lang bei 50 °C gerührt. Nach dem Abkühlen auf Raumtemperatur erfolgte die Zugabe von Wasser und Toluol und die mehrfache Extraktion der wässrigen Phase mit Toluol. Die vereinigten organischen Phasen wurden über Toluene sulfonic acid (1 .22 g, 7.08 mmol) was added. The resulting reaction mixture was stirred at 50 ° C for 7 hours. After cooling to room temperature, the addition of water and toluene and the multiple extraction of the aqueous phase with toluene. The combined organic phases were over
Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Gradient Essigester/Heptan) wurde 2,3,7,9,9-Pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-on (20.01 g, 88 % der Theorie) erhalten. 2,3,7,9,9-Pentamethyl-1 ,4-dioxaspiro[4.5]dec- 6-en-8-on (10.00 g, 44.58 mmol) wurde danach in einem Rundkolben unter Argon in abs. Tetrahydrofuran (50 ml) gelöst und tropfenweise zu einer Lösung eines Dried magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatographic purification of the resulting crude product (gradient ethyl acetate / heptane) was 2,3,7,9,9-pentamethyl-1, 4-dioxaspiro [4.5] dec-6-en-8-one (20.01 g, 88% of theory ) receive. 2,3,7,9,9-Pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-one (10.00 g, 44.58 mmol) was then dissolved in a round-bottomed flask under argon in abs. Tetrahydrofuran (50 ml) and added dropwise to a solution of a
Lithiumacetylid-Ethylendiaminkomplexes (6.28 g, 57.96 mmol, 85% Gehalt) in abs. Tetrahydrofuran (70 ml) gegeben. Die Reaktionslösung wurde nach erfolgter Zugabe 4 h lang bei Raumtemperatur gerührt, anschließend mit Wasser versetzt und unter vermindertem Druck eingeengt. Der verbleibende Rückstand wurde mit Wasser und Dichlormethan versetzt und die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch  Lithium acetylide-ethylenediamine complex (6.28 g, 57.96 mmol, 85% content) in abs. Tetrahydrofuran (70 ml) was added. The reaction solution was stirred for 4 h after the addition at room temperature, then treated with water and concentrated under reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By
säulenchromatographische Reinigung des erhaltenen Rohproduktes (Gradient Essigester/Heptan) wurde 8-Ethinyl-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6- en-8-ol (10.02 g, 85 % der Theorie) als farbloser Feststoff isoliert. Natriumhydrid (97 mg, 2.42 mmol, 60%ige Suspension) wurde in einem ausgeheizten Rundkolben mit abs. Diethylether (10 ml) unter Argon versetzt und nach 5 Minuten Rühren bei Raumtemperatur auf 0 °C eingekühlt. Danach erfolgte die Zugabe von column chromatographic purification of the resulting crude product (gradient ethyl acetate / heptane) was 8-ethynyl-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (10.02 g, 85 % of theory) as a colorless solid. Sodium hydride (97 mg, 2.42 mmol, 60% suspension) was dissolved in a heated round bottom flask with abs. Diethyl ether (10 ml) under argon and cooled after stirring for 5 minutes at room temperature to 0 ° C. Thereafter, the addition of
Ethylcyclopentanon-2-carboxylat (300 mg, 1.86 mmol) und nach weiteren 10 min bei 0 °C wurde Trifluormethansulfonsäureanhydrid langsam zugetropft (2.42 ml, 2.42 mmol). Das resultierende Reaktionsgemisch wurde 1 h lang bei 0 °C gerührt und danach mit ges. Ammoniumchloridlösung versetzt. Die wässrige Phase wurde mehrfach mit Diethylether extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und vorsichtig unter vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter Verwendung eines Essigester/Heptan-Gradienten) wurde Ethyl-2-{[(trifluormethyl)sulfonyl]oxy}cyclopent-1 -en-1 -carboxylat (250 mg, 50 % der Theorie) als farblose Flüssigkeit erhalten. Anschließend wurden Kupfer(l)iodid (7 mg, 0.04 mmol) und Bis(triphenylphosphin)palladium(ll)chlorid (13 mg, 0.02 mmol) unter Argon in einem ausgeheizten Rundkolben vorgelegt und mit abs. Ethylcyclopentanone-2-carboxylate (300 mg, 1.86 mmol) and after a further 10 min At 0 ° C, trifluoromethanesulfonic anhydride was slowly added dropwise (2.42 mL, 2.42 mmol). The resulting reaction mixture was stirred for 1 h at 0 ° C and then washed with sat. Ammonium chloride solution added. The aqueous phase was extracted several times with diethyl ether. The combined organic phases were dried over magnesium sulfate, filtered and concentrated carefully under reduced pressure. Final purification by column chromatography of the crude product obtained (using an ethyl acetate / heptane gradient) gave ethyl 2 - {[(trifluoromethyl) sulfonyl] oxy} cyclopent-1-ene-1-carboxylate (250 mg, 50% of theory) obtained colorless liquid. Then copper (I) iodide (7 mg, 0.04 mmol) and bis (triphenylphosphine) palladium (II) chloride (13 mg, 0.02 mmol) were placed under argon in a heated round bottom flask and washed with abs.
Tetrahydrofuran (2 ml) sowie einer Lösung von 8-Ethinyl-2,3,7,9,9-pentamethyl-1 ,4- dioxaspiro[4.5]dec-6-en-8-ol (230 mg, 0.92 mmol) in abs. Tetrahydrofuran (1 ml) und mit Diisopropylamin (1.29 ml, 9.2 mmol) versetzt. Danach erfolgte die Zugabe einer Lösung von Ethyl-2-{[(trifluormethyl)sulfonyl]oxy}cyclopent-1 -en-1 -carboxylat (250 mg, 0.92 mmol) in abs. Tetrahydrofuran (1 ml). Das resultierende Reaktionsgemisch wurde 4 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Die wässrige Phase wurde mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter Verwendung eines Tetrahydrofuran (2 ml) and a solution of 8-ethynyl-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (230 mg, 0.92 mmol) in Section. Tetrahydrofuran (1 ml) and diisopropylamine (1.29 ml, 9.2 mmol) were added. This was followed by the addition of a solution of ethyl 2 - {[(trifluoromethyl) sulfonyl] oxy} cyclopent-1-en-1-carboxylate (250 mg, 0.92 mmol) in abs. Tetrahydrofuran (1 ml). The resulting reaction mixture was stirred at room temperature for 4 hours and then water was added. The aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final column chromatographic purification of the resulting crude product (using a
Essigester/Heptan-Gradienten) wurde Ethyl-2-[(8-hydroxy-2,3,7,9,9-pentamethyl-1 ,4- dioxaspiro[4.5]dec-6-en-8-yl)ethinyl]cyclopent-1 -en-1 -carboxylat (139 mg, 39 % der Theorie) in Form eines farblosen Öls isoliert. 1H-NMR (400 MHz, CDCI3 δ, ppm) 5.42 / 5.39 (s, 1 H), 4.23 / 3.59 (m, 2H), 4.21 (q, 2H), 2.69 (m, 2H), 2.63 (m, 2H), 2.20 (br. s, 1 H, OH), 2.09 (d, 1 H), 1 .96 / 1 .94 (s, 3H), 1 .90 (m, 2H), 1.82 (d, 1 H), 1 .29 (t, 3H), 1 .23 (m, 3H), 1 .18 (d, 3H), 1 .17 (s, 3H), 1 .15 (s, 3H). Ethyl acetate / heptane gradient) was ethyl 2 - [(8-hydroxy-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-yl) ethynyl] cyclopent -1 -ene-1-carboxylate (139 mg, 39% of theory) in the form of a colorless oil. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 5.42 / 5.39 (s, 1H), 4.23 / 3.59 (m, 2H), 4.21 (q, 2H), 2.69 (m, 2H), 2.63 (m , 2H), 2.20 (brs s, 1H, OH), 2.09 (d, 1H), 1.96 / 1.94 (s, 3H), 1.90 (m, 2H), 1.82 (d, 1 H), 1 .29 (t, 3H), 1 .23 (m, 3H), 1 .18 (d, 3H), 1 .17 (s, 3H), 1 .15 (s, 3H).
No. I.4-26: Ethyl-2-[(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 -yl)ethinyl]- cyclopent-1 -en-1 -carboxylat No. I.4-26: Ethyl 2 - [(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) ethynyl] cyclopent-1-ene-1-carboxylate
Ethyl-2-[(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 -yl)ethinyl]cyclopent-1 -en-1 - carboxylat (85 mg, 0.22 mmol) wurde unter Argon in einem Rundkolben in Aceton (3 ml) gelöst und mit 5 Tropfen konz. Salzsäure versetzt. Die resultierende Ethyl 2 - [(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) ethynyl] cyclopent-1-ene-1-carboxylate (85 mg, 0.22 mmol) was added Dissolve argon in acetone (3 ml) in a round bottom flask and add 5 drops of conc. Hydrochloric acid added. The resulting
Reaktionslösung wurde 4 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Nach dem Entfernen von Aceton unter vermindertem Druck wurde die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch säulenchromatographische Reinigung des resultierenden Rohproduktes (Essigester/Heptan-Gradient) wurde Ethyl-2-[(1 - hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 -yl)ethinyl]-cyclopent-1 -en-1 -carboxylat (57 mg, 82 % der Theorie) in Form eines farblosen viskosen Öles isoliert. 1H-NMR (400 MHz, CDCIs δ, ppm) 5.86 (s, 1 H), 4.22 (q, 2H), 2.71 (m, 2H), 2.63 (m, 2H), 2.61 (d, 1 H), 2.42 (d, 1 H), 2.15 (s, 3H), 1 .93 (m, 2H), 1 .29 (t, 3H), 1 .24 (s, 3H), 1 .13 (s, 3H). Reaction solution was stirred for 4 hours at room temperature and then treated with water. After removal of acetone under reduced pressure, the aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. Purification by column chromatography of the resulting crude product (ethyl acetate / heptane gradient) gave ethyl 2 - [(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) ethynyl] cyclopent-1 -en-1-carboxylate (57 mg, 82% of theory) in the form of a colorless viscous oil isolated. 1 H-NMR (400 MHz, CDCl 2 δ, ppm) 5.86 (s, 1H), 4.22 (q, 2H), 2.71 (m, 2H), 2.63 (m, 2H), 2.61 (d, 1 H), 2.42 (d, 1H), 2.15 (s, 3H), 1 .93 (m, 2H), 1 .29 (t, 3H), 1 .24 (s, 3H), 1 .13 (s, 3H) ,
No. I.4-27: Ethyl-2-[(E)-2-(8-hydroxy-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6- en-8-yl)vinyl]cyclopent-1 -en-1 -carboxylat No. I.4-27: ethyl 2 - [(E) -2- (8-hydroxy-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-ene-8- yl) vinyl] cyclopent-1-ene-1-carboxylate
Tetrakis(triphenylphosphin)palladium(0) (231 mg, 0.20 mmol) wurde unter Argon in einem ausgeheizten Rundkolben vorgelegt und mit abs. Tetrahydrofuran (25 ml) sowie 8-Ethinyl-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol (1 .0 g, 3.99 mmol) versetzt. Nach 5 Minuten Rühren bei Raumtemperatur erfolgte die Zugabe von Tributylzinnhydrid (1.29 ml, 4.79 mmol). Das resultierende Reaktionsgemisch wurde 1 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Die wässrige Phase wurde mehrfach gründlich mit Dichlormethan extrahiert und die vereinigten organischen Phasen anschließend über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende Tetrakis (triphenylphosphine) palladium (0) (231 mg, 0.20 mmol) was placed under argon in a heated round bottom flask and washed with abs. Tetrahydrofuran (25 ml) and 8-ethynyl-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (1 .0 g, 3.99 mmol) were added. After stirring for 5 minutes at room temperature, the addition was made of tributyltin hydride (1.29 mL, 4.79 mmol). The resulting reaction mixture was stirred for 1 h at room temperature and then treated with water. The aqueous phase was extracted several times thoroughly with dichloromethane and the combined organic phases were then dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final
säulenchromatographische Reinigung des resultierenden Rohproduktes column chromatographic purification of the resulting crude product
(Essigester/Heptan-Gradient) konnte 2,3,7,9,9-Pentamethyl-8-[(E)-2- (tributylstannyl)vinyl]-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol (1 .50 g, 66 % der Theorie) in Form eines farblosen Öls erhalten werden. 1H-NMR (400 MHz, CDCI3 δ, ppm) 6.13 (d, 1 H), 5.93 (d, 1 H), 5.42 (s, 1 H), 4.22 / 3.63 (m, 2H), 1 .61 (s, 3H), 1 .59 (d, 1 H),(Ethyl acetate / heptane gradient) could give 2,3,7,9,9-pentamethyl-8 - [(E) -2- (tributylstannyl) vinyl] -1,4-dioxaspiro [4.5] dec-6-ene-8 -ol (1.50 g, 66% of theory) are obtained in the form of a colorless oil. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 6.13 (d, 1H), 5.93 (d, 1H), 5.42 (s, 1H), 4.22 / 3.63 (m, 2H), 1 .61 (s, 3H), 1 .59 (d, 1H),
1 .52 (d, 1 H), 1 .49 (m, 6H), 1 .32-1 .24 (m, 12H), 1 .09 (s, 3H), 0.89 (m, 18H). 2,3,7,9,9- Pentamethyl-8-[(E)-2-(tributylstannyl)vinyl]-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol (400 mg, 0.74 mmol) wurde in einem ausgeheizten Rundkolben unter Argon in abs. N,N- Dimethylformamid gelöst (5 ml) und mit Tetrakis(triphenylphosphin)palladium(0) (85 mg, 0.07 mmol) sowie Ethyl-2-{[(trifluormethyl)sulfonyl]oxy}cyclopent-1 -en-1 - carboxylat (213 mg, 0.74 mmol) versetzt. Nach 5 min Rühren bei Raumtemperatur erfolgte die Zugabe von Kupfer(l)iodid (105 mg, 0.55 mmol), und das resultierende Reaktionsgemsich wurde 6 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Die wässrige Phase wurde mehrfach gründlich mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter 1 .52 (d, 1H), 1 .49 (m, 6H), 1 .32-1 .24 (m, 12H), 1 .09 (s, 3H), 0.89 (m, 18H). 2,3,7,9,9-Pentamethyl-8 - [(E) -2- (tributylstannyl) vinyl] -1,4-dioxaspiro [4.5] dec-6-en-8-ol (400 mg, 0.74 mmol ) was in a heated round bottom flask under argon in abs. N, N-dimethylformamide dissolved (5 ml) and with tetrakis (triphenylphosphine) palladium (0) (85 mg, 0.07 mmol) and ethyl 2 - {[(trifluoromethyl) sulfonyl] oxy} cyclopent-1-ene-1-carboxylate (213 mg, 0.74 mmol). After stirring at room temperature for 5 minutes, copper (I) iodide (105 mg, 0.55 mmol) was added, and the resulting reaction mixture was stirred at room temperature for 6 hours and then water was added. The aqueous phase was extracted several times thoroughly with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final column chromatographic purification of the resulting crude product (under
Verwendung eines Essigester/Heptan-Gradienten) wurde Ethyl-2-[(E)-2-(8-hydroxy- 2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-yl)vinyl]cyclopent-1 -en-1 - carboxylat (180 mg, 62 % der Theorie) in Form eines farblosen Öls isoliert. 1H-NMR (400 MHz, CDCI3 δ, ppm) 7.47 (d, 1 H), 5.93 (d, 1 H), 5.45 / 5.43 (s, 1 H), 4.25 / 3.58 (m, 2H), 4.21 (q, 2H), 2.71 (m, 2H), 2.63 (m, 2H), 2.18 (br. s, 1 H, OH), 1 .93 (d, 1 H), 1 .85 (m, 2H), 1 .82 (d, 1 H), 1 .68 / 1 .67 (s, 3H), 1 .31 (t, 3H), 1.26-1 .23 (m, 6H), 1 .1 1 / 1 .09 (s, 3H), 0.92 / 0.90 (s, 3H) Using an ethyl acetate / heptane gradient) was added ethyl 2 - [(E) -2- (8-hydroxy-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-ene -8-yl) vinyl] cyclopent-1 -ene-1-carboxylate (180 mg, 62% of theory) as a colorless oil. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7:47 (d, 1 H), 5.93 (d, 1 H), 5.45 / 5:43 (s, 1 H), 4.25 / 3:58 (m, 2H), 4.21 ( q, 2H), 2.71 (m, 2H), 2.63 (m, 2H), 2.18 (br, s, 1H, OH), 1.93 (d, 1H), 1.85 (m, 2H), 1 .82 (d, 1H), 1 .68 / 1 .67 (s, 3H), 1 .31 (t, 3H), 1.26-1 .23 (m, 6H), 1 .1 1/1. 09 (s, 3H), 0.92 / 0.90 (s, 3H)
No. I.4-28: Ethyl-2-[(E)-2-(1 -hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 - yl)vinyl]cyclopent-1 -en-1 -carboxylat No. I.4-28: ethyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] cyclopent-1-ene 1-carboxylate
Ethyl-2-[(E)-2-(8-hydroxy-2,37,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8- yl)vinyl]cyclopent-1 -en-1 -carboxylat (180 mg, 0.46 mmol) wurde unter Argon in einem Rundkolben in Aceton (5 ml) gelöst und mit 5 Tropfen konz. Salzsäure versetzt. Die resultierende Reaktionslösung wurde 1 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Nach dem Entfernen von Aceton unter vermindertem Druck wurde die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch Ethyl 2 - [(E) -2- (8-hydroxy-2,37,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-yl) vinyl] cyclopent-1 - En-1-carboxylate (180 mg, 0.46 mmol) was dissolved under argon in a round bottom flask in acetone (5 ml) and concentrated with 5 drops of conc. Hydrochloric acid added. The resulting reaction solution was stirred at room temperature for 1 hour and then added with water. After removal of acetone under reduced pressure, the aqueous phase was extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By
säulenchromatographische Reinigung des resultierenden Rohproduktes column chromatographic purification of the resulting crude product
(Essigester/Heptan-Gradient) wurde Ethyl-2-[(E)-2-(1 -hydroxy-2,6,6-trimethyl-4- oxocyclohex-2-en-1 -yl)vinyl]cyclopent-1 -en-1 -carboxylat (100 mg, 65 % der Theorie) in Form eines farblosen viskosen Öles isoliert. 1H-NMR (400 MHz, CDC δ, ppm)(Ethyl acetate / heptane gradient) was ethyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] cyclopent-1 - en-1-carboxylate (100 mg, 65% of theory) in the form of a colorless viscous oil. 1 H-NMR (400 MHz, CDC δ, ppm)
7.58 (d, 1 H), 5.99 (d, 1 H), 5.94 (s, 1 H), 4.22 (q, 2H), 2.73 (m, 2H), 2.67 (m, 2H), 2.49 (d, 1 H), 2.29 (d, 1 H), 1 .93 (s, 3H), 1 .89 (m, 2H), 1.30 (t, 3H), 1 .1 1 (s, 3H), 1 .02 (s, 3H). No. I.4-54: 4-[(2-Hydroxy-1 ,3-dimethyl-5-oxobicyclo[4.1 .0]hept-3-en-2- yl)ethinyl]furan-2(5H)-on 7.58 (d, 1H), 5.99 (d, 1H), 5.94 (s, 1H), 4.22 (q, 2H), 2.73 (m, 2H), 2.67 (m, 2H), 2.49 (d, 1 H), 2.29 (d, 1H), 1 .93 (s, 3H), 1 .89 (m, 2H), 1.30 (t, 3H), 1 .1 1 (s, 3H), 1 .02 ( s, 3H). No. I.4-54: 4 - [(2-Hydroxy-1,3-dimethyl-5-oxobicyclo [4.1.0] hept-3-en-2-yl) ethynyl] furan-2 (5H) -one
Dimethyl-p-benzochinon (2.00 g, 14.69 mmol) wurde in einem Rundkolben unter Argon in Dioxan (7.20 ml) und 1 ,2-Ethandiol (7.20 ml) gelöst und mit Dimethyl p-benzoquinone (2.00 g, 14.69 mmol) was dissolved in dioxane (7.20 ml) and 1, 2-ethanediol (7.20 ml) in a round bottom flask under argon in argon and washed with
Orthoameisensäuretrimethyl-ester (7.20 ml, 60.45 mmol) sowie p-Toluolsulfonsäure (0.10 g, 0.59 mmol) versetzt. Das resultierende Reaktionsgemisch wurde 48 h lang bei Raumtemperatur gerührt. Danach erfolgte die Zugabe von Wasser und Methyl- tert.-butylether und die mehrfache Extraktion der wässrigen Phase mit Methyl-tert.- butylether. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch Orthoformic acid trimethyl ester (7.20 ml, 60.45 mmol) and p-toluenesulfonic acid (0.10 g, 0.59 mmol) was added. The resulting reaction mixture was allowed to stand for 48 hours stirred at room temperature. This was followed by the addition of water and methyl tert-butyl ether and the multiple extraction of the aqueous phase with methyl tert-butyl ether. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By
säulenchromatographische Reinigung des resultierenden Rohproduktes (Gradient Essigester/Heptan) wurde 7,9-Dimethyl-1 ,4-dioxaspiro[4.5]deca-6,9-dien-8-on (0.80 g, 30 % der Theorie) erhalten. 7,9-Dimethyl-1 ,4-dioxaspiro[4.5]deca-6,9-dien-8-on (500 mg, 2.78 mmol) wurde unter Argon in abs. N,N-Dimethylformamid (3 ml) gelöst und zu einer vorgerührten Reaktionsmischung aus Natriumhydrid (177 mg, 60 % Gehalt, 4.44 mmol) und Trimethylsulfoxoniumiodid (916 mg, 4.16 mmol) in N,N-column chromatographic purification of the resulting crude product (gradient ethyl acetate / heptane) was 7,9-dimethyl-1, 4-dioxaspiro [4.5] deca-6,9-dien-8-one (0.80 g, 30% of theory). 7,9-Dimethyl-1,4-dioxaspiro [4.5] deca-6,9-dien-8-one (500 mg, 2.78 mmol) was dissolved under argon in abs. N, N-dimethylformamide (3ml) and added to a preliminarily stirred reaction mixture of sodium hydride (177mg, 60% content, 4.44mmol) and trimethylsulfoxonium iodide (916mg, 4.16mmol) in N, N-
Dimethylformamid (3 ml) unter Argon gegeben. Das resultierende Reaktionsgemisch wurde 20 min lang bei Raumtemperatur gerührt und danach mit Wasser sowie Methyl-tert.-butylether versetzt. Die wässrige Phase wurde mehrfach mit Methyl-tert.- butylether extrahiert, und die vereinigten organischen Phasen wurden im Anschluß mit ges. Natriumhydrogencarbonatlösung gewaschen, über Magnesiumsulfat getrocknet, filtriert sowie unter vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter Dimethylformamide (3 ml) was added under argon. The resulting reaction mixture was stirred for 20 minutes at room temperature and then treated with water and methyl tert-butyl ether. The aqueous phase was extracted several times with methyl tert-butyl ether, and the combined organic phases were washed with sat. Washed sodium bicarbonate solution, dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final column chromatographic purification of the resulting crude product (under
Verwendung eines Essigester/Heptan-Gradienten) wurde 4,6-Dimethyl-5H-spiro- [bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]dioxolan]-5-on (400 mg, 74 % der Theorie) in Form eines farblosen Öls isoliert. 4,6-Dimethyl-5H-spiro-[bicyclo[4.1 .0]hept-3-en-2,2'- [1 ,3]dioxolan]-5-on (740 mg, 3.81 mmol) wurde danach in einem Rundkolben unter Argon in abs. Tetrahydrofuran (5 ml) gelöst und tropfenweise zu einer Lösung eines Lithiumacetylid-Ethylendiaminkomplexes (507 mg, 4.95 mmol, 90% Gehalt) in abs. Tetrahydrofuran (10 ml) gegeben. Die Reaktionslösung wurde nach erfolgter Zugabe 4 h lang bei Raumtemperatur gerührt, anschließend mit Wasser versetzt und unter vermindertem Druck eingeengt. Der verbleibende Rückstand wurde mit Wasser und Dichlormethan versetzt und die wässrige Phase mehrfach mit Dichlormethan extrahiert. Die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch Use of an ethyl acetate / heptane gradient) 4,6-dimethyl-5H-spiro- [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolan] -5-one (400 mg, 74% of theory) in the form of a colorless oil. 4,6-Dimethyl-5H-spiro- [bicyclo [4.1.0] hept-3-ene-2,2'- [1,3] dioxolane] -5-one (740 mg, 3.81 mmol) was then added in a Round bottom flask under argon in abs. Tetrahydrofuran (5 ml) was dissolved and added dropwise to a solution of a Lithiumacetylid-ethylenediamine complex (507 mg, 4.95 mmol, 90% content) in abs. Tetrahydrofuran (10 ml) was added. The reaction solution was stirred for 4 h after the addition at room temperature, then treated with water and concentrated under reduced pressure. The remaining residue was mixed with water and dichloromethane and the aqueous phase extracted several times with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By
säulenchromatographische Reinigung des erhaltenen Rohproduktes (Gradient Essigester/Heptan) wurde 5-Ethinyl-4,6-dimethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'- [1 ,3]dioxolan]-5-ol (450 mg, 54 % der Theorie) als farbloser Feststoff isoliert. Anschließend wurden Kupfer(l)iodid (55 mg, 0.29 mmol) und column chromatographic purification of the resulting crude product (gradient ethyl acetate / heptane) was 5-ethynyl-4,6-dimethylspiro [bicyclo [4.1.0] hept-3-ene-2,2'- [1,3] dioxolane] -5-ol (450 mg, 54% of theory) isolated as a colorless solid. Subsequently, copper (I) iodide (55 mg, 0.29 mmol) and
Bis(triphenylphosphin)palladium(ll)chlorid (102 mg, 0.15 mmol) unter Argon in einem ausgeheizten Rundkolben vorgelegt und mit abs. Toluol (6 ml) sowie 4-lodfuran- 2(5H)-on (610 mg, 2.91 mmol) versetzt. Nach 10 Min Rühren bei Raumtemperatur erfolgte die tropfenweise Zugabe einer Lösung von 5-Ethinyl-4,6- dimethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]dioxolan]-5-ol (320 mg, 1.45 mmol) in abs. Toluol (2 ml) und von Diisopropylamin (0.41 ml, 2.91 mmol). Das resultierende Reaktionsgemisch wurde 4 h lang bei Raumtemperatur gerührt, danach mit Wasser und gesättigter Ammoniumchloridlösung versetzt und 15 Minuten nachgerührt. Die wässrige Phase wurde mehrfach mit Dichlormethan extrahiert, und die vereinigten organischen Phasen wurden über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende säulenchromatographische Reinigung des erhaltenen Rohproduktes (unter Verwendung eines Provided bis (triphenylphosphine) palladium (II) chloride (102 mg, 0.15 mmol) under argon in a heated round bottom flask and with abs. Toluene (6 ml) and 4-iodofuran-2 (5H) -one (610 mg, 2.91 mmol) were added. After 10 minutes of stirring at room temperature, the dropwise addition of a solution of 5-ethynyl-4,6-dimethylspiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolane] -5- ol (320 mg, 1.45 mmol) in abs. Toluene (2 mL) and diisopropylamine (0.41 mL, 2.91 mmol). The resulting reaction mixture was stirred for 4 hours at room temperature, then treated with water and saturated ammonium chloride solution and stirred for 15 minutes. The aqueous phase was extracted several times with dichloromethane and the combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final column chromatographic purification of the resulting crude product (using a
Essigester/Heptan-Gradienten) wurde 4-[(2-Hydroxy-1 ,3-dimethyl-5- oxobicyclo[4.1.0]hept-3-en-2-yl)ethinyl]furan-2(5H)-on (80 mg, 21 % der Theorie) in Form eines farblosen Feststoffe isoliert. 1H-NMR (400 MHz, CDCI3 δ, ppm) 6.30 / 6.29 (s, 1 H), 5.71 (s, 1 H), 4.88 (s, 2H), 3.06 (br. s, 1 H, OH), 2.15 (s, 3H), 1 .96 / 1 .77 (m, 1 H), 1 .50 / 1 .41 (s, 3H), 1 .24 (m, 1 H), 1 .17 / 0.96 (m, 1 H). Zusätzlich wurde im Zuge der säulenchromatographischen Reinigung das geschützte Analogon 4-[(5- Hydroxy-4,6-dimethylspiro[bicyclo[4.1 .0]hept-3-en-2,2'-[1 ,3]dioxolan]-5- yl)ethinyl]furan-2(5H)-on I.4-X (20 mg, 5 % der Theorie) in Form eines farblosen Öls isoliert. 1H-NMR (400 MHz, CDC δ, ppm) 6.24 / 6.23 (s, 1 H), 5.38 (s, 1 H), 4.83 (s, 2H), 4.02 (m, 4H), 2.27 (br. s, 1 H, OH), 1 .96 (s, 3H), 1 .42 (s, 3H), 1 .39 (m, 1 H), 0.66 (m, 2H). Ethyl acetate / heptane gradient), 4 - [(2-hydroxy-1,3-dimethyl-5-oxobicyclo [4.1.0] hept-3-en-2-yl) ethynyl] furan-2 (5H) -one ( 80 mg, 21% of theory) in the form of a colorless solid. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 6.30 / 6.29 (s, 1H), 5.71 (s, 1H), 4.88 (s, 2H), 3.06 (br. S, 1H, OH) , 2.15 (s, 3H), 1.96 / 1.77 (m, 1H), 1.50 / 1.41 (s, 3H), 1.24 (m, 1H), 1.17 / 0.96 (m, 1H). In addition, in the course of column chromatographic purification, the protected analogue 4 - [(5-hydroxy-4,6-dimethylspiro [bicyclo [4.1.0] hept-3-ene-2,2 '- [1,3] dioxolane] -5 - yl) ethynyl] furan-2 (5H) -one I.4-X (20 mg, 5% of theory) isolated as a colorless oil. 1 H-NMR (400 MHz, CDC δ, ppm) 6.24 / 6.23 (s, 1H), 5.38 (s, 1H), 4.83 (s, 2H), 4.02 (m, 4H), 2.27 (br , 1H, OH), 1 .96 (s, 3H), 1 .42 (s, 3H), 1 .39 (m, 1H), 0.66 (m, 2H).
No. 11.41 : 8-[(E)-2-lodvinyl]-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol No. 11.41: 8 - [(E) -2-iodovinyl] -2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol
Tetrakis(triphenylphosphin)palladium(0) (231 mg, 0.20 mmol) wurde unter Argon in einem ausgeheizten Rundkolben vorgelegt und mit abs. Tetrahydrofuran (25 ml) sowie 8-Ethinyl-2,3,7,9,9-pentamethyl-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol (1 .0 g, 3.99 mmol) versetzt. Nach 5 Minuten Rühren bei Raumtemperatur erfolgte die Zugabe von Tributylzinnhydrid (1 .29 ml, 4.79 mmol). Das resultierende Reaktionsgemisch wurde 1 h lang bei Raumtemperatur gerührt und danach mit Wasser versetzt. Die wässrige Phase wurde mehrfach gründlich mit Dichlormethan extrahiert und die vereinigten organischen Phasen anschließend über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende Tetrakis (triphenylphosphine) palladium (0) (231 mg, 0.20 mmol) was placed under argon in a heated round bottom flask and washed with abs. Tetrahydrofuran (25 ml) and 8-ethynyl-2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol (1 .0 g, 3.99 mmol) were added. After stirring for 5 minutes at room temperature, tributyltin hydride (1.29 ml, 4.79 mmol) was added. The resulting reaction mixture was stirred for 1 h at room temperature and then treated with water. The aqueous phase was extracted several times thoroughly with dichloromethane and the combined organic phases were then dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final
säulenchromatographische Reinigung des resultierenden Rohproduktes column chromatographic purification of the resulting crude product
(Essigester/Heptan-Gradient) konnte 2,3,7,9,9-Pentamethyl-8-[(E)-2- (tributylstannyl)vinyl]-1 ,4-dioxaspiro[4.5]dec-6-en-8-ol (1.50 g, 66 % der Theorie) in Form eines farblosen Öls erhalten werden. 2,3,7,9,9-Pentamethyl-8-[(E)-2- (tributylstannyl)vinyl]-1 ,4-dioxaspiro[4.5]-dec-6-en-8-ol (320 mg, 0.59 mmol) wurde in abs. Dichlormethan (3 ml) unter Argon gelöst, auf 0 °C eingekühlt und danach tropfenweise mit einer Lösung von lod (150 mg, 0.59 mmol) in Dichlormethan (2 ml) versetzt. Die Reaktionslösung wurde 15 Minuten lang bei 0 °C, 1 h lang bei (Ethyl acetate / heptane gradient) could give 2,3,7,9,9-pentamethyl-8 - [(E) -2- (tributylstannyl) vinyl] -1,4-dioxaspiro [4.5] dec-6-ene-8 -ol (1.50 g, 66% of theory) are obtained in the form of a colorless oil. 2,3,7,9,9-Pentamethyl-8 - [(E) -2- (tributylstannyl) vinyl] -1,4-dioxaspiro [4.5] -dec-6-en-8-ol (320 mg, 0.59 mmol) was dissolved in abs. Dichloromethane (3 ml) was dissolved under argon, cooled to 0 ° C and then treated dropwise with a solution of iodine (150 mg, 0.59 mmol) in dichloromethane (2 ml). The reaction solution was allowed to stand for 15 minutes at 0 ° C for 1 h
Raumtempratur gerührt und anschließend mit Wasser und Na2S20s-Lösung versetzt. Die wässrige Phase wurde mehrfach gründlich mit Dichlormethan extrahiert und die vereinigten organischen Phasen anschließend über Magnesiumsulfat getrocknet, filtriert und unter vermindertem Druck eingeengt. Durch abschließende Room temperature stirred and then treated with water and Na2S20s solution. The aqueous phase was extracted several times thoroughly with dichloromethane and the combined organic phases were then dried over magnesium sulfate, filtered and concentrated under reduced pressure. By final
säulenchromatographische Reinigung des resultierenden Rohproduktes column chromatographic purification of the resulting crude product
(Essigester/Heptan-Gradient) konnte 8-[(E)-2-lodvinyl]-2,3,7,9,9-pentamethyl-1 ,4- dioxaspiro[4.5]dec-6-en-8-ol (200 mg, 85 % der Theorie) in Form eines schwach gelblichen Feststoffs erhalten werden. 1H-NMR (400 MHz, CDCI3 δ, ppm) 6.51 (d, 1 H), 6.33 (d, 1 H), 5.44 (s, 1 H), 4.22 (m, 1 H), 3.62 / 3.55 (m, 1 H), 1 .92 (d, 1 H), 1 .80 (d, 1 H), 1.68 (s, 3H), 1.24 (m, 3H), 1 .15 (m, 3H), 1 .07 (s, 3H), 0.92 (s, 3H). (Ethyl acetate / heptane gradient), 8 - [(E) -2-iodovinyl] -2,3,7,9,9-pentamethyl-1,4-dioxaspiro [4.5] dec-6-en-8-ol ( 200 mg, 85% of theory) in the form of a pale yellowish solid. 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 6.51 (d, 1H), 6.33 (d, 1H), 5.44 (s, 1H), 4.22 (m, 1H), 3.62 / 3.55 ( m, 1H), 1 .92 (d, 1H), 1 .80 (d, 1H), 1.68 (s, 3H), 1.24 (m, 3H), 1 .15 (m, 3H), 1 .07 (s, 3H), 0.92 (s, 3H).
In Analogie zu oben angeführten Herstellungsbeispielen und unter Berücksichtigung der allgemeinen Angaben zur Herstellung von substituierten Vinyl- und Alkinyl- cyclohexenolen der allgemeinen Formel (I) erhält man folgende in den Tabellen 1 bis 5 spezifisch genannten Verbindungen: Tabelle 1: In analogy to the above-mentioned preparation examples and taking into account the general information on the preparation of substituted vinyl and alkynylcyclohexenols of the general formula (I), the following compounds are specifically mentioned in Tables 1 to 5: Table 1:
No. R1 R2 R5 R3 R4 X-Y Q No. R 1 R 2 R 5 R 3 R 4 XY Q
°- ° -
1.1-1 CH3 H H Q-1.1 1.1-1 CH 3 HH-Q 1.1
1.1-2 CH3 H H o=: Q-1.1 1.1-2 CH 3 HH o =: Q-1.1
°- H  ° - H
1.1-3 CH3 H H Q-1.1 1.1-3 CH 3 HH Q-1.1
H  H
H  H
1.1-4 CH3 H H o=: Q-1.1 1.1-4 CH 3 HH o =: Q-1.1
H  H
1.1-5 CH3 H SiEt3 o=: Q-1.1 1.1-5 CH 3 H SiEt 3 o =: Q-1.1
H  H
1.1-6 CH3 H SiEt3 o=: Q-1.1 1.1-6 CH 3 H SiEt 3 o =: Q-1.1
H  H
H °- H ° -
1.1-7 H Q-1.1 1.1-7 H Q-1.1
H~~f\ H ~~ f \
H  H
1.1-8 H o=: Q-1.1  1.1-8 H o =: Q-1.1
H °- H H ° - H
1.1-9 H Q-1.1  1.1-9 H Q-1.1
H~~f\ H ~~ f \
H H
H H H H
1.1-10 H o=: Q-1.1  1.1-10 H o =: Q-1.1
H  H
H  H
1.1-11 SiEt3 o=: Q-1.1 R2 R5 R3 R4 X-Y Q1.1-11 SiEt 3 o =: Q-1.1 R 2 R 5 R 3 R 4 XY Q
H H H H
SiEt3 o=: Q-1.1 SiEt 3 o =: Q-1.1
H  H
°- ° -
H H Q-1.2 H H Q-1.2
H H o=: Q-1.2 H H o =: Q-1.2
°- H  ° - H
H H Q-1.2  H H Q-1.2
H H
HH
H H o=: Q-1.2 H H o =: Q-1.2
H H
H SiEt3 o=: Q-1.2 H SiEt 3 o =: Q-1.2
H H
H SiEt3 o=: Q-1.2 H SiEt 3 o =: Q-1.2
H  H
H °- H ° -
H Q-1.2H Q-1.2
H~~f\ H ~~ f \
H  H
H o=: Q-1.2  H o =: Q-1.2
H °- H H ° - H
H Q-1.2  H Q-1.2
H H
H H H H
H o=: Q-1.2 H o =: Q-1.2
H~~f\ H ~~ f \
H H
H H
SiEt3 o=: Q-1.2 SiEt 3 o =: Q-1.2
H H H H
SiEt3 o=: Q-1.2 SiEt 3 o =: Q-1.2
H  H
°- ° -
H H Q-1.3 H H Q-1.3
H H o=: Q-1.3 R2 R5 R3 R4 X-Y QHH o =: Q-1.3 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.3  H H Q-1.3
H H
HH
H H o=: Q-1.3 H H o =: Q-1.3
H H
H SiEt3 o=: Q-1.3 H SiEt 3 o =: Q-1.3
H H
H SiEt3 o=: Q-1.3 H SiEt 3 o =: Q-1.3
H  H
H °- H ° -
H Q-1.3H Q-1.3
H~~f\ H ~~ f \
H  H
H o=: Q-1.3  H o =: Q-1.3
H °- H H ° - H
H Q-1.3 H Q-1.3
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.3  H o =: Q-1.3
H H
H H
SiEt3 o=: Q-1.3 SiEt 3 o =: Q-1.3
H H H H
SiEt3 o=: Q-1.3 SiEt 3 o =: Q-1.3
H  H
°- ° -
H H Q-1.4 H H Q-1.4
H H o=: Q-1.4 H H o =: Q-1.4
°- H  ° - H
H H Q-1.4  H H Q-1.4
H H
HH
H H o=: Q-1.4 H H o =: Q-1.4
H H
H SiEt3 o=: Q-1.4 R2 R5 R3 R4 X-Y Q H SiEt 3 o =: Q-1.4 R 2 R 5 R 3 R 4 XY Q
H H
H SiEt3 o=: Q-1.4 H SiEt 3 o =: Q-1.4
H  H
H °- H ° -
H Q-1.4H Q-1.4
H~~f\ H ~~ f \
H  H
H o=: Q-1.4 H o =: Q-1.4
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.4 H Q-1.4
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.4  H o =: Q-1.4
H H
H H
SiEt3 o=: Q-1.4SiEt 3 o =: Q-1.4
H~~f\ H ~~ f \
H H  H H
SiEt3 o=: Q-1.4 SiEt 3 o =: Q-1.4
H  H
°- ° -
H H Q-1.5 H H Q-1.5
H H o=: Q-1.5 H H o =: Q-1.5
°- H  ° - H
H H Q-1.5  H H Q-1.5
H H
HH
H H o=: Q-1.5 H H o =: Q-1.5
H H
H SiEt3 o=: Q-1.5 H SiEt 3 o =: Q-1.5
H H
H SiEt3 o=: Q-1.5 H SiEt 3 o =: Q-1.5
H  H
H °- H ° -
H Q-1.5 R2 R5 R3 R4 X-Y QH Q-1.5 R 2 R 5 R 3 R 4 XY Q
H H
H o=: Q-1.5 H o =: Q-1.5
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.5 H Q-1.5
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.5 H o =: Q-1.5
H~~f\ H ~~ f \
H H
H H
SiEt3 o=: Q-1.5SiEt 3 o =: Q-1.5
H~~f\ H ~~ f \
H H  H H
SiEt3 o=: Q-1.5 SiEt 3 o =: Q-1.5
H  H
°- ° -
H H Q-1.6 H H Q-1.6
H H o=: Q-1.6 H H o =: Q-1.6
°- H  ° - H
H H Q-1.6  H H Q-1.6
H H
HH
H H o=: Q-1.6 H H o =: Q-1.6
H H
H SiEt3 o=: Q-1.6 H SiEt 3 o =: Q-1.6
H H
H SiEt3 o=: Q-1.6 H SiEt 3 o =: Q-1.6
H  H
H °- H ° -
H Q-1.6 H Q-1.6
H H
H o=: Q-1.6  H o =: Q-1.6
H °- H H ° - H
H Q-1.6  H Q-1.6
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H H H H
H o=: Q-1.6 H o =: Q-1.6
H~~f\ H ~~ f \
H H
H H
SiEt3 o=: Q-1.6SiEt 3 o =: Q-1.6
H~~f\ H ~~ f \
H H  H H
SiEt3 o=: Q-1.6 SiEt 3 o =: Q-1.6
H  H
°- ° -
H H Q-1.7 H H Q-1.7
H H o=: Q-1.7 H H o =: Q-1.7
°- H  ° - H
H H Q-1.7  H H Q-1.7
H H
HH
H H o=: Q-1.7 H H o =: Q-1.7
H H
H SiEt3 o=: Q-1.7 H SiEt 3 o =: Q-1.7
H H
H SiEt3 o=: Q-1.7 H SiEt 3 o =: Q-1.7
H  H
H °- H ° -
H Q-1.7 H Q-1.7
H H
H o=: Q-1.7 H o =: Q-1.7
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.7  H Q-1.7
H H
H H H H
H o=: Q-1.7  H o =: Q-1.7
H H
H H
SiEt3 o=: Q-1.7 R2 R5 R3 R4 X-Y QSiEt 3 o =: Q-1.7 R 2 R 5 R 3 R 4 XY Q
H H H H
SiEt3 o=: Q-1.7 SiEt 3 o =: Q-1.7
H  H
°- ° -
H H Q-1.8 H H Q-1.8
H H o=: Q-1.8 H H o =: Q-1.8
°- H  ° - H
H H Q-1.8  H H Q-1.8
H H
HH
H H o=: Q-1.8 H H o =: Q-1.8
H H
H SiEt3 o=: Q-1.8 H SiEt 3 o =: Q-1.8
H H
H SiEt3 o=: Q-1.8 H SiEt 3 o =: Q-1.8
H  H
H °- H ° -
H Q-1.8H Q-1.8
H~~f\ H ~~ f \
H  H
H o=: Q-1.8  H o =: Q-1.8
H °- H H ° - H
H Q-1.8  H Q-1.8
H H
H H H H
H o=: Q-1.8 H o =: Q-1.8
H~~f\ H ~~ f \
H H
H H
SiEt3 o=: Q-1.8 SiEt 3 o =: Q-1.8
H H H H
SiEt3 o=: Q-1.8 SiEt 3 o =: Q-1.8
H  H
°- ° -
H H Q-1.9 H H Q-1.9
H H o=: Q-1.9 R2 R5 R3 R4 X-Y QHH o =: Q-1.9 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.9  H H Q-1.9
H H
HH
H H o=: Q-1.9 H H o =: Q-1.9
H H
H SiEt3 o=: Q-1.9 H SiEt 3 o =: Q-1.9
H H
H SiEt3 o=: Q-1.9 H SiEt 3 o =: Q-1.9
H  H
H °- H ° -
H Q-1.9H Q-1.9
H~~f\ H ~~ f \
H  H
H o=: Q-1.9  H o =: Q-1.9
H °- H H ° - H
H Q-1.9 H Q-1.9
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.9  H o =: Q-1.9
H H
H H
SiEt3 o=: Q-1.9 SiEt 3 o =: Q-1.9
H H H H
SiEt3 o=: Q-1.9 SiEt 3 o =: Q-1.9
H  H
°- ° -
H H Q-1.10 H H Q-1.10
H H o=: Q-1.10 H H o =: Q-1.10
°- H  ° - H
H H Q-1.10  H H Q-1.10
H H
HH
H H o=: Q-1.10 H H o =: Q-1.10
H H
H SiEt3 o=: Q-1.10 R2 R5 R3 R4 X-Y Q H SiEt 3 o =: Q-1.10 R 2 R 5 R 3 R 4 XY Q
H H
H SiEt3 o=: Q-1.10 H SiEt 3 o =: Q-1.10
H  H
H °- H ° -
H Q-1.10H Q-1.10
H~~f\ H ~~ f \
H  H
H o=: Q-1.10 H o =: Q-1.10
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.10 H Q-1.10
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.10  H o =: Q-1.10
H H
H H
SiEt3 o=: Q-1.10SiEt 3 o =: Q-1.10
H~~f\ H ~~ f \
H H  H H
SiEt3 o=: Q-1.10 SiEt 3 o =: Q-1.10
H  H
°- ° -
H H Q-1.11 H H Q-1.11
H H o=: Q-1.11 H H o =: Q-1.11
°- H  ° - H
H H Q-1.11  H H Q-1.11
H H
HH
H H o=: Q-1.11 H H o =: Q-1.11
H H
H SiEt3 o=: Q-1.11 H SiEt 3 o =: Q-1.11
H H
H SiEt3 o=: Q-1.11 H SiEt 3 o =: Q-1.11
H  H
H °- H ° -
H Q-1.11 R2 R5 R3 R4 X-Y QH Q-1.11 R 2 R 5 R 3 R 4 XY Q
H H
H o=: Q-1.11 H o =: Q-1.11
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.11 H Q-1.11
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.11 H o =: Q-1.11
H~~f\ H ~~ f \
H H
H H
SiEt3 o=: Q-1.11SiEt 3 o =: Q-1.11
H~~f\ H ~~ f \
H H  H H
SiEt3 o=: Q-1.11 SiEt 3 o =: Q-1.11
H  H
°- ° -
H H Q-1.12 H H Q-1.12
H H o=: Q-1.12 H H o =: Q-1.12
°- H  ° - H
H H Q-1.12  H H Q-1.12
H H
HH
H H o=: Q-1.12 H H o =: Q-1.12
H H
H SiEt3 o=: Q-1.12 H SiEt 3 o =: Q-1.12
H H
H SiEt3 o=: Q-1.12 H SiEt 3 o =: Q-1.12
H  H
H °- H ° -
H Q-1.12 H Q-1.12
H H
H o=: Q-1.12  H o =: Q-1.12
H °- H H ° - H
H Q-1.12  H Q-1.12
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H H H H
H o=: Q-1.12 H o =: Q-1.12
H~~f\ H ~~ f \
H H
H H
SiEt3 o=: Q-1.12SiEt 3 o =: Q-1.12
H~~f\ H ~~ f \
H H  H H
SiEt3 o=: Q-1.12 SiEt 3 o =: Q-1.12
H  H
°- ° -
H H Q-1.13 H H Q-1.13
H H o=: Q-1.13 H H o =: Q-1.13
°- H  ° - H
H H Q-1.13  H H Q-1.13
H H
HH
H H o=: Q-1.13 H H o =: Q-1.13
H H
H SiEt3 o=: Q-1.13 H SiEt 3 o =: Q-1.13
H H
H SiEt3 o=: Q-1.13 H SiEt 3 o =: Q-1.13
H  H
H °- H ° -
H Q-1.13 H Q-1.13
H H
H o=: Q-1.13 H o =: Q-1.13
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.13  H Q-1.13
H H
H H H H
H o=: Q-1.13  H o =: Q-1.13
H H
H H
SiEt3 o=: Q-1.13 R2 R5 R3 R4 X-Y QSiEt 3 o =: Q-1.13 R 2 R 5 R 3 R 4 XY Q
H H H H
SiEt3 o=: Q-1.13 SiEt 3 o =: Q-1.13
H  H
°- ° -
H H Q-1.14 H H Q-1.14
H H o=: Q-1.14 H H o =: Q-1.14
°- H  ° - H
H H Q-1.14  H H Q-1.14
H H
HH
H H o=: Q-1.14 H H o =: Q-1.14
H H
H SiEt3 o=: Q-1.14 H SiEt 3 o =: Q-1.14
H H
H SiEt3 o=: Q-1.14 H SiEt 3 o =: Q-1.14
H  H
H °- H ° -
H Q-1.14H Q-1.14
H~~f\ H ~~ f \
H  H
H o=: Q-1.14  H o =: Q-1.14
H °- H H ° - H
H Q-1.14  H Q-1.14
H H
H H H H
H o=: Q-1.14 H o =: Q-1.14
H~~f\ H ~~ f \
H H
H H
SiEt3 o=: Q-1.14 SiEt 3 o =: Q-1.14
H H H H
SiEt3 o=: Q-1.14 SiEt 3 o =: Q-1.14
H  H
°- ° -
H H Q-1.15 H H Q-1.15
H H o=: Q-1.15 R2 R5 R3 R4 X-Y QHH o =: Q-1.15 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.15  H H Q-1.15
H H
HH
H H o=: Q-1.15 H H o =: Q-1.15
H H
H SiEt3 o=: Q-1.15 H SiEt 3 o =: Q-1.15
H H
H SiEt3 o=: Q-1.15 H SiEt 3 o =: Q-1.15
H  H
H °- H ° -
H Q-1.15H Q-1.15
H~~f\ H ~~ f \
H  H
H o=: Q-1.15  H o =: Q-1.15
H °- H H ° - H
H Q-1.15 H Q-1.15
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.15  H o =: Q-1.15
H H
H H
SiEt3 o=: Q-1.15 SiEt 3 o =: Q-1.15
H H H H
SiEt3 o=: Q-1.15 SiEt 3 o =: Q-1.15
H  H
°- ° -
H H Q-1.16 H H Q-1.16
H H o=: Q-1.16 H H o =: Q-1.16
°- H  ° - H
H H Q-1.16  H H Q-1.16
H H
HH
H H o=: Q-1.16 H H o =: Q-1.16
H H
H SiEt3 o=: Q-1.16 R2 R5 R3 R4 X-Y Q H SiEt 3 o =: Q-1.16 R 2 R 5 R 3 R 4 XY Q
H H
H SiEt3 o=: Q-1.16 H SiEt 3 o =: Q-1.16
H  H
H °- H ° -
H Q-1.16H Q-1.16
H~~f\ H ~~ f \
H  H
H o=: Q-1.16 H o =: Q-1.16
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.16 H Q-1.16
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.16  H o =: Q-1.16
H H
H H
SiEt3 o=: Q-1.16SiEt 3 o =: Q-1.16
H~~f\ H ~~ f \
H H  H H
SiEt3 o=: Q-1.16 SiEt 3 o =: Q-1.16
H  H
°- ° -
H H Q-1.19 H H Q-1.19
H H o=: Q-1.19 H H o =: Q-1.19
°- H  ° - H
H H Q-1.19  H H Q-1.19
H H
HH
H H o=: Q-1.19 H H o =: Q-1.19
H  H
H °- H ° -
H Q-1.19 H Q-1.19
H H
H o=: Q-1.19 H o =: Q-1.19
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.19  H Q-1.19
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H H H H
H o=: Q-1.19  H o =: Q-1.19
H  H
°- ° -
H H Q-1.20 H H Q-1.20
H H o=: Q-1.20 H H o =: Q-1.20
°- H  ° - H
H H Q-1.20  H H Q-1.20
H H
HH
H H o=: Q-1.20 H H o =: Q-1.20
H  H
H °- H ° -
H Q-1.20 H Q-1.20
H H
H o=: Q-1.20  H o =: Q-1.20
H °- H H ° - H
H Q-1.20 H Q-1.20
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.20  H o =: Q-1.20
H  H
°- ° -
H H Q-1.21 H H Q-1.21
H H o=: Q-1.21 H H o =: Q-1.21
°- H  ° - H
H H Q-1.21  H H Q-1.21
H H
HH
H H o=: Q-1.21 H H o =: Q-1.21
H  H
H °- H ° -
H Q-1.21 R2 R5 R3 R4 X-Y QH Q-1.21 R 2 R 5 R 3 R 4 XY Q
H H
H o=: Q-1.21 H o =: Q-1.21
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.21 H Q-1.21
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.21  H o =: Q-1.21
H  H
°- ° -
H H Q-1.22 H H Q-1.22
H H o=: Q-1.22 H H o =: Q-1.22
°- H  ° - H
H H Q-1.22  H H Q-1.22
H H
HH
H H o=: Q-1.22 H H o =: Q-1.22
H  H
H °- H ° -
H Q-1.22H Q-1.22
H~~f\ H ~~ f \
H  H
H o=: Q-1.22  H o =: Q-1.22
H °- H H ° - H
H Q-1.22 H Q-1.22
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.22  H o =: Q-1.22
H  H
°- ° -
H H Q-1.23 H H Q-1.23
H H o=: Q-1.23 H H o =: Q-1.23
°- H  ° - H
H H Q-1.23  H H Q-1.23
H R2 R5 R3 R4 X-Y Q H R 2 R 5 R 3 R 4 XY Q
H H
H H o=: Q-1.23 H H o =: Q-1.23
H  H
H °- H ° -
H X-Y-1 Q-1.23H X-Y-1 Q-1.23
H~~f\ H ~~ f \
H  H
H o=: Q-1.23 H o =: Q-1.23
H~~f\ H ~~ f \
H °- H ° -
H Q-1.23H Q-1.23
H~~f\ H ~~ f \
H H  H H
H o=: Q-1.23  H o =: Q-1.23
H H
HH
H H Q-1.24 H H Q-1.24
H H
H H o=: Q-1.24 H H o =: Q-1.24
°- H  ° - H
H H Q-1.24  H H Q-1.24
H H
HH
H H o=: Q-1.24 H H o =: Q-1.24
H  H
H °- H ° -
H Q-1.24 H Q-1.24
H H
H o=: Q-1.24 H o =: Q-1.24
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.24  H Q-1.24
H H
H H H H
H o=: Q-1.24  H o =: Q-1.24
H  H
°- ° -
H H Q-1.25 R2 R5 R3 R4 X-Y QHH Q-1.25 R 2 R 5 R 3 R 4 XY Q
H H o=: Q-1.25 H H o =: Q-1.25
°- H  ° - H
H H Q-1.25  H H Q-1.25
H H
HH
H H o=: Q-1.25 H H o =: Q-1.25
H  H
H °- H ° -
H Q-1.25 H Q-1.25
H H
H o=: Q-1.25 H o =: Q-1.25
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.25  H Q-1.25
H H
H H H H
H o=: Q-1.25  H o =: Q-1.25
H  H
°- ° -
H H Q-1.26 H H Q-1.26
H H o=: Q-1.26 H H o =: Q-1.26
°- H  ° - H
H H Q-1.26  H H Q-1.26
H H
HH
H H o=: Q-1.26 H H o =: Q-1.26
H  H
H °- H ° -
H Q-1.26H Q-1.26
H~~f\ H ~~ f \
H  H
H o=: Q-1.26  H o =: Q-1.26
H °- H H ° - H
H Q-1.26  H Q-1.26
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H H H H
H o=: Q-1.26  H o =: Q-1.26
H  H
°- ° -
H H Q-1.28 H H Q-1.28
H H o=: Q-1.28 H H o =: Q-1.28
°- H  ° - H
H H Q-1.28  H H Q-1.28
H H
HH
H H o=: Q-1.28 H H o =: Q-1.28
H  H
H °- H ° -
H Q-1.28 H Q-1.28
H H
H o=: Q-1.28  H o =: Q-1.28
H °- H H ° - H
H Q-1.28 H Q-1.28
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.28  H o =: Q-1.28
H  H
°- ° -
H H Q-1.29 H H Q-1.29
H H o=: Q-1.29 H H o =: Q-1.29
°- H  ° - H
H H Q-1.29  H H Q-1.29
H H
HH
H H o=: Q-1.29 H H o =: Q-1.29
H  H
H °- H ° -
H Q-1.29 R2 R5 R3 R4 X-Y QH Q-1.29 R 2 R 5 R 3 R 4 XY Q
H H
H o=: Q-1.29 H o =: Q-1.29
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.29 H Q-1.29
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.29  H o =: Q-1.29
H  H
°- ° -
H H Q-1.31 HH Q-1.31
H H o=: Q-1.31 H H o =: Q-1.31
°- H  ° - H
H H Q-1.31  HH Q-1.31
H H
HH
H H o=: Q-1.31 H H o =: Q-1.31
H  H
H °- H ° -
H Q-1.31H Q-1.31
H~~f\ H ~~ f \
H  H
H o=: Q-1.31  H o =: Q-1.31
H °- H H ° - H
H Q-1.31 H Q-1.31
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.31  H o =: Q-1.31
H  H
°- ° -
H H Q-1.32 H H Q-1.32
H H o=: Q-1.32 H H o =: Q-1.32
°- H  ° - H
H H Q-1.32  H H Q-1.32
H R2 R5 R3 R4 X-Y Q H R 2 R 5 R 3 R 4 XY Q
H H
H H o=: Q-1.32 H H o =: Q-1.32
H  H
H °- H ° -
H Q-1.32H Q-1.32
H~~f\ H ~~ f \
H  H
H o=: Q-1.32 H o =: Q-1.32
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.32 H Q-1.32
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.32  H o =: Q-1.32
H  H
°- ° -
H H Q-1.33 H H Q-1.33
H H o=: Q-1.33 H H o =: Q-1.33
°- H  ° - H
H H Q-1.33  H H Q-1.33
H H
HH
H H o=: Q-1.33 H H o =: Q-1.33
H  H
H °- H ° -
H Q-1.33 H Q-1.33
H H
H o=: Q-1.33 H o =: Q-1.33
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.33  H Q-1.33
H H
H H H H
H o=: Q-1.33  H o =: Q-1.33
H  H
°- ° -
H H Q-1.34 R2 R5 R3 R4 X-Y QHH Q-1.34 R 2 R 5 R 3 R 4 XY Q
H H o=: Q-1.34 H H o =: Q-1.34
°- H  ° - H
H H Q-1.34  H H Q-1.34
H H
HH
H H o=: Q-1.34 H H o =: Q-1.34
H  H
H °- H ° -
H Q-1.34 H Q-1.34
H H
H o=: Q-1.34 H o =: Q-1.34
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.34  H Q-1.34
H H
H H H H
H o=: Q-1.34  H o =: Q-1.34
H  H
°- ° -
H H Q-1.35 H H Q-1.35
H H o=: Q-1.35 H H o =: Q-1.35
°- H  ° - H
H H Q-1.35  H H Q-1.35
H H
HH
H H o=: Q-1.35 H H o =: Q-1.35
H  H
H °- H ° -
H Q-1.35H Q-1.35
H~~f\ H ~~ f \
H  H
H o=: Q-1.35  H o =: Q-1.35
H °- H H ° - H
H Q-1.35  H Q-1.35
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H H H H
H o=: Q-1.35  H o =: Q-1.35
H H
H SiEt3 o=: Q-1.35 H SiEt 3 o =: Q-1.35
H H
H SiEt3 o=: Q-1.35 H SiEt 3 o =: Q-1.35
H  H
°- ° -
H H Q-1.37 H H Q-1.37
H H o=: Q-1.37 H H o =: Q-1.37
°- H  ° - H
H H Q-1.37  H H Q-1.37
H H
HH
H H o=: Q-1.37 H H o =: Q-1.37
H  H
H °- H ° -
H Q-1.37H Q-1.37
H~~f\ H ~~ f \
H  H
H o=: Q-1.37  H o =: Q-1.37
H °- H H ° - H
H Q-1.37  H Q-1.37
H H
H H H H
H o=: Q-1.37  H o =: Q-1.37
H  H
°- ° -
H H Q-1.38 H H Q-1.38
H H o=: Q-1.38 H H o =: Q-1.38
°- H  ° - H
H H Q-1.38  H H Q-1.38
H H
HH
H H o=: Q-1.38 H H o =: Q-1.38
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.38H Q-1.38
H~~f\ H ~~ f \
H  H
H o=: Q-1.38 H o =: Q-1.38
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.38 H Q-1.38
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.38  H o =: Q-1.38
H  H
°- ° -
H H Q-1.43 H H Q-1.43
H H o=: Q-1.43 H H o =: Q-1.43
°- H  ° - H
H H Q-1.43  H H Q-1.43
H H
HH
H H o=: Q-1.43 H H o =: Q-1.43
H  H
H °- H ° -
H Q-1.43 H Q-1.43
H H
H o=: Q-1.43 H o =: Q-1.43
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.43  H Q-1.43
H H
H H H H
H o=: Q-1.43  H o =: Q-1.43
H  H
°- ° -
H H Q-1.44 H H Q-1.44
H H o=: Q-1.44 R2 R5 R3 R4 X-Y QHH o =: Q-1.44 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.44  H H Q-1.44
H H
HH
H H o=: Q-1.44 H H o =: Q-1.44
H  H
H °- H ° -
H Q-1.44H Q-1.44
H~~f\ H ~~ f \
H  H
H o=: Q-1.44 H o =: Q-1.44
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.44  H Q-1.44
H H
H H H H
H o=: Q-1.44  H o =: Q-1.44
H  H
°- ° -
H H Q-1.46 H H Q-1.46
H H o=: Q-1.46 H H o =: Q-1.46
°- H  ° - H
H H Q-1.46  H H Q-1.46
H H
HH
H H o=: Q-1.46 H H o =: Q-1.46
H  H
H °- H ° -
H Q-1.46H Q-1.46
H~~f\ H ~~ f \
H  H
H o=: Q-1.46  H o =: Q-1.46
H °- H H ° - H
H Q-1.46  H Q-1.46
H H
H H H H
H o=: Q-1.46  H o =: Q-1.46
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.49 HH Q-1.49
H H o=: Q-1.49 H H o =: Q-1.49
°- H  ° - H
H H Q-1.49  HH Q-1.49
H H
HH
H H o=: Q-1.49 H H o =: Q-1.49
H  H
H °- H ° -
H Q-1.49H Q-1.49
H~~f\ H ~~ f \
H  H
H o=: Q-1.49  H o =: Q-1.49
H °- H H ° - H
H Q-1.49  H Q-1.49
H H
H H H H
H o=: Q-1.49  H o =: Q-1.49
H  H
°- ° -
H H Q-1.50 H H Q-1.50
H H o=: Q-1.50 H H o =: Q-1.50
°- H  ° - H
H H Q-1.50  H H Q-1.50
H H
HH
H H o=: Q-1.50 H H o =: Q-1.50
H  H
H °- H ° -
H Q-1.50 H Q-1.50
H H
H o=: Q-1.50 R2 R5 R3 R4 X-Y QH o =: Q-1.50 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.50 H Q-1.50
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.50  H o =: Q-1.50
H  H
°- ° -
H H Q-1.52 H H Q-1.52
H H o=: - Q-1.52 H H o =: - Q-1.52
°- H  ° - H
H H Q-1.52  H H Q-1.52
H H
HH
H H o=: Q-1.52 H H o =: Q-1.52
H  H
H °- H ° -
H Q-1.52 H Q-1.52
H H
H o=: Q-1.52 H o =: Q-1.52
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.52  H Q-1.52
H H
H H H H
H o=: Q-1.52  H o =: Q-1.52
H  H
°- ° -
H H Q-1.55 H H Q-1.55
H H o=: Q-1.55 H H o =: Q-1.55
°- H  ° - H
H H Q-1.55  H H Q-1.55
H H
HH
H H o=: Q-1.55 H H o =: Q-1.55
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.55H Q-1.55
H~~f\ H ~~ f \
H  H
H o=: Q-1.55 H o =: Q-1.55
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.55 H Q-1.55
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.55  H o =: Q-1.55
H  H
°- ° -
H H Q-1.56 H H Q-1.56
H H o=: Q-1.56 H H o =: Q-1.56
°- H  ° - H
H H Q-1.56  H H Q-1.56
H H
HH
H H o=: Q-1.56 H H o =: Q-1.56
H  H
H °- H ° -
H Q-1.56 H Q-1.56
H H
H o=: Q-1.56 H o =: Q-1.56
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.56  H Q-1.56
H H
H H H H
H o=: Q-1.56  H o =: Q-1.56
H  H
°- ° -
H H Q-1.61 H H Q-1.61
H H o=: Q-1.61 R2 R5 R3 R4 X-Y QHH o =: Q-1.61 R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.61H Q-1.61
H~~f\ H ~~ f \
H  H
H o=: Q-1.61 H o =: Q-1.61
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.61 H Q-1.61
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.61  H o =: Q-1.61
H  H
°- ° -
H H Q-1.62 H H Q-1.62
H H o=: Q-1.62 H H o =: Q-1.62
°- H  ° - H
H H Q-1.62  H H Q-1.62
H H
HH
H H o=: Q-1.62 H H o =: Q-1.62
H  H
H °- H ° -
H Q-1.62 H Q-1.62
H H
H o=: Q-1.62 H o =: Q-1.62
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.62  H Q-1.62
H H
H H H H
H o=: Q-1.62  H o =: Q-1.62
H  H
°- ° -
H H Q-1.64 H H Q-1.64
H H o=: Q-1.64 R2 R5 R3 R4 X-Y QHH o =: Q-1.64 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.64  H H Q-1.64
H H
HH
H H o=: Q-1.64 H H o =: Q-1.64
H  H
H °- H ° -
H Q-1.64H Q-1.64
H~~f\ H ~~ f \
H  H
H o=: Q-1.64 H o =: Q-1.64
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.64  H Q-1.64
H H
H H H H
H o=: Q-1.64  H o =: Q-1.64
H  H
°- ° -
H H Q-1.65 H H Q-1.65
H H o=: Q-1.65 H H o =: Q-1.65
°- H  ° - H
H H Q-1.65  H H Q-1.65
H H
HH
H H o=: Q-1.65 H H o =: Q-1.65
H  H
H °- H ° -
H Q-1.65H Q-1.65
H~~f\ H ~~ f \
H  H
H o=: Q-1.65  H o =: Q-1.65
H °- H H ° - H
H Q-1.65  H Q-1.65
H H
H H H H
H o=: Q-1.65  H o =: Q-1.65
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.67 H H Q-1.67
H H o=: Q-1.67 H H o =: Q-1.67
°- H  ° - H
H H Q-1.67  H H Q-1.67
H H
HH
H H o=: Q-1.67 H H o =: Q-1.67
H  H
H °- H ° -
H Q-1.67H Q-1.67
H~~f\ H ~~ f \
H  H
H o=: Q-1.67  H o =: Q-1.67
H °- H H ° - H
H Q-1.67  H Q-1.67
H H
H H H H
H o=: Q-1.67  H o =: Q-1.67
H  H
°- ° -
H H Q-1.68 H H Q-1.68
H H o=: Q-1.68 H H o =: Q-1.68
°- H  ° - H
H H Q-1.68  H H Q-1.68
H H
HH
H H o=: Q-1.68 H H o =: Q-1.68
H  H
H °- H ° -
H Q-1.68 H Q-1.68
H H
H o=: Q-1.68 R2 R5 R3 R4 X-Y QH o =: Q-1.68 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.68 H Q-1.68
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.68  H o =: Q-1.68
H  H
°- ° -
H H Q-1.71 H H Q-1.71
H H o=: - Q-1.71 H H o =: - Q-1.71
°- H  ° - H
H H Q-1.71  H H Q-1.71
H H
HH
H H o=: Q-1.71 H H o =: Q-1.71
H  H
H °- H ° -
H Q-1.71 H Q-1.71
H H
H o=: Q-1.71 H o =: Q-1.71
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.71  H Q-1.71
H H
H H H H
H o=: Q-1.71  H o =: Q-1.71
H  H
°- ° -
H H Q-1.73 H H Q-1.73
H H o=: Q-1.73 H H o =: Q-1.73
°- H  ° - H
H H Q-1.73  H H Q-1.73
H H
HH
H H o=: Q-1.73 H H o =: Q-1.73
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.73H Q-1.73
H~~f\ H ~~ f \
H  H
H o=: Q-1.73 H o =: Q-1.73
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.73 H Q-1.73
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.73  H o =: Q-1.73
H  H
°- ° -
H H Q-1.76 H H Q-1.76
H H o=: Q-1.76 H H o =: Q-1.76
°- H  ° - H
H H Q-1.76  H H Q-1.76
H H
HH
H H o=: Q-1.76 H H o =: Q-1.76
H  H
H °- H ° -
H Q-1.76 H Q-1.76
H H
H o=: Q-1.76 H o =: Q-1.76
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.76  H Q-1.76
H H
H H H H
H o=: Q-1.76  H o =: Q-1.76
H  H
°- ° -
H H Q-1.77 H H Q-1.77
H H o=: Q-1.77 R2 R5 R3 R4 X-Y QHH o =: Q-1.77 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.77  H H Q-1.77
H H
HH
H H o=: Q-1.77 H H o =: Q-1.77
H  H
H °- H ° -
H Q-1.77H Q-1.77
H~~f\ H ~~ f \
H  H
H o=: Q-1.77 H o =: Q-1.77
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.77  H Q-1.77
H H
H H H H
H o=: Q-1.77  H o =: Q-1.77
H  H
°- ° -
H H Q-1.79 H H Q-1.79
H H o=: Q-1.79 H H o =: Q-1.79
°- H  ° - H
H H Q-1.79  H H Q-1.79
H H
HH
H H o=: Q-1.79 H H o =: Q-1.79
H  H
H °- H ° -
H Q-1.79H Q-1.79
H~~f\ H ~~ f \
H  H
H o=: Q-1.79  H o =: Q-1.79
H °- H H ° - H
H Q-1.79  H Q-1.79
H H
H H H H
H o=: Q-1.79  H o =: Q-1.79
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.80 H H Q-1.80
H H o=: Q-1.80 H H o =: Q-1.80
°- H  ° - H
H H Q-1.80  H H Q-1.80
H H
HH
H H o=: Q-1.80 H H o =: Q-1.80
H  H
H °- H ° -
H Q-1.80H Q-1.80
H~~f\ H ~~ f \
H  H
H o=: Q-1.80  H o =: Q-1.80
H °- H H ° - H
H Q-1.80  H Q-1.80
H H
H H H H
H o=: Q-1.80  H o =: Q-1.80
H  H
°- ° -
H H Q-1.82 H H Q-1.82
H H o=: Q-1.82 H H o =: Q-1.82
°- H  ° - H
H H Q-1.82  H H Q-1.82
H H
HH
H H o=: Q-1.82 H H o =: Q-1.82
H  H
H °- H ° -
H Q-1.82 H Q-1.82
H H
H o=: Q-1.82 R2 R5 R3 R4 X-Y QH o =: Q-1.82 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.82 H Q-1.82
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.82  H o =: Q-1.82
H  H
°- ° -
H H Q-1.83 H H Q-1.83
H H o=: - Q-1.83 H H o =: - Q-1.83
°- H  ° - H
H H Q-1.83  H H Q-1.83
H H
HH
H H o=: Q-1.83 H H o =: Q-1.83
H  H
H °- H ° -
H Q-1.83 H Q-1.83
H H
H o=: Q-1.83 H o =: Q-1.83
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.83  H Q-1.83
H H
H H H H
H o=: Q-1.83  H o =: Q-1.83
H  H
°- ° -
H H Q-1.85 H H Q-1.85
H H o=: Q-1.85 H H o =: Q-1.85
°- H  ° - H
H H Q-1.85  H H Q-1.85
H H
HH
H H o=: Q-1.85 H H o =: Q-1.85
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.85H Q-1.85
H~~f\ H ~~ f \
H  H
H o=: Q-1.85 H o =: Q-1.85
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.85 H Q-1.85
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.85  H o =: Q-1.85
H  H
°- ° -
H H Q-1.86 H H Q-1.86
H H o=: Q-1.86 H H o =: Q-1.86
°- H  ° - H
H H Q-1.86  H H Q-1.86
H H
HH
H H o=: Q-1.86 H H o =: Q-1.86
H  H
H °- H ° -
H Q-1.86 H Q-1.86
H H
H o=: Q-1.86 H o =: Q-1.86
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.86  H Q-1.86
H H
H H H H
H o=: Q-1.86  H o =: Q-1.86
H  H
°- ° -
H H Q-1.88 H H Q-1.88
H H o=: Q-1.88 R2 R5 R3 R4 X-Y QHH o =: Q-1.88 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.88  H H Q-1.88
H H
HH
H H o=: Q-1.88 H H o =: Q-1.88
H  H
H °- H ° -
H Q-1.88H Q-1.88
H~~f\ H ~~ f \
H  H
H o=: Q-1.88 H o =: Q-1.88
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.88  H Q-1.88
H H
H H H H
H o=: Q-1.88  H o =: Q-1.88
H  H
°- ° -
H H Q-1.89 H H Q-1.89
H H o=: Q-1.89 H H o =: Q-1.89
°- H  ° - H
H H Q-1.89  H H Q-1.89
H H
HH
H H o=: Q-1.89 H H o =: Q-1.89
H  H
H °- H ° -
H Q-1.89H Q-1.89
H~~f\ H ~~ f \
H  H
H o=: Q-1.89  H o =: Q-1.89
H °- H H ° - H
H Q-1.89  H Q-1.89
H H
H H H H
H o=: Q-1.89  H o =: Q-1.89
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.91 H H Q-1.91
H H o=: Q-1.91 H H o =: Q-1.91
°- H  ° - H
H H Q-1.91  H H Q-1.91
H H
HH
H H o=: Q-1.91 H H o =: Q-1.91
H  H
H °- H ° -
H Q-1.91H Q-1.91
H~~f\ H ~~ f \
H  H
H o=: Q-1.91  H o =: Q-1.91
H °- H H ° - H
H Q-1.91  H Q-1.91
H H
H H H H
H o=: Q-1.91  H o =: Q-1.91
H  H
°- ° -
H H Q-1.93 H H Q-1.93
H H o=: Q-1.93 H H o =: Q-1.93
°- H  ° - H
H H Q-1.93  H H Q-1.93
H H
HH
H H o=: Q-1.93 H H o =: Q-1.93
H  H
H °- H ° -
H Q-1.93 H Q-1.93
H H
H o=: Q-1.93 R2 R5 R3 R4 X-Y QH o =: Q-1.93 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.93 H Q-1.93
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.93  H o =: Q-1.93
H  H
°- ° -
H H Q-1.94 H H Q-1.94
H H o=: - Q-1.94 H H o =: - Q-1.94
°- H  ° - H
H H Q-1.94  H H Q-1.94
H H
HH
H H o=: Q-1.94 H H o =: Q-1.94
H  H
H °- H ° -
H Q-1.94 H Q-1.94
H H
H o=: Q-1.94 H o =: Q-1.94
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.94  H Q-1.94
H H
H H H H
H o=: Q-1.94  H o =: Q-1.94
H  H
°- ° -
H H Q-1.97 H H Q-1.97
H H o=: Q-1.97H H o =: Q-1.97
H °-H ° -
H Q-1.97 H Q-1.97
H H
H o=: Q-1.97 R2 R5 R3 R4 X-Y QH o =: Q-1.97 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.97 H Q-1.97
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.97  H o =: Q-1.97
H  H
°- ° -
H H Q-1.98 H H Q-1.98
H H o=: - Q-1.98 H H o =: - Q-1.98
°- H  ° - H
H H Q-1.98  H H Q-1.98
H H
HH
H H o=: Q-1.98 H H o =: Q-1.98
H  H
H °- H ° -
H Q-1.98 H Q-1.98
H H
H o=: Q-1.98 H o =: Q-1.98
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.98  H Q-1.98
H H
H H H H
H o=: Q-1.98  H o =: Q-1.98
H  H
°- ° -
H H Q-1.99 H H Q-1.99
H H o=: Q-1.99 H H o =: Q-1.99
°- H  ° - H
H H Q-1.99  H H Q-1.99
H H
HH
H H o=: Q-1.99 H H o =: Q-1.99
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.99H Q-1.99
H~~f\ H ~~ f \
H  H
H o=: Q-1.99 H o =: Q-1.99
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.99 H Q-1.99
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.99  H o =: Q-1.99
H  H
°- ° -
H H Q-1.100 H H Q-1,100
H H o=: Q-1.100H H o =: Q-1,100
H °-H ° -
H Q-1.100H Q-1.100
H~~f\ ■ ' H ~~ f \ ■ '
H  H
H o=: Q-1.100  H o =: Q-1,100
H °- H H ° - H
H Q-1.100 H Q-1.100
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.100  H o =: Q-1,100
H  H
°- ° -
H H Q-1.101 H H Q-1.101
H H o=: Q-1.101 H H o =: Q-1.101
°- H  ° - H
H H Q-1.101  H H Q-1.101
H H
HH
H H o=: Q-1.101 H H o =: Q-1.101
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.101H Q-1.101
H~~f\ H ~~ f \
H  H
H o=: Q-1.101 H o =: Q-1.101
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.101 H Q-1.101
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.101  H o =: Q-1.101
H  H
°- ° -
H H Q-1.102 H H Q-1.102
H H o=: Q-1.102 H H o =: Q-1.102
°- H  ° - H
H H Q-1.102  H H Q-1.102
H H
HH
H H o=: Q-1.102 H H o =: Q-1.102
H  H
H °- H ° -
H Q-1.102 H Q-1.102
H H
H o=: Q-1.102 H o =: Q-1.102
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.102  H Q-1.102
H H
H H H H
H o=: Q-1.102  H o =: Q-1.102
H  H
°- ° -
H H Q-1.103 H H Q-1.103
H H o=: Q-1.103 R2 R5 R3 R4 X-Y QHH o =: Q-1.103 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.103  H H Q-1.103
H H
HH
H H o=: Q-1.103 H H o =: Q-1.103
H  H
H °- H ° -
H Q-1.103H Q-1.103
H~~f\ H ~~ f \
H  H
H o=: Q-1.103 H o =: Q-1.103
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.103  H Q-1.103
H H
H H H H
H o=: Q-1.103  H o =: Q-1.103
H  H
°- ° -
H H Q-1.104 H H Q-1.104
H H o=: Q-1.104 H H o =: Q-1.104
°- H  ° - H
H H Q-1.104  H H Q-1.104
H H
HH
H H o=: Q-1.104 H H o =: Q-1.104
H  H
H °- H ° -
H Q-1.104H Q-1.104
H~~f\ H ~~ f \
H  H
H o=: Q-1.104  H o =: Q-1.104
H °- H H ° - H
H Q-1.104  H Q-1.104
H H
H H H H
H o=: Q-1.104  H o =: Q-1.104
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.109 H H Q-1.109
H H o=: Q-1.109 H H o =: Q-1.109
°- H  ° - H
H H Q-1.109  H H Q-1.109
H H
HH
H H o=: Q-1.109 H H o =: Q-1.109
H  H
H °- H ° -
H Q-1.109H Q-1.109
H~~f\ H ~~ f \
H  H
H o=: Q-1.109  H o =: Q-1.109
H °- H H ° - H
H Q-1.109  H Q-1.109
H H
H H H H
H o=: Q-1.109  H o =: Q-1.109
H  H
°- ° -
H H Q-1.110 HH Q-1.110
H H o=: Q-1.110 H H o =: Q-1.110
°- H  ° - H
H H Q-1.110  HH Q-1.110
H H
HH
H H o=: Q-1.110 H H o =: Q-1.110
H  H
H °- H ° -
H Q-1.110 H Q-1.110
H H
H o=: Q-1.110 R2 R5 R3 R4 X-Y QH o =: Q-1.110 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.110 H Q-1.110
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.110  H o =: Q-1.110
H  H
°- ° -
H H Q-1.111 H H Q-1,111
H H o=: - Q-1.111 H H o =: - Q-1.111
°- H  ° - H
H H Q-1.111  H H Q-1,111
H H
HH
H H o=: Q-1.111 H H o =: Q-1.111
H  H
H °- H ° -
H Q-1.111 H Q-1,111
H H
H o=: Q-1.111 H o =: Q-1.111
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.111  H Q-1,111
H H
H H H H
H o=: Q-1.111  H o =: Q-1.111
H  H
°- ° -
H H Q-1.112 H H Q-1.112
H H o=: Q-1.112 H H o =: Q-1.112
°- H  ° - H
H H Q-1.112  H H Q-1.112
H H
HH
H H o=: Q-1.112 H H o =: Q-1.112
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.112H Q-1.112
H~~f\ H ~~ f \
H  H
H o=: Q-1.112 H o =: Q-1.112
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.112 H Q-1.112
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.112  H o =: Q-1.112
H  H
°- ° -
H H Q-1.113 H H Q-1,113
H H o=: Q-1.113 H H o =: Q-1,113
°- H  ° - H
H H Q-1.113  H H Q-1,113
H H
HH
H H o=: Q-1.113 H H o =: Q-1,113
H  H
H °- H ° -
H Q-1.113 H Q-1,113
H H
H o=: Q-1.113 H o =: Q-1,113
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.113  H Q-1,113
H H
H H H H
H o=: Q-1.113  H o =: Q-1,113
H  H
°- ° -
H H Q-1.114 H H Q-1,114
H H o=: Q-1.114 R2 R5 R3 R4 X-Y QHH o =: Q-1.114 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.114  H H Q-1,114
H H
HH
H H o=: Q-1.114 H H o =: Q-1.114
H  H
H °- H ° -
H Q-1.114H Q-1,114
H~~f\ H ~~ f \
H  H
H o=: Q-1.114 H o =: Q-1.114
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.114  H Q-1,114
H H
H H H H
H o=: Q-1.114  H o =: Q-1.114
H  H
°- ° -
H H Q-1.115 H H Q-1,115
H H o=: Q-1.115 H H o =: Q-1.115
°- H  ° - H
H H Q-1.115  H H Q-1,115
H H
HH
H H o=: Q-1.115 H H o =: Q-1.115
H  H
H °- H ° -
H Q-1.115H Q-1,115
H~~f\ H ~~ f \
H  H
H o=: Q-1.115  H o =: Q-1.115
H °- H H ° - H
H Q-1.115  H Q-1,115
H H
H H H H
H o=: Q-1.115  H o =: Q-1.115
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.116 H H Q-1,116
H H o=: Q-1.116 H H o =: Q-1.116
°- H  ° - H
H H Q-1.116  H H Q-1,116
H H
HH
H H o=: Q-1.116 H H o =: Q-1.116
H  H
H °- H ° -
H Q-1.116H Q-1,116
H~~f\ H ~~ f \
H  H
H o=: Q-1.116  H o =: Q-1.116
H °- H H ° - H
H Q-1.116  H Q-1,116
H H
H H H H
H o=: Q-1.116  H o =: Q-1.116
H  H
°- ° -
H H Q-1.118 H H Q-1,118
H H o=: Q-1.118 H H o =: Q-1.118
°- H  ° - H
H H Q-1.118  H H Q-1,118
H H
HH
H H o=: Q-1.118 H H o =: Q-1.118
H  H
H °- H ° -
H Q-1.118 H Q-1,118
H H
H o=: Q-1.118 R2 R5 R3 R4 X-Y QH o =: Q-1.118 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.118 H Q-1,118
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.118  H o =: Q-1.118
H  H
°- ° -
H H Q-1.119 H H Q-1,119
H H o=: - Q-1.119 H H o =: - Q-1.119
°- H  ° - H
H H Q-1.119  H H Q-1,119
H H
HH
H H o=: Q-1.119 H H o =: Q-1.119
H  H
H °- H ° -
H Q-1.119 H Q-1,119
H H
H o=: Q-1.119 H o =: Q-1.119
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.119  H Q-1,119
H H
H H H H
H o=: Q-1.119  H o =: Q-1.119
H  H
°- ° -
H H Q-1.121 H H Q-1.121
H H o=: Q-1.121 H H o =: Q-1.121
°- H  ° - H
H H Q-1.121  H H Q-1.121
H H
HH
H H o=: Q-1.121 H H o =: Q-1.121
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.121H Q-1.121
H~~f\ H ~~ f \
H  H
H o=: Q-1.121 H o =: Q-1.121
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.121 H Q-1.121
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.121  H o =: Q-1.121
H  H
°- ° -
H H Q-1.122 H H Q-1.122
H H o=: Q-1.122 H H o =: Q-1.122
°- H  ° - H
H H Q-1.122  H H Q-1.122
H H
HH
H H o=: Q-1.122 H H o =: Q-1.122
H  H
H °- H ° -
H Q-1.122 H Q-1.122
H H
H o=: Q-1.122 H o =: Q-1.122
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.122  H Q-1.122
H H
H H H H
H o=: Q-1.122  H o =: Q-1.122
H  H
°- ° -
H H Q-1.127 H H Q-1.127
H H o=: Q-1.127 R2 R5 R3 R4 X-Y QHH o =: Q-1.127 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.127  H H Q-1.127
H H
HH
H H o=: Q-1.127 H H o =: Q-1.127
H  H
H °- H ° -
H Q-1.127H Q-1.127
H~~f\ H ~~ f \
H  H
H o=: Q-1.127 H o =: Q-1.127
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.127  H Q-1.127
H H
H H H H
H o=: Q-1.127  H o =: Q-1.127
H  H
°- ° -
H H Q-1.130 HH Q-1.130
H H o=: Q-1.130 H H o =: Q-1.130
°- H  ° - H
H H Q-1.130  HH Q-1.130
H H
HH
H H o=: Q-1.130 H H o =: Q-1.130
H  H
H °- H ° -
H Q-1.130H Q-1.130
H~~f\ H ~~ f \
H  H
H o=: Q-1.130  H o =: Q-1.130
H °- H H ° - H
H Q-1.130  H Q-1.130
H H
H H H H
H o=: Q-1.130  H o =: Q-1.130
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.132 H H Q-1.132
H H o=: Q-1.132 H H o =: Q-1.132
°- H  ° - H
H H Q-1.132  H H Q-1.132
H H
HH
H H o=: Q-1.132 H H o =: Q-1.132
H  H
H °- H ° -
H Q-1.132H Q-1,132
H~~f\ H ~~ f \
H  H
H o=: Q-1.132  H o =: Q-1.132
H °- H H ° - H
H Q-1.132  H Q-1,132
H H
H H H H
H o=: Q-1.132  H o =: Q-1.132
H  H
°- ° -
H H Q-1.133 H H Q-1.133
H H o=: Q-1.133 H H o =: Q-1,133
°- H  ° - H
H H Q-1.133  H H Q-1.133
H H
HH
H H o=: Q-1.133 H H o =: Q-1,133
H  H
H °- H ° -
H Q-1.133 H Q-1,133
H H
H o=: Q-1.133 R2 R5 R3 R4 X-Y QH o =: Q-1,133 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.133 H Q-1,133
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.133  H o =: Q-1,133
H  H
°- ° -
H H Q-1.134 HH Q-1.134
H H o=: - Q-1.134 H H o =: - Q-1.134
°- H  ° - H
H H Q-1.134  HH Q-1.134
H H
HH
H H o=: Q-1.134 H H o =: Q-1.134
H  H
H °- H ° -
H Q-1.134 H Q-1,134
H H
H o=: Q-1.134 H o =: Q-1.134
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.134  H Q-1,134
H H
H H H H
H o=: Q-1.134  H o =: Q-1.134
H  H
°- ° -
H H Q-1.139 H H Q-1.139
H H o=: Q-1.139 H H o =: Q-1.139
°- H  ° - H
H H Q-1.139  H H Q-1.139
H H
HH
H H o=: Q-1.139 H H o =: Q-1.139
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.139H Q-1.139
H~~f\ H ~~ f \
H  H
H o=: Q-1.139 H o =: Q-1.139
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.139 H Q-1.139
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.139  H o =: Q-1.139
H  H
°- ° -
H H Q-1.140 H H Q-1,140
H H o=: Q-1.140 H H o =: Q-1,140
°- H  ° - H
H H Q-1.140  H H Q-1,140
H H
HH
H H o=: Q-1.140 H H o =: Q-1,140
H  H
H °- H ° -
H Q-1.140 HQ-1,140
H H
H o=: Q-1.140 H o =: Q-1,140
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.140  HQ-1,140
H H
H H H H
H o=: Q-1.140  H o =: Q-1,140
H  H
°- ° -
H H Q-1.141 HH Q-1.141
H H o=: Q-1.141 R2 R5 R3 R4 X-Y QHH o =: Q-1.141 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.141  HH Q-1.141
H H
HH
H H o=: Q-1.141 H H o =: Q-1.141
H  H
H °- H ° -
H Q-1.141H Q-1,141
H~~f\ H ~~ f \
H  H
H o=: Q-1.141 H o =: Q-1.141
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.141  H Q-1,141
H H
H H H H
H o=: Q-1.141  H o =: Q-1.141
H  H
°- ° -
H H Q-1.145 HH Q-1.145
H H o=: Q-1.145 H H o =: Q-1.145
°- H  ° - H
H H Q-1.145  HH Q-1.145
H H
HH
H H o=: Q-1.145 H H o =: Q-1.145
H  H
H °- H ° -
H Q-1.145H Q-1.145
H~~f\ H ~~ f \
H  H
H o=: Q-1.145  H o =: Q-1.145
H °- H H ° - H
H Q-1.145  H Q-1.145
H H
H H H H
H o=: Q-1.145  H o =: Q-1.145
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.146 H H Q-1,146
H H o=: Q-1.146 H H o =: Q-1.146
°- H  ° - H
H H Q-1.146  H H Q-1,146
H H
HH
H H o=: Q-1.146 H H o =: Q-1.146
H  H
H °- H ° -
H Q-1.146H Q-1,146
H~~f\ H ~~ f \
H  H
H o=: Q-1.146  H o =: Q-1.146
H °- H H ° - H
H Q-1.146  H Q-1,146
H H
H H H H
H o=: Q-1.146  H o =: Q-1.146
H  H
°- ° -
H H Q-1.147 H H Q-1,147
H H o=: Q-1.147 H H o =: Q-1,147
°- H  ° - H
H H Q-1.147  H H Q-1,147
H H
HH
H H o=: Q-1.147 H H o =: Q-1,147
H  H
H °- H ° -
H Q-1.147 H Q-1,147
H H
H o=: Q-1.147 R2 R5 R3 R4 X-Y QH o =: Q-1,147 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.147 H Q-1,147
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.147  H o =: Q-1,147
H  H
°- ° -
H H Q-1.148 H H Q-1,148
H H o=: - Q-1.148 H H o =: - Q-1.148
°- H  ° - H
H H Q-1.148  H H Q-1,148
H H
HH
H H o=: Q-1.148 H H o =: Q-1.148
H  H
H °- H ° -
H Q-1.148 H Q-1,148
H H
H o=: Q-1.148 H o =: Q-1.148
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.148  H Q-1,148
H H
H H H H
H o=: Q-1.148  H o =: Q-1.148
H  H
°- ° -
H H Q-1.151 H H Q-1.151
H H o=: Q-1.151 H H o =: Q-1.151
°- H  ° - H
H H Q-1.151  H H Q-1.151
H H
HH
H H o=: Q-1.151 H H o =: Q-1.151
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.151H Q-1,151
H~~f\ H ~~ f \
H  H
H o=: Q-1.151 H o =: Q-1.151
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.151 H Q-1,151
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.151  H o =: Q-1.151
H  H
°- ° -
H H Q-1.154 H H Q-1,154
H H o=: Q-1.154 H H o =: Q-1.154
°- H  ° - H
H H Q-1.154  H H Q-1,154
H H
HH
H H o=: Q-1.154 H H o =: Q-1.154
H  H
H °- H ° -
H Q-1.154 H Q-1,154
H H
H o=: Q-1.154 H o =: Q-1.154
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.154  H Q-1,154
H H
H H H H
H o=: Q-1.154  H o =: Q-1.154
H  H
°- ° -
H H Q-1.155 H H Q-1.155
H H o=: Q-1.155 R2 R5 R3 R4 X-Y QHH o =: Q-1.155 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.155  H H Q-1.155
H H
HH
H H o=: Q-1.155 H H o =: Q-1.155
H  H
H °- H ° -
H Q-1.155H Q-1,155
H~~f\ H ~~ f \
H  H
H o=: Q-1.155 H o =: Q-1.155
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.155  H Q-1,155
H H
H H H H
H o=: Q-1.155  H o =: Q-1.155
H  H
°- ° -
H H Q-1.157 H H Q-1.157
H H o=: Q-1.157 H H o =: Q-1.157
°- H  ° - H
H H Q-1.157  H H Q-1.157
H H
HH
H H o=: Q-1.157 H H o =: Q-1.157
H  H
H °- H ° -
H Q-1.157H Q-1,157
H~~f\ H ~~ f \
H  H
H o=: Q-1.157  H o =: Q-1.157
H °- H H ° - H
H Q-1.157  H Q-1,157
H H
H H H H
H o=: Q-1.157  H o =: Q-1.157
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.158 H H Q-1.158
H H o=: Q-1.158 H H o =: Q-1.158
°- H  ° - H
H H Q-1.158  H H Q-1.158
H H
HH
H H o=: Q-1.158 H H o =: Q-1.158
H  H
H °- H ° -
H Q-1.158H Q-1,158
H~~f\ H ~~ f \
H  H
H o=: Q-1.158  H o =: Q-1.158
H °- H H ° - H
H Q-1.158  H Q-1,158
H H
H H H H
H o=: Q-1.158  H o =: Q-1.158
H  H
°- ° -
H H Q-1.163 H H Q-1.163
H H o=: Q-1.163 H H o =: Q-1.163
°- H  ° - H
H H Q-1.163  H H Q-1.163
H H
HH
H H o=: Q-1.163 H H o =: Q-1.163
H  H
H °- H ° -
H Q-1.163 H Q-1.163
H H
H o=: Q-1.163 R2 R5 R3 R4 X-Y QH o =: Q-1.163 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.163 H Q-1.163
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.163  H o =: Q-1.163
H  H
°- ° -
H H Q-1.164 H H Q-1.164
H H o=: - Q-1.164 H H o =: - Q-1.164
°- H  ° - H
H H Q-1.164  H H Q-1.164
H H
HH
H H o=: Q-1.164 H H o =: Q-1.164
H  H
H °- H ° -
H Q-1.164 H Q-1.164
H H
H o=: Q-1.164 H o =: Q-1.164
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.164  H Q-1.164
H H
H H H H
H o=: Q-1.164  H o =: Q-1.164
H  H
°- ° -
H H Q-1.166 HH Q-1.166
H H o=: Q-1.166 H H o =: Q-1.166
°- H  ° - H
H H Q-1.166  HH Q-1.166
H H
HH
H H o=: Q-1.166 H H o =: Q-1.166
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.166H Q-1.166
H~~f\ H ~~ f \
H  H
H o=: Q-1.166 H o =: Q-1.166
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.166 H Q-1.166
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.166  H o =: Q-1.166
H  H
°- ° -
H H Q-1.167 H H Q-1.167
H H o=: Q-1.167 H H o =: Q-1.167
°- H  ° - H
H H Q-1.167  H H Q-1.167
H H
HH
H H o=: Q-1.167 H H o =: Q-1.167
H  H
H °- H ° -
H Q-1.167 H Q-1.167
H H
H o=: Q-1.167 H o =: Q-1.167
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.167  H Q-1.167
H H
H H H H
H o=: Q-1.167  H o =: Q-1.167
H  H
°- ° -
H H Q-1.169 HH Q-1.169
H H o=: Q-1.169 R2 R5 R3 R4 X-Y QHH o =: Q-1.169 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.169  HH Q-1.169
H H
HH
H H o=: Q-1.169 H H o =: Q-1.169
H  H
H °- H ° -
H Q-1.169H Q-1.169
H~~f\ H ~~ f \
H  H
H o=: Q-1.169 H o =: Q-1.169
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.169  H Q-1.169
H H
H H H H
H o=: Q-1.169  H o =: Q-1.169
H  H
°- ° -
H H Q-1.170 H H Q-1,170
H H o=: Q-1.170 H H o =: Q-1,170
°- H  ° - H
H H Q-1.170  H H Q-1,170
H H
HH
H H o=: Q-1.170 H H o =: Q-1,170
H  H
H °- H ° -
H Q-1.170HQ-1,170
H~~f\ H ~~ f \
H  H
H o=: Q-1.170  H o =: Q-1,170
H °- H H ° - H
H Q-1.170  HQ-1,170
H H
H H H H
H o=: Q-1.170  H o =: Q-1,170
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.175 H H Q-1.175
H H o=: Q-1.175 H H o =: Q-1.175
°- H  ° - H
H H Q-1.175  H H Q-1.175
H H
HH
H H o=: Q-1.175 H H o =: Q-1.175
H  H
H °- H ° -
H Q-1.175H Q-1.175
H~~f\ H ~~ f \
H  H
H o=: Q-1.175  H o =: Q-1.175
H °- H H ° - H
H Q-1.175  H Q-1.175
H H
H H H H
H o=: Q-1.175  H o =: Q-1.175
H  H
°- ° -
H H Q-1.176 H H Q-1,176
H H o=: Q-1.176 H H o =: Q-1.176
°- H  ° - H
H H Q-1.176  H H Q-1,176
H H
HH
H H o=: Q-1.176 H H o =: Q-1.176
H  H
H °- H ° -
H Q-1.176 H Q-1,176
H H
H o=: Q-1.176 R2 R5 R3 R4 X-Y QH o =: Q-1.176 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.176 H Q-1,176
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.176  H o =: Q-1.176
H  H
°- ° -
H H Q-1.181 H H Q-1.181
H H o=: - Q-1.181 H H o =: - Q-1.181
°- H  ° - H
H H Q-1.181  H H Q-1.181
H H
HH
H H o=: Q-1.181 H H o =: Q-1.181
H  H
H °- H ° -
H Q-1.181 H Q-1,181
H H
H o=: Q-1.181 H o =: Q-1.181
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.181  H Q-1,181
H H
H H H H
H o=: Q-1.181  H o =: Q-1.181
H  H
°- ° -
H H Q-1.182 H H Q-1.182
H H o=: Q-1.182 H H o =: Q-1.182
°- H  ° - H
H H Q-1.182  H H Q-1.182
H H
HH
H H o=: Q-1.182 H H o =: Q-1.182
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.182H Q-1.182
H~~f\ H ~~ f \
H  H
H o=: Q-1.182 H o =: Q-1.182
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.182 H Q-1.182
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.182  H o =: Q-1.182
H  H
°- ° -
H H Q-1.184 H H Q-1.184
H H o=: Q-1.184 H H o =: Q-1.184
°- H  ° - H
H H Q-1.184  H H Q-1.184
H H
HH
H H o=: Q-1.184 H H o =: Q-1.184
H  H
H °- H ° -
H Q-1.184 H Q-1,184
H H
H o=: Q-1.184 H o =: Q-1.184
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.184  H Q-1,184
H H
H H H H
H o=: Q-1.184  H o =: Q-1.184
H  H
°- ° -
H H Q-1.185 H H Q-1.185
H H o=: Q-1.185 R2 R5 R3 R4 X-Y QHH o =: Q-1.185 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.185  H H Q-1.185
H H
HH
H H o=: Q-1.185 H H o =: Q-1.185
H  H
H °- H ° -
H Q-1.185H Q-1,185
H~~f\ H ~~ f \
H  H
H o=: Q-1.185 H o =: Q-1.185
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.185  H Q-1,185
H H
H H H H
H o=: Q-1.185  H o =: Q-1.185
H  H
°- ° -
H H Q-1.190 H H Q-1,190
H H o=: Q-1.190 H H o =: Q-1.190
°- H  ° - H
H H Q-1.190  H H Q-1,190
H H
HH
H H o=: Q-1.190 H H o =: Q-1.190
H  H
H °- H ° -
H Q-1.190H Q-1,190
H~~f\ H ~~ f \
H  H
H o=: Q-1.190  H o =: Q-1.190
H °- H H ° - H
H Q-1.190  H Q-1,190
H H
H H H H
H o=: Q-1.190  H o =: Q-1.190
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.191 H H Q-1.191
H H o=: Q-1.191 H H o =: Q-1.191
°- H  ° - H
H H Q-1.191  H H Q-1.191
H H
HH
H H o=: Q-1.191 H H o =: Q-1.191
H  H
H °- H ° -
H Q-1.191H Q-1,191
H~~f\ H ~~ f \
H  H
H o=: Q-1.191  H o =: Q-1.191
H °- H H ° - H
H Q-1.191  H Q-1,191
H H
H H H H
H o=: Q-1.191  H o =: Q-1.191
H  H
°- ° -
H H Q-1.192 HH Q-1.192
H H o=: Q-1.192 H H o =: Q-1.192
°- H  ° - H
H H Q-1.192  HH Q-1.192
H H
HH
H H o=: Q-1.192 H H o =: Q-1.192
H  H
H °- H ° -
H Q-1.192 H Q-1.192
H H
H o=: Q-1.192 R2 R5 R3 R4 X-Y QH o =: Q-1.192 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.192 H Q-1.192
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.192  H o =: Q-1.192
H  H
°- ° -
H H Q-1.193 H H Q-1.193
H H o=: - Q-1.193 H H o =: - Q-1.193
°- H  ° - H
H H Q-1.193  H H Q-1.193
H H
HH
H H o=: Q-1.193 H H o =: Q-1.193
H  H
H °- H ° -
H Q-1.193 H Q-1,193
H H
H o=: Q-1.193 H o =: Q-1.193
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.193  H Q-1,193
H H
H H H H
H o=: Q-1.193  H o =: Q-1.193
H  H
°- ° -
H H Q-1.196 H H Q-1,196
H H o=: Q-1.196 H H o =: Q-1.196
°- H  ° - H
H H Q-1.196  H H Q-1,196
H H
HH
H H o=: Q-1.196 H H o =: Q-1.196
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.196H Q-1,196
H~~f\ H ~~ f \
H  H
H o=: Q-1.196 H o =: Q-1,196
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.196 H Q-1,196
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.196  H o =: Q-1,196
H  H
°- ° -
H H Q-1.199 H H Q-1.199
H H o=: Q-1.199 H H o =: Q-1.199
°- H  ° - H
H H Q-1.199  H H Q-1.199
H H
HH
H H o=: Q-1.199 H H o =: Q-1.199
H  H
H °- H ° -
H Q-1.199 H Q-1,199
H H
H o=: Q-1.199 H o =: Q-1.199
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.199  H Q-1,199
H H
H H H H
H o=: Q-1.199  H o =: Q-1.199
H  H
°- ° -
H H Q-1.206 H H Q-1.206
H H o=: Q-1.206 R2 R5 R3 R4 X-Y QHH o =: Q-1.206 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.206  H H Q-1.206
H H
HH
H H o=: Q-1.206 H H o =: Q-1.206
H  H
H °- H ° -
H Q-1.206H Q-1.206
H~~f\ H ~~ f \
H  H
H o=: Q-1.206 H o =: Q-1.206
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.206  H Q-1.206
H H
H H H H
H o=: Q-1.206  H o =: Q-1.206
H  H
°- ° -
H H Q-1.150 HH Q-1.150
H H o=: Q-1.150 H H o =: Q-1,150
°- H  ° - H
H H Q-1.150  HH Q-1.150
H H
HH
H H o=: Q-1.150 H H o =: Q-1,150
H  H
H °- H ° -
H Q-1.150H Q-1.150
H~~f\ H ~~ f \
H  H
H o=: Q-1.150  H o =: Q-1,150
H °- H H ° - H
H Q-1.150  H Q-1.150
H H
H H H H
H o=: Q-1.150  H o =: Q-1,150
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-1.106 H H Q-1.106
H H o=: Q-1.106 H H o =: Q-1.106
°- H  ° - H
H H Q-1.106  H H Q-1.106
H H
HH
H H o=: Q-1.106 H H o =: Q-1.106
H  H
H °- H ° -
H Q-1.106H Q-1.106
H~~f\ H ~~ f \
H  H
H o=: Q-1.106  H o =: Q-1.106
H °- H H ° - H
H Q-1.106  H Q-1.106
H H
H H H H
H o=: Q-1.106  H o =: Q-1.106
H  H
°- ° -
H H Q-1.125 HH Q-1.125
H H o=: Q-1.125 H H o =: Q-1.125
°- H  ° - H
H H Q-1.125  HH Q-1.125
H H
HH
H H o=: Q-1.125 H H o =: Q-1.125
H  H
H °- H ° -
H Q-1.125 H Q-1.125
H H
H o=: Q-1.125 R2 R5 R3 R4 X-Y QH o =: Q-1.125 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-1.125 H Q-1.125
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.125  H o =: Q-1.125
H  H
°- ° -
H H Q-1.72 H H Q-1.72
H H o=: - Q-1.72 H H o =: - Q-1.72
°- H  ° - H
H H Q-1.72  H H Q-1.72
H H
HH
H H o=: Q-1.72 H H o =: Q-1.72
H  H
H °- H ° -
H Q-1.72 H Q-1.72
H H
H o=: Q-1.72 H o =: Q-1.72
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.72  H Q-1.72
H H
H H H H
H o=: Q-1.72  H o =: Q-1.72
H  H
°- ° -
H H Q-1.219 H H Q-1.219
H H o=: Q-1.219 H H o =: Q-1.219
°- H  ° - H
H H Q-1.219  H H Q-1.219
H H
HH
H H o=: Q-1.219 H H o =: Q-1.219
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-1.219H Q-1.219
H~~f\ H ~~ f \
H  H
H o=: Q-1.219 H o =: Q-1.219
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.219 H Q-1.219
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-1.219  H o =: Q-1.219
H  H
°- ° -
H H Q-1.221 H H Q-1.221
H H o=: Q-1.221 H H o =: Q-1.221
°- H  ° - H
H H Q-1.221  H H Q-1.221
H H
HH
H H o=: Q-1.221 H H o =: Q-1.221
H  H
H °- H ° -
H Q-1.221 H Q-1.221
H H
H o=: Q-1.221 H o =: Q-1.221
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-1.221  H Q-1.221
H H
H H H H
H o=: Q-1.221  H o =: Q-1.221
H H
H H ,N = i H H, N = i
— o" Q-1.2  - o "Q-1.2
- -
HH
H H ,N = i H H, N = i
— o" Q-1.2  - o "Q-1.2
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H H
H ,N = i  H, N = i
H~~f\ — o" Q-1.2 H ~~ f \ - o "Q-1.2
H H H H
H ,N = i  H, N = i
— o" Q-1.2  - o "Q-1.2
H H
N = i  N = i
H H /— ° Q-1.2  H H / ° Q-1.2
H H
N = i  N = i
H H /— ° Q-1.2  H H / ° Q-1.2
H H
HH
N = i  N = i
H /— ° Q-1.2  H / - ° Q-1.2
H H H H
,N = i  , N = i
H Q-1.2  H Q-1.2
/— ° H  / - ° H
H H ,N = i  H H, N = i
— o' Q-1.7  - o 'Q-1.7
- -
HH
H H ,N = i H H, N = i
— o" Q-1.7  - o "Q-1.7
H H
H H
H ,N = i  H, N = i
— o" Q-1.7  - o "Q-1.7
H H H H
H ,N = i  H, N = i
— o" Q-1.7  - o "Q-1.7
H H
N = i  N = i
H H /— ° Q-1.7  H H / ° Q-1.7
H H
N = i  N = i
H H / -1.7 — ° Q  H H / -1.7 - ° Q
H H
HH
N = i  N = i
H  H
H~~f\ /— ° Q-1.7 H ~~ f \ / - ° Q-1.7
H H H H
,N = i  , N = i
H Q-1.7  H Q-1.7
/— ° H  / - ° H
H H ,N = i  H H, N = i
— o' - Q-1.13 R2 R5 R3 R4 X-Y Q - o '- Q-1.13 R 2 R 5 R 3 R 4 XY Q
H H
H H ,N = i H H, N = i
— o" Q-1.13  - o "Q-1.13
H H
H H
H ,N = i  H, N = i
H~~f\ — o" Q-1.13 H ~~ f \ - o "Q-1.13
H H H H
H ,N = i  H, N = i
— o" Q-1.13  - o "Q-1.13
H  H
,N = i  , N = i
H H Q-1.13  H H Q-1.13
/— °  / - °
H H
N = i  N = i
H H Q-1.13  H H Q-1.13
/— ° H  / - ° H
H H
N = i  N = i
H /— ° Q-1.13  H / - ° Q-1.13
H H H H
H / .13 — ° Q-1  H / .13 - ° Q-1
H H
H H — o" Q-1.100 H H - o "Q-1.100
- -
HH
H H ,N = i H H, N = i
— o" Q-1.100  - o "Q-1.100
H H
H H
H ,N = i  H, N = i
— o" Q-1.100  - o "Q-1.100
H H H H
H ,N = i  H, N = i
— o" Q-1.100  - o "Q-1.100
H  H
H H /— ° Q-1.100 H H / ° Q-1,100
H H
H H / .100 — ° Q-1 H H / .100 - ° Q-1
H H
H H
H /— ° Q-1.100 R2 R5 R3 R4 X-Y QH / - ° Q-1,100 R 2 R 5 R 3 R 4 XY Q
H H H H
,N = i  , N = i
H Q-1.100  H Q-1.100
/— ° H  / - ° H
H H ,N = i  H H, N = i
— o" Q-1.110  - o "Q-1.110
H H
H H ,N = i H H, N = i
— o" Q-1.110  - o "Q-1.110
H H
H H
H ,N = i  H, N = i
H~~f\ — o" Q-1.110 H ~~ f \ - o "Q-1.110
H H H H
H ,N = i  H, N = i
— o" Q-1.110  - o "Q-1.110
H H
N = i  N = i
H H /— ° Q-1.110  H H / ° Q-1.110
H H
N = i  N = i
H H / -1.110 — ° Q  H H / -1,110 - ° Q
H  H
H  H
,N = i  , N = i
H Q-1.110 H Q-1.110
H~~f\ /— ° H ~~ f \ / - °
H H H H
N = i  N = i
H Q-1.110  H Q-1.110
/— ° H  / - ° H
H H ,N = i  H H, N = i
— o" Q-1.103  - o "Q-1.103
- -
HH
H H ,N = i H H, N = i
— o" Q-1.103  - o "Q-1.103
H H
H H
H ,N = i  H, N = i
— o" Q-1.103  - o "Q-1.103
H H H H
H ,N = i  H, N = i
— o" Q-1.103  - o "Q-1.103
H H
N = i  N = i
H H Q-1.103  H H Q-1.103
/— ° R2 R5 R3 R4 X-Y Q / - ° R 2 R 5 R 3 R 4 XY Q
H H
N = i  N = i
H H / ° Q-1.103 —  H H / ° Q-1.103 -
H H
HH
N = i  N = i
H Q-1.103 H Q-1.103
H~~f\ /— ° H ~~ f \ / - °
H H H H
N = i  N = i
H Q-1.103  H Q-1.103
/— ° H  / - ° H
H H ,N = i Q-1.103  H H, N = i Q-1.103
H H
H H ,N = i Q-1.103 H H, N = i Q-1.103
H H
H H
H ,N = i Q-1.103  H, N = i Q-1.103
H H H H
H ,N = i  H, N = i
HO" Q-1.103  HO "Q-1.103
H  H
H H Q-1.100 H H Q-1,100
H H o=: Q-1.100 H H o =: Q-1,100
°- H  ° - H
H H Q-1.100  H H Q-1,100
H H
HH
H H o=: Q-1.100 H H o =: Q-1,100
H H
H SiEt3 o=: Q-1.100 H SiEt 3 o =: Q-1,100
H H
H SiEt3 o=: Q-1.100 H SiEt 3 o =: Q-1,100
H  H
°- ° -
H H Q-1.100 H H Q-1,100
H H o=: Q-1.100 R2 R5 R3 R4 X-Y QHH o =: Q-1,100 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-1.100  H H Q-1,100
H H
HH
H H o=: Q-1.100 H H o =: Q-1,100
H H
H SiEt3 o=: Q-1.100 H SiEt 3 o =: Q-1,100
H H
H SiEt3 o=: Q-1.100 H SiEt 3 o =: Q-1,100
H  H
°- ° -
H H Q-1.100 H H Q-1,100
H H o=: Q-1.100 H H o =: Q-1,100
°- H  ° - H
H H Q-1.100  H H Q-1,100
H H
HH
H H o=: Q-1.100 H H o =: Q-1,100
H H
H SiEt3 o=: Q-1.100 H SiEt 3 o =: Q-1,100
H H
H SiEt3 o=: Q-1.100 H SiEt 3 o =: Q-1,100
H H
H H ,N = i H H, N = i
—0' Q-1.31 -0 'Q 1.31
H H
H H ,N = i H H, N = i
—0' Q-1.31 -0 'Q 1.31
H H
H H
H ,N = i  H, N = i
—0' Q-1.31 -0 'Q 1.31
H H H H
H ,N = i  H, N = i
—0' Q-1.31 -0 'Q 1.31
H H
N = i  N = i
H H Q-1.31  HH Q-1.31
/— 0 R2 R5 R3 R4 X-Y Q / - 0 R 2 R 5 R 3 R 4 XY Q
H  H
,N = i  , N = i
H H Q-1.31  HH Q-1.31
/— ° H  / - ° H
H H
N = i  N = i
H Q-1.31 H Q-1.31
H~~f\ /— ° H ~~ f \ / - °
H H
HH
N = i  N = i
H Q-1.31  H Q-1.31
/— ° H  / - ° H
H H ,N = i Q-1.31  H H, N = i Q-1.31
H H
H H ,N = i Q-1.31 H H, N = i Q-1.31
H H
H H
H ,N = i Q-1.31  H, N = i Q-1.31
H H
H H
H ,N = i  H, N = i
HO" Q-1.31  HO "Q-1.31
H H
H H ,N = i H H, N = i
HO" Q-1.13  HO "Q-1.13
- -
HH
H H ,N = i H H, N = i
HO" Q-1.13  HO "Q-1.13
H H
H H
H ,N = i  H, N = i
H~~f\ HO" Q-1.13 H ~~ f \ HO "Q-1.13
H H
H H
H ,N = i  H, N = i
HO" Q-1.13  HO "Q-1.13
H  H
H H Q-1.101 H H Q-1.101
H H o=: - Q-1.101 H H o =: - Q-1.101
°- H  ° - H
H H Q-1.101  H H Q-1.101
H H
HH
H H o=: Q-1.101 H H o =: Q-1.101
H No. R1 R2 R5 R3 R4 X-Y QH No. R 1 R 2 R 5 R 3 R 4 XY Q
1.1-1143 CF3 H SiEt3 o=: Q-1.101 1.1-1143 CF 3 H SiEt 3 o =: Q-1.101
H  H
1.1-1144 CF3 H SiEt3 o=: Q-1.101 1.1-1144 CF 3 H SiEt 3 o =: Q-1.101
H  H
°- ° -
1.1-1145 C2F5 H H Q-1.101 1.1-1145 C 2 F 5 HH Q-1.101
1.1-1146 C2F5 H H o=: Q-1.101 1.1-1146 C2F5 H H o =: Q-1.101
°- H  ° - H
1.1-1147 C2F5 H H Q-1.101  1.1-1147 C2F5 H H Q-1.101
H  H
H  H
1.1-1148 C2F5 H H o=: Q-1.101  1.1-1148 C2F5 H H o =: Q-1.101
H  H
1.1-1149 C2F5 H SiEt3 o=: Q-1.101 1.1-1149 C2F5 H SiEt 3 o =: Q-1.101
H  H
1.1-1150 C2F5 H SiEt3 o=: Q-1.101 1.1-1150 C2F5 H SiEt 3 o =: Q-1.101
H  H
°- ° -
1.1-1151 CHF2 H H Q-1.101 1.1-1151 CHF 2 HH Q-1.101
1.1-1152 CHF2 H H o=: Q-1.101 1.1-1152 CHF 2 HH o =: Q-1.101
°- H  ° - H
1.1-1153 CHF2 H H Q-1.101 1.1-1153 CHF 2 HH Q-1.101
H  H
H  H
1.1-1154 CHF2 H H o=: Q-1.101 1.1-1154 CHF 2 HH o =: Q-1.101
H  H
1.1-1155 CHF2 H SiEt3 o=: Q-1.101 1.1-1155 CHF 2 H SiEt 3 o =: Q-1.101
H  H
1.1-1156 CHF2 H SiEt3 o=: Q-1.101 1.1-1156 CHF 2 H SiEt 3 o =: Q-1.101
H  H
1.1-1157 CH3 H H ,N = i 1.1-1157 CH 3 HH, N = i
—0' Q-1.64 -0 'Q 1.64
- -
H H
1.1-1158 CH3 H H ,N = i 1.1-1158 CH 3 HH, N = i
—0' Q-1.64 -0 'Q 1.64
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H H
H ,N = i  H, N = i
H~~f\ — o" Q-1.64 H ~~ f \ - o "Q-1.64
H H
H H
H ,N = i  H, N = i
— o" Q-1.64  - o "Q-1.64
H H
N = i  N = i
H H /— ° Q-1.64  H H / ° Q-1.64
H H
N = i  N = i
H H / Q-1.64 — ° H  H H / Q-1.64 - ° H
H H
N = i  N = i
H /— ° Q-1.64  H / - ° Q-1.64
H  H
H  H
,N = i  , N = i
H Q-1.64  H Q-1.64
/— ° H  / - ° H
H H ,N = i Q-1.64  H H, N = i Q-1.64
- -
HH
H H ,N = i H H, N = i
HO" Q-1.64  HO "Q-1.64
H H
H H
H ,N = i  H, N = i
HO" Q-1.64  HO "Q-1.64
H H
H H
H ,N = i  H, N = i
HO" Q-1.64  HO "Q-1.64
H H
Tabelle 2: Table 2:
No. R1 R2 R5 R3 R4 X-Y Q No. R 1 R 2 R 5 R 3 R 4 XY Q
°- ° -
1.2-1 CH3 H H Q-2.1 1.2-1 CH 3 HH-Q 2.1
I.2-2 CH3 H H o=: Q-2.1 I.2-2 CH 3 HH o =: Q-2.1
°- H  ° - H
I.2-3 CH3 H H Q-2.1 I.2-3 CH 3 HH Q-2.1
H H
H H
I.2-4 CH3 H H o=: Q-2.1 I.2-4 CH 3 HH o =: Q-2.1
H  H
H °- H ° -
I.2-5 H Q-2.1 I.2-5 H Q-2.1
H~~f\ H ~~ f \
H  H
I.2-6 H o=: Q-2.1  I.2-6 H o =: Q-2.1
H °- H H ° - H
I.2-7 H Q-2.1  I.2-7 H Q-2.1
H~~f\ H ~~ f \
H H
H H H H
I.2-8 H o=: Q-2.1  I.2-8 H o =: Q-2.1
H  H
°- ° -
I.2-9 CH3 H H Q-2.2 I.2-9 CH 3 HH Q-2.2
1.2-10 CH3 H H o=: Q-2.2 1.2-10 CH 3 HH o =: Q-2.2
°- H  ° - H
1.2-1 1 CH3 H H Q-2.2 1.2-1 1 CH 3 HH Q-2.2
H  H
H  H
1.2-12 CH3 H H o=: Q-2.2 1.2-12 CH 3 HH o =: Q-2.2
H No. R1 R2 R5 R3 R4 X-Y QH No. R 1 R 2 R 5 R 3 R 4 XY Q
H °-H ° -
1.2-13 H Q-2.2 1.2-13 H Q-2.2
H~~f\ H ~~ f \
H  H
1.2-14 H o=: Q-2.2  1.2-14 H o =: Q-2.2
H~~f\ H ~~ f \
H °- H H ° - H
1.2-15 H Q-2.2 1.2-15 H Q-2.2
H~~f\ H ~~ f \
H H
H H H H
1.2-16 H o=: Q-2.2  1.2-16 H o =: Q-2.2
H  H
°- ° -
1.2-17 CH3 H H Q-2.3 1.2-17 CH 3 HH Q-2.3
1.2-18 CH3 H H o=: Q-2.3 1.2-18 CH 3 HH o =: Q-2.3
°- H  ° - H
1.2-19 CH3 H H Q-2.3 1.2-19 CH 3 HH Q-2.3
H H
H H
I.2-20 CH3 H H o=: Q-2.3 I.2-20 CH 3 HH o =: Q-2.3
H  H
H °- H ° -
1.2-21 H Q-2.3 1.2-21 H Q-2.3
H H
I.2-22 H o=: Q-2.3  I.2-22 H o =: Q-2.3
H~~f\ H ~~ f \
H °- H H ° - H
I.2-23 H Q-2.3 I.2-23 H Q-2.3
H H
H H H H
I.2-24 H o=: Q-2.3  I.2-24 H o =: Q-2.3
H  H
°- ° -
I.2-25 CH3 H H Q-2.4 I.2-25 CH 3 HH Q-2.4
I.2-26 CH3 H H o=: Q-2.4 No. R1 R2 R5 R3 R4 X-Y Q I.2-26 CH 3 HH o =: Q-2.4 No. R 1 R 2 R 5 R 3 R 4 XY Q
°- H  ° - H
I.2-27 CH3 H H Q-2.4 I.2-27 CH 3 HH Q-2.4
H H
H H
I.2-28 CH3 H H o=: Q-2.4 I.2-28 CH 3 HH o =: Q-2.4
H  H
H °- H ° -
I.2-29 H Q-2.4 I.2-29 H Q-2.4
H~~f\ H ~~ f \
H  H
I.2-30 H o=: Q-2.4  I.2-30 H o =: Q-2.4
H~~f\ H ~~ f \
H °- H H ° - H
1.2-31 H Q-2.4 1.2-31 H Q-2.4
H H
H H H H
I.2-32 H o=: Q-2.4  I.2-32 H o =: Q-2.4
H  H
°- ° -
I.2-33 CH3 H H Q-2.5 I.2-33 CH 3 HH Q-2.5
I.2-34 CH3 H H o=: Q-2.5 I.2-34 CH 3 HH o =: Q-2.5
°- H  ° - H
I.2-35 CH3 H H Q-2.5 I.2-35 CH 3 HH Q-2.5
H H
H H
I.2-36 CH3 H H o=: Q-2.5 I.2-36 CH 3 HH o =: Q-2.5
H  H
H °- H ° -
I.2-37 H Q-2.5 I.2-37 H Q-2.5
H~~f\ H ~~ f \
H  H
I.2-38 H o=: Q-2.5  I.2-38 H o =: Q-2.5
H °- HH ° - H
I.2-39 H Q-2.5 I.2-39 H Q-2.5
H H
H H H H
I.2-40 H o=: Q-2.5  I.2-40 H o =: Q-2.5
H No. R1 R2 R5 R3 R4 X-Y Q H No. R 1 R 2 R 5 R 3 R 4 XY Q
°- ° -
1.2-41 CH3 H H Q-2.6 1.2-41 CH 3 HH Q-2.6
I.2-42 CH3 H H o=: Q-2.6 I.2-42 CH 3 HH o =: Q-2.6
°- H  ° - H
I.2-43 CH3 H H Q-2.6 I.2-43 CH 3 HH Q-2.6
H H
H H
I.2-44 CH3 H H o=: Q-2.6 I.2-44 CH 3 HH o =: Q-2.6
H  H
H °- H ° -
I.2-45 H Q-2.6 I.2-45 H Q-2.6
H~~f\ H ~~ f \
H  H
I.2-46 H o=: Q-2.6  I.2-46 H o =: Q-2.6
H °- HH ° - H
I.2-47 H Q-2.6 I.2-47 H Q-2.6
H H
H H H H
I.2-48 H o=: Q-2.6  I.2-48 H o =: Q-2.6
H  H
°- ° -
I.2-49 CH3 H H Q-2.7 I.2-49 CH 3 HH Q-2.7
I.2-50 CH3 H H o=: Q-2.7 I.2-50 CH 3 HH o =: Q-2.7
°- H  ° - H
1.2-51 CH3 H H Q-2.7 1.2-51 CH 3 HH Q-2.7
H H
H H
I.2-52 CH3 H H o=: Q-2.7 I.2-52 CH 3 HH o =: Q-2.7
H  H
H °- H ° -
I.2-53 H Q-2.7 I.2-53 H Q-2.7
H H
I.2-54 H o=: Q-2.7 No. R1 R2 R5 R3 R4 X-Y QI.2-54 H o =: Q-2.7 No. R 1 R 2 R 5 R 3 R 4 XY Q
H °- HH ° - H
I.2-55 H Q-2.7 I.2-55 H Q-2.7
H~~f\ H ~~ f \
H H
H H H H
I.2-56 H o=: Q-2.7  I.2-56 H o =: Q-2.7
H  H
°- ° -
I.2-57 CH3 H H Q-2.8 I.2-57 CH 3 HH Q-2.8
I.2-58 CH3 H H o=: - Q-2.8 I.2-58 CH 3 HH o =: - Q-2.8
°- H  ° - H
I.2-59 CH3 H H Q-2.8 I.2-59 CH 3 HH Q-2.8
H H
H H
I.2-60 CH3 H H o=: Q-2.8 I.2-60 CH 3 HH o =: Q-2.8
H  H
H °- H ° -
1.2-61 H Q-2.8 1.2-61 H Q-2.8
H H
I.2-62 H o=: Q-2.8  I.2-62 H o =: Q-2.8
H~~f\ H ~~ f \
H °- H H ° - H
I.2-63 H Q-2.8 I.2-63 H Q-2.8
H H
H H H H
I.2-64 H o=: Q-2.8  I.2-64 H o =: Q-2.8
H  H
°- ° -
I.2-65 CH3 H H Q-2.9 I.2-65 CH 3 HH Q-2.9
I.2-66 CH3 H H o=: Q-2.9 I.2-66 CH 3 HH o =: Q-2.9
°- H  ° - H
I.2-67 CH3 H H Q-2.9 I.2-67 CH 3 HH Q-2.9
H H
H H
I.2-68 CH3 H H o=: Q-2.9 I.2-68 CH 3 HH o =: Q-2.9
H No. R1 R2 R5 R3 R4 X-Y QH No. R 1 R 2 R 5 R 3 R 4 XY Q
H °-H ° -
I.2-69 H Q-2.9 I.2-69 H Q-2.9
H~~f\ H ~~ f \
H  H
I.2-70 H o=: Q-2.9  I.2-70 H o =: Q-2.9
H~~f\ H ~~ f \
H °- H H ° - H
1.2-71 H Q-2.9 1.2-71 H Q-2.9
H~~f\ H ~~ f \
H H
H H H H
I.2-72 H o=: Q-2.9  I.2-72 H o =: Q-2.9
H  H
°- ° -
I.2-73 CH3 H H Q-2.10 I.2-73 CH 3 HH Q-2.10
I.2-74 CH3 H H o=: Q-2.10 I.2-74 CH 3 HH o =: Q-2.10
°- H  ° - H
I.2-75 CH3 H H Q-2.10 I.2-75 CH 3 HH Q-2.10
H H
H H
I.2-76 CH3 H H o=: Q-2.10 I.2-76 CH 3 HH o =: Q-2.10
H  H
H °- H ° -
I.2-77 H Q-2.10 I.2-77 H Q-2.10
H H
I.2-78 H o=: Q-2.10  I.2-78 H o =: Q-2.10
H~~f\ H ~~ f \
H °- H H ° - H
I.2-79 H Q-2.10 I.2-79 H Q-2.10
H H
H H H H
I.2-80 H o=: Q-2.10  I.2-80 H o =: Q-2.10
H  H
°- ° -
1.2-81 CH3 H H Q-2.1 1 1.2-81 CH 3 HH Q-2.1 1
I.2-82 CH3 H H o=: Q-2.1 1 No. R1 R2 R5 R3 R4 X-Y Q I.2-82 CH 3 HH o =: Q-2.1 1 No. R 1 R 2 R 5 R 3 R 4 XY Q
°- H  ° - H
I.2-83 CH3 H H Q-2.1 1 I.2-83 CH 3 HH Q-2.1 1
H H
H H
I.2-84 CH3 H H o=: Q-2.1 1 I.2-84 CH 3 HH o =: Q-2.1 1
H  H
H °- H ° -
I.2-85 H Q-2.1 1 I.2-85 H Q-2.1 1
H~~f\ H ~~ f \
H  H
I.2-86 H o=: Q-2.1 1  I.2-86 H o =: Q-2.1 1
H~~f\ H ~~ f \
H °- H H ° - H
I.2-87 H Q-2.1 1 I.2-87 H Q-2.1 1
H H
H H H H
I.2-88 H o=: Q-2.1 1  I.2-88 H o =: Q-2.1 1
H  H
°- ° -
I.2-89 CH3 H H Q-2.12 I.2-89 CH 3 HH Q-2.12
I.2-90 CH3 H H o=: Q-2.12 I.2-90 CH 3 HH o =: Q-2.12
°- H  ° - H
1.2-91 CH3 H H Q-2.12 1.2-91 CH 3 HH Q-2.12
H H
H H
I.2-92 CH3 H H o=: Q-2.12 I.2-92 CH 3 HH o =: Q-2.12
H  H
H °- H ° -
I.2-93 H Q-2.12 I.2-93 H Q-2.12
H~~f\ H ~~ f \
H  H
I.2-94 H o=: Q-2.12  I.2-94 H o =: Q-2.12
H °- HH ° - H
I.2-95 H Q-2.12 I.2-95 H Q-2.12
H H
H H H H
I.2-96 H o=: Q-2.12  I.2-96 H o =: Q-2.12
H No. R1 R2 R5 R3 R4 X-Y Q H No. R 1 R 2 R 5 R 3 R 4 XY Q
°- ° -
I.2-97 CH3 H H Q-2.13 I.2-97 CH 3 HH Q-2.13
I.2-98 CH3 H H o=: Q-2.13 I.2-98 CH 3 HH o =: Q-2.13
°- H  ° - H
I.2-99 CH3 H H Q-2.13 I.2-99 CH 3 HH Q-2.13
H  H
H H
.2-100 CH3 H H o=: Q-2.13 .2-100 CH 3 HH o =: Q-2.13
H  H
H °-.2-101 H Q-2.13  H ° -2-101 H Q-2.13
H~~f\ H ~~ f \
H H
.2-102 H o=: Q-2.13 .2-102 H o =: Q-2.13
H °- H.2-103 H Q-2.13 H ° - H.2-103 H Q-2.13
H H
H HH H
.2-104 H o=: Q-2.13 .2-104 H o =: Q-2.13
H  H
°-.2-105 CH3 H H Q-2.14 .2-106 CH3 H H o=: Q-2.14 ° -.2-105 CH 3 HH Q-2.14 .2-106 CH 3 HH o =: Q-2.14
°- H ° - H
.2-107 CH3 H H Q-2.14 .2-107 CH 3 HH Q-2.14
H  H
H H
.2-108 CH3 H H o=: Q-2.14 .2-108 CH 3 HH o =: Q-2.14
H  H
H °-.2-109 H Q-2.14  H ° -2-109 H Q-2.14
HH
.2-1 10 H o=: Q-2.14 R2 R5 R3 R4 X-Y Q.2-1 10 H o =: Q-2.14 R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-2.14 H Q-2.14
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-2.14  H o =: Q-2.14
H  H
°- ° -
H H Q-2.15 H H Q-2.15
H H o=: - Q-2.15 H H o =: - Q-2.15
°- H  ° - H
H H Q-2.15  H H Q-2.15
H H
HH
H H o=: Q-2.15 H H o =: Q-2.15
H  H
H °- H ° -
H Q-2.15 H Q-2.15
H H
H o=: Q-2.15 H o =: Q-2.15
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-2.15  H Q-2.15
H H
H H H H
H o=: Q-2.15  H o =: Q-2.15
H  H
°- ° -
H H Q-2.16 H H Q-2.16
H H o=: Q-2.16 H H o =: Q-2.16
°- H  ° - H
H H Q-2.16  H H Q-2.16
H H
HH
H H o=: Q-2.16 H H o =: Q-2.16
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-2.16H Q-2.16
H~~f\ H ~~ f \
H  H
H o=: Q-2.16 H o =: Q-2.16
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-2.16 H Q-2.16
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-2.16  H o =: Q-2.16
H  H
°- ° -
H H Q-2.17 H H Q-2.17
H H o=: Q-2.17 H H o =: Q-2.17
°- H  ° - H
H H Q-2.17  H H Q-2.17
H H
HH
H H o=: Q-2.17 H H o =: Q-2.17
H  H
H °- H ° -
H Q-2.17 H Q-2.17
H H
H o=: Q-2.17 H o =: Q-2.17
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-2.17  H Q-2.17
H H
H H H H
H o=: Q-2.17  H o =: Q-2.17
H  H
°- ° -
H H Q-2.18 H H Q-2.18
H H o=: Q-2.18 No. R1 R2 R5 R3 R4 X-Y Q HH o =: Q-2.18 No. R 1 R 2 R 5 R 3 R 4 XY Q
°- H  ° - H
1.2-139 CH3 H H Q-2.18 1.2-139 CH 3 HH Q-2.18
H  H
H  H
1.2-140 CH3 H H o=: Q-2.18 1.2-140 CH 3 HH o =: Q-2.18
H  H
H °- H ° -
1.2-141 H Q-2.18 1.2-141 H Q-2.18
H~~f\ H ~~ f \
H  H
1.2-142 H o=: Q-2.18  1.2-142 H o =: Q-2.18
H °- H H ° - H
1.2-143 H Q-2.18  1.2-143 H Q-2.18
H H
H H H H
1.2-144 H o=: Q-2.18  1.2-144 H o =: Q-2.18
H  H
Tabelle 3: Table 3:
No. R1 R2 R5 R3 R4 X-Y Q No. R 1 R 2 R 5 R 3 R 4 XY Q
°- ° -
1.3-1 CH3 H H Q-3.1 1.3-1 CH 3 HH-Q 3.1
I.3-2 CH3 H H o=: Q-3.1 I.3-2 CH 3 HH o =: Q-3.1
°- H  ° - H
I.3-3 CH3 H H Q-3.1 I.3-3 CH 3 HH Q-3.1
H H
H H
I.3-4 CH3 H H o=: Q-3.1 I.3-4 CH 3 HH o =: Q-3.1
H No. R1 R2 R5 R3 R4 X-Y QH No. R 1 R 2 R 5 R 3 R 4 XY Q
H °-H ° -
I.3-5 H Q-3.1 I.3-5 H Q-3.1
H~~f\ H ~~ f \
H  H
I.3-6 H o=: Q-3.1  I.3-6 H o =: Q-3.1
H~~f\ H ~~ f \
H °- H H ° - H
I.3-7 H Q-3.1 I.3-7 H Q-3.1
H~~f\ H ~~ f \
H H
H H H H
I.3-8 H o=: Q-3.1  I.3-8 H o =: Q-3.1
H  H
°- ° -
I.3-9 CH3 H H Q-3.2 .3-10 CH3 H H o=: Q-3.2 I.3-9 CH 3 HH Q-3.2 .3-10 CH 3 HH o =: Q-3.2
°- H ° - H
.3-1 1 CH3 H H Q-3.2 .3-1 1 CH 3 HH Q-3.2
H  H
H H
.3-12 CH3 H H o=: Q-3.2 .3-12 CH 3 HH o =: Q-3.2
H  H
H °-.3-13 H Q-3.2  H ° -.3-13 H Q-3.2
HH
.3-14 H o=: Q-3.2 .3-14 H o =: Q-3.2
H~~f\ H ~~ f \
H °- H.3-15 H Q-3.2  H ° - H.3-15 H Q-3.2
H H
H HH H
.3-16 H o=: Q-3.2 .3-16 H o =: Q-3.2
H  H
°-.3-17 CH3 H H Q-3.3 .3-18 CH3 H H o=: Q-3.3 No. R1 R2 R5 R3 R4 X-Y Q ° -.3-17 CH 3 HH Q-3.3 .3-18 CH 3 HH o =: Q-3.3 No. R 1 R 2 R 5 R 3 R 4 XY Q
°- H  ° - H
1.3-19 CH3 H H Q-3.3 1.3-19 CH 3 HH Q-3.3
H H
H H
I.3-20 CH3 H H o=: Q-3.3 I.3-20 CH 3 HH o =: Q-3.3
H  H
H °- H ° -
1.3-21 H Q-3.3 1.3-21 H Q-3.3
H~~f\ H ~~ f \
H  H
I.3-22 H o=: Q-3.3  I.3-22 H o =: Q-3.3
H~~f\ H ~~ f \
H °- H  H ° - H
I.3-23 H Q-3.3  I.3-23 H Q-3.3
H H
H H H H
I.3-24 H o=: Q-3.3  I.3-24 H o =: Q-3.3
H  H
°- ° -
I.3-25 CH3 H H Q-3.4 I.3-25 CH 3 HH Q-3.4
I.3-26 CH3 H H o=: Q-3.4 I.3-26 CH 3 HH o =: Q-3.4
°- H  ° - H
I.3-27 CH3 H H Q-3.4 I.3-27 CH 3 HH Q-3.4
H H
H H
I.3-28 CH3 H H o=: Q-3.4 I.3-28 CH 3 HH o =: Q-3.4
H  H
H °- H ° -
I.3-29 H Q-3.4 I.3-29 H Q-3.4
H~~f\ H ~~ f \
H  H
I.3-30 H o=: Q-3.4  I.3-30 H o =: Q-3.4
H °- H H ° - H
1.3-31 H Q-3.4  1.3-31 H Q-3.4
H H
H H H H
I.3-32 H o=: Q-3.4  I.3-32 H o =: Q-3.4
H No. R1 R2 R5 R3 R4 X-Y Q H No. R 1 R 2 R 5 R 3 R 4 XY Q
°- ° -
I.3-33 CH3 H H Q-3.5 I.3-33 CH 3 HH Q-3.5
I.3-34 CH3 H H o=: Q-3.5 I.3-34 CH 3 HH o =: Q-3.5
°- H  ° - H
I.3-35 CH3 H H Q-3.5 I.3-35 CH 3 HH Q-3.5
H H
H H
I.3-36 CH3 H H o=: Q-3.5 I.3-36 CH 3 HH o =: Q-3.5
H  H
H °- H ° -
I.3-37 H Q-3.5 I.3-37 H Q-3.5
H~~f\ H ~~ f \
H  H
I.3-38 H o=: Q-3.5  I.3-38 H o =: Q-3.5
H °- H H ° - H
I.3-39 H Q-3.5  I.3-39 H Q-3.5
H H
H H H H
I.3-40 H o=: Q-3.5  I.3-40 H o =: Q-3.5
H  H
°- ° -
1.3-41 CH3 H H Q-3.6 1.3-41 CH 3 HH Q-3.6
I.3-42 CH3 H H o=: Q-3.6 I.3-42 CH 3 HH o =: Q-3.6
°- H  ° - H
I.3-43 CH3 H H Q-3.6 I.3-43 CH 3 HH Q-3.6
H H
H H
I.3-44 CH3 H H o=: Q-3.6 I.3-44 CH 3 HH o =: Q-3.6
H  H
H °- H ° -
I.3-45 H Q-3.6 I.3-45 H Q-3.6
H H
I.3-46 H o=: Q-3.6  I.3-46 H o =: Q-3.6
- ' No. R1 R2 R5 R3 R4 X-Y Q- ' No. R 1 R 2 R 5 R 3 R 4 XY Q
H °- HH ° - H
I.3-47 H Q-3.6 I.3-47 H Q-3.6
H~~f\ H ~~ f \
H H
H H H H
I.3-48 H o=: Q-3.6  I.3-48 H o =: Q-3.6
H  H
°- ° -
I.3-49 CH3 H H Q-3.13 I.3-49 CH 3 HH Q-3.13
I.3-50 CH3 H H o=: Q-3.13 I.3-50 CH 3 HH o =: Q-3.13
°- H  ° - H
1.3-51 CH3 H H Q-3.13 1.3-51 CH 3 HH Q-3.13
H H
H H
I.3-52 CH3 H H o=: Q-3.13 I.3-52 CH 3 HH o =: Q-3.13
H  H
H °- H ° -
I.3-53 H Q-3.13 I.3-53 H Q-3.13
H H
I.3-54 H o=: Q-3.13  I.3-54 H o =: Q-3.13
H~~f\ H ~~ f \
H °- H H ° - H
I.3-55 H Q-3.13 I.3-55 H Q-3.13
H H
H H H H
I.3-56 H o=: Q-3.13  I.3-56 H o =: Q-3.13
H  H
°- ° -
I.3-57 CH3 H H Q-3.14 I.3-57 CH 3 HH Q-3.14
I.3-58 CH3 H H o=: Q-3.14 I.3-58 CH 3 HH o =: Q-3.14
°- H  ° - H
I.3-59 CH3 H H Q-3.14 I.3-59 CH 3 HH Q-3.14
H H
H H
I.3-60 CH3 H H o=: Q-3.14 I.3-60 CH 3 HH o =: Q-3.14
H No. R1 R2 R5 R3 R4 X-Y QH No. R 1 R 2 R 5 R 3 R 4 XY Q
H °-H ° -
1.3-61 H Q-3.14 1.3-61 H Q-3.14
H~~f\ H ~~ f \
H  H
I.3-62 H o=: Q-3.14  I.3-62 H o =: Q-3.14
H~~f\ H ~~ f \
H °- H H ° - H
I.3-63 H Q-3.14 I.3-63 H Q-3.14
H~~f\ H ~~ f \
H H
H H H H
I.3-64 H o=: Q-3.14  I.3-64 H o =: Q-3.14
H  H
°- ° -
I.3-65 CH3 H H Q-3.15 I.3-65 CH 3 HH Q-3.15
I.3-66 CH3 H H o=: Q-3.15 I.3-66 CH 3 HH o =: Q-3.15
°- H  ° - H
I.3-67 CH3 H H Q-3.15 I.3-67 CH 3 HH Q-3.15
H H
H H
I.3-68 CH3 H H o=: Q-3.15 I.3-68 CH 3 HH o =: Q-3.15
H  H
H °- H ° -
I.3-69 H Q-3.15 I.3-69 H Q-3.15
H H
I.3-70 H o=: Q-3.15  I.3-70 H o =: Q-3.15
H~~f\ H ~~ f \
H °- H H ° - H
1.3-71 H Q-3.15 1.3-71 H Q-3.15
H H
H H H H
I.3-72 H o=: Q-3.15  I.3-72 H o =: Q-3.15
H  H
°- ° -
I.3-73 CH3 H H Q-3.16 I.3-73 CH 3 HH Q-3.16
I.3-74 CH3 H H o=: Q-3.16 No. R1 R2 R5 R3 R4 X-Y Q I.3-74 CH 3 HH o =: Q-3.16 No. R 1 R 2 R 5 R 3 R 4 XY Q
°- H  ° - H
I.3-75 CH3 H H Q-3.16 I.3-75 CH 3 HH Q-3.16
H H
H H
I.3-76 CH3 H H o=: Q-3.16 I.3-76 CH 3 HH o =: Q-3.16
H  H
H °- H ° -
I.3-77 H Q-3.16 I.3-77 H Q-3.16
H~~f\ H ~~ f \
H  H
I.3-78 H o=: Q-3.16  I.3-78 H o =: Q-3.16
H~~f\ H ~~ f \
H °- H H ° - H
I.3-79 H Q-3.16 I.3-79 H Q-3.16
H H
H H H H
I.3-80 H o=: Q-3.16  I.3-80 H o =: Q-3.16
H  H
°- ° -
1.3-81 CH3 H H Q-3.17 1.3-81 CH 3 HH Q-3.17
I.3-82 CH3 H H o=: Q-3.17 I.3-82 CH 3 HH o =: Q-3.17
°- H  ° - H
I.3-83 CH3 H H Q-3.17 I.3-83 CH 3 HH Q-3.17
H H
H H
I.3-84 CH3 H H o=: Q-3.17 I.3-84 CH 3 HH o =: Q-3.17
H  H
H °- H ° -
I.3-85 H Q-3.17 I.3-85 H Q-3.17
H~~f\ H ~~ f \
H  H
I.3-86 H o=: Q-3.1 1  I.3-86 H o =: Q-3.1 1
H °- HH ° - H
I.3-87 H Q-3.17 I.3-87 H Q-3.17
H H
H H H H
I.3-88 H o=: Q-3.17  I.3-88 H o =: Q-3.17
H No. R1 R2 R5 R3 R4 X-Y Q H No. R 1 R 2 R 5 R 3 R 4 XY Q
°- ° -
I.3-89 CH3 H H Q-3.18 I.3-89 CH 3 HH Q-3.18
I.3-90 CH3 H H o=: Q-3.18 I.3-90 CH 3 HH o =: Q-3.18
°- H  ° - H
1.3-91 CH3 H H Q-3.18 1.3-91 CH 3 HH Q-3.18
H H
H H
I.3-92 CH3 H H o=: Q-3.18 I.3-92 CH 3 HH o =: Q-3.18
H  H
H °- H ° -
I.3-93 H Q-3.18 I.3-93 H Q-3.18
H~~f\ H ~~ f \
H  H
I.3-94 H o=: Q-3.18  I.3-94 H o =: Q-3.18
H °- HH ° - H
I.3-95 H Q-3.18 I.3-95 H Q-3.18
H H
H H H H
I.3-96 H o=: Q-3.18  I.3-96 H o =: Q-3.18
H  H
°- ° -
I.3-97 CH3 H H Q-3.19 I.3-97 CH 3 HH Q-3.19
I.3-98 CH3 H H o=: Q-3.19 I.3-98 CH 3 HH o =: Q-3.19
°- H  ° - H
I.3-99 CH3 H H Q-3.19 I.3-99 CH 3 HH Q-3.19
H  H
H H
.3-100 CH3 H H o=: Q-3.19 .3-100 CH 3 HH o =: Q-3.19
H  H
H °-.3-101 H Q-3.19  H ° -.3-101 H Q-3.19
HH
.3-102 H o=: Q-3.19 .3-102 H o =: Q-3.19
- ' R2 R5 R3 R4 X-Y Q- ' R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-3.19 H Q-3.19
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-3.19  H o =: Q-3.19
H  H
°- ° -
H H Q-3.20 H H Q-3.20
H H o=: Q-3.20 H H o =: Q-3.20
°- H  ° - H
H H Q-3.20  H H Q-3.20
H H
HH
H H o=: Q-3.20 H H o =: Q-3.20
H  H
H °- H ° -
H Q-3.20 H Q-3.20
H H
H o=: Q-3.20 H o =: Q-3.20
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.20  H Q-3.20
H H
H H H H
H o=: Q-3.20  H o =: Q-3.20
H  H
°- ° -
H H Q-3.21 H H Q-3.21
H H o=: Q-3.21 H H o =: Q-3.21
°- H  ° - H
H H Q-3.21  H H Q-3.21
H H
HH
H H o=: Q-3.21 H H o =: Q-3.21
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-3.21H Q-3.21
H~~f\ H ~~ f \
H  H
H o=: Q-3.21 H o =: Q-3.21
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.21 H Q-3.21
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-3.21  H o =: Q-3.21
H  H
°- ° -
H H Q-3.22 H H Q-3.22
H H o=: Q-3.22 H H o =: Q-3.22
°- H  ° - H
H H Q-3.22  H H Q-3.22
H H
HH
H H o=: Q-3.22 H H o =: Q-3.22
H  H
H °- H ° -
H Q-3.22 H Q-3.22
H H
H o=: Q-3.22 H o =: Q-3.22
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.22  H Q-3.22
H H
H H H H
H o=: Q-3.22  H o =: Q-3.22
H  H
°- ° -
H H Q-3.23 H H Q-3.23
H H o=: Q-3.23 R2 R5 R3 R4 X-Y QHH o =: Q-3.23 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-3.23  H H Q-3.23
H H
HH
H H o=: Q-3.23 H H o =: Q-3.23
H  H
H °- H ° -
H Q-3.23H Q-3.23
H~~f\ H ~~ f \
H  H
H o=: Q-3.23 H o =: Q-3.23
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.23  H Q-3.23
H H
H H H H
H o=: Q-3.23  H o =: Q-3.23
H  H
°- ° -
H H Q-3.24 HH Q-3.24
H H o=: Q-3.24 H H o =: Q-3.24
°- H  ° - H
H H Q-3.24  HH Q-3.24
H H
HH
H H o=: Q-3.24 H H o =: Q-3.24
H  H
H °- H ° -
H Q-3.24H Q-3.24
H~~f\ H ~~ f \
H  H
H o=: Q-3.24  H o =: Q-3.24
H °- H H ° - H
H Q-3.24  H Q-3.24
H H
H H H H
H o=: Q-3.24  H o =: Q-3.24
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-3.25 HH Q-3.25
H H o=: Q-3.25 H H o =: Q-3.25
°- H  ° - H
H H Q-3.25  HH Q-3.25
H H
HH
H H o=: Q-3.25 H H o =: Q-3.25
H  H
H °- H ° -
H Q-3.25H Q-3.25
H~~f\ H ~~ f \
H  H
H o=: Q-3.25  H o =: Q-3.25
H °- H H ° - H
H Q-3.25  H Q-3.25
H H
H H H H
H o=: Q-3.25  H o =: Q-3.25
H  H
°- ° -
H H Q-3.26 HH Q-3.26
H H o=: Q-3.26 H H o =: Q-3.26
°- H  ° - H
H H Q-3.26  HH Q-3.26
H H
HH
H H o=: Q-3.26 H H o =: Q-3.26
H  H
H °- H ° -
H Q-3.26 H Q-3.26
H H
H o=: Q-3.26  H o =: Q-3.26
- ' R2 R5 R3 R4 X-Y Q- ' R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-3.26 H Q-3.26
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-3.26  H o =: Q-3.26
H  H
°- ° -
H H Q-3.27 H H Q-3.27
H H o=: Q-3.27 H H o =: Q-3.27
°- H  ° - H
H H Q-3.27  H H Q-3.27
H H
HH
H H o=: Q-3.27 H H o =: Q-3.27
H  H
H °- H ° -
H Q-3.27 H Q-3.27
H H
H o=: Q-3.27 H o =: Q-3.27
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.27  H Q-3.27
H H
H H H H
H o=: Q-3.27  H o =: Q-3.27
H  H
°- ° -
H H Q-3.28 H H Q-3.28
H H o=: Q-3.28 H H o =: Q-3.28
°- H  ° - H
H H Q-3.28  H H Q-3.28
H H
HH
H H o=: Q-3.28 H H o =: Q-3.28
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-3.28H Q-3.28
H~~f\ H ~~ f \
H  H
H o=: Q-3.28 H o =: Q-3.28
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.28 H Q-3.28
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-3.28  H o =: Q-3.28
H  H
°- ° -
H H Q-3.29 HH Q-3.29
H H o=: Q-3.29 H H o =: Q-3.29
°- H  ° - H
H H Q-3.29  HH Q-3.29
H H
HH
H H o=: Q-3.29 H H o =: Q-3.29
H  H
H °- H ° -
H Q-3.29 H Q-3.29
H H
H o=: Q-3.29 H o =: Q-3.29
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.29  H Q-3.29
H H
H H H H
H o=: Q-3.29  H o =: Q-3.29
H  H
°- ° -
H H Q-3.30 H H Q-3.30
H H o=: Q-3.30 R2 R5 R3 R4 X-Y QHH o =: Q-3.30 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-3.30  H H Q-3.30
H H
HH
H H o=: Q-3.30 H H o =: Q-3.30
H  H
H °- H ° -
H Q-3.30H Q-3.30
H~~f\ H ~~ f \
H  H
H o=: Q-3.30 H o =: Q-3.30
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.30  H Q-3.30
H H
H H H H
H o=: Q-3.30  H o =: Q-3.30
H  H
°- ° -
H H Q-3.31 HH Q-3.31
H H o=: Q-3.31 H H o =: Q-3.31
°- H  ° - H
H H Q-3.31  HH Q-3.31
H H
HH
H H o=: Q-3.31 H H o =: Q-3.31
H  H
H °- H ° -
H Q-3.31H Q-3.31
H~~f\ H ~~ f \
H  H
H o=: Q-3.31  H o =: Q-3.31
H °- H H ° - H
H Q-3.31  H Q-3.31
H H
H H H H
H o=: Q-3.31  H o =: Q-3.31
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
°-° -
H H Q-3.32 HH Q-3.32
H H o=: Q-3.32 H H o =: Q-3.32
°- H  ° - H
H H Q-3.32  HH Q-3.32
H H
HH
H H o=: Q-3.32 H H o =: Q-3.32
H  H
H °- H ° -
H Q-3.32H Q-3.32
H~~f\ H ~~ f \
H  H
H o=: Q-3.32  H o =: Q-3.32
H °- H H ° - H
H Q-3.32  H Q-3.32
H H
H H H H
H o=: Q-3.32  H o =: Q-3.32
H  H
°- ° -
H H Q-3.33 HH Q-3.33
H H o=: Q-3.33 H H o =: Q-3.33
°- H  ° - H
H H Q-3.33  HH Q-3.33
H H
HH
H H o=: Q-3.33 H H o =: Q-3.33
H  H
H °- H ° -
H Q-3.33 H Q-3.33
H H
H o=: Q-3.33  H o =: Q-3.33
- ' R2 R5 R3 R4 X-Y Q- ' R 2 R 5 R 3 R 4 XY Q
H °- H H ° - H
H Q-3.33 H Q-3.33
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-3.33  H o =: Q-3.33
H  H
°- ° -
H H Q-3.34 H H Q-3.34
H H o=: Q-3.34 H H o =: Q-3.34
°- H  ° - H
H H Q-3.34  H H Q-3.34
H H
HH
H H o=: Q-3.34 H H o =: Q-3.34
H  H
H °- H ° -
H Q-3.34 H Q-3.34
H H
H o=: Q-3.34 H o =: Q-3.34
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.34  H Q-3.34
H H
H H H H
H o=: Q-3.34  H o =: Q-3.34
H  H
°- ° -
H H Q-3.35 HH Q-3.35
H H o=: Q-3.35 H H o =: Q-3.35
°- H  ° - H
H H Q-3.35  HH Q-3.35
H H
HH
H H o=: Q-3.35 H H o =: Q-3.35
H R2 R5 R3 R4 X-Y QH R 2 R 5 R 3 R 4 XY Q
H °-H ° -
H Q-3.35H Q-3.35
H~~f\ H ~~ f \
H  H
H o=: Q-3.35 H o =: Q-3.35
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.35 H Q-3.35
H~~f\ H ~~ f \
H H
H H H H
H o=: Q-3.35  H o =: Q-3.35
H  H
°- ° -
H H Q-3.36 HH Q-3.36
H H o=: Q-3.36 H H o =: Q-3.36
°- H  ° - H
H H Q-3.36  HH Q-3.36
H H
HH
H H o=: Q-3.36 H H o =: Q-3.36
H  H
H °- H ° -
H Q-3.36 H Q-3.36
H H
H o=: Q-3.36 H o =: Q-3.36
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.36  H Q-3.36
H H
H H H H
H o=: Q-3.36  H o =: Q-3.36
H  H
°- ° -
H H Q-3.37 H H Q-3.37
H H o=: Q-3.37 R2 R5 R3 R4 X-Y QHH o =: Q-3.37 R 2 R 5 R 3 R 4 XY Q
°- H ° - H
H H Q-3.37  H H Q-3.37
H H
HH
H H o=: Q-3.37 H H o =: Q-3.37
H  H
H °- H ° -
H Q-3.37H Q-3.37
H~~f\ H ~~ f \
H  H
H o=: Q-3.37 H o =: Q-3.37
H~~f\ H ~~ f \
H °- H  H ° - H
H Q-3.37  H Q-3.37
H H
H H H H
H o=: Q-3.37  H o =: Q-3.37
H  H
°- ° -
H H Q-3.38 HH Q-3.38
H H o=: Q-3.38 H H o =: Q-3.38
°- H  ° - H
H H Q-3.38  HH Q-3.38
H H
HH
H H o=: Q-3.38 H H o =: Q-3.38
H  H
H °- H ° -
H Q-3.38H Q-3.38
H~~f\ H ~~ f \
H  H
H o=: Q-3.38  H o =: Q-3.38
H °- H H ° - H
H Q-3.38  H Q-3.38
H H
H H H H
H o=: Q-3.38  H o =: Q-3.38
H No. R1 R2 R5 R3 R4 X-Y Q H No. R 1 R 2 R 5 R 3 R 4 XY Q
H  H
1.3-272 CHF2 H H o=: Q-3.5 1.3-272 CHF 2 HH o =: Q-3.5
H  H
1.3-273 CHF2 H SiEt3 o=: Q-3.5 1.3-273 CHF 2 H SiEt 3 o =: Q-3.5
H  H
1.3-274 CHF2 H SiEt3 o=: Q-3.5 1.3-274 CHF 2 H SiEt 3 o =: Q-3.5
H  H
Tabelle 4: Table 4:
No. R1 R2 R5 R3 R4 X-Y Q No. R 1 R 2 R 5 R 3 R 4 XY Q
°- ° -
1.4-1 CH3 H H Q-4.1 1.4-1 CH 3 HH Q-4.1
I.4-2 CH3 H H o=: - Q-4.1 I.4-2 CH 3 HH o =: - Q-4.1
°- H  ° - H
I.4-3 CH3 H H Q-4.1 I.4-3 CH 3 HH-Q 4.1
H H
H H
I.4-4 CH3 H H o=: Q-4.1 I.4-4 CH 3 HH o =: Q-4.1
H  H
H °- H ° -
I.4-5 H Q-4.1 I.4-5 H Q-4.1
H~~f\ H ~~ f \
H  H
I.4-6 H o=: Q-4.1  I.4-6 H o =: Q-4.1
H °- HH ° - H
I.4-7 H Q-4.1 I.4-7 H Q-4.1
H No. R1 R2 R5 R3 R4 X-Y QH No. R 1 R 2 R 5 R 3 R 4 XY Q
H H H H
I.4-8 H o=: Q-4.1  I.4-8 H o =: Q-4.1
H  H
°- ° -
I.4-9 CH3 H H Q-4.2 I.4-9 CH 3 HH Q-4.2
1.4-10 CH3 H H o=: Q-4.2 1.4-10 CH 3 HH o =: Q-4.2
°- ° -
1.4-1 1 CH3 H H Q-4.2 1.4-1 1 CH 3 HH Q-4.2
H H
1.4-12 CH3 H H o=: Q-4.2 1.4-12 CH 3 HH o =: Q-4.2
H  H
H °- H H ° - H
1.4-13 H 1.4-13 H
H  H
H  H
1.4-14 H o=: Q-4.2  1.4-14 H o =: Q-4.2
H °- HH ° - H
1.4-15 H Q-4.2 1.4-15 H Q-4.2
H~~f\ H ~~ f \
H H
H H H H
1.4-16 H o=: Q-4.2  1.4-16 H o =: Q-4.2
H  H
°- ° -
1.4-17 CH3 H H Q-4.3 1.4-17 CH 3 HH Q-4.3
1.4-18 CH3 H H o=: Q-4.3 1.4-18 CH 3 HH o =: Q-4.3
°- H  ° - H
1.4-19 CH3 H H Q-4.3 1.4-19 CH 3 HH Q-4.3
H H
H H
I.4-20 CH3 H H o=: Q-4.3 I.4-20 CH 3 HH o =: Q-4.3
H  H
H °- H ° -
1.4-21 H Q-4.3 No. R1 R2 R5 R3 R4 X-Y Q1.4-21 H Q-4.3 No. R 1 R 2 R 5 R 3 R 4 XY Q
H H
I.4-22 H o=: Q-4.3  I.4-22 H o =: Q-4.3
H~~f\ H ~~ f \
H °- H H ° - H
I.4-23 H Q-4.3 I.4-23 H Q-4.3
H~~f\ H ~~ f \
H H
H H H H
I.4-24 H o=: Q-4.3  I.4-24 H o =: Q-4.3
H  H
°- ° -
I.4-25 CH3 H H Q-4.4 I.4-25 CH 3 HH Q-4.4
I.4-26 CH3 H H o=: Q-4.4 I.4-26 CH 3 HH o =: Q-4.4
°- H  ° - H
I.4-27 CH3 H H Q-4.4 I.4-27 CH 3 HH Q-4.4
H H
H H
I.4-28 CH3 H H o=: Q-4.4 I.4-28 CH 3 HH o =: Q-4.4
H  H
H °- H ° -
I.4-29 H Q-4.4 I.4-29 H Q-4.4
H~~f\ H ~~ f \
H  H
I.4-30 H o=: Q-4.4  I.4-30 H o =: Q-4.4
H °- HH ° - H
1.4-31 H Q-4.4 1.4-31 H Q-4.4
H~~f\ H ~~ f \
H H
H H H H
I.4-32 H o=: Q-4.4  I.4-32 H o =: Q-4.4
H  H
°- ° -
I.4-33 CH3 H H Q-4.5 I.4-33 CH 3 HH Q-4.5
I.4-34 CH3 H H o=: Q-4.5 I.4-34 CH 3 HH o =: Q-4.5
°- H  ° - H
I.4-35 CH3 H H Q-4.5 I.4-35 CH 3 HH Q-4.5
H No. R1 R2 R5 R3 R4 X-Y Q H No. R 1 R 2 R 5 R 3 R 4 XY Q
H  H
I.4-36 CH3 H H o=: Q-4.5 I.4-36 CH 3 HH o =: Q-4.5
H  H
H °- H ° -
I.4-37 H Q-4.5 I.4-37 H Q-4.5
H~~f\ H ~~ f \
H  H
I.4-38 H o=: Q-4.5  I.4-38 H o =: Q-4.5
H~~f\ H ~~ f \
H °- H H ° - H
I.4-39 H Q-4.5 I.4-39 H Q-4.5
H~~f\ H ~~ f \
H H
H H H H
I.4-40 H o=: Q-4.5  I.4-40 H o =: Q-4.5
H  H
°- ° -
1.4-41 CH3 H H Q-4.6 1.4-41 CH 3 HH Q-4.6
I.4-42 CH3 H H o=: Q-4.6 I.4-42 CH 3 HH o =: Q-4.6
°- H  ° - H
I.4-43 CH3 H H Q-4.6 I.4-43 CH 3 HH Q-4.6
H H
H H
I.4-44 CH3 H H o=: Q-4.6 I.4-44 CH 3 HH o =: Q-4.6
H  H
H °- H ° -
I.4-45 H Q-4.6 I.4-45 H Q-4.6
H H
I.4-46 H o=: Q-4.6  I.4-46 H o =: Q-4.6
H~~f\ H ~~ f \
H °- H H ° - H
I.4-47 H Q-4.6 I.4-47 H Q-4.6
H H
H H H H
I.4-48 H o=: Q-4.6  I.4-48 H o =: Q-4.6
H  H
°- ° -
I.4-49 CH3 H H Q-4.7 No. R1 R2 R5 R3 R4 X-Y QI.4-49 CH 3 HH Q-4.7 No. R 1 R 2 R 5 R 3 R 4 XY Q
I.4-50 CH3 H H o=: Q-4.7 I.4-50 CH 3 HH o =: Q-4.7
°- H  ° - H
1.4-51 CH3 H H Q-4.7 1.4-51 CH 3 HH Q-4.7
H H
H H
I.4-52 CH3 H H o=: Q-4.7 I.4-52 CH 3 HH o =: Q-4.7
H  H
H °- H ° -
I.4-53 H Q-4.7 I.4-53 H Q-4.7
H H
I.4-54 H o=: Q-4.7  I.4-54 H o =: Q-4.7
H~~f\ H ~~ f \
H °- H H ° - H
I.4-55 H Q-4.7 I.4-55 H Q-4.7
H H
H H H H
I.4-56 H o=: Q-4.7  I.4-56 H o =: Q-4.7
H  H
°- ° -
I.4-57 CH3 H H Q-4.8 I.4-57 CH 3 HH Q-4.8
I.4-58 CH3 H H o=: Q-4.8 I.4-58 CH 3 HH o =: Q-4.8
°- H  ° - H
I.4-59 CH3 H H Q-4.8 I.4-59 CH 3 HH Q-4.8
H H
H H
I.4-60 CH3 H H o=: Q-4.8 I.4-60 CH 3 HH o =: Q-4.8
H  H
H °- H ° -
1.4-61 H Q-4.8 1.4-61 H Q-4.8
H~~f\ H ~~ f \
H  H
I.4-62 H o=: Q-4.8  I.4-62 H o =: Q-4.8
H °- HH ° - H
I.4-63 H Q-4.8 I.4-63 H Q-4.8
H No. R1 R2 R5 R3 R4 X-Y QH No. R 1 R 2 R 5 R 3 R 4 XY Q
H H H H
I.4-64 H o=: Q-4.8  I.4-64 H o =: Q-4.8
H  H
°- ° -
I.4-65 CH3 H H Q-4.9 I.4-65 CH 3 HH Q-4.9
I.4-66 CH3 H H o=: Q-4.9 I.4-66 CH 3 HH o =: Q-4.9
°- H  ° - H
I.4-67 CH3 H H Q-4.9 I.4-67 CH 3 HH Q-4.9
H H
H H
I.4-68 CH3 H H o=: Q-4.9 I.4-68 CH 3 HH o =: Q-4.9
H  H
H °- H ° -
I.4-69 H Q-4.9 I.4-69 H Q-4.9
H H
I.4-70 H o=: Q-4.9  I.4-70 H o =: Q-4.9
H~~f\ H ~~ f \
H °- H H ° - H
1.4-71 H Q-4.9 1.4-71 H Q-4.9
H H
H H H H
I.4-72 H o=: Q-4.9  I.4-72 H o =: Q-4.9
H  H
I.4-73 CF3 H H Q-4.7 I.4-73 CF 3 HH Q-4.7
I.4-74 CF3 H H o=: Q-4.7 I.4-74 CF 3 HH o =: Q-4.7
H  H
I.4-75 CF3 H H Q-4.7 I.4-75 CF 3 HH Q-4.7
H H
H H
I.4-76 CF3 H H o=: Q-4.7 I.4-76 CF 3 HH o =: Q-4.7
H  H
I.4-77 CF3 H SiEt3 o=: Q-4.7 I.4-77 CF 3 H SiEt 3 o =: Q-4.7
H  H
I.4-78 CF3 H SiEt3 o=: Q-4.7 I.4-78 CF 3 H SiEt 3 o =: Q-4.7
H Tabelle 5: H Table 5:
No. R1 R2 R5 R3 R4 X No. R 1 R 2 R 5 R 3 R 4 X
°- ° -
11.1 CH3 H H Cl 11.1 CH 3 HH Cl
II.2 CH3 H H o=: Cl II.2 CH 3 HH o =: Cl
°- ° -
II.3 CH3 H SiEt3 Cl II.3 CH 3 H SiT 3 Cl
II.4 CH3 H SiEt3 o=: Cl II.4 CH 3 H SiT 3 o =: Cl
°- ° -
II.5 CH3 H SiMe2(t-Hex) Cl II.5 CH 3 H SiMe 2 (t-Hex) Cl
II S CH3 H SiMe2(t-Hex) o=: Cl II S CH 3 H SiMe 2 (t-Hex) o =: Cl
°- ° -
II.7 CH3 H SiMe2Ph Cl II.7 CH 3 H SiMe 2 Ph Cl
II.8 CH3 H SiMe2Ph o=: Cl II.8 CH 3 H SiMe 2 Ph o =: Cl
°- ° -
II.9 CH3 H SiMe2(t-Bu) Cl II.9 CH 3 H SiMe 2 (t-Bu) Cl
11.10 CH3 H SiMe2(t-Bu) o=: Cl 11.10 CH 3 H SiMe 2 (t-Bu) o =: Cl
H °- H ° -
11.1 1 H Cl 11.1 1 H Cl
H H
11.12 H o=: Cl  11.12 H o =: Cl
H~~f\ H ~~ f \
H °- H ° -
11.13 SiEt3 Cl 11.13 SiEt 3 Cl
H H
11.14 SiEt3 o=: Cl No. R1 R2 R5 R3 R4 X11.14 SiEt 3 o =: Cl No. R 1 R 2 R 5 R 3 R 4 X
H °-H ° -
11.15 SiMe2(t-Hex) Cl 11.15 SiMe 2 (t-Hex) Cl
H H
11.16 SiMe2(t-Hex) o=: Cl 11.16 SiMe 2 (t-hex) o =: Cl
H °-H ° -
11.17 SiMe2Ph Cl 11.17 SiMe 2 Ph Cl
H H
11.18 SiMe2Ph o=: Cl 11.18 SiMe 2 Ph o =: Cl
H °-H ° -
11.19 SiMe2(t-Bu) Cl 11.19 SiMe 2 (t-Bu) Cl
H~~f\ H ~~ f \
H H
II.20 SiMe2(t-Bu) o=: Cl II.20 SiMe 2 (t-Bu) o =: Cl
°- ° -
11.21 CH3 H H Br 11.21 CH 3 HH Br
II.22 CH3 H H o=: Br II.22 CH 3 HH o =: Br
°- ° -
II.23 CH3 H SiEt3 Br II.23 CH 3 H 3 3 Br
II.24 CH3 H SiEt3 o=: Br II.24 CH 3 H siEt 3 o =: Br
°- ° -
II.25 CH3 H SiMe2(t-Hex) Br II.25 CH 3 H SiMe 2 (t-Hex) Br
II.26 CH3 H SiMe2(t-Hex) o=: Br II.26 CH 3 H SiMe 2 (t-Hex) o =: Br
°- ° -
U.27 CH3 H SiMe2Ph Br U.27 CH 3 H SiMe 2 Ph Br
II.28 CH3 H SiMe2Ph o=: Br II.28 CH 3 H SiMe 2 Ph o =: Br
°- ° -
II.29 CH3 H SiMe2(t-Bu) Br II.29 CH 3 H SiMe 2 (t-Bu) Br
II.30 CH3 H SiMe2(t-Bu) o=: Br No. R1 R2 R5 R3 R4 XII.30 CH 3 H SiMe 2 (t-Bu) o =: Br No. R 1 R 2 R 5 R 3 R 4 X
H °-H ° -
11.31 H Br 11.31 H Br
HH
II.32 H o=: Br II.32 H o =: Br
H °-H ° -
II.33 SiEt3 Br II.33 SiEt 3 Br
HH
II.34 SiEt3 o=: Br II.34 SiEt 3 o =: Br
H °-H ° -
II.35 SiMe2(t-Hex) Br II.35 SiMe 2 (t-Hex) Br
H~~f\ H ~~ f \
H H
II.36 SiMe2(t-Hex) o=: Br II.36 SiMe 2 (t-hex) o =: Br
H °-H ° -
II.37 SiMe2Ph Br II.37 SiMe 2 Ph Br
HH
II.38 SiMe2Ph o=: Br II.38 SiMe 2 Ph o =: Br
H~~f\ H ~~ f \
H °- H ° -
II.39 SiMe2(t-Bu) Br II.39 SiMe 2 (t-Bu) Br
HH
II.40 SiMe2(t-Bu) o=: Br II.40 SiMe 2 (t-Bu) o =: Br
°- ° -
11.41 CH3 H H 11.41 CH 3 HH
11
II.42 CH3 H H o=: II.42 CH 3 HH o =:
11
°-° -
II.43 CH3 H SiEt3 II.43 CH 3 H 3
11
II.44 CH3 H SiEt3 o=: II.44 CH 3 H SiEt 3 o =:
11
°-° -
II.45 CH3 H SiMe2(t-Hex) II.45 CH 3 H SiMe 2 (t-Hex)
1 No. R1 R2 R5 R3 R4 X 1 No. R 1 R 2 R 5 R 3 R 4 X
II.46 CH3 H SiMe2(t-Hex) θ=: II.46 CH 3 H SiMe 2 (t-Hex) θ =:
11
°-° -
II.47 CH3 H SiMe2Ph II.47 CH 3 H SiMe 2 Ph
' '
II.48 CH3 H SiMe2Ph o=: II.48 CH 3 H SiMe 2 Ph o =:
11
°-° -
II.49 CH3 H SiMe2(t-Bu) II.49 CH 3 H SiMe 2 (t-Bu)
II.50 CH3 H SiMe2(t-Bu) o=: II.50 CH 3 H SiMe 2 (t-Bu) o =:
11
H °-H ° -
11.51 H 11.51 H
HH
II.52 H o=: II.52 H o =:
H °-H ° -
II.53 SiEt3 II.53 SiEt 3
H~~f\ H ~~ f \
H H
II.54 SiEt3 o=: II.54 SiEt 3 o =:
H °-H ° -
II.55 SiMe2(t-Hex) II.55 SiMe 2 (t-Hex)
H~~f\ H ~~ f \
H H
II.56 SiMe2(t-Hex) o=: II.56 SiMe 2 (t-hex) o =:
H °-H ° -
II.57 SiMe2Ph II.57 SiMe 2 Ph
HH
II.58 SiMe2Ph o=: II.58 SiMe 2 Ph o =:
H~~f\ H ~~ f \
H °- H ° -
II.59 SiMe2(t-Bu) II.59 SiMe 2 (t-Bu)
HH
II.60 SiMe2(t-Bu) o=: Spektroskopische Daten ausgewählter Tabellenbeispiele: Beispiel No.1.1-1: II.60 SiMe 2 (t-Bu) o =: Spectroscopic data of selected table examples: Example No.1.1-1:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (m, 2H), 7.30 (m, 3H), 5.53 / 5.42 (s, 1 H), 4.23 / 3.61 (m, 2H), 2.11 (d, 1 H), 1.98 (s, 3H), 1.87 (d, 1 H), 1.24 (m, 6H), 1.16 (m, 6H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.42 (m, 2H), 7.30 (m, 3H), 5.53 / 5.42 (s, 1H), 4.23 / 3.61 (m, 2H), 2.11 (i.e. , 1H), 1.98 (s, 3H), 1.87 (d, 1H), 1.24 (m, 6H), 1.16 (m, 6H).
Beispiel No.1.1-2: Example No.1.1-2:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (m, 2H), 7.33 (m, 3H), 5.88 (s, 1 H), 2.62 (d, 1H), 2.46 (d, 1H), 2.30 (br. s, 1H, OH), 2.19 (s, 3H), 1.29 (s, 3H), 1.16 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.42 (m, 2H), 7.33 (m, 3H), 5.88 (s, 1H), 2.62 (d, 1H), 2.46 (d, 1H), 2.30 (brs s, 1H, OH), 2.19 (s, 3H), 1.29 (s, 3H), 1.16 (s, 3H).
Beispiel No.1.1-13: Example No.1.1-13:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.58 (d, 1 H), 7.53 (m, 1 H), 7.42 (m, 1 H), 7.22 (m, 1H), 5.56/5.43 (s, 1H), 4.22/3.62 (m, 2H), 2.28 (br. s, 1H, OH), 2.15 (d, 1H), 2.01 / 1.98 (s, 3H), 1.88 (d, 1H), 1.25 (m, 6H), 1.17 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.58 (d, 1H), 7.53 (m, 1H), 7.42 (m, 1H), 7.22 (m, 1H), 5.56 / 5.43 (s, 1H), 4.22 / 3.62 (m, 2H), 2.28 (brs s, 1H, OH), 2.15 (d, 1H), 2.01 / 1.98 (s, 3H), 1.88 (d, 1H), 1.25 (m, 6H), 1.17 (m, 6H).
Beispiel No.1.1-14: Example No.1.1-14:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.61 (d, 1 H), 7.68 (d, 1 H), 7.43 (m, 1 H), 7.28 (m, 1H), 5.90 (s, 1H), 2.87 (br. s, 1H, OH), 2.63 (d, 1H), 2.48 (d, 1H), 2.19 (s, 3H), 1.31 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.61 (d, 1H), 7.68 (d, 1H), 7.43 (m, 1H), 7.28 (m, 1H), 5.90 (s, 1H) , 2.87 (brs s, 1H, OH), 2.63 (d, 1H), 2.48 (d, 1H), 2.19 (s, 3H), 1.31 (s, 3H), 1.17 (s, 3H).
Beispiel No.1.1-19: Example No.1.1-19:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.60 / 8.58 (d, 1 H), 7.63 (m, 1 H), 7.47 / 7.44 (m, 1 H), 7.23 (m, 1 H), 5.44 / 5.31 (s, 1 H), 4.36 / 3.69 (m, 2H), 2.42 / 2.34 (br. s, 1 H, OH), 2.05 / 2.04 (s, 3H), 1.95 / 1.40 (m, 1 H), 1.51 /1.49 (s, 3H), 1.28 (m, 3H), 1.23 (m, 3H), 1.18/0.68 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.60 / 8.58 (d, 1H), 7.63 (m, 1H), 7.47 / 7.44 (m, 1H), 7.23 (m, 1H), 5.44 / 5.31 (s, 1H), 4.36 / 3.69 (m, 2H), 2.42 / 2.34 (brs s, 1H, OH), 2.05 / 2.04 (s, 3H), 1.95 / 1.40 (m, 1H) , 1.51 / 1.49 (s, 3H), 1.28 (m, 3H), 1.23 (m, 3H), 1.18 / 0.68 (m, 2H).
Beispiel No.1.1-20: Example No.1.1-20:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.62 / 8.59 (d, 1 H), 7.68 (m, 1 H), 7.48 / 7.42 (d, 1H), 7.29 (m, 1H), 5.73/5.66 (s, 1H), 3.58 (br. m, 1H, OH), 2.22/2.13 (s, 3H), 1.96/ 1.72 (m, 1H), 1.57/1.55 (s, 3H), 1.23/1.18 (m, 2H). Beispiel No.1.1-73: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.62 / 8.59 (d, 1H), 7.68 (m, 1H), 7.48 / 7.42 (d, 1H), 7.29 (m, 1H), 5.73 / 5.66 (s, 1H), 3.58 (br, m, 1H, OH), 2.22 / 2.13 (s, 3H), 1.96 / 1.72 (m, 1H), 1.57 / 1.55 (s, 3H), 1.23 / 1.18 (m, 2H). Example No.1.1-73:
1H-NMR(400MHz, CDC δ, ppm) 7.38 (d, 1H), 7.19 (m, 2H), 7.11 (m, 1H), 5.43 (s, 1H), 4.22 (m, 1H), 3.60 (m, 1H), 2.41 (s, 3H), 2.08 (d, 1H), 1.89 (d, 1H), 1.98 (s, 3H), 1.24 (m, 6H), 1.16 (m, 6H). 1 H NMR (400MHz, CDC δ, ppm) 7.38 (d, 1H), 7.19 (m, 2H), 7.11 (m, 1H), 5.43 (s, 1H), 4.22 (m, 1H), 3.60 (m , 1H), 2.41 (s, 3H), 2.08 (d, 1H), 1.89 (d, 1H), 1.98 (s, 3H), 1.24 (m, 6H), 1.16 (m, 6H).
Beispiel No.1.1-74: Example No.1.1-74:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.39 (d, 1 H), 7.20 (m, 2H), 7.13 (dd, 1 H), 5.89 (s, 1H), 2.63 (d, 1H), 2.47 (d, 1H), 2.41 (s, 3H), 2.27 (br. s, 1H, OH), 2.20 (s, 3H), 1.53 (s, 3H), 1.30 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.39 (d, 1H), 7.20 (m, 2H), 7.13 (dd, 1H), 5.89 (s, 1H), 2.63 (d, 1H), 2.47 (d, 1H), 2.41 (s, 3H), 2.27 (br, s, 1H, OH), 2.20 (s, 3H), 1.53 (s, 3H), 1.30 (s, 3H).
Beispiel No.1.1-79: Example No.1.1-79:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.43 (m, 1 H), 7.20 (m, 2H), 7.12 (m, 1 H), 5.42 / 5.30 (s, 1H), 4.38/3.70 (m, 2H), 2.43 (s, 3H), 2.13 (br. s, 1H, OH), 2.04/1.95 (s, 3H), 1.49 / 1.42 (d, 3H), 1.28 (m, 6H), 1.20 / 1.07 (m, 1 H), 0.66 / 0.42 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.43 (m, 1H), 7.20 (m, 2H), 7.12 (m, 1H), 5.42 / 5.30 (s, 1H), 4.38 / 3.70 (m , 2H), 2.43 (s, 3H), 2.13 (br s, 1H, OH), 2.04 / 1.95 (s, 3H), 1.49 / 1.42 (d, 3H), 1.28 (m, 6H), 1.20 / 1.07 (m, 1H), 0.66 / 0.42 (m, 2H).
Beispiel No.1.1-80: Example No.1.1-80:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.46 (d, 1H), 7.22 (m, 1H), 7.18 (m, 2H), 5.73/ 5.64 (s, 1 H), 2.48 (br. s, 1 H, OH), 2.47 / 2.39 (s, 3H), 2.21 / 2.14 (s, 3H), 1.97 / 1.79 (m, 1H), 1.56/1.46 (s, 3H), 1.19/0.93 (m, 2H). 1 H NMR (400MHz, CDCl3 δ, ppm) 7.46 (d, 1H), 7.22 (m, 1H), 7.18 (m, 2H), 5.73 / 5.64 (s, 1H), 2.48 (br, s, 1 H, OH), 2.47 / 2.39 (s, 3H), 2.21 / 2.14 (s, 3H), 1.97 / 1.79 (m, 1H), 1.56 / 1.46 (s, 3H), 1.19 / 0.93 (m, 2H).
Beispiel No.1.1-97: Example No.1.1-97:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.30 (d, 2H), 7.10 (d, 2H), 5.52 / 5.43 / 5.41 (s, 1 H), 4.24 / 3.60 (m, 2H), 2.34 (s, 3H), 2.11 (d, 1 H), 2.02 / 1.93 (br. s, 1 H, OH), 1.99 / 1.97 (s, 3H), 1.87 (d, 1H), 1.23 (m, 6H), 1.18 (m,6H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.30 (d, 2H), 7.10 (d, 2H), 5.52 / 5.43 / 5.41 (s, 1H), 4.24 / 3.60 (m, 2H), 2.34 ( s, 3H), 2.11 (d, 1H), 2.02 / 1.93 (brs s, 1H, OH), 1.99 / 1.97 (s, 3H), 1.87 (d, 1H), 1.23 (m, 6H), 1.18 (m, 6H).
Beispiel No.1.1-98: Example No.1.1-98:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.31 (d, 2H), 7.12 (d, 2H), 5.88 (s, 1H), 2.61 (d, 1H), 2.45 (d, 1H), 2.36 (s, 3H), 2.27 (br. s, 1H, OH), 2.18 (s, 3H), 1.28 (s, 3H), 1.15 (s, 3H). Beispiel No.1.1-109: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.31 (d, 2H), 7.12 (d, 2H), 5.88 (s, 1H), 2.61 (d, 1H), 2.45 (d, 1H), 2.36 ( s, 3H), 2.27 (br s, 1H, OH), 2.18 (s, 3H), 1.28 (s, 3H), 1.15 (s, 3H). Example No.1.1-109:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.09 (m, 1 H), 7.02 (d, 2H), 5.54 / 5.42 (s, 1 H), 4.22/3.59 (m, 2H), 2.42 (s, 6H), 2.10 (d, 1H), 2.03/2.00 (s, 3H), 1.94 (d, 1H), 1.88/ 1.79 (br. s, 1H, OH), 1.24 (m, 6H), 1.20 (m, 3H), 1.18 (m, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.09 (m, 1H), 7.02 (d, 2H), 5.54 / 5.42 (s, 1H), 4.22 / 3.59 (m, 2H), 2.42 ( s, 6H), 2.10 (d, 1H), 2.03 / 2.00 (s, 3H), 1.94 (d, 1H), 1.88 / 1.79 (brs s, 1H, OH), 1.24 (m, 6H), 1.20 ( m, 3H), 1.18 (m, 3H).
Beispiel No.1.1-110: Example No.1.1-110:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.14 (dd, 1H), 7.05 (d, 2H), 5.89 (s, 1H), 2.63 (d, 1H), 2.47 (d, 1H), 2.41 (s, 6H), 2.28 (br. s, 1H, OH), 2.21 (s, 3H), 1.32 (s, 3H), 1.18 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.14 (dd, 1H), 7.05 (d, 2H), 5.89 (s, 1H), 2.63 (d, 1H), 2.47 (d, 1H), 2.41 ( s, 6H), 2.28 (br s, 1H, OH), 2.21 (s, 3H), 1.32 (s, 3H), 1.18 (s, 3H).
Beispiel No.1.1-133: Example No.1.1-133:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.24 (s, 1 H), 7.09 (m, 1 H), 5.54 / 5.42 (s, 1 H), 4.23 / 3.62 (m, 2H), 2.33 (br. s, 1 H, OH), 2.29 (s, 3H), 2.09 (d, 1 H), 1.99 / 1.97 (s, 3H), 1.88 (d, 1H), 1.23 (m, 6H), 1.20 (m, 3H), 1.18 (m, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.24 (s, 1H), 7.09 (m, 1H), 5.54 / 5.42 (s, 1H), 4.23 / 3.62 (m, 2H), 2.33 ( br. s, 1H, OH), 2.29 (s, 3H), 2.09 (d, 1H), 1.99 / 1.97 (s, 3H), 1.88 (d, 1H), 1.23 (m, 6H), 1.20 ( m, 3H), 1.18 (m, 3H).
Beispiel No.1.1-134: Example No.1.1-134:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.29 (s, 1H), 7.11 (m, 1H), 5.89 (s, 1H), 2.58 (d, 1H), 2.47 (d, 1H), 2.35 (br. s, 1H, OH), 2.32 (s, 3H), 2.18 (s, 3H), 1.28 (s, 3H), 1.16 (s, 3H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.29 (s, 1H), 7.11 (m, 1H), 5.89 (s, 1H), 2.58 (d, 1H), 2.47 (d, 1H), 2.35 (br s, 1H, OH), 2.32 (s, 3H), 2.18 (s, 3H), 1.28 (s, 3H), 1.16 (s, 3H).
Beispiel No.1.1-115: Example No.1.1-115:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.09 (m, 1 H), 7.00 (m, 2H), 5.42 / 5.29 (s, 1 H), 4.36/3.70 (m, 2H), 2.43/2.41 (s, 6H), 2.16/2.06 (s, 3H), 1.96/1.78 (m, 1H), 1.51 / 1.49 (s, 3H), 1.29 (m, 3H), 1.22 (m, 3H), 1.19/0.65 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7:09 (m, 1 H) 7.00 (m, 2H), 5.42 / 5.29 (s, 1 H), 4:36 / 3.70 (m, 2H), 2.43 / 2:41 (s, 6H), 2.16 / 2.06 (s, 3H), 1.96 / 1.78 (m, 1H), 1.51 / 1.49 (s, 3H), 1.29 (m, 3H), 1.22 (m, 3H), 1.19 / 0.65 (m, 2H).
Beispiel No.1.1-116: Example No.1.1-116:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.12 (m, 1 H), 7.04 (m, 2H), 5.73 / 5.64 (s, 1 H), 2.56 / 2.49 (s, 6H), 2.23 / 2.16 (s, 3H), 1.98 / 1.93 (m, 1 H), 1.57 / 1.55 (s, 3H), 1.31 / 1.20 (m, 2H). Beispiel No.1.1-121: 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.12 (m, 1H), 7.04 (m, 2H), 5.73 / 5.64 (s, 1H), 2.56 / 2.49 (s, 6H), 2.23 / 2.16 (s, 3H), 1.98 / 1.93 (m, 1H), 1.57 / 1.55 (s, 3H), 1.31 / 1.20 (m, 2H). Example No.1.1-121:
1H-NMR(400MHz, CDC δ, ppm) 7.17 (m, 1H), 7.05 (d, 2H), 5.54/5.42 (s, 1H), 4.23/3.61 (m, 2H), 2.80 (m, 4H), 2.11 (d, 1H), 2.02/1.99 (s, 3H), 1.98 / 1.96 (br. s, 1H, OH), 1.89 (d, 1H), 1.21 (m, 12H), 1.16 (m, 6H). 1 H-NMR (400MHz, CDC δ, ppm) 7.17 (m, 1H), 7.05 (d, 2H), 5.54 / 5.42 (s, 1H), 4.23 / 3.61 (m, 2H), 2.80 (m, 4H) , 2.11 (d, 1H), 2.02 / 1.99 (s, 3H), 1.98 / 1.96 (brs s, 1H, OH), 1.89 (d, 1H), 1.21 (m, 12H), 1.16 (m, 6H) ,
Beispiel No.1.1-122: Example No.1.1-122:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.21 (dd, 1 H), 7.08 (d, 2H), 5.90 (s, 1 H), 2.79 (q, 4H), 2.66 (d, 1H), 2.44 (d, 1H), 2.29 (br. s, 1H, OH), 2.20 (s, 3H), 1.31 (s, 3H), 1.21 (t, 6H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.21 (dd, 1H), 7.08 (d, 2H), 5.90 (s, 1H), 2.79 (q, 4H), 2.66 (d, 1H), 2.44 (d, 1H), 2.29 (br s, 1H, OH), 2.20 (s, 3H), 1.31 (s, 3H), 1.21 (t, 6H), 1.17 (s, 3H).
Beispiel No.1.1-147: Example No.1.1-147:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.63 (d, 1 H), 7.54 (m, 2H), 7.40 (m, 1 H), 6.09 (d, 1 H), 5.68 (s, 1 H), 5.20 (d, 1 H), 4.20 / 3.58 (m, 2H), 1.92 (d, 1 H), 1.84 (d, 1 H), 1.81 (s, 3H), 1.24 (m, 3H), 1.22 (s, 3H), 1.14 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.63 (d, 1H), 7.54 (m, 2H), 7.40 (m, 1H), 6.09 (d, 1H), 5.68 (s, 1H ), 5.20 (d, 1H), 4.20 / 3.58 (m, 2H), 1.92 (d, 1H), 1.84 (d, 1H), 1.81 (s, 3H), 1.24 (m, 3H), 1.22 (s, 3H), 1.14 (m, 6H).
Beispiel No.1.1-148: Example No.1.1-148:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.65 (d, 1 H), 7.52 (m, 2H), 7.38 (m, 1 H), 7.12 (d, 1H), 6.19 (d, 1H), 5.96 (s, 1H), 2.54 (d, 1H), 2.33 (d, 1H), 1.97 (s, 3H), 1.14 (s, 3H), 1.10 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.65 (d, 1H), 7.52 (m, 2H), 7.38 (m, 1H), 7.12 (d, 1H), 6.19 (d, 1H), 5.96 (s, 1H), 2.54 (d, 1H), 2.33 (d, 1H), 1.97 (s, 3H), 1.14 (s, 3H), 1.10 (s, 3H).
Beispiel No.1.1-151: Example No.1.1-151:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.63 (m, 2H), 7.48 (m, 1 H), 7.39 (m, 1 H), 5.43 / 5.29 (s, 1 H), 4.32 / 3.71 (m, 2H), 1.99 (br. s, 1 H, OH), 1.58 / 1.42 (s, 3H), 1.46 / 1.39 (d, 3H), 1.32/1.24 (d, 3H), 1.21 (m, 3H), 1.19/1.09 (m, 1H), 0.66/0.42 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.63 (m, 2H), 7.48 (m, 1H), 7.39 (m, 1H), 5.43 / 5.29 (s, 1H), 4.32 / 3.71 ( m, 2H), 1.99 (br s, 1H, OH), 1.58 / 1.42 (s, 3H), 1.46 / 1.39 (d, 3H), 1.32 / 1.24 (d, 3H), 1.21 (m, 3H) , 1.19 / 1.09 (m, 1H), 0.66 / 0.42 (m, 2H).
Beispiel No.1.1-152: Example No.1.1-152:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.68 (d, 1 H), 7.64 (d, 1 H), 7.52 (dd, 1 H), 7.45 (dd, 1 H), 5.73 (s, 1 H), 2.49 (br. s, 1 H, OH), 2.20 (s, 3H), 1.96 / 1.77 (m, 1 H), 1.44 (s, 3H), 1.21 /0.94 (m, 2H). Beispiel No.1.1-153: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.68 (d, 1H), 7.64 (d, 1H), 7.52 (dd, 1H), 7.45 (dd, 1H), 5.73 (s, 1 H), 2.49 (br s, 1H, OH), 2.20 (s, 3H), 1.96 / 1.77 (m, 1H), 1.44 (s, 3H), 1.21 / 0.94 (m, 2H). Example No.1.1-153:
1H-NMR(400MHz, CDC δ, ppm) 7.62 (m, 2H), 7.58 (m, 1H), 7.49 (m, 1H), 7.18 (m, 1 H), 6.28 / 6.14 / 6.01 (d, 1 H), 5.42 / 5.31 / 5.28 (s, 1 H), 4.38 / 3.72 (m, 2H), 2.00 / 1.89 (br. s, 1H, OH), 1.79/1.54 (m, 1H), 1.72/1.61 (s, 3H), 1.28 (m, 6H), 1.22/1.19 (m, 3H), 1.04/0.61 / 0.38 (m, 2H). 1 H-NMR (400MHz, CDCδ, ppm) 7.62 (m, 2H), 7.58 (m, 1H), 7.49 (m, 1H), 7.18 (m, 1H), 6.28 / 6.14 / 6.01 (d, 1 H), 5.42 / 5.31 / 5.28 (s, 1H), 4.38 / 3.72 (m, 2H), 2.00 / 1.89 (brs s, 1H, OH), 1.79 / 1.54 (m, 1H), 1.72 / 1.61 ( s, 3H), 1.28 (m, 6H), 1.22 / 1.19 (m, 3H), 1.04 / 0.61 / 0.38 (m, 2H).
Beispiel No.1.1-154: Example No.1.1-154:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.67 (m, 2H), 7.55 (m, 2H), 7.38 (m, 1H), 6.20 / 6.04 (d, 1 H), 5.74 / 5.52 (s, 1 H), 2.00 (br. s, 1 H, OH), 1.93 / 1.72 (m, 1 H), 1.91 /1.84 (s, 3H), 1.29/ 1.24 (s, 3H), 1.21 / 1.19 / 0.92 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.67 (m, 2H), 7.55 (m, 2H), 7.38 (m, 1H), 6.20 / 6.04 (d, 1H), 5.74 / 5.52 (s, 1H), 2.00 (brs s, 1H, OH), 1.93 / 1.72 (m, 1H), 1.91 / 1.84 (s, 3H), 1.29 / 1.24 (s, 3H), 1.21 / 1.19 / 0.92 ( m, 2H).
Beispiel No.1.1-157: Example No.1.1-157:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.66 (s, 1 H), 7.57 (m, 2H), 7.42 (m, 1 H), 5.55 / 5.43 (s, 1H), 4.23/3.61 (m, 2H), 2.10 (d, 1H), 2.02/1.94 (br. s, 1H, OH), 1.99/1.96 (s, 3H), 1.87 (d, 1H), 1.25 (m, 6H), 1.17 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.66 (s, 1H), 7.57 (m, 2H), 7.42 (m, 1H), 5.55 / 5.43 (s, 1H), 4.23 / 3.61 (m , 2H), 2.10 (d, 1H), 2.02 / 1.94 (br s, 1H, OH), 1.99 / 1.96 (s, 3H), 1.87 (d, 1H), 1.25 (m, 6H), 1.17 (m , 6H).
Beispiel No.1.1-158: Example No.1.1-158:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.68 (s, 1 H), 7.59 (m, 2H), 7.47 (m, 1 H), 5.90 (s, 1H), 2.61 (d, 1H), 2.48 (d, 1H), 2.31 (br. s, 1H, OH), 2.19 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.68 (s, 1H), 7.59 (m, 2H), 7.47 (m, 1H), 5.90 (s, 1H), 2.61 (d, 1H), 2.48 (d, 1H), 2.31 (br s, 1H, OH), 2.19 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H).
Beispiel No.1.1-161: Example No.1.1-161:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.68 (s, 1 H), 7.51 (m, 2H), 7.47 (dd, 1 H), 5.91 (s, 1H), 2.61 (d, 1H), 2.48 (d, 1H), 2.19 (s, 3H), 1.29 (s, 3H), 1.19 (s, 3H), 0.94 (t, 9H), 0.52 (q, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.68 (s, 1H), 7.51 (m, 2H), 7.47 (dd, 1H), 5.91 (s, 1H), 2.61 (d, 1H), 2.48 (d, 1H), 2.19 (s, 3H), 1.29 (s, 3H), 1.19 (s, 3H), 0.94 (t, 9H), 0.52 (q, 6H).
Beispiel No.1.1-163: Example No.1.1-163:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.71 (s, 1 H), 7.62 (m, 1 H), 7.57 (m, 1 H), 7.43 (m, 1H), 5.43/5.30 (s, 1H), 4.35/3.70 (m, 2H), 2.23 / 2.19 (br. s, 1H, OH), 2.09/2.03 (s, 3H), 1.94 / 1.42 (m, 1 H), 1.49 / 1.48 (s, 3H), 1.29 (m, 3H), 1.26 (m, 3H), 1.20 / 0.67 (m, 2H). Beispiel No.1.1-164: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.71 (s, 1H), 7.62 (m, 1H), 7.57 (m, 1H), 7.43 (m, 1H), 5.43 / 5.30 (s, 1H), 4.35 / 3.70 (m, 2H), 2.23 / 2.19 (brs s, 1H, OH), 2.09 / 2.03 (s, 3H), 1.94 / 1.42 (m, 1H), 1.49 / 1.48 (s, 3H), 1.29 (m, 3H), 1.26 (m, 3H), 1.20 / 0.67 (m, 2H). Example No.1.1-164:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.73 (s, 1 H), 7.67 (m, 1 H), 7.60 (m, 1 H), 7.48 (m, 1H), 5.73/ 5.64 (s, 1H), 2.85/2.51 (br. s, 1H, OH), 2.21 / 2.13 (s, 3H), 1.97/1.29 (m, 1 H), 1.56 / 1.55 (s, 3H), 1.26 / 1.20 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.73 (s, 1H), 7.67 (m, 1H), 7.60 (m, 1H), 7.48 (m, 1H), 5.73 / 5.64 (s , 1H), 2.85 / 2.51 (brs s, 1H, OH), 2.21 / 2.13 (s, 3H), 1.97 / 1.29 (m, 1H), 1.56 / 1.55 (s, 3H), 1.26 / 1.20 (m , 2H).
Beispiel No.1.1-169: Example No.1.1-169:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.54 (d, 2H), 7.52 (d, 2H), 5.56 / 5.46 / 5.43 (s, 1H), 4.24/3.61 (m, 2H), 2.10 (d, 1H), 2.02/1.94 (br. s, 1H, OH), 1.99/1.97 (s, 3H), 1.88 (d, 1H), 1.24 (m, 9H), 1.18 (m, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.54 (d, 2H), 7.52 (d, 2H), 5.56 / 5.46 / 5.43 (s, 1H), 4.24 / 3.61 (m, 2H), 2.10 (i.e. , 1H), 2.02 / 1.94 (br s, 1H, OH), 1.99 / 1.97 (s, 3H), 1.88 (d, 1H), 1.24 (m, 9H), 1.18 (m, 3H).
Beispiel No.1.1-170: Example No.1.1-170:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.60 (d, 2H), 7.54 (d, 2H), 5.91 (s, 1 H), 2.60 (d, 1H), 2.47 (d, 1H), 2.31 (br. s, 1H, OH), 2.18 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H). Beispiel No.1.1-193: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.60 (d, 2H), 7.54 (d, 2H), 5.91 (s, 1H), 2.60 (d, 1H), 2.47 (d, 1H), 2.31 (brs s, 1H, OH), 2.18 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H). Example No.1.1-193:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.41 (m, 1 H), 7.29 (m, 1 H), 7.08 (m, 2H), 5.56 / 5.45 / 5.42 (s, 1 H), 4.22 / 3.60 (m, 2H), 2.12 (d, 1 H), 2.03 / 1.98 (br. s, 1 H, OH), 2.01 / 1.99 (s, 3H), 1.90 (d, 1H), 1.22 (m, 6H), 1.17 (m, 6H). Beispiel No.1.1-194: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.41 (m, 1H), 7.29 (m, 1H), 7.08 (m, 2H), 5.56 / 5.45 / 5.42 (s, 1H), 4.22 / 3.60 (m, 2H), 2.12 (d, 1H), 2.03 / 1.98 (br s, 1H, OH), 2.01 / 1.99 (s, 3H), 1.90 (d, 1H), 1.22 (m, 6H ), 1.17 (m, 6H). Example No.1.1-194:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (m, 1 H), 7.33 (m, 1 H), 7.11 (m, 2H), 5.90 (s, 1H), 2.62 (d, 1H), 2.46 (d, 1H), 2.35 (br. s, 1H, OH), 2.19 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H). Beispiel No.1.1-257: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.42 (m, 1H), 7.33 (m, 1H), 7.11 (m, 2H), 5.90 (s, 1H), 2.62 (d, 1H), 2.46 (d, 1H), 2.35 (br s, 1H, OH), 2.19 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H). Example No.1.1-257:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.39 (d, 1H), 7.37 (m, 1H), 7.18 (m, 1H), 5.55/ 5.43 (s, 1 H), 4.22 / 3.59 (m, 2H), 2.09 (d, 1 H), 2.01 / 1.98 (s, 3H), 1.88 (d, 1 H), 1.79 / 1.77 (br. s, 1H, OH), 1.24 (m, 6H), 1.17 (m, 6H). Beispiel No.1.1-258: 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.39 (d, 1H), 7.37 (m, 1H), 7.18 (m, 1H), 5.55 / 5.43 (s, 1H), 4.22 / 3.59 (m, 2H ), 2.09 (d, 1H), 2.01 / 1.98 (s, 3H), 1.88 (d, 1H), 1.79 / 1.77 (br s, 1H, OH), 1.24 (m, 6H), 1.17 (m , 6H). Example No.1.1-258:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.44 (d, 1 H), 7.38 (d, 1 H), 7.21 (dd, 1 H), 5.90 (s, 1H), 2.62 (d, 1H), 2.47 (d, 1H), 2.34 (br. s, 1H, OH), 2.19 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.44 (d, 1H), 7.38 (d, 1H), 7.21 (dd, 1H), 5.90 (s, 1H), 2.62 (d, 1H ), 2.47 (d, 1H), 2.34 (br s, 1H, OH), 2.19 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H).
Beispiel No.1.1-275: Example No.1.1-275:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.41 (d, 1H), 7.19 (m, 1H), 6.97 (d, 1H), 6.91 (d, 1 H), 6.86 (m, 1 H), 6.23 (d, 1 H), 5.53 / 5.44 (s, 1 H), 4.24 / 3.58 (m, 2H), 3.83 (s, 3H), 2.04 (d, 1H), 1.93 (d, 1H), 1.72 (s, 3H), 1.26 (m, 3H), 1.14 (m, 6H), 0.98 (m, 3H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.41 (d, 1H), 7.19 (m, 1H), 6.97 (d, 1H), 6.91 (d, 1H), 6.86 (m, 1H), 6.23 (d, 1H), 5.53 / 5.44 (s, 1H), 4.24 / 3.58 (m, 2H), 3.83 (s, 3H), 2.04 (d, 1H), 1.93 (d, 1H), 1.72 (s , 3H), 1.26 (m, 3H), 1.14 (m, 6H), 0.98 (m, 3H).
Beispiel No.1.1-276: Example No.1.1-276:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.39 (dd, 1 H), 7.22 (m, 1 H), 6.96 (d, 1 H), 6.90 (m, 1H), 6.87 (m, 1H), 6.32 (d, 1H), 5.93 (s, 1H), 3.83 (s, 3H), 2.57 (d, 1H), 2.28 (d, 1H), 1.96 (s, 3H), 1.86 (br. s, 1H, OH), 1.13 (s, 3H), 1.08 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.39 (dd, 1H), 7.22 (m, 1H), 6.96 (d, 1H), 6.90 (m, 1H), 6.87 (m, 1H) , 6.32 (d, 1H), 5.93 (s, 1H), 3.83 (s, 3H), 2.57 (d, 1H), 2.28 (d, 1H), 1.96 (s, 3H), 1.86 (br. S, 1H , OH), 1.13 (s, 3H), 1.08 (s, 3H).
Beispiel No.1.1-277: Example No.1.1-277:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (m, 1 H), 7.29 (m, 1 H), 6.37 (m, 2H), 5.41 / 5.29 (s, 1 H), 4.37 / 3.69 (m, 2H), 3.85 (s, 3H), 2.06 (br. s, 1 H, OH), 1.52 / 1.50 (s, 3H), 1.42/1.38 (d, 3H), 1.29 (m, 6H), 1.19/1.09 (m, 1H), 0.67/0.43 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.42 (m, 1H), 7.29 (m, 1H), 6.37 (m, 2H), 5.41 / 5.29 (s, 1H), 4.37 / 3.69 ( m, 2H), 3.85 (s, 3H), 2.06 (brs s, 1H, OH), 1.52 / 1.50 (s, 3H), 1.42 / 1.38 (d, 3H), 1.29 (m, 6H), 1.19 /1.09 (m, 1H), 0.67 / 0.43 (m, 2H).
Beispiel No.1.1-278: Example No.1.1-278:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.43 (d, 1 H), 7.33 (m, 1 H), 6.91 (m, 2H), 5.73 / 5.62 (s, 1H), 3.89/3.85 (s, 3H), 2.48 (br. s, 1H, OH), 2.23/2.15 (s, 3H), 1.96/1.78 (m, 1H), 1.55/1.47 (s, 3H), 1.19/0.93 (m, 2H). 1 H NMR (400 MHz, CDCl3 δ, ppm) 7.43 (d, 1H), 7.33 (m, 1H), 6.91 (m, 2H), 5.73 / 5.62 (s, 1H), 3.89 / 3.85 (s , 3H), 2.48 (brs s, 1H, OH), 2.23 / 2.15 (s, 3H), 1.96 / 1.78 (m, 1H), 1.55 / 1.47 (s, 3H), 1.19 / 0.93 (m, 2H) ,
Beispiel No.1.1-279: Example No.1.1-279:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.45 (m, 1 H), 7.21 (m, 1 H), 7.09 (d, 1 H), 6.91 (m, 1H), 6.89 (m, 1H), 6.18/6.10 (d, 1H), 5.42/ 5.30 (s, 1H), 4.38/3.71 (m, 2H), 3.86/ 3.85 (s, 3H), 2.00/1.92 (br. s, 1H, OH), 1.70/1.68 (s, 3H), 1.36/ 1.10 (m, 1H), 1.29 (m, 6H), 1.21 /1.19(m, 3H), 0.64 / 0.58 (m, 2H). Beispiel No. 1.1 -280: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.45 (m, 1H), 7.21 (m, 1H), 7.09 (d, 1H), 6.91 (m, 1H), 6.89 (m, 1H) , 6.18 / 6.10 (d, 1H), 5.42 / 5.30 (s, 1H), 4.38 / 3.71 (m, 2H), 3.86 / 3.85 (s, 3H), 2.00 / 1.92 (brs s, 1H, OH), 1.70 / 1.68 (s, 3H), 1.36 / 1.10 (m, 1H), 1.29 (m, 6H), 1.21 / 1.19 (m, 3H), 0.64 / 0.58 (m, 2H). Example No. 1.1-280:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.48 / 7.41 (m, 1 H), 7.24 (m, 1 H), 7.20 / 7.08 (d, 1 H), 6.92 (m, 2H), 6.16 / 6.05 (d, 1 H), 5.74 / 5.62 (s, 1 H), 3.88 / 3.86 (s, 3H), 1 .93 / 1 .84 (br. s, 1 H, OH), 1 .72 / 1 .48 (m, 1 H), 1 .91 / 1 .89 (s, 3H), 1.28 / 1 .26 (s, 3H), 1 .21 / 1 .17 / 0.89 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.48 / 7.41 (m, 1H), 7.24 (m, 1H), 7.20 / 7.08 (d, 1H), 6.92 (m, 2H), 6.16 / 6.05 (d, 1H), 5.74 / 5.62 (s, 1H), 3.88 / 3.86 (s, 3H), 1 .93 / 1 .84 (brs s, 1H, OH), 1 .72 / 1 .48 (m, 1H), 1 .91 / 1 .89 (s, 3H), 1.28 / 1 .26 (s, 3H), 1 .21 / 1 .17 / 0.89 (m, 2H).
Beispiel No. 1.1 -289: Example No. 1.1 -289:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.34 (d, 2H), 6.82 (d, 2H), 5.52 / 5.42 / 5.40 (s, 1 H), 4.22 / 3.60 (m, 2H), 3.80 (s, 3H), 2.12 (d, 1 H), 2.01 / 1 .95 (br. s, 1 H, OH), 1 .98 / 1 .96 (s, 3H), 1 .88 (d, 1 H), 1 .23 (m, 6H), 1 .16 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.34 (d, 2H), 6.82 (d, 2H), 5.52 / 5.42 / 5.40 (s, 1H), 4.22 / 3.60 (m, 2H), 3.80 ( s, 3H), 2.12 (d, 1H), 2.01 / 1 .95 (br s, 1H, OH), 1 .98 / 1 .96 (s, 3H), 1 .88 (d, 1H ), 1 .23 (m, 6H), 1 .16 (m, 6H).
Beispiel No. 1.1 -290: Example No. 1.1-290:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.37 (d, 2H), 6.85 (d, 2H), 5.87 (s, 1 H), 3.82 (s, 3H), 2.61 (d, 1 H), 2.45 (d, 1 H), 2.26 (br. s, 1 H, OH), 2.18 (s, 3H), 1 .28 (s, 3H), 1 .15 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.37 (d, 2H), 6.85 (d, 2H), 5.87 (s, 1H), 3.82 (s, 3H), 2.61 (d, 1H), 2.45 (d, 1H), 2.26 (br s, 1H, OH), 2.18 (s, 3H), 1 .28 (s, 3H), 1 .15 (s, 3H).
Beispiel No. 1.1 -291 : Example No. 1.1 -291:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.32 (d, 2H), 6.85 (d, 2H), 6.57 (d, 1 H), 6.08 (d, 1 H), 5.58 / 5.47 / 5.45 (s, 1 H), 4.24 / 3.58 (m, 2H), 3.84 (s, 3H), 2.02 (d, 1 H), 1 .71 / 1 .69 (s, 3H), 1 .58 (br. s, 1 H, OH), 1 .65 (d, 1 H), 1 .28 (m, 6H), 1 .12 (m, 3H), 0.93 (m, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.32 (d, 2H), 6.85 (d, 2H), 6.57 (d, 1H), 6.08 (d, 1H), 5.58 / 5.47 / 5.45 (s , 1H), 4.24 / 3.58 (m, 2H), 3.84 (s, 3H), 2.02 (d, 1H), 1 .71 / 1 .69 (s, 3H), 1 .58 (br. S, 1H, OH), 1 .65 (d, 1H), 1 .28 (m, 6H), 1 .12 (m, 3H), 0.93 (m, 3H).
Beispiel No. 1.1 -292: Example No. 1.1 -292:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.32 (d, 2H), 6.88 (d, 2H), 6.61 (d, 1 H), 6.16 (d, 1 H), 5.96 (s, 1 H), 3.82 (s, 3H), 2.56 (d, 1 H), 2.30 (d, 1 H), 1 .95 (s, 3H), 1 .81 (br. s, 1 H, OH), 1 .13 (s, 3H), 1 .06 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.32 (d, 2H), 6.88 (d, 2H), 6.61 (d, 1H), 6.16 (d, 1H), 5.96 (s, 1H) , 3.82 (s, 3H), 2.56 (d, 1H), 2.30 (d, 1H), 1 .95 (s, 3H), 1 .81 (br. S, 1H, OH), 1 .13 (s, 3H), 1 .06 (s, 3H).
Beispiel No. 1.1 -305: Example No. 1.1 -305:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.55 (s, 2H), 6.42 (m, 1 H), 5.54 / 5.41 (s, 1 H), 4.22 / 3.60 (m, 2H), 2.1 1 (d, 1 H), 1 .99 / 1 .96 (s, 3H), 1 .88 (d, 1 H), 1 .25 (m, 6H), 1 .16 (m, 6H). Beispiel No.1.1-306: 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 6.55 (s, 2H), 6.42 (m, 1H), 5.54 / 5.41 (s, 1H), 4.22 / 3.60 (m, 2H), 2.1 1 ( d, 1H), 1 .99 / 1 .96 (s, 3H), 1 .88 (d, 1H), 1 .25 (m, 6H), 1 .16 (m, 6H). Example No.1.1-306:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.56 (s, 2H), 6.47 (d, 1 H), 5.89 (s, 1 H), 3.79 (s, 6H), 2.59 (d, 1H), 2.46 (d, 1H), 2.32 (br. s, 1H, OH), 2.18 (s, 3H), 1.28 (s, 3H), 1.16 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 6.56 (s, 2H), 6.47 (d, 1H), 5.89 (s, 1H), 3.79 (s, 6H), 2.59 (d, 1H) , 2.46 (d, 1H), 2.32 (br s, 1H, OH), 2.18 (s, 3H), 1.28 (s, 3H), 1.16 (s, 3H).
Beispiel No.1.1-309: Example No.1.1-309:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.62 / 6.56 (s, 2H), 6.43 / 6.42 (s, 1 H), 5.41 / 5.30 (s, 1 H), 4.37 / 3.71 (m, 2H), 3.78 / 3.76 (s, 6H), 2.28 / 2.22 (br. s, 1 H, OH), 2.02 / 2.01 (s, 3H), 1.94/1.38 (m, 1H), 1.48/ 1.46 (s, 3H), 1.29 (m, 3H), 1.26 (m, 3H), 1.19 /0.65(m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 6.62 / 6.56 (s, 2H), 6.43 / 6.42 (s, 1H), 5.41 / 5.30 (s, 1H), 4.37 / 3.71 (m, 2H) , 3.78 / 3.76 (s, 6H), 2.28 / 2.22 (brs s, 1H, OH), 2.02 / 2.01 (s, 3H), 1.94 / 1.38 (m, 1H), 1.48 / 1.46 (s, 3H) , 1.29 (m, 3H), 1.26 (m, 3H), 1.19 / 0.65 (m, 2H).
Beispiel No.1.1-310: Example No.1.1-310:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.62 / 6.56 (s, 2H), 6.48 / 6.46 (s, 1 H), 5.71 / 5.64 (s, 1H), 3.81 /3.78 (s, 6H), 2.79/2.52 (br. s, 1H, OH), 2.20/2.12 (s, 3H), 1.96/1.46 (m, 1H), 1.62/ 1.54 (s, 3H), 1.23/ 1.19 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 6.62 / 6.56 (s, 2H), 6.48 / 6.46 (s, 1H), 5.71 / 5.64 (s, 1H), 3.81 / 3.78 (s, 6H), 2.79 / 2.52 (brs s, 1H, OH), 2.20 / 2.12 (s, 3H), 1.96 / 1.46 (m, 1H), 1.62 / 1.54 (s, 3H), 1.23 / 1.19 (m, 2H).
Beispiel No.1.1-313: Example No.1.1-313:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.56 (s, 2H), 6.47 (s, 1 H), 5.89 (s, 1 H), 3.79 (s, 6H), 2.61 (d, 1H), 2.46 (d, 1H), 2.19 (s, 3H), 1.28 (s, 3H), 1.16 (s, 3H), 0.93 (t, 9H), 0.52 (q, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 6.56 (s, 2H), 6.47 (s, 1H), 5.89 (s, 1H), 3.79 (s, 6H), 2.61 (d, 1H), 2.46 (d, 1H), 2.19 (s, 3H), 1.28 (s, 3H), 1.16 (s, 3H), 0.93 (t, 9H), 0.52 (q, 6H).
Beispiel No.1.1-331: Example No.1.1-331:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.51 (d, 1 H), 7.42 (d, 1 H), 7.34 (m, 2H), 5.39 (s, 1H), 4.22/3.60 (m, 2H), 2.13 (d, 1H), 1.96 (s, 3H), 1.89 (d, 1H), 1.23 (m, 3H), 1.21 (s, 3H), 1.16 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.51 (d, 1H), 7.42 (d, 1H), 7.34 (m, 2H), 5.39 (s, 1H), 4.22 / 3.60 (m, 2H ), 2.13 (d, 1H), 1.96 (s, 3H), 1.89 (d, 1H), 1.23 (m, 3H), 1.21 (s, 3H), 1.16 (m, 6H).
Beispiel No.1.1-332: Example No.1.1-332:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.67 (d, 1 H), 7.58 (d, 1 H), 7.52 (dd, 1 H), 7.46 (dd, 1H), 5.90 (s, 1H), 2.62 (d, 1H), 2.47 (d, 1H), 2.31 (br. s, 1H, OH), 2.18 (s, 3H), 1.29 (s, 3H), 1.16 (s, 3H). Beispiel No.1.1-395: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.67 (d, 1H), 7.58 (d, 1H), 7.52 (dd, 1H), 7.46 (dd, 1H), 5.90 (s, 1H) , 2.62 (d, 1H), 2.47 (d, 1H), 2.31 (br, s, 1H, OH), 2.18 (s, 3H), 1.29 (s, 3H), 1.16 (s, 3H). Example No.1.1-395:
1H-NMR(400MHz, CDC δ, ppm) 10.49/10.08 (s, 1H), 7.96/7.91 (d, 1H), 7.54 (m, 2H), 7.43 (m, 1H), 5.56/5.45 (s, 1H), 4.23/3.61 (m, 2H), 2.12 (d, 1H), 2.10 (br. s, 1H, OH), 2.01 / 1.99 (s, 3H), 1.93 (d, 1H), 1.24 (m, 6H), 1.18 (m, 6H). 1 H-NMR (400MHz, CDC δ, ppm) 10.49 / 10.08 (s, 1H), 7.96 / 7.91 (d, 1H), 7.54 (m, 2H), 7.43 (m, 1H), 5.56 / 5.45 (s, 1H), 4.23 / 3.61 (m, 2H), 2.12 (d, 1H), 2.10 (brs s, 1H, OH), 2.01 / 1.99 (s, 3H), 1.93 (d, 1H), 1.24 (m, 6H), 1.18 (m, 6H).
Beispiel No.1.1-396: Example No.1.1-396:
1H-NMR (400 MHz, CDCI3 δ, ppm) 10.40 (s, 1 H), 7.92 (d, 1 H), 7.57 (m, 2H), 7.51 (m, 1H), 5.92 (s, 1H), 2.64 (d, 1H), 2.48 (br. s, 1H, OH), 2.46 (d, 1H), 2.20 (s, 3H), 1.32 (s, 3H), 1.19 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 10.40 (s, 1H), 7.92 (d, 1H), 7.57 (m, 2H), 7.51 (m, 1H), 5.92 (s, 1H), 2.64 (d, 1H), 2.48 (br s, 1H, OH), 2.46 (d, 1H), 2.20 (s, 3H), 1.32 (s, 3H), 1.19 (s, 3H).
Beispiel No.1.1-409: Example No.1.1-409:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.60 (m, 1 H), 7.52 (m, 2H), 7.39 (m, 1 H), 5.44 (s, 1H), 4.22 (m, 1H), 3.61 (m, 1H), 2.10 (d, 1H), 2.02 (s, 3H), 1.88 (d, 1H), 1.24 (m, 6H), 1.15 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.60 (m, 1H), 7.52 (m, 2H), 7.39 (m, 1H), 5.44 (s, 1H), 4.22 (m, 1H), 3.61 (m, 1H), 2.10 (d, 1H), 2.02 (s, 3H), 1.88 (d, 1H), 1.24 (m, 6H), 1.15 (m, 6H).
Beispiel No.1.1-410: Example No.1.1-410:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.68 (d, 1 H), 7.57 (m, 2H), 7.47 (d, 1 H), 5.92 (s, 1H), 2.67 (d, 1H), 2.50 (d, 1H), 2.22 (s, 3H), 1.34 (s, 3H), 1.18 (s, 3H). Beispiel No.1.1-411: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.68 (d, 1H), 7.57 (m, 2H), 7.47 (d, 1H), 5.92 (s, 1H), 2.67 (d, 1H), 2.50 (d, 1H), 2.22 (s, 3H), 1.34 (s, 3H), 1.18 (s, 3H). Example No.1.1-411:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.61 (d, 1 H), 7.52 (m, 2H), 7.29 (m, 1 H), 7.04 (d, 1 H), 6.41 (d, 1 H), 5.49 (s, 1 H), 4.24 / 3.60 (m, 2H), 2.03 (d, 1 H), 1.91 (d, 1 H), 1.72 (s, 3H), 1.24 (m, 6H), 1.14 (m, 3H), 0.99 (m, 3H). Beispiel No.1.1-412: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.61 (d, 1H), 7.52 (m, 2H), 7.29 (m, 1H), 7.04 (d, 1H), 6.41 (d, 1H ), 5.49 (s, 1H), 4.24 / 3.60 (m, 2H), 2.03 (d, 1H), 1.91 (d, 1H), 1.72 (s, 3H), 1.24 (m, 6H), 1.14 (m, 3H), 0.99 (m, 3H). Example No.1.1-412:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.67 (s, 1 H), 7.57 (m, 2H), 7.37 (m, 1 H), 7.11 (d, 1H), 6.51 (d, 1H), 5.98 (s, 1H), 2.59 (d, 1H), 2.37 (d, 1H), 1.97 (s, 3H), 1.16 (s, 3H), 1.11 (s, 3H). Beispiel No.1.1-413: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.67 (s, 1H), 7.57 (m, 2H), 7.37 (m, 1H), 7.11 (d, 1H), 6.51 (d, 1H), 5.98 (s, 1H), 2.59 (d, 1H), 2.37 (d, 1H), 1.97 (s, 3H), 1.16 (s, 3H), 1.11 (s, 3H). Example No.1.1-413:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.62 (m, 1 H), 7.59 (d, 1 H), 7.54 (m, 1 H), 7.40 (m, 1 H), 5.43 / 5.31 (s, 1 H), 4.37 / 3.71 (m, 2H), 2.33 (br. s, 1 H, OH), 2.08 / 1.98 (s, 3H), 1.51 /1.42 (d, 3H), 1.29 (m, 6H), 1.19/ 1.13 (m, 1H), 0.71 / 0.48 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.62 (m, 1H), 7.59 (d, 1H), 7.54 (m, 1H), 7.40 (m, 1H), 5.43 / 5.31 ( s, 1H), 4.37 / 3.71 (m, 2H), 2.33 (br s, 1H, OH), 2.08 / 1.98 (s, 3H), 1.51 / 1.42 (d, 3H), 1.29 (m, 6H ), 1.19 / 1.13 (m, 1H), 0.71 / 0.48 (m, 2H).
Beispiel No.1.1-414: Example No.1.1-414:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.68 (d, 1 H), 7.59 (m, 1 H), 7.51 (m, 1 H), 7.46 (m, 1H), 5.75/5.67 (s, 1H), 2.42 (br. s, 1H, OH), 2.23/2.19 (s, 3H), 1.98/1.79 (m, 1H), 1.60 / 1.57 (s, 3H), 1.28 / 0.99 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.68 (d, 1H), 7.59 (m, 1H), 7.51 (m, 1H), 7.46 (m, 1H), 5.75 / 5.67 (s, 1H), 2.42 (brs s, 1H, OH), 2.23 / 2.19 (s, 3H), 1.98 / 1.79 (m, 1H), 1.60 / 1.57 (s, 3H), 1.28 / 0.99 (m, 2H).
Beispiel No.1.1-415: Example No.1.1-415:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.63 (m, 2H), 7.54 (m, 1H), 7.31 (m, 1H), 7.17 (d, 1 H), 6.38 / 6.31 (d, 1 H), 5.43 / 5.31 (s, 1 H), 4.38 / 3.71 (m, 2H), 2.06 / 1.99 (br. s, 1H, OH), 1.72/1.70 (s, 3H), 1.42/1.12 (m, 1H), 1.29 (m, 6H), 1.21 / 1.19 (m, 3H), 0.67/0.62 (m, 2H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.63 (m, 2H), 7.54 (m, 1H), 7.31 (m, 1H), 7.17 (d, 1H), 6.38 / 6.31 (d, 1H) , 5.43 / 5.31 (s, 1H), 4.38 / 3.71 (m, 2H), 2.06 / 1.99 (brs s, 1H, OH), 1.72 / 1.70 (s, 3H), 1.42 / 1.12 (m, 1H) , 1.29 (m, 6H), 1.21 / 1.19 (m, 3H), 0.67 / 0.62 (m, 2H).
Beispiel No.1.1-416: Example No.1.1-416:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.68 (m, 1 H), 7.60 (m, 2H), 7.37 (m, 1 H), 7.31 / 7.22 (d, 1 H), 6.36 / 6.14 (d, 1 H), 5.74 / 5.66 (s, 1 H), 2.98 (br. s, 1 H, OH), 1.96 / 1.73 (m, 1H), 1.93/1.91 (s, 3H), 1.30/ 1.28 (s, 3H), 1.24 / 1.18 / 0.94 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.68 (m, 1H), 7.60 (m, 2H), 7.37 (m, 1H), 7.31 / 7.22 (d, 1H), 6.36 / 6.14 ( d, 1H), 5.74 / 5.66 (s, 1H), 2.98 (brs s, 1H, OH), 1.96 / 1.73 (m, 1H), 1.93 / 1.91 (s, 3H), 1.30 / 1.28 ( s, 3H), 1.24 / 1.18 / 0.94 (m, 2H).
Beispiel No.1.1-425: Example No.1.1-425:
1H-NMR(400MHz, CDCI3 δ, ppm) 10.48 / 10.15 (s, 1H), 7.58/7.53 (m, 1H), 7.33 (m, 1H), 7.13 (dd, 1H), 5.55/5.37 (s, 1H), 4.23/3.61 (m, 2H), 2.17 (br. s, 1H, OH), 2.12 (d, 1H), 1.99/1.97 (s, 3H), 1.89 (d, 1H), 1.34 (m, 6H), 1.17 (m, 6H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 10.48 / 10.15 (s, 1H), 7.58 / 7.53 (m, 1H), 7.33 (m, 1H), 7.13 (dd, 1H), 5.55 / 5.37 (s, 1H), 4.23 / 3.61 (m, 2H), 2.17 (brs s, 1H, OH), 2.12 (d, 1H), 1.99 / 1.97 (s, 3H), 1.89 (d, 1H), 1.34 (m, 6H), 1.17 (m, 6H).
Beispiel No.1.1-426: Example No.1.1-426:
1H-NMR(400 MHz, CDCI3 δ, ppm) 10.47 (s, 1H), 7.53 (m, 1H), 7.32 (d, 1H), 7.18 (dd, 1H), 5.91 (s, 1H), 2.74 (br. s, 1H, OH), 2.68 (d, 1H), 2.47 (d, 1H), 2.20 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H). Beispiel No.1.1-441: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 10.47 (s, 1H), 7.53 (m, 1H), 7.32 (d, 1H), 7.18 (dd, 1H), 5.91 (s, 1H), 2.74 ( br. s, 1H, OH), 2.68 (d, 1H), 2.47 (d, 1H), 2.20 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H). Example No.1.1-441:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (m, 2H), 7.32 (m, 1 H), 7.21 (m, 1 H), 5.54 / 5.42 (s, 1 H), 4.60 / 4.59 (s, 2H), 4.23 / 3.61 (m, 2H), 3.42 (s, 3H), 2.12 / 2.11 (br. s, 1H, OH), 2.08 (d, 1H), 2.02/1.99 (s, 3H), 1.89 (d, 1H), 1.26 (m, 6H), 1.17 (m, 6H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.42 (m, 2H), 7.32 (m, 1H), 7.21 (m, 1H), 5.54 / 5.42 (s, 1H), 4.60 / 4.59 (s, 2H), 4.23 / 3.61 (m, 2H), 3.42 (s, 3H), 2.12 / 2.11 (br s, 1H, OH), 2.08 (d, 1H), 2.02 / 1.99 (s, 3H) , 1.89 (d, 1H), 1.26 (m, 6H), 1.17 (m, 6H).
Beispiel No.1.1-442: Example No.1.1-442:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (m, 2H), 7.36 (m, 1 H), 7.26 (m, 1 H), 5.90 (s, 1H), 4.55 (s, 2H), 3.40 (s, 3H), 2.61 (d, 1H), 2.48 (br. s, 1H, OH), 2.45 (d, 1H), 2.20 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.42 (m, 2H), 7.36 (m, 1H), 7.26 (m, 1H), 5.90 (s, 1H), 4.55 (s, 2H), 3.40 (s, 3H), 2.61 (d, 1H), 2.48 (brs s, 1H, OH), 2.45 (d, 1H), 2.20 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H).
Beispiel No.1.1-445: Example No.1.1-445:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.46 (m, 2H), 7.33 (m, 1 H), 7.23 (m, 1 H), 5.43 / 5.31 (s, 1 H), 4.65 / 4.63 (s, 3H), 4.38 / 3.71 (m, 2H), 3.44 / 3.43 (s, 3H), 2.25 / 2.21 (m, 1 H, OH), 2.05 / 2.04 (s, 3H), 1.96 / 1.47 (m, 1 H), 1.51 / 1.42 (s, 3H), 1.31 (m, 3H), 1.28 (m, 3H), 1.20/ 0.68 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.46 (m, 2H), 7.33 (m, 1H), 7.23 (m, 1H), 5.43 / 5.31 (s, 1H), 4.65 / 4.63 ( s, 3H), 4.38 / 3.71 (m, 2H), 3.44 / 3.43 (s, 3H), 2.25 / 2.21 (m, 1H, OH), 2.05 / 2.04 (s, 3H), 1.96 / 1.47 (m, 1H), 1.51 / 1.42 (s, 3H), 1.31 (m, 3H), 1.28 (m, 3H), 1.20 / 0.68 (m, 2H).
Beispiel No.1.1-446: Example No.1.1-446:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.48 (m, 2H), 7.37 (m, 1 H), 7.29 (m, 1 H), 5.73 / 5.64 (s, 1 H), 4.62 / 4.53 (s, 2H), 3.45 / 3.44 (s, 3H), 2.58 / 2.54 (br. s, 1 H, OH), 2.22 / 2.14 (s, 3H), 1.98 / 1.79 (m, 1 H), 1.58 / 1.46 (s, 3H), 1.20 / 0.96 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.48 (m, 2H), 7.37 (m, 1H), 7.29 (m, 1H), 5.73 / 5.64 (s, 1H), 4.62 / 4.53 ( s, 2H), 3.45 / 3.44 (s, 3H), 2.58 / 2.54 (brs s, 1H, OH), 2.22 / 2.14 (s, 3H), 1.98 / 1.79 (m, 1H), 1.58 / 1.46 (s, 3H), 1.20 / 0.96 (m, 2H).
Beispiel No.1.1-449: Example No.1.1-449:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.27 (d, 1 H), 7.81 (m, 2H), 7.64 (d, 1 H), 7.53 (m, 1 H), 7.50 (m, 1 H), 7.39 (m, 1 H), 5.59 / 5.48 (s, 1 H), 4.24 / 3.62 (m, 2H), 2.21 (d, 1 H), 2.09/2.06 (s, 3H), 1.93 (d, 1H), 1.33 / 1.32 (s, 3H), 1.23 (m,6H), 1.17 (m, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.27 (d, 1H), 7.81 (m, 2H), 7.64 (d, 1H), 7.53 (m, 1H), 7.50 (m, 1H ), 7.39 (m, 1H), 5.59 / 5.48 (s, 1H), 4.24 / 3.62 (m, 2H), 2.21 (d, 1H), 2.09 / 2.06 (s, 3H), 1.93 (d, 1H), 1.33 / 1.32 (s, 3H), 1.23 (m, 6H), 1.17 (m, 3H).
Beispiel No.1.1-450: Example No.1.1-450:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.16 (d, 1 H), 7.85 (d, 2H), 7.67 (d, 1 H), 7.54 (m, 1H), 7.51 (m, 1H), 7.41 (dd, 1H), 5.95 (s, 1H), 2.70 (d, 1H), 2.52 (d, 1H), 2.42 (br. s, 1 H, OH), 2.27 (s, 3H), 1.38 (s, 3H), 1.23 (s, 3H). Beispiel No.1.1-457: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.16 (d, 1H), 7.85 (d, 2H), 7.67 (d, 1H), 7.54 (m, 1H), 7.51 (m, 1H), 7.41 (dd, 1H), 5.95 (s, 1H), 2.70 (d, 1H), 2.52 (d, 1H), 2.42 (br, s, 1H, OH), 2.27 (s, 3H), 1.38 (s , 3H), 1.23 (s, 3H). Example No.1.1-457:
1H-NMR(400MHz, CDC δ, ppm) 8.13 (s, 1H), 7.94 (s, 1H), 7.47 (d, 1H), 7.31 (m, 3H), 5.46 (s, 2H), 5.44 / 5.37 (s, 1 H), 4.22 / 3.61 (m, 2H), 2.87 (br. s, 1 H, OH), 2.12 (d, 1 H), 1.94 (s, 3H), 1.87 (d, 1 H), 1.22 (m, 6H), 1.16 (m, 6H). 1 H NMR (400MHz, CDC δ, ppm) 8.13 (s, 1H), 7.94 (s, 1H), 7.47 (d, 1H), 7.31 (m, 3H), 5.46 (s, 2H), 5.44 / 5.37 (s, 1H), 4.22 / 3.61 (m, 2H), 2.87 (brs s, 1H, OH), 2.12 (d, 1H), 1.94 (s, 3H), 1.87 (d, 1H) , 1.22 (m, 6H), 1.16 (m, 6H).
Beispiel No.1.1-458: Example No.1.1-458:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.06 (s, 1 H), 7.98 (s, 1 H), 7.47 (d, 1 H), 7.40 (m, 3H), 5.89 (s, 1H), 5.50 (d, 1H), 5.48 (d, 1H), 4.32 (br. s, 1H, OH), 2.60 (d, 1H), 2.48 (d, 1H), 2.13 (s, 3H), 1.25 (s, 3H), 1.16 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.06 (s, 1H), 7.98 (s, 1H), 7.47 (d, 1H), 7.40 (m, 3H), 5.89 (s, 1H) , 5.50 (d, 1H), 5.48 (d, 1H), 4.32 (brs s, 1H, OH), 2.60 (d, 1H), 2.48 (d, 1H), 2.13 (s, 3H), 1.25 (s , 3H), 1.16 (s, 3H).
Beispiel No.1.1-465: Example No.1.1-465:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (m, 2H), 7.29 (m, 1 H), 7.20 (m, 1 H), 5.53 / 5.41 (s, 1H), 4.21 / 3.60 (m, 2H), 3.69 (m, 4H), 3.64 (m, 2H), 2.47 (m, 4H), 2.13 (br. s, 1H, OH), 2.11 (d, 1H), 2.00/ 1.98 (s, 3H), 1.85 (d, 1H), 1.24 (m, 6H), 1.16 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.42 (m, 2H), 7.29 (m, 1H), 7.20 (m, 1H), 5.53 / 5.41 (s, 1H), 4.21 / 3.60 (m , 2H), 3.69 (m, 4H), 3.64 (m, 2H), 2.47 (m, 4H), 2.13 (br, s, 1H, OH), 2.11 (d, 1H), 2.00 / 1.98 (s, 3H ), 1.85 (d, 1H), 1.24 (m, 6H), 1.16 (m, 6H).
Beispiel No.1.1-466: Example No.1.1-466:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.43 (m, 2H), 7.33 (dd, 1 H), 7.24 (m, 1 H), 5.90 (s, 1H), 3.69 (m, 4H), 3.62 (d, 1H), 3.59 (d, 1H), 2.75 (d, 1H), 2.62 (d, 1H), 2.43 (m, 4H), 2.20 (s, 3H), 1.31 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.43 (m, 2H), 7.33 (dd, 1H), 7.24 (m, 1H), 5.90 (s, 1H), 3.69 (m, 4H), 3.62 (d, 1H), 3.59 (d, 1H), 2.75 (d, 1H), 2.62 (d, 1H), 2.43 (m, 4H), 2.20 (s, 3H), 1.31 (s, 3H), 1.17 (s, 3H).
Beispiel No.1.1-490: Example No.1.1-490:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.43 (s, 1 H), 7.89 (d, 1 H), 7.43 (d, 1 H), 7.34 (m, 2H), 5.91 (s, 1H), 4.25 (q, 2H), 2.61 (d, 1H), 2.49 (d, 1H), 2.41 (br. s, 1H, OH), 2.20 (s, 3H), 1.33 (t, 3H), 1.30 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.43 (s, 1H), 7.89 (d, 1H), 7.43 (d, 1H), 7.34 (m, 2H), 5.91 (s, 1H) , 4.25 (q, 2H), 2.61 (d, 1H), 2.49 (d, 1H), 2.41 (br, s, 1H, OH), 2.20 (s, 3H), 1.33 (t, 3H), 1.30 (s , 3H), 1.17 (s, 3H).
Beispiel No.1.1-506: Example No.1.1-506:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.46 (s, 1 H), 7.88 (d, 1 H), 7.43 (d, 1 H), 7.33 (m, 2H), 5.91 (s, 1H), 4.02 (d, 2H), 2.61 (d, 1H), 2.50 (d, 1H), 2.47 (br. s, 1H, OH), 2.21 (s, 3H), 1.31 (s, 3H), 1.20 (m, 1H), 1.18 (s, 3H), 0.60 (m, 2H), 0.33 (m, 2H). Beispiel No.1.1-537: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.46 (s, 1H), 7.88 (d, 1H), 7.43 (d, 1H), 7.33 (m, 2H), 5.91 (s, 1H) , 4.02 (d, 2H), 2.61 (d, 1H), 2.50 (d, 1H), 2.47 (br, s, 1H, OH), 2.21 (s, 3H), 1.31 (s, 3H), 1.20 (m , 1H), 1.18 (s, 3H), 0.60 (m, 2H), 0.33 (m, 2H). Example No.1.1-537:
1H-NMR(400MHz, CDC δ, ppm) 10.38/10.34 (s, 1H), 7.37 (m, 1H), 7.32 (m, 1H), 7.01 (m, 2H), 5.80 / 5.64 (br. s, 1 H, OH), 5.57 / 5.44 (s, 1 H), 4.25 / 3.62 (m, 2H), 2.13 (d, 1H), 2.01 /1.99 (s, 3H), 1.90 (d, 1H), 1.26 (m, 6H), 1.18 (m, 6H). 1 H-NMR (400MHz, CDC δ, ppm) 10.38 / 10.34 (s, 1H), 7.37 (m, 1H), 7.32 (m, 1H), 7.01 (m, 2H), 5.80 / 5.64 (br. S, 1H, OH), 5.57 / 5.44 (s, 1H), 4.25 / 3.62 (m, 2H), 2.13 (d, 1H), 2.01 / 1.99 (s, 3H), 1.90 (d, 1H), 1.26 ( m, 6H), 1.18 (m, 6H).
Beispiel No.1.1-538: Example No.1.1-538:
1H-NMR(400MHz, CDCI3 δ, ppm) 10.32 (s, 1H), 7.46 (m, 1H), 7.33 (d, 1H), 7.08 (dd, 1H), 5.91 (s, 1H), 5.82 (br. s, 1H, OH), 2.61 (d, 1H), 2.49 (d, 1H), 2.45 (br. s, 1H, OH), 2.19 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 10.32 (s, 1H), 7.46 (m, 1H), 7.33 (d, 1H), 7.08 (dd, 1H), 5.91 (s, 1H), 5.82 (br s, 1H, OH), 2.61 (d, 1H), 2.49 (d, 1H), 2.45 (br s, 1H, OH), 2.19 (s, 3H), 1.29 (s, 3H), 1.17 (s , 3H).
Beispiel No.1.1-545: Example No.1.1-545:
1H-NMR(400MHz, CDCI3 δ, ppm) 9.15 (s, 1H), 8.24 (d, 1H), 7.48 (d, 1H), 5.55 (s, 1 H), 4.22 / 3.60 (m, 2H), 3.95 (s, 3H), 2.17 (br. s, 1 H, OH), 2.13 (d, 1 H), 1.97 (s, 3H), 1.95 (d, 1H), 1.24 (m, 6H), 1.15 (m, 6H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 9.15 (s, 1H), 8.24 (d, 1H), 7.48 (d, 1H), 5.55 (s, 1H), 4.22 / 3.60 (m, 2H), 3.95 (s, 3H), 2.17 (brs s, 1H, OH), 2.13 (d, 1H), 1.97 (s, 3H), 1.95 (d, 1H), 1.24 (m, 6H), 1.15 ( m, 6H).
Beispiel No.1.1-546: Example No.1.1-546:
1H-NMR (400 MHz, CDCI3 δ, ppm) 9.18 (s, 1 H), 8.28 (d, 1 H), 7.49 (d, 1 H), 5.92 (s, 1H), 3.97 (s, 3H), 2.65 (d, 1H), 2.58 (br. s, 1H, OH), 2.48 (d, 1H), 2.19 (s, 3H), 1.32 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 9.18 (s, 1H), 8.28 (d, 1H), 7.49 (d, 1H), 5.92 (s, 1H), 3.97 (s, 3H) , 2.65 (d, 1H), 2.58 (br s, 1H, OH), 2.48 (d, 1H), 2.19 (s, 3H), 1.32 (s, 3H), 1.17 (s, 3H).
Beispiel No.1.1-554: Example No.1.1-554:
1H-NMR (400 MHz, CD3OD δ, ppm) 9.08 (s, 1H), 8.38 (d, 1H), 7.68 (d, 1H), 5.88 (s, 1H), 2.62 (d, 1H), 2.43 (d, 1H), 2.20 (s, 3H), 1.29 (s, 3H), 1.14 (s, 3H). Beispiel No.1.1-565: 1 H-NMR (400 MHz, CD3OD δ, ppm) 9.08 (s, 1H), 8.38 (d, 1H), 7.68 (d, 1H), 5.88 (s, 1H), 2.62 (d, 1H), 2.43 ( d, 1H), 2.20 (s, 3H), 1.29 (s, 3H), 1.14 (s, 3H). Example No.1.1-565:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.00 (m, 1 H), 7.88 (m, 1 H), 7.61 (d, 1 H), 7.52 (m, 1 H),7.23 (m, 1 H), 5.78 / 5.61 (d, 1 H), 5.43 / 5.41 / 5.30 (s, 1 H), 4.38 / 3.72 (m, 2H), 2.05/1.93 (br. s, 1H, OH), 1.88/1.12 (m, 1H), 1.73/1.71 (s, 3H), 1.28 (m, 6H), 1.21 / 1.19 (m, 3H), 0.91 / 0.62 (m, 2H). Beispiel No.1.1-566: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.00 (m, 1H), 7.88 (m, 1H), 7.61 (d, 1H), 7.52 (m, 1H), 7.23 (m, 1 H), 5.78 / 5.61 (d, 1H), 5.43 / 5.41 / 5.30 (s, 1H), 4.38 / 3.72 (m, 2H), 2.05 / 1.93 (brs s, 1H, OH), 1.88 / 1.12 (m, 1H), 1.73 / 1.71 (s, 3H), 1.28 (m, 6H), 1.21 / 1.19 (m, 3H), 0.91 / 0.62 (m, 2H). Example No.1.1-566:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.98 (m, 1 H), 7.73 (m, 2H), 7.61 (m, 1 H), 7.53 (d, 1 H), 7.43 / 6.71 (d, 1 H), 5.87 / 5.61 (s, 1 H), 5.83 / 5.76 (d, 1 H), 2.92 (br. s, 1 H, OH), 1.99 / 1.98 (s, 3H), 1.84 / 1.36 (m, 1 H), 1.78 / 1.76 (s, 3H), 1.30 / 1.28 / 0.83 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.98 (m, 1H), 7.73 (m, 2H), 7.61 (m, 1H), 7.53 (d, 1H), 7.43 / 6.71 (i.e. , 1H), 5.87 / 5.61 (s, 1H), 5.83 / 5.76 (d, 1H), 2.92 (brs s, 1H, OH), 1.99 / 1.98 (s, 3H), 1.84 / 1.36 ( m, 1H), 1.78 / 1.76 (s, 3H), 1.30 / 1.28 / 0.83 (m, 2H).
Beispiel No.1.1-568: Example No.1.1-568:
1H-NMR (400 MHz, CD3OD δ, ppm) 8.07 (d, 1H), 8.00 (d, 1H), 7.67 (dd, 1H), 7.48 (dd, 1H), 5.87 (s, 1H), 2.58 (d, 1H), 2.45 (d, 1H), 2.20 (s, 3H), 1.30 (s, 3H), 1.14 (s, 3H). 1 H-NMR (400 MHz, CD3OD δ, ppm) 8.07 (d, 1H), 8.00 (d, 1H), 7.67 (dd, 1H), 7.48 (dd, 1H), 5.87 (s, 1H), 2.58 ( d, 1H), 2.45 (d, 1H), 2.20 (s, 3H), 1.30 (s, 3H), 1.14 (s, 3H).
Beispiel No.1.1-584: Example No.1.1-584:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.97 (d, 1 H), 7.49 (m, 2H), 7.40 (m, 1 H), 5.89 (s, 1H), 3.90 (s, 3H), 2.78 (br. s, 1H, OH), 2.69 (d, 1H), 2.45 (d, 1H), 2.20 (s, 3H), 1.30 (s, 3H), 1.16 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.97 (d, 1H), 7.49 (m, 2H), 7.40 (m, 1H), 5.89 (s, 1H), 3.90 (s, 3H), 2.78 (br s, 1H, OH), 2.69 (d, 1H), 2.45 (d, 1H), 2.20 (s, 3H), 1.30 (s, 3H), 1.16 (s, 3H).
Beispiel No.1.1-585: Example No.1.1-585:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.92 (d, 1 H), 7.55 (d, 1 H), 7.43 (dd, 1 H), 7.35 (dd, 1H), 5.23 (s, 1H), 4.21 (m, 1H), 3.93 (s, 3H), 3.58 (m, 1H), 2.51 (br. s, 1H, OH), 1.97 (s, 3H), 1.50 (s, 3H), 1.42 (m, 1H), 0.78 (m, 1H), 0.67 (m, 1H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.92 (d, 1H), 7.55 (d, 1H), 7.43 (dd, 1H), 7.35 (dd, 1H), 5.23 (s, 1H) , 4.21 (m, 1H), 3.93 (s, 3H), 3.58 (m, 1H), 2.51 (br, s, 1H, OH), 1.97 (s, 3H), 1.50 (s, 3H), 1.42 (m , 1H), 0.78 (m, 1H), 0.67 (m, 1H).
Beispiel No.1.1-586: Example No.1.1-586:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.98 (d, 1 H), 7.58 (d, 1 H), 7.49 (dd, 1 H), 7.41 (dd, 1H), 5.74 (s, 1H), 3.92 (s, 3H), 2.73 (br. s, 1H, OH), 2.22 (s, 3H), 1.96 (m, 1H), 1.22 (m, 2H), 1.20 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.98 (d, 1 H), 7:58 (d, 1 H), 7:49 (dd, 1 H), 7:41 (dd, 1H), 5.74 (s, 1H) , 3.92 (s, 3H), 2.73 (br s, 1H, OH), 2.22 (s, 3H), 1.96 (m, 1H), 1.22 (m, 2H), 1.20 (s, 3H).
Beispiel No.1.1-589: Example No.1.1-589:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.07 (s, 1 H), 7.98 (d, 1 H), 7.60 (d, 1 H), 7.38 (dd, 1H), 5.42 (s, 1H), 4.22 (m, 1H), 3.60 (m, 1H), 3.92 (s, 3H), 2.11 (d, 1H), 1.96 (s, 3H), 1.86 (d, 1H), 1.35 (m, 6H), 1.16 (m, 6H). Beispiel No.1.1-590: 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 8.07 (s, 1H), 7.98 (d, 1H), 7.60 (d, 1H), 7.38 (dd, 1H), 5.42 (s, 1H) , 4.22 (m, 1H), 3.60 (m, 1H), 3.92 (s, 3H), 2.11 (d, 1H), 1.96 (s, 3H), 1.86 (d, 1H), 1.35 (m, 6H), 1.16 (m, 6H). Example No.1.1-590:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.09 (s, 1 H), 8.02 (d, 1 H), 7.61 (d, 1 H), 7.42 (dd, 1H), 5.90 (s, 1H), 3.94 (s, 3H), 2.63 (d, 1H), 2.48 (d, 1H), 2.31 (br. s, 1H, OH), 2.19 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 8.09 (s, 1H), 8.02 (d, 1H), 7.61 (d, 1H), 7.42 (dd, 1H), 5.90 (s, 1H ), 3.94 (s, 3H), 2.63 (d, 1H), 2.48 (d, 1H), 2.31 (br, s, 1H, OH), 2.19 (s, 3H), 1.30 (s, 3H), 1.17 ( s, 3H).
Beispiel No.1.1-606: Example No.1.1-606:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.97 (d, 1 H), 7.48 (m, 2H), 7.39 (m, 1 H), 5.89 (s, 1H), 4.37 (q, 2H), 2.82 (br. s, 1H, OH), 2.69 (d, 1H), 2.43 (d, 1H), 2.20 (s, 3H), 1.38 (t, 3H), 1.30 (s, 3H), 1.16 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.97 (d, 1H), 7.48 (m, 2H), 7.39 (m, 1H), 5.89 (s, 1H), 4.37 (q, 2H), 2.82 (br s, 1H, OH), 2.69 (d, 1H), 2.43 (d, 1H), 2.20 (s, 3H), 1.38 (t, 3H), 1.30 (s, 3H), 1.16 (s, 3H).
Beispiel No.1.1-611: Example No.1.1-611:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.88 (m, 1 H), 7.56 (m, 1 H), 7.48 (m, 2H), 7.30 (m, 1 H), 6.08 / 5.93 (d, 1 H), 5.41 / 5.30 / 5.27 (s, 1 H), 4.38 (q, 2H), 4.35 / 3.71 (m, 2H), 1.96 / 1.88 (br. s, 1 H, OH), 1.87 / 1.65 (m, 1 H), 1.73 / 1.71 (s, 3H), 1.40 (t, 3H), 1.28 (m, 3H), 1.24 (m, 3H), 1.21 (m, 3H), 0.91 / 0.60 / 0.48 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.88 (m, 1H), 7.56 (m, 1H), 7.48 (m, 2H), 7.30 (m, 1H), 6.08 / 5.93 (d, 1H), 5.41 / 5.30 / 5.27 (s, 1H), 4.38 (q, 2H), 4.35 / 3.71 (m, 2H), 1.96 / 1.88 (brs s, 1H, OH), 1.87 / 1.65 ( m, 1H), 1.73 / 1.71 (s, 3H), 1.40 (t, 3H), 1.28 (m, 3H), 1.24 (m, 3H), 1.21 (m, 3H), 0.91 / 0.60 / 0.48 (m , 2H).
Beispiel No.1.1-612: Example No.1.1-612:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.92 (m, 1 H), 7.72 (m, 1 H), 7.61 / 7.52 (d, 1 H), 7.50 (m, 1 H), 7.34 (m, 1 H), 5.86 / 5.76 / 5.63 (s, 1 H), 6.16 / 5.87 (d, 1 H), 4.38 (q, 2H), 2.43 / 2.00 (br. s, 1 H, OH), 1.96 / 1.98 (s, 3H), 1.76 / 1.46 (m, 1 H), 1.42 (t, 3H), 1.30 / 1.27 (s, 3H), 1.22 / 1.16 / 0.92 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.92 (m, 1H), 7.72 (m, 1H), 7.61 / 7.52 (d, 1H), 7.50 (m, 1H), 7.34 (m , 1H), 5.86 / 5.76 / 5.63 (s, 1H), 6.16 / 5.87 (d, 1H), 4.38 (q, 2H), 2.43 / 2.00 (brs s, 1H, OH), 1.96 / 1.98 (s, 3H), 1.76 / 1.46 (m, 1H), 1.42 (t, 3H), 1.30 / 1.27 (s, 3H), 1.22 / 1.16 / 0.92 (m, 2H).
Beispiel No.1.1-615: Example No.1.1-615:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.04 (s, 1 H), 7.90 (d, 1 H), 7.58 (d, 1 H), 7.39 (dd, 1 H), 6.68 (d, 1 H), 6.28 (d, 1 H), 5.48 (s, 1 H), 4.40 (q, 2H), 4.24 / 3.58 (m, 2H), 2.03 (d, 1H), 1.82 (d, 1H), 1.71 (s, 3H), 1.40 (t, 3H), 1.28 (m, 3H), 1.20-1.11 (m, 6H), 0.98 (m, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 8:04 (s, 1 H), 7.90 (d, 1 H), 7:58 (d, 1 H), 7:39 (dd, 1 H), 6.68 (d, 1 H), 6.28 (d, 1H), 5.48 (s, 1H), 4.40 (q, 2H), 4.24 / 3.58 (m, 2H), 2.03 (d, 1H), 1.82 (d, 1H), 1.71 (s, 3H), 1.40 (t, 3H), 1.28 (m, 3H), 1.20-1.11 (m, 6H), 0.98 (m, 3H).
Beispiel No.1.1-616: Example No.1.1-616:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.07 (s, 1 H), 7.94 (d, 1 H), 7.58 (d, 1 H), 7.42 (dd, 1H), 6.74 (d, 1H), 6.36 (d, 1H), 5.98 (s, 1H), 4.41 (q, 2H), 2.58 (d, 1H), 2.32 (d, 1H), 1.96 (s, 3H), 1.41 (t, 3H), 1.13 (s, 3H), 1.09 (s, 3H). Beispiel No.1.1-629: 1H-NMR (400 MHz, CDCl3 δ, ppm) 8.07 (s, 1H), 7.94 (d, 1H), 7.58 (d, 1H), 7.42 (dd, 1H), 6.74 (d, 1H), 6.36 (d, 1H), 5.98 (s, 1H), 4.41 (q, 2H), 2.58 (d, 1H), 2.32 (d, 1H), 1.96 (s, 3H), 1.41 (t, 3H), 1.13 (s, 3H), 1.09 (s, 3H). Example No.1.1-629:
1H-NMR(400MHz, CDC δ, ppm) 7.30 (m, 1H), 7.22 (m, 1H), 7.17 (m, 1H), 5.52/ 5.40 (s, 1 H), 4.21 / 3.59 (m, 2H), 3.91 (s, 3H), 2.32 (s, 3H), 2.03 (d, 1 H), 1.94 / 1.92 (s, 3H), 1.89 (d, 1H), 1.22 (m, 3H), 1.19 (m, 3H), 1.14 (m, 6H). 1 H NMR (400MHz, CDC δ, ppm) 7.30 (m, 1H), 7.22 (m, 1H), 7.17 (m, 1H), 5.52 / 5.40 (s, 1H), 4.21 / 3.59 (m, 2H ), 3.91 (s, 3H), 2.32 (s, 3H), 2.03 (d, 1H), 1.94 / 1.92 (s, 3H), 1.89 (d, 1H), 1.22 (m, 3H), 1.19 (m , 3H), 1.14 (m, 6H).
Beispiel No.1.1-630: Example No.1.1-630:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.29 (m, 1 H), 7.27 (d, 1 H), 7.21 (d, 1 H), 5.87 (s, 1H), 3.88 (s, 3H), 2.60 (d, 1H), 2.44 (d, 1H), 2.42 (br. s, 1H, OH), 2.33 (s, 3H), 2.16 (s, 3H), 1.26 (s, 3H), 1.14 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.29 (m, 1H), 7.27 (d, 1H), 7.21 (d, 1H), 5.87 (s, 1H), 3.88 (s, 3H) , 2.60 (d, 1H), 2.44 (d, 1H), 2.42 (br s, 1H, OH), 2.33 (s, 3H), 2.16 (s, 3H), 1.26 (s, 3H), 1.14 (s , 3H).
Beispiel No.1.1-633: Example No.1.1-633:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.35 (m, 1H), 7.23 (m, 1H), 7.18 (m, 1H), 5.42/ 5.29 (s, 1H), 4.36/3.70 (m, 2H), 3.92/3.90 (s, 3H), 2.32/2.19 (s, 3H), 1.99 (br. s, 1 H, OH), 1.45 / 1.43 (s, 3H), 1.40 / 1.38 (d, 3H), 1.30 (m, 6H), 1.20 / 1.05 (m, 1 H), 0.62/0.42 (m, 2H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.35 (m, 1H), 7.23 (m, 1H), 7.18 (m, 1H), 5.42 / 5.29 (s, 1H), 4.36 / 3.70 (m, 2H) , 3.92 / 3.90 (s, 3H), 2.32 / 2.19 (s, 3H), 1.99 (brs s, 1H, OH), 1.45 / 1.43 (s, 3H), 1.40 / 1.38 (d, 3H), 1.30 (m, 6H), 1.20 / 1.05 (m, 1H), 0.62 / 0.42 (m, 2H).
Beispiel No.1.1-634: Example No.1.1-634:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.37 (d, 1 H), 7.29 (m, 1 H), 7.21 (m, 1 H), 5.72 / 5.62 (s, 1H), 3.94/3.88 (s, 3H), 2.44 (br. s, 1H, OH), 2.23/2.22 (s, 3H), 2.17/2.10 (s, 3H), 1.96/1.77 (m, 1H), 1.51 / 1.42 (s, 3H), 1.19/0.91 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.37 (d, 1H), 7.29 (m, 1H), 7.21 (m, 1H), 5.72 / 5.62 (s, 1H), 3.94 / 3.88 ( s, 3H), 2.44 (brs s, 1H, OH), 2.23 / 2.22 (s, 3H), 2.17 / 2.10 (s, 3H), 1.96 / 1.77 (m, 1H), 1.51 / 1.42 (s, 3H ), 1.19 / 0.91 (m, 2H).
Beispiel No.1.1-646: Example No.1.1-646:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.89 (s, 1 H), 7.45 (d, 1 H), 7.33 (d, 1 H), 5.90 (s, 1H), 2.72 (d, 1H), 2.46 (br. s, 1H, OH), 2.44 (d, 1H), 2.41 (s, 3H), 2.19 (s, 3H), 1.30 (s, 3H), 1.14 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.89 (s, 1H), 7.45 (d, 1H), 7.33 (d, 1H), 5.90 (s, 1H), 2.72 (d, 1H) , 2.46 (brs s, 1H, OH), 2.44 (d, 1H), 2.41 (s, 3H), 2.19 (s, 3H), 1.30 (s, 3H), 1.14 (s, 3H).
Beispiel No.1.1-653: Example No.1.1-653:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.72 (s, 1 H), 7.39 (d, 1 H), 7.22 (d, 1 H), 5.53 / 5.42 (s, 1H), 4.22/3.60 (m, 2H), 3.90 (s, 3H), 2.36 (s, 3H), 2.33 (br. s, 1H, OH), 2.12 (d, 1H), 1.98 (s, 3H), 1.88 (d, 1H), 1.23 (m, 6H), 1.17 (m, 6H). Beispiel No.1.1-654: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.72 (s, 1H), 7.39 (d, 1H), 7.22 (d, 1H), 5.53 / 5.42 (s, 1H), 4.22 / 3.60 ( m, 2H), 3.90 (s, 3H), 2.36 (s, 3H), 2.33 (br s, 1H, OH), 2.12 (d, 1H), 1.98 (s, 3H), 1.88 (d, 1H) , 1.23 (m, 6H), 1.17 (m, 6H). Example No.1.1-654:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.78 (s, 1 H), 7.40 (d, 1 H), 7.29 (d, 1 H), 5.88 (s, 1H), 3.89 (s, 3H), 2.78 (br. s, 1H, OH), 2.67 (d, 1H), 2.46 (d, 1H), 2.40 (s, 3H), 2.19 (s, 3H), 1.30 (s, 3H), 1.16 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.78 (s, 1H), 7.40 (d, 1H), 7.29 (d, 1H), 5.88 (s, 1H), 3.89 (s, 3H , 2.78 (br, s, 1H, OH), 2.67 (d, 1H), 2.46 (d, 1H), 2.40 (s, 3H), 2.19 (s, 3H), 1.30 (s, 3H), 1.16 ( s, 3H).
Beispiel No.1.1-658: Example No.1.1-658:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.79 (s, 1 H), 7.48 (d, 1 H), 7.28 (m, 1 H), 5.73 (s, 1H), 3.92/3.91 (s, 3H), 2.63/2.32 (br. s, 1H, OH), 2.40/2.39 (s, 3H), 2.19/2.14 (s, 3H), 1.94 / 1.76 (m, 1 H), 1.53 (s, 3H), 1.20 / 0.93 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.79 (s, 1H), 7.48 (d, 1H), 7.28 (m, 1H), 5.73 (s, 1H), 3.92 / 3.91 (s, 3H), 2.63 / 2.32 (brs s, 1H, OH), 2.40 / 2.39 (s, 3H), 2.19 / 2.14 (s, 3H), 1.94 / 1.76 (m, 1H), 1.53 (s, 3H) , 1.20 / 0.93 (m, 2H).
Beispiel No.1.1-733: Example No.1.1-733:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.20 (d, 1 H), 7.54 (m, 1 H), 6.61 (d, 1 H), 5.53 / 5.42 (s, 1H), 5.29 (m, 1H), 4.24/3.60 (m, 2H), 2.11 (d, 1H), 1.98/ 1.96 (s, 3H), 1.86 (d, 1H), 1.32 (d, 6H), 1.24 (m, 3H), 1.21 (m, 3H), 1.16 (m, 6H). 1 H NMR (400 MHz, CDCl3 δ, ppm) 8.20 (d, 1H), 7.54 (m, 1H), 6.61 (d, 1H), 5.53 / 5.42 (s, 1H), 5.29 (m, 1H), 4.24 / 3.60 (m, 2H), 2.11 (d, 1H), 1.98 / 1.96 (s, 3H), 1.86 (d, 1H), 1.32 (d, 6H), 1.24 (m, 3H), 1.21 (m, 3H), 1.16 (m, 6H).
Beispiel No.1.1-734: Example No.1.1-734:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.22 (d, 1 H), 7.56 (dd, 1 H), 6.64 (d, 1 H), 5.88 (s, 1H), 5.30 (sept, 1H), 2.58 (d, 1H), 2.44 (d, 1H), 2.32 (br. s, 1H, OH), 2.18 (s, 3H), 1.33 (d, 6H), 1.27 (s, 3H), 1.15 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 8.22 (d, 1H), 7.56 (dd, 1H), 6.64 (d, 1H), 5.88 (s, 1H), 5.30 (sept, 1H) , 2.58 (d, 1H), 2.44 (d, 1H), 2.32 (br, s, 1H, OH), 2.18 (s, 3H), 1.33 (d, 6H), 1.27 (s, 3H), 1.15 (s , 3H).
Beispiel No.1.1-821: Example No.1.1-821:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.11 (d, 1 H), 7.57 (d, 1 H), 7.50 (m, 1 H), 7.44 (dd, 1 H), 5.99 (br. s, 1 H, NH), 5.51 / 5.42 (s, 1 H), 4.21 / 3.60 (m, 2H), 2.22 (m, 1 H), 2.04 (d, 1H), 1.93/1.89 (s, 3H), 1.87 (d, 1H), 1.24 (m, 6H), 1.17 (m, 6H), 0.50 (m, 4H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.11 (d, 1H), 7.57 (d, 1H), 7.50 (m, 1H), 7.44 (dd, 1H), 5.99 (br , 1H, NH), 5.51 / 5.42 (s, 1H), 4.21 / 3.60 (m, 2H), 2.22 (m, 1H), 2.04 (d, 1H), 1.93 / 1.89 (s, 3H), 1.87 (d, 1H), 1.24 (m, 6H), 1.17 (m, 6H), 0.50 (m, 4H).
Beispiel No.1.1-822: Example No.1.1-822:
1H-NMR(400MHz, CDCI3 δ, ppm) 8.13 (d, 1H), 7.57 (m, 1H), 7.53 (m, 2H), 5.93 (s, 1H), 5.45 (br. s, 1H, NH), 3.04 (br. s, 1H, OH), 2.62 (d, 1H), 2.44 (d, 1H), 2.20 (s, 3H), 2.18 (m, 1H), 1.31 (s, 3H), 1.17 (s, 3H), 0.58 (m, 4H). Beispiel No.1.1-837: 1 H-NMR (400MHz, CDCl3 δ, ppm) 8.13 (d, 1H), 7.57 (m, 1H), 7.53 (m, 2H), 5.93 (s, 1H), 5.45 (br, s, 1H, NH) , 3.04 (brs s, 1H, OH), 2.62 (d, 1H), 2.44 (d, 1H), 2.20 (s, 3H), 2.18 (m, 1H), 1.31 (s, 3H), 1.17 (s , 3H), 0.58 (m, 4H). Example No.1.1-837:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.07 (m, 1 H), 7.50 (m, 1 H), 7.44 (m, 1 H), 7.20 (m, 1 H), 5.56 / 5.43 (s, 1 H), 5.28 (br. s, 2H, NH), 4.21 / 3.59 (m, 1 H), 2.34 (br. m, 1 H, OH), 2.11 (d, 1H), 2.00/1.98 (s, 3H), 1.91 (d, 1H), 1.23 (m, 6H), 1.17 (m, 6H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 8.07 (m, 1H), 7.50 (m, 1H), 7.44 (m, 1H), 7.20 (m, 1H), 5.56 / 5.43 ( s, 1H), 5.28 (br, s, 2H, NH), 4.21 / 3.59 (m, 1H), 2.34 (br, m, 1H, OH), 2.11 (d, 1H), 2.00 / 1.98 ( s, 3H), 1.91 (d, 1H), 1.23 (m, 6H), 1.17 (m, 6H).
Beispiel No.1.1-838: Example No.1.1-838:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.08 (d, 1 H), 7.57 (m, 2H), 7.51 (m, 1 H), 5.93 (s, 1H), 5.10 (br. s, 2H, NH), 2.91 (br. s, 1H, OH), 2.66 (d, 1H), 2.48 (d, 1H), 2.21 (s, 3H), 1.32 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.08 (d, 1H), 7.57 (m, 2H), 7.51 (m, 1H), 5.93 (s, 1H), 5.10 (br. S, 2H , NH), 2.91 (br s, 1H, OH), 2.66 (d, 1H), 2.48 (d, 1H), 2.21 (s, 3H), 1.32 (s, 3H), 1.17 (s, 3H).
Beispiel No.1.1-901: Example No.1.1-901:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.60 (br. s, 1 H, NH), 8.33 (d, 1 H), 7.43 (d, 1 H), 7.38 (m, 1H), 7.17 (m, 1H), 5.57/5.46 (s, 1H), 4.22/3.60 (m, 2H), 2.09 (d, 1H), 2.00 / 1.98 (s, 3H), 1.89 (d, 1H), 1.22 (m, 6H), 1.17 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.60 (br.s, 1H, NH), 8.33 (d, 1H), 7.43 (d, 1H), 7.38 (m, 1H), 7.17 ( m, 1H), 5.57 / 5.46 (s, 1H), 4.22 / 3.60 (m, 2H), 2.09 (d, 1H), 2.00 / 1.98 (s, 3H), 1.89 (d, 1H), 1.22 (m, 6H), 1.17 (m, 6H).
Beispiel No.1.1-902: Example No.1.1-902:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.48 (br. s, 1 H, NH), 8.34 (d, 1 H), 7.47 (m, 2H), 7.21 (dd, 1H), 5.93 (s, 1H), 2.60 (d, 1H), 2.49 (d, 1H), 2.35 (br. s, 1H, OH), 2.19 (s, 3H), 1.31 (s, 3H), 1.18 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.48 (br.s, 1H, NH), 8.34 (d, 1H), 7.47 (m, 2H), 7.21 (dd, 1H), 5.93 (s , 1H), 2.60 (d, 1H), 2.49 (d, 1H), 2.35 (br s, 1H, OH), 2.19 (s, 3H), 1.31 (s, 3H), 1.18 (s, 3H).
Beispiel No.1.1-933: Example No.1.1-933:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.59 (d, 1H), 7.42 (d, 1H), 7.36 (m, 1H), 7.11 (m, 1 H), 6.92 (m, 1 H, NH), 5.47 / 5.38 (s, 1 H), 4.22 / 3.60 (m, 2H), 3.01 / 2.99 (s, 3H), 2.11 (d, 1H), 2.01 /1.98 (s, 3H), 1.89 (d, 1H), 1.25 (m, 6H), 1.16 (m, 6H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.59 (d, 1H), 7.42 (d, 1H), 7.36 (m, 1H), 7.11 (m, 1H), 6.92 (m, 1H, NH) , 5.47 / 5.38 (s, 1H), 4.22 / 3.60 (m, 2H), 3.01 / 2.99 (s, 3H), 2.11 (d, 1H), 2.01 / 1.98 (s, 3H), 1.89 (d, 1H ), 1.25 (m, 6H), 1.16 (m, 6H).
Beispiel No.1.1-934: Example No.1.1-934:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.58 (d, 1H), 7.43 (d, 1H), 7.39 (dd, 1H), 7.13 (dd, 1H), 6.85 (br. s, 1H, NH), 5.93 (s, 1H), 3.04 (s, 3H), 2.59 (d, 1H), 2.46 (br. s, 1H, OH), 2.48 (d, 1H), 2.21 (s, 3H), 1.31 (s, 3H), 1.18 (s, 3H). Beispiel No.1.1-990: 1 H NMR (400MHz, CDCl3 δ, ppm) 7.58 (d, 1H), 7.43 (d, 1H), 7.39 (dd, 1H), 7.13 (dd, 1H), 6.85 (br, s, 1H, NH) , 5.93 (s, 1H), 3.04 (s, 3H), 2.59 (d, 1H), 2.46 (br, s, 1H, OH), 2.48 (d, 1H), 2.21 (s, 3H), 1.31 (s , 3H), 1.18 (s, 3H). Example No.1.1-990:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.01 (d, 1 H), 7.70 (d, 1 H), 7.57 (dd, 1 H), 5.93 (s, 1H), 2.76 (d, 1H), 2.63 (br. s, 1H, OH), 2.53 (d, 1H), 2.27 (s, 3H), 1.39 (s, 3H), 1.22 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 8.01 (d, 1H), 7.70 (d, 1H), 7.57 (dd, 1H), 5.93 (s, 1H), 2.76 (d, 1H ), 2.63 (br s, 1H, OH), 2.53 (d, 1H), 2.27 (s, 3H), 1.39 (s, 3H), 1.22 (s, 3H).
Beispiel No.1.1-1006: Example No.1.1-1006:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.08 (s, 1 H), 7.88 (br. d, 1 H, NH), 7.44 (m, 3H), 5.90 (s, 1H), 4.91 (m, 1H), 4.29 (q, 2H), 2.59 (d, 1H), 2.50 (d, 1H), 2.29 (m, 1H), 2.14 (s, 3H), 1.32 (t, 3H), 1.26 (s, 3H), 1.17 (s, 3H), 1.10 (d, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.08 (s, 1H), 7.88 (br d, 1H, NH), 7.44 (m, 3H), 5.90 (s, 1H), 4.91 (m , 1H), 4.29 (q, 2H), 2.59 (d, 1H), 2.50 (d, 1H), 2.29 (m, 1H), 2.14 (s, 3H), 1.32 (t, 3H), 1.26 (s, 3H), 1.17 (s, 3H), 1.10 (d, 6H).
Beispiel No.1.1-1013: Example No.1.1-1013:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.94 (d, 1 H), 7.51 (m, 2H), 7.42 (m, 3H), 7.33 (m, 3H), 5.40 (s, 1 H), 5.37 (s, 2H), 4.22 / 3.60 (m, 2H), 2.11 (d, 1 H), 1.94 (s, 3H), 1.89 (d, 1H), 1.23 (m, 3H), 1.21 (s, 3H), 1.16 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.94 (d, 1H), 7.51 (m, 2H), 7.42 (m, 3H), 7.33 (m, 3H), 5.40 (s, 1H), 5.37 (s, 2H), 4.22 / 3.60 (m, 2H), 2.11 (d, 1H), 1.94 (s, 3H), 1.89 (d, 1H), 1.23 (m, 3H), 1.21 (s, 3H ), 1.16 (m, 6H).
Beispiel No.1.1-1014: Example No.1.1-1014:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.02 (d, 1 H), 7.51 (m, 2H), 7.42 (m, 2H), 7.39 (m, 4H), 5.87 (s, 1H), 5.36 (s, 2H), 2.69 (br. s, 1H, OH), 2.67 (d, 1H), 2.44 (d, 1H), 2.15 (s, 3H), 1.27 (s, 3H), 1.14 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.02 (d, 1H), 7.51 (m, 2H), 7.42 (m, 2H), 7.39 (m, 4H), 5.87 (s, 1H), 5.36 (s, 2H), 2.69 (brs s, 1H, OH), 2.67 (d, 1H), 2.44 (d, 1H), 2.15 (s, 3H), 1.27 (s, 3H), 1.14 (s, 3H ).
Beispiel No.1.1-1026: Example No.1.1-1026:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.50 / 7.48 (s, 1H), 6.98/6.96 (s, 1H), 6.17/6.14 (s, 1 H), 4.07 / 4.01 (s, 3H), 3.93 / 3.90 (s, 3H), 2.65 (m, 1 H), 2.58 / 2.52 (m, 1 H), 2.41 / 2.31 (br. s, 1 H, OH), 2.02 / 1.91 (s, 3H), 1.51 (s, 3H), 1.25 / 0.83 (m, 1 H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.50 / 7.48 (s, 1H), 6.98 / 6.96 (s, 1H), 6.17 / 6.14 (s, 1H), 4.07 / 4.01 (s, 3H), 3.93 / 3.90 (s, 3H), 2.65 (m, 1H), 2.58 / 2.52 (m, 1H), 2.41 / 2.31 (brs s, 1H, OH), 2.02 / 1.91 (s, 3H), 1.51 (s, 3H), 1.25 / 0.83 (m, 1H).
Beispiel No.1.1-1029: Example No.1.1-1029:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.57 (d, 1 H), 7.46 (d, 1 H), 7.33 (m, 1 H), 7.24 (m, 1H), 7.13 (m, 2H), 6.87 (m, 2H), 5.51 /5.41 (s, 1H), 5.21 /5.04 (s, 2H), 4.21 / 3.58 (m, 2H), 2.30 (s, 3H), 2.11 (d, 1H), 1.93 (s, 3H), 1.91 (d, 1H), 1.22 (m, 6H), 1.13 (m, 6H). Beispiel No.1.1-1030: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.57 (d, 1H), 7.46 (d, 1H), 7.33 (m, 1H), 7.24 (m, 1H), 7.13 (m, 2H) , 6.87 (m, 2H), 5.51 / 5.41 (s, 1H), 5.21 /5.04 (s, 2H), 4.21 / 3.58 (m, 2H), 2.30 (s, 3H), 2.11 (d, 1H), 1.93 (s, 3H), 1.91 (d, 1H), 1.22 (m, 6H), 1.13 (m, 6H). Example No.1.1-1030:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.56 (d, 1 H), 7.48 (d, 1 H), 7.39 (dd, 1 H), 7.30 (m, 1H), 7.14 (m, 2H), 6.89 (dd, 1H), 6.83 (d, 1H), 5.83 (s, 1H), 5.16 (s, 2H), 2.58 (d, 1H), 2.42 (d, 1H), 2.26 (s, 3H), 2.13 (br. s, 1H, OH), 2.10 (s, 3H), 1.25 (s, 3H), 1.12 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.56 (d, 1H), 7.48 (d, 1H), 7.39 (dd, 1H), 7.30 (m, 1H), 7.14 (m, 2H ), 6.89 (dd, 1H), 6.83 (d, 1H), 5.83 (s, 1H), 5.16 (s, 2H), 2.58 (d, 1H), 2.42 (d, 1H), 2.26 (s, 3H) , 2.13 (brs s, 1H, OH), 2.10 (s, 3H), 1.25 (s, 3H), 1.12 (s, 3H).
Beispiel No.1.1-1069: Example No.1.1-1069:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.67 (d, 1 H), 7.58 (d, 1 H), 7.51 (m, 1 H), 7.42 (m, 1 H), 6.63 / 5.99 (s, 1 H), 3.89 / 3.87 (s, 3H), 2.47 (d, 1 H), 2.38 (d, 1 H), 2.18 / 2.14 (br. s, 1H, OH), 2.11 /2.08 (s, 3H), 1.22 (s, 3H), 1.12 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.67 (d, 1H), 7.58 (d, 1H), 7.51 (m, 1H), 7.42 (m, 1H), 6.63 / 5.99 (s , 1H), 3.89 / 3.87 (s, 3H), 2.47 (d, 1H), 2.38 (d, 1H), 2.18 / 2.14 (br.s, 1H, OH), 2.11 / 2.08 (s, 3H ), 1.22 (s, 3H), 1.12 (s, 3H).
Beispiel No.1.1-1073: Example No.1.1-1073:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.67 (d, 1 H), 7.58 (d, 1 H), 7.50 (m, 1 H), 7.43 (m, 1H), 6.66/6.00 (s, 1H), 4.14/4.10 (q, 2H), 2.48 (d, 1H), 2.38 (d, 1H), 2.17 / 2.13 (br. s, 1H, OH), 2.11 /2.08 (s, 3H), 1.28 (t, 3H), 1.22 (s, 3H), 1.12 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.67 (d, 1H), 7.58 (d, 1H), 7.50 (m, 1H), 7.43 (m, 1H), 6.66 / 6.00 (s, 1H), 4.14 / 4.10 (q, 2H), 2.48 (d, 1H), 2.38 (d, 1H), 2.17 / 2.13 (brs s, 1H, OH), 2.11 / 2.08 (s, 3H), 1.28 ( t, 3H), 1.22 (s, 3H), 1.12 (s, 3H).
Beispiel No.1.1-1093: Example No.1.1-1093:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.93 (m, 1 H), 7.51 (m, 1 H), 7.47 (m, 1 H), 7.38 (m, 1 H), 6.61 / 5.97 (s, 1 H), 4.38 (q, 2H), 3.89 / 3.86 (s, 3H), 2.64 / 2.56 (br. s, 1 H, OH), 2.51 (d, 1H), 2.39 (d, 1H), 2.13/2.09 (s, 3H), 1.39 (t, 3H), 1.26 (s, 3H), 1.12 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.93 (m, 1H), 7.51 (m, 1H), 7.47 (m, 1H), 7.38 (m, 1H), 6.61 / 5.97 (s , 1H), 4.38 (q, 2H), 3.89 / 3.86 (s, 3H), 2.64 / 2.56 (brs s, 1H, OH), 2.51 (d, 1H), 2.39 (d, 1H), 2.13 /2.09 (s, 3H), 1.39 (t, 3H), 1.26 (s, 3H), 1.12 (s, 3H).
Beispiel No.1.1-1101: Example No.1.1-1101:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.93 (d, 1 H), 7.51 (d, 1 H), 7.46 (m, 1 H), 7.38 (m, 1 H), 7.36 (br. s, 1 H, OH), 6.71 / 5.98 (s, 1 H), 4.37 (q, 2H), 2.68 / 2.64 (br. s, 1 H, OH), 2.55 (d, 1H), 2.41 (d, 1 H), 2.15 / 2.10 (s, 3H), 1.39 (t, 3H), 1.25 (s, 3H), 1.12 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.93 (d, 1H), 7.51 (d, 1H), 7.46 (m, 1H), 7.38 (m, 1H), 7.36 (br , 1H, OH), 6.71 / 5.98 (s, 1H), 4.37 (q, 2H), 2.68 / 2.64 (br s, 1H, OH), 2.55 (d, 1H), 2.41 (d, 1 H), 2.15 / 2.10 (s, 3H), 1.39 (t, 3H), 1.25 (s, 3H), 1.12 (s, 3H).
Beispiel No.1.1-1123: Example No.1.1-1123:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.38 (d, 1 H), 7.29 (m, 1 H), 6.89 (m, 2H), 6.60 / 5.97 (s, 1 H), 3.88 / 3.86 (s, 3H), 3.85 (s, 3H), 2.63 (br. s, 1 H, OH), 2.51 (d, 1 H), 2.40 (d, 1H), 2.13/2.10 (s, 3H), 1.24 (s, 3H), 1.13 (s, 3H). Beispiel No.1.1-1127: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.38 (d, 1H), 7.29 (m, 1H), 6.89 (m, 2H), 6.60 / 5.97 (s, 1H), 3.88 / 3.86 ( s, 3H), 3.85 (s, 3H), 2.63 (br s, 1H, OH), 2.51 (d, 1H), 2.40 (d, 1H), 2.13 / 2.10 (s, 3H), 1.24 ( s, 3H), 1.13 (s, 3H). Example No.1.1-1127:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.37 (d, 1 H), 7.28 (m, 1 H), 6.88 (m, 2H), 6.62 / 5.99 (s, 1H), 4.13/4.10 (q, 2H), 3.85 (s, 3H), 2.62/2.53 (br. s, 1H, OH), 2.52 (d, 1H), 2.40 (d, 1H), 2.13/ 2.10 (s, 3H), 1.29 (t, 3H), 1.26 (s, 3H), 1.13 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.37 (d, 1H), 7.28 (m, 1H), 6.88 (m, 2H), 6.62 / 5.99 (s, 1H), 4.13 / 4.10 ( q, 2H), 3.85 (s, 3H), 2.62 / 2.53 (brs s, 1H, OH), 2.52 (d, 1H), 2.40 (d, 1H), 2.13 / 2.10 (s, 3H), 1.29 ( t, 3H), 1.26 (s, 3H), 1.13 (s, 3H).
Beispiel No.1.1-1131: Example No.1.1-1131:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.37 (d, 1 H), 7.30 (m, 1 H), 7.27 (br. s, 1 H, OH), 6.90 (m, 2H), 6.70 / 5.98 (s, 1 H), 3.85 (s, 3H), 2.71 (br. s, 1 H, OH), 2.52 (d, 1 H), 2.41 (d, 1H), 2.17/2.12(s, 3H), 1.25 (s, 3H), 1.13 (s, 3H). 1 H NMR (400 MHz, CDCl3 δ, ppm) 7.37 (d, 1H), 7.30 (m, 1H), 7.27 (br, s, 1H, OH), 6.90 (m, 2H), 6.70 / 5.98 (s, 1H), 3.85 (s, 3H), 2.71 (brs s, 1H, OH), 2.52 (d, 1H), 2.41 (d, 1H), 2.17 / 2.12 (s, 3H) , 1.25 (s, 3H), 1.13 (s, 3H).
Beispiel No.1.1-1135: Example No.1.1-1135:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.67 (d, 1 H), 7.59 (d, 1 H), 7.51 (m, 1 H), 7.43 (m, 1 H), 7.22 (br. s, 1 H, OH), 6.73 / 5.99 (s, 1 H), 2.62 (br. s, 1 H, OH), 2.48 (d, 1 H), 2.39 (d, 1H), 2.13/2.09 (s, 3H), 1.25/1.23 (s, 3H), 1.12 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.67 (d, 1H), 7.59 (d, 1H), 7.51 (m, 1H), 7.43 (m, 1H), 7.22 (br , 1H, OH), 6.73 / 5.99 (s, 1H), 2.62 (brs s, 1H, OH), 2.48 (d, 1H), 2.39 (d, 1H), 2.13 / 2.09 (s, 3H), 1.25 / 1.23 (s, 3H), 1.12 (s, 3H).
Beispiel No.1.2-1: Example No.1.2-1:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.08 (m, 1 H), 5.47 / 5.34 (s, 1 H), 4.20 / 3.58 (m, 2H), 2.08 (m, 4H), 2.01 (d, 1 H), 1.91 / 1.89 (s, 3H), 1.87 (d, 1 H), 1.85 / 1.78 (br. s, 1H, OH), 1.61 (m, 2H), 1.58 (m, 2H), 1.22 (m, 6H), 1.12 (m, 3H), 1.09 (m, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 6.08 (m, 1H), 5.47 / 5.34 (s, 1H), 4.20 / 3.58 (m, 2H), 2.08 (m, 4H), 2.01 (i.e. , 1H), 1.91 / 1.89 (s, 3H), 1.87 (d, 1H), 1.85 / 1.78 (br.s, 1H, OH), 1.61 (m, 2H), 1.58 (m, 2H), 1.22 (m, 6H), 1.12 (m, 3H), 1.09 (m, 3H).
Beispiel No. I.2-2: Example No. I.2-2:
1H-NMR(400MHz, CDCI3 δ, ppm) 6.13 (m, 1H), 5.82 (s, 1H), 2.55 (d, 1H), 2.38 (d, 1H), 2.19 (br. s, 1H, OH), 2.11 (s, 3H), 2.09 (m, 4H), 1.62 (m, 2H), 1.59 (m, 2H), 1.20 (s, 3H), 1.10 (s, 3H); 13C-NMR (125 MHz, CDCI3 δ, ppm) 198.5, 136.5, 126.3, 125.9, 119.6, 88.4, 84.9, 73.6, 28.9, 25.6, 25.1, 25.0, 23.9, 22.1, 21.3, 18.7. 1 H-NMR (400MHz, CDCl 3 δ, ppm) 6.13 (m, 1H), 5.82 (s, 1H), 2:55 (d, 1H), 2:38 (d, 1H), 2.19 (br. S, 1H, OH) , 2.11 (s, 3H), 2.09 (m, 4H), 1.62 (m, 2H), 1.59 (m, 2H), 1.20 (s, 3H), 1.10 (s, 3H); 13 C-NMR (125 MHz, CDCl3 δ, ppm) 198.5, 136.5, 126.3, 125.9, 119.6, 88.4, 84.9, 73.6, 28.9, 25.6, 25.1, 25.0, 23.9, 22.1, 21.3, 18.7.
Beispiel No. I.2-5: Example No. I.2-5:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.12 (m, 1 H), 5.36 / 5.23 (s, 1 H), 4.32 / 3.68 (m, 2H), 2.12/2.08 (m, 4H), 1.94/1.92 (s, 3H), 1.88/1.78 (m, 1H), 1.61 (m, 2H), 1.59 (m, 2H), 1.40 / 1.38 (s, 3H), 1.28 (m, 3H), 1.22 (m, 3H), 1.18 / 0.58 (m, 2H). Beispiel No.1.2-6: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 6.12 (m, 1H), 5.36 / 5.23 (s, 1H), 4.32 / 3.68 (m, 2H), 2.12 / 2.08 (m, 4H), 1.94 /1.92 (s, 3H), 1.88 / 1.78 (m, 1H), 1.61 (m, 2H), 1.59 (m, 2H), 1.40 / 1.38 (s, 3H), 1.28 (m, 3H), 1.22 (m , 3H), 1.18 / 0.58 (m, 2H). Example No.1.2-6:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.34 (m, 1 H), 5.81 (s, 1 H), 2.32 / 2.04 (m, 4H), 2.02 / 1.97 (m, 1 H), 1.92 (s, 3H), 1.68 (m, 2H), 1.53 (m, 2H), 1.23 / 1.21 (s, 3H), 1.27 / 1.20 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 6.34 (m, 1H), 5.81 (s, 1H), 2.32 / 2.04 (m, 4H), 2.02 / 1.97 (m, 1H), 1.92 (s, 3H), 1.68 (m, 2H), 1.53 (m, 2H), 1.23 / 1.21 (s, 3H), 1.27 / 1.20 (m, 2H).
Beispiel No. I.2-27: Example No. I.2-27:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.06 (d, 1 H), 5.93 (d, 1 H), 5.52 / 5.43 / 5.40 (s, 1 H), 4.25 / 3.57 (m, 2H), 4.22 (q, 2H), 2.38 (m, 2H), 2.29 (m, 2H), 2.06 (br. s, 1 H, OH), 1.94 (d, 1 H), 1.70 (d, 1 H), 1.65 (m, 4H), 1.53 (s, 3H), 1.31 (t, 3H), 1.28-1.22 (m, 6H), 1.11 /1.09(s, 3H), 0.91 /0.89(s, 3H) 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.06 (d, 1H), 5.93 (d, 1H), 5.52 / 5.43 / 5.40 (s, 1H), 4.25 / 3.57 (m, 2H), 4.22 (q, 2H), 2.38 (m, 2H), 2.29 (m, 2H), 2.06 (br, s, 1H, OH), 1.94 (d, 1H), 1.70 (d, 1H), 1.65 (m, 4H), 1.53 (s, 3H), 1.31 (t, 3H), 1.28-1.22 (m, 6H), 1.11 / 1.09 (s, 3H), 0.91 / 0.89 (s, 3H)
Beispiel No. I.2-28: Example No. I.2-28:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.16 (d, 1H), 5.92 (d, 1H), 5.91 (s, 1H), 4.23 (q, 2H), 2.49 (d, 1H), 2.40 (m, 2H), 2.30 (m, 2H), 2.28 (d, 1H), 1.92 (s, 3H), 1.67 (m, 4H), 1.31 (t, 3H), 1.10 (s, 3H), 1.01 (s, 3H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.16 (d, 1H), 5.92 (d, 1H), 5.91 (s, 1H), 4.23 (q, 2H), 2.49 (d, 1H), 2.40 (m , 2H), 2.30 (m, 2H), 2.28 (d, 1H), 1.92 (s, 3H), 1.67 (m, 4H), 1.31 (t, 3H), 1.10 (s, 3H), 1.01 (s, 3H).
Beispiel No.1.2-41: Example No.1.2-41:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.38 (s, 1 H), 5.51 / 5.38 (s, 1 H), 4.21 / 3.59 (m, 2H), 3.41 (s, 3H), 3.36 (s, 3H), 2.32 / 2.29 (br. s, 1 H, OH), 2.09 (d, 1 H), 1.96 (s, 3H), 1.83 (d, 1H), 1.23 (m, 6H), 1.13 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.38 (s, 1H), 5.51 / 5.38 (s, 1H), 4.21 / 3.59 (m, 2H), 3.41 (s, 3H), 3.36 (s , 3H), 2.32 / 2.29 (br s, 1H, OH), 2.09 (d, 1H), 1.96 (s, 3H), 1.83 (d, 1H), 1.23 (m, 6H), 1.13 (m , 6H).
Beispiel No. I.2-42: Example No. I.2-42:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.44 (s, 1 H), 5.86 (s, 1 H), 3.45 (s, 3H), 3.37 (s, 3H), 2.58 (d, 1H), 2.43 (d, 1H), 2.16 (s, 3H), 1.27 (s, 3H), 1.13 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.44 (s, 1H), 5.86 (s, 1H), 3.45 (s, 3H), 3.37 (s, 3H), 2.58 (d, 1H), 2.43 (d, 1H), 2.16 (s, 3H), 1.27 (s, 3H), 1.13 (s, 3H).
Beispiel No. I.2-49: Example No. I.2-49:
1H-NMR(400MHz, CDCI3 δ, ppm) 5.47 / 5.35 (s, 1H), 5.13 (d, 1H), 5.11 (d, 1H), 4.19/3.59 (m, 2H), 2.18/2.17 (s, 3H), 2.08 (d, 1H), 1.96/1.94 (s, 3H), 1.90 (d, 1H), 1.49 (s, 6H), 1.42 (s, 9H), 1.22 (m, 6H), 1.13 (m, 6H). Beispiel No.1.2-50: 1 H-NMR (400MHz, CDCl3 δ, ppm) 5.47 / 5.35 (s, 1H), 5.13 (d, 1H), 5.11 (d, 1H), 4.19 / 3.59 (m, 2H), 2.18 / 2.17 (s, 3H), 2.08 (d, 1H), 1.96 / 1.94 (s, 3H), 1.90 (d, 1H), 1.49 (s, 6H), 1.42 (s, 9H), 1.22 (m, 6H), 1.13 (m , 6H). Example No.1.2-50:
1H-NMR(400MHz, CDC δ, ppm) 5.84 (s, 1H), 5.18 (d, 1H), 5.16 (d, 1H), 4.09 (br. s, 1H, OH), 2.54 (d, 1H), 2.42 (d, 1H), 2.17 (s, 3H), 2.16 (s, 3H), 1.50 (s, 6H), 1.43 (s, 9H), 1.27 (s, 3H), 1.12 (s, 3H). 1 H-NMR (400MHz, CDC δ, ppm) 5.84 (s, 1H), 5.18 (d, 1H), 5.16 (d, 1H), 4.09 (br, s, 1H, OH), 2.54 (d, 1H) , 2.42 (d, 1H), 2.17 (s, 3H), 2.16 (s, 3H), 1.50 (s, 6H), 1.43 (s, 9H), 1.27 (s, 3H), 1.12 (s, 3H).
Beispiel No. I.2-65: Example No. I.2-65:
1H-NMR (400 MHz, CDCb δ, ppm) 8.65 / 8.63 (br. s, 1 H, NH), 7.11 (m, 2H), 6.52 (m, 1H), 5.49/5.37 (s, 1H), 5.18 (d, 1H), 5.17 (d, 1H), 4.20/3.58 (m, 2H), 2.21 (s, 3H), 2.08 (d, 1H), 1.93/1.91 (s, 3H), 1.82 (d, 1H), 1.65 (s, 6H), 1.22 (m, 6H), 1.12 (m, 6H). 1 H-NMR (400 MHz, CDCb δ, ppm) 8.65 / 8.63 (br.s, 1H, NH), 7.11 (m, 2H), 6.52 (m, 1H), 5.49 / 5.37 (s, 1H), 5.18 (d, 1H), 5.17 (d, 1H), 4.20 / 3.58 (m, 2H), 2.21 (s, 3H), 2.08 (d, 1H), 1.93 / 1.91 (s, 3H), 1.82 (d, 1H), 1.65 (s, 6H), 1.22 (m, 6H), 1.12 (m, 6H).
Beispiel No. I.2-66: Example No. I.2-66:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.27 (br. s, 1 H, NH), 7.12 (m, 2H), 6.54 (m, 1 H), 5.82 (s, 1H), 5.23 (d, 1H), 5.21 (d, 1H), 3.93 (br. s, 1H, OH), 2.54 (d, 1H), 2.40 (d, 1H), 2.21 (s, 3H), 2.12 (s, 3H), 1.64 (s, 6H), 1.22 (s, 3H), 1.10 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.27 (br. S, 1H, NH), 7.12 (m, 2H), 6.54 (m, 1H), 5.82 (s, 1H), 5.23 (d , 1H), 5.21 (d, 1H), 3.93 (br s, 1H, OH), 2.54 (d, 1H), 2.40 (d, 1H), 2.21 (s, 3H), 2.12 (s, 3H), 1.64 (s, 6H), 1.22 (s, 3H), 1.10 (s, 3H).
Beispiel No.1.3-1: Example No.1.3-1:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.22 (m, 1 H), 7.18 (m, 1 H), 6.94 (m, 1 H), 5.53 / 5.41 (s, 1 H), 4.21 / 3.60 (m, 2H), 2.09 (d, 1 H), 1.98 / 1.96 (s, 3H), 1.84 (d, 1 H), 1.22 (m, 6H), 1.16 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.22 (m, 1H), 7.18 (m, 1H), 6.94 (m, 1H), 5.53 / 5.41 (s, 1H), 4.21 / 3.60 (m, 2H), 2.09 (d, 1H), 1.98 / 1.96 (s, 3H), 1.84 (d, 1H), 1.22 (m, 6H), 1.16 (m, 6H).
Beispiel No. I.3-2: Example No. I.3-2:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.30 (d, 1 H), 7.22 (d, 1 H), 6.99 (dd, 1 H), 5.89 (s, 1H), 2.61 (d, 1H), 2.46 (d, 1H), 2.17 (s, 3H), 1.27 (s, 3H), 1.15 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.30 (d, 1H), 7.22 (d, 1H), 6.99 (dd, 1H), 5.89 (s, 1H), 2.61 (d, 1H) , 2.46 (d, 1H), 2.17 (s, 3H), 1.27 (s, 3H), 1.15 (s, 3H).
Beispiel No. I.3-5: Example No. I.3-5:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.23 (m, 2H), 6.96 (m, 1 H), 5.41 / 5.29 (s, 1 H), 4.37 / 3.71 (m, 2H), 2.24 / 2.20 (m, 1 H, OH), 2.09 / 2.00 (s, 3H), 1.92 / 1.39 (m, 1 H), 1.47/1.46 (s, 3H), 1.28 (m, 3H), 1.25 (m, 3H), 1.19/0.64 (m, 2H). Beispiel No.1.3-6: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.23 (m, 2H), 6.96 (m, 1H), 5.41 / 5.29 (s, 1H), 4.37 / 3.71 (m, 2H), 2.24 / 2.20 (m, 1H, OH), 2.09 / 2.00 (s, 3H), 1.92 / 1.39 (m, 1H), 1.47 / 1.46 (s, 3H), 1.28 (m, 3H), 1.25 (m, 3H) , 1.19 / 0.64 (m, 2H). Example No.1.3-6:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.29 (m, 1 H), 7.22 (m, 1 H), 6.99 (m, 1 H), 5.72 / 5.63 (s, 1H), 2.39/2.27 (br. s, 1H, OH), 2.18/2.11 (s, 3H), 1.95/1.92 (m, 1H), 1.54 /1.52 (s, 3H), 1.28/ 1.18 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.29 (m, 1H), 7.22 (m, 1H), 6.99 (m, 1H), 5.72 / 5.63 (s, 1H), 2.39 / 2.27 (brs s, 1H, OH), 2.18 / 2.11 (s, 3H), 1.95 / 1.92 (m, 1H), 1.54 / 1.52 (s, 3H), 1.28 / 1.18 (m, 2H).
Beispiel No. I.3-9: Example No. I.3-9:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.40 (m, 1 H), 7.23 (m, 1 H), 7.07 (m, 1 H), 5.52 / 5.41 (s, 1H), 4.22/3.59 (m, 2H), 2.11 (d, 1H), 1.97/1.95 (s, 3H), 1.84 (d, 1H), 1.23 (m, 6H), 1.15 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.40 (m, 1H), 7.23 (m, 1H), 7.07 (m, 1H), 5.52 / 5.41 (s, 1H), 4.22 / 3.59 ( m, 2H), 2.11 (d, 1H), 1.97 / 1.95 (s, 3H), 1.84 (d, 1H), 1.23 (m, 6H), 1.15 (m, 6H).
Beispiel No.1.3-10: Example No.1.3-10:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.47 (d, 1 H), 7.28 (m, 1 H), 7.09 (d, 1 H), 5.88 (s, 1H), 2.59 (d, 1H), 2.45 (d, 1H), 2.28 (br. s, 1H, OH), 2.17 (s, 3H), 1.27 (s, 3H), 1.15 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.47 (d, 1H), 7.28 (m, 1H), 7.09 (d, 1H), 5.88 (s, 1H), 2.59 (d, 1H) , 2.45 (d, 1H), 2.28 (br s, 1H, OH), 2.17 (s, 3H), 1.27 (s, 3H), 1.15 (s, 3H).
Beispiel No.1.3-13: Example No.1.3-13:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.51 / 7.44 (m, 1 H), 7.23 / 7.21 (m, 1 H), 7.12 / 7.10 (m, 1 H), 5.40 / 5.28 (s, 1 H), 4.34 / 3.70 (m, 2H), 2.14 / 2.09 (m, 1 H, OH), 2.01 / 1.99 (s, 3H), 1.93/1.78 (m, 1H), 1.46/1.44 (s, 3H), 1.27 (m, 3H), 1.22 (m, 3H), 1.19 /0.62 (m, 2H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.51 / 7.44 (m, 1H), 7.23 / 7.21 (m, 1H), 7.12 / 7.10 (m, 1H), 5.40 / 5.28 (s, 1 H), 4.34 / 3.70 (m, 2H), 2.14 / 2.09 (m, 1H, OH), 2.01 / 1.99 (s, 3H), 1.93 / 1.78 (m, 1H), 1.46 / 1.44 (s, 3H) , 1.27 (m, 3H), 1.22 (m, 3H), 1.19 / 0.62 (m, 2H).
Beispiel No.1.3-14: Example No.1.3-14:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.50 / 7.47 (m, 1H), 7.30/7.28 (m, 1H), 7.12/ 7.09 (d, 1H), 5.72/5.62 (s, 1H), 2.36/2.28 (m, 1H, OH), 2.19/2.11 (s, 3H), 1.94 (m, 1H), 1.56/ 1.54 (s, 3H), 1.27/ 1.19 (m, 2H). 1 H-NMR (400MHz, CDCl 3 δ, ppm) 7.50 / 7.47 (m, 1H), 7.30 / 7.28 (m, 1H), 7.12 / 7.09 (d, 1H), 5.72 / 5.62 (s, 1H), 2.36 / 2.28 (m, 1H, OH), 2.19 / 2.11 (s, 3H), 1.94 (m, 1H), 1.56 / 1.54 (s, 3H), 1.27 / 1.19 (m, 2H).
Beispiel No.1.3-17: Example No.1.3-17:
1H-NMR(400MHz, CDCI3 δ, ppm) 10.11 / 10.09 (s, 1H), 7.66 (m, 1H), 7.14 (m, 1H), 5.56 / 5.44 (s, 1 H), 4.21 / 3.59 (m, 2H), 2.09 (d, 1 H), 2.06 (br. s, 1 H, OH), 1.98 / 1.96 (s, 3H), 1.89 (d, 1H), 1.23 (m, 6H), 1.16 (m, 6H). Beispiel No.1.3-18: 1 H-NMR (400MHz, CDCl 3 δ, ppm) 10.11 / 9.10 (s, 1H), 7.66 (m, 1H), 7.14 (m, 1H), 5.56 / 5:44 (s, 1 H), 4.21 / 3:59 (m , 2H), 2.09 (d, 1H), 2.06 (brs s, 1H, OH), 1.98 / 1.96 (s, 3H), 1.89 (d, 1H), 1.23 (m, 6H), 1.16 (m , 6H). Example No.1.3-18:
1H-NMR(400MHz, CDC δ, ppm) 10.08 (s, 1H), 7.71 (d, 1H), 7.18 (d, 1H), 5.92 (s, 1H), 2.60 (d, 1H), 2.51 (br. s, 1H, OH), 2.49 (d, 1H), 2.19 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400MHz, CDC δ, ppm) 10.08 (s, 1H), 7.71 (d, 1H), 7.18 (d, 1H), 5.92 (s, 1H), 2.60 (d, 1H), 2.51 (br s, 1H, OH), 2.49 (d, 1H), 2.19 (s, 3H), 1.30 (s, 3H), 1.17 (s, 3H).
Beispiel No. I.3-25: Example No. I.3-25:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.53 (d, 1H), 7.13 (d, 1H), 5.51 /5.39 (s, 1H), 4.22/3.60 (m, 2H), 2.04 (d, 1H), 1.95/1.91 (s, 3H), 1.88 (d, 1H), 1.24 (m, 3H), 1.17 (m, 9H). 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.53 (d, 1H), 7.13 (d, 1H), 5.51 / 5.39 (s, 1H), 4.22 / 3.60 (m, 2H), 2.04 (d, 1H) , 1.95 / 1.91 (s, 3H), 1.88 (d, 1H), 1.24 (m, 3H), 1.17 (m, 9H).
Beispiel No. I.3-26: Example No. I.3-26:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.53 (d, 1H), 7.13 (d, 1H), 5.91 (s, 1H), 2.68 (d, 1H), 2.46 (d, 1H), 2.19 (s, 3H), 1.30 (s, 3H), 1.16 (s, 3H). Beispiel No. I.3-29: 1 H-NMR (400MHz, CDCl3 δ, ppm) 7.53 (d, 1H), 7.13 (d, 1H), 5.91 (s, 1H), 2.68 (d, 1H), 2.46 (d, 1H), 2.19 (s , 3H), 1.30 (s, 3H), 1.16 (s, 3H). Example No. I.3-29:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.69 (m, 1 H), 7.37 (m, 1 H), 5.39 / 5.28 (s, 1 H), 4.36 / 3.70 (m, 2H), 2.36 / 2.29 (m, 1 H, OH), 1.96 / 1.94 (s, 3H), 1.89 / 1.52 (m, 1 H), 1.43/1.41 (s, 3H), 1.30 (m, 3H), 1.23 (m, 3H), 1.19/0.61 (m, 2H). Beispiel No. I.3-30: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.69 (m, 1H), 7.37 (m, 1H), 5.39 / 5.28 (s, 1H), 4.36 / 3.70 (m, 2H), 2.36 / 2.29 (m, 1H, OH), 1.96 / 1.94 (s, 3H), 1.89 / 1.52 (m, 1H), 1.43 / 1.41 (s, 3H), 1.30 (m, 3H), 1.23 (m, 3H ), 1.19 / 0.61 (m, 2H). Example No. I.3-30:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.61 (m, 1 H), 7.55 (m, 1 H), 5.76 / 5.62 (s, 1 H), 2.02 / 1.99 (s, 3H), 1.96 / 1.93 (br. s, 1 H, OH), 1.80 / 1.57 (m, 1 H), 1.33 / 1.23 (s, 3H), 1.21 /0.98 (m, 2H). Beispiel No. I.3-34: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.61 (m, 1H), 7.55 (m, 1H), 5.76 / 5.62 (s, 1H), 2.02 / 1.99 (s, 3H), 1.96 / 1.93 (brs s, 1H, OH), 1.80 / 1.57 (m, 1H), 1.33 / 1.23 (s, 3H), 1.21 / 0.98 (m, 2H). Example No. I.3-34:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.47 (d, 1H), 7.11 (d, 1H), 5.90 (s, 1H), 3.88 (s, 3H), 2.71 (d, 1H), 2.69 (br. s, 1H, OH), 2.46 (d, 1H), 2.20 (s, 3H), 1.31 (s, 3H), 1.17 (s, 3H). Beispiel No.1.3-36: 1 H-NMR (400MHz, CDCl 3 δ, ppm) 7.47 (d, 1H), 7.11 (d, 1H), 5.90 (s, 1H), 3.88 (s, 3H), 2.71 (d, 1H), 2.69 (br s, 1H, OH), 2.46 (d, 1H), 2.20 (s, 3H), 1.31 (s, 3H), 1.17 (s, 3H). Example No.1.3-36:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.65 (d, 1 H), 7.44 (d, 1 H), 7.25 (d, 1 H), 6.32 (d, 1H), 5.97 (s, 1H), 3.88 (s, 3H), 2.55 (d, 1H), 2.32 (d, 1H), 1.97 (s, 3H), 1.93 (br. s, 1H, OH), 1.14 (s, 3H), 1.06 (s, 3H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.65 (d, 1H), 7.44 (d, 1H), 7.25 (d, 1H), 6.32 (d, 1H), 5.97 (s, 1H ), 3.88 (s, 3H), 2.55 (d, 1H), 2.32 (d, 1H), 1.97 (s, 3H), 1.93 (br, s, 1H, OH), 1.14 (s, 3H), 1.06 ( s, 3H).
Beispiel No.1.3-81: Example No.1.3-81:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.54 (d, 1 H), 7.67 (m, 1 H), 7.49 (d, 1 H), 7.41 (d, 1H), 7.17 (m, 2H), 5.54/5.43 (s, 1H), 4.22/3.60 (m, 2H), 2.08 (d, 1H), 2.02 (br. s, 1H, OH), 1.99/1.97 (s, 3H), 1.87 (d, 1H), 1.23 (m, 6H), 1.17 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.54 (d, 1H), 7.67 (m, 1H), 7.49 (d, 1H), 7.41 (d, 1H), 7.17 (m, 2H) , 5.54 / 5.43 (s, 1H), 4.22 / 3.60 (m, 2H), 2.08 (d, 1H), 2.02 (brs s, 1H, OH), 1.99 / 1.97 (s, 3H), 1.87 (d, 1H), 1.23 (m, 6H), 1.17 (m, 6H).
Beispiel No. I.3-82: Example No. I.3-82:
1H-NMR (400 MHz, CDCI3 δ, ppm) 8.56 (d, 1 H), 7.69 (m, 1 H), 7.51 (d, 1 H), 7.43 (d, 1H), 7.19 (d, 1H), 7.18 (m, 1H), 5.90 (s, 1H), 2.60 (d, 1H), 2.47 (d, 1H), 2.37 (br. s, 1H, OH), 2.18 (s, 3H), 1.28 (s, 3H), 1.16 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 8.56 (d, 1H), 7.69 (m, 1H), 7.51 (d, 1H), 7.43 (d, 1H), 7.19 (d, 1H) , 7.18 (m, 1H), 5.90 (s, 1H), 2.60 (d, 1H), 2.47 (d, 1H), 2.37 (br, s, 1H, OH), 2.18 (s, 3H), 1.28 (s , 3H), 1.16 (s, 3H).
Beispiel No. I.3-97: Example No. I.3-97:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 (s, 1 H), 6.39 (s, 1 H), 5.56 / 5.44 (s, 1 H), 4.21 / 3.60 (m, 2H), 3.91 (s, 3H), 2.09 (d, 1 H), 2.01 / 1.98 (s, 3H), 1.93 (d, 1 H), 1.23 (m, 6H), 1.16 (m, 6H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.42 (s, 1H), 6.39 (s, 1H), 5.56 / 5.44 (s, 1H), 4.21 / 3.60 (m, 2H), 3.91 ( s, 3H), 2.09 (d, 1H), 2.01 / 1.98 (s, 3H), 1.93 (d, 1H), 1.23 (m, 6H), 1.16 (m, 6H).
Beispiel No. I.3-98: Example No. I.3-98:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.44 (s, 1 H), 6.43 (s, 1 H), 5.90 (s, 1 H), 3.91 (s, 3H), 2.57 (d, 1H), 2.51 (br. s, 1H, OH), 2.48 (d, 1H), 2.19 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.44 (s, 1H), 6.43 (s, 1H), 5.90 (s, 1H), 3.91 (s, 3H), 2.57 (d, 1H) , 2.51 (brs s, 1H, OH), 2.48 (d, 1H), 2.19 (s, 3H), 1.29 (s, 3H), 1.17 (s, 3H).
Beispiel No.1.3-125: Example No.1.3-125:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.42 / 7.40 (m, 1 H), 7.31 / 7.23 (m, 1 H), 5.42 / 5.29 (s, 1 H), 4.33 / 3.71-3.66 (m, 2H) 3.69 / 3.67 (s, 3H), 2.09 / 2.02 (s, 3H), 1.93 / 1.77 (m, 1H), 1.46/1.44 (s, 3H), 1.28 (m, 3H), 1.23 (m, 3H), 1.19/0.62 (m, 2H). Beispiel No.1.3-126: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.42 / 7.40 (m, 1H), 7.31 / 7.23 (m, 1H), 5.42 / 5.29 (s, 1H), 4.33 / 3.71-3.66 (m , 2H) 3.69 / 3.67 (s, 3H), 2.09 / 2.02 (s, 3H), 1.93 / 1.77 (m, 1H), 1.46 / 1.44 (s, 3H), 1.28 (m, 3H), 1.23 (m, 3H), 1.19 / 0.62 (m, 2H). Example No.1.3-126:
1H-NMR (400 MHz, CD3OD δ, ppm) 8.94 / 8.92 (m, 1 H), 7.89 / 7.84 (m, 1 H), 5.73 / 5.66 (s, 1H), 3.93/3.89 (s, 3H), 2.19/2.12 (s, 3H), 1.95/1.90 (m, 1H), 1.54/1.51 (s, 3H), 1.30/1.17 (m, 2H). 1 H-NMR (400 MHz, CD 3 OD δ, ppm) 8.94 / 8.92 (m, 1H), 7.89 / 7.84 (m, 1H), 5.73 / 5.66 (s, 1H), 3.93 / 3.89 (s, 3H), 2.19 / 2.12 (s, 3H), 1.95 / 1.90 (m, 1H), 1.54 / 1.51 (s, 3H), 1.30 / 1.17 (m, 2H).
Beispiel No.1.3-161: Example No.1.3-161:
1H-NMR(400MHz, CDCI3 δ, ppm) 7.19 (m, 1H), 6.47 (m, 1H), 6.12 (m, 1H), 5.51 / 5.41 (s, 1H), 4.24/3.61 (m, 2H), 2.23/2.21 (br. s, 1H, OH), 2.13 (d, 1H), 1.99/1.96 (s, 3H), 1.86 (d, 1H), 1.59/1.55 (s, 9H), 1.23 (m, 6H), 1.15 (m, 6H). 1 H-NMR (400MHz, CDCl 3 δ, ppm) 7.19 (m, 1H), 6.47 (m, 1H), 6.12 (m, 1H), 5.51 / 5.41 (s, 1H), 4.24 / 3.61 (m, 2H) , 2.23 / 2.21 (brs s, 1H, OH), 2.13 (d, 1H), 1.99 / 1.96 (s, 3H), 1.86 (d, 1H), 1.59 / 1.55 (s, 9H), 1.23 (m, 6H), 1.15 (m, 6H).
Beispiel No.1.3-162: Example No.1.3-162:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.20 (m, 1 H), 6.52 (m, 1 H), 6.15 (m, 1 H), 5.86 (s, 1H), 2.68 (d, 1H), 2.61 (br. s, 1H, OH), 2.43 (d, 1H), 2.18 (s, 3H), 1.58 (s, 9H), 1.28 (s, 3H), 1.14 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.20 (m, 1H), 6.52 (m, 1H), 6.15 (m, 1H), 5.86 (s, 1H), 2.68 (d, 1H) , 2.61 (brs s, 1H, OH), 2.43 (d, 1H), 2.18 (s, 3H), 1.58 (s, 9H), 1.28 (s, 3H), 1.14 (s, 3H).
Beispiel No.1.3-177: Example No.1.3-177:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.28 (s, 1 H), 5.53 / 5.41 (s, 1 H), 4.21 / 3.59 (m, 2H), 2.69 (s, 3H), 2.09 (d, 1 H), 1.97 / 1.95 (s, 3H), 1.83 (d, 1 H), 1.22 (m, 6H), 1.14 (m, 6H). 1 H NMR (400 MHz, CDCl3 δ, ppm) 7.28 (s, 1H), 5.53 / 5.41 (s, 1H), 4.21 / 3.59 (m, 2H), 2.69 (s, 3H), 2.09 (i.e. , 1H), 1.97 / 1.95 (s, 3H), 1.83 (d, 1H), 1.22 (m, 6H), 1.14 (m, 6H).
Beispiel No.1.3-178: Example No.1.3-178:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.33 (s, 1 H), 5.88 (s, 1 H), 2.72 (s, 3H), 2.61 (d, 1H), 2.46 (br. s, 1H, OH), 2.45 (d, 1H), 2.17 (s, 3H), 1.29 (s, 3H), 1.14 (s, 3H). Beispiel No.1.3-181: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.33 (s, 1H), 5.88 (s, 1H), 2.72 (s, 3H), 2.61 (d, 1H), 2.46 (br. S, 1H , OH), 2.45 (d, 1H), 2.17 (s, 3H), 1.29 (s, 3H), 1.14 (s, 3H). Example No.1.3-181:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.31 / 7.29 (s, 1 H), 5.40 / 5.29 (s, 1 H), 4.35 / 3.69 (m, 2H), 2.71 / 2.70 (s, 3H), 2.28 / 2.23 (m, 1 H, OH), 2.03 / 2.01 (s, 3H), 1.92 / 1.72 (m, 1H), 1.48/1.46 (s, 3H), 1.28 (m, 3H), 1.22 (m, 3H), 1.18/0.65 (m, 2H). Beispiel No.1.3-182: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.31 / 7.29 (s, 1H), 5.40 / 5.29 (s, 1H), 4.35 / 3.69 (m, 2H), 2.71 / 2.70 (s, 3H) , 2.28 / 2.23 (m, 1H, OH), 2.03 / 2.01 (s, 3H), 1.92 / 1.72 (m, 1H), 1.48 / 1.46 (s, 3H), 1.28 (m, 3H), 1.22 (m , 3H), 1.18 / 0.65 (m, 2H). Example No.1.3-182:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.38 / 7.33 (s, 1 H), 5.72 / 5.63 (s, 1 H), 2.73 / 2.71 (s, 3H), 2.57/2.50 (br. s, 1H, OH), 2.19/2.11 (s, 3H), 1.93 (m, 1H), 1.55/1.52 (s, 3H), 1.27/ 1.19 (m, 2H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.38 / 7.33 (s, 1H), 5.72 / 5.63 (s, 1H), 2.73 / 2.71 (s, 3H), 2.57 / 2.50 (br , 1H, OH), 2.19 / 2.11 (s, 3H), 1.93 (m, 1H), 1.55 / 1.52 (s, 3H), 1.27 / 1.19 (m, 2H).
Beispiel No. I.4-33: Example No. I.4-33:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.44 (m, 2H), 7.36 (m, 2H), 7.28 (m, 1 H), 5.49 / 5.38 (s, 1H), 4.21 / 3.59 (m, 2H), 3.13/3.12 (s, 3H), 2.54/2.48 (br. s, 1H, OH), 2.32 / 2.31 (s, 3H), 2.09 (d, 1 H), 1.99 / 1.97 (s, 3H), 1.86 (d, 1 H), 1.24 (m, 6H), 1.14 (m, 6H). 1 H-NMR (400 MHz, CDCl 3 δ, ppm) 7.44 (m, 2H), 7.36 (m, 2H), 7.28 (m, 1H), 5.49 / 5.38 (s, 1H), 4.21 / 3.59 (m, 2H), 3.13 / 3.12 (s, 3H), 2.54 / 2.48 (brs s, 1H, OH), 2.32 / 2.31 (s, 3H), 2.09 (d, 1H), 1.99 / 1.97 (s, 3H) , 1.86 (d, 1H), 1.24 (m, 6H), 1.14 (m, 6H).
Beispiel No. I.4-34: Example No. I.4-34:
1H-NMR (400 MHz, CDCI3 δ, ppm) 7.44 (m, 2H), 7.36 (m, 2H), 7.28 (m, 1 H), 5.91 (s, 1H), 3.15 (s, 3H), 2.37 (s, 3H), 2.10 (s, 3H), 1.93 (d, 1H), 1.68 (d, 1H), 1.29 (s, 3H), 1.24 (s,3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 7.44 (m, 2H), 7.36 (m, 2H), 7.28 (m, 1H), 5.91 (s, 1H), 3.15 (s, 3H), 2.37 (s, 3H), 2.10 (s, 3H), 1.93 (d, 1H), 1.68 (d, 1H), 1.29 (s, 3H), 1.24 (s, 3H).
Beispiel No. I.4-49: Example No. I.4-49:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.20 (s, 1 H), 5.56 / 5.45 (s, 1 H), 4.80 (s, 2H), 4.22 / 3.60 (m, 2H), 2.02 (d, 1 H), 1.99 (br. s, 1 H, OH), 1.88 (d, 1 H), 1.92 / 1.90 (s, 3H), 1.25 (m, 3H), 1.14 (m, 6H), 1.12 (m, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 6.20 (s, 1H), 5.56 / 5.45 (s, 1H), 4.80 (s, 2H), 4.22 / 3.60 (m, 2H), 2.02 (i.e. , 1H), 1.99 (brs s, 1H, OH), 1.88 (d, 1H), 1.92 / 1.90 (s, 3H), 1.25 (m, 3H), 1.14 (m, 6H), 1.12 ( m, 3H).
Beispiel No. I.4-50: Example No. I.4-50:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.27 (s, 1 H), 5.92 (s, 1 H), 4.83 (s, 2H), 2.51 (d, 1H), 2.48 (d, 1H), 2.36 (br. s, 1H, OH), 2.13 (s, 3H), 1.24 (s, 3H), 1.14 (s, 3H). 1 H-NMR (400 MHz, CDCl3 δ, ppm) 6.27 (s, 1H), 5.92 (s, 1H), 4.83 (s, 2H), 2.51 (d, 1H), 2.48 (d, 1H), 2.36 (br s, 1H, OH), 2.13 (s, 3H), 1.24 (s, 3H), 1.14 (s, 3H).
Beispiel No.1.4-51: Example No.1.4-51:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.71 (d, 1 H), 6.08 (d, 1 H), 5.96 (s, 1 H), 5.49 / 5.40 (s, 1 H), 4.94 (s, 2H), 4.21 / 3.58 (m, 2H), 1.91 (d, 1 H), 1.75 (d, 1 H), 1.67 / 1.66 (s, 3H), 1.26 (m, 6H), 1.11 (m, 3H), 0.92 (m, 3H). Beispiel No. I.4-52: 1 H-NMR (400 MHz, CDCl3 δ, ppm) 6.71 (d, 1H), 6.08 (d, 1H), 5.96 (s, 1H), 5.49 / 5.40 (s, 1H), 4.94 (s , 2H), 4.21 / 3.58 (m, 2H), 1.91 (d, 1H), 1.75 (d, 1H), 1.67 / 1.66 (s, 3H), 1.26 (m, 6H), 1.11 (m, 3H ), 0.92 (m, 3H). Example No. I.4-52:
1H-NMR (400 MHz, CDC δ, ppm) 6.82 (d, 1 H), 6.15 (d, 1 H), 6.03 (s, 1 H), 5.98 (s, 1 H), 4.97 (s, 2H), 2.46 (d, 1 H), 2.36 (d, 1 H), 1.91 (s, 3H), 1 .90 (br. s, 1 H, OH), 1 .13 (s, 3H), 1.03 (s, 3H). 1 H-NMR (400 MHz, CDC δ, ppm) 6.82 (d, 1H), 6.15 (d, 1H), 6.03 (s, 1H), 5.98 (s, 1H), 4.97 (s, 2H ), 2.46 (d, 1H), 2.36 (d, 1H), 1.91 (s, 3H), 1.90 (br s, 1H, OH), 1.13 (s, 3H), 1.03 ( s, 3H).
Beispiel No. I.4-74: Example No. I.4-74:
1H-NMR (400 MHz, CDCI3 δ, ppm) 6.32 (s, 1 H), 6.00 (s, 1 H), 4.85 (s, 2H), 3.03 (d, 1 H), 2.69 (br. s, 1 H, OH), 2.56 (d, 1 H), 2.19 (s, 3H), 1 .45 (s, 3H), 1 .03 (s, 3H). Weiterer Gegenstand der vorliegenden Erfindung ist die Verwendung mindestens einer Verbindung, ausgewählt aus der Gruppe, bestehend aus substituierten Vinyl- und Alkinyl-cyclohexenolen der allgemeinen Formel (I), sowie von beliebigen 1 H-NMR (400 MHz, CDCl3 δ, ppm) 6.32 (s, 1H), 6.00 (s, 1H), 4.85 (s, 2H), 3.03 (d, 1H), 2.69 (br. S, 1H, OH), 2.56 (d, 1H), 2.19 (s, 3H), 1 .45 (s, 3H), 1 .03 (s, 3H). Another object of the present invention is the use of at least one compound selected from the group consisting of substituted vinyl and alkynyl cyclohexenols of the general formula (I), as well as any
Mischungen dieser erfindungsgemäßen substituierten Vinyl- und Alkinyl- cyclohexenole der allgemeinen Formel (I) mit agrochemischen Wirkstoffen Mixtures of these inventive substituted vinyl and alkynylcyclohexenols of the general formula (I) with agrochemical active compounds
entsprechend der unten stehenden Definition, zur Steigerung der according to the definition below, to increase the
Widerstandsfähigkeit von Pflanzen gegenüber abiotischen Stressfaktoren, bevorzugt Trockenstress, sowie zur Stärkung des Pflanzenwachstums und/oder zur Erhöhung des Pflanzenertrags. Weiterer Gegenstand der vorliegenden Erfindung ist eine Sprühlösung zur  Resistance of plants to abiotic stress factors, preferably drought stress, as well as to the strengthening of plant growth and / or to increase the plant yield. Another object of the present invention is a spray solution for
Behandlung von Pflanzen, enthaltend eine zur Steigerung der Widerstandsfähigkeit von Pflanzen gegenüber abiotischen Stressfaktoren wirksame Menge von  Treatment of plants containing an amount effective to increase the resistance of plants to abiotic stresses
mindestens einer Verbindung, ausgewählt aus der Gruppe, bestehend aus substituierten Vinyl- und Alkinyl-cyclohexenolen, der allgemeinen Formel (I). Zu den dabei relativierbaren abiotischen Streßbedingungen können zum Beispiel Hitze, Dürre, Kälte- und Trockenstress (Stress verursacht durch Trockenheit und/oder Wassenmangel), osmotischer Streß, Staunässe, erhöhter Bodensalzgehalt, erhöhtes Ausgesetztsein an Mineralien, Ozonbedingungen, Starklichtbedingungen, at least one compound selected from the group consisting of substituted vinyl and alkynyl cyclohexenols, the general formula (I). For example, heat, drought, cold and dry stress (stress caused by drought and / or water deficiency), osmotic stress, waterlogging, increased soil salt content, increased exposure to minerals, ozone conditions, high-light conditions, can be added to the abiotic stress conditions which can be relieved thereby.
beschränkte Verfügbarkeit von Stickstoffnährstoffen, beschränkte Verfügbarkeit von Phosphornährstoffen zählen. In einer Ausführungsform kann beispielsweise vorgesehen sein, dass die erfindungsgemäß vorgesehenen Verbindungen, d. h. die entsprechenden limited availability of nitrogen nutrients, limited availability of phosphorus nutrients. In one embodiment, it may be provided, for example, that the compounds provided according to the invention, ie the corresponding ones
substituierten Vinyl- und Alkinyl-cyclohexenole der allgemeinen Formel (I), durch eine Sprühapplikation auf entsprechende zu behandelnde Pflanzen oder substituted vinyl and alkynylcyclohexenols of the general formula (I), by spray application to corresponding plants to be treated or
Pflanzenteile aufgebracht werden. Die erfindungsgemäß vorgesehene Verwendung der Verbindungen der allgemeinen Formel (I) oder deren Salze erfolgt vorzugsweise mit einer Dosierung zwischen 0,00005 und 3 kg/ha, besonders bevorzugt zwischen 0,0001 und 2 kg/ha, insbesondere bevorzugt zwischen 0,0005 und 1 kg/ha, im Speziellen bevorzugt zwischen 0,001 und 0,25 kg/ha. Plant parts are applied. The use according to the invention of the compounds of the general formula (I) or salts thereof is preferably carried out with a dosage of between 0.00005 and 3 kg / ha, more preferably between 0.0001 and 2 kg / ha, particularly preferably between 0.0005 and 1 kg / ha, more preferably between 0.001 and 0.25 kg / ha.
Unter der Bezeichnung Resistenz bzw. Widerstandsfähigkeit gegenüber abiotischem Stress werden im Rahmen der vorliegenden Erfindung verschiedenartige Vorteile für Pflanzen verstanden. Solche vorteilhaften Eigenschaften äußern sich beispielsweise in den nachfolgend genannten verbesserten Pflanzencharakteristika: verbessertes Wurzelwachstum hinsichtlich Oberfläche und Tiefe, vermehrte Ausläuferbildung oder Bestückung, stärkere und produktivere Ausläufer und Bestockungstriebe, In the context of the present invention, the term resistance or resistance to abiotic stress is understood to mean various advantages for plants. Such advantageous properties are manifested, for example, in the following improved plant characteristics: improved root growth in terms of surface area and depth, increased tailing or stocking, stronger and more productive shoots and tillers,
Verbesserung des Sproßwachstums, erhöhte Standfestigkeit, vergrößerte Improvement of shoot growth, increased stability, increased
Sprossbasisdurchmesser, vergrößerte Blattfläche, höhere Erträge an Nähr- und Inhaltsstoffen, wie z.B. Kohlenhydrate, Fette, Öle, Proteine, Vitamine, Mineralstoffe, ätherische Öle, Farbstoffe, Fasern, bessere Faserqualität, früheres Blühen, gesteigerte Blütenanzahl, reduzierter Gehalt an toxischen Produkten wie Shoot base diameter, increased leaf area, higher yields of nutrients and ingredients, e.g. Carbohydrates, fats, oils, proteins, vitamins, minerals, essential oils, dyes, fibers, better fiber quality, earlier flowering, increased number of flowers, reduced content of toxic products such as
Mycotoxine, reduzierter Gehalt an Rückständen oder unvorteilhaften Bestandteilen jeglicher Art oder bessere Verdaulichkeit, verbesserte Lagerstabilität des Erntegutes, verbesserter Toleranz gegenüber unvorteilhaften Temperaturen, verbesserter Toleranz gegenüber Dürre und Trockenheit, wie auch Sauerstoffmangel durch Wasserüberschuß, verbesserte Toleranz gegenüber erhöhten Salzgehalten in Böden und Wasser, gesteigerte Toleranz gegenüber Ozonstress, verbesserte Verträglichkeit gegenüber Herbiziden und anderen Pflanzenbehandlungsmitteln, verbesserte Wasseraufnahme und Photosyntheseleistung, vorteilhafte Mycotoxins, reduced levels of residues or unfavorable components of any kind or better digestibility, improved storage stability of the crop, improved tolerance to unfavorable temperatures, improved tolerance to drought and drought, as well as lack of oxygen due to excess water, improved tolerance to increased salt levels in soils and water, enhanced Tolerance to ozone stress, improved tolerance to herbicides and other plant treatment products, improved water absorption and photosynthetic performance, beneficial
Pflanzeneigenschaften, wie beispielsweise Beschleunigung der Reifung, Plant properties, such as acceleration of maturation,
gleichmäßigere Abreife, größere Anziehungskraft für Nützlinge, verbesserte more uniform maturity, greater attractiveness for beneficials, improved
Bestäubung oder andere Vorteile, die einem Fachmann durchaus bekannt sind. Insbesondere zeigt die erfindungsgemäße Verwendung einer oder mehrerer Verbindungen der allgemeinen Formel (I) in der Sprühapplikation auf Pflanzen und Pflanzenteilen die beschriebenen Vorteile. Kombinationen von den entsprechenden substituierten Vinyl- und Alkinyl-cyclohexenolen der allgemeinen Formel (I) unter anderem mit Insektiziden, Lockstoffen, Akariziden, Fungiziden, Nematiziden, Herbiziden, wachstumsregulierenden Stoffen, Safenern, die Pflanzenreife beeinflussenden Stoffen und Bakteriziden können bei der Bekämpfung von Pollination or other advantages that are well known to a person skilled in the art. In particular, the use according to the invention of one or more compounds of the general formula (I) in the spray application to plants and parts of plants has the advantages described. Combinations of the corresponding substituted vinyl and alkynylcyclohexenols of the general formula (I) with, inter alia, insecticides, attractants, acaricides, fungicides, nematicides, herbicides, growth regulators, safeners, plant maturity affecting substances and bactericides can be used in the control of
Pflanzenkrankheiten im Rahmen der vorliegenden Erfindung ebenfalls Anwendung finden. Die kombinierte Verwendung von entsprechenden substituierten Vinyl- und Alkinyl-cyclohexenole der allgemeinen Formel (I) mit gentechnisch veränderten Sorten in Bezug auf erhöhte abiotische Stresstoleranz ist darüber hinaus ebenfalls möglich. Die weiter oben genannten verschiedenartigen Vorteile für Pflanzen lassen sich bekannterweise partiell zusammenfassen und mit allgemein gültigen Begriffen belegen. Soche Begriffe sind beispielsweise die nachfolgend aufgeführten Plant diseases in the context of the present invention also find application. The combined use of corresponding substituted vinyl and alkynyl cyclohexenols of the general formula (I) with genetically modified varieties with regard to increased abiotic stress tolerance is also possible. The various advantages for plants mentioned above can, as is known, be partially summarized and substantiated by generally valid terms. Soche terms are, for example, those listed below
Bezeichnungen: phytotonischer Effekt, Widerstandsfähigkeit gegenüber Terms: phytotonic effect, resistance to
Stressfaktoren, weniger Pflanzenstress, Pflanzengesundheit, gesunde Pflanzen, Pflanzenfitness, („Plant Fitness"),„Plant Wellness",„Plant Concept",„Vigor Effect", „Stress Shield", Schutzschild,„Crop Health",„Crop Health Properties",„Crop Health Products",„Crop Health Management",„Crop Health Therapy",„Plant Health", Plant Health Properties", Plant Health Products",„Plant Health Management",„Plant Health Therapy", Grünungseffekt („Greening Effect" oder„Re-greening Effect"), „Freshness" oder andere Begriffe, die einem Fachmann durchaus bekannt sind. Stress Factors, Less Plant Stress, Plant Health, Healthy Plants, Plant Fitness, Plant Wellness, Plant Concept, Vigor Effect, Stress Shield, Shield, Crop Health, Crop Health Properties "Crop Health Products", "Crop Health Management", "Crop Health Therapy", "Plant Health", Plant Health Properties, "Plant Health Products", "Plant Health Management", "Plant Health Therapy", Greening Effect (" Greening effect "or" re-greening effect ")," Freshness "or other terms that are well known to a person skilled in the art.
Im Rahmen der vorliegenden Erfindung wird unter einem guten Effekt auf die Widerstandsfähigkeit gegenüber abiotischem Stress nicht beschränkend · mindestens ein um im Allgemeinen 3 %, insbesondere größer als 5 % besonders bevorzugt größer als 10 % verbessertes Auflaufen, mindestens einen im Allgemeinen 3 %, insbesondere größer als 5 % besonders bevorzugt größer als 10 % gesteigerten Ertrag, In the context of the present invention, a good effect on the abiotic stress resistance is not limited to: · at least one emergence improved by generally 3%, in particular greater than 5%, particularly preferably greater than 10%, at least one generally 3%, in particular greater than 5%, particularly preferably greater than 10% increased yield,
mindestens eine um im Allgemeinen 3 %, insbesondere größer als 5 % besonders bevorzugt größer als 10 % verbesserte Wurzelentwicklung,  at least one root development generally improved by 3%, in particular greater than 5%, particularly preferably greater than 10%,
· mindestens eine um im Allgemeinen 3 %, insbesondere größer als 5 % besonders bevorzugt größer als 10 % ansteigende Sproßgröße, At least one shoot size increasing by generally 3%, in particular greater than 5%, particularly preferably greater than 10%,
mindestens eine um im Allgemeinen 3 %, insbesondere größer als 5 % besonders bevorzugt größer als 10 % vergrößerte Blattfläche,  at least one leaf area increased by generally 3%, in particular greater than 5%, particularly preferably greater than 10%,
mindestens eine um im Allgemeinen 3 %, insbesondere größer als 5 % besonders bevorzugt größer als 10 % verbesserte Photosyntheseleistung und/oder mindestens eine um im Allgemeinen 3 %, insbesondere größer als 5 % besonders bevorzugt größer als 10 % verbesserte Blütenausbildung verstanden, wobei die Effekte einzeln oder aber in beliebiger Kombination von zwei oder mehreren Effekten auftreten können.  at least one generally improved by 3%, in particular greater than 5%, more preferably greater than 10% improved photosynthesis and / or at least one generally improved by 3%, in particular greater than 5%, more preferably greater than 10% improved flower formation, the effects individually or in any combination of two or more effects.
Weiterer Gegenstand der vorliegenden Erfindung ist eine Sprühlösung zur Another object of the present invention is a spray solution for
Behandlung von Pflanzen, enthaltend eine zur Steigerung der Widerstandsfähigkeit von Pflanzen gegenüber abiotischen Stressfaktoren wirksame Menge von Treatment of plants containing an amount effective to increase the resistance of plants to abiotic stresses
mindestens einer Verbindung aus der Gruppe der Vinyl- und Alkinyl-cyclohexenole der allgemeinen Formel (I). Die Sprühlösung kann andere übliche Bestandteile aufweisen, wie Lösungsmittel, Formulierhilfsstoffe, insbesondere Wasser, enthalten. Weitere Bestandteile können unter anderem agrochemische Wirkstoffe sein, welche unten noch weiter beschrieben werden. at least one compound from the group of vinyl and alkynylcyclohexenols of the general formula (I). The spray solution may comprise other conventional ingredients, such as solvents, formulation auxiliaries, especially water. Other ingredients may include agrochemical agents, which are further described below.
Weiterer Gegenstand der vorliegenden Erfindung ist die Verwendung von Another object of the present invention is the use of
entsprechenden Sprühlösungen zur Steigerung der Widerstandsfähigkeit von Pflanzen gegenüber abiotischen Stressfaktoren. Die nachfolgenden Ausführungen gelten sowohl für die erfindungsgemäße Verwendung der Verbindungen der allgemeinen Formel (I) an sich als auch für die entsprechenden Sprühlösungen. Erfindunsgemäß wurde darüber hinaus gefunden, dass die Anwendung der corresponding spray solutions to increase the resistance of plants to abiotic stress factors. The following statements apply both to the inventive use of the compounds of general formula (I) per se and for the corresponding spray solutions. According to the invention, it has also been found that the application of the
Verbindungen der allgemeinen Formel (I) in Kombination mit mindestens einem Düngemittel wie weiter unten stehend definiert auf Pflanzen oder in deren Compounds of general formula (I) in combination with at least one fertilizer as defined below on plants or in their
Umgebung möglich ist. Environment is possible.
Düngemittel, die erfindungsgemäß zusammen mit den oben näher erläuterten Verbindungen der allgemeinen Formel (I) verwendet werden können, sind im Fertilizers which can be used according to the invention together with the compounds of general formula (I) explained in more detail above are described in US Pat
Allgemeinen organische und anorganische Stickstoff-haltige Verbindungen wie beispielsweise Harnstoffe, Harnstoff-Formaldehyd-Kondensationsprodukte, General organic and inorganic nitrogen-containing compounds such as, for example, ureas, urea-formaldehyde condensation products,
Aminosäuren, Ammoniumsalze und -nitrate, Kaliumsalze (bevorzugt Chloride, Sulfate, Nitrate), Phosphorsäuresalze und/oder Salze von Phosphoriger Säure (bevorzugt Kaliumsalze und Ammoniumsalze). Insbesondere zu nennen sind in diesem Zusammenhang die NPK-Dünger, d.h. Düngemittel, die Stickstoff, Phosphor und Kalium enthalten, Kalkammonsalpeter, d.h. Düngemittel, die noch Calcium enthalten, Ammonsulfatsalpeter (Allgemeine Formel (NH4)2S04 NH4N03), Amino acids, ammonium salts and nitrates, potassium salts (preferably chlorides, sulfates, nitrates), phosphoric acid salts and / or salts of phosphorous acid (preferably potassium salts and ammonium salts). Particularly noteworthy in this connection are the NPK fertilizers, ie fertilizers containing nitrogen, phosphorus and potassium, calcium ammonium nitrate, ie fertilizers which still contain calcium, ammonium sulphate nitrate (general formula (NH 4 ) 2 SO 4 NH 4 NO 3),
Ammonphosphat und Ammonsulfat. Diese Düngemittel sind dem Fachmann allgemein bekannt, siehe auch beispielsweise Ullmann's Encyclopedia of Industrial Chemistry, 5. Edition, Vol. A 10, Seiten 323 bis 431 , Verlagsgesellschaft, Weinheim, 1987. Ammonium phosphate and ammonium sulfate. These fertilizers are well known to those skilled in the art, see also, for example, Ullmann's Encyclopedia of Industrial Chemistry, 5th Edition, Vol. A 10, pages 323 to 431, Verlagsgesellschaft, Weinheim, 1987.
Die Düngemittel können auch Salze aus Mikronährstoffen (bevorzugt Calcium, Schwefel, Bor, Mangan, Magnesium, Eisen, Bor, Kupfer, Zink, Molybdän und Kobalt) und Phytohormonen (z. B. Vitamin B1 und Indol-(lll)essigsäure) oder Gemische davon enthalten. Erfindungsgemäß eingesetzte Düngemittel können auch weitere Salze wie Monoammoniumphosphat (MAP), Diammoniumphosphat (DAP), The fertilizers may also contain salts of micronutrients (preferably calcium, sulfur, boron, manganese, magnesium, iron, boron, copper, zinc, molybdenum and cobalt) and phytohormones (eg, vitamin B1 and indole (III) acetic acid) or mixtures included. Fertilizers used according to the invention may also contain other salts such as monoammonium phosphate (MAP), diammonium phosphate (DAP),
Kaliumsulfat, Kaliumchlorid, Magnesiumsulfat enthalten. Geeignete Mengen für die sekundären Nährstoffe oder Spurenelemente sind Mengen von 0,5 bis 5 Gew.-%, bezogen auf das gesamte Düngemittel. Weitere mögliche Inhaltsstoffe sind  Potassium sulfate, potassium chloride, magnesium sulfate. Suitable amounts for the secondary nutrients or trace elements are amounts of 0.5 to 5 wt .-%, based on the total fertilizer. Other possible ingredients are
Pflanzenschutzmittel, Insektizide oder Fungizide, Wachstumsregulatoren oder Gemische davon. Hierzu folgen weiter unten weitergehende Ausführungen. Die Düngemittel können beispielsweise in Form von Pulvern, Granulaten, Prills oder Kompaktaten eingesetzt werden. Die Düngemittel können jedoch auch in flüssiger Form, gelöst in einem wässrigen Medium, eingesetzt werden. In diesem Fall kann auch verdünnter wässriger Ammoniak als Stickstoffdüngemittel eingesetzt werden. Weitere mögliche Inhaltsstoffe für Düngemittel sind beispielsweise in Ullmann's Encyclopedia of Industrial Chemistry, 5. Auflage, 1987, Band A 10, Seiten 363 bis 401 , DE-A 41 28 828, DE-A 19 05 834 und DE-A 196 31 764 beschrieben. Die allgemeine Zusammensetzung der Düngemittel, bei welchen es sich im Rahmen der vorliegenden Erfindung um Einzelnährstoff- und/oder Mehrnährstoffdünger handeln kann, beispielsweise aus Stickstoff, Kalium oder Phosphor, kann innerhalb eines breiten Bereichs variieren. Im Allgemeinen ist ein Gehalt von 1 bis 30 Gew.-% Stickstoff (bevorzugt 5 bis 20 Gew.-%), von 1 bis 20 Gew.-% Kalium (bevorzugt 3 bis 15 Gew.-%) und ein Gehalt von 1 bis 20 Gew.-% Phosphor (bevorzugt 3 bis 10 Gew.-%) vorteilhaft. Der Gehalt von Mikroelementen ist üblicherweise im ppm- Bereich, bevorzugt im Bereich von von 1 bis 1000 ppm. Crop protection agents, insecticides or fungicides, growth regulators or mixtures thereof. Further explanations follow below. The fertilizers can be used, for example, in the form of powders, granules, prills or compactates. However, the fertilizers can also be used in liquid form dissolved in an aqueous medium. In this case, dilute aqueous ammonia can be used as nitrogen fertilizer. Further possible ingredients for fertilizers are described, for example, in Ullmann's Encyclopedia of Industrial Chemistry, 5th Edition, 1987, Volume A 10, pages 363 to 401, DE-A 41 28 828, DE-A 19 05 834 and DE-A 196 31 764 , The general composition of the fertilizers, which in the context of the present invention may be single nutrient and / or multi-nutrient fertilizers, for example nitrogen, potassium or phosphorus, may vary within a wide range. In general, a content of 1 to 30 wt .-% of nitrogen (preferably 5 to 20 wt .-%), from 1 to 20 wt .-% potassium (preferably 3 to 15 wt .-%) and a content of 1 to 20% by weight of phosphorus (preferably 3 to 10% by weight) is advantageous. The content of microelements is usually in the ppm range, preferably in the range of from 1 to 1000 ppm.
Im Rahmen der vorliegenden Erfindung können das Düngemittel sowie die In the context of the present invention, the fertilizer and the
Verbindungen der allgemeinen Formel (I) zeitgleich verabreicht werden. Es ist jedoch auch möglich, zunächst das Düngemittel und dann eine Verbindung der allgemeinen Formel (I) oder zunächst eine Verbindung der allgemeinen Formel (I) und dann das Düngemittel anzuwenden. Bei nicht zeitgleicher Anwendung einer Verbindung der allgemeinen Formel (I) und des Düngemittels erfolgt im Rahmen der vorliegenden Erfindung jedoch die Anwendung in funktionellem Zusammenhang, insbesondere innerhalb eines Zeitraums von im Allgemeinen 24 Stunden, bevorzugt 18 Stunden, besonders bevorzugt 12 Stunden, speziell 6 Stunden, noch spezieller 4 Stunden, noch weiter spezieller innerhalb 2 Stunden. In ganz besonderen Compounds of general formula (I) are administered at the same time. However, it is also possible to use first the fertilizer and then a compound of the general formula (I) or first a compound of the general formula (I) and then the fertilizer. In the case of non-simultaneous application of a compound of the general formula (I) and of the fertilizer, however, the application is carried out in a functional context, in particular within a period of generally 24 hours, preferably 18 hours, more preferably 12 hours, especially 6 hours , even more special 4 hours, even more special within 2 hours. In a very special way
Ausführungsformen der vorliegenden Erfindung erfolgt die Anwendung der erfindungsgemäßen Verbindung der Formel (I) und des Düngemittels in einem zeitlichen Rahmen von weniger als 1 Stunden, vorzugsweise weniger als 30 Embodiments of the present invention use the compound of the formula (I) and the fertilizer according to the invention in a time frame of less than 1 hour, preferably less than 30
Minuten, besonders bevorzugt weniger als 15 Minuten. Bevorzugt ist die Verwendung von Verbindungen der allgemeinen Formel (I) auf Pflanzen aus der Gruppe der Nutzpflanzen, Zierpflanzen, Rasenarten, allgemein genutzte Bäume, die in öffentlichen und privaten Bereichen als Zierpflanzen Minutes, more preferably less than 15 minutes. Preference is given to the use of compounds of the general formula (I) on plants from the group of crops, ornamental plants, lawn species, generally used trees, which are used in ornamental plants in public and private sectors
Verwendungen finden, und Forstbestand. Der Forstbestand umfasst Bäume für die Herstellung von Holz, Zellstoff, Papier und Produkten die aus Teilen der Bäume hergestellt werden. Der Begriff Nutzpflanzen, wie hier verwendet, bezeichnet Find uses, and forest stands. The forest stock includes trees for the production of wood, pulp, paper and products made from parts of the trees. The term crops as used herein refers to
Kulturpflanzen, die als Pflanzen für die Gewinnung von Nahrungsmitteln, Crops used as plants for the production of food,
Futtermitteln, Treibstoffe oder für technische Zwecke eingesetzt werden. Zu den Nutzpflanzen zählen z. B. folgende Pflanzenarten: Triticale, Durum Feed, fuel or for technical purposes. Among the useful plants include z. For example, the following plant species: Triticale, Durum
(Hartweizen), Turf, Reben, Getreide, beispielsweise Weizen, Gerste, Roggen, Hafer, Reis, Mais und Hirse; Rüben, beispielsweise Zuckerrüben und Futterrüben; Früchte, beispielsweise Kernobst, Steinobst und Beerenobst, beispielsweise Äpfel, Birnen, Pflaumen, Pfirsiche, Mandeln, Kirschen und Beeren, z. B. Erdbeeren, Himbeeren, Brombeeren; Hülsenfrüchte, beispielsweise Bohnen, Linsen, Erbsen und  (Durum wheat), turf, vines, cereals, such as wheat, barley, rye, oats, rice, corn and millet; Beets, for example sugar beets and fodder beets; Fruits, such as pome fruit, stone fruit and soft fruit, such as apples, pears, plums, peaches, almonds, cherries and berries, eg. Strawberries, raspberries, blackberries; Legumes, such as beans, lentils, peas and
Sojabohnen; Ölkulturen, beispielsweise Raps, Senf, Mohn, Oliven, Sonnenblumen, Kokos, Castorölpflanzen, Kakaobohnen und Erdnüsse; Gurkengewächse,  soybeans; Oil crops such as rapeseed, mustard, poppy, olive, sunflower, coconut, castor oil, cocoa beans and peanuts; Cucumber plants,
beispielsweise Kürbis, Gurken und Melonen; Fasergewächse, beispielsweise for example, pumpkin, cucumbers and melons; Fiber plants, for example
Baumwolle, Flachs, Hanf und Jute; Citrusfrüchte, beispielsweise Orangen, Zitronen, Pampelmusen und Mandarinen; Gemüsesorten, beispielsweise Spinat, (Kopf)-Salat, Spargel, Kohlarten, Möhren, Zwiebeln, Tomaten, Kartoffeln und Paprika; Cotton, flax, hemp and jute; Citrus fruits, such as oranges, lemons, grapefruit and mandarins; Vegetables such as spinach, (head) salad, asparagus, cabbages, carrots, onions, tomatoes, potatoes and peppers;
Lorbeergewächse, beispielsweise Avocado, Cinnamomum, Kampfer, oder ebenso Pflanzen wie Tabak, Nüsse, Kaffee, Aubergine, Zuckerrohr, Tee, Pfeffer, Weinreben, Hopfen, Bananen, Naturkautschukgewächse sowie Zierpflanzen, beispielsweise Blumen, Sträucher, Laubbäume und Nadelbäume wie Koniferen. Diese Aufzählung stellt keine Limitierung dar. Laurel family, such as avocado, Cinnamomum, camphor, or as plants such as tobacco, nuts, coffee, eggplant, sugar cane, tea, pepper, vines, hops, bananas, natural rubber plants and ornamental plants, such as flowers, shrubs, deciduous trees and conifers such as conifers. This list is not a limitation.
Als besonders geeignete Zielkulturen für die Anwendung des erfindungsgemäßen Verfahrens sind folgende Pflanzen anzusehen: Hafer, Roggen, Triticale, Durum, Baumwolle, Aubergine, Turf, Kernobst, Steinobst, Beerenobst, Mais, Weizen,The following plants are to be regarded as particularly suitable target cultures for the application of the method according to the invention: oats, rye, triticale, durum, cotton, eggplant, turf, pome fruit, stone fruit, berry fruit, maize, wheat,
Gerste, Gurke, Tabak, Reben, Reis, Getreide, Birne, Pfeffer, Bohnen, Sojabohnen, Raps, Tomate, Paprika, Melonen, Kohl, Kartoffel und Apfel. Als Bäume, die entsprechend dem erfindungsgemäßen Verfahren verbessert werden können, seien beispielhaft genannt: Abies sp., Eucalyptus sp., Picea sp., Pinus sp., Aesculus sp., Platanus sp., Tilia sp., Acer sp., Tsuga sp., Fraxinus sp., Sorbus sp., Betula sp., Crataegus sp., Ulmus sp., Quercus sp., Fagus sp., Salix sp., Populus sp.. Barley, cucumber, tobacco, vines, rice, cereals, pear, pepper, beans, soybeans, rapeseed, tomato, peppers, melons, cabbage, potato and apple. Examples of trees which can be improved according to the method of the invention are: Abies sp., Eucalyptus sp., Picea sp., Pinus sp., Aesculus sp., Platanus sp., Tilia sp., Acer sp., Tsuga sp , Fraxinus sp., Sorbus sp., Betula sp., Crataegus sp., Ulmus sp., Quercus sp., Fagus sp., Salix sp., Populus sp.
Als bevorzugte Bäume, die entsprechend dem erfindungsgemäßen Verfahren verbessert werden können, können genannt werden: Aus der Baumart Aesculus: A. hippocastanum, A. pariflora, A. carnea; aus der Baumart Platanus: P. aceriflora, P. occidentalis, P. racemosa; aus der Baumart Picea: P. abies; aus der Baumart Pinus: P. radiate, P. ponderosa, P. contorta, P. sylvestre, P. elliottii, P. montecola, P. As preferred trees, which can be improved according to the method of the invention, may be mentioned: From the tree species Aesculus: A. hippocastanum, A. pariflora, A. carnea; from the tree species Platanus: P. aceriflora, P. occidentalis, P. racemosa; from the tree species Picea: P. abies; from the tree Pinus: P. radiate, P. ponderosa, P. contorta, P. sylvestre, P. elliottii, P. montecola, P.
albicaulis, P. resinosa, P. palustris, P. taeda, P. flexilis, P. jeffregi, P. baksiana, P. strobes; aus der Baumart Eucalyptus: E. grandis, E. globulus, E. camadentis, E. nitens, E. obliqua, E. regnans, E. pilularus. albicaulis, P. resinosa, P. palustris, P. taeda, P. flexilis, P. jeffregi, P. baksiana, P. strobes; from the tree species Eucalyptus: E. grandis, E. globulus, E. camadentis, E. nitens, E. obliqua, E. regnans, E. pilularus.
Als besonders bevorzugte Bäume, die entsprechend dem erfindungsgemäßen Verfahren verbessert werden können, können genannt werden: Aus der Baumart Pinus: P. radiate, P. ponderosa, P. contorta, P. sylvestre, P. strobes; aus der Baumart Eucalyptus: E. grandis, E. globulus und E. camadentis. As particularly preferred trees, which can be improved according to the method of the invention, may be mentioned: From the species Pinus: P. radiate, P. ponderosa, P. contorta, P. sylvestre, P. strobes; from the tree species Eucalyptus: E. grandis, E. globulus and E. camadentis.
Als besonders bevorzugte Bäume, die entsprechend dem erfindungsgemäßen Verfahren verbessert werden können, können genannt werden: Rosskastanie, Platanengewächs, Linde und Ahornbaum. As particularly preferred trees that can be improved according to the method of the invention can be mentioned: horse chestnut, sycamore, linden and maple tree.
Die vorliegende Erfindung kann auch an beliebigen Rasenarten („turfgrasses") durchgeführt werden, einschließlich„cool season turfgrasses" und„warm season turfgrasses". Beispiele für Rasenarten für die kalte Jahreszeit sind Blaugräser („blue grasses"; Poa spp.), wie„Kentucky bluegrass" (Poa pratensis L),„rough bluegrass" (Poa trivialis L),„Canada bluegrass" (Poa compressa L),„annual bluegrass" (Poa annua L),„upland bluegrass" (Poa glaucantha Gaudin),„wood bluegrass" (Poa nemoralis L.) und„bulbous bluegrass" (Poa bulbosa L); Straussgräser („Bentgrass", Agrostis spp.), wie„creeping bentgrass" (Agrostis palustris Huds.),„colonial bentgrass" (Agrostis tenuis Sibth.),„velvet bentgrass" (Agrostis canina L),„South German Mixed Bentgrass" (Agrostis spp. einschließlich Agrostis tenius Sibth., Agrostis canina L, und Agrostis palustris Huds.), und„redtop" (Agrostis alba L); The present invention may also be practiced on any turfgrasses, including "cool season turfgrasses" and "warm season turfgrasses." Examples of cold season turf species are blue grasses (Poa spp.), Such as "Kentucky bluegrass" (Poa pratensis L), "rough bluegrass" (Poa trivialis L), "Canada bluegrass" (Poa compressa L), "annual bluegrass" (Poa annua L), "upland bluegrass" (Poa glaucantha Gaudin), "Wood bluegrass" (Poa nemoralis L.) and "bulbous bluegrass" (Poa bulbosa L); Agrostis spp.), Such as "creeping bentgrass" (Agrostis palustris Huds.), "Colonial bentgrass" (Agrostis tenuis sib.), "Velvet bentgrass" (Agrostis canina L.), "South German Mixed Bentgrass" (Agrostis spp., Including Agrostis Tenius Sibth., Agrostis canina L, and Agrostis palustris Huds.), and "redtop" (Agrostis alba L);
Schwingel („Fescues", Festucu spp.), wie„red fescue" (Festuca rubra L. spp. rubra), „creeping fescue" (Festuca rubra L),„chewings fescue" (Festuca rubra commutata Gaud.),„sheep fescue" (Festuca ovina L),„hard fescue" (Festuca longifolia Thuill.), „hair fescue" (Festucu capillata Lam.),„tall fescue" (Festuca arundinacea Schreb.) und„meadow fescue" (Festuca elanor L); Fescue ("Fescues", Festucu spp.), Such as "red fescue" (Festuca rubra L. spp. Rubra), "creeping fescue" (Festuca rubra L), "chewings fescue" (Festuca rubra commutata Gaud.), "Sheep fescue "(Festuca ovina L)," hard fescue "(Festuca longifolia Thuill.)," hair fescue "(Festucu capillata Lam.)," tall fescue "(Festuca arundinacea Schreb.) and" meadow fescue "(Festuca elanor L) ;
Lolch („ryegrasses", Lolium spp.), wie„annual ryegrass" (Lolium multiflorum Lam.), „perennial ryegrass" (Lolium perenne L.) und„italian ryegrass" (Lolium multiflorum Lam.); und Weizengräser ("wheatgrasses", Agropyron spp..), wie "fairway wheatgrass" (Agropyron cristatum (L.) Gaertn.),„crested wheatgrass" (Agropyron desertorum (Fisch.) Schult.) und "western wheatgrass" (Agropyron smithii Rydb.). Beispiele für weitere "cool season turfgrasses" sind "beachgrass" (Ammophila breviligulata Fern.), "smooth bromegrass" (Bromus inermis Leyss.), Schilf ("cattails") wie "Timothy" (Phleum pratense L.), "sand cattail" (Phleum subulatum L), Lolium ("ryegrasses", Lolium spp.), Such as "annual ryegrass" (Lolium multiflorum Lam.), "Perennial ryegrass" (Lolium perenne L.) and "Italian ryegrass" (Lolium multiflorum Lam.); and wheat grasses ("wheatgrasses", Agropyron spp.), such as "fairway wheatgrass" (Agropyron cristatum (L.) Gaertn.), "crested wheatgrass" (Agropyron desertorum (fish.) Schult.) and "western wheatgrass" (Agropyron smithii Rydb.) Examples of other "cool season turfgrasses" are "beachgrass" (Ammophila breviligulata Fern.), "smooth bromegrass" (Bromus inermis leyss.), reeds ("cattails") such as "Timothy" (Phleum pratense L. ), "sand cattail" (Phleum subulatum L),
"orchardgrass" (Dactylis glomerata L.), "weeping alkaligrass" (Puccinellia distans (L.) Pari.) und "crested dog's-tail" (Cynosurus cristatus L.). "orchardgrass" (Dactylis glomerata L.), "weeping alkaligrass" (Puccinellia distans (L.) Pari.) and "crested dog's-tail" (Cynosurus cristatus L.).
Beispiele für "warm season turfgrasses" sind„Bermudagrass" (Cynodon spp. L. C. Rieh), "zoysiagrass" (Zoysia spp. Willd.),„St. Augustine grass" (Stenotaphrum secundatum Walt Kuntze),„centipedegrass" (Eremochloa ophiuroides Munro Hack.), „carpetgrass" (Axonopus affinis Chase),„Bahia grass" (Paspalum notatum Flügge), „Kikuyugrass" (Pennisetum clandestinum Höchst, ex Chiov.),„buffalo grass" Examples of "warm season turfgrasses" are "Bermudagrass" (Cynodon spp., LC Rieh), "zoysiagrass" (Zoysia spp. Willd.), "St. Augustine grass" (Stenotaphrum secundatum Walt Kuntze), "centipedegrass" (Eremochloa ophiuroides Munro Hack.), "Carpetgrass" (Axonopus affinis chase), "Bahia grass" (Paspalum notatum flügge), "Kikuyugrass" (Pennisetum clandestinum Höchst, ex Chiov.), "Buffalo grass"
(Buchloe daetyloids (Nutt.) Engelm.), "Blue gramma" (Bouteloua gracilis (H.B.K.) Lag. ex Griffiths),„seashore paspalum" (Paspalum vaginatum Swartz) und„sideoats grama" (Bouteloua curtipendula (Michx. Torr.). "Cool season turfgrasses" sind für die erfindungsgemäße Verwendung im Allgemeinen bevorzugt. Besonders bevorzugt sind Blaugras, Straussgras und„redtop", Schwingel und Lolch. Straussgras ist insbesondere bevorzugt. (Buchloe daetyloids (Nutt.) Engelm.), "Blue gramma" (Bouteloua gracilis (HBK) Lag. Ex Griffiths), "seashore paspalum" (Paspalum vaginatum Swartz) and "sideoats grama "(Bouteloua curtipendula (Michx.Torr.)." Cool season turfgrasses "are generally preferred for use in the present invention.) Particularly preferred are bluegrass, ostrichgrass and redtop, fescue and lolly. Ostrichgrass is particularly preferred.
Besonders bevorzugt werden mit den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) Pflanzen der jeweils handelsüblichen oder in Gebrauch befindlichen Pflanzensorten behandelt. Unter Pflanzensorten versteht man Pflanzen mit neuen Eigenschaften ("Traits"), die sowohl durch konventionelle Züchtung, durch Mutagenese oder mit Hilfe rekombinanter DNA-Techniken, gezüchtet worden sind. Kulturpflanzen können demnach Pflanzen sein, die durch konventionelle Züchtungsund Optimierungsmethoden oder durch biotechnologische und gentechnologische Methoden oder Kombinationen dieser Methoden erhalten werden können, einschließlich der transgenen Pflanzen und einschließlich der durch Sortenschutzrechte schützbaren oder nicht schützbaren Pflanzensorten. Particular preference is given to treating the compounds of the general formula (I) according to the invention with plants of the respective commercially available or used plant cultivars. Plant varieties are understood to be plants with new traits which have been bred either by conventional breeding, by mutagenesis or by recombinant DNA techniques. Crop plants can accordingly be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant varieties which can or can not be protected by plant breeders' rights.
Das erfindungsgemäße Behandlungsverfahren kann somit auch für die Behandlung von genetisch modifizierten Organismen (GMOs), z. B. Pflanzen oder Samen, verwendet werden. Genetisch modifizierte Pflanzen (oder transgene Pflanzen) sind Pflanzen, bei denen ein heterologes Gen stabil in das Genom integriert worden ist. Der Begriff "heterologes Gen" bedeutet im wesentlichen ein Gen, das außerhalb der Pflanze bereitgestellt oder assembliert wird und das bei Einführung in das The treatment method according to the invention can thus also for the treatment of genetically modified organisms (GMOs), z. As plants or seeds are used. Genetically modified plants (or transgenic plants) are plants in which a heterologous gene has been stably integrated into the genome. The term "heterologous gene" essentially means a gene that is provided or assembled outside the plant and that when introduced into the plant
Zellkerngenom, das Chloroplastengenom oder das Hypochondriengenom der transformierten Pflanze dadurch neue oder verbesserte agronomische oder sonstige Eigenschaften verleiht, dass es ein interessierendes Protein oder Polypeptid exprimiert oder dasses ein anderes Gen, das in der Pflanze vorliegt bzw. andere Gene, die in der Pflanze vorliegen, herunterreguliert oder abschaltet (zum Beispiel mittels Antisense-Technologie, Co-suppressionstechnologie oder RNAi-Technologie [RNA Interference]). Ein heterologes Gen, das im Genom vorliegt, wird ebenfalls als Transgen bezeichnet. Ein Transgen, das durch sein spezifisches Vorliegen im Pflanzengenom definiert ist, wird als Transformations- bzw. transgenes Event bezeichnet. Zu Pflanzen und Pflanzensorten, die vorzugsweise mit den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) behandelt werden, zählen alle Pflanzen, die über Erbgut verfügen, das diesen Pflanzen besonders vorteilhafte, nützliche Merkmale verleiht (egal, ob dies durch Züchtung und/oder Biotechnologie erzielt wurde). Cell nucleus genome, the chloroplast genome or the hypochondrial genome of the transformed plant by conferring new or improved agronomic or other properties by expressing a protein or polypeptide of interest or by having another gene present in the plant or other genes present in the plant; downregulated or switched off (for example by means of antisense technology, co-suppression technology or RNAi technology [RNA Interference]). A heterologous gene present in the genome is also referred to as a transgene. A transgene defined by its specific presence in the plant genome is referred to as a transformation or transgenic event. Plants and plant varieties which are preferably treated with the compounds of the general formula (I) according to the invention include all plants which have genetic material which gives these plants particularly advantageous, useful features (regardless of whether this is achieved by breeding and / or biotechnology has been).
Pflanzen und Pflanzensorten, die ebenfalls mit den erfindungsgemäßen Plants and plant varieties, which also with the inventive
Verbindungen der allgemeinen Formel (I) behandelt werden können, sind solche Pflanzen, die gegen einen oder mehrere abiotische Streßfaktoren resistent sind. Zu den abiotischen Streßbedingungen können zum Beispiel Hitze, Dürre, Kälte- und Trockenstress,, osmotischer Streß, Staunässe, erhöhter Bodensalzgehalt, erhöhtes Ausgesetztsein an Mineralien, Ozonbedingungen, Starklichtbedingungen, beschränkte Verfügbarkeit von Stickstoffnährstoffen, beschränkte Verfügbarkeit von Phosphornährstoffen oder Vermeidung von Schatten zählen. Compounds of general formula (I) can be treated are those plants which are resistant to one or more abiotic stress factors. Abiotic stress conditions may include, for example, heat, drought, cold and dry stress, osmotic stress, waterlogging, increased soil salt content, increased exposure to minerals, ozone conditions, high light conditions, limited availability of nitrogen nutrients, limited availability of phosphorous nutrients, or avoidance of shade.
Pflanzen und Pflanzensorten, die ebenfalls mit den erfindungsgemäßen Plants and plant varieties, which also with the inventive
Verbindungen der allgemeinen Formel (I) behandelt werden können, sind solche Pflanzen, die durch erhöhte Ertragseigenschaften gekennzeichnet sind. Ein erhöhter Ertrag kann bei diesen Pflanzen z. B. auf verbesserter Pflanzenphysiologie, verbessertem Pflanzenwuchs und verbesserter Pflanzenentwicklung, wie Compounds of the general formula (I) can be treated are those plants which are characterized by increased yield properties. An increased yield can in these plants z. B. on improved plant physiology, improved plant growth and improved plant development, such as
Wasserverwertungseffizienz, Wasserhalteeffizienz, verbesserter Water utilization efficiency, water retention efficiency, improved
Stickstoffverwertung, erhöhter Kohlenstoffassimilation, verbesserter Photosynthese, verstärkter Keimkraft und beschleunigter Abreife beruhen. Der Ertrag kann weiterhin durch eine verbesserte Pflanzenarchitektur (unter Streß- und nicht-Streß- Bedingungen) beeinflußt werden, darunter frühe Blüte, Kontrolle der Blüte für die Produktion von Hybridsaatgut, Keimpflanzenwüchsigkeit, Pflanzengröße, Nitrogen utilization, increased carbon assimilation, improved photosynthesis, increased germination power and accelerated Abreife based. The yield may be further influenced by improved plant architecture (under stress and non-stress conditions), including early flowering, control of flowering for hybrid seed production, seedling vigor, plant size,
Internodienzahl und -abstand, Wurzelwachstum, Samengröße, Fruchtgröße, Schotengröße, Schoten- oder Ährenzahl, Anzahl der Samen pro Schote oder Ähre, Samenmasse, verstärkte Samenfüllung, verringerter Samenausfall, verringertes Schotenplatzen sowie Standfestigkeit. Zu weiteren Ertragsmerkmalen zählen Samenzusammensetzung wie Kohlenhydratgehalt, Proteingehalt, Ölgehalt und Ölzusammensetzung, Nährwert, Verringerung der nährwidrigen Verbindungen, verbesserte Verarbeitbarkeit und verbesserte Lagerfähigkeit. Internode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, number of seeds per pod or ear, seed mass, increased seed filling, reduced seed drop, reduced pod popping and stability. Other yield-related traits include seed composition such as carbohydrate content, protein content, oil content and Oil composition, nutritional value, reduction of nontoxic compounds, improved processability and improved shelf life.
Pflanzen, die ebenfalls mit den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) behandelt werden können, sind Hybridpflanzen, die bereits die Plants which can also be treated with the compounds of the general formula (I) according to the invention are hybrid plants which have already been used
Eigenschaften der Heterosis bzw. des Hybrideffekts exprimieren, was im Properties of the heterosis or the hybrid effect express, what im
allgemeinen zu höherem Ertrag, höherer Wüchsigkeit, besserer Gesundheit und besserer Resistenz gegen biotische und abiotische Streßfaktoren führt. Solche Pflanzen werden typischerweise dadurch erzeugt, dass man eine ingezüchtete pollensterile Elternlinie (den weiblichen Kreuzungspartner) mit einer anderen ingezüchteten pollenfertilen Elternlinie (dem männlichen Kreuzungspartner) kreuzt. Das Hybridsaatgut wird typischerweise von den pollensterilen Pflanzen geerntet und an Vermehrer verkauft. Pollensterile Pflanzen können manchmal (z. B. beim Mais) durch Entfahnen (d. h. mechanischem Entfernen der männlichen Geschlechtsorgane bzw. der männlichen Blüten), produziert werden; es ist jedoch üblicher, dass die Pollensterilität auf genetischen Determinanten im Pflanzengenom beruht. In diesem Fall, insbesondere dann, wenn es sich bei dem gewünschten Produkt, da man von den Hybridpflanzen ernten will, um die Samen handelt, ist es üblicherweise günstig, sicherzustellen, dass die Pollenfertilität in Hybridpflanzen, die die für die generally leads to higher yields, higher vigor, better health and better resistance to biotic and abiotic stress factors. Such plants are typically produced by crossing an inbred male sterile parental line (the female crossover partner) with another inbred male fertile parent line (the male crossbred partner). The hybrid seed is typically harvested from the male sterile plants and sold to propagators. Pollen sterile plants can sometimes be produced (eg in maize) by delaving (i.e., mechanically removing male genitalia or male flowers); however, it is more common for male sterility to be due to genetic determinants in the plant genome. In this case, especially when the desired product, as one wants to harvest from the hybrid plants, is the seeds, it is usually beneficial to ensure that the pollen fertility in hybrid plants corresponding to those for the
Pollensterilität verantwortlichen genetischen Determinanten enthalten, völlig restoriert wird. Dies kann erreicht werden, indem sichergestellt wird, dass die männlichen Kreuzungspartner entsprechende Fertilitätsrestorergene besitzen, die in der Lage sind, die Pollenfertilität in Hybridpflanzen, die die genetischen Containing pollen sterility responsible genetic determinant is completely restorated. This can be achieved by ensuring that the male cross-breeding partners possess appropriate fertility restorer genes capable of controlling the pollen fertility in hybrid plants that are the genetic source
Determinanten, die für die Pollensterilität verantwortlich sind, enthalten, zu Containing determinants that are responsible for the pollens sterility, too
restorieren. Genetische Determinanten für Pollensterilität können im Cytoplasma lokalisiert sein. Beispiele für cytoplasmatische Pollensterilität (CMS) wurden zum Beispiel für Brassica-Arten beschrieben (WO 92/005251 , WO 95/009910, WO 98/27806, WO 05/002324, WO 06/021972 und US 6,229,072). Genetische restorieren. Genetic determinants of pollen sterility may be localized in the cytoplasm. Examples of cytoplasmic male sterility (CMS) have been described, for example, for Brassica species (WO 92/005251, WO 95/009910, WO 98/27806, WO 05/002324, WO 06/021972 and US 6,229,072). genetic
Determinanten für Pollensterilität können jedoch auch im Zellkerngenom lokalisiert sein. Pollensterile Pflanzen können auch mit Methoden der pflanzlichen However, determinants of male sterility may also be localized in the nuclear genome. Pollen sterile plants can also be used with methods of plant
Biotechnologie, wie Gentechnik, erhalten werden. Ein besonders günstiges Mittel zur Erzeugung von pollensterilen Pflanzen ist in WO 89/10396 beschrieben, wobei zum Beispiel eine Ribonuklease wie eine Barnase selektiv in den Tapetumzellen in den Staubblättern exprimiert wird. Die Fertilität kann dann durch Expression eines Ribonukleasehemmers wie Barstar in den Tapetumzellen restoriert werden (z. B. WO 91/002069). Biotechnology, such as genetic engineering. A particularly favorable means of producing male sterile plants is described in WO 89/10396, wherein the For example, a ribonuclease such as a barnase is selectively expressed in the tapetum cells in the stamens. The fertility can then be restorated by expression of a ribonuclease inhibitor such as barstar in the tapetum cells (eg WO 91/002069).
Pflanzen oder Pflanzensorten (die mit Methoden der Pflanzenbiotechnologie, wie der Gentechnik, erhalten werden), die ebenfalls mit den erfindungsgemäßen Plants or plant varieties (which are obtained by plant biotechnology methods, such as genetic engineering), which also with the inventive
Verbindungen der allgemeinen Formel (I) behandelt werden können, sind Compounds of general formula (I) can be treated are
herbizidtolerante Pflanzen, d. h. Pflanzen, die gegenüber einem oder mehreren vorgegebenen Herbiziden tolerant gemacht worden sind. Solche Pflanzen können entweder durch genetische Transformation oder durch Selektion von Pflanzen, die eine Mutation enthalten, die solch eine Herbizidtoleranz verleiht, erhalten werden. herbicide-tolerant plants, d. H. Plants tolerant to one or more given herbicides. Such plants can be obtained either by genetic transformation or by selection of plants containing a mutation conferring such herbicide tolerance.
Herbizidtolerante Pflanzen sind zum Beispiel glyphosatetolerante Pflanzen, d. h. Pflanzen, die gegenüber dem Herbizid Glyphosate oder dessen Salzen tolerant gemacht worden sind. So können zum Beispiel glyphosatetolerante Pflanzen durch Transformation der Pflanze mit einem Gen, das für das Enzym 5- Enolpyruvylshikimat-3-phosphatsynthase (EPSPS) kodiert, erhalten werden. Herbicide-tolerant plants are, for example, glyphosate-tolerant plants, i. H. Plants tolerant to the herbicide glyphosate or its salts. Thus, for example, glyphosate-tolerant plants can be obtained by transforming the plant with a gene encoding the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS).
Beispiele für solche EPSPS-Gene sind das AroA-Gen (Mutante CT7) des Bakterium Salmonella typhimurium (Comai et al., Science (1983), 221 , 370-371 ), das CP4-Gen des Bakteriums Agrobacterium sp. (Barry et al., Curr. Topics Plant Physiol. (1992), 7, 139-145), die Gene, die für eine EPSPS aus der Petunie (Shah et al., Science (1986), 233, 478-481 ), für eine EPSPS aus der Tomate (Gasser et al., J. Biol. Chem. (1988), 263, 4280-4289) oder für eine EPSPS aus Eleusine (WO 01/66704) kodieren. Es kann sich auch um eine mutierte EPSPS handeln, wie sie zum Beispiel in EP-A 0837944, WO 00/066746, WO 00/066747 oder WO 02/026995 beschrieben ist. Glyphosatetolerante Pflanzen können auch dadurch erhalten werden, dass man ein Gen exprimiert, das für ein Glyphosate-Oxidoreduktase-Enzym, wie es in US 5,776,760 und US 5,463, 175 beschrieben ist, kodiert. Glyphosatetolerante Pflanzen können auch dadurch erhalten werden, dass man ein Gen exprimiert, das für ein Glyphosate-acetyltransferase-Enzym, wie es in z. B. WO 02/036782, WO Examples of such EPSPS genes are the AroA gene (mutant CT7) of the bacterium Salmonella typhimurium (Comai et al., Science (1983), 221, 370-371), the CP4 gene of the bacterium Agrobacterium sp. (Barry et al., Curr Topics Plant Physiol. (1992), 7, 139-145), the genes that are useful for EPSPS from the petunia (Shah et al., Science (1986), 233, 478-481). , for an EPSPS from the tomato (Gasser et al., J. Biol. Chem. (1988), 263, 4280-4289) or for an EPSPS from Eleusine (WO 01/66704) encode. It may also be a mutated EPSPS, as described for example in EP-A 0837944, WO 00/066746, WO 00/066747 or WO 02/026995. Glyphosate-tolerant plants can also be obtained by expressing a gene encoding a glyphosate oxidoreductase enzyme as described in US 5,776,760 and US 5,463,175. Glyphosate-tolerant plants can also be obtained by expressing a gene encoding a glyphosate acetyltransferase enzyme as described in e.g. WO 02/036782, WO
03/092360, WO 05/012515 und WO 07/024782 beschrieben ist, kodiert. Glyphosatetolerante Pflanzen können auch dadurch erhalten werden, dass man Pflanzen, die natürlich vorkommende Mutationen der oben erwähnten Gene, wie sie zum Beispiel in WO 01/024615 oder WO 03/013226 beschrieben sind, enthalten, selektiert. 03/092360, WO 05/012515 and WO 07/024782. Glyphosate-tolerant plants can also be obtained by selecting plants containing naturally-occurring mutations of the above-mentioned genes, as described, for example, in WO 01/024615 or WO 03/013226.
Sonstige herbizidresistente Pflanzen sind zum Beispiel Pflanzen, die gegenüber Herbiziden, die das Enzym Glutaminsynthase hemmen, wie Bialaphos, Other herbicide-resistant plants are, for example, plants which are resistant to herbicides which inhibit the enzyme glutamine synthase, such as bialaphos,
Phosphinotricin oder Glufosinate, tolerant gemacht worden sind. Solche Pflanzen können dadurch erhalten werden, dass man ein Enzym exprimiert, das das Herbizid oder eine Mutante des Enzyms Glutaminsynthase, das gegenüber Hemmung resistent ist, entgiftet. Solch ein wirksames entgiftendes Enzym ist zum Beispiel ein Enzym, das für ein Phosphinotricin-acetyltransferase kodiert (wie zum Beispiel das bar- oder pat-Protein aus Streptomyces-Arten). Pflanzen, die eine exogene Phosphinotricin or glufosinate, have been tolerant. Such plants can be obtained by expressing an enzyme which detoxifies the herbicide or a mutant of the enzyme glutamine synthase, which is resistant to inhibition. Such an effective detoxifying enzyme is, for example, an enzyme encoding a phosphinotricin acetyltransferase (such as the bar or pat protein from Streptomyces species). Plants that are an exogenous
Phosphinotricin-acetyltransferase exprimieren, sind zum Beispiel in US 5,561 ,236; US 5,648,477; US 5,646,024; US 5,273,894; US 5,637,489; US 5,276,268; US 5,739,082; US 5,908,810 und US 7, 1 12,665 beschrieben. Phosphinotricin acetyltransferase are described, for example, in US 5,561,236; US 5,648,477; US 5,646,024; US 5,273,894; US 5,637,489; US 5,276,268; US 5,739,082; US 5,908,810 and US 7,112,665.
Weitere herbizidtolerante Pflanzen sind auch Pflanzen, die gegenüber den Other herbicide tolerant plants are also plants that are compared to the
Herbiziden, die das Enzym Hydroxyphenylpyruvatdioxygenase (HPPD) hemmen, tolerant gemacht worden sind. Bei den Hydroxyphenylpyruvatdioxygenasen handelt es sich um Enzyme, die die Reaktion, in der para-Hydroxyphenylpyruvat (HPP) zu Homogentisat umgesetzt wird, katalysieren. Pflanzen, die gegenüber HPPD- Hemmern tolerant sind, können mit einem Gen, das für ein natürlich vorkommendes resistentes HPPD-Enzym kodiert, oder einem Gen, das für ein mutiertes HPPD- Enzym gemäß WO 96/038567, WO 99/024585 und WO 99/024586 kodiert, transformiert werden. Eine Toleranz gegenüber HPPD-Hemmern kann auch dadurch erzielt werden, dass man Pflanzen mit Genen transformiert, die für gewisse Enzyme kodieren, die die Bildung von Homogentisat trotz Hemmung des nativen HPPD- Enzyms durch den HPPD-Hemmer ermöglichen. Solche Pflanzen und Gene sind in WO 99/034008 und WO 2002/36787 beschrieben. Die Toleranz von Pflanzen gegenüber HPPD-Hemmern kann auch dadurch verbessert werden, dass man Pflanzen zusätzlich zu einem Gen, das für ein HPPD-tolerantes Enzym kodiert, mit einem Gen transformiert, das für ein Prephenatdehydrogenase-Enzym kodiert, wie dies in WO 2004/024928 beschrieben ist. Herbicides that inhibit the enzyme hydroxyphenylpyruvate dioxygenase (HPPD) have been tolerated. The hydroxyphenylpyruvate dioxygenases are enzymes that catalyze the reaction in which para-hydroxyphenylpyruvate (HPP) is converted to homogentisate. Plants tolerant to HPPD inhibitors may be treated with a gene encoding a naturally occurring resistant HPPD enzyme, or a gene encoding a mutant HPPD enzyme as described in WO 96/038567, WO 99/024585 and WO 99/1998 / 024586, are transformed. Tolerance to HPPD inhibitors can also be achieved by transforming plants with genes encoding certain enzymes that allow the formation of homogentisate despite inhibition of the native HPPD enzyme by the HPPD inhibitor. Such plants and genes are described in WO 99/034008 and WO 2002/36787. The tolerance of plants to HPPD inhibitors can also be improved by including plants in addition to a gene coding for an HPPD-tolerant enzyme a gene encoding a prephenate dehydrogenase enzyme, as described in WO 2004/024928.
Weitere herbizidresistente Pflanzen sind Pflanzen, die gegenüber Other herbicide-resistant plants are plants that are opposite
Acetolactatsynthase (ALS)-Hemmern tolerant gemacht worden sind. Zu bekannten ALS-Hemmern zählen zum Beispiel Sulfonylharnstoff, Imidazolinon, Acetolactate synthase (ALS) inhibitors have been made tolerant. Examples of known ALS inhibitors include sulfonylurea, imidazolinone,
Triazolopyrimidine, Pyrimidinyloxy(thio)benzoate und/oder Sulfonylaminocarbonyl- triazolinon-Herbizide. Es ist bekannt, dass verschiedene Mutationen im Enzym ALS (auch als Acetohydroxysäure-Synthase, AHAS, bekannt) eine Toleranz gegenüber unterschiedlichen Herbiziden bzw. Gruppen von Herbiziden verleihen, wie dies zum Beispiel bei Tranel und Wright, Weed Science (2002), 50, 700-712, jedoch auch in US 5,605,01 1 , US 5,378,824, US 5,141 ,870 und US 5,013,659, beschrieben ist. Die Herstellung von sulfonylharnstofftoleranten Pflanzen und imidazolinontoleranten Pflanzen ist in US 5,605,01 1 ; US 5,013,659; US 5, 141 ,870; US 5,767,361 ; US 5,731 , 180; US 5,304,732; US 4,761 ,373; US 5,331 ,107; US 5,928,937; und US 5,378,824; sowie in der internationalen Veröffentlichung WO 96/033270 Triazolopyrimidines, pyrimidinyloxy (thio) benzoates and / or sulfonylaminocarbonyltriazolinone herbicides. It is known that various mutations in the enzyme ALS (also known as acetohydroxy acid synthase, AHAS) confer tolerance to different herbicides or groups of herbicides, as described, for example, by Tranel and Wright, Weed Science (2002), 50, 700-712, but also in US 5,605,011, US 5,378,824, US 5,141,870 and US 5,013,659. The preparation of sulfonylurea tolerant plants and imidazolinone tolerant plants is described in US 5,605,011 1; US 5,013,659; US 5,141,870; US 5,767,361; US 5,731,180; US 5,304,732; US 4,761,373; US 5,331, 107; US 5,928,937; and US 5,378,824; as well as in international publication WO 96/033270
beschrieben. Weitere imidazolinontolerante Pflanzen sind auch in z. B. WO described. Other imidazolinontolerante plants are also in z. For example WO
2004/040012, WO 2004/106529, WO 2005/020673, WO 2005/093093, WO 2004/040012, WO 2004/106529, WO 2005/020673, WO 2005/093093, WO
2006/007373, WO 2006/015376, WO 2006/024351 und WO 2006/060634 beschrieben. Weitere Sulfonylharnstoff- und imidazolinontolerante Pflanzen sind auch in z.B. WO 2007/024782 beschrieben. 2006/007373, WO 2006/015376, WO 2006/024351 and WO 2006/060634. Other sulfonylurea and imidazolinone tolerant plants are also disclosed in e.g. WO 2007/024782 described.
Weitere Pflanzen, die gegenüber ALS-Inhibitoren, insbesondere gegenüber Imidazolinonen, Sulfonylharnstoffen und/oder Sulfamoylcarbonyltriazolinonen tolerant sind, können durch induzierte Mutagenese, Selektion in Zellkulturen inOther plants which are tolerant to ALS inhibitors, in particular to imidazolinones, sulfonylureas and / or sulfamoylcarbonyltriazolinones, can be obtained by induced mutagenesis, selection in cell cultures in
Gegenwart des Herbizids oder durch Mutationszüchtung erhalten werden, wie dies zum Beispiel für die Sojabohne in US 5,084,082, für Reis in WO 97/41218, für die Zuckerrübe in US 5,773,702 und WO 99/057965, für Salat in US 5, 198,599 oder für die Sonnenblume in WO 2001/065922 beschrieben ist. Presence of the herbicide or by mutation breeding, as for example for the soybean in US 5,084,082, for rice in WO 97/41218, for the sugar beet in US 5,773,702 and WO 99/057965, for salad in US 5,198,599 or for the Sunflower is described in WO 2001/065922.
Pflanzen oder Pflanzensorten (die nach Methoden der pflanzlichen Biotechnologie, wie der Gentechnik, erhalten wurden), die ebenfalls mit den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) behandelt werden können, sind insektenresistente transgene Pflanzen, d.h. Pflanzen, die gegen Befall mit gewissen Zielinsekten resistent gemacht wurden. Solche Pflanzen können durch genetische Transformation oder durch Selektion von Pflanzen, die eine Mutation enthalten, die solch eine Insektenresistenz verleiht, erhalten werden. Plants or plant varieties (obtained by plant biotechnology methods, such as genetic engineering), which are also with the inventive Compounds of general formula (I) can be treated are insect-resistant transgenic plants, ie plants that have been made resistant to attack by certain target insects. Such plants can be obtained by genetic transformation or by selection of plants containing a mutation conferring such insect resistance.
Der Begriff "insektenresistente transgene Pflanze" umfaßt im vorliegenden The term "insect-resistant transgenic plant" as used herein
Zusammenhang jegliche Pflanze, die mindestens ein Transgen enthält, das eine Kodiersequenz umfaßt, die für folgendes kodiert: Relates to any plant containing at least one transgene comprising a coding sequence coding for:
1 ) ein Insektizides Kristallprotein aus Bacillus thuringiensis oder einen 1) an insecticidal crystal protein from Bacillus thuringiensis or a
Insektiziden Teil davon, wie die Insektiziden Kristallproteine, die von Crickmore et al., Microbiology and Molecular Biology Reviews (1998), 62, 807-813, zusammengestellt wurden, von Crickmore et al. (2005) in der Bacillus thuringiensis-Toxinnomenklatur aktualisiert (online bei: Insecticides part of how the insecticidal crystal proteins, compiled by Crickmore et al., Microbiology and Molecular Biology Reviews (1998), 62, 807-813, by Crickmore et al. (2005) in the Bacillus thuringiensis toxin nomenclature (online at:
http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/), oder Insektizide Teile davon, z.B. Proteine der Cry-Proteinklassen CrylAb, CrylAc, Cryl F, Cry2Ab, Cry3Ae oder Cry3Bb oder Insektizide Teile davon; oder 2) ein Kristallprotein aus Bacillus thuringiensis oder einen Teil davon, der in Gegenwart eines zweiten, anderen Kristallproteins als Bacillus thuringiensis oder eines Teils davon insektizid wirkt, wie das binäre Toxin, das aus den http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/), or insecticidal parts thereof, e.g. Proteins of Cry protein classes CrylAb, CrylAc, Cryl F, Cry2Ab, Cry3Ae or Cry3Bb or insecticidal parts thereof; or 2) a Bacillus thuringiensis crystal protein or a part thereof which is insecticidal in the presence of a second, other crystal protein than Bacillus thuringiensis or a part thereof, such as the binary toxin derived from the
Kristallproteinen Cy34 und Cy35 besteht (Moellenbeck et al., Nat. Biotechnol. Crystal proteins Cy34 and Cy35 (Moellenbeck et al., Nat. Biotechnol.
(2001 ), 19, 668-72; Schnepf et al., Applied Environm. Microb. (2006), 71 , 1765- 1774); oder (2001), 19, 668-72; Schnepf et al., Applied Environm. Microb. (2006), 71, 1765-1774); or
3) ein Insektizides Hybridprotein, das Teile von zwei unterschiedlichen 3) an insecticidal hybrid protein that is part of two different
Insektiziden Kristallproteinen aus Bacillus thuringiensis umfaßt, wie zum Beispiel ein Hybrid aus den Proteinen von 1 ) oben oder ein Hybrid aus den Proteinen von 2) oben, z. B. das Protein Cry1A.105, das von dem Mais-Event MON98034 produziert wird (WO 2007/027777); oder 4) ein Protein gemäß einem der Punkte 1 ) bis 3) oben, in dem einige, Insecticidal crystal proteins from Bacillus thuringiensis, such as, for example, a hybrid of the proteins of 1) above or a hybrid of the proteins of 2) above, e.g. The protein Cry1A.105 produced by the corn event MON98034 (WO 2007/027777); or 4) a protein according to any one of items 1) to 3) above, in which some,
insbesondere 1 bis 10, Aminosäuren durch eine andere Aminosäure ersetzt wurden, um eine höhere Insektizide Wirksamkeit gegenüber einer Zielinsektenart zu erzielen und/oder um das Spektrum der entsprechenden Zielinsektenarten zu erweitern und/oder wegen Veränderungen, die in die Kodier- DNA während der Klonierung oder Transformation induziert wurden, wie das Protein Cry3Bb1 in Mais-Events MON863 oder MON88017 oder das Protein Cry3A im Mais-Event MIR 604; oder In particular, 1 to 10, amino acids have been replaced by another amino acid to achieve higher insecticidal activity against a target insect species and / or to broaden the spectrum of the corresponding target insect species and / or due to changes in the coding DNA during cloning or Transformation were induced, such as the protein Cry3Bb1 in maize events MON863 or MON88017 or the protein Cry3A in the maize event MIR 604; or
5) ein Insektizides sezerniertes Protein aus Bacillus thuringiensis oder Bacillus cereus oder einen Insektiziden Teil davon, wie die vegetativ wirkenden 5) an insecticidal secreted protein from Bacillus thuringiensis or Bacillus cereus or an insecticidal part thereof, such as the vegetative
insektentoxischen Proteine (vegetative insecticidal proteins, VIP), die unter folgendem Link angeführt sind, z. B. Proteine der Proteinklasse VIP3Aa: insecticidal proteins (VIP) listed under the following link, e.g. B. Proteins of protein class VIP3Aa:
http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/vip.html oder 6) ein sezerniertes Protein aus Bacillus thuringiensis oder Bacillus cereus, das in Gegenwart eines zweiten sezernierten Proteins aus Bacillus thuringiensis oder B. cereus insektizid wirkt, wie das binäre Toxin, das aus den Proteinen VIP1A und VIP2A besteht (WO 94/21795); oder 7) ein Insektizides Hybridprotein, das Teile von verschiedenen sezerniertenhttp://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/vip.html or 6) a secreted protein from Bacillus thuringiensis or Bacillus cereus, which is expressed in the presence of a second secreted protein from Bacillus thuringiensis or B. cereus insecticide, such as the binary toxin consisting of the proteins VIP1A and VIP2A (WO 94/21795); or 7) an insecticidal hybrid protein that secretes parts of various
Proteinen von Bacillus thuringiensis oder Bacillus cereus umfaßt, wie ein Hybrid der Proteine von 1 ) oder ein Hybrid der Proteine von 2) oben; oder Proteins of Bacillus thuringiensis or Bacillus cereus, such as a hybrid of the proteins of 1) or a hybrid of the proteins of 2) above; or
8) ein Protein gemäß einem der Punkte 1 ) bis 3) oben, in dem einige, 8) a protein according to any one of items 1) to 3) above, in which some,
insbesondere 1 bis 10, Aminosäuren durch eine andere Aminosäure ersetzt wurden, um eine höhere Insektizide Wirksamkeit gegenüber einer Zielinsektenart zu erzielen und/oder um das Spektrum der entsprechenden Zielinsektenarten zu erweitern und/oder wegen Veränderungen, die in die Kodier- DNA während der Klonierung oder Transformation induziert wurden (wobei die Kodierung für ein Insektizides Protein erhalten bleibt), wie das Protein VIP3Aa im Baumwoll-Event COT 102. Natürlich zählt zu den insektenresistenten transgenen Pflanzen im vorliegenden Zusammenhang auch jegliche Pflanze, die eine Kombination von Genen umfaßt, die für die Proteine von einer der oben genannten Klassen 1 bis 8 kodieren. In einer Ausführungsform enthält eine insektenresistente Pflanze mehr als ein Transgen, das für ein Protein nach einer der oben genannten 1 bis 8 kodiert, um das Spektrum der entsprechenden Zielinsektenarten zu erweitern oder um die Entwicklung einer Resistenz der Insekten gegen die Pflanzen dadurch hinauszuzögern, dass man verschiedene Proteine einsetzt, die für dieselbe Zielinsektenart insektizid sind, jedoch eine unterschiedliche Wirkungsweise, wie Bindung an unterschiedliche Rezeptorbindungsstellen im Insekt, aufweisen. In particular, 1 to 10, amino acids have been replaced by another amino acid to achieve higher insecticidal activity against a target insect species and / or to broaden the spectrum of the corresponding target insect species and / or due to changes in the coding DNA during cloning or Transformation (retaining coding for an insecticidal protein) such as protein VIP3Aa in cotton event COT 102. Of course, insect-resistant transgenic plants in the present context also include any plant comprising a combination of genes encoding the proteins of any of the above classes 1 to 8. In one embodiment, an insect resistant plant contains more than one transgene encoding a protein of any one of the above 1 to 8 in order to extend the spectrum of the corresponding target insect species or to delay the development of resistance of the insects to the plants by use different proteins which are insecticidal for the same target insect species, but have a different mode of action, such as binding to different receptor binding sites in the insect.
Pflanzen oder Pflanzensorten (die nach Methoden der pflanzlichen Biotechnologie, wie der Gentechnik, erhalten wurden), die ebenfalls mit den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) behandelt werden können, sind gegenüber abiotischen Streßfaktoren tolerant. Solche Pflanzen können durch genetischePlants or plant varieties (obtained by methods of plant biotechnology, such as genetic engineering), which can also be treated with the compounds of the general formula (I) according to the invention, are tolerant of abiotic stress factors. Such plants can be caused by genetic
Transformation oder durch Selektion von Pflanzen, die eine Mutation enthalten, die solch eine Streßresistenz verleiht, erhalten werden. Zu besonders nützlichen Transformation or by selection of plants containing a mutation conferring such stress resistance. Too particularly useful
Pflanzen mit Streßtoleranz zählen folgende: a. Pflanzen, die ein Transgen enthalten, das die Expression und/oder Aktivität des Gens für die Poly(ADP-ribose)polymerase (PARP) in den Pflanzenzellen oder Pflanzen zu reduzieren vermag, wie dies in WO 2000/004173 oder EP 04077984.5 oder EP 06009836.5 beschrieben ist. b. Pflanzen, die ein streßtoleranzförderndes Transgen enthalten, das die Plants with stress tolerance include the following: a. Plants which contain a transgene capable of reducing the expression and / or activity of the gene for the poly (ADP-ribose) polymerase (PARP) in the plant cells or plants, as described in WO 2000/004173 or EP 04077984.5 or EP 06009836.5 is described. b. Plants containing a stress tolerance-enhancing transgene which causes the
Expression und/oder Aktivität der für PARG kodierenden Gene der Pflanzen oder Pflanzenzellen zu reduzieren vermag, wie dies z.B. in WO 2004/090140 beschrieben ist; c. Pflanzen, die ein streßtoleranzförderndes Transgen enthalten, das für ein in Pflanzen funktionelles Enzym des Nicotinamidadenindinukleotid-Salvage- Biosynthesewegs kodiert, darunter Nicotinamidase, Nicotinatphosphoribosyltransferase, Nicotinsäuremononukleotid-adenyltransferase, Nicotinamidadenindinukleotidsynthetase oder Nicotinamidphosphoribosyl- transferase, wie dies z. B. in EP 04077624.7 oder WO 2006/133827 oder Can reduce expression and / or activity of PARG encoding genes of plants or plant cells, as described for example in WO 2004/090140; c. Plants which contain a stress tolerance enhancing transgene coding for a plant functional enzyme of the nicotinamide adenine dinucleotide salvage biosynthetic pathway, including nicotinamidase, Nicotinate phosphoribosyltransferase, nicotinic acid mononucleotide adenyltransferase, nicotinamide adenine dinucleotide synthetase or nicotinamide phosphoribosyltransferase, as described e.g. In EP 04077624.7 or WO 2006/133827 or
PCT/EP07/002433 beschrieben ist. PCT / EP07 / 002433 is described.
Pflanzen oder Pflanzensorten (die nach Methoden der pflanzlichen Biotechnologie, wie der Gentechnik, erhalten wurden), die ebenfalls mit den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) behandelt werden können, weisen eine veränderte Menge, Qualität und/oder Lagerfähigkeit des Ernteprodukts und/oder veränderte Eigenschaften von bestimmten Bestandteilen des Ernteprodukts auf, wie zum Beispiel: Plants or plant varieties (obtained by plant biotechnology methods, such as genetic engineering), which can also be treated with the compounds of the general formula (I) according to the invention, have a modified amount, quality and / or shelf life of the harvested product and / or altered properties of certain components of the crop, such as:
1 ) Transgene Pflanzen, die eine modifizierte Stärke synthetisieren, die bezüglich ihrer chemisch-physikalischen Eigenschaften, insbesondere des Amylosegehalts oder des Amylose/Amylopektin-Verhältnisses, des Verzweigungsgrads, der durchschnittlichen Kettenlänge, der Verteilung der Seitenketten, des 1) Transgenic plants that synthesize a modified starch with respect to their physicochemical properties, in particular the amylose content or the amylose / amylopectin ratio, the degree of branching, the average chain length, the distribution of side chains, the
Viskositätsverhaltens, der Gelfestigkeit, der Stärkekorngröße und/oder Viscosity behavior, the gel strength, the starch grain size and / or
Stärkekornmorphologie im Vergleich mit der synthetisierten Stärke in Starch grain morphology in comparison with the synthesized starch in
Wildtyppflanzenzellen oder -pflanzen verändert ist, so dass sich diese modifizierte Stärke besser für bestimmte Anwendungen eignet. Diese transgenen Pflanzen, die eine modifizierte Stärke synthetisieren, sind zum Beispiel in EP 0571427, WO Wild-type plant cells or plants, so that this modified starch is better suited for certain applications. These transgenic plants synthesizing a modified starch are described, for example, in EP 0571427, WO
95/004826, EP 0719338, WO 96/15248, WO 96/19581 , WO 96/27674, WO 95/004826, EP 0719338, WO 96/15248, WO 96/19581, WO 96/27674, WO
97/1 1 188, WO 97/26362, WO 97/32985, WO 97/42328, WO 97/44472, WO 97/1 1 188, WO 97/26362, WO 97/32985, WO 97/42328, WO 97/44472, WO
97/45545, WO 98/27212, WO 98/40503, WO 99/58688, WO 99/58690, WO 97/45545, WO 98/27212, WO 98/40503, WO 99/58688, WO 99/58690, WO
99/58654, WO 2000/008184, WO 2000/008185, WO 2000/28052, WO 2000/77229, WO 2001/12782, WO 2001/12826, WO 2002/101059, WO 2003/071860, WO 99/58654, WO 2000/008184, WO 2000/008185, WO 2000/28052, WO 2000/77229, WO 2001/12782, WO 2001/12826, WO 2002/101059, WO 2003/071860, WO
2004/056999, WO 2005/030942, WO 2005/030941 , WO 2005/095632, WO 2004/056999, WO 2005/030942, WO 2005/030941, WO 2005/095632, WO
2005/095617, WO 2005/095619, WO 2005/095618, WO 2005/123927, WO 2005/095617, WO 2005/095619, WO 2005/095618, WO 2005/123927, WO
2006/018319, WO 2006/103107, WO 2006/108702, WO 2007/009823, WO 2006/018319, WO 2006/103107, WO 2006/108702, WO 2007/009823, WO
2000/22140, WO 2006/063862, WO 2006/072603, WO 2002/034923, EP 2000/22140, WO 2006/063862, WO 2006/072603, WO 2002/034923, EP
06090134.5, EP 06090228.5, EP 06090227.7, EP 07090007.1 , EP 07090009.7, WO 2001/14569, WO 2002/79410, WO 2003/33540, WO 2004/078983, WO 2001/19975, WO 95/26407, WO 96/34968, WO 98/20145, WO 99/12950, WO 99/66050, WO 99/53072, US 6,734,341 , WO 2000/1 1 192, WO 98/22604, WO 98/32326, WO 2001/98509, WO 2001/98509, WO 2005/002359, US 5,824,790, US 6,013,861 , WO 94/004693, WO 94/009144, WO 94/1 1520, WO 95/35026 bzw. WO 97/20936 beschrieben. 06090134.5, EP 06090228.5, EP 06090227.7, EP 07090007.1, EP 07090009.7, WO 2001/14569, WO 2002/79410, WO 2003/33540, WO 2004/078983, WO 2001/19975, WO 95/26407, WO 96/34968, WO 98/20145, WO 99/12950, WO 99/66050, WO 99/53072, US Pat. No. 6,734,341, WO 2000/1 1 192, WO 98/22604, WO 98/32326, WO 2001/98509, WO 2001/98509, WO 2005/002359, US Pat. No. 5,824,790, US Pat. No. 6,013,861, WO 94/004693, WO 94/009144, WO 94/1 1520, WO 95/35026 and WO 97/20936, respectively.
2) Transgene Pflanzen, die Nichtstärkekohlenhydratpolymere synthetisieren, oder Nichtstärkekohlenhydratpolymere, deren Eigenschaften im Vergleich zu Wildtyppflanzen ohne genetische Modifikation verändert sind. Beispiele sind 2) Transgenic plants that synthesize non-starch carbohydrate polymers or non-starch carbohydrate polymers whose properties are altered compared to wild-type plants without genetic modification. examples are
Pflanzen, die Polyfructose, insbesondere des Inulin- und Levantyps, produzieren, wie dies in EP 0663956, WO 96/001904, Wo 96/021023, WO 98/039460 und WO 99/024593 beschrieben ist, Pflanzen, die alpha-1 ,4-Glucane produzieren, wie dies in WO 95/031553, US 2002/031826, US 6,284,479, US 5,712, 107, WO 97/047806, WO 97/047807, WO 97/047808 und WO 2000/14249 beschrieben ist, Pflanzen, die alpha-1 ,6-verzweigte alpha-1 ,4-Glucane produzieren, wie dies in WO 2000/73422 beschrieben ist, und Pflanzen, die Alternan produzieren, wie dies in WO Plants which produce polyfructose, in particular of the inulin and levan type, as described in EP 0663956, WO 96/001904, WO 96/021023, WO 98/039460 and WO 99/024593, plants which contain alpha-1,4 Produce glucans, as described in WO 95/031553, US 2002/031826, US 6,284,479, US 5,712,107, WO 97/047806, WO 97/047807, WO 97/047808 and WO 2000/14249, plants which producing alpha-1, 6-branched alpha-1, 4-glucans, as described in WO 2000/73422, and plants producing alternan, as described in WO
2000/047727, EP 06077301 .7, US 5,908,975 und EP 0728213 beschrieben ist. 2000/047727, EP 06077301 .7, US 5,908,975 and EP 0728213.
3) Transgene Pflanzen, die Hyaluronan produzieren, wie dies zum Beispiel in WO 06/032538, WO 2007/039314, WO 2007/039315, WO 2007/039316, JP 3) Transgenic plants producing hyaluronan, as described, for example, in WO 06/032538, WO 2007/039314, WO 2007/039315, WO 2007/039316, JP
2006/304779 und WO 2005/012529 beschrieben ist.  2006/304779 and WO 2005/012529.
Pflanzen oder Pflanzensorten (die nach Methoden der pflanzlichen Biotechnologie, wie der Gentechnik, erhalten wurden), die ebenfalls mit den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) behandelt werden können, sind Pflanzen wie Baumwollpflanzen mit veränderten Fasereigenschaften. Solche Pflanzen können durch genetische Transformation oder durch Selektion von Pflanzen, die eine Mutation enthalten, die solche veränderten Fasereigenschaften verleiht, erhalten werden; dazu zählen: a) Pflanzen wie Baumwollpflanzen, die eine veränderte Form von Plants or plant varieties (obtained by plant biotechnology methods such as genetic engineering) which can also be treated with the compounds of the general formula (I) according to the invention are plants such as cotton plants with altered fiber properties. Such plants can be obtained by genetic transformation or by selection of plants containing a mutation conferring such altered fiber properties; These include: a) plants, such as cotton plants, which have an altered form of
Cellulosesynthasegenen enthalten, wie dies in WO 98/000549 beschrieben ist, b) Pflanzen wie Baumwollpflanzen, die eine veränderte Form von rsw2- oder rsw3-homologen Nukleinsäuren enthalten, wie dies in WO 2004/053219 beschrieben ist; c) Pflanzen wie Baumwollpflanzen mit einer erhöhten Expression der Contain cellulose synthase genes, as described in WO 98/000549, b) plants, such as cotton plants, which contain an altered form of rsw2 or rsw3-homologous nucleic acids, as described in WO 2004/053219; c) plants such as cotton plants with an increased expression of the
Saccharosephosphatsynthase, wie dies in WO 2001/017333 beschrieben ist; d) Pflanzen wie Baumwollpflanzen mit einer erhöhten Expression der Sucrose phosphate synthase as described in WO 2001/017333; d) plants such as cotton plants with an increased expression of
Saccharosesynthase, wie dies in WO 02/45485 beschrieben ist; e) Pflanzen wie Baumwollpflanzen bei denen der Zeitpunkt der Sucrose synthase as described in WO 02/45485; e) plants such as cotton plants where the date of
Durchlaßsteuerung der Plasmodesmen an der Basis der Faserzelle verändert ist, z. B. durch Herunterregulieren der faserselektiven ß-1 ,3-Glucanase, wie dies in WO 2005/017157 beschrieben ist; f) Pflanzen wie Baumwollpflanzen mit Fasern mit veränderter Reaktivität, z. B. durch Expression des N-Acetylglucosamintransferasegens, darunter auch nodC, und von Chitinsynthasegenen, wie dies in WO 2006/136351 beschrieben ist. Transmission control of the Plasmodesmen is changed at the base of the fiber cell, z. By down-regulating the fiber-selective β-1,3-glucanase as described in WO 2005/017157; f) plants such as cotton plants with modified reactivity fibers, e.g. By expression of the N-acetylglucosamine transferase gene, including nodC, and chitin synthase genes, as described in WO 2006/136351.
Pflanzen oder Pflanzensorten (die nach Methoden der pflanzlichen Biotechnologie, wie der Gentechnik, erhalten wurden), die ebenfalls mit den erfindungsgemäßen Verbindungen der allgemeinen Formel (I) behandelt werden können, sind Pflanzen wie Raps oder verwandte Brassica-Pflanzen mit veränderten Eigenschaften der Ölzusammensetzung. Solche Pflanzen können durch genetische Transformation oder durch Selektion von Pflanzen, die eine Mutation enthalten, die solche veränderten Öleigenschaften verleiht, erhalten werden; dazu zählen: a) Pflanzen wie Rapspflanzen, die Öl mit einem hohen Ölsäuregehalt Plants or plant varieties (obtained by plant biotechnology methods such as genetic engineering) which can also be treated with the compounds of the general formula (I) according to the invention are plants such as rape or related Brassica plants with altered properties of the oil composition. Such plants can be obtained by genetic transformation or by selection of plants containing a mutation conferring such altered oil properties; These include: a) plants such as rape plants, the oil with a high oleic acid content
produzieren, wie dies zum Beispiel in US 5,969, 169, US 5,840,946 oder US as described, for example, in US 5,969,169, US 5,840,946 or US
6,323,392 oder US 6,063, 947 beschrieben ist; b) Pflanzen wie Rapspflanzen, die Öl mit einem niedrigen Linolensäuregehalt produzieren, wie dies in US 6,270828, US 6, 169, 190 oder US 5,965,755 6,323,392 or US 6,063,947; b) plants such as oilseed rape plants which produce oil of low linolenic acid content as described in US 6,270,828, US 6,169,190 or US 5,965,755
beschrieben ist. c) Pflanzen wie Rapspflanzen, die Öl mit einem niedrigen gesättigten is described. c) plants such as rape plants, the oil with a low saturated
Fettsäuregehalt produzieren, wie dies z. B. in US 5,434,283 beschrieben ist. Produce fatty acid content, as z. As described in US 5,434,283.
Besonders nützliche transgene Pflanzen, die mit den erfindungsgemäßen Particularly useful transgenic plants with the inventive
Verbindungen der allgemeinen Formel (I) behandelt werden können, sind Pflanzen, die Transformations-Events, oder eine Kombination von Transformations-Events, enthalten und die zum Beispiel in den Dateien von verschiedenen nationalen oder regionalen Behörden angeführt sind. Compounds of general formula (I) may be treated as plants containing transformation events, or a combination of transformation events, for example as listed in the files of various national or regional authorities.
Besonders nützliche transgene Pflanzen, die mit den erfindungsgemäßen Particularly useful transgenic plants with the inventive
Verbindungen der allgemeinen Formel (I) behandelt werden können, sind Compounds of general formula (I) can be treated are
beispielhaft Pflanzen mit einem oder mehreren Genen, die für ein oder mehrere Toxine kodieren, sind die transgenen Pflanzen, die unter den folgenden Exemplary plants having one or more genes encoding one or more toxins are the transgenic plants, which are among the following
Handelsbezeichnungen angeboten werden: YIELD GARD® (zum Beispiel Mais, Baumwolle, Sojabohnen), KnockOut® (zum Beispiel Mais), BiteGard® (zum Beispiel Mais), BT-Xtra® (zum Beispiel Mais), StarLink® (zum Beispiel Mais), Bollgard®Commercial names: YIELD GARD® (for example, corn, cotton, soybeans), KnockOut® (for example, corn), BiteGard® (for example, corn), BT-Xtra® (for example, corn), StarLink® (for example, corn) , Bollgard®
(Baumwolle), Nucotn® (Baumwolle), Nucotn 33B® (Baumwolle), NatureGard® (zum Beispiel Mais), Protecta® und NewLeaf® (Kartoffel). Herbizidtolerante Pflanzen, die zu erwähnen sind, sind zum Beispiel Maissorten, Baumwollsorten und (Cotton), Nucotn® (cotton), Nucotn 33B® (cotton), NatureGard® (for example corn), Protecta® and NewLeaf® (potato). Herbicide-tolerant plants to be mentioned are, for example, maize varieties, cotton varieties and
Sojabohnensorten, die unter den folgenden Handelsbezeichnungen angeboten werden: Roundup Ready® (Glyphosatetoleranz, zum Beispiel Mais, Baumwolle, Sojabohne), Liberty Link® (Phosphinotricintoleranz, zum Beispiel Raps), IM leg) Soybean varieties sold under the following tradenames: Roundup Ready® (glyphosate tolerance, for example corn, cotton, soybean), Liberty Link® (phosphinotricin tolerance, for example rapeseed), IM leg )
(Imidazolinontoleranz) und SCS® (Sylfonylharnstofftoleranz), zum Beispiel Mais. Zu den herbizidresistenten Pflanzen (traditionell auf Herbizidtoleranz gezüchtete (Imidazolinone tolerance) and SCS® (Sylfonylurea tolerance), for example corn. To the herbicide-resistant plants (traditionally grown on herbicide tolerance
Pflanzen), die zu erwähnen sind, zählen die unter der Bezeichnung Clearfield® angebotenen Sorten (zum Beispiel Mais). Die erfindungsgemäß zu verwendenden Verbindungen der Formel (I) können in übliche Formulierungen überführt werden, wie Lösungen, Emulsionen, Spritzpulver, wasser- und ölbasierte Suspensionen, Pulver, Stäubemittel, Pasten, lösliche Pulver, lösliche Granulate, Streugranulate, Suspensions-Emulsions-Konzentrate, Wirkstoff- imprägnierte Naturstoffe, Wirkstoff-imprägnierte synthetische Stoffe, Düngemittel sowie Feinstverkapselungen in polymeren Stoffen. Im Rahmen der vorliegenden Erfindung ist es insbesondere bevorzugt, wenn die Verbindungen der allgemeinen Formel (I) in der Form einer Sprühformulieruing verwendet werden. Die vorliegende Erfindung betrifft daher darüber hinaus auch eine Sprühformulierung zur Steigerung der Widerstandsfähigkeit von Pflanzen gegenüber abiotischem Stress. Im Folgenden wird eine Sprühformulierung näher beschrieben: Plants) to be mentioned include the varieties offered under the name Clearfield® (for example corn). The compounds of the formula (I) to be used according to the invention can be converted into customary formulations, such as solutions, emulsions, wettable powders, water- and oil-based suspensions, powders, dusts, pastes, soluble powders, soluble granules, scattering granules, suspension-emulsion concentrates, Active substance-impregnated natural substances, active substance-impregnated synthetic substances, fertilizers and microencapsulation in polymeric substances. In the context of the present invention it is particularly preferred if the compounds of the general formula (I) are used in the form of a spray formulation. The present invention therefore further relates to a spray formulation for increasing the resistance of plants to abiotic stress. In the following, a spray formulation is described in more detail:
Die Formulierungen zur Sprühapplikation werden in bekannter Weise hergestellt, z.B. durch Vermischen der erfindungsgemäß zu verwendenden Verbindungen der allgmeinen Formel (I) mit Streckmitteln, also flüssigen Lösungsmitteln und/oder festen Trägerstoffen, gegebenenfalls unter Verwendung von oberflächenaktiven Mitteln, also Emulgiermitteln und/oder Dispergiermitteln und/oder schaumerzeugenden Mitteln. Weitere übliche Zusatzstoffe, wie zum Beispiel übliche The formulations for spray application are prepared in a known manner, e.g. by mixing the compounds of the general formula (I) to be used according to the invention with extenders, ie liquid solvents and / or solid carriers, if appropriate using surface-active agents, ie emulsifiers and / or dispersants and / or foam-forming agents. Other common additives, such as usual
Streckmittel sowie Lösungs- oder Verdünnungsmittel, Farbstoffe, Netzmittel, Dispergiermittel, Emulgatoren, Entschäumer, Konservierungsmittel, sekundäre Verdickungsmittel, Kleber, Gibberelline und auch Wasser, können gegebenenfalls auch verwendet werden. Die Herstellung der Formulierungen erfolgt entweder in geeigneten Anlagen oder auch vor oder während der Anwendung. Extenders, as well as solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, defoamers, preservatives, secondary thickeners, adhesives, gibberellins, and also water, may optionally also be used. The preparation of the formulations is carried out either in suitable systems or before or during use.
Als Hilfsstoffe können solche Stoffe Verwendung finden, die geeignet sind, dem Mittel selbst oder und/oder davon abgeleitete Zubereitungen (z.B. Spritzbrühen) besondere Eigenschaften zu verleihen, wie bestimmte technische Eigenschaften und/oder auch besondere biologische Eigenschaften. Als typische Hilfsmittel kommen in Frage: Streckmittel, Lösemittel und Trägerstoffe. Als Streckmittel eignen sich z.B. Wasser, polare und unpolare organische chemische Flüssigkeiten z.B. aus den Klassen der aromatischen und nicht-aromatischen Kohlenwasserstoffe (wie Paraffine, Alkylbenzole, Alkylnaphthaline, Chlorbenzole), der Alkohole und Polyole (die ggf. auch substituiert, verethert und/oder verestert sein können), der Ketone (wie Aceton, Cyclohexanon), Ester (auch Fette und Öle) und (Poly-)Ether, der einfachen und substituierten Amine, Amide, Lactame (wie N- Alkylpyrrolidone) und Lactone, der Sulfone und Sulfoxide (wie Dimethylsysulfoxid). As excipients, it is possible to use those substances which are suitable for imparting special properties to the agent itself and / or preparations derived therefrom (for example spray liquors), such as certain technical properties and / or also particular biological properties. Typical auxiliaries are: extenders, solvents and carriers. Suitable extenders include, for example, water, polar and non-polar organic chemical liquids, for example from the classes of aromatic and non-aromatic hydrocarbons (such as paraffins, alkylbenzenes, alkylnaphthalenes, chlorobenzenes), alcohols and polyols (which may also be substituted, etherified and / or esterified esters (also fats and oils) and (poly) ethers, simple and substituted amines, amides, lactams (such as N-alkylpyrrolidones) and lactones, sulfones and sulfoxides (such as dimethylsulfoxide).
Im Falle der Benutzung von Wasser als Streckmittel können z.B. auch organische Lösemittel als Hilfslösungsmittel verwendet werden. Als flüssige Lösemittel kommen im wesentlichen in Frage: Aromaten, wie Xylol, Toluol, oder Alkylnaphthaline, chlorierte Aromaten und chlorierte aliphatische Kohlenwasserstoffe, wie Chlorbenzole, Chlorethylene oder Methylenchlorid, aliphatische Kohlenwasserstoffe, wie Cyclohexan oder Paraffine, z.B. Erdölfraktionen, mineralische und pflanzliche Öle, Alkohole, wie Butanol oder Glykol sowie deren Ether und Ester, Ketone wie Aceton, Methylethylketon, Methylisobutylketon oder Cyclohexanon, stark polare In the case of using water as an extender, e.g. also organic solvents can be used as auxiliary solvent. Suitable liquid solvents are essentially: aromatics, such as xylene, toluene, or alkylnaphthalenes, chlorinated aromatics and chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, e.g. Petroleum fractions, mineral and vegetable oils, alcohols such as butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar
Lösungsmittel, wie Dimethylsulfoxid, sowie Wasser. Solvents, such as dimethyl sulfoxide, as well as water.
Es können Farbstoffe wie anorganische Pigmente, z.B. Eisenoxid, Titanoxid, Ferro- cyanblau und organische Farbstoffe, wie Alizarin-, Azo- und Metallphthalocyanin- farbstoffe und Spurennährstoffe wie Salze von Eisen, Mangan, Bor, Kupfer, Kobalt, Molybdän und Zink verwendet werden. Dyes such as inorganic pigments, e.g. Iron oxide, titanium oxide, ferrocyan blue and organic dyes such as alizarin, azo and metal phthalocyanine dyes and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
Als Netzmittel, die in den erfindungsgemäß verwendbaren Formulierungen enthalten sein können, kommen alle zur Formulierung von agrochemischen Wirkstoffen üblichen, die Benetzung fördernden Stoffe in Frage. Vorzugsweise verwendbar sind Alkylnaphthalin-Sulfonate, wie Diisopropyl- oder Diisobutylnaphthalin-Sulfonate. Suitable wetting agents which may be present in the formulations which can be used according to the invention are all wetting-promoting substances customary for the formulation of agrochemical active compounds. Preferably usable are alkylnaphthalene sulfonates such as diisopropyl or diisobutylnaphthalene sulfonates.
Als Dispergiermittel und/oder Emulgatoren, die in den erfindungsgemäß As dispersants and / or emulsifiers, which in the invention
verwendbaren Formulierungen enthalten sein können, kommen alle zur usable formulations can be included, all come to
Formulierung von agrochemischen Wirkstoffen üblichen nichtionischen, anionischen und kationischen Dispergiermittel in Betracht. Vorzugsweise verwendbar sind nichtionische oder anionische Dispergiermittel oder Gemische von nichtionischen oder anionischen Dispergiermitteln. Als geeignete nichtionische Dispergiermittel sind insbesondere Ethylenoxid-Propylenoxid-Blockpolymere, Alkylphenolpolyglykolether sowie Tristryrylphenolpolyglykolether und deren phosphatierte oder sulfatierte Derivate zu nennen. Geeignete anionische Dispergiermittel sind insbesondere Ligninsulfonate, Polyacrylsäuresalze und Arylsulfonat-Formaldehydkondensate. Formulation of agrochemical active ingredients conventional nonionic, anionic and cationic dispersants into consideration. Preferably usable nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants. Particularly suitable nonionic dispersants are ethylene oxide-propylene oxide block polymers, alkylphenol polyglycol ethers and tristryrylphenol polyglycol ethers and their phosphated or sulfated derivatives. Suitable anionic dispersants are in particular lignosulfonates, polyacrylic acid salts and arylsulfonate-formaldehyde condensates.
Als Entschäumer können in den erfindungsgemäß verwendbaren Formulierungen alle zur Formulierung von agrochemischen Wirkstoffen üblichen schaumhemmenden Stoffe enthalten sein. Vorzugsweise verwendbar sind Silikonentschäumer und Magnesiumstearat. Defoamers which may be present in the formulations which can be used according to the invention are all foam-inhibiting substances customary for the formulation of agrochemical active compounds. Preferably usable are silicone defoamers and magnesium stearate.
Als Konservierungsmittel können in den erfindungsgemäß verwendbaren As preservatives can be used in the invention
Formulierungen alle für derartige Zwecke in agrochemischen Mitteln einsetzbaren Stoffe vorhanden sein. Beispielhaft genannt seien Dichlorophen und Benzylalkohol- hemiformal. Formulations all substances that can be used for such purposes in agrochemical agents be present. Examples include dichlorophen and benzyl alcohol hemiformal.
Als sekundäre Verdickungsmittel, die in den erfindungsgemäß verwendbaren Formulierungen enthalten sein können, kommen alle für derartige Zwecke in As secondary thickening agents which may be included in the formulations usable according to the invention, all come for such purposes in
agrochemischen Mitteln einsetzbaren Stoffe in Frage. Vorzugsweise in Betracht kommen Cellulosederivate, Acrylsäurederivate, Xanthan, modifizierte Tone und hochdisperse Kieselsäure. Agrochemical agents usable substances in question. Preference is given to cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica.
Als Kleber, die in den erfindungsgemäß verwendbaren Formulierungen enthalten sein können, kommen alle üblichen in Beizmitteln einsetzbaren Bindemittel in Frage. Vorzugsweise genannt seien Polyvinylpyrrolidon, Polyvinylacetat, Polyvinylalkohol und Tylose. Als Gibberelline, die in den erfindungsgemäß verwendbaren Formulierungen enthalten sein können, kommen vorzugsweise die Gibberelline A1 , A3 (= Gibberellinsäure), A4 und A7 infrage, besonders bevorzugt verwendet man die Gibberellinsäure. Die Gibberelline sind bekannt (vgl. R. Wegler„Chemie der Suitable adhesives which may be present in the formulations which can be used according to the invention are all customary binders which can be used in pickling agents. Preferably mentioned are polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and Tylose. Gibberellins which may be present in the formulations which can be used according to the invention are preferably the gibberellins A1, A3 (= gibberellic acid), A4 and A7, gibberellic acid is particularly preferably used. The gibberellins are known (see R. Wegler "Chemie der
Pflanzenschutz- und Schädlingsbekämpfungsmittel", Bd. 2, Springer Verlag, 1970, S. 401 -412). Weitere Additive können Duftstoffe, mineralische oder vegetabilische gegebenenfalls modifizierte Öle, Wachse und Nährstoffe (auch Spurennährstoffe), wie Salze von Eisen, Mangan, Bor, Kupfer, Kobalt, Molybdän und Zink sein. Weiterhin enthalten sein können Stabilisatoren wie Kältestabilisatoren, Oxidationsschutzmittel, Phytosanitary and Pesticides ", Vol. 2, Springer Verlag, 1970, pp. 401-412). Other additives may be fragrances, mineral or vegetable optionally modified oils, waxes and nutrients (also micronutrients), such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. May also contain stabilizers such as cold stabilizers, antioxidants,
Lichtschutzmittel oder andere die chemische und / oder physikalische Stabilität verbessernde Mittel. Light stabilizers or other chemical and / or physical stability-improving agent.
Die Formulierungen enthalten im allgemeinen zwischen 0,01 und 98 Gew.-%, vorzugsweise zwischen 0,5 und 90 %, der Verbindung der allgemeinen Formel (I). The formulations generally contain between 0.01 and 98% by weight, preferably between 0.5 and 90%, of the compound of general formula (I).
Die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) können in handelsüblichen Formulierungen sowie in den aus diesen Formulierungen bereiteten Anwendungsformen in Mischung mit anderen Wirkstoffen wie Insektiziden, The compounds of the general formula (I) according to the invention can be prepared in commercial formulations and in the formulations prepared from these formulations in admixture with other active substances such as insecticides,
Lockstoffen, Sterilantien, Bakteriziden, Akariziden, Nematiziden, Fungiziden, wachstumsregulierenden Stoffen, Herbiziden, Safenern, Düngemitteln oder Attractants, sterilants, bactericides, acaricides, nematicides, fungicides, growth regulators, herbicides, safeners, fertilizers or
Semiochemicals vorliegen. Semiochemicals are present.
Ferner lässt sich die beschriebene positive Wirkung der Verbindungen der Formel (I) auf die pflanzeneigenen Abwehrkräfte durch eine zusätzliche Behandlung mit insektziden, fungiziden oder bakteriziden Wirkstoffen unterstützen. Furthermore, the described positive effect of the compounds of the formula (I) on the plant's own defenses can be assisted by additional treatment with insecticidal, fungicidal or bactericidal active substances.
Bevorzugte Zeitpunkte für die Applikation von Verbindungen der allgemeinen Formel (I) zur Seigerung der Resistanz gegenüber abiotischem Stress sind Boden-, Stamm- und/oder Blattbehandlungen mit den zugelassenen Aufwandmengen. Preferred times for the application of compounds of the general formula (I) for the seizure of the resistance to abiotic stress are soil, stem and / or leaf treatments with the permitted application rates.
Die Wirkstoffe der allgemeinen Formel (I) können im Allgemeinen darüber hinaus in ihren handelsüblichen Formulierungen sowie in den aus diesen Formulierungen bereiteten Anwendungsformen in Mischungen mit anderen Wirkstoffen, wie The active compounds of the general formula (I) can generally also be used in their commercial formulations and in the formulations prepared from these formulations in mixtures with other active ingredients, such as
Insektiziden, Lockstoffen, Sterilantien, Akariziden, Nematiziden, Fungiziden, Insecticides, attractants, sterilants, acaricides, nematicides, fungicides,
Bakteriziden, wachstumsregulierenden Stoffen, die Pflanzenreife beeinflussenden Stoffen, Safenern oder Herbiziden vorliegen. Besonders günstige Mischpartner sind beispielsweise die nachfolgend gruppenweise genannten Wirkstoffe der verschiedenen Klassen, ohne dass durch deren Reihenfolge eine Präferenz gesetzt wird: Bactericides, growth-regulating substances, the plant maturity affecting substances, safeners or herbicides are present. Particularly favorable mixing partners are For example, the following groupwise mentioned active substances of different classes, without their order of preference being set:
Fungizide: fungicides:
F1 ) Inhibitoren der Nucleinsäure Synthese, z. B. Benalaxyl, Benalaxyl-M, Bupirimat, Chiralaxyl, Clozylacon, Dimethirimol, Ethirimol, Furalaxyl, Hymexazol, Metalaxyl, Metalaxyl-M, Ofurace, Oxadixyl, Oxolinsäure; F1) inhibitors of nucleic acid synthesis, e.g. Benalaxyl, benalaxyl-M, bupirimate, chiralaxyl, clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazole, metalaxyl, metalaxyl-M, ofurace, oxadixyl, oxolinic acid;
F2) Inhibitoren der Mitose und Zellteilung, z. B. Benomyl, Carbendazim, F2) inhibitors of mitosis and cell division, e.g. Benomyl, carbendazim,
Diethofencarb, Fuberidazole, Fluopicolid, Pencycuron, Thiabendazol, Thiophanat- methyl, Zoxamid und Chlor-7-(4-methylpiperidin-1 -yl)-6-(2,4,6- Trifluorphenyl Diethofenc, fuberidazole, fluopicolide, pencycuron, thiabendazole, thiophanate-methyl, zoxamide and chloro-7- (4-methylpiperidin-1-yl) -6- (2,4,6-trifluorophenyl
[1 ,2,4]triazolo[1 ,5-a]pyrimidin; [1, 2,4] triazolo [1,5-a] pyrimidine;
F3) Inhibitoren der Atmungskette Komplex I / II, z. B. Diflumetorim, Bixafen, F3) inhibitors of the respiratory chain complex I / II, z. B. Diflumetorim, Bixafen,
Boscalid, Carboxin, Diflumethorim Fenfuram, Fluopyram, Flutolanil, Furametpyr, Mepronil, Oxycarboxin, Penflufen, Penthiopyrad, Thifluzamid, N-[2-(1 ,3- Dimethylbutyl)phenyl]-5-fluor-1 ,3-dimethyl-1 H-pyrazol-4-carboxamid, Isopyrazam, Sedaxan, 3-(Difluormethyl)-1 -methyl-N-(3',4',5'-trifluorbiphenyl-2-yl)-1 H-pyrazol-4- carboxamid, 3-(Difluormethyl)-1 -methyl-N-[2-(1 ,1 ,2,2-tetrafluorethoxy)phenyl]-1 H- pyrazol-4-carboxamid, 3-(Difluormethyl)-N-[4-fluoro-2-(1 , 1 ,2,3,3,3- hexafluorpropoxy)phenyl]-1 -methyl-1 H-pyrazol-4-carboxamid, N-[1 -(2,4- Dichlorphenyl)-1 -methoxypropan-2-yl]-3-(difluormethyl)-1 -methyl-1 H-pyrazol-4- carboxamid und entsprechende Salze; Boscalid, carboxin, diflumethorim fenfuram, fluopyram, flutolanil, furametpyr, mepronil, oxycarboxine, penflufen, penthiopyrad, thifluzamide, N- [2- (1, 3-dimethylbutyl) phenyl] -5-fluoro-1,3-dimethyl-1H pyrazole-4-carboxamide, isopyrazam, sedaxane, 3- (difluoromethyl) -1-methyl-N- (3 ', 4', 5'-trifluorobiphenyl-2-yl) -1H-pyrazole-4-carboxamide, 3 (Difluoromethyl) -1-methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -1H-pyrazole-4-carboxamide, 3- (difluoromethyl) -N- [4-fluoro- 2- (1,1,3,3,3,3-hexafluoropropoxy) phenyl] -1-methyl-1H-pyrazole-4-carboxamide, N- [1- (2,4-dichlorophenyl) -1-methoxypropane 2-yl] -3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxamide and corresponding salts;
F4) Inhibitoren der Atmungskette Komplex III, z. B.Amisulbrom, Azoxystrobin, Cyazofamid, Dimoxystrobin, Enestrobin, Famoxadon, Fenamidon, Fluoxastrobin, Kresoximmethyl, Metominostrobin, Orysastrobin, Pyraclostrobin, Pyribencarb, Picoxystrobin, Trifloxystrobin, (2E)-2-(2-{[6-(3-Chlor-2-methylphenoxy)-5- fluorpyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamid, (2E)-2- (Ethoxyimino)-N-methyl-2-(2-{[({(1 E)-1 -[3-(trifluoromethyl)- phenyl]ethyliden}amino)oxy]methyl}phenyl)ethanamid und entsprechende Salze, (2E)-2-(Methoxyimino)-N-methyl-2-{2-[(E)-({1 -[3-(trifluormethyl)phenyl]ethoxy}- imino)methyl]phenyl}ethanamid, (2E)-2-{2-[({[(1 E)-1 -(3-{[(E)-1 -Fluor-2- phenylethenyl]-oxy}phenyl)ethyliden]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N- methylethanamid, (2E)-2-{2-[({[(2E,3E)-4-(2,6-Dichlorophenyl)but-3-en-2- yliden]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamid, 2-Chlor-N- (1 , 1 ,3-trimethyl-2,3-dihydro-1 H-inden-4-yl)pyridin-3-carboxamid, 5-Methoxy-2- methyl-4-(2-{[({(1 E)-1 -[3-(trifluormethyl)phenyl]ethyliden}amino)oxy]methyl}phenyl)- 2,4-dihydro-3H-1 ,2,4-triazol-3-on, 2-Methyl-{2-[({cyclopropyl[(4-methoxyphenyl)- imino]methyl}sulfanyl)methyl]phenyl}-3-methoxyacrylat, N-(3-Ethyl-3,5,5- trimethylcyclohexyl)-3-(formylamino)-2-hydroxybenzamid und entsprechende Salze; F4) inhibitors of the respiratory chain complex III, z. B. Amesulbrom, Azoxystrobin, Cyazofamide, Dimoxystrobin, Enestrobin, Famoxadone, Fenamidone, Fluoxastrobin, Kresoximethyl, Metominostrobin, Orysastrobin, Pyraclostrobin, Pyribencarb, Picoxystrobin, Trifloxystrobin, (2E) -2- (2 - {[6- (3-Chloro) 2-methylphenoxy) -5-fluoropyrimidin-4-yl] oxy} phenyl) -2- (methoxyimino) -N-methylethanamide, (2E) -2- (Ethoxyimino) -N-methyl-2- (2 - {[({(1 E) -1 - [3- (trifluoromethyl) phenyl] ethylidene} amino) oxy] methyl} phenyl) ethanamide and corresponding salts, (2E ) -2- (methoxyimino) -N-methyl-2- {2 - [(E) - ({1- [3- (trifluoromethyl) phenyl] ethoxy} - imino) methyl] phenyl} ethanamide, (2E) -2 - {2 - [({[(1 E) -1 - (3 - {[(E) -1-fluoro-2-phenylethenyl] -oxy} phenyl) ethylidene] amino} oxy) methyl] phenyl} -2- (methoxyimino) -N-methylethaneamide, (2E) -2- {2 - [({[(2E, 3E) -4- (2,6-dichlorophenyl) but-3-en-2-ylidene] amino} oxy) methyl] phenyl} -2- (methoxyimino) -N-methylethaneamide, 2-chloro-N- (1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl) pyridine-3-carboxamide , 5-Methoxy-2-methyl-4- (2 - {[({(1 E) -1 - [3- (trifluoromethyl) phenyl] ethylidene} amino) oxy] methyl} phenyl) -2,4-dihydro- 3H-1, 2,4-triazol-3-one, 2-methyl {2 - [({cyclopropyl [(4-methoxyphenyl) imino] methyl} sulfanyl) methyl] phenyl} -3-methoxyacrylate, N- ( 3-ethyl-3,5,5-trimethylcyclohexyl) -3- (formylamino) -2-hydroxybenzamide and corresponding salts;
F5) Entkoppler, z. B. Dinocap, Fluazinam; F5) decoupler, z. Dinocap, fluazinam;
F6) Inhibitoren der ATP Produktion, z. B. Fentinacetat, Fentinchlorid, Fentinhydroxid, Silthiofam F6) inhibitors of ATP production, e.g. Fentin acetate, fentin chloride, fentin hydroxide, silthiofam
F7) Inhibitoren der Aminosäure- und Proteinbiosynthese, z.B. Andoprim, Blasticidin- S, Cyprodinil, Kasugamycin, Kasugamycinhydrochlorid Hydrat, Mepanipyrim, Pyrimethanil F7) inhibitors of amino acid and protein biosynthesis, e.g. Andoprim, blasticidin-S, cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim, pyrimethanil
F8) Inhibitoren der Signal-Transduktion, z. B. Fenpiclonil, Fludioxonil, Quinoxyfen F9) Inhibitoren der Fett- und Membran Synthese, z. B. Chlozolinat, Iprodion, F8) inhibitors of signal transduction, e.g. Fenpiclonil, fludioxonil, quinoxyfen F9) inhibitors of fat and membrane synthesis, e.g. B. chlozolinate, iprodione,
Procymidon, Vinclozolin, Ampropylfos, Kalium-Ampropylfos, Edifenphos, Iprobenfos (IBP), Isoprothiolan, Pyrazophos, Tolclofos-methyl, Biphenyl, lodocarb,  Procymidone, vinclozolin, ampropylfos, potassium ampropylfos, edifenphos, ip samples (IBP), isoprothiolane, pyrazophos, tolclofos-methyl, biphenyl, iodocarb,
Propamocarb, Propamocarb hydrochlorid F10) Inhibitoren der Ergosterol Biosynthese, z. B. Fenhexamid, Azaconazol, Propamocarb, propamocarb hydrochloride F10) inhibitors of ergosterol biosynthesis, e.g. Fenhexamid, azaconazole,
Bitertanol, Bromuconazol, Diclobutrazol, Difenoconazol, Diniconazol, Diniconazol-M, Etaconazol, Fenbuconazol, Fluquinconazol, Flusilazol, Flutriafol, Furconazol, Furconazol-cis, Hexaconazol, Imibenconazol, Ipconazol, Metconazol, Myclobutanil, Paclobutrazol, Penconazol, Propiconazol, Prothioconazol, Simeconazol, Spiroxamin, Tebuconazol, Triadimefon, Triadimenol, Triticonazol, Uniconazol, Voriconazol, Imazalil, Imazalilsulfat, Oxpoconazol, Fenarimol, Flurprimidol, Nuarimol, Pyrifenox, Triforin, Pefurazoat, Prochloraz, Triflumizol, Viniconazol, Aldimorph, Dodemorph, Dodemorphacetat, Fenpropimorph, Tridemorph, Fenpropidin, Naftifin, Pyributicarb, Terbinafin, 1 -(4-Chlorophenyl)-2-(1 H-1 ,2,4-triazol-1 -yl)cycloheptanol, Methyl-1 -(2,2- dimethyl-2,3-dihydro-1 H-inden-1 -yl)-1 H-imidazol-5-carboxylat, N'-{5-(Difluormethyl)- 2-methyl-4-[3-(trimethyl-silyl)propoxy]phenyl}-N-ethyl-N-methylimidoformamid, N- Ethyl-N-methyl-N'-{2-methyl-5-(trifluormethyl)-4-[3-Bitertanol, bromuconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, furconazole, Furconazole-cis, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, paclobutrazol, penconazole, propiconazole, prothioconazole, simeconazole, spiroxamine, tebuconazole, triadimefon, triadiconol, triticonazole, uniconazole, voriconazole, imazalil, imazalil sulfate, oxpoconazole, fenarimol, flurprimidol, nuarimol, Pyrifenox, triforin, pefurazoate, prochloraz, triflumizole, viniconazole, aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph, fenpropidin, naftifine, pyributicarb, terbinafine, 1- (4-chlorophenyl) -2- (1H-1, 2,4- triazole-1-yl) cycloheptanol, methyl 1 - (2,2-dimethyl-2,3-dihydro-1H-inden-1-yl) -1H-imidazole-5-carboxylate, N '- {5- (Difluoromethyl) -2-methyl-4- [3- (trimethylsilyl) propoxy] phenyl} -N-ethyl-N-methylimidoformamide, N-ethyl-N-methyl-N '- {2-methyl-5- ( trifluoromethyl) -4- [3-
(trimethylsilyl)propoxy]phenyl}imidoformamid und 0-{1 -[(4-Methoxy- phenoxy)methyl]-2,2-dimethylpropyl}-1 H-imidazol-1 -carbothioat; (trimethylsilyl) propoxy] phenyl} imidoformamide and 0- {1 - [(4-methoxyphenoxy) methyl] -2,2-dimethylpropyl} -1H-imidazole-1-carbothioate;
F1 1 ) Inhibitoren der Zellwand Synthese, z. B. Benthiavalicarb, Bialaphos, F1 1) inhibitors of cell wall synthesis, e.g. Benthiavalicarb, Bialaphos,
Dimethomorph, Flumorph, Iprovalicarb, Polyoxins, Polyoxorim, Validamycin A Dimethomorph, flumorph, iprovalicarb, polyoxins, polyoxorim, validamycin A
F12) Inhibitoren der Melanin Biosynthese, z. B. Capropamid, Diclocymet, Fenoxanil, Phtalid, Pyroquilon, Tricyclazol F13) Resistenzinduktion, z. B. Acibenzolar-S-methyl, Probenazol, Tiadinil F12) inhibitors of melanin biosynthesis, e.g. Capropamide, diclocymet, fenoxanil, phtalid, pyroquilone, tricyclazole F13) resistance induction, e.g. Acibenzolar-S-methyl, probenazole, tiadinil
F14) Multisite, z. B. Captafol, Captan, Chlorothalonil, Kupfersalze wie: F14) Multisite, z. B. Captafol, captan, chlorothalonil, copper salts such as:
Kupferhydroxid, Kupfernaphthenat, Kupferoxychlorid, Kupfersulfat, Kupferoxid, Oxin- Kupfer und Bordeaux Mischung, Dichlofluanid, Dithianon, Dodin, Dodin freie Base, Ferbam, Folpet, Fluorofolpet, Guazatin, Guazatinacetat, Iminoctadin, Copper hydroxide, copper naphthenate, copper oxychloride, copper sulfate, copper oxide, oxine-copper and bordeaux mixture, dichlofluanid, dithianon, dodin, dodine free base, ferbam, folpet, fluorofolpet, guazatine, guazatine acetate, iminoctadine,
Iminoctadinalbesilat, Iminoctadintriacetat, Mankupfer, Mancozeb, Maneb, Metiram, Metiram Zink, Propineb, Schwefel und Schwefelpräparate enthaltend  Iminoctadinal besylate, iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, metiram zinc, propineb, sulfur and sulfur preparations
Calciumpolysulphid, Thiram, Tolylfluanid, Zineb, Ziram F15) Unbekannter Mechanismus, z. B. Amibromdol, Benthiazol, Bethoxazin, Calcium polysulphide, thiram, tolylfluanid, zineb, ziram F15). Unknown mechanism, e.g. Amibromdole, benthiazole, bethoxazine,
Capsimycin, Carvon, Chinomethionat, Chloropicrin, Cufraneb, Cyflufenamid, Capsimycin, carvone, quinomethionate, chloropicrin, cufraneb, cyflufenamid,
Cymoxanil, Dazomet, Debacarb, Diclomezine, Dichlorophen, Dicloran, Difenzoquat, Difenzoquat Methylsulphat, Diphenylamin, Ethaboxam, Ferimzon, flumetover, Flusulfamid, Fluopicolid, Fluoroimid, Fosatyl-Al, Hexachlorobenzol, 8-Hydroxy- chinolinsulfat, Iprodione, Irumamycin, Isotianil, Methasulphocarb, Metrafenon, Methyl Isothiocyanat, Mildiomycin, Natamycin, Nickel dimethyldithiocarbamat, Nitrothal- isopropyl, Octhilinon, Oxamocarb, Oxyfenthiin, Pentachlorophenol und Salze, 2- Phenylphenol und Salze, Piperalin, Propanosin -Natrium, Proquinazid, Pyrrolnitrin, Quintozen, Tecloftalam, Tecnazen, Triazoxid, Trichlamid, Zarilamid und 2,3,5,6- Tetrachlor-4-(methylsulfonyl)-pyridin, N-(4-Chlor-2-nitrophenyl)-N-ethyl-4-methyl- benzenesulfonamid, 2-Amino-4-methyl-N-phenyl-5-thiazolecarboxamid, 2-Chlor-N- (2,3-dihydro-1 , 1 ,3-trimethyl-1 H-inden-4-yl)-3-pyridincarboxamid, 3-[5-(4-Cymoxanil, Dazomet, Debacarb, Diclomezine, Dichlorophene, Dicloran, Difenzoquat, Difenzoquat methylsulphate, diphenylamine, ethaboxam, ferimzone, flumetover, flusulfamide, fluopicolide, fluoroimide, fosatyl-Al, hexachlorobenzene, 8-hydroxyquinoline sulfate, iprodione, irumamycin, isotianil, methasulphocarb, metrafenone, methyl isothiocyanate, mildiomycin, natamycin, nickel dimethyldithiocarbamate, nitrothal isopropyl, octhilinone, oxamocarb, oxyfenthiine, pentachlorophenol and salts, 2-phenylphenol and salts, piperaline, propanosine sodium, proquinazide, pyrroline nitrate, quintozene, tecloftalam, tecnazene, triazoxide, trichlamide, zarilamide and 2,3,5,6-tetrachloro -4- (methylsulfonyl) -pyridine, N- (4-chloro-2-nitrophenyl) -N-ethyl-4-methyl-benzenesulfonamide, 2-amino-4-methyl-N-phenyl-5-thiazolecarboxamide, 2-chloro -N- (2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl) -3-pyridinecarboxamide, 3- [5- (4-
Chlorphenyl)-2,3-dimethylisoxazolidin-3-yl]pyridin, cis-1 -(4-Chlorphenyl)-2-(1 H-1 ,2,4- triazol-1 -yl)-cycloheptanol, 2,4-Dihydro-5-methoxy-2-methyl-4-[[[[1 -[3- (trifluoromethyl)-phenyl]-ethyliden]-amino]-oxy]-methyl]-phenyl]-3H-1 ,2,3-triazol-3-on (185336-79-2), Methyl 1 -(2,3-dihydro-2,2-dimethyl-1 H-inden-1 -yl)-1 H-imidazole-5- carboxylat, 3,4,5-Trichlor-2,6-pyridindicarbonitril, Methyl 2-[[[cyclopropyl[(4- methoxyphenyl) imino]methyl]thio]methyl]-.alpha. -(methoxymethylen)- benzacetat, 4- Chlor-alpha-propinyloxy-N-[2-[3-methoxy-4-(2-propinyloxy)phenyl]ethyl]- benzacetamide, (2S)-N-[2-[4-[[3-(4-chlorophenyl)-2-propinyl]oxy]-3- methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)amino]-butanamid, 5-Chlor-7-(4- methylpiperidin-1 -yl)-6-(2,4,6-trifluorophenyl)[1 ,2,4]triazolo[1 ,5-a]pyrimidin, 5-Chlor-Chlorophenyl) -2,3-dimethylisoxazolidin-3-yl] pyridine, cis-1 - (4-chlorophenyl) -2- (1H-1, 2,4-triazol-1-yl) -cycloheptanol, 2,4- Dihydro-5-methoxy-2-methyl-4 - [[[[1- [3- (trifluoromethyl) phenyl] ethylidene] amino] oxy] methyl] phenyl] -3H-1,2,3 -triazol-3-one (185336-79-2), methyl 1- (2,3-dihydro-2,2-dimethyl-1H-inden-1-yl) -1H-imidazole-5-carboxylate, 3 , 4,5-trichloro-2,6-pyridinedicarbonitrile, methyl 2 - [[[cyclopropyl [(4-methoxyphenyl) imino] methyl] thio] methyl] -. Alpha. - (methoxymethylene) - benzoacetate, 4-chloro-alpha-propynyloxy-N- [2- [3-methoxy-4- (2-propynyloxy) phenyl] ethyl] benzacetamide, (2S) -N- [2- [4 - [[3- (4-chlorophenyl) -2-propynyl] oxy] -3-methoxyphenyl] ethyl] -3-methyl-2 - [(methylsulfonyl) amino] butanamide, 5-chloro-7- (4-methylpiperidine 1 -yl) -6- (2,4,6-trifluorophenyl) [1,2,4] triazolo [1,5-a] pyrimidine, 5-chloro
6- (2,4,6-trifluorophenyl)-N-[(1 R)-1 ,2,2-trimethylpropyl][1 ,2,4]triazolo[1 ,5-a]pyrimidin-6- (2,4,6-trifluorophenyl) -N - [(1R) -1,2,2-trimethylpropyl] [1,2,4] triazolo [1,5-a] pyrimidine
7- amin, 5-Chlor-N-[(1 R)-1 ,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl) 7-amine, 5-chloro-N - [(1R) -1,2-dimethylpropyl] -6- (2,4,6-trifluorophenyl)
[1 ,2,4]triazolo[1 ,5-a]pyrimidin-7-amine, N-[1 -(5-Brom-3-chloropyridin-2-yl)ethyl]-2,4- dichloronicotinamid, N-(5-Brom-3-chlorpyridin-2-yl)methyl-2,4-dichlornicotinamid, 2- Butoxy-6-iod-3-propyl-benzopyranon-4-on, N-{(Z)-[(cyclopropylmethoxy) imino][6- (difluormethoxy)-2,3-difluorphenyl]methyl}-2-benzacetamid, N-(3-Ethyl-3,5,5- trimethyl-cyclohexyl)-3-formylamino-2-hydroxy-benzamid, 2-[[[[1 -[3(1 Fluor-2-phenyl- ethyl)oxy] phenyl] ethyliden]amino]oxy]methyl]-alpha-(methoxyimino)-N-methyl- alphaE-benzacetamid, N-{2-[3-Chlor-5-(trifluormethyl)pyridin-2-yl]ethyl}-2-(trifluoro- methyl)benzamid, N-(3',4'-dichlor-5-fluorbiphenyl-2-yl)-3-(difluormethyl)-1 -methyl-1 H- pyrazol-4-carboxamid, N-(6-Methoxy-3-pyridinyl)-cyclopropan carboxamid, 1 -[(4- Methoxyphenoxy)methyl]-2,2-dimethylpropyl-1 H-imidazol-1 - carbonsäure, 0-[1 -[(4- Methoxyphenoxy)methyl]-2,2-dimethylpropyl]-1 H-imidazol- 1 - carbothioic acid, 2-(2-[1,2,4] triazolo [1,5-a] pyrimidin-7-amine, N- [1- (5-bromo-3-chloropyridin-2-yl) ethyl] -2,4-dichloronicotinamide, N- (5-bromo-3-chloropyridin-2-yl) methyl-2,4-dichloronotinotin, 2-butoxy-6-iodo-3-propyl-benzopyranon-4-one, N - {(Z) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy) -2,3-difluorophenyl] methyl} -2-benzacetamide, N- (3-ethyl-3,5,5-trimethylcyclohexyl) -3-formylamino-2-hydroxybenzamide, 2 - [[[[1- [3 (1-fluoro-2-phenylethyl) oxy] phenyl] ethylidene] amino] oxy] methyl] -alpha (methoxyimino) -N-methyl-alpha-E-benzoacetamide, N- { 2- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] ethyl} -2- (trifluoromethyl) benzamide, N- (3 ', 4'-dichloro-5-fluorobiphenyl-2-yl) - 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxamide, N- (6-methoxy-3-pyridinyl) -cyclopropane carboxamide, 1 - [(4-methoxyphenoxy) methyl] -2,2-dimethylpropyl -1H-imidazole-1-carboxylic acid, 0- [1 - [(4- Methoxyphenoxy) methyl] -2,2-dimethylpropyl] -1H-imidazole-1-carbothioic acid, 2- (2-
{[6-(3-Chlor-2-methylphenoxy)-5-fluorpyrimidin-4-yl]oxy}phenyl)-2-(methoxyimi methylacetamid {[6- (3-Chloro-2-methylphenoxy) -5-fluoropyrimidin-4-yl] oxy} phenyl) -2- (methoxyimethylacetamide
Bakterizide: bactericides:
Bronopol, Dichlorophen, Nitrapyrin, Nickel-Dimethyldithiocarbamat, Kasugamycin, Octhilinon, Furancarbonsäure, Oxytetracyclin, Probenazol, Streptomycin, Teclofta- lam, Kupfersulfat und andere Kupfer-Zubereitungen. Bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracycline, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.
Insektizide / Akarizide / Nematizide: Insecticides / acaricides / nematicides:
11 ) Acetylcholinesterase (AChE) Inhibitoren, wie beispielsweise Carbamate, z.B. Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarboxim, Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC und Xylylcarb; oder Organophosphate, z.B. Acephate, Azamethiphos, Azinphos (-methyl, -ethyl), Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos (-methyl), Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos/DDVP, 11) Acetylcholinesterase (AChE) inhibitors such as carbamates, e.g. Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarboxime, Butoxycarboxime, Carbaryl, Carbofuran, Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC and xylylcarb; or organophosphates, e.g. Acephates, azamethiphos, azinphos (-methyl, -ethyl), cadusafos, chloroethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos (-methyl), coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos / DDVP,
Dicrotophos, Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate, Heptenophos, Dicrotophos, dimethoates, dimethylvinphos, disulphoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos,
Isofenphos, Isopropyl O-(methoxyaminothio-phosphoryl) salicylat, Isoxathion, Malathion, Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion (-methyl), Phenthoate, Phorate, Phosalone, Phosmet, Phosphamidon, Phoxim, Pirimiphos (-methyl), Profenofos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, Triclorfon und Vamidothion. 12) GABA-gesteuerte Chlorid-Kanal-Antagonisten, wie beispielsweise Organochlorine, z.B. Chlordane und Endosulfan (alpha-); oder Fiprole Isofenphos, isopropyl O- (methoxyaminothio-phosphoryl) salicylate, isoxathione, malathion, mecarbam, methamidophos, methidathione, mevinphos, monocrotophos, naled, omethoates, oxydemeton-methyl, parathion (-methyl), phenthoates, phorates, phosalones, phosmet, phosphamidone, Phoxim, pirimiphos (-methyl), profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometone, triazophos, triclorfone and vamidothion. 12) GABA-controlled chloride channel antagonists such as organochlorines, eg, chlordane and endosulfan (alpha); or Fiprole
(Phenylpyrazole), z.B. Ethiprole, Fipronil, Pyrafluprole und Pyriprole. 13) Natrium-Kanal-Modulatoren / Spannungsabhängige Natrium-Kanal-Blocker, wie beispielsweise Pyrethroide, z.B. Acrinathrin, Allethrin (d-cis-trans, d-trans), Bifen- thrin, Bioallethrin, Bioallethrin-S-cyclopentenyl, Bioresmethrin, Cycloprothrin, Cy- fluthrin (beta-), Cyhalothrin (gamma-, lambda-), Cypermethrin (alpha-, beta-, theta-, zeta-), Cyphenothrin [(I R)-frans-lsomere], Deltamethrin, Dimefluthrin, Empenthrin [(EZ)-(1 R)-lsomere], Esfenvalerate, Etofenprox, Fenpropathrin, Fenvalerate,(Phenylpyrazoles), e.g. Ethiprole, Fipronil, Pyrafluprole and Pyriprole. 13) Sodium channel modulators / voltage dependent sodium channel blockers such as pyrethroids, e.g. Acrinathrin, allethrin (d-cis-trans, d-trans), biphenol, bioallethrin, bioallethrin-S-cyclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin (beta-), cyhalothrin (gamma, lambda), cypermethrin ( alpha-, beta-, theta-, zeta-), cyphenothrin [(IR) -frans-isomers], deltamethrin, dimefluthrin, empenthrin [(EZ) - (1R) -isomers], esfenvalerates, etofenprox, fenpropathrin, fenvalerates,
Flucythrinate, Flumethrin, Fluvalinate (tau-), Halfenprox, Imiprothrin, Metofluthrin, Permethrin, Phenothrin [(I R)-trans-lsomer], Prallethrin, Profluthrin, Pyrethrine (pyrethrum), Resmethrin, RU 15525, Silafluofen, Tefluthrin, Tetramethrin [(1 R)- Isomere], Tralomethrin, Transfluthrin und ZXI 8901 ; oder_DDT; oder Methoxychlor. Flucythrinates, Flumethrin, Fluvalinate (tau-), Halfenprox, Imiprothrin, Metofluthrin, Permethrin, Phenothrin [(IR) -trans-isomer], Prallethrin, Profluthrin, Pyrethrin (pyrethrum), Resmethrin, RU 15525, Silafluofen, Tefluthrin, Tetramethrin [( 1 R) - isomers], tralomethrin, transfluthrin and ZXI 8901; oder_DDT; or methoxychlor.
14) Nikotinerge Acetylcholin-Rezeptor-Agonisten, wie beispielsweise Neonikotinoide, z.B. Acetamiprid, Clothianidin, Dinotefuran, Imidacloprid, Nitenpyram, Thiacloprid, Thiamethoxam; oder Nikotin. 15) Allosterische Acetylcholin-Rezeptor-Modulatoren (Agonisten), wie beispielsweise Spinosyne, z.B. Spinetoram und Spinosad. 14) nicotinergic acetylcholine receptor agonists such as neonicotinoids, e.g. Acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam; or nicotine. 15) Allosteric acetylcholine receptor modulators (agonists), such as spinosyns, e.g. Spinetoram and spinosad.
16) Chlorid-Kanal-Aktivatoren, wie beispielsweise Avermectine/Milbemycine, z.B. Abamectin, Emamectin, Emamectin-benzoate, Lepimectin und Milbemectin. 16) chloride channel activators, such as avermectins / milbemycins, e.g. Abamectin, Emamectin, Emamectin benzoate, Lepimectin and Milbemectin.
17) Juvenilhormon-Analoge, z.B. Hydroprene, Kinoprene, Methoprene; oder 17) Juvenile hormone analogs, e.g. Hydroprene, kinoprene, methoprene; or
Fenoxycarb; Pyriproxyfen. fenoxycarb; Pyriproxyfen.
18) Wirkstoffe mit unbekannten oder nicht spezifischen Wirkmechanismen, wie beispielsweise Begasungsmittel, z.B. Methylbromid und andere Alkylhalogenide; oder 18) Active ingredients with unknown or non-specific mechanisms of action, such as fumigants, e.g. Methyl bromide and other alkyl halides; or
Chloropicrin; Sulfurylfluorid; Borax; Brechweinstein. 19) Selektive Fraßhemmer, z.B. Pymetrozine; oder Flonicamid. chloropicrin; sulfuryl fluoride; Borax; Tartar emetic. 19) Selective feeding inhibitors, eg pymetrozines; or flonicamide.
110) Milbenwachstumsinhibitoren, z.B. Clofentezine, Diflovidazin, Hexythiazox, Etoxazole. 110) mite growth inhibitors, e.g. Clofentezine, diflovidazine, hexythiazox, etoxazole.
11 1 ) Mikrobielle Disruptoren der Insektendarmmembran, wie beispielsweise Bacillus thuringiensis Subspezies israelensis, Bacillus sphaericus, Bacillus thuringiensis Subspezies aizawai, Bacillus thuringiensis Subspezies kurstaki, Bacillus 11 1) Microbial disruptors of insect intestinal membrane, such as Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus
thuringiensis Subspezies tenebrionis, und BT-Pflanzen-Proteine, z.B. CrylAb, CrylAc, Cryl Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1 . thuringiensis subspecies tenebrionis, and BT plant proteins, e.g. CrylAb, CrylAc, Cryl Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34 / 35Ab1.
112) Inhibitoren der oxidativen Phosphorylierung, ATP-Disruptoren, wie 112) inhibitors of oxidative phosphorylation, ATP disruptors, such as
beispielsweise Diafenthiuron; oder Organozinnverbindungen, z.B. Azocyclotin, Cyhexatin, Fenbutatin oxide; oder Propargite; Tetradifon. for example, diafenthiuron; or organotin compounds, e.g. Azocyclotine, cyhexatin, fenbutatin oxide; or propargite; Tetradifon.
113) Entkoppler der oxidativen Phoshorylierung durch Unterbrechung des H-Proton- gradienten, wie beispielsweise Chlorfenapyr und DNOC. 114) Nikotinerge Acetylcholin-Rezeptor-Antagonisten, wie beispielsweise Bensultap, Cartap (-Hydrochlorid), Thiocyclam, und Thiosultap (-sodium). 113) Decoupling of oxidative phosphorylation by interruption of the H proton gradient, such as chlorfenapyr and DNOC. 114) nicotinergic acetylcholine receptor antagonists, such as Bensultap, Cartap (hydrochloride), thiocyclam, and thiosultap (-sodium).
115) Inhibitoren der Chitinbiosynthese, Typ 0, wie beispielsweise Benzoylharnstoffe, z.B. Bistrifluron, Chlorfluazuron, Diflubenzuron, Flucycloxuron, Flufenoxuron, Hexaflumuron, Lufenuron, Novaluron, Noviflumuron, Teflubenzuron und Triflumuron. 115) inhibitors of chitin biosynthesis, type 0, such as benzoylureas, e.g. Bistrifluron, chlorofluorazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron.
116) Inhibitoren der Chitinbiosynthese, Typ 1 , wie beispielsweise Buprofezin. 116) inhibitors of chitin biosynthesis, type 1, such as buprofezin.
117) Häutungsstörende Wirkstoffe, wie beispielsweise Cyromazine. 117) Moisture-disrupting agents, such as cyromazines.
118) Ecdysonagonisten/-disruptoren, wie beispielsweise Diacylhydrazine, z.B. 118) ecdysone agonists / disruptors such as diacylhydrazines, e.g.
Chromafenozide, Halofenozide, Methoxyfenozide und Tebufenozide. 119) Oktopaminerge Agonisten, wie beispielsweise Amitraz. Chromafenozide, Halofenozide, Methoxyfenozide and Tebufenozide. 119) Octopaminergic agonists, such as amitraz.
120) Komplex-Ill-Elektronentransportinhibitoren, wie beispielsweise 120) complex III electron transport inhibitors, such as
Hydramethylnon; Acequinocyl; Fluacrypyrim. hydramethylnon; acequinocyl; Fluacrypyrim.
121 ) Komplex-I-Elektronentransportinhibitoren, beispielsweise aus der Gruppe der METI-Akarizide, z.B. Fenazaquin, Fenpyroximate, Pyrimidifen, Pyridaben, Tebufen- pyrad, Tolfenpyrad; oder Rotenone (Derris). 121) Complex I electron transport inhibitors, for example from the group of the METI acaricides, e.g. Fenazaquin, Fenpyroximate, Pyrimidifen, Pyridaben, Tebufenpyrad, Tolfenpyrad; or Rotenone (Derris).
122) Spannungsabhängige Natriumkanal-Blocker, z.B. Indoxacarb; Metaflumizone. 122) voltage dependent sodium channel blockers, e.g. indoxacarb; Metaflumizone.
123) Inhibitoren der Acetyl-CoA-Carboxylase, wie beispielsweise Tetronsäure- Derivate, z.B. Spirodiclofen und Spiromesifen; oder Tetramsäure-Derivate, z.B. Spirotetramat. 123) inhibitors of acetyl-CoA carboxylase, such as tetronic acid derivatives, e.g. Spirodiclofen and spiromesifen; or tetramic acid derivatives, e.g. Spirotetramat.
124) Komplex-IV-Elektronentransportinhibitoren, wie beispielsweise Phosphine, z.B. Aluminiumphosphid, Kalziumphosphid, Phosphin, Zinkphosphid; oder Cyanid. I25) Komplex-Il-Elektronentransportinhibitoren, wie beispielsweise Cyenopyrafen. 124) complex IV electron transport inhibitors such as phosphines, e.g. Aluminum phosphide, calcium phosphide, phosphine, zinc phosphide; or cyanide. I25) complex II electron transport inhibitors, such as cyenopyrafen.
I26) Ryanodinrezeptor-Effektoren, wie beispielsweise Diamide, z.B. Flubendiamide, Chlorantraniliprole (Rynaxypyr), Cyantraniliprole (Cyazypyr) sowie 3-Brom-N-{2- brom-4-chlor-6-[(1 -cyclopropylethyl)carbamoyl]phenyl}-1 -(3-chlorpyridin-2-yl)-1 H- pyrazol-5-carboxamid (bekannt aus WO2005/077934) oder Methyl-2-[3,5-dibrom-2- ({[3-brom-1 -(3-chlorpyridin-2-yl)-1 H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1 ,2- dimethylhydrazincarboxy-lat (bekannt aus WO2007/043677). I26) ryanodine receptor effectors, such as diamides, e.g. Flubendiamide, chlorantraniliprole (Rynaxypyr), cyantraniliprole (Cyazypyr) and 3-bromo-N- {2-bromo-4-chloro-6 - [(1-cyclopropylethyl) carbamoyl] phenyl} -1 - (3-chloropyridin-2-yl ) -1-H-pyrazole-5-carboxamide (known from WO2005 / 077934) or methyl 2- [3,5-dibromo-2- ({[3-bromo-1- (3-chloropyridin-2-yl) -] 1 H-pyrazol-5-yl] carbonyl} amino) benzoyl] -1, 2-dimethylhydrazinecarboxylate (known from WO2007 / 043677).
Weitere Wirkstoffe mit unbekanntem Wirkmechanismus, wie beispielsweise Other drugs with unknown mechanism of action, such as
Azadirachtin, Amidoflumet, Benzoximate, Bifenazate, Chinomethionat, Cryolite, Cyflumetofen, Dicofol, 5-chloro-2-[(3,4,4-trifluorobut-3-en-1 -yl)sulfonyl]-1 ,3-thiazol, Flufenerim, Pyridalyl und Pyrifluquinazon; desweiteren Präparate auf Basis von Bacillus firmus (1-1582, BioNeem, Votivo) sowie folgende bekannte wirksame Azadirachtin, amidoflumet, benzoximate, bifenazate, quinomethionate, cryolite, cyflumetofen, dicofol, 5-chloro-2 - [(3,4,4-trifluorobut-3-en-1-yl-1-yl) -sulfonyl] -1, 3-thiazole, flufenerim , Pyralidyl and pyrifluquinazone; furthermore preparations based on Bacillus firmus (1-1582, BioNeem, Votivo) and the following known effective
Verbindungen 4-{[(6-Brompyrid-3-yl)methyl](2-fluorethyl)amino}furan-2(5H)-on (bekannt aus WO 2007/1 15644), 4-{[(6-Fluorpyrid-3-yl)methyl](2,2- difluorethyl)amino}furan-2(5H)-on (bekannt aus WO 2007/1 15644), 4-{[(2-Chlor-1 ,3- thiazol-5-yl)methyl](2-fluorethyl)amino}furan-2(5H)-on (bekannt aus WO Compounds 4 - {[(6-bromopyrid-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from WO 2007/1 15644), 4 - {[(6-fluoropyridine) 3-yl) methyl] (2,2-difluoroethyl) amino} furan-2 (5H) -one (known from WO 2007/1 15644), 4 - {[(2-chloro-1,3-thiazole-5- yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from WO
2007/1 15644), 4-{[(6-Chlorpyrid-3-yl)methyl](2-fluorethyl)amino}furan-2(5H)-on (bekannt aus WO 2007/1 15644), 4-{[(6-Chlorpyrid-3-yl)methyl](2,2- difluorethyl)amino}furan-2(5H)-on (bekannt aus WO 2007/1 15644), 4-{[(6-Chlor-5- fluorpyrid-3-yl)methyl](methyl)amino}furan-2(5H)-on (bekannt aus WO  2007/1 15644), 4 - {[(6-chloropyrid-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from WO 2007/1 15644), 4 - {[ (6-chloropyrid-3-yl) methyl] (2,2-difluoroethyl) amino} furan-2 (5H) -one (known from WO 2007/1 15644), 4 - {[(6-chloro-5-fluoropyrid 3-yl) methyl] (methyl) amino} furan-2 (5H) -one (known from WO
2007/1 15643), 4-{[(5,6-Dichlorpyrid-3-yl)methyl](2-fluorethyl)amino}furan-2(5H)-on (bekannt aus WO 2007/1 15646), 4-{[(6-Chlor-5-fluorpyrid-3- yl)methyl](cyclopropyl)amino}furan-2(5H)-on (bekannt aus WO 2007/1 15643), 4-{[(6- Chlorpyrid-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-on (bekannt aus EP0539588), 4-{[(6-Chlorpyrid-3-yl)methyl](rnethyl)amino}furan-2(5H)-on (bekannt aus 2007/1 15643), 4 - {[(5,6-dichloropyrid-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from WO 2007/1 15646), 4- {[(6-chloro-5-fluoropyrid-3-yl) methyl] (cyclopropyl) amino} furan-2 (5H) -one (known from WO 2007/1 15643), 4 - {[(6-chloropyrid-3 -yl) methyl] (cyclopropyl) amino} furan-2 (5H) -one (known from EP0539588), 4 - {[(6-chloropyrid-3-yl) methyl] (methyl) amino} furan-2 (5H) -on (known from
EP0539588), [1 -(6-Chlorpyridin-3-yl)ethyl](methyl)oxido-A4-sulfanylidencyanamidEP0539588), [1- (6-chloropyridin-3-yl) ethyl] (methyl) oxido-A 4 -sulfanylidenecyanoanamide
(bekannt aus WO 2007/149134) und seine Diastereomere {[(1 R)-1 -(6-Chlorpyridin-3- yl)ethyl](methyl)oxido- 6-sulfanyliden}cyanamid und {[(1 S)-1 -(6-Chlorpyridin-3- yl)ethyl](methyl)oxido- 6-sulfanyliden}cyanamid (ebenfalls bekannt aus WO (known from WO 2007/149134) and its diastereomers {[(1R) -1- (6-chloropyridin-3-yl) ethyl] (methyl) oxo- 6- sulfanyliden} cyanamide and {[(1S) -1 - (6-chloropyridin-3-yl) ethyl] (methyl) oxido- 6- sulfanyliden} cyanamide (also known from WO
2007/149134) sowie Sulfoxaflor (ebenfalls bekannt aus WO 2007/149134), 1 -[2- fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1 H-1 ,2,4- Triazol-5-amine (bekannt aus WO 2006/043635), [(3S,4aR, 12R, 12aS, 12ßS)-3- [(Cyclopropylcarbonyl)oxy]-6, 12-dihydroxy-4, 12b-dimethyl-1 1 -oxo-9-(pyridin-3-yl)- 1 ,3,4,4a,5,6,6a, 12, 12a, 12ß-decahydro-2H, 1 1 H-benzo[f]pyrano[4,3-b]chromen-4- yl]methylcyclopropancarboxylat (bekannt aus WO 2006/129714), 2-Cyano-3- (difluormethoxy)-N,N-dimethylbenzolsulfonamid (bekannt aus WO2006/056433), 2- Cyano-3-(difluormethoxy)-N-methylbenzolsulfonamid (bekannt aus 2007/149134) and sulfoxaflor (also known from WO 2007/149134), 1 - [2-fluoro-4-methyl-5 - [(2,2,2-trifluoroethyl) sulfinyl] phenyl] -3- (trifluoromethyl) - 1 H-1, 2,4-triazole-5-amine (known from WO 2006/043635), [(3S, 4aR, 12R, 12aS, 12ßS) -3- [(cyclopropylcarbonyl) oxy] -6, 12-dihydroxy -4,12b-dimethyl-1 1 -oxo-9- (pyridin-3-yl) -1,4,4,4a, 5,6,6a, 12,12a, 12β-decahydro-2H, 1 l H- benzo [f] pyrano [4,3-b] chromen-4-yl] methylcyclopropanecarboxylate (known from WO 2006/129714), 2-cyano-3- (difluoromethoxy) -N, N-dimethylbenzenesulfonamide (known from WO2006 / 056433) , 2-cyano-3- (difluoromethoxy) -N-methylbenzenesulfonamide (known from
WO2006/100288), 2-Cyano-3-(difluormethoxy)-N-ethylbenzolsulfonamid (bekannt aus WO2005/035486), 4-(Difluormethoxy)-N-ethyl-N-methyl-1 ,2-benzothiazol-3- amin-1 , 1 -dioxid (bekannt aus WO2007/057407), N-[1 -(2,3-Dimethylphenyl)-2-(3,5- dimethylphenyl)ethyl]-4,5-dihydro-1 ,3-thiazol-2-amin (bekannt aus WO2008/104503), {1 '-[(2E)-3-(4-Chlorphenyl)prop-2-en-1 -yl]-5-fluorspiro[indol-3,4'-piperidin]-1 (2H)- yl}(2-chlorpyridin-4-yl)methanon (bekannt aus WO2003106457), 3-(2,5- Dimethylphenyl)-4-hydroxy-8-methoxy-1 ,8-diazaspiro[4.5]dec-3-en-2-on (bekannt aus WO2009049851 ), 3-(2,5-Dimethylphenyl)-8-methoxy-2-oxo-1 ,8- diazaspiro[4.5]dec-3-en-4-yl-ethylcarbonat (bekannt aus WO2009049851 ), 4-(But-2- in-1 -yloxy)-6-(3,5-dimethylpiperidin-1 -yl)-5-fluorpyrimidin (bekannt aus WO2006 / 100288), 2-cyano-3- (difluoromethoxy) -N-ethylbenzenesulfonamide (known from WO2005 / 035486), 4- (difluoromethoxy) -N-ethyl-N-methyl-1,2-benzothiazole-3-amine 1, 1-dioxide (known from WO2007 / 057407), N- [1- (2,3-dimethylphenyl) -2- (3,5-dimethylphenyl) ethyl] -4,5-dihydro-1,3-thiazole 2-amine (known from WO2008 / 104503), {1 '- [(2E) -3- (4-chlorophenyl) -prop-2-en-1-yl] -5-fluorospiro [indole-3,4'-piperidine ] -1 (2H) -yl} (2-chloropyridin-4-yl) methanone (known from WO2003106457), 3- (2,5-) Dimethylphenyl) -4-hydroxy-8-methoxy-1,8-diazaspiro [4.5] dec-3-en-2-one (known from WO2009049851), 3- (2,5-dimethylphenyl) -8-methoxy-2- oxo-1, 8-diazaspiro [4.5] dec-3-en-4-yl ethyl carbonate (known from WO2009049851), 4- (but-2-yn-1-ynyloxy) -6- (3,5-dimethylpiperidine) 1 -yl) -5-fluoropyrimidine (known from
WO2004099160), (2,2,3,3,4,4,5,5-Octafluorpentyl)(3,3,3-tnfluorpropyl)malononitnl (bekannt aus WO2005063094), (2,2,3,3,4,4,5,5-Octafluorpentyl)(3,3,4,4,4- pentafluorbutyl)malononitril (bekannt aus WO2005063094), 8-[2- (Cyclopropylmethoxy)-4-(trifluormethyl)phenoxy]-3-[6-(trifluormethyl)pyridazin-3-yl]-3- azabicyclo[3.2.1 ]octan (bekannt aus WO2007040280 / 282), 2-Ethyl-7-methoxy-3- methyl-6-[(2,2,3,3-tetrafluor-2,3-dihydro-1 ,4-benzodioxin-6-yl)oxy]chinolin-4-yl- methylcarbonat (bekannt aus JP20081 10953), 2-Ethyl-7-methoxy-3-methyl-6- [(2,2,3,3-tetrafluor-2,3-dihydro-1 ,4-benzodioxin-6-yl)oxy]chinolin-4-ylacetat (bekannt aus JP20081 10953), PF1364 (Chemical Abstracts Nr 1204776-60-2, bekannt aus JP2010018586), 5-[5-(3,5-Dichlorphenyl)-5-(trifluormethyl)-4,5-dihydro-1 ,2-oxazol-3- yl]-2-(1 H-1 ,2,4-triazol-1 -yl)benzonitril (bekannt aus WO2007075459), 5-[5-(2-WO2004099160), (2,2,3,3,4,4,5,5-octafluoropentyl) (3,3,3-tnfluoropropyl) malononitrile (known from WO2005063094), (2,2,3,3,4,4 , 5,5-octafluoropentyl) (3,3,4,4,4-pentafluorobutyl) malononitrile (known from WO2005063094), 8- [2- (cyclopropylmethoxy) -4- (trifluoromethyl) phenoxy] -3- [6- ( trifluoromethyl) pyridazin-3-yl] -3-azabicyclo [3.2.1] octane (known from WO2007040280 / 282), 2-ethyl-7-methoxy-3-methyl-6 - [(2,2,3,3- tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) oxy] quinolin-4-ylmethyl carbonate (known from JP20081 10953), 2-ethyl-7-methoxy-3-methyl-6- [( 2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) oxy] quinolin-4-yl acetate (known from JP20081 10953), PF1364 (Chemical Abstracts No. 1204776-60-2 JP2010018586), 5- [5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2- (1H-1, 2,4-triazol-1-yl) benzonitrile (known from WO2007075459), 5- [5- (2-
Chlorpyridin-4-yl)-5-(trifluormethyl)-4,5-dihydro-1 ,2-oxazol-3-yl]-2-(1 H-1 ,2,4-triazol-1 - yl)benzonitril (bekannt aus WO2007075459), 4-[5-(3,5-Dichlorphenyl)-5- (trifluormethyl)-4,5-dihydro-1 ,2-oxazol-3-yl]-2-methyl-N-{2-oxo-2-[(2,2,2- trifluorethyl)amino]ethyl}benzamid (bekannt aus WO2005085216). Chloropyridin-4-yl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2- (1H-1,2,4-triazol-1-yl) benzonitrile ( known from WO2007075459), 4- [5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2-methyl-N- {2- oxo-2 - [(2,2,2-trifluoroethyl) amino] ethyl} benzamide (known from WO2005085216).
Safener sind vorzugsweise ausgewählt aus der Gruppe bestehend aus: S1 ) Verbindungen der Formel (S1 ), wobei die Symbole und Indizes folgende Bedeutungen haben: Safeners are preferably selected from the group consisting of: S1) compounds of the formula (S1), where the symbols and indices have the following meanings:
ΠΑ ist eine natürliche Zahl von 0 bis 5, vorzugsweise 0 bis 3; ΠΑ is a natural number from 0 to 5, preferably 0 to 3;
RA1 ist Halogen, (Ci-C4)Alkyl, (Ci-C4)Alkoxy, Nitro oder (Ci-C4)Haloalkyl; RA 1 is halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, nitro or (C 1 -C 4 ) haloalkyl;
WA ist ein unsubstituierter oder substituierter divalenter heterocyclischer Rest aus der Gruppe der teilungesättigten oder aromatischen Fünfring-Heterocyclen mit 1 bis 3 Heteroringatomen aus der Gruppe N und 0, wobei mindestens ein N-Atom und höchstens ein O-Atom im Ring enthalten ist, vorzugsweise ein Rest aus der Gruppe (WA1) bis (WA4),WA is an unsubstituted or substituted divalent heterocyclic radical from the group of unsaturated or unsaturated five-membered ring heterocycles having from 1 to 3 hetero ring N and O groups, at least one N atom and at most one O atom in the ring, preferably one Remainder of the group (WA 1 ) to (WA 4 ),
RA2 ist ORA3, SRA3 oder N RA3RA4 oder ein gesättigter oder ungesättigter 3- bis 7- gliedriger Heterocyclus mit mindestens einem N-Atom und bis zu 3 Heteroatomen, vorzugsweise aus der Gruppe 0 und S, der über das N-Atom mit der RA 2 is ORA 3 , SRA 3 or N RA 3 RA 4 or a saturated or unsaturated 3- to 7-membered heterocycle having at least one N atom and up to 3 heteroatoms, preferably from the group 0 and S, via the N Atom with the
Carbonylgruppe in (S1 ) verbunden ist und unsubstituiert oder durch Reste aus der Gruppe (Ci-C4)Alkyl, (Ci-C4)Alkoxy oder gegebenenfalls substituiertes Phenyl substituiert ist, vorzugsweise ein Rest der Formel ORA3, N H RA4 oder N(CH3)2, insbesondere der Formel ORA3; Carbonyl group in (S1) and is unsubstituted or substituted by radicals from the group (Ci-C 4 ) alkyl, (Ci-C 4 ) alkoxy or optionally substituted phenyl, preferably a radical of the formula ORA 3 , NH RA 4 or N (CH 3) 2, in particular the formula ORA 3 ;
RA3 ist Wasserstoff oder ein unsubstituierter oder substituierter aliphatischer Kohlenwasserstoffrest, vorzugsweise mit insgesamt 1 bis 18 C-Atomen; RA 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably having a total of 1 to 18 C atoms;
RA4 ist Wasserstoff, (Ci-Ce)Alkyl, (Ci-Ce)Alkoxy oder substituiertes oder unsubstituiertes Phenyl; RA 4 is hydrogen, (Ci-Ce) alkyl, (Ci-Ce) alkoxy or substituted or unsubstituted phenyl;
RA 5 ist H, (Ci-Ce)Alkyl, (Ci-Ce)Haloalkyl, (Ci-C4)Alkoxy(Ci-C8)Alkyl, Cyano oder COORA9, worin RA 9 Wasserstoff, (Ci-Ce)Alkyl, (Ci-C8)Haloalkyl, (Ci-C4)Alkoxy- (Ci-C4)alkyl, (Ci-Ce)Hydroxyalkyl, (C3-Ci2)Cycloalkyl oder Tri-(Ci-C4)-alkyl-silyl ist; RA6, RA7, RA8 sind gleich oder verschieden Wasserstoff, (Ci-C-8)Alkyl, (Ci-C-8)Halo- alkyl, (C3- Ci2)Cycloalkyl oder substituiertes oder unsubstituiertes Phenyl; vorzugsweise: R A 5 is H, (C 1 -C 6) alkyl, (C 1 -C 6) haloalkyl, (C 1 -C 4 ) alkoxy (C 1 -C 8 ) alkyl, cyano or COORA 9 , where R A 9 is hydrogen, (C 1 -C 6 ) ) alkyl, (Ci-C 8) haloalkyl, (Ci-C 4) alkoxy (Ci-C 4) alkyl, (Ci-Ce) hydroxyalkyl, (C3 -Ci2) cycloalkyl or tri- (Ci-C 4) -alkyl-silyl; RA 6 , RA 7 , RA 8 are identical or different hydrogen, (C 1 -C 8) alkyl, (C 1 -C 8) haloalkyl, (C 3 -C 12) cycloalkyl or substituted or unsubstituted phenyl; preferably:
a) Verbindungen vom Typ der Dichlorphenylpyrazolin-3-carbonsäure (S1 a), vorzugsweise Verbindungen wie 1 -(2,4-Dichlorphenyl)-5-(ethoxycarbonyl)-5-methyl- 2-pyrazolin-3-carbonsäure, 1 -(2,4-Dichlorphenyl)-5-(ethoxycarbonyl)-5-methyl-2- pyrazolin-3-carbonsäureethylester (S1 -1 ) ("Mefenpyr-diethyl"), und verwandte Verbindungen, wie sie in der WO-A-91/07874 beschrieben sind; a) compounds of the type of dichlorophenylpyrazoline-3-carboxylic acid (S1 a ), preferably compounds such as 1- (2,4-dichlorophenyl) -5- (ethoxycarbonyl) -5-methyl- 2-pyrazoline-3-carboxylic acid, 1- (2,4-dichlorophenyl) -5- (ethoxycarbonyl) -5-methyl-2-pyrazoline-3-carboxylic acid ethyl ester (S1 -1) ("mefenpyr-diethyl"), and related Compounds as described in WO-A-91/07874;
b) Derivate der Dichlorphenylpyrazolcarbonsäure (S1 b), vorzugsweise Ver- bindungen wie 1 -(2,4-Dichlorphenyl)-5-methyl-pyrazol-3-carbonsäureethylester (S1 -2), 1 -(2,4-Di-chlorphenyl)-5-isopropyl-pyrazol-3-carbonsäureethylester (S1 -3), 1 -(2,4-Dichlor-phenyl)-5-(1 , 1 -dimethyl-ethyl)pyrazol-3-carbonsäureethyl-ester (S1 -4) und verwandte Verbindungen, wie sie in EP-A-333 131 und EP-A-269 806 beschrieben sind; b) dichlorophenylpyrazolecarboxylic acid derivatives (S1 b), preferably comparison compounds such as 1 - (2,4-dichlorophenyl) -5-methyl-pyrazole-3-carboxylate (S1 -2), 1 - (2,4-dichlorophenyl ) -5-isopropyl-pyrazole-3-carboxylic acid ethyl ester (S1 -3), 1 - (2,4-dichloro-phenyl) -5- (1, 1-dimethyl-ethyl) -pyrazole-3-carboxylic acid ethyl ester (S1 - 4) and related compounds as described in EP-A-333,131 and EP-A-269,806;
c) Derivate der 1 ,5-Diphenylpyrazol-3-carbonsäure (S1 c), vorzugsweise Verbindungen wie 1 -(2,4-Dichlorphenyl)-5-phenylpyrazol-3-carbonsäureethylester (S1 -5), 1 -(2-Chlorphenyl)-5-phenylpyrazol-3-carbonsäuremethylester (S1 -6) und verwandte Verbindungen wie sie beispielsweise in der EP-A-268554 beschrieben sind; c) derivatives of 1, 5-diphenylpyrazole-3-carboxylic acid (S1 c), preferably compounds such as 1 - (2,4-dichlorophenyl) -5-phenylpyrazole-3-carboxylate (S1 -5), 1 - (2-chlorophenyl ) -5-phenylpyrazole-3-carboxylic acid methyl ester (S1 -6) and related compounds as described, for example, in EP-A-268554;
d) Verbindungen vom Typ der Triazolcarbonsäuren (S1 d), vorzugsweise d) compounds of the type of the triazolecarboxylic acids (S1 d ), preferably
Verbindungen wie Fenchlorazol(-ethylester), d.h. Compounds such as fenchlorazole (ethyl ester), i.
1 -(2,4-Dichlorphenyl)-5-trichlormethyl-(1 H)-1 ,2,4-triazol-3-carbonsäureethylester (S1 -7), und verwandte Verbindungen wie sie in EP-A-174 562 und EP-A-346 620 beschrieben sind;  1- (2,4-dichlorophenyl) -5-trichloromethyl- (1 H) -1, 2,4-triazole-3-carboxylic acid ethyl ester (S1 -7), and related compounds as described in EP-A-174 562 and EP -A-346 620;
e) Verbindungen vom Typ der 5-Benzyl- oder 5-Phenyl-2-isoxazolin-3- carbonsäure oder der 5,5-Diphenyl-2-isoxazolin-3-carbonsäure (S1 e), vorzugsweise Verbindungen wie 5-(2,4-Dichlorbenzyl)-2-isoxazolin-3-carbonsäureethylester (S1 -8) oder 5-Phenyl-2-isoxazolin-3-carbonsäureethylester (S1 -9) und verwandte e) Compounds of the 5-benzyl- or 5-phenyl-2-isoxazoline-3-carboxylic acid or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (S1 e), preferably compounds such as 5- (2, 4-dichlorobenzyl) -2-isoxazoline-3-carboxylic acid ethyl ester (S1 -8) or 5-phenyl-2-isoxazoline-3-carboxylic acid ethyl ester (S1 -9) and related
Verbindungen, wie sie in WO-A-91/08202 beschrieben sind, bzw. 5,5-Diphenyl-2- isoxazolin-3-carbonsäure (S1 -10) oder 5,5-Diphenyl-2-isoxazolin-3- carbonsäureethylester (S1 -1 1 ) ("Isoxadifen-ethyl") oder -n-propylester (S1 -12) oder der 5-(4-Fluorphenyl)-5-phenyl-2-isoxazolin-3-carbonsäureethylester (S1 -13), wie sie in der Patentanmeldung WO-A-95/07897 beschrieben sind. S2) Chinolinderivate der Formel (S2), Compounds as described in WO-A-91/08202 or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1 -10) or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate ( S1 -1 1) ("isoxadifen-ethyl") or n-propyl ester (S1 -12) or 5- (4-fluorophenyl) -5-phenyl-2-isoxazoline-3-carboxylic acid ethyl ester (S1 -13), as described they are described in the patent application WO-A-95/07897. S2) quinoline derivatives of the formula (S2)
wobei die Symbole und Indizes folgende Bedeutungen haben: where the symbols and indices have the following meanings:
RB1 ist Halogen, (Ci-C4)Alkyl, (Ci-C4)Alkoxy, Nitro oder (Ci-C4)Haloalkyl; RB 1 is halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, nitro or (C 1 -C 4 ) haloalkyl;
ΠΒ ist eine natürliche Zahl von 0 bis 5, vorzugsweise 0 bis 3; ΠΒ is a natural number from 0 to 5, preferably 0 to 3;
RB2 ist ORB 3, SRB3 oder NRB 3RB4 oder ein gesättigter RB 2 is OR B 3 , SRB 3 or NR B 3 RB 4 or a saturated one
oder ungesättigter 3- bis 7-gliedriger Heterocyclus mit mindestens einem N-Atom und bis zu 3 Heteroatomen, vorzugsweise aus der Gruppe 0 und S, der über das N- Atom mit der Carbonylgruppe in (S2) verbunden ist und unsubstituiert oder durch Reste aus der Gruppe (Ci-C4)Alkyl, (Ci-C4)Alkoxy oder gegebenenfalls or unsaturated 3- to 7-membered heterocycle having at least one N atom and up to 3 heteroatoms, preferably from the group 0 and S, which is connected via the N atom with the carbonyl group in (S2) and unsubstituted or by radicals the group (Ci-C 4 ) alkyl, (Ci-C 4 ) alkoxy or optionally
substituiertes Phenyl substituiert ist, vorzugsweise ein Rest der Formel ORB3, NHRB4 oder N(CH3)2, insbesondere der Formel ORB3; substituted phenyl, preferably a radical of the formula ORB 3 , NHRB 4 or N (CH 3) 2, in particular of the formula ORB 3 ;
RB3 ist Wasserstoff oder ein unsubstituierter oder substituierter aliphatischer Kohlenwasserstoffrest, vorzugsweise mit insgesamt 1 bis 18 C-Atomen; RB 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably having a total of 1 to 18 C atoms;
RB4 ist Wasserstoff, (Ci-Ce)Alkyl, (Ci-Ce)Alkoxy oder substituiertes oder unsubstituiertes Phenyl; RB 4 is hydrogen, (Ci-Ce) alkyl, (Ci-Ce) alkoxy or substituted or unsubstituted phenyl;
TB ist eine (Ci oder C2)-Alkandiylkette, die unsubstituiert oder mit einem oder zwei (Ci-C4)Alkylresten oder mit [(Ci-C3)-Alkoxy]-carbonyl substituiert ist; vorzugsweise: TB is a (Ci or C2) alkanediyl chain which is unsubstituted or substituted by one or two (Ci-C 4 ) alkyl radicals or by [(Ci-C3) alkoxy] carbonyl; preferably:
a) Verbindungen vom Typ der 8-Chinolinoxyessigsäure (S2a), vorzugsweise (5-Chlor-8-chinolinoxy)essigsäure-(1 -methylhexyl)ester ("Cloquintocet-mexyl") (S2-1 ), (5-Chlor-8-chinolinoxy)essigsäure-(1 ,3-dimethyl-but-1 -yl)ester (S2-2), (5-Chlor-8-chinolinoxy)essigsäure-4-allyloxy-butylester (S2-3), (5-Chlor-8-chinolin- oxy)essigsäure-1 -allyloxy-prop-2-ylester (S2-4), (5-Chlor-8-chinolinoxy)essigsäure- ethylester (S2-5), (5-Chlor-8-chinolinoxy)essigsäuremethylester (S2-6), (5-Chlor-8- chinolinoxy)essigsäureallylester (S2-7), (5-Chlor-8-chinolinoxy)essigsäure-2-(2- propyliden-iminoxy)-1 -ethylester (S2-8), (5-Chlor-8-chinolinoxy)essigsäure-2-oxo- prop-1 -ylester (S2-9) und verwandte Verbindungen, wie sie in EP-A-86 750, EP-A-94 349 und EP-A-191 736 oder EP-A-0 492 366 beschrieben sind, sowie (5- Chlor-8-chinolinoxy)essigsäure (S2-10), deren Hydrate und Salze, beispielsweise deren Lithium-, Natrium- Kalium-, Kalzium-, Magnesium-, Aluminium-, Eisen-, Ammonium-, quartäre Ammonium-, Sulfonium-, oder Phosphoniumsalze wie sie in der WO-A-2002/34048 beschrieben sind; a) Compounds of the 8-quinolinoxyacetic acid (S2 a), preferably (5-chloro-8-quinolinoxy) acetic acid (1 -methylhexyl) ester ( "cloquintocet-mexyl") (S2-1), (5-chloro- 8-quinolinoxy) acetic acid (1, 3-dimethylbut-1-yl) ester (S2-2), (5-chloro-8-quinolinoxy) acetic acid 4-allyloxybutyl ester (S2-3), (5 Chloro-8-quinolineoxy) acetic acid 1-allyloxy-prop-2-yl ester (S2-4), (5-chloro-8-quinolinoxy) acetic acid ethyl ester (S2-5), (5-chloro-8 -quinolinoxy) acetic acid methyl ester (S2-6), (5-chloro-8-quinolinoxy) allyl acetate (S2-7), (5-chloro-8-quinolinoxy) acetic acid 2- (2-propylidene-iminoxy) -1-ethyl ester (S2-8), (5-chloro-8-quinolinoxy) acetic acid 2-oxo-prop-1-yl-ester (S2-9) and related compounds as described in EP-A-86 750, EP-A-94 349 and EP-A-191 736 or EP-A-0 492 366, and (5-chloro-8-quinolinoxy) acetic acid (S2-10), their hydrates and salts, for example their lithium Sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium or phosphonium salts as described in WO-A-2002/34048;
b) Verbindungen vom Typ der (5-Chlor-8-chinolinoxy)malonsäure (S2b), vorzugsweise Verbindungen wie (5-Chlor-8-chinolinoxy)malonsäurediethylester, (5-Chlor- 8-chinolinoxy)malonsäurediallylester, b) compounds of the (5-chloro-8-quinolinoxy) malonic acid type (S2 b ), preferably compounds such as diethyl (5-chloro-8-quinolinoxy) malonate, (5-chloro-8-quinolinoxy) malonic acid diallyl ester,
(5-Chlor-8-chinolinoxy)malonsäure-methyl-ethylester und verwandte Verbindungen, wie sie in EP-A-0 582 198 beschrieben sind.  (5-chloro-8-quinolinoxy) malonic acid methyl ethyl ester and related compounds as described in EP-A-0 582 198.
Verbindungen der Formel (S3) Compounds of the formula (S3)
wobei die Symbole und Indizes folgende Bedeutungen haben: where the symbols and indices have the following meanings:
Rc1 ist (Ci-C4)Alkyl, (Ci-C4)Haloalkyl, (C2-C4)Alkenyl, (C2-C4)Haloalkenyl, Rc 1 is (Ci-C 4) alkyl, (Ci-C 4) haloalkyl, (C 2 -C 4) alkenyl, (C 2 -C 4) haloalkenyl,
(C3-C7)Cycloalkyl, vorzugsweise Dichlormethyl; (C3-C7) cycloalkyl, preferably dichloromethyl;
Rc2, Rc3 sind gleich oder verschieden Wasserstoff, (Ci-C4)Alkyl, (C2-C4)Alkenyl, (C2-C4)Alkinyl, (Ci-C4)Haloalkyl, (C2-C4)Haloalkenyl, (Ci-C4)Alkylcarbamoyl- (Ci-C4)alkyl, (C2-C4)Alkenylcarbamoyl-(Ci-C4)alkyl, (Ci-C4)Alkoxy-(Ci-C4)alkyl,Rc 2, rc 3 are identical or different hydrogen, (Ci-C 4) alkyl, (C2-C4) alkenyl, (C 2 -C 4) alkynyl, (Ci-C 4) haloalkyl, (C 2 -C 4 ) haloalkenyl, (Ci-C 4) alkylcarbamoyl (Ci-C4) alkyl, (C 2 -C 4) Alkenylcarbamoyl- (Ci-C 4) alkyl, (Ci-C 4) alkoxy (Ci-C 4) alkyl,
Dioxolanyl-(Ci-C4)alkyl, Thiazolyl, Furyl, Furylalkyl, Thienyl, Piperidyl, substituiertes oder unsubstituiertes Phenyl, oder Rc2 und Rc3 bilden zusammen einen Dioxolanyl- (C 1 -C 4 ) alkyl, thiazolyl, furyl, furylalkyl, thienyl, piperidyl, substituted or unsubstituted phenyl, or Rc 2 and Rc 3 together form one
substituierten oder unsubstituierten heterocyclischen Ring, vorzugsweise einen Oxazolidin-, Thiazolidin-, Piperidin-, Morpholin-, Hexahydropyrimidin- oder substituted or unsubstituted heterocyclic ring, preferably an oxazolidine, thiazolidine, piperidine, morpholine, hexahydropyrimidine or
Benzoxazinring; vorzugsweise: Wirkstoffe vom Typ der Dichloracetamide, die häufig als Vorauflaufsafener (bodenwirksame Safener) angewendet werden, wie z. B. benzoxazine ring; preferably: active substances of the dichloroacetamide type, which are often used as pre-emergence safeners (soil-active safeners), such as B.
"Dichlormid" (N,N-Diallyl-2,2-dichloracetamid) (S3-1 ), "R-29148" (3-Dichloracetyl- 2,2,5-trimethyl-1 ,3-oxazolidin) der Firma Stauffer (S3-2), "R-28725" (3-Dichloracetyl- 2,2,-dimethyl-1 ,3-oxazolidin) der Firma Stauffer (S3-3), "Benoxacor" (4-Dichloracetyl- 3,4-dihydro-3-methyl-2H-1 ,4-benzoxazin) (S3-4), "PPG-1292" (N-Allyl-N-[(1 ,3- dioxolan-2-yl)-methyl]-dichloracetamid) der Firma PPG Industries (S3-5), "DKA-24" (N-Allyl-N-[(allylaminocarbonyl)methyl]-dichloracetamid) der Firma Sagro-Chem (S3-6), "AD-67" oder "MON 4660" (3-Dichloracetyl-1 -oxa-3-aza-spiro[4,5]decan) der Firma Nitrokemia bzw. Monsanto (S3-7), "TI-35" (1 -Dichloracetyl-azepan) der Firma TRI-Chemical RT (S3-8), "Diclonon" (Dicyclonon) oder "BAS145138" oder "Dichloromid" (N, N-diallyl-2,2-dichloroacetamide) (S3-1), "R-29148" (3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidine) from Stauffer ( S3-2), "R-28725" (3-dichloroacetyl-2,2, -dimethyl-1,3-oxazolidine) from Stauffer (S3-3), "Benoxacor" (4-dichloroacetyl- 3,4-dihydro-3-methyl-2H-1,4-benzoxazine) (S3-4), "PPG-1292" (N-allyl-N - [(1,3-dioxolan-2-yl) -methyl ] -dichloroacetamide) from PPG Industries (S3-5), "DKA-24" (N-allyl-N - [(allylaminocarbonyl) methyl] -dichloroacetamide) from Sagro-Chem (S3-6), "AD-67 "or" MON 4660 "(3-dichloroacetyl-1-oxa-3-aza-spiro [4,5] decane) from Nitrokemia or Monsanto (S3-7)," TI-35 "(1-dichloroacetyl-azepane ) from TRI-Chemical RT (S3-8), "diclonone" (dicyclonone) or "BAS145138" or
"LAB145138" (S3-9) ((RS)-1 -Dichloracetyl-3,3,8a-trimethylperhydropyrrolo[1 ,2- a]pyrimidin-6-on) der Firma BASF, "Furilazol" oder "MON 13900" ((RS)-3- Dichloracetyl-5-(2-furyl)-2,2-dimethyloxazolidin) (S3-10); sowie dessen (R)-Isomer (S3-1 1 ). "LAB145138" (S3-9) ((RS) -1-dichloroacetyl-3,3,8a-trimethyl-perhydropyrrolo [1,2-a] pyrimidin-6-one) from BASF, "furilazole" or "MON 13900" ( (RS) -3-dichloroacetyl-5- (2-furyl) -2,2-dimethyloxazolidine) (S3-10); and its (R) isomer (S3-1 1).
S4) N-Acylsulfonamide der Formel (S4) und ihre Salze, S4) N-acylsulfonamides of the formula (S4) and their salts,
worin die Symbole und Indizes folgende Bedeutungen haben: wherein the symbols and indices have the following meanings:
XD ist CH oder N; XD is CH or N;
RD1 ist CO-NRD5RD6 oder N HCO-RD7; RD 1 is CO-NRD 5 RD 6 or N HCO-RD 7 ;
RD 2 ist Halogen, (Ci-C4)Haloalkyl, (Ci-C4)Haloalkoxy, Nitro, (Ci-C4)Alkyl, R D 2 is halogen, (Ci-C 4) haloalkyl, (Ci-C 4) haloalkoxy, nitro, (Ci-C 4) alkyl,
(Ci-C4)Alkoxy, (Ci-C4)Alkylsulfonyl, (Ci-C4)Alkoxycarbonyl oder (C 1 -C 4 ) alkoxy, (C 1 -C 4 ) alkylsulfonyl, (C 1 -C 4 ) alkoxycarbonyl or
(Ci-C4)Alkylcarbonyl; (C 1 -C 4 ) alkylcarbonyl;
RD3 ist Wasserstoff, (Ci-C4)Alkyl, (C2-C4)Alkenyl oder (C2-C4)Alkinyl; RD 3 is hydrogen, (C 1 -C 4 ) alkyl, (C 2 -C 4 ) alkenyl or (C 2 -C 4 ) alkynyl;
RD4 ist Halogen, Nitro, (Ci-C4)Alkyl, (Ci-C4)Haloalkyl, (Ci-C4)Haloalkoxy, RD 4 is halogen, nitro, (Ci-C 4) alkyl, (Ci-C 4) haloalkyl, (Ci-C 4) haloalkoxy,
(C3-C6)Cycloalkyl, Phenyl, (Ci-C4)Alkoxy, Cyano, (Ci-C4)Alkylthio, (Ci-C4)Alkyl- sulfinyl, (Ci-C4)Alkylsulfonyl, (Ci-C4)Alkoxycarbonyl oder (Ci-C4)Alkylcarbonyl; (C 3 -C 6) cycloalkyl, phenyl, (Ci-C 4) alkoxy, cyano, (Ci-C 4) alkylthio, (Ci-C 4) alkyl sulfinyl, (Ci-C 4) alkylsulfonyl, (Ci- C 4 ) alkoxycarbonyl or (C 1 -C 4 ) alkylcarbonyl;
RD5 ist Wasserstoff, (Ci-C6)Alkyl, (C3-C6)Cycloalkyl, (C2-C6)Alkenyl, (C2-C6)Alkinyl, (C5-C6)Cycloalkenyl, Phenyl oder 3- bis 6-gliedriges Heterocyclyl enthaltend VD Heteroatome aus der Gruppe Stickstoff, Sauerstoff und Schwefel, wobei die sieben letztgenannten Reste durch VD Substituenten aus der Gruppe Halogen, (Ci- C6)Alkoxy, (Ci-C6)Haloalkoxy, (Ci-C2)Alkylsulfinyl, (Ci-C2)Alkylsulfonyl, (C3- C6)Cycloalkyl, (Ci-C4)Alkoxycarbonyl, (Ci-C4)Alkylcarbonyl und Phenyl und im Falle cyclischer Reste auch (Ci-C4) Alkyl und (Ci-C4)Haloalkyl substituiert sind; RD 5 is hydrogen, (C 1 -C 6 ) alkyl, (C 3 -C 6 ) cycloalkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 5 -C 6 ) cycloalkenyl, phenyl or 3 - to 6-membered heterocyclyl containing VD heteroatoms from the group nitrogen, oxygen and sulfur, wherein the seven last-mentioned radicals by VD substituents from the group halogen, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkoxy, (C 1 -C 2 ) alkylsulfinyl, (C 1 -C 2 ) -alkylsulfonyl, (C 3 -C 6 ) -cycloalkyl, (Ci-C 4) alkoxycarbonyl, (Ci-C 4) are substituted alkylcarbonyl and phenyl and, in the case of cyclic radicals, also (Ci-C4) alkyl and (Ci-C4) haloalkyl;
RD 6 ist Wasserstoff, (Ci-C6)Alkyl, (C2-C6)Alkenyl oder (C2-C6)Alkinyl, wobei die drei letztgenannten Reste durch VD Reste aus der Gruppe Halogen, Hydroxy, R D 6 is hydrogen, (Ci-C 6) alkyl, (C 2 -C 6) alkenyl or (C2-C6) -alkynyl, where the three last-mentioned radicals are substituted by VD radicals from the group halogen, hydroxy,
(Ci-C4)Alkyl, (Ci-C4)Alkoxy und (Ci-C4)Alkylthio substituiert sind, oder (Ci-C 4 ) alkyl, (Ci-C 4 ) alkoxy and (Ci-C 4 ) alkylthio are substituted, or
RD5 und RD6 gemeinsam mit dem dem sie tragenden Stickstoffatom einen RD 5 and RD 6 together with the nitrogen atom carrying them
Pyrrolidinyl- oder Piperidinyl-Rest bilden; Pyrrolidinyl or piperidinyl moiety;
RD 7 ist Wasserstoff, (Ci-C4)Alkylamino, Di-(Ci-C4)alkylamino, (Ci-C6)Alkyl, R D 7 is hydrogen, (Ci-C 4) alkylamino, di (Ci-C 4) alkylamino, (Ci-C 6) alkyl,
(C3-C6)Cycloalkyl, wobei die 2 letztgenannten Reste durch VD Substituenten aus der Gruppe Halogen, (Ci-C4)Alkoxy, (Ci-C6)Haloalkoxy und (Ci-C4)Alkylthio und im Falle cyclischer Reste auch (Ci-C4)Alkyl und (Ci-C4)Haloalkyl substituiert sind; (C3-C6) cycloalkyl, where the 2 last-mentioned radicals by VD substituents selected from the group consisting of halogen, (Ci-C 4 ) alkoxy, (Ci-C6) haloalkoxy and (Ci-C 4 ) alkylthio and in the case of cyclic radicals also (Ci -C 4) alkyl and (Ci-C4) haloalkyl groups;
VD ist 0, 1 , 2 oder 3; davon bevorzugt sind Verbindungen vom Typ der N-Acylsulfonamide, z.B. der nachfolgenden Formel (S4a), die z. B. bekannt sind aus WO-A-97/45016 VD is 0, 1, 2 or 3; Of these, preference is given to compounds of the N-acylsulfonamide type, for example of the following formula (S4 a ), which are, for example, B. are known from WO-A-97/45016
worin wherein
RD7 (Ci-C6)Alkyl, (C3-C6)Cycloalkyl, wobei die 2 letztgenannten Reste durch VD Substituenten aus der Gruppe Halogen, (Ci-C4)Alkoxy, (Ci-C6)Haloalkoxy und (Ci- C4)Alkylthio und im Falle cyclischer Reste auch (Ci-C4)Alkyl und (Ci-C4)Haloalkyl substituiert sind; RD 7 (C 1 -C 6) -alkyl, (C 3 -C 6) -cycloalkyl, where the 2 last-mentioned radicals are represented by VD substituents from the group consisting of halogen, (C 1 -C 4 ) -alkoxy, (C 1 -C 6) -haloalkoxy and (C 1 -C 4 ) Alkylthio and in the case of cyclic radicals are also (Ci-C 4 ) alkyl and (Ci-C 4 ) haloalkyl substituted;
RD4 Halogen, (Ci-C4)Alkyl, (Ci-C4)Alkoxy, CF3; RD 4 is halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, CF 3;
VD ist 0, 1 , 2 oder 3 bedeutet; sowie Acylsulfamoylbenzoesäureamide, z.B. der nachfolgenden Formel (S4b), die z.B. bekannt sind aus WO-A-99/16744, VD is 0, 1, 2 or 3; and acylsulfamoylbenzamides, for example of the formula (S4 b), for example are known from WO-A-99/16744,
z.B. solche worin eg those in which
RD5 = Cyclopropyl und (RD 4) = 2-OMe ist ("Cyprosulfamide", S4-1 ), RD 5 = cyclopropyl and (R D 4 ) = 2-OMe ("Cyprosulfamide", S4-1),
RD5 = Cyclopropyl und (RD4) = 5-CI-2-OMe ist (S4-2), RD 5 = cyclopropyl and (RD 4 ) = 5-CI-2-OMe is (S4-2),
RD5 = Ethyl und (RD4) = 2-OMe ist (S4-3), RD 5 = ethyl and (RD 4 ) = 2-OMe is (S4-3),
RD 5 = Isopropyl und (Rd 4) = 5-CI-2-OMe ist (S4-4) und R D 5 = isopropyl and (R d 4 ) = 5-CI-2-OMe is (S4-4) and
RD5 = Isopropyl und (RD4) = 2-OMe ist (S4-5). sowie Verbindungen vom Typ der N-Acylsulfamoylphenylharnstoffe der Formel (S4C), die z.B. bekannt sind aus der EP-A-365484, RD 5 = isopropyl and (RD 4 ) = 2-OMe is (S4-5). and also compounds of the type of the N-acylsulfamoylphenylureas of the formula (S 4 C ) which are known, for example, from EP-A-365484,
worin wherein
RD8 und RD9 unabhängig voneinander Wasserstoff, (Ci-C8)Alkyl, (C3-C8)Cycloalkyl, (C3-C6)Alkenyl, (C3-C6)Alkinyl, RD 8 and RD 9 independently of one another are hydrogen, (C 1 -C 8 ) -alkyl, (C 3 -C 8 ) -cycloalkyl, (C 3 -C 6 ) -alkenyl, (C 3 -C 6 ) -alkynyl,
RD4 Halogen, (Ci-C4)Alkyl, (Ci-C4)Alkoxy, CF3 RD 4 halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, CF 3
rriD 1 oder 2 bedeutet; beispielsweise triD is 1 or 2; for example
1 -[4-(N-2-Methoxybenzoylsulfamoyl)phenyl]-3-methylharnstoff, 1 - [4- (N-2-methoxybenzoylsulfamoyl) phenyl] -3-methylurea,
1 -[4-(N-2-Methoxybenzoylsulfamoyl)phenyl]-3,3-dimethylharnstoff, 1 - [4- (N-2-methoxybenzoylsulfamoyl) phenyl] -3,3-dimethylurea,
1 -[4-(N-4,5-Dimethylbenzoylsulfamoyl)phenyl]-3-methylharnstoff. 55) Wirkstoffe aus der Klasse der Hydroxyaromaten und der aromatisch- aliphatischen Carbonsäurederivate (S5), z.B. 3,4,5-1 - [4- (N-4,5-dimethylbenzoylsulfamoyl) phenyl] -3-methylurea. 55) Active substances from the class of hydroxyaromatics and aromatic-aliphatic carboxylic acid derivatives (S5), eg 3,4,5-
Triacetoxybenzoesäureethylester, 3,5-Di-methoxy-4-hydroxybenzoesäure, 3,5- Dihydroxybenzoesäure, 4-Hydroxysalicylsäure, 4-Fluorsalicyclsäure, 2-Hydroxy- zimtsäure, 2,4-Dichlorzimtsäure, wie sie in der WO-A-2004/084631 , WO-A- 2005/015994, WO-A-2005/016001 beschrieben sind. Ethyl triacetoxybenzoate, 3,5-di-methoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicyclic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid, as described in WO-A-2004 / 084631, WO-A-2005/015994, WO-A-2005/016001.
56) Wirkstoffe aus der Klasse der 1 ,2-Dihydrochinoxalin-2-one (S6), z.B. 56) Agents from the class of 1, 2-dihydroquinoxaline-2-ones (S6), e.g.
1 -Methyl-3-(2-thienyl)-1 ,2-dihydrochinoxalin-2-on, 1 -Methyl-3-(2-thienyl)-1 ,2-dihydro- chinoxalin-2-thion, 1 -(2-Aminoethyl)-3-(2-thienyl)-1 ,2-dihydro-chinoxalin-2-on-hydro- chlorid, 1 -(2-Methylsulfonylaminoethyl)-3-(2-thienyl)-1 ,2-dihydrochinoxa-lin-2-on, wie sie in der WO-A-2005/1 12630 beschrieben sind.  1-Methyl-3- (2-thienyl) -1,2-dihydroquinoxalin-2-one, 1-methyl-3- (2-thienyl) -1,2-dihydroquinoxaline-2-thione, 1- (2 Aminoethyl) -3- (2-thienyl) -1,2-dihydroquinoxalin-2-one hydrochloride, 1- (2-methylsulfonylaminoethyl) -3- (2-thienyl) -1,2-dihydroquinoxa lin-2-one, as described in WO-A-2005/1 12630.
57) Verbindungen der Formel (S7),wie sie in der WO-A-1998/38856 beschrieben 57) Compounds of the formula (S7) as described in WO-A-1998/38856
H C'AE H C ' AE
sind worin die Symbole und Indizes folgende Bedeutungen haben: E1 , RE2 sind unabhängig voneinander Halogen, (Ci-C4)Alkyl, (Ci-C4)Alkoxy, (Ci-C4)Haloalkyl, (Ci-C4)Alkylamino, Di-(Ci-C4)Alkylamino, Nitro; are where the symbols and indices have the following meanings: E 1, RE 2 are independently halogen, (Ci-C 4) alkyl, (Ci-C 4) alkoxy, (Ci-C 4) haloalkyl, (Ci-C 4) Alkylamino, di- (C 1 -C 4 ) alkylamino, nitro;
AE ist COORE3 oder COSRE4 A E is Coore 3 or 4 COSRE
RE3, RE4 sind unabhängig voneinander Wasserstoff, (Ci-C4)Alkyl, (C2-C6)Alkenyl, (C2-C4)Alkinyl, Cyanoalkyl, (Ci-C4)Haloalkyl, Phenyl, Nitrophenyl, Benzyl, RE 3 , RE 4 are each independently hydrogen, (C 1 -C 4 ) alkyl, (C 2 -C 6) alkenyl, (C 2 -C 4 ) alkynyl, cyanoalkyl, (C 1 -C 4 ) haloalkyl, phenyl, nitrophenyl, benzyl,
Halobenzyl, Pyridinylalkyl und Alkylammonium, Halobenzyl, pyridinylalkyl and alkylammonium,
nE 1 ist 0 oder 1 n E 1 is 0 or 1
ΠΕ2, ΠΕ3 sind unabhängig voneinander 0, 1 oder 2, vorzugsweise Diphenylmethoxyessigsäure, Diphenylmethoxyessigsäureethylester, Diphenyl-methoxyessigsäuremethylester (CAS-Reg.Nr. 41858-19-9) (S7-1 ). ΠΕ 2 , ΠΕ 3 are independently 0, 1 or 2, preferably diphenylmethoxyacetic acid, ethyl diphenylmethoxyacetate, methyl diphenylmethoxyacetate (CAS No. 41858-19-9) (S7-1).
S8) Verbindungen der Formel (S8),wie sie in der WO-A-98/27049 beschrieben S8) compounds of the formula (S8) as described in WO-A-98/27049
sind are
Worin Wherein
XF CH oder N, XF CH or N,
nF für den Fall, dass XF=N ist, eine ganze Zahl von 0 bis 4 und nF for the case that XF = N, an integer from 0 to 4 and
für den Fall, dass XF=CH ist, eine ganze Zahl von 0 bis 5 ,  for the case that XF = CH, an integer from 0 to 5,
RF1 Halogen, (Ci-C4)Alkyl, (Ci-C4)Haloalkyl, (Ci-C4)Alkoxy, (Ci-C4)Haloalkoxy, Nitro, (Ci-C4)Alkylthio, (Ci-C4)-Alkylsulfonyl, (Ci-C4)Alkoxycarbonyl, ggf. RF 1 halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) haloalkyl, (C 1 -C 4 ) alkoxy, (C 1 -C 4 ) haloalkoxy, nitro, (C 1 -C 4 ) alkylthio, (C 1 -C 4 ) 4 ) -alkylsulfonyl, (C 1 -C 4 ) -alkoxycarbonyl, if appropriate
substituiertes. Phenyl, ggf. substituiertes Phenoxy, substituted. Phenyl, optionally substituted phenoxy,
RF 2 Wasserstoff oder (Ci-C4)Alkyl R F 2 is hydrogen or (Ci-C 4 ) alkyl
RF3 Wasserstoff, (Ci-C8)Alkyl, (C2-C4)Alkenyl, (C2-C4)Alkinyl, oder Aryl, wobei jeder der vorgenannten C-haltigen Reste unsubstituiert oder durch einen oder mehrere, vorzugsweise bis zu drei gleiche oder verschiedene Reste aus der Gruppe, bestehend aus Halogen und Alkoxy substituiert ist; bedeuten, oder deren Salze, vorzugsweise Verbindungen worin RF 3 is hydrogen, (Ci-C 8 ) alkyl, (C 2 -C 4 ) alkenyl, (C 2 -C 4 ) alkynyl, or aryl, wherein each of the aforementioned C-containing radicals unsubstituted or by one or more, preferably substituted into three identical or different radicals from the group consisting of halogen and alkoxy; or their salts, preferably compounds wherein
XF CH, XF CH,
nF eine ganze Zahl von 0 bis 2 , nF is an integer from 0 to 2,
RF1 Halogen, (Ci-C4)Alkyl, (Ci-C4)Haloalkyl, (Ci-C4)Alkoxy, (Ci-C4)Haloalkoxy, RF2 Wasserstoff oder (Ci-C4)Alkyl, RF 1 is halogen, (Ci-C 4) alkyl, (Ci-C 4) haloalkyl, (Ci-C 4) alkoxy, (Ci-C 4) haloalkoxy, RF 2 is hydrogen or (Ci-C 4) alkyl,
RF3 Wasserstoff, (Ci-C8)Alkyl, (C2-C4)Alkenyl, (C2-C4)Alkinyl, oder Aryl, wobei jeder der vorgenannten C-haltigen Reste unsubstituiert oder durch einen oder mehrere, vorzugsweise bis zu drei gleiche oder verschiedene Reste aus der Gruppe, bestehend aus Halogen und Alkoxy substituiert ist, bedeuten, RF 3 is hydrogen, (Ci-C 8 ) alkyl, (C 2 -C 4 ) alkenyl, (C 2 -C 4 ) alkynyl, or aryl, wherein each of the aforementioned C-containing radicals unsubstituted or by one or a plurality, preferably up to three, identical or different radicals from the group consisting of halogen and alkoxy are substituted,
oder deren Salze. S9) Wirkstoffe aus der Klasse der 3-(5-Tetrazolylcarbonyl)-2-chinolone (S9), z.B. 1 ,2-Dihydro-4-hydroxy-1 -ethyl-3-(5-tetrazolylcarbonyl)-2-chinolon (CAS-Reg. Nr. 219479-18-2), 1 ,2-Dihydro-4-hydroxy-1 -methyl-3-(5-tetrazolyl-carbonyl)-2-chinolon (CAS-Reg. Nr. 95855-00-8), wie sie in der WO-A-1999/000020 beschrieben sind. S10) Verbindungen der Formeln (S10a) oder (S10b) or their salts. S9) Active substances from the class of 3- (5-tetrazolylcarbonyl) -2-quinolones (S9), for example 1, 2-dihydro-4-hydroxy-1-ethyl-3- (5-tetrazolylcarbonyl) -2-quinolone (CAS Reg. No. 219479-18-2), 1, 2-dihydro-4-hydroxy-1-methyl-3- (5-tetrazolyl-carbonyl) -2-quinolone (CAS Reg. No. 95855-00- 8) as described in WO-A-1999/000020. S10) Compounds of the formulas (S10 a ) or (S10 b )
wie sie in der WO-A-2007/023719 und WO-A-2007/023764 beschrieben sind  as described in WO-A-2007/023719 and WO-A-2007/023764
(S10a) (S10b) (S10 a) (S10 b)
worin wherein
RG1 Halogen, (Ci-C4)Alkyl, Methoxy, Nitro, Cyano, CF3, OCF3 RG 1 halogen, (C 1 -C 4 ) alkyl, methoxy, nitro, cyano, CF 3 , OCF 3
YG, ZG unabhängig voneinander O oder S, YG, ZG independently of one another O or S,
nG eine ganze Zahl von 0 bis 4, nG is an integer from 0 to 4,
RG2 (Ci-Cie)Alkyl, (C2-C6)Alkenyl, (C3-C6)Cycloalkyl, Aryl; Benzyl, Halogenbenzyl, RG 3 Wasserstoff oder (Ci-C6)Alkyl bedeutet. RG 2 (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 3 -C 6 ) cycloalkyl, aryl; Benzyl, halobenzyl, R G 3 is hydrogen or (Ci-C 6 ) alkyl.
S1 1 ) Wirkstoffe vom Typ der Oxyimino-Verbindungen (S1 1 ), die als Saatbeizmittel bekannt sind, wie z. B. "Oxabetrinil" ((Z)-1 ,3-Dioxolan-2-ylmethoxyimino- (phenyl)acetonitril) (S1 1 -1 ), das als Saatbeiz-Safener für Hirse gegen Schäden von Metolachlor bekannt ist, "Fluxofenim" (1 -(4-Chlorphenyl)-2,2,2-trifluor-1 -ethanon-O- (1 ,3-dioxolan-2-ylmethyl)-oxim) (S1 1 -2), das als Saatbeiz-Safener für Hirse gegen Schäden von Metolachlor bekannt ist, und "Cyometrinil" oder "CGA-43089" ((Z)- Cyanomethoxyimino(phenyl)acetonitril) (S1 1 -3), das als Saatbeiz-Safener für Hirse gegen Schäden von Metolachlor bekannt ist. S1 1) active ingredients of the type of oxyimino compounds (S1 1), which are known as seed dressing, such. "Oxabetrinil" ((Z) -1,3-dioxolan-2-ylmethoxyimino- (phenyl) acetonitrile) (S1 1 -1), known as millet safener for millet against damage by metolachlor, "Fluxofenim" ( 1- (4-chlorophenyl) -2,2,2-trifluoro-1-ethanone O- (1,3-dioxolan-2-ylmethyl) -oxime) (S1 1 -2), which was used as a seed dressing safener for millet is known against damage by metolachlor, and "Cyometrinil" or "CGA-43089" ((Z) - Cyanomethoxyimino (phenyl) acetonitrile) (S1 1 -3), which is known as millet safener for millet against damage by metolachlor.
512) Wirkstoffe aus der Klasse der Isothiochromanone (S12), wie z.B. Methyl-[(3- oxo-1 H-2-benzothiopyran-4(3H)-yliden)methoxy]acetat (CAS-Reg.Nr. 205121 -04-6)512) Isothiochromanone (S12) class agents, e.g. Methyl - [(3-oxo-1H-2-benzothiopyran-4 (3H) -ylidene) methoxy] acetate (CAS Reg. No. 205121 -04-6)
(S12-1 ) und verwandte Verbindungen aus WO-A-1998/13361 . (S12-1) and related compounds of WO-A-1998/13361.
513) Eine oder mehrere Verbindungen aus Gruppe (S13): "Naphthalic anhydrid" (1 ,8-Naphthalindicarbonsäureanhydrid) (S13-1 ), das als Saatbeiz-Safener für Mais gegen Schäden von Thiocarbamatherbiziden bekannt ist, "Fenclorim" (4,6-Dichlor-2- phenylpyrimidin) (S13-2), das als Safener für Pretilachlor in gesätem Reis bekannt ist, "Flurazole" (Benzyl-2-chlor-4-trifluormethyl-1 ,3-thiazol-5-carboxylat) (S13-3), das als Saatbeiz-Safener für Hirse gegen Schäden von Alachlor und Metolachlor bekannt ist, "CL 304415" (CAS-Reg.Nr. 31541 -57-8) (4-Carboxy-3,4-dihydro-2H-1 - benzopyran-4-essigsäure) (S13-4) der Firma American Cyanamid, das als Safener für Mais gegen Schäden von Imidazolinonen bekannt ist, "MG 191 " (CAS-Reg.Nr. 96420-72-3) (2-Dichlormethyl-2-methyl-1 ,3-dioxolan) (S13-5) der Firma Nitrokemia, das als Safener für Mais bekannt ist, "MG-838" (CAS-Reg.Nr. 133993-74-5) (2- propenyl 1 -oxa-4-azaspiro[4.5]decan-4-carbodithioat) (S13-6) der Firma Nitrokemia, "Disulfoton" (0,0-Diethyl S-2-ethylthioethyl phosphordithioat) (S13-7), "Dietholate" (0,0-Diethyl-O-phenylphosphorothioat) (S13-8), "Mephenate" (4-Chlorphenyl- methylcarbamat) (S13-9). 513) One or more compounds of group (S13): "naphthalene anhydride" (1,8-naphthalenedicarboxylic anhydride) (S13-1), known as a seed safener for corn against damage by thiocarbamate herbicides, "fenclorim" (4,6 Dichloro-2-phenylpyrimidine) (S13-2) known as safener for pretilachlor in seeded rice, "flurazole" (benzyl-2-chloro-4-trifluoromethyl-1,3-thiazole-5-carboxylate) (S13 -3) known as seeding safener for millet against damage by alachlor and metolachlor, "CL 304415" (CAS No. 31541-57-8) (4-carboxy-3,4-dihydro-2H- 1-benzopyran-4-acetic acid) (S13-4) from American Cyanamid, which is known as safener for corn against damage of imidazolinones, "MG 191" (CAS Reg. No. 96420-72-3) (2- Dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) from Nitrokemia, which is known as safener for corn, "MG-838" (CAS Reg. No. 133993-74-5) (2- propenyl 1 -oxa-4-azaspiro [4.5] decane-4-carbodithioate) (S13-6) from Nitrokemia, "Disulfoton" (0,0-di ethyl S-2-ethylthioethyl phosphorodithioate) (S13-7), "dietholate" (0,0-diethyl-O-phenyl phosphorothioate) (S13-8), "mephenate" (4-chlorophenyl methylcarbamate) (S13-9).
514) Wirkstoffe, die neben einer herbiziden Wirkung gegen Schadpflanzen auch Safenerwirkung an Kulturpflanzen wie Reis aufweisen, wie z. B. 514) active substances which, in addition to a herbicidal activity against harmful plants, also have safener action on crops such as rice, such as, for example, rice. B.
"Dimepiperate" oder "MY-93" (S-1 -Methyl-1 -phenylethyl-piperidin-1 -carbothioat), das als Safener für Reis gegen Schäden des Herbizids Molinate bekannt ist, "Daimuron" oder "SK 23" (1 -(1 -Methyl-1 -phenylethyl)-3-p-tolyl-harnstoff), das als Safener für Reis gegen Schäden des Herbizids Imazosulfuron bekannt ist, "Cumyluron" = "JC- 940" (3-(2-Chlorphenylmethyl)-1 -(1 -methyl-1 -phenyl-ethyl)harnstoff, siehe JP-A- 60087254), das als Safener für Reis gegen Schäden einiger Herbizide bekannt ist, "Methoxyphenon" oder "NK 049" (3,3'-Dimethyl-4-methoxy-benzophenon), das als Safener für Reis gegen Schäden einiger Herbizide bekannt ist, "CSB" (1 -Brom-4- (chlormethylsulfonyl)benzol) von Kumiai, (CAS-Reg.Nr. 54091 -06-4), das als "Dimepiperate" or "MY-93" (S-1-methyl-1-phenylethyl-piperidine-1-carbothioate), which is known as a safener for rice against damage by the herbicide Molinate, "daimuron" or "SK 23" (1 - (1-methyl-1-phenylethyl) -3-p-tolyl-urea) known as safener for rice against damage of the herbicide imazosulfuron, "cumyluron" = "JC-940" (3- (2-chlorophenylmethyl) 1 - (1-methyl-1-phenyl-ethyl) urea, see JP-A-60087254) known as safener for rice against damage of some herbicides, "methoxyphenone" or "NK 049"(3,3'- Dimethyl-4-methoxy-benzophenone), which is known as Safener for rice against damage of some herbicides is known, "COD" (1-bromo-4- (chloromethylsulfonyl) benzene) of Kumiai, (CAS reg. No. 54091 -06-4), which as
Safener gegen Schäden einiger Herbizide in Reis bekannt ist. S15) Verbindungen der Formel (S15) oder deren Tautomere Safener is known against damage of some herbicides in rice. S15) compounds of the formula (S15) or their tautomers
wie sie in der WO-A-2008/131861 und WO-A-2008/131860 beschrieben sind  as described in WO-A-2008/131861 and WO-A-2008/131860
worin  wherein
RH1 einen (Ci-C6)Haloalkylrest bedeutet und RH 1 is a (Ci-C6) haloalkyl radical and
RH2 Wasserstoff oder Halogen bedeutet und RH 2 is hydrogen or halogen and
RH3, RH4 unabhängig voneinander Wasserstoff, (Ci-Ci6)Alkyl, (C2-Ci6)Alkenyl oder (C2-Ci6)Alkinyl, wobei jeder der letztgenannten 3 Reste unsubstituiert oder durch einen oder mehrere Reste aus der Gruppe Halogen, Hydroxy, Cyano, (Ci-C4)Alkoxy, (Ci-C4)Haloalkoxy, (Ci-C4)Alkylthio, (Ci-C4)Alkylamino, Di[(Ci-C4)alkyl]-amino, RH 3, RH 4 are independently hydrogen, (Ci-Ci6) alkyl, (C2-Ci6) alkenyl or (C2-Ci6) alkynyl, where each of the 3 last-mentioned radicals being unsubstituted or substituted by one or more radicals from the group halogen, hydroxy cyano, (Ci-C 4) alkoxy, (Ci-C 4) haloalkoxy, (Ci-C 4) alkylthio, (Ci-C 4) alkylamino, di [(Ci-C 4) alkyl] amino,
[(Ci-C4)Alkoxy]-carbonyl, [(Ci-C4)Haloalkoxy]-carbonyl, (C3-C6)Cycloalkyl, das unsubstituiert oder substituiert ist, Phenyl, das unsubstituiert oder substituiert ist, und Heterocyclyl, das unsubstituiert oder substituiert ist, substituiert ist, oder (C3- C6)Cycloalkyl, (C4-C6)Cycloalkenyl, (C3-C6)Cycloalkyl, das an einer Seite des Rings mit einem 4 bis 6-gliedrigen gesättigten oder ungesättigten carbocyclischen Ring kondensiert ist, oder (C4-C6)Cycloalkenyl, das an einer Seite des Rings mit einem 4 bis 6-gliedrigen gesättigten oder ungesättigten carbocyclischen Ring kondensiert ist, wobei jeder der letztgenannten 4 Reste unsubstituiert oder durch einen oder mehrere Reste aus der Gruppe Halogen, Hydroxy, Cyano, (C1 -C4)Alkyl, [(C 1 -C 4 ) alkoxy] carbonyl, [(C 1 -C 4 ) haloalkoxy] carbonyl, (C 3 -C 6) cycloalkyl which is unsubstituted or substituted, phenyl which is unsubstituted or substituted, and heterocyclyl which is unsubstituted or (C 3 -C 6) cycloalkyl, (C 4 -C 6) cycloalkenyl, (C 3 -C 6) cycloalkyl fused on one side of the ring with a 4- to 6-membered saturated or unsaturated carbocyclic ring , or (C 4 -C 6) cycloalkenyl fused on one side of the ring with a 4- to 6-membered saturated or unsaturated carbocyclic ring, each of the last 4 radicals unsubstituted or substituted by one or more of halo, hydroxy , Cyano, (C 1 -C 4) alkyl,
(C1 -C4)Haloalkyl, (C1 -C4)Alkoxy, (C1 -C4)Haloalkoxy, (C1 -C4)Alkylthio, (C1-C4) haloalkyl, (C1-C4) alkoxy, (C1-C4) haloalkoxy, (C1-C4) alkylthio,
(C1 -C4)Alkylamino, Di[(C1 -C4)alkyl]-amino, [(C1 -C4)Alkoxy]-carbonyl, (C1-C4) alkylamino, di [(C1-C4) alkyl] amino, [(C1-C4) alkoxy] carbonyl,
[(C1 -C4)Haloalkoxy]-carbonyl, (C3-C6)Cycloalkyl, das unsubstituiert oder substituiert ist, Phenyl, das unsubstituiert oder substituiert ist, und Heterocyclyl, das  [(C 1 -C 4) haloalkoxy] carbonyl, (C 3 -C 6) cycloalkyl which is unsubstituted or substituted, phenyl which is unsubstituted or substituted, and heterocyclyl, the
unsubstituiert oder substituiert ist, substituiert ist, bedeutet oder is unsubstituted or substituted, is substituted, means or
RH3 (Ci-C4)-Alkoxy, (C2-C4)Alkenyloxy, (C2-C6)Alkinyloxy oder (C2-C4)Haloalkoxy bedeutet und RH 3 is (C 1 -C 4 ) alkoxy, (C 2 -C 4 ) alkenyloxy, (C 2 -C 6 ) alkynyloxy or (C 2 -C 4 ) haloalkoxy and
RH4 Wasserstoff oder (Ci-C4)-Alkyl bedeutet oder RH 4 is hydrogen or (C 1 -C 4 ) -alkyl or
RH3 und RH4 zusammen mit dem direkt gebundenen N-Atom einen vier- bis achtgliedrigen RH 3 and RH 4 together with the directly attached N atom form a four- to eight-membered one
heterocyclischen Ring, der neben dem N-Atom auch weitere Heteroringatome, vorzugsweise bis zu zwei weitere Heteroringatome aus der Gruppe N, 0 und S enthalten kann und der unsubstituiert oder durch einen oder mehrere Reste aus der Gruppe Halogen, Cyano, Nitro, (Ci-C4)Alkyl, (Ci-C4)Haloalkyl, (Ci-C4)Alkoxy, (Ci- C4)Haloalkoxy und (Ci-C4)Alkylthio substituiert ist, bedeutet. S16) Wirkstoffe, die vorrangig als Herbizide eingesetzt werden, jedoch auch heterocyclic ring which, in addition to the N atom, may also contain further hetero ring atoms, preferably up to two further hetero ring atoms from the group N, O and S, and which is unsubstituted or substituted by one or more radicals from the group consisting of halogen, cyano, nitro, C 4) alkyl, (Ci-C 4) haloalkyl, (Ci-C 4) alkoxy, (Ci C 4) haloalkoxy and (Ci-C 4) alkylthio means. S16) active substances, which are primarily used as herbicides, but also
Safenerwirkung auf Kulturpflanzen aufweisen, z.B. (2,4-Dichlorphenoxy)essigsäure (2,4-D), (4-Chlorphenoxy)essigsäure, (R,S)-2-(4-Chlor-o-tolyloxy)propionsäure (Mecoprop), 4-(2,4-Dichlorphenoxy)buttersäure (2,4-DB), (4-Chlor-o-tolyloxy)- essigsäure (MCPA), 4-(4-Chlor-o-tolyloxy)buttersäure, 4-(4-Chlorphenoxy)- buttersäure, 3,6-Dichlor-2-methoxybenzoesäure (Dicamba), 1 -(Ethoxycarbonyl)ethyl- 3,6-dichlor-2-methoxybenzoat (Lactidichlor-ethyl).  Safeners on crops, e.g. (2,4-dichlorophenoxy) acetic acid (2,4-D), (4-chlorophenoxy) acetic acid, (R, S) -2- (4-chloro-o-tolyloxy) propionic acid (mecoprop), 4- (2, 4-dichlorophenoxy) butanoic acid (2,4-DB), (4-chloro-o-tolyloxy) acetic acid (MCPA), 4- (4-chloro-o-tolyloxy) butyric acid, 4- (4-chlorophenoxy) -butyric acid , 3,6-dichloro-2-methoxybenzoic acid (Dicamba), 1- (ethoxycarbonyl) ethyl-3,6-dichloro-2-methoxybenzoate (lactidichloroethyl).
Pflanzenreife beeinflussende Stoffe: Als Kombinationspartner für die Verbindungen der allgemeinen Formel (I) in Plant-maturity influencing substances: As combination partner for the compounds of the general formula (I) in
Mischungsformulierungen oder im Tank-Mix sind beispielsweise bekannte Mixture formulations or in the tank mix are known, for example
Wirkstoffe, die auf einer Inhibition von beispielsweise 1 -Aminocyclopropan-1 - carboxylatsynthase, 1 -aminocyclopropane-1 -carboxylatoxidase und den Active ingredients which are based on an inhibition of, for example, 1-aminocyclopropane-1-carboxylate synthase, 1 -aminocyclopropane-1-carboxylate oxidase and the
Ethylenrezeptoren, z. B. ETR1 , ETR2, ERS1 , ERS2 oder EIN4, beruhen, einsetzbar, wie sie z. B. in Biotechn. Adv. 2006, 24, 357-367; Bot. Bull. Acad. Sin. 199, 40, 1 -7 oder Plant Growth Reg. 1993, 13, 41 -46 und dort zitierter Literatur beschrieben sind. Als bekannte die Pflanzenreife beeinflussende Stoffe, die mit den Verbindungen der allgemeinen Formel (I) kombiniert werden können, sind z.B. folgende Wirkstoffe zu nennen (die Verbindungen sind entweder mit dem "common name" nach der International Organization for Standardization (ISO) oder mit dem chemischen Namen oder mit der Codenummer bezeichnet) und umfassen stets sämtliche Ethylene receptors, e.g. As ETR1, ETR2, ERS1, ERS2 or EIN4, are based, can be used as z. B. in biotechnology. Adv. 2006, 24, 357-367; Bot. Bull. Acad. Sin. 199, 40, 1-7 or Plant Growth Reg. 1993, 13, 41-46 and references cited therein. Substances which can influence plant maturity and which can be combined with the compounds of the general formula (I) are, for example, the following active compounds (the compounds are either with the "common name" according to the International Organization for Standardization (ISO) or with US Pat chemical names or with the code number) and always include all
Anwendungsformen wie Säuren, Salze, Ester und Isomere wie Stereoisomere und optische Isomere. Dabei sind beispielhaft eine und zum Teil auch mehrere  Use forms such as acids, salts, esters and isomers such as stereoisomers and optical isomers. Here are one example and some also several
Anwendungsformen genannt: Rhizobitoxin, 2-Amino-ethoxy-vinylglycin (AVG), Methoxyvinylglycin (MVG), Application forms called: rhizobitoxin, 2-amino-ethoxy-vinylglycine (AVG), methoxyvinylglycine (MVG),
Vinylglycin, Aminooxyessigsäure, Sinefungin, S-Adenosylhomocystein, 2-Keto-4- Methylthiobutyrat, (lsopropyliden)-aminooxyessigsäure-2-(methoxy)-2-oxoethylester, (lsopropyliden)-aminooxyessigsäure-2-(hexyloxy)-2-oxoethylester,  Vinyl glycine, aminooxyacetic acid, sinefungin, S-adenosyl homocysteine, 2-keto-4-methylthiobutyrate, (isopropylidene) aminooxyacetic acid 2- (methoxy) -2-oxoethyl ester, (isopropylidene) aminooxyacetic acid 2- (hexyloxy) -2-oxoethyl ester,
(Cyclohexylidene)-aminooxyessigsäure-2-(isopropyloxy)-2-oxoethylester, Putrescin, Spermidin, Spermin, 1 ,8-Diamino-4-aminoethyloctan, L-Canalin, Daminozid, 1 - Aminocyclopropyl-1 -carbonsäure-methylester, N-Methyl-1 -aminocyclopropyl-1 - carbonsäure, 1 -Aminocyclopropyl-1 -carbonsäureamid, Substituierte 1 - Aminocyclopropyl-1 -carbonsäurederivate wie sie in DE3335514, EP30287, (Cyclohexylidenes) aminooxyacetic acid 2- (isopropyloxy) -2-oxoethyl ester, putrescine, spermidine, spermine, 1,8-diamino-4-aminoethyloctane, L-canaline, daminozide, 1-aminocyclopropyl-1-carboxylic acid methyl ester, N- Methyl-1-aminocyclopropyl-1-carboxylic acid, 1-aminocyclopropyl-1-carboxamide, substituted 1-aminocyclopropyl-1-carboxylic acid derivatives as described in DE3335514, EP30287,
DE2906507 oder US5123951 beschrieben werden, 1 -Aminocyclopropyl-1 - hydroxamsäure, 1 -Methylcyclopropen, 3-Methylcyclopropen, 1 -Ethylcyclopropen, 1 - n-Propylcyclopropen, 1 -Cyclopropenyl-Methanol, Carvon, Eugenol, DE2906507 or US5123951, 1-aminocyclopropyl-1-hydroxamic acid, 1-methylcyclopropene, 3-methylcyclopropene, 1-ethylcyclopropene, 1-n-propylcyclopropene, 1-cyclopropanyl-methanol, carvone, eugenol,
Natriumcycloprop-1 -en-1 -ylacetat, Natriumcycloprop-2-en-1 -ylacetat, Natrium-3- (cycloprop-2-en-1 -yl)propanoat, Natrium-3-(cycloprop-1 -en-1 -yl)propanoat, Sodium cycloprop-1 -en-1-ylacetate, sodium cycloprop-2-en-1-ylacetate, sodium 3- (cycloprop-2-en-1-yl) propanoate, sodium 3- (cycloprop-1-ene-1 - yl) propanoate,
Jasmonsäure, Jasmonsäuremethylester, Jasmonsäureethylester. Jasmonic acid, methyl jasmonate, jasmonate.
Pflanzengesundheit und Keimung beeinflussende Stoffe: Plant health and germination affecting substances:
Als Kombinationspartner für die Verbindungen der allgemeinen Formel (I) in As a combination partner for the compounds of general formula (I) in
Mischungsformulierungen oder im Tank-Mix sind beispielsweise bekannte Mixture formulations or in the tank mix are known, for example
Wirkstoffe, die die Pflanzengesundheit beeinflussen, einsetzbar (die Verbindungen sind entweder mit dem "common name" nach der International Organization for Standardization (ISO) oder mit dem chemischen Namen oder mit der Codenummer bezeichnet und umfassen stets sämtliche Anwendungsformen wie Säuren, Salze, Ester und Isomere wie Stereoisomere und optische Isomere): Sarcosin, Active ingredients that affect plant health (the compounds are either with the "common name" according to the International Organization for Standardization (ISO) or with the chemical name or with the code number denotes and always includes all forms of use such as acids, salts, esters and isomers such as stereoisomers and optical isomers): sarcosine,
Phenylalanin, Tryptophan, N'-Methyl-1 -phenyl-1 -N,N- diethylaminomethanesulfonamid, Apio-galacturonane wie sie in WO2010017956 beschrieben werden, 4-Oxo-4-[(2-phenylethyl)amino]butansäure, 4-{[2-(1 H-lndol-3- yl)ethyl]amino}-4-oxobutansäure, 4-[(3-Methylpyridin-2-yl)amino]-4-oxobutansäure, Allantoin, 5-Aminolevulinsäure, (2S,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H- chromen-3,5,7-triol und strukturell verwandte Catechine wie sie in WO2010122956 beschrieben werden, 2-Hydroxy-4-(methylsulfanyl)butansäure, (3E,3aR,8ßS)-3- ({[(2R)-4-Methyl-5-oxo-2,5-dihydrofuran-2-yl]oxy}methylen)-3,3a,4,8ß-tetrahydro-2H- indeno[1 ,2-b]furan-2-on und analoge Lactone wie sie in EP2248421 beschrieben werden, Abscisinsäure, (2Z,4E)-5-[6-Ethinyl-1 -hydroxy-2,6-dimethyl-4-oxocyclohex- 2-en-1 -yl]-3-methylpenta-2,4-diensäure, Methyl-(2Z,4E)-5-[6-ethinyl-1 -hydroxy-2,6- dimethyl-4-oxocyclohex-2-en-1 -yl]-3-methylpenta-2,4-dienoat, 4-Phenylbuttersäure, Natrium-4-phenylbutanoat, Kalium-4-phenylbutanoat. Phenylalanine, tryptophan, N'-methyl-1-phenyl-1-N, N-diethylaminomethanesulfonamide, apio-galacturonans as described in WO2010017956, 4-oxo-4 - [(2-phenylethyl) amino] butanoic acid, 4- { [2- (1H-indol-3-yl) ethyl] amino} -4-oxobutanoic acid, 4 - [(3-methylpyridin-2-yl) amino] -4-oxobutanoic acid, allantoin, 5-aminolevulinic acid, (2S, 3R) -2- (3,4-Dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol and structurally related catechins as described in WO2010122956, 2-hydroxy-4- (methylsulfanyl) butanoic acid, (3E, 3aR, 8βS) -3- ({[(2R) -4-methyl-5-oxo-2,5-dihydrofuran-2-yl] oxy} methylene) -3,3a, 4,8ß- tetrahydro-2H-indeno [1,2-b] furan-2-one and analogous lactones as described in EP2248421, abscisic acid, (2Z, 4E) -5- [6-ethynyl-1-hydroxy-2,6- dimethyl 4-oxocyclohex-2-en-1-yl] -3-methylpenta-2,4-dienoic acid, methyl (2Z, 4E) -5- [6-ethynyl-1-hydroxy-2,6-dimethyl 4-oxocyclohex-2-en-1-yl] -3-methylpenta-2,4-dienoate, 4-phenylbutyric acid, sodium 4-phenylbutanoate, potassium 4-phenylbutanoate ,
Herbizide oder Pflanzenwachstumsregulatoren: Herbicides or plant growth regulators:
Als Kombinationspartner für die Verbindungen der allgemeinen Formel (I) in As a combination partner for the compounds of general formula (I) in
Mischungsformulierungen oder im Tank-Mix sind beispielsweise bekannte Mixture formulations or in the tank mix are known, for example
Wirkstoffe, die auf einer Inhibition von beispielsweise Acetolactat-Synthase, Acetyl- CoA-Carboxylase, Cellulose-Synthase, Enolpyruvylshikimat-3-phosphat-Synthase, Glutamin-Synthetase, p-Hydroxyphenylpyruvat-Dioxygenase, Phytoendesaturase, Photosystem I, Photosystem II, Protoporphyrinogen-Oxidase beruhen, einsetzbar, wie sie z.B. aus Weed Research 26 (1986) 441 -445 oder "The Pesticide Manual", 14th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2006 und dort zitierter Literatur beschrieben sind.  Active substances which are based on an inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate-3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II, protoporphyrinogen Oxidase based, can be used, as for example from Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 14th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2006 and cited therein.
Als bekannte Herbizide oder Pflanzenwachstumsregulatoren, die mit Verbindungen der allgemeinen Formel (I) kombiniert werden können, sind z.B. folgende Wirkstoffe zu nennen (die Verbindungen sind entweder mit dem "common name" nach der International Organization for Standardization (ISO) oder mit dem chemischen Namen oder mit der Codenummer bezeichnet) und umfassen stets sämtliche Anwendungsformen wie Säuren, Salze, Ester und Isomere wie Stereoisomere und optische Isomere. Dabei sind beispielhaft eine und zum Teil auch mehrere Examples of known herbicides or plant growth regulators which can be combined with compounds of the general formula (I) are the following active compounds (the compounds are either with the "common name" according to the International Organization for Standardization (ISO) or with the chemical name Names or with the code number) and always include all forms of use such as acids, salts, esters and isomers such as stereoisomers and optical isomers. Here are one example and some also several
Anwendungsformen genannt: Application forms called:
Acetochlor, Acibenzolar, Acibenzolar-S-methyl, Acifluorfen, Acifluorfen-sodium, Aclonifen, Alachlor, Allidochlor, Alloxydim, Alloxydim-sodium, Ametryn, Acetochlor, acibenzolar, acibenzolar-S-methyl, acifluorfen, acifluorfen-sodium, aclonifen, alachlor, allidochlor, alloxydim, alloxydim-sodium, ametryn,
Amicarbazone, Amidochlor, Amidosulfuron, Aminocyclopyrachlor, Aminopyralid, Amitrole, Ammoniumsulfamat, Ancymidol, Anilofos, Asulam, Atrazine, Azafenidin, Azimsulfuron, Aziprotryn, Beflubutamid, Benazolin, Benazolin-ethyl, Bencarbazone, Benfluralin, Benfuresate, Bensulide, Bensulfuron, Bensulfuron-methyl, Bentazone, Benzfendizone, Benzobicyclon, Benzofenap, Benzofluor, Benzoylprop, Amicarbazone, amidochlor, amidosulfuron, aminocyclopyrachlor, aminopyralid, amitrole, ammonium sulfamate, ancymidol, anilofos, asulam, atrazines, azafenidine, azimsulfuron, aziprotryn, beflubutamide, benazoline, benazolin-ethyl, bencarbazone, benfluralin, benfuresate, bensulide, bensulfuron, bensulfuron-methyl, Bentazone, Benzfendizone, Benzobicyclone, Benzofenap, Benzofluor, Benzoylprop,
Bicyclopyrone, Bifenox, Bilanafos, Bilanafos-natrium, Bispyribac, Bispyribac-natrium, Bromacil, Bromobutide, Bromofenoxim, Bromoxynil, Bromuron, Buminafos, Bicyclopyrone, Bifenox, Bilanafos, Bilanafos Sodium, Bispyribac, Bispyribac Sodium, Bromacil, Bromobutide, Bromofenoxime, Bromoxynil, Bromuron, Buminafos,
Busoxinone, Butachlor, Butafenacil, Butamifos, Butenachlor, Butralin, Butroxydim, Butylate, Cafenstrole, Carbetamide, Carfentrazone, Carfentrazone-ethyl, Busoxinone, butachlor, butafenacil, butamifos, butenachlor, butraline, butroxydim, butylates, cafenstroles, carbetamides, carfentrazone, carfentrazone-ethyl,
Chlomethoxyfen, Chloramben, Chlorazifop, Chlorazifop-butyl, Chlorbromuron, Chlorbufam, Chlorfenac, Chlorfenac-natrium, Chlorfenprop, Chlorflurenol, Chlomethoxyfen, Chloramben, Chlorazifop, Chlorazifop-butyl, Chlorobromuron, Chlorbufam, Chlorfenac, Chlorfenac-Sodium, Chlorfenprop, Chlorflurenol,
Chlorflurenol-methyl, Chloridazon, Chlorimuron, Chlorimuron-ethyl, Chlormequat- chlorid, Chlornitrofen, Chlorophthalim, Chlorthal-dimethyl, Chlorotoluron, Chlorofluorol-methyl, Chloridazon, Chlorimuron, Chlorimuron-ethyl, Chlormequat-chloride, Chloronitrofen, Chlorophthalim, Chlorthal-dimethyl, Chlorotoluron,
Chlorsulfuron, Cinidon, Cinidon-ethyl, Cinmethylin, Cinosulfuron, Clethodim, Chlorsulfuron, cinidone, cinidon-ethyl, cinmethylin, cinosulfuron, clethodim,
Clodinafop, Clodinafop-propargyl, Clofencet, Clomazone, Clomeprop, Cloprop, Clopyralid, Cloransulam, Cloransulam-methyl, Cumyluron, Cyanamide, Cyanazine, Cyclanilide, Cycloate, Cyclosulfamuron, Cycloxydim, Cycluron, Cyhalofop, Clodinafop, Clodinafop-propargyl, Clofenacet, Clomazone, Clomeprop, Cloprop, Clopyralid, Cloransulam, Cloransulam-methyl, Cumyluron, Cyanamide, Cyanazine, Cyclanilide, Cycloate, Cyclosulfamuron, Cycloxydim, Cycluron, Cyhalofop,
Cyhalofop-butyl, Cyperquat, Cyprazine, Cyprazole, 2,4-D, 2,4-DB, Cyhalofop-butyl, Cyperquat, Cyprazine, Cyprazole, 2,4-D, 2,4-DB,
Daimuron/Dymron, Dalapon, Daminozid, Dazomet, n-Decanol, Desmedipham, Desmetryn, Detosyl-Pyrazolate (DTP), Diallate, Dicamba, Dichlobenil, Dichlorprop, Dichlorprop-P, Diclofop, Diclofop-methyl, Diclofop-P-methyl, Diclosulam, Diethatyl, Diethatyl-ethyl, Difenoxuron, Difenzoquat, Diflufenican, Diflufenzopyr, Diflufenzopyr- natrium, Dimefuron, Dikegulac-sodium, Dimefuron, Dimepiperate, Dimethachlor, Dimethametryn, Dimethenamid, Dimethenamid-P, Dimethipin, Dimetrasulfuron, Dinitramine, Dinoseb, Dinoterb, Diphenamid, Dipropetryn, Diquat, Diquat-dibromide, Dithiopyr, Diuron, DNOC, Eglinazine-ethyl, Endothal, EPTC, Esprocarb, Ethalfluralin, Ethametsulfuron, Ethametsulfuron-methyl, Ethephon, Ethidimuron, Ethiozin, Daimurone / dymron, dalapon, daminozide, dazomet, n-decanol, desmedipham, desmetryne, detosyl pyrazolates (DTP), dialkylates, dicamba, dichlobenil, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl, diclosulam , Diethatyl, Diethyl ethyl, Difenoxuron, Difenzoquat, Diflufenican, Diflufenzopyr, Diflufenzopyr- sodium, Dimefuron, Dikegulac-sodium, Dimefuron, Dimepiperate, Dimethachlor, Dimethametryn, Dimethenamid, Dimethenamid-P, Dimethipin, Dimetrasulfuron, Dinitramine, Dinoseb, Dinoterb, Diphenamid , Dipropetryn, diquat, diquat-dibromide, Dithiopyr, Diuron, DNOC, Eglinazine-ethyl, Endothal, EPTC, Esprocarb, Ethalfluralin, Ethametsulfuron, Ethametsulfuron-methyl, Ethephon, Ethidimuron, Ethiozine,
Ethofumesate, Ethoxyfen, Ethoxyfen-ethyl, Ethoxysulfuron, Etobenzanid, F-5331 , d.h. N-[2-Chlor-4-fluor-5-[4-(3-fluorpropyl)-4,5-dihydro-5-oxo-1 H-tetrazol-1 -yl]- phenyl]-ethansulfonamid, F-7967, d. h. 3-[7-Chlor-5-fluor-2-(trifluormethyl)-1 H- benzimidazol-4-yl]-1 -methyl-6-(trifluormethyl)pyrimidin-2,4(1 H,3H)-dion, Fenoprop, Fenoxaprop, Fenoxaprop-P, Fenoxaprop-ethyl, Fenoxaprop-P-ethyl, Fenoxasulfone, Fentrazamide, Fenuron, Flamprop, Flamprop-M-isopropyl, Flamprop-M-methyl, Flazasulfuron, Florasulam, Fluazifop, Fluazifop-P, Fluazifop-butyl, Fluazifop-P-butyl, Fluazolate, Flucarbazone, Flucarbazone-sodium, Flucetosulfuron, Fluchloralin, Flufenacet (Thiafluamide), Flufenpyr, Flufenpyr-ethyl, Flumetralin, Flumetsulam, Flumiclorac, Flumiclorac-pentyl, Flumioxazin, Flumipropyn, Fluometuron, Ethofumesate, ethoxyfen, ethoxyfen-ethyl, ethoxysulfuron, etobenzanide, F-5331, i. N- [2-Chloro-4-fluoro-5- [4- (3-fluoro-propyl) -4,5-dihydro-5-oxo-1H-tetrazol-1-yl] -phenyl] -ethanesulfonamide, F-7967 , d. H. 3- [7-chloro-5-fluoro-2- (trifluoromethyl) -1H-benzimidazol-4-yl] -1-methyl-6- (trifluoromethyl) pyrimidine-2,4 (1H, 3H) -dione, Fenoprop, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fenoxasulfones, fentrazamides, fenuron, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop- butyl, fluazifop-p-butyl, fluazolates, flucarbazones, flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet (thiafluamide), flufenpyr, flufenpyr-ethyl, flumetralin, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazine, flumipropyne, fluometuron,
Fluorodifen, Fluoroglycofen, Fluoroglycofen-ethyl, Flupoxam, Flupropacil, Fluorodifene, fluoroglycofen, fluoroglycofen-ethyl, flupoxam, flupropacil,
Flupropanate, Flupyrsulfuron, Flupyrsulfuron-methyl-sodium, Flurenol, Flurenol-butyl, Fluridone, Flurochloridone, Fluroxypyr, Fluroxypyr-meptyl, Flurprimidol, Flurtamone, Fluthiacet, Fluthiacet-methyl, Fluthiamide, Fomesafen, Foramsulfuron, Flupropanate, Flupyrsulfuron, Flupyrsulfuron-methyl-sodium, Flurenol, Flurenol-butyl, Fluridone, Flurochloridone, Fluroxypyr, Fluroxypyr-meptyl, Flurprimidol, Flurtamone, Fluthiacet, Fluthiacet-methyl, Fluthiamide, Fomesafen, Foramsulfuron,
Forchlorfenuron, Fosamine, Furyloxyfen, Gibberellinsäure, Glufosinate, Glufosinate- ammonium, Glufosinate-P, Glufosinate-P-ammonium, Glufosinate-P-natrium, Glyphosate, Glyphosate-isopropylammonium, H-9201 , d. h. O-(2,4-Dimethyl-6- nitrophenyl)-O-ethyl-isopropylphosphoramidothioat, Halosafen, Halosulfuron, Forchlorfenuron, fosamine, furyloxyfen, gibberellic acid, glufosinate, glufosinate-ammonium, glufosinate-P, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-isopropylammonium, H-9201, d. H. O- (2,4-dimethyl-6-nitrophenyl) -O-ethyl-isopropylphosphoramidothioate, halosafen, halosulfuron,
Halosulfuron-methyl, Haloxyfop, Haloxyfop-P, Haloxyfop-ethoxyethyl, Haloxyfop-P- ethoxyethyl, Haloxyfop-methyl, Haloxyfop-P-methyl, Hexazinone, HW-02, d. h. 1 - (Dimethoxyphosphoryl)-ethyl(2,4-dichlorphenoxy)acetat, Imazamethabenz,  Halosulfuron-methyl, Haloxyfop, Haloxyfop-P, Haloxyfopethoxyethyl, Haloxyfop-P-ethoxyethyl, Haloxyfop-methyl, Haloxyfop-P-methyl, Hexazinone, HW-02, d. H. 1 - (Dimethoxyphosphoryl) ethyl (2,4-dichlorophenoxy) acetate, imazamethabenz,
Imazamethabenz-methyl, Imazamox, Imazamox-ammonium, Imazapic, Imazapyr, Imazapyr-isopropylammonium, Imazaquin, Imazaquin-ammonium, Imazethapyr, Imazethapyr-ammonium, Imazosulfuron, Inabenfide, Indanofan, Indaziflam, Imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazethapyr, imazethapyr-ammonium, imazosulfuron, inabenfide, indanofan, indaziflam,
Indolessigsäure (IAA), 4-lndol-3-ylbuttersäure (IBA), lodosulfuron, lodosulfuron- methyl-natrium, loxynil, Ipfencarbazone, Isocarbamid, Isopropalin, Isoproturon, Isouron, Isoxaben, Isoxachlortole, Isoxaflutole, Isoxapyrifop, KUH-043, d. h. 3-({[5- (Difluormethyl)-I -methyl-3-(trifluormethyl)-1 H-pyrazol-4-yl]methyl}sulfonyl)-5,5- dimethyl-4,5-dihydro-1 ,2-oxazol, Karbutilate, Ketospiradox, Lactofen, Lenacil, Linuron, Maleinsäurehydrazid, MCPA, MCPB, MCPB-methyl, -ethyl und -natrium, Mecoprop, Mecoprop-natrium, Mecoprop-butotyl, Mecoprop-P-butotyl, Mecoprop-P- dimethylammonium, Mecoprop-P-2-ethylhexyl, Mecoprop-P-kalium, Mefenacet, Mefluidide, Mepiquat-chlorid, Mesosulfuron, Mesosulfuron-methyl, Mesotrione, Methabenzthiazuron, Metam, Metamifop, Metamitron, Metazachlor, Metazasulfuron, Methazole, Methiopyrsulfuron, Methiozolin, Methoxyphenone, Methyldymron, 1 - Methylcyclopropen, Methylisothiocyanat, Metobenzuron, Metobromuron, Indoleacetic acid (IAA), 4-indol-3-yl-butyric acid (IBA), iodosulfuron, iodosulfuron-methyl-sodium, loxynil, isoparbazone, isocarbamide, isopropalin, isoproturon, isourone, isoxaben, isoxachlorotole, isoxaflutole, isoxapyrifop, KUH-043, ie - ({[5- (difluoromethyl) -1-methyl-3- (trifluoromethyl) -1H-pyrazol-4-yl] methyl} sulfonyl) -5,5-dimethyl-4,5-dihydro-1,2 oxazole, carbutilates, ketospiradox, lactofen, lenacil, linuron, maleic hydrazide, MCPA, MCPB, MCPB-methyl, -ethyl and -sodium, Mecoprop, mecoprop-sodium, mecopropbututyl, mecoprop-p-butotyl, mecoprop-P-dimethylammonium, mecoprop-P-2-ethylhexyl, mecoprop-potassium, mefenacet, mefluidides, mepiquat chloride, mesosulfuron, mesosulfuron-methyl, Mesotrione, methabenzthiazuron, metam, metamifop, metamitron, metazachlor, metazasulfuron, methazole, methiopyrsulfuron, methiozoline, methoxyphenones, methyldymron, 1-methylcyclopropene, methylisothiocyanate, metobenzuron, metobromuron,
Metolachlor, S-Metolachlor, Metosulam, Metoxuron, Metribuzin, Metsulfuron, Metsulfuron-methyl, Molinate, Monalide, Monocarbamide, Monocarbamide- dihydrogensulfat, Monolinuron, Monosulfuron, Monosulfuron-ester, Monuron, MT- 128, d. h. 6-Chlor-N-[(2E)-3-chlorprop-2-en-1 -yl]-5-methyl-N-phenylpyridazin-3-amin, MT-5950, d. h. N-[3-Chlor-4-(1 -methylethyl)-phenyl]-2-methylpentanamid, NGGC- 01 1 , Naproanilide, Napropamide, Naptalam, NC-310, d.h. 4-(2,4-Dichlorobenzoyl)-1 - methyl-5-benzyloxypyrazole, Neburon, Nicosulfuron, Nipyraclofen, Nitralin, Nitrofen, Nitrophenolat-natrium (Isomerengemisch), Nitrofluorfen, Nonansäure, Norflurazon, Orbencarb, Orthosulfamuron, Oryzalin, Oxadiargyl, Oxadiazon, Oxasulfuron, Oxaziclomefone, Oxyfluorfen, Paclobutrazol, Paraquat, Paraquat-dichlorid, Metolachlor, S-metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinates, monalides, monocarbamides, monocarbamides dihydrogen sulfate, monolinuron, monosulfuron, monosulfuron ester, monuron, MT-128, d. H. 6-Chloro-N - [(2E) -3-chloroprop-2-en-1-yl] -5-methyl-N-phenylpyridazine-3-amine, MT-5950, d. H. N- [3-chloro-4- (1-methylethyl) phenyl] -2-methylpentanamide, NGGC-01 1, naproanilides, napropamide, naptalam, NC-310, i. 4- (2,4-Dichlorobenzoyl) -1-methyl-5-benzyloxypyrazoles, neburon, nicosulfuron, nipyraclofen, nitralin, nitrofen, nitrophenolate sodium (isomeric mixture), nitrofluoropropene, nonanoic acid, norflurazon, orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon , Oxasulfuron, oxaziclomefones, oxyfluorfen, paclobutrazole, paraquat, paraquat dichloride,
Pelargonsäure (Nonansäure), Pendimethalin, Pendralin, Penoxsulam, Pentanochlor, Pentoxazone, Perfluidone, Pethoxamid, Phenisopham, Phenmedipham, Pelargonic acid (nonanoic acid), pendimethalin, pendralin, penoxsulam, pentanochlor, pentoxazone, perfluidone, pethoxamide, phenisopham, phenmedipham,
Phenmedipham-ethyl, Picloram, Picolinafen, Pinoxaden, Piperophos, Pirifenop, Pirifenop-butyl, Pretilachlor, Primisulfuron, Primisulfuron-methyl, Probenazole, Profluazol, Procyazine, Prodiamine, Prifluraline, Profoxydim, Prohexadione, Phenmedipham-ethyl, picloram, picolinafen, pinoxaden, piperophos, pirifenop, pirifenop-butyl, pretilachlor, primisulfuron, primisulfuron-methyl, probenazoles, profluazole, procyazene, pro-diamines, prifluralins, profoxydim, prohexadione,
Prohexadione-calcium, Prohydrojasmone, Prometon, Prometryn, Propachlor, Propanil, Propaquizafop, Propazine, Propham, Propisochlor, Propoxycarbazone, Propoxycarbazone-natrium, Propyrisulfuron, Propyzamide, Prosulfalin, Prosulfocarb, Prosulfuron, Prynachlor, Pyraclonil, Pyraflufen, Pyraflufen-ethyl, Pyrasulfotole, Pyrazolynate (Pyrazolate), Pyrazosulfuron, Pyrazosulfuron-ethyl, Pyrazoxyfen, Pyribambenz, Pyribambenz-isopropyl, Pyribambenz-propyl, Pyribenzoxim, Prohexadione-calcium, Prohydrojasmone, Prometon, Prometry, Propachlor, Propanil, Propaquizafop, Propazine, Propham, Propisochlor, Propoxycarbazone, Propoxycarbazone-Sodium, Propyrisulfuron, Propyzamide, Prosulfine, Prosulfocarb, Prosulfuron, Prynachlor, Pyraclonil, Pyraflufen, Pyraflufen-ethyl, Pyrasulfotole, Pyrazolynates (pyrazolates), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyfen, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxime,
Pyributicarb, Pyridafol, Pyridate, Pyriftalid, Pyriminobac, Pyriminobac-methyl, Pyrimisulfan, Pyrithiobac, Pyrithiobac-natrium, Pyroxasulfone, Pyroxsulam, Pyributicarb, Pyridafol, Pyridate, Pyriftalid, Pyriminobac, Pyriminobac-methyl, Pyrimisulfan, Pyrithiobac, Pyrithiobac Sodium, Pyroxasulfones, Pyroxsulam,
Quinclorac, Quinmerac, Quinoclamine, Quizalofop, Quizalofop-ethyl, Quizalofop-P, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Rimsulfuron, Saflufenacil, Secbumeton, Sethoxydim, Siduron, Simazine, Simetryn, SN-106279, d. h. Methyl-(2R)-2-({7-[2- chlor-4-(trifluormethyl)phenoxy]-2-naphthyl}oxy)-propanoat, Sulcotrione, Sulfallate (CDEC), Sulfentrazone, Sulfometuron, Sulfometuron-methyl, Sulfosate (Glyphosate- trimesium), Sulfosulfuron, SYN-523, SYP-249, d. h. 1 -Ethoxy-3-methyl-1 -oxobut-3- en-2-yl-5-[2-chlor-4-(trifluormethyl)phenoxy]-2-nitrobenzoat, SYP-300, d. h. 1 -[7- Fluor-3-oxo-4-(prop-2-in-1 -yl)-3,4-dihydro-2H-1 ,4-benzoxazin-6-yl]-3-propyl-2- thioxoimidazolidin-4,5-dion, Tebutam, Tebuthiuron, Tecnazene, Tefuryltrione, Tembotrione, Tepraloxydim, Terbacil, Terbucarb, Terbuchlor, Terbumeton, Quinclorac, Quinmerac, Quinoclamine, Quizalofop, Quizalofop-ethyl, Quizalofop-P, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Rimsulfuron, Saflufenacil, Secbumetone, Sethoxydim, Siduron, Simazine, Simetryn, SN-106279, ie methyl ( 2R) -2 - ({7- [2- chloro-4- (trifluoromethyl) phenoxy] -2-naphthyl} oxy) -propanoate, sulctotrione, sulfallates (CDEC), sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosate (glyphosate trimesium), sulfosulfuron, SYN-523, SYP-249 ie 1-ethoxy-3-methyl-1-oxobut-3-en-2-yl-5- [2-chloro-4- (trifluoromethyl) phenoxy] -2-nitrobenzoate, SYP-300, ie 1 - [7 Fluoro-3-oxo-4- (prop-2-yn-1-yl) -3,4-dihydro-2H-1,4-benzoxazin-6-yl] -3-propyl-2-thioxoimidazolidine-4, 5-dione, tebutam, tebuthiuron, tecnazene, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbuchlor, terbumeton,
Terbuthylazine, Terbutryn, Thenylchlor, Thiafluamide, Thiazafluron, Thiazopyr, Thidiazimin, Thidiazuron, Thiencarbazone, Thiencarbazone-methyl, Thifensulfuron, Thifensulfuron-methyl, Thiobencarb, Thiocarbazil, Topramezone, Tralkoxydim, Triallate, Triasulfuron, Triaziflam, Triazofenamide, Tribenuron, Tribenuron-methyl, Trichloressigsäure (TCA), Triclopyr, Tridiphane, Trietazine, Trifloxysulfuron, Terbuthylazine, terbutryn, thenylchloro, thiafluamides, thiazafluron, thiazopyr, thidiazimine, thidiazuron, thiencarbazones, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, thiocarbazil, toramezone, tralkoxydim, triallate, triasulfuron, triaziflam, triazofenamide, tribenuron, tribenuron-methyl, Trichloroacetic acid (TCA), triclopyr, tridiphane, trietazine, trifloxysulfuron,
Trifloxysulfuron-natrium, Trifluralin, Triflusulfuron, Triflusulfuron-methyl, Trimeturon, Trinexapac, Trinexapac-ethyl, Tritosulfuron, Tsitodef, Uniconazole, Uniconazole-P, Vernolate, ZJ-0862, d. h. 3,4-Dichlor-N-{2-[(4,6-dimethoxypyrimidin-2- yl)oxy]benzyl}anilin, sowie die folgenden Verbindungen: Trifloxysulfuron Sodium, Trifluralin, Triflusulfuron, Triflusulfuron-methyl, Trimeturon, Trinexapac, Trinexapac-ethyl, Tritosulfuron, Tsitodef, Uniconazole, Uniconazole-P, Vernolate, ZJ-0862, d. H. 3,4-Dichloro-N- {2 - [(4,6-dimethoxypyrimidin-2-yl) oxy] benzyl} aniline, and the following compounds:
Die Erfindung soll durch die nachfolgenden biologischen Beispiele veranschaulicht werden, ohne sie jedoch darauf einzuschränken. The invention will be illustrated by the following biological examples without, however, limiting them thereto.
Biologische Beispiele: Samen von mono- bzw. dikotylen Kulturpflanzen wurden in Holzfasertöpfen in sandigem Lehmboden ausgelegt, mit Erde abgedeckt und im Gewächshaus unter guten Wachstumsbedingungen angezogen. Die Behandlung der Versuchspflanzen erfolgte im frühen Laubblattstadium (BBCH10 - BBCH13). Zur Gewährleistung einer uniformen Wasserversorgung vor Stressbeginn wurden die bepflanzten Töpfe unmittelbar zuvor durch Anstaubewässerung maximal mit Wasser versorgt und nach Applikation in Plastikeinsätze transferiert, um anschließendes, zu schnelles Biological examples: Seeds of monocotyledonous or dicotyledonous crops were placed in sandy loam soil in wood fiber pots, covered with soil and grown in the greenhouse under good growth conditions. The treatment of the test plants took place in the early leaf foliage stage (BBCH10 - BBCH13). To ensure a uniform supply of water before the onset of stress, the planted pots were immediately supplied with water by means of dewatering and, after application, transferred to plastic inserts in order to be followed by too fast
Abtrocknen zu verhindern. Die in Form von benetzbaren Pulvern (WP), benetzbaren Granulaten (WG), Suspensionskonzentraten (SC) oder Emulsionskonzentraten (EC) formulierten erfindungsgemäßen Verbindungen wurden als wässrige Suspension mit einer Wasseraufwandmenge von umgerechnet 600 l/ha unter Zusatz von 0,2% Netzmittel (Agrotin) auf die grünen Pflanzenteile gesprüht. Unmittelbar nach Prevent drying. The compounds according to the invention formulated in the form of wettable powders (WP), wettable granules (WG), suspension concentrates (SC) or emulsion concentrates (EC) were prepared as aqueous suspension with a water application rate of 600 l / ha with addition of 0.2% wetting agent ( Agrotin) sprayed on the green parts of the plant. Immediately after
Substanzapplikation erfolgt die Stressbehandlung der Pflanzen (Kälte- oder Substance application is the stress treatment of plants (cold or
Trockenstress). Zur Kältestressbehandlung wurden die Pflanzen unter folgenden kontrollierten Bedingungen gehalten: Drought stress). For cold stress treatment, the plants were kept under the following controlled conditions:
„Tag": 12 Stunden beleuchtet bei 8°C  "Day": 12 hours lit at 8 ° C
„Nacht": 12 Stunden ohne Beleuchtung bei 1 °C.  "Night": 12 hours without lighting at 1 ° C.
Der Trockenstreß wurde durch langsames Abtrocknen unter folgenden Bedingungen induziert: „Tag": 14 Stunden beleuchtet bei 26°C  The dry stress was induced by slow drying under the following conditions: "day": illuminated for 14 hours at 26 ° C
„Nacht": 10 Stunden ohne Beleuchtung bei 18°C.  "Night": 10 hours without lighting at 18 ° C.
Die Dauer der jeweiligen Streßphasen richtete sich hauptsächlich nach dem Zustand der unbehandelten (= mit Leerformulierung, aber ohne Testverbindung  The duration of the respective stress phases was based mainly on the condition of the untreated (= with empty formulation, but without test compound
behandelten), gestressten Kontrollpflanzen und variierte somit von Kultur zu Kultur. Sie wurde (durch Wiederbewässerung bzw. Transfer in Gewächshaus mit guten Wachstumsbedingungen) beendet, sobald irreversible Schäden an den treated), stressed control plants and thus varied from culture to culture. It was terminated (by irrigation or transfer in greenhouse with good growth conditions), as soon as irreversible damage to the
unbehandelten, gestressten Kontrollpflanzen zu beobachten waren. Bei dikotylen Kulturen wie beispielsweise Raps und Soja variierte die Dauer der untreated, stressed control plants were observed. For dicotyledonous crops such as oilseed rape and soybean, the duration of the diet varied
Trockenstreßphase zwischen 3 und 5 Tagen, bei monokotylen Kulturen wie beispielweise Weizen, Gerste oder Mais zwischen 6 und 10 Tagen. Die Dauer der Kältestreßphase variierte zwischen 12 und 14 Tagen. Dry stress phase between 3 and 5 days, in monocotyledonous crops such as For example, wheat, barley or corn between 6 and 10 days. The duration of the cold stress phase varied between 12 and 14 days.
Nach Beendigung der Stressphase folgte eine ca. 5-7 tägige Erholungsphase, während der die Pflanzen abermals unter guten Wachstumsbedingungen im  After completion of the stress phase followed by a 5-7 day recovery period during which the plants again under good growth conditions in
Gewächshaus gehalten wurden. Um auszuschließen, daß die beobachteten Effekte von der ggf. fungiziden Wirkung der Testverbindungen beeinflußt werden, wurde zudem darauf geachtet, daß die Versuche ohne Pilzinfektion bzw. ohne Greenhouse were kept. To rule out that the observed effects are influenced by the possibly fungicidal action of the test compounds, it was also ensured that the experiments without fungal infection or without
Infektionsdruck ablaufen. Expire infection pressure.
Nach Beendigung der Erholungsphase wurden die Schadintensitäten visuell im Vergleich zu unbehandelten, ungestressten Kontrollen gleichen Alters (bei  At the end of the recovery period, the damage intensities were visually compared to untreated, unstressed controls of the same age (at
Trockenstreß) bzw. gleichen Wuchsstadiums (bei Kältestreß) bonitiert. Die Dry stress) or the same growth stage (at cold stress). The
Erfassung der Schadintensität erfolgte zunächst prozentual (100% = Pflanzen sind abgestorben, 0 % = wie Kontrollpflanzen). Aus diesen Werten wurde sodann der Wirkungsgrad der Testverbindungen (= prozentuale Reduktion der Schadintensität durch Substanzapplikation) nach folgender Formel ermittelt: Detection of the damage intensity was initially percentage (100% = plants are dead, 0% = as control plants). From these values, the efficiency of the test compounds (= percentage reduction of the damage intensity by substance application) was then determined according to the following formula:
SW, ug  SW, ug
WG: Wirkungsgrad (%) WG: Efficiency (%)
SWug: Schadwert der unbehandelten, gestressten Kontrolle SW ug : Damage value of the untreated, stressed control
SWbg: Schadwert der mit Testverbindung behandelten Pflanzen SWb g : damage value of test compound-treated plants
In untenstehenden Tabellen sind jeweils Mittelwerte aus drei Ergebniswerten des gleichen Versuches aufgeführt. The tables below each show mean values from three results of the same experiment.
Wirkungen ausgewählter Verbindungen der allgemeinenFormel (I) unter Effects of selected compounds of general formula (I) below
Trockenstress: Tabelle A-1 Drought Stress: Table A-1
Tabelle A-2 Table A-2
WG  WG
No. Substanz Dosierung Einheit  No. Substance dosage unit
(ZEAMX) (ZEAMX)
1 1.1-152 25 g/ha > 51 1.1-152 25 g / ha> 5
2 1.1-278 25 g/ha > 52 1.1-278 25 g / ha> 5
3 1.1-646 250 g/ha > 53 1.1-646 250 g / ha> 5
4 1.1-654 25 g/ha > 54 1.1-654 25 g / ha> 5
5 1.1-822 25 g/ha > 55 1.1-822 25 g / ha> 5
6 1.1-1014 25 g/ha > 56 1.1-1014 25 g / ha> 5
7 1.1-1127 25 g/ha > 57 1.1-1127 25 g / ha> 5
8 1.3-18 250 g/ha > 58 1.3-18 250 g / ha> 5
9 I.4-54 25 g/ha > 5 Tabelle A-3 9 I.4-54 25 g / ha> 5 Table A-3
In den zuvor genannten Tabellen bedeuten: In the aforementioned tables mean:
BRSNS = Brassica napus BRSNS = Brassica napus
TRZAS = Triticum aestivum TRZAS = Triticum aestivum
ZEAMX = Zea mays Ähnliche Ergebnisse konnten auch noch mit weiteren Verbindungen der allgemeinen Formel (I) auch bei Applikation auf andere Pflanzenarten erzielt werden. ZEAMX = Zea mays Similar results could also be obtained with other compounds of the general formula (I) even when applied to other plant species.

Claims

Patentansprüche claims
Substituierte Vinyl- und Alkinyl-cyclohexenole der allgemeinen Formel (I) oder deren Salze, Substituted vinyl and alkynylcyclohexenols of the general formula (I) or salts thereof,
wobei in which
[X-Y] für die Gruppierungen [X-Y] for the groupings
[X-Y]1 [X-Y]3 und [X-Y]4 ste h [XY] 1 [XY] 3 and [XY] 4 ste h
Q für die carbocyclischen und heterocyclischen Gruppierungen Q-1 bis Q-4 Q for the carbocyclic and heterocyclic moieties Q-1 to Q-4
Q-1 Q-2 Q-3 und Q-4 steht, wobei die Gruppierungen R6 bis R21 und A1 bis A12 jeweils die Bedeutung gemäß der nachstehenden Definitionen haben und wobei der Pfeil für eine Bindung zur jeweiligen Gruppierung [X-Y] steht, R1 für Alkyl, Alkenyl, Alkinyl, Alkenylalkyl, Alkinylalkyl, Alkoxyalkyl, Hydroxyalkyl, Alkylamino, Sulfonylamino, Alkoxy, Haloalkyl, Q-1 Q-2 Q-3 and Q-4, wherein the groups R 6 to R 21 and A 1 to A 12 each have the meaning according to the definitions below and wherein the arrow for a bond to the respective grouping [XY ] stands, R 1 is alkyl, alkenyl, alkynyl, alkenylalkyl, alkynylalkyl, alkoxyalkyl, hydroxyalkyl, alkylamino, sulfonylamino, alkoxy, haloalkyl,
Haloalkoxyalkyl steht,  Haloalkoxyalkyl stands,
R2 für Wasserstoff, Alkyl, Nitroalkyl, Hydroxyalkyl, Haloalkyl, Alkylamino, Sulfonylamino, Alkoxy, Trialkylsilylalkyl, Cyanoalkyl, Arylalkyl, R 2 is hydrogen, alkyl, nitroalkyl, hydroxyalkyl, haloalkyl, alkylamino, sulfonylamino, alkoxy, trialkylsilylalkyl, cyanoalkyl, arylalkyl,
Alkoxycarbonylalkyl, Haloalkoxycarbonylalkyl, Alkylthioalkyl,  Alkoxycarbonylalkyl, haloalkoxycarbonylalkyl, alkylthioalkyl,
Arylthioalkyl steht,  Arylthioalkyl is
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig R 1 and R 2 with the atoms to which they are attached, a complete
gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden,  form saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
R3 und R4 unabhängig voneinander für Alkoxy, Alkoxyalkoxy, R 3 and R 4 independently of one another represent alkoxy, alkoxyalkoxy,
Cycloalkylalkoxy, Haloalkoxy, Alkylthio, Haloalkylthio stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, Alkoxyiminogruppe, Cycloalkoxyiminogruppe, Cycloalkylalkoximinogruppe, , Alkenyloximinogruppe, Aryl-(Ci-C8)- alkoxyiminogruppe oder einen 5-7-gliedrigen heterocyclischen Ring, der gegebenenfalls weiter substituiert sein kann, bilden,  Cycloalkylalkoxy, haloalkoxy, alkylthio, haloalkylthio or, together with the atom to which they are attached, an oxo group, hydroxyimino group, alkoxyimino group, cycloalkoxyimino group, cycloalkylalkoximino group, alkenyloxyimino group, aryl- (C 1 -C 8) -alkoxyimino group or a 5-7-membered one heterocyclic ring, which may optionally be further substituted form,
R5 für Wasserstoff, Alkyl, Alkenyl, Alkenylalkyl, Alkoxyalkyl, Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, Cycloalkylcarbonyl, Alkoxycarbonyl, Allyloxycarbonyl, Aryloxyalkyl, Arylalkyl, Alkoxyalkoxy alkyl, R 5 is hydrogen, alkyl, alkenyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, allyloxycarbonyl, aryloxyalkyl, arylalkyl, alkoxyalkoxyalkyl,
Alkylthioalkyl, Trialkylsilyl, Alkyl(Bis-alkyl)silyl, Alkyl(Bis-Aryl)silyl, Aryl(Bis-alkyl)silyl, Cycloalkyl(Bis-alkyl)silyl, Halo(Bis-alkyl)silyl, Trialkylsilylalkoxyalkyl steht,  Alkylthioalkyl, trialkylsilyl, alkyl (bis-alkyl) silyl, alkyl (bis-aryl) silyl, aryl (bis-alkyl) silyl, cycloalkyl (bis-alkyl) silyl, halo (bis-alkyl) silyl, trialkylsilylalkoxyalkyl,
R6 und R7 unabhängig voneinander für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, Alkyl, Cycloalkyl, Alkenyl, Alkinyl, Aryl, Arylalkyl, Alkenylalkyl, Alkinylalkyl, Arylalkoxy, Heteroaryl, Alkoxyalkyl, Hydroxyalkyl, Haloalkyl, Halocycloalkyl, Alkoxy, Haloalkoxy, Aryloxy, Heteroaryloxy, Cycloalkyloxy, Hydroxy, R 6 and R 7 independently of one another represent hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, alkenylalkyl, alkynylalkyl, arylalkoxy, heteroaryl, alkoxyalkyl, hydroxyalkyl, haloalkyl, halocycloalkyl, alkoxy, Haloalkoxy, aryloxy, heteroaryloxy, cycloalkyloxy, hydroxy,
Cycloalkylalkoxy, Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, Alkylaminocarbonyl, Cycloalkylaminocarbonyl,  Cycloalkylalkoxy, alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, alkylaminocarbonyl, cycloalkylaminocarbonyl,
Cyanoalkylaminocarbonyl, Alkenylaminocarbonyl,  Cyanoalkylaminocarbonyl, alkenylaminocarbonyl,
Alkinylaminocarbonyl, Alkylamino, Alkylthio, Haloalkylthio, Hydrothio, Bisalkylamino, Cycloalkylamino, Alkylcarbonylamino,  Alkynylaminocarbonyl, alkylamino, alkylthio, haloalkylthio, hydrothio, bisalkylamino, cycloalkylamino, alkylcarbonylamino,
Cycloalkylcarbonylamino, Formylamino, Haloalkylcarbonylamino, Alkoxycarbonylamino, Alkylaminocarbonylamino, Alkyl(Alkyl- )aminocarbonylamino, Alkylsulfonylamino, Cycloalkylsulfonylamino, Arylsulfonylamino, Hetarylsulfonylamino, Sulfonylhaloalkylamino, Aminosulfonyl, Aminoalkylsulfonyl, Aminohaloalkylsulfonyl,  Cycloalkylcarbonylamino, formylamino, haloalkylcarbonylamino, alkoxycarbonylamino, alkylaminocarbonylamino, alkyl (alkyl) aminocarbonylamino, alkylsulfonylamino, cycloalkylsulfonylamino, arylsulfonylamino, hetarylsulfonylamino, sulfonylhaloalkylamino, aminosulfonyl, aminoalkylsulfonyl, aminohaloalkylsulfonyl,
Alkylaminosulfonyl, Bisalkylaminosulfonyl, Cycloalkylaminosulfonyl, Haloalkylaminosulfonyl, Arylaminosulfonyl, Arylalkylaminosulfonyl, Alkylsulfonyl, Cycloalkylsulfonyl, Arylsulfonyl, Alkylsulfinyl,  Alkylaminosulfonyl, bisalkylaminosulfonyl, cycloalkylaminosulfonyl, haloalkylaminosulfonyl, arylaminosulfonyl, arylalkylaminosulfonyl, alkylsulfonyl, cycloalkylsulfonyl, arylsulfonyl, alkylsulfinyl,
Cycloalkylsulfinyl, Arylsulfinyl, N,S-Dialkylsulfonimidoyl, S- Alkylsulfonimidoyl, Alkylsulfonylaminocarbonyl,  Cycloalkylsulfinyl, arylsulfinyl, N, S-dialkylsulfonimidoyl, S-alkylsulfonimidoyl, alkylsulfonylaminocarbonyl,
Cycloalkylsulfonylaminocarbonyl, Cycloalkylaminosulfonyl,  Cycloalkylsulfonylaminocarbonyl, cycloalkylaminosulfonyl,
Arylalkylcarbonylam ino, Cycloalkylalkylcarbonylam ino,  Arylalkylcarbonylamino, cycloalkylalkylcarbonylamino,
Heteroarylcarbonylamino, Alkoxyalkylcarbonylamino,  Heteroarylcarbonylamino, alkoxyalkylcarbonylamino,
Hydroxyalkylcarbonylamino, Trialkylsilyl stehen,  Hydroxyalkylcarbonylamino, trialkylsilyl,
A1, A2, A3 gleich oder verschieden sind und unabhängig voneinander für NA 1 , A 2 , A 3 are the same or different and are independently N
(Stickstoff) oder die Gruppierung C-R8 stehen, wobei jedoch in keinem Fall mehr als zwei N-Atome benachbart sind, und wobei R8 in der Gruppierung C-R8 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, (Nitrogen) or the group CR 8 , but in no case more than two N atoms are adjacent, and wherein R 8 in the group CR 8 each have the same or different meanings as defined below,
A1 und A2, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6- gliedrigen Ring bilden, A2 und A3, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6- gliedrigen Ring bilden, A 1 and A 2 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form, A 2 and A 3 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
R8, R14, R15 und R21 unabhängig voneinander jeweils für Wasserstoff, Nitro, Amino, Hydroxy, Hydrothio, Thiocyanato, Isothiocyanato, Halogen, Alkyl, Cycloalkyl, Alkenyl, Alkinyl, Aryl, Arylalkyl, Aryiaikoxy, Heteroaryl,R 8 , R 14 , R 15 and R 21 independently of one another each represent hydrogen, nitro, amino, hydroxyl, hydrothio, thiocyanato, isothiocyanato, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, arylakoxy, heteroaryl,
Haloalkyl, Halocycloalkyl, Alkoxy, Haloalkoxy, Aryloxy, Heteroaryloxy, Cycloalkyloxy, Cycloalkylalkoxy, Hydroxyalkyl, Alkoxyalkyl, Haloalkyl, halocycloalkyl, alkoxy, haloalkoxy, aryloxy, heteroaryloxy, cycloalkyloxy, cycloalkylalkoxy, hydroxyalkyl, alkoxyalkyl,
Aryloxyalkyl, Heteroaryloxyalkyl, Alkenylaminocarbonyl, Alkylamino, Alkylthio, Haloalkylthio, Bisalkylamino, Cycloalkylamino,  Aryloxyalkyl, heteroaryloxyalkyl, alkenylaminocarbonyl, alkylamino, alkylthio, haloalkylthio, bisalkylamino, cycloalkylamino,
Alkylcarbonylamino, Cycloalkylcarbonylamino, Formylamino,  Alkylcarbonylamino, cycloalkylcarbonylamino, formylamino,
Haloalkylcarbonylamino, Alkoxycarbonylamino,  Haloalkylcarbonylamino, alkoxycarbonylamino,
Alkylaminocarbonylamino, (Alkyl-)aminocarbonylamino,  Alkylaminocarbonylamino, (alkyl) aminocarbonylamino,
Alkylsulfonylamino, Cycloalkylsulfonylamino, Arylsulfonylamino, Hetarylsulfonylamino, Sulfonylhaloalkylamino, Aminoalkylsulfonyl, Aminohaloalkylsulfonyl, Alkylaminosulfonyl, Bisalkylaminosulfonyl, Alkylsulfonylamino, cycloalkylsulfonylamino, arylsulfonylamino, hetarylsulfonylamino, sulfonylhaloalkylamino, aminoalkylsulfonyl, aminohaloalkylsulfonyl, alkylaminosulfonyl, bisalkylaminosulfonyl,
Cycloalkylaminosulfonyl, Haloalkylaminosulfonyl, Arylaminosulfonyl, Arylalkylaminosulfonyl, Alkylsulfonyl, Cycloalkylsulfonyl, Arylsulfonyl, Alkylsulfinyl, Cycloalkylsulfinyl, Aryisuifinyi, N,S-Dialkylsulfonimidoyl, S- Alkylsulfonimidoyl, Alkylsulfonylaminocarbonyl, Cycloalkylaminosulfonyl, haloalkylaminosulfonyl, arylaminosulfonyl, arylalkylaminosulfonyl, alkylsulfonyl, cycloalkylsulfonyl, arylsulfonyl, alkylsulfinyl, cycloalkylsulfinyl, arylsulfinyl, N, S-dialkylsulfonimidoyl, S-alkylsulfonimidoyl, alkylsulfonylaminocarbonyl,
Cycloalkylsulfonylaminocarbonyl, Cycloalkylaminosulfonyl,  Cycloalkylsulfonylaminocarbonyl, cycloalkylaminosulfonyl,
Arylalkylcarbonylam ino, Cycloalkylalkylcarbonylam ino,  Arylalkylcarbonylamino, cycloalkylalkylcarbonylamino,
Heteroarylcarbonylamino, Alkoxyalkylcarbonylamino,  Heteroarylcarbonylamino, alkoxyalkylcarbonylamino,
Hydroxyalkylcarbonylamino, Cyano, Cyanoalkyl, Hydroxycarbonyl, Alkoxycarbonyl, Cycloalkoxycarbonyl, Cycloalkylalkoxycarbonyl, Aryloxycarbonyl, Arylalkoxycarbonyl, Aminocarbonyl,  Hydroxyalkylcarbonylamino, cyano, cyanoalkyl, hydroxycarbonyl, alkoxycarbonyl, cycloalkoxycarbonyl, cycloalkylalkoxycarbonyl, aryloxycarbonyl, arylalkoxycarbonyl, aminocarbonyl,
Alkylaminocarbonyl, Bisalkylaminocarbonyl,  Alkylaminocarbonyl, bisalkylaminocarbonyl,
Alkyl(Alkoxy)aminocarbonyl, Cycloalkylaminocarbonyl, Arylalkylaminocarbonyl, Heteroarylalkylaminocarbonyl, Alkyl (alkoxy) aminocarbonyl, cycloalkylaminocarbonyl, Arylalkylaminocarbonyl, heteroarylalkylaminocarbonyl,
Cyanoalkylaminocarbonyl, Haloalkylaminocarbonyl, Cyanoalkylaminocarbonyl, haloalkylaminocarbonyl,
Alkinylalkylaminocarbonyl, Alkoxycarbonylaminocarbonyl, Alkynylalkylaminocarbonyl, alkoxycarbonylaminocarbonyl,
Arylalkoxycarbonylaminocarbonyl, Hydroxycarbonylalkyl, Arylalkoxycarbonylaminocarbonyl, hydroxycarbonylalkyl,
Alkoxycarbonylalkyl, Cycloalkoxycarbonylalkyl, Alkoxycarbonylalkyl, cycloalkoxycarbonylalkyl,
Cycloalkylalkoxycarbonylalkyl, Alkylaminocarbonylalkyl,  Cycloalkylalkoxycarbonylalkyl, alkylaminocarbonylalkyl,
Aminocarbonylalkyl, Bisalkylaminocarbonylalkyl, Aminocarbonylalkyl, bisalkylaminocarbonylalkyl,
Cycloalkylaminocarbonylalkyl, Arylalkylaminocarbonylalkyl, Cycloalkylaminocarbonylalkyl, arylalkylaminocarbonylalkyl,
Heteroarylalkylaminocarbonylalkyl, Cyanoalkylaminocarbonylalkyl, Haloalkylaminocarbonylalkyl, Alkinylalkylaminocarbonylalkyl, Heteroarylalkylaminocarbonylalkyl, cyanoalkylaminocarbonylalkyl, haloalkylaminocarbonylalkyl, alkynylalkylaminocarbonylalkyl,
Cycloalkylalkylaminocarbonylalkyl, Alkoxycarbonylaminocarbonylalkyl, Arylalkoxycarbonylaminocarbonylalkyl,  Cycloalkylalkylaminocarbonylalkyl, alkoxycarbonylaminocarbonylalkyl, arylalkoxycarbonylaminocarbonylalkyl,
Alkoxycarbonylalkylaminocarbonyl, Alkoxycarbonylalkylaminocarbonyl,
Hydroxycarbonylalkylaminocarbonyl, Hydroxycarbonylalkylaminocarbonyl,
Aminocarbonylalkylaminocarbonyl, Aminocarbonylalkylaminocarbonyl,
Alkylaminocarbonylalkylaminocarbonyl,  Alkylaminocarbonylalkylaminocarbonyl,
Cycloalkylaminocarbonylalkylaminocarbonyl, Cycloalkylaminocarbonylalkylaminocarbonyl,
Cycloalkylalkylaminocarbonyl, Cycloalkylalkylaminocarbonylalkyl, Alkenyloxycarbonyl, Alkenyloxycarbonylalkyl, Alkenylaminocarbonyl, Alkenylalkylaminocarbonyl, Alkenylaminocarbonylalkyl, Cycloalkylalkylaminocarbonyl, cycloalkylalkylaminocarbonylalkyl, alkenyloxycarbonyl, alkenyloxycarbonylalkyl, alkenylaminocarbonyl, alkenylalkylaminocarbonyl, alkenylaminocarbonylalkyl,
Alkenylalkylaminocarbonylalkyl, Alkylcarbonyl, Cycloalkylcarbonyl, Formyl, Hydroxyiminomethyl, Aminoiminomethyl, Alkoxyiminomethyl, Alkylaminoiminomethyl, Dialkylaminoiminomethyl,  Alkenylalkylaminocarbonylalkyl, alkylcarbonyl, cycloalkylcarbonyl, formyl, hydroxyiminomethyl, aminoiminomethyl, alkoxyiminomethyl, alkylaminoiminomethyl, dialkylaminoiminomethyl,
Cycloalkoxyiminomethyl, Cycloalkylalkoximinomethyl, Cycloalkoxyiminomethyl, cycloalkylalkoximinomethyl,
Aryloximinomethyl, Arylalkoxyiminomethyl, Arylalkylaminoiminomethyl,Aryloximinomethyl, arylalkoxyiminomethyl, arylalkylaminoiminomethyl,
Alkenyloxyiminomethyl, Arylaminoiminomethyl, Alkenyloxyiminomethyl, arylaminoiminomethyl,
Arylsulfonylaminoiminomethyl, Heteroarylalkyl, Heterocyclylalkyl, Hydroxycarbonylheterocyclyl, Alkoxycarbonylheterocyclyl, Arylsulfonylaminoiminomethyl, heteroarylalkyl, heterocyclylalkyl, hydroxycarbonylheterocyclyl, alkoxycarbonylheterocyclyl,
Alkenyloxycarbonylheterocyclyl, Alkenylalkoxycarbonylheterocyclyl, Arylalkoxycarbonylheterocyclyl, Cycloalkoxycarbonylheterocyclyl,Alkenyloxycarbonylheterocyclyl, alkenylalkoxycarbonylheterocyclyl, arylalkoxycarbonylheterocyclyl, cycloalkoxycarbonylheterocyclyl,
Cycloalkylalkoxycarbonylheterocyclyl, Aminocarbonylheterocyclyl, Alkylaminocarbonylheterocyclyl, Bis-Alkylaminocarbonylheterocyclyl, Cycloalkylaminocarbonylheterocyclyl, Cycloalkylalkoxycarbonylheterocyclyl, aminocarbonylheterocyclyl, alkylaminocarbonylheterocyclyl, bis-alkylaminocarbonylheterocyclyl, Cycloalkylaminocarbonylheterocyclyl,
Arylalkylaminocarbonylheterocyclyl, Alkenylaminocarbonylheterocyclyl, Hydroxycarbonylheterocyclylalkyl, Alkoxycarbonylheterocyclylalkyl, Hydroxycarbonylcycloalkylalkyl, Alkoxycarbonylcycloalkylalkyl stehen,  Arylalkylaminocarbonylheterocyclyl, alkenylaminocarbonylheterocyclyl, hydroxycarbonylheterocyclylalkyl, alkoxycarbonylheterocyclylalkyl, hydroxycarbonylcycloalkylalkyl, alkoxycarbonylcycloalkylalkyl,
R9 und R10 unabhängig voneinander für Wasserstoff, Halogen, Alkyl, Alkoxy, Haloalkyl, Haloalkoxy, Aryl, Heteroaryl, Arylalkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine R 9 and R 10 are each independently hydrogen, halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, aryl, heteroaryl, arylalkyl, or together with the atom to which they are attached
Carbonylgruppe bilden,  Form carbonyl group,
A4, A5 gleich oder verschieden sind und unabhängig voneinander für N-R11, Sauerstoff, Schwefel oder die Gruppierung C-R11 stehen, wobei jedoch in keinem Fall mehr als ein Sauerstoffatom im Heterocyclus enthalten ist, und wobei R11 in den Gruppierungen N-R11 und C-R11 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, A 4 , A 5 are the same or different and are independently NR 11 , oxygen, sulfur or the group CR 11 , but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groups NR 11 and CR 11 has the same or different meanings as defined below,
R11 für Wasserstoff, Alkyl, Alkenylalkyl, Alkoxyalkyl, Alkylcarbonyl, R 11 is hydrogen, alkyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl,
Arylcarbonyl, Heteroarylcarbonyl, Cycloalkylcarbonyl, Alkoxycarbonyl, Alkenyloxycarbonyl, Alkoxycarbonylalkyl, Alkylaminocarbonylalkyl, Arylaminocarbonylalkyl, Aryloxyalkyl, Arylalkyl, Heteroarylalkyl, Haloalkyl steht,  Arylcarbonyl, heteroarylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, alkenyloxycarbonyl, alkoxycarbonylalkyl, alkylaminocarbonylalkyl, arylaminocarbonylalkyl, aryloxyalkyl, arylalkyl, heteroarylalkyl, haloalkyl,
R12 und R13 unabhängig voneinander für Wasserstoff, Halogen, Alkyl, Alkoxy, Haloalkyl, Haloalkoxy, Aryl, Heteroaryl, Arylalkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine R 12 and R 13 independently represent hydrogen, halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, aryl, heteroaryl, arylalkyl or together with the atom to which they are attached, a
Carbonylgruppe bilden,  Form carbonyl group,
A6, A7, A8, A9 gleich oder verschieden sind und unabhängig voneinander für 0, S, N, NH, N-Alkyl, Alkoxycarbonyl-N, N-Aryl, N-Heteroaryl, N- Heterocyclyl, Alkoxyalkyl-N, Arylsulfonyl-N, Alkylsulfonyl-N, A 6 , A 7 , A 8 , A 9 are the same or different and are each independently 0, S, N, NH, N-alkyl, alkoxycarbonyl-N, N-aryl, N-heteroaryl, N-heterocyclyl, alkoxyalkyl-N , Arylsulfonyl-N, alkylsulfonyl-N,
Cycloalkylsulfonyl-N oder die Gruppierung C-R15 stehen, wobei maximal zwei 0- oder S-Atome im Heterocyclus vorhanden sind sind, und wobei keine 0- oder S-Atome benachbart zueinander sind, und wobei R15 in der Gruppierung C-R15 jeweils gleiche oder verschiedene Bedeutungen gemäß der vorstehenden Definition hat, Cycloalkylsulfonyl-N or the group CR 15 , wherein a maximum of two O or S atoms are present in the heterocycle, and wherein no O or S atoms are adjacent to one another, and wherein R 15 in the group CR 15 has the same or different meanings as defined above,
R16 und R17 unabhängig voneinander für Wasserstoff, Halogen, Alkyl, Alkoxy, Haloalkyl, Haloalkoxy, Aryl, Heteroaryl, Arylalkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine R 16 and R 17 independently represent hydrogen, halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, aryl, heteroaryl, arylalkyl or together with the atom to which they are attached, a
Carbonylgruppe bilden,  Form carbonyl group,
A10 für N-R18, Sauerstoff oder die Gruppierung C-R18 steht und wobei R18 in den Gruppierungen N-R18 und C-R18 jeweils gleiche oder A 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or
verschiedene Bedeutungen gemäß der nachstehenden Definition hat,  has different meanings as defined below,
R18 für Wasserstoff, Alkyl, Alkenylalkyl, Alkoxyalkyl, Alkylcarbonyl, R 18 is hydrogen, alkyl, alkenylalkyl, alkoxyalkyl, alkylcarbonyl,
Arylcarbonyl, Heteroarylcarbonyl, Cycloalkylcarbonyl, Alkoxycarbonyl, Allyloxycarbonyl, Aryloxyalkyl, Arylalkyl, Haloalkyl, Aryl steht,  Arylcarbonyl, heteroarylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, allyloxycarbonyl, aryloxyalkyl, arylalkyl, haloalkyl, aryl,
A11 für N oder die Gruppierung C-R21 steht und wobei R21 in der A 11 is N or the group CR 21 and R 21 is in the
Gruppierung C-R21 die Bedeutung gemäß der vorstehenen Definition hat, Grouping CR 21 has the meaning as defined above,
A12 für N-R18 oder die Gruppierung C(R19)R20 steht und wobei R19 und R20 in der Gruppierung C(R19)R20 die Bedeutung gemäß der A 12 stands for NR 18 or the group C (R 19 ) R 20 and where R 19 and R 20 in the group C (R 19 ) R 20 are as defined in the group
nachstehenden Definition haben,  have the following definition,
R19 und R20 unabhängig voneinander für Wasserstoff, Halogen, Alkyl, Alkoxy, Haloalkyl, Haloalkoxy, Aryl, Heteroaryl, Arylalkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine R 19 and R 20 independently represent hydrogen, halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, aryl, heteroaryl, arylalkyl or together with the atom to which they are attached, a
Carbonylgruppe bilden, mit Ausnahme von 4-Hydroxy-4-{(E)-2-[2-(hydroxymethyl)phenyl]vinyl}-3,5,5- trimethylcyclohex-2-en-1 -on, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4- oxocyclohex-2-en-1 -yl)vinyl]benzaldehyd, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl- 4-oxocyclohex-2-en-1 -yl)vinyl]benzoesäure und Methyl-2-[(E)-2-(1 -hydroxy- 2,6,6-trimethyl-4-oxocyclohex-2-en-1 -yl)vinyl]benzoat. Form carbonyl group, with the exception of 4-hydroxy-4 - {(E) -2- [2- (hydroxymethyl) phenyl] vinyl} -3,5,5-trimethylcyclohex-2-en-1-one, 2 - [(E) - 2- (1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzaldehyde, 2 - [(E) -2- (1-hydroxy-2,6,6 -trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid and methyl 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-ene 1 -yl) vinyl] benzoate.
Substituierte Vinyl- und Alkinyl-cyclohexenole der allgemeinen Formel (I) nach Anspruch 1 oder deren Salze, worin Substituted vinyl and alkynylcyclohexenols of the general formula (I) according to Claim 1 or their salts, in which
[X-Y] für die Gruppierungen [X-Y] for the groupings
[χ-γ]ΐ [χ-γ und [x-Y]3 ste ht [χ-γ] ΐ [χ-γ and [XY] ste 3 ht
Q für die carbocyclischen und heterocyclischen Gruppierungen Q-1 bis Q-4 Q for the carbocyclic and heterocyclic moieties Q-1 to Q-4
Q-1 , Q-2 _ Q-3 und Q"4 steht, wobei die Gruppierungen R6 bis R21 und A1 bis A12 jeweils die Q-1, Q-2 _ Q-3 and Q " 4 , wherein the groups R 6 to R 21 and A 1 to A 12 are each the
Bedeutung gemäß der nachstehenden Definitionen haben und wobei der Pfeil für eine Bindung zur jeweiligen Gruppierung [X-Y] steht, Have meaning according to the definitions below and wherein the arrow represents a bond to the respective grouping [X-Y],
R1 für (Ci-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C2-C8)-Alkenyl-R 1 is (Ci-C 8) alkyl, (C 2 -C 8) alkenyl, (C 2 -C 8) -alkynyl, (C 2 -C 8) alkenyl
(Ci-Cs)-alkyl, (C2-C8)-Alkinyl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Hydroxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylamino, Sulfonylamino, (Ci-Ce)- Alkoxy, (Ci-Ce)-Haloalkyl, (Ci-C8)-Haloalkoxy-(Ci-C8)-alkyl steht, (Ci-Cs) alkyl, (C2-C8) alkynyl (Ci-C 8) alkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, Hydroxy (Ci-C8) -alkyl, (Ci-C8) -alkylamino, sulfonylamino, (Ci-Ce) - alkoxy, (Ci-Ce) -haloalkyl, (Ci-C 8 ) -haloalkoxy- (Ci-C 8 ) -alkyl,
R2 für Wasserstoff, (Ci-C8)-Alkyl, Nitro-(Ci-C8)-alkyl, Hydroxy-(Ci-C8)- alkyl, (Ci-C8)-Haloalkyl, (Ci-C8)-Alkylamino, Sulfonylamino, (Ci-C8)- Alkoxy, Tris-[(Ci-Ce)-alkylsilyl]- (Ci-C8)-alkyl, Cyano-(Ci-C8)-alkyl, Aryl- (Ci-Ce)-alkyl, (Ci-C8)-Alkoxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)- Haloalkoxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)-Alkylthio-(Ci-C8)-alkyl, Arylthio-(Ci-C8)-alkyl steht, R 2 is hydrogen, (Ci-C 8) -alkyl, nitro, (Ci-C 8) alkyl, hydroxy (Ci-C 8) - alkyl, (Ci-C 8) haloalkyl, (Ci-C 8 ) -Alkylamino, sulfonylamino, (C 1 -C 8 ) -alkoxy, tris - [(C 1 -C 6) -alkylsilyl] - (C 1 -C 8 ) -alkyl, cyano- (C 1 -C 8 ) -alkyl, aryl- ( C 1 -C 6) -alkyl, (C 1 -C 8 ) -alkoxycarbonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -haloalkoxycarbonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) - Alkylthio (C 1 -C 8 ) -alkyl, arylthio (C 1 -C 8 ) -alkyl,
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig R 1 and R 2 with the atoms to which they are attached, a complete
gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden, R3 und R4 unabhängig voneinander für (Ci-C8)-Alkoxy, (Ci-C8)-Alkoxy-(Ci-C8)- alkoxy, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxy, (Ci-C8)-Haloalkoxy, (Ci-C8)- Alkylthio, (Ci-C8)-Haloalkylthio stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, form saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring, R 3 and R 4 are independently (Ci-C8) alkoxy, (Ci-C8) alkoxy- (Ci-C8) - alkoxy, (C3-C8) -cycloalkyl- (Ci-C8) alkoxy, (Ci-C8) -haloalkoxy, (Ci-C 8) - alkylthio, (Ci-C8) haloalkylthio or together with the atom to which they are attached, an oxo group, hydroxyimino group,
(Ci-C8)-Alkoxyiminogruppe, (Ci-C8)-alkenyloximinogruppe, (C3-Cs)- Cycloalkoxyiminogruppe, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoximinogruppe, (C 1 -C 8) -alkoxyimino group, (C 1 -C 8) -alkenyloximino group, (C 3 -C 5) -cycloalkoxyimino group, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkoximino group,
Aryl-(Ci-C8)-alkoxyiminogruppe oder einen 5-7-gliedrigen Aryl- (C 1 -C 8) alkoxyimino group or a 5-7 membered one
heterocyclischen Ring, der gegebenenfalls weiter substituiert sein kann, bilden, R5 für Wasserstoff, (Ci-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkenyl-(Ci-C8)- alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C8)-Cycloalkylcarbonyl, (Ci-Cs)- Alkoxycarbonyl, (C2-C8)-Alkenyloxycarbonyl, Aryloxy-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkoxy-(Ci-C8)-alkyl, (Ci-C8)- Alkylthio-(Ci-C8)-alkyl, Tris-[(Ci-C8)-alkyl]silyl, (Ci-C8)-Alkyl-Bis-heterocyclic ring, which may optionally be further substituted, form, R 5 is hydrogen, (Ci-C 8 ) alkyl, (C 2 -C 8 ) alkenyl, (C 2 -C 8 ) alkenyl (Ci-C 8 ) - alkyl, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 8 ) -cycloalkylcarbonyl, (C 1 -C 8 ) -alkoxycarbonyl , (C 2 -C 8 ) -alkenyloxycarbonyl, aryloxy- (C 1 -C 8 ) -alkyl, aryl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkoxy- (ci) C 8) alkyl, (Ci-C 8) - alkylthio (Ci-C8) alkyl, tris - [(Ci-C 8) alkyl] silyl, (Ci-C 8) -alkyl-bis-
[(Ci-C8)-alkyl]silyl, (Ci-C8)-Alkyl-bis-Arylsilyl, Aryl-bis-[(Ci-C8)-alkyl]silyl, (C3-Ce)-Cycloalkyl-bis-[(Ci-Ce)-alkyl]silyl, Halo-bis-[(Ci-C8)-alkyl]silyl, Tns-[(Ci-C8)-alkyl]silyl-(Ci-C8)-alkoxy-(Ci-C8)-alkyl steht, und R7 unabhängig voneinander für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-C8)-Alkyl, (C3-C8)- Cycloalkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, Aryl, Aryl-(Ci-C8)-alkyl, (C2-C8)-Alkenyl-(Ci-C8)-alkyl, (C2-C8)-Alkinyl-(Ci-C8)-alkyl, Aryl-(Ci-Cs) alkoxy, Heteroaryl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Hydroxy-(Ci-C8)-alkyl, (Ci-C8)-Haloalkyl, (C3-C8)-Halocycloalkyl, (Ci-C8)-Alkoxy, (Ci-C8)- Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C8)-Cycloalkyloxy, Hydroxy, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxy, (Ci-C8)-Alkoxycarbonyl, [(C 1 -C 8 ) -alkyl] silyl, (C 1 -C 8 ) -alkyl-bis-arylsilyl, aryl-bis - [(C 1 -C 8 ) -alkyl] -silyl, (C3-Ce) cycloalkyl-bis - [(Ci-Ce) alkyl] silyl, halo-bis - [(Ci-C 8) alkyl] silyl, Tns - [(Ci-C 8) alkyl] silyl (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, and R 7 independently of one another represent hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, (C 1 -C 8 ) -alkyl, (C 3 -C 4) -alkyl C 8) - cycloalkyl, (C 2 -C 8) alkenyl, (C 2 -C 8) alkynyl, aryl, aryl (Ci-C8) alkyl, (C2-C8) alkenyl (C -C 8) alkyl, (C2-C8) alkynyl (Ci-C 8) alkyl, aryl (Ci-Cs) alkoxy, heteroaryl, (Ci-C 8) alkoxy (Ci-C 8 ) alkyl, hydroxy (Ci-C 8) alkyl, (Ci-C8) -haloalkyl, (C 3 -C 8) halocycloalkyl, (Ci-C 8) alkoxy, (Ci-C 8) - Haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 8 ) -cycloalkyloxy, hydroxy, (C 3 -C 8 ) -cycloalkyl- (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -alkoxycarbonyl,
Hydroxycarbonyl, Aminocarbonyl, (Ci-C8)-Alkylaminocarbonyl, (C3-C8)- Cycloalkylaminocarbonyl, Cyano-(Ci-C8)-alkylaminocarbonyl, (C2-C8)- Alkenylaminocarbonyl, (C2-C8)-Alkinylaminocarbonyl, (Ci-C8)- Alkylamino, (Ci-C8)-Alkylthio, (Ci-C8)-Haloalkylthio, Hydrothio, Bis- (Ci-C8)-alkylamino, (C3-C8)-Cycloalkylamino, (Ci-C8)- Alkylcarbonylamino, (C3-C8)-Cycloalkylcarbonylamino, Formylamino, (Ci-C8)-Haloalkylcarbonylamino, (Ci-C8)-Alkoxycarbonylamino, Hydroxycarbonyl, aminocarbonyl, (Ci-C8) alkylaminocarbonyl, (C3-C8) - cycloalkylaminocarbonyl, cyano (Ci-C8) alkylaminocarbonyl, (C2-C8) - alkenylaminocarbonyl, (C2-C8) -Alkinylaminocarbonyl, (C -C 8) - alkylamino, (Ci-C8) alkylthio, (Ci-C8) haloalkylthio, Hydrothio, bis (Ci-C8) alkylamino, (C3-C8) cycloalkylamino, (Ci-C 8 ) - alkylcarbonylamino, (C 3 -C 8) -cycloalkylcarbonylamino, formylamino, (C 1 -C 8) -haloalkylcarbonylamino, (C 1 -C 8) -alkoxycarbonylamino,
(Ci-C8)-Alkylaminocarbonylamino, (Ci-C8)-Alkyl-[(Ci-C8)-Alkyl]- aminocarbonylamino, (Ci-C8)-Alkylsulfonylamino, (C3-C8)- Cycloalkylsulfonylamino, Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl-(Ci-C8)-haloalkylamino, Aminosulfonyl, Amino-(Ci-C8)- alkylsulfonyl, Amino-(Ci-C8)-haloalkylsulfonyl, (Ci-C8)- Alkylaminosulfonyl, Bis-[(Ci-C8)-alkyl]aminosulfonyl, (C3-C8)- Cycloalkylaminosulfonyl, (Ci-C8)-Haloalkylaminosulfonyl, (Ci-C8) alkylaminocarbonylamino, (Ci-C8) alkyl - [(Ci-C 8) -alkyl] - aminocarbonylamino, (Ci-C8) alkylsulfonylamino, (C3-C8) - cycloalkylsulfonylamino, arylsulfonylamino, Hetarylsulfonylamino, sulfonyl (Ci-C8) -haloalkylamino, aminosulfonyl, amino (Ci-C 8) - alkylsulfonyl, amino (Ci-C8) haloalkylsulfonyl, (Ci-C 8) - alkylaminosulfonyl, bis - [(Ci- C 8 ) -alkyl] aminosulfonyl, (C 3 -C 8 ) -cycloalkylaminosulfonyl, (C 1 -C 8 ) -haloalkylaminosulfonyl,
Arylaminosulfonyl, Aryl-(Ci-C8)-alkylaminosulfonyl, (Ci-C8)- Alkylsulfonyl, (C3-C8)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C8)- Alkylsulfinyl, (C3-C8)-Cycloalkylsulfinyl, Arylsulfinyl, N,S-Di-(Ci-C8)- alkylsulfonimidoyl, S-(Ci-C8)-Alkylsulfonimidoyl, (Ci-C8)- Alkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylaminosulfonyl, Aryl-(Ci-C8)-alkylcarbonylamino, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C8)-Alkoxy-(Ci-C8)-alkylcarbonylamino, Hydroxy-(Ci-C8)-alkylcarbonylamino, Tris-[(Ci-C8)-alkyl]silyl stehen, Arylaminosulfonyl, aryl (Ci-C8) -alkylaminosulfonyl, (Ci-C 8) - alkylsulfonyl, (C 3 -C 8) cycloalkylsulfonyl, arylsulfonyl, (Ci-C 8) - alkylsulfinyl, (C 3 -C 8) - cycloalkylsulfinyl, arylsulfinyl, N, S-di- (Ci-C 8) - alkylsulfonimidoyl, S- (Ci-C8) -Alkylsulfonimidoyl, (Ci-C 8) - alkylsulfonylaminocarbonyl, (C3-C8) -Cycloalkylsulfonylaminocarbonyl, (C3 -C 8) -Cycloalkylaminosulfonyl, aryl (Ci-C8) alkylcarbonylamino, (C3-C8) -cycloalkyl- (Ci-C8) alkylcarbonylamino, Heteroarylcarbonylamino, (C 1 -C 8) -alkoxy- (C 1 -C 8) -alkylcarbonylamino, hydroxy- (C 1 -C 8) -alkylcarbonylamino, tris - [(C 1 -C 8) -alkyl] silyl,
A1, A2, A3 gleich oder verschieden sind und unabhängig voneinander für NA 1 , A 2 , A 3 are the same or different and are independently N
(Stickstoff) oder die Gruppierung C-R8 stehen, wobei jedoch in keinem Fall mehr als zwei N-Atome benachbart sind, und wobei R8 in der Gruppierung C-R8 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, (Nitrogen) or the group CR 8 , but in no case more than two N atoms are adjacent, and wherein R 8 in the group CR 8 each have the same or different meanings as defined below,
A1 und A2, wenn beide für eine Gruppe C-R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6- gliedrigen Ring bilden, A 1 and A 2 , when both represent a group CR 8 , with the atoms to which they are attached form a completely saturated, partially saturated or completely unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring,
A2 und A3, wenn beide für eine Gruppe C-R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6- gliedrigen Ring bilden, A 2 and A 3 , when both represent a group CR 8 , with the atoms to which they are attached form a fully saturated, partially saturated or completely unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring,
R8, R14, R15 und R21 unabhängig voneinander jeweils für Wasserstoff, Nitro, Amino, Hydroxy, Hydrothio, Thiocyanato, Isothiocyanato, Halogen, (Ci-Ce)-Alkyl, (C3-C8)-Cycloalkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, Aryl, Aryl-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkoxy, Heteroaryl, (Ci-C8)-Haloalkyl, (Ci-C8)-Halocycloalkyl, (Ci-C8)-Alkoxy, (Ci-C8)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C8)-Cycloalkyloxy, (C3-C8)-Cycloalkyl-(Ci-C8)- alkoxy, Hydroxy-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Aryloxy- (Ci-C8)-alkyl, Heteroaryloxy-(Ci-C8)-alkyl, (C2-C8)- Alkenylaminocarbonyl, (Ci-C8)-Alkylamino, (Ci-C8)-Alkylthio, (Ci-C8)- Haloalkylthio, Bis-[(Ci-C8)-alkyl]amino, (C3-C8)-Cycloalkylamino, (Ci-C8)-Alkylcarbonylamino, (C3-C8)-Cycloalkylcarbonylamino, Formylamino, (Ci-C8)-Haloalkylcarbonylamino, (Ci-Cs)- Alkoxycarbonylamino, (Ci-C8)-Alkylaminocarbonylamino, (Ci-Cs)- Alkyl[(Ci-C8)-Alkyl]-aminocarbonylamino, (Ci-C8)-Alkylsulfonylamino, (C3-C8)-Cycloalkylsulfonylamino, Arylsulfonylamino, R 8 , R 14 , R 15 and R 21 independently of one another each represent hydrogen, nitro, amino, hydroxyl, hydrothio, thiocyanato, isothiocyanato, halogen, (C 1 -C 6 ) -alkyl, (C 3 -C 8 ) -cycloalkyl, ( C 2 -C 8) alkenyl, (C 2 -C 8) alkynyl, aryl, aryl (Ci-C 8) alkyl, aryl (Ci-C 8) alkoxy, heteroaryl, (Ci-C 8 ) -Haloalkyl, (C 1 -C 8 ) -halocycloalkyl, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 8 ) -cycloalkyloxy, (C 3 -C 8 ) -cycloalkyl - (C 1 -C 8 ) -alkoxy, hydroxy- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, aryloxy- (C 1 -C 8 ) -alkyl, heteroaryloxy - (Ci-C 8) alkyl, (C 2 -C 8) - alkenylaminocarbonyl, (Ci-C 8) alkylamino, (Ci-C8) alkylthio, (Ci-C 8) - haloalkylthio, bis [ (C 1 -C 8) -alkyl] amino, (C 3 -C 8) -cycloalkylamino, (C 1 -C 8) -alkylcarbonylamino, (C 3 -C 8) -cycloalkylcarbonylamino, Formylamino, (C 1 -C 8) -haloalkylcarbonylamino, (C 1 -C 8) -alkoxycarbonylamino, (C 1 -C 8) -alkylaminocarbonylamino, (C 1 -C 8) -alkyl [(C 1 -C 8) -alkyl] -aminocarbonylamino, (C 1 -C 8) Alkylsulfonylamino, (C 3 -C 8) -cycloalkylsulfonylamino, arylsulfonylamino,
Hetarylsulfonylamino, Sulfonyl-(Ci-C8)-haloalkylamino, Amino-(Ci-C8)- alkylsulfonyl, Amino-(Ci-C8)-haloalkylsulfonyl, (Ci-Cs)- Alkylaminosulfonyl, Bis-(Ci-C8)-alkylaminosulfonyl, (C3-C8)- Cycloalkylaminosulfonyl, (Ci-C8)-Haloalkylaminosulfonyl, Hetarylsulfonylamino, sulfonyl- (C 1 -C 8) -haloalkylamino, amino- (C 1 -C 8) -alkylsulfonyl, amino- (C 1 -C 8) -haloalkylsulfonyl, (C 1 -C 8) -alkylaminosulfonyl, bis (C 1 -C 8) -alkylaminosulfonyl, (C 3 -C 8) -cycloalkylaminosulfonyl, (C 1 -C 8) -haloalkylaminosulfonyl,
Arylaminosulfonyl, Aryl-(Ci-C8)-alkylaminosulfonyl, (Ci-Ce)- Alkylsulfonyl, (C3-C8)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C8)- Alkylsulfinyl, (C3-C8)-Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-(Ci-C8)- alkylsulfonimidoyl, S-(Ci-C8)-Alkylsulfonimidoyl, (Ci-Cs)- Alkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylaminosulfonyl, Aryl-(Ci-C8)-alkylcarbonylamino, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylcarbonylamino, Arylaminosulfonyl, aryl (Ci-C8) -alkylaminosulfonyl, (Ci-Ce) - alkylsulfonyl, (C 3 -C 8) cycloalkylsulfonyl, arylsulfonyl, (Ci-C 8) - alkylsulfinyl, (C 3 -C 8) cycloalkylsulfinyl , Arylsulfinyl, N, S-bis- (C 1 -C 8 ) -alkylsulfonimidoyl, S- (C 1 -C 8 ) -alkylsulfonimidoyl, (C 1 -C 8 ) -alkylsulfonylaminocarbonyl, (C 3 -C 8 ) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 8 ) - Cycloalkylaminosulfonyl, aryl- (C 1 -C 8) -alkylcarbonylamino, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkylcarbonylamino,
Heteroarylcarbonylamino, (Ci-C8)-Alkoxy-(Ci-C8)-alkylcarbonylamino, Hydroxy-(Ci-C8)-alkylcarbonylamino, Cyano, Cyano-(Ci-C8)-alkyl, Hydroxycarbonyl, (Ci-C8)-Alkoxycarbonyl, (C3-C8)- Cycloalkoxycarbonyl, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxycarbonyl, Aryloxycarbonyl, Aryl-(Ci-C8)-alkoxycarbonyl, Aminocarbonyl, (Ci-Cs)- Alkylaminocarbonyl, Bis-(Ci-C8)-alkylaminocarbonyl, (Ci-Cs)- Alkyl[(Ci-C8)-Alkoxy]aminocarbonyl, (C3-C8)-Cycloalkylaminocarbonyl, Aryl-(Ci-C8)-alkylaminocarbonyl, Heteroaryl-(Ci-C8)- alkylaminocarbonyl, Cyano-(Ci-C8)-alkylaminocarbonyl, (Ci-Cs)- Haloalkylaminocarbonyl, (C2-C8)-Alkinyl-(Ci-C8)-alkylaminocarbonyl, (Ci-C8)-Alkoxycarbonylaminocarbonyl, Aryl-(Ci-Cs)- alkoxycarbonylaminocarbonyl, Hydroxycarbonyl-(Ci-C8)-alkyl, (Ci-Cs)- Alkoxycarbonyl-(Ci-C8)-alkyl, (C3-C8)-Cycloalkoxycarbonyl-(Ci-C8)- alkyl, (Ci-C8)-Cycloalkyl-(Ci-C8)-alkoxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)- Alkylaminocarbonyl-(Ci-C8)-alkyl, Aminocarbonyl-(Ci-C8)-alkyl, Bis- (Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (C3-C8)- Cycloalkylaminocarbonyl-(Ci-C8)-alkyl, Aryl-(Ci-Cs)- alkylaminocarbonyl-(Ci-C8)-alkyl, Heteroaryl-(Ci-C8)- alkylaminocarbonyl-(Ci-C8)-alkyl, Cyano-(Ci-C8)-alkylaminocarbonyl- (Ci-Ce)-alkyl, (Ci-C8)-Haloalkylaminocarbonyl-(Ci-C8)-alkyl, (C2-C8)- Alkinyl-(Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (C3-C8)-Cycloalkyl- (Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (Ci-C8)- Alkoxycarbonylaminocarbonyl-(Ci-C8)-alkyl, Aryl-(Ci-Cs)- alkoxycarbonylaminocarbonyl-(Ci-C8)-alkyl, Heteroarylcarbonylamino, (C 1 -C 8) -alkoxy- (C 1 -C 8) -alkylcarbonylamino, hydroxy- (C 1 -C 8) -alkylcarbonylamino, cyano, cyano- (C 1 -C 8) -alkyl, hydroxycarbonyl, (C 1 -C 8) -alkoxycarbonyl, (C 3 -C 8) -cycloalkoxycarbonyl, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkoxycarbonyl, aryloxycarbonyl, aryl- (C 1 -C 8) -alkoxycarbonyl, aminocarbonyl, (C 1 -C 8) -alkylaminocarbonyl, bis (Ci -C8) -alkylaminocarbonyl, (Ci-Cs) - alkyl [(Ci-C8) -alkoxy] aminocarbonyl, (C3-C8) -cycloalkylaminocarbonyl, aryl- (Ci-C8) -alkylaminocarbonyl, heteroaryl- (Ci-C8) - alkylaminocarbonyl, cyano- (Ci-C8) -alkylaminocarbonyl, (Ci-Cs) - haloalkylaminocarbonyl, (C2-C8) -alkynyl- (Ci-C8) -alkylaminocarbonyl, (Ci-C8) -alkoxycarbonylaminocarbonyl, aryl- (Ci-Cs ) - alkoxycarbonylaminocarbonyl, hydroxycarbonyl- (Ci-C8) -alkyl, (Ci-Cs) - alkoxycarbonyl- (Ci-C8) -alkyl, (C3-C8) -cycloalkoxycarbonyl- (Ci-C8) - alkyl, (Ci-C8 ) -Cycloalkyl- (C 1 -C 8 ) -alkoxycarbonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylaminocarbonyl- (C 1 -C 8 ) -alkyl, aminocarbonyl- (C 1 -C 8 ) -alkyl, bis - (Ci-C 8 ) -alkylaminocarbonyl- (Ci-C 8 ) -alkyl, (C 3 -C 8 ) -cycloalkylaminocarbonyl- (C 1 -C 8 ) -alkyl, aryl- (C 1 -C 8 ) - alkylaminocarbonyl (C 1 -C 8) -alkyl, heteroaryl- (C 1 -C 8) -alkylaminocarbonyl- (C 1 -C 8) -alkyl, cyano- (C 1 -C 8) -alkylaminocarbonyl- (C 1 -C 6) -alkyl, (C 1 -C 8) -alkyl) 8) -Haloalkylaminocarbonyl- (Ci-C 8) alkyl, (C 2 -C 8) - alkynyl, (Ci-C8) alkylaminocarbonyl (Ci-C8) alkyl, (C 3 -C 8) - cycloalkyl (Ci-C8) alkylaminocarbonyl (Ci-C8) alkyl, (Ci-C 8) - Alkoxycarbonylaminocarbonyl- (Ci-C8) alkyl, aryl (Ci-Cs) - alkoxycarbonylaminocarbonyl- (Ci- C8) alkyl,
(Ci-C8)-Alkoxycarbonyl-(Ci-C8)-alkylaminocarbonyl, Hydroxycarbonyl- (Ci-C8)-alkylaminocarbonyl, Aminocarbonyl-(Ci-C8)- alkylaminocarbonyl, (Ci-C8)-Alkylaminocarbonyl-(Ci-C8)- alkylaminocarbonyl, (C3-C8)-Cycloalkylaminocarbonyl-(Ci-C8)- alkylaminocarbonyl, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylaminocarbonyl, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylaminocarbonyl-(Ci-C8)-alkyl, (C2-C8)- Alkenyloxycarbonyl, (C2-C8)-Alkenyloxycarbonyl-(Ci-C8)-alkyl, (C2-C8)- Alkenylaminocarbonyl, (C2-C8)-Alkenyl-(Ci-C8)-alkylaminocarbonyl, (C2-C8)-Alkenylaminocarbonyl-(Ci-C8)-alkyl, (C2-C8)-Alkenyl-(Ci-C8)- alkylaminocarbonyl-(Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, (C3-C8)- Cycloalkylcarbonyl, Formyl, Hydroxyiminomethyl, Aminoiminomethyl, (Ci-C8)-Alkoxyiminomethyl, (Ci-C8)-Alkylaminoiminomethyl, Bis- (Ci-C8)-alkylaminoiminomethyl, (C3-C8)-Cycloalkoxyiminomethyl, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoximinomethyl, Aryloximinomethyl, Aryl- (Ci-C8)-alkoxyiminomethyl, Aryl-(Ci-C8)-alkylaminoiminomethyl, (C2-C8)-Alkenyloxyiminomethyl, Arylaminoiminomethyl, (C 1 -C 8) -alkoxycarbonyl- (C 1 -C 8) -alkylaminocarbonyl, hydroxycarbonyl- (C 1 -C 8) -alkylaminocarbonyl, aminocarbonyl- (C 1 -C 8) -alkylaminocarbonyl, (C 1 -C 8) -alkylaminocarbonyl- (C 1 -C 8) - alkylaminocarbonyl, (C 3 -C 8) -cycloalkylaminocarbonyl- (C 1 -C 8) -alkylaminocarbonyl, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkylaminocarbonyl, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkylaminocarbonyl- (C 1 -C 8 ) -alkyl, (C 2 -C 8 ) -alkenyloxycarbonyl, (C 2 -C 8 ) -alkenyloxycarbonyl- (C 1 -C 8 ) -alkyl, (C 2 -C 8 ) -alkenylaminocarbonyl, (C 2 -C 8 ) -alkenyl (C 1 -C 8 ) -alkylaminocarbonyl, (C 2 -C 8 ) -alkenylaminocarbonyl- (C 1 -C 8 ) -alkyl, (C 2 -C 8 ) -alkenyl- (C 1 -C 8 ) -alkylaminocarbonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8) -alkylcarbonyl, (C 3 -C 8) -cycloalkylcarbonyl, formyl, hydroxyiminomethyl, aminoiminomethyl, (C 1 -C 8) -alkoxyiminomethyl, (C 1 -C 8) -alkylaminoiminomethyl, bis (C 1 -C 8) -alkylaminoiminomethyl , (C 3 -C 8) -cycloalkoxyiminomethyl, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkoximinomethyl, aryloximinomethyl, aryl- (C 1 -C 8) -alkoxyiminomethyl, aryl- (C 1 -C 8) -alkylaminoiminomethyl, (C2- C8) -Alkenylo xyiminomethyl, arylaminoiminomethyl,
Arylsulfonylaminoiminomethyl, Heteroaryl-(Ci-C8)-alkyl, Heterocyclyl- (Ci-C8)-alkyl, Hydroxycarbonyl heterocyclyl, (Ci-Cs)- Alkoxycarbonylheterocyclyl, (C2-C8)-Alkenyloxycarbonylheterocyclyl, (C2-C8)-Alkenyl-(Ci-C8)-alkoxycarbonylheterocyclyl, Aryl-(Ci-Cs)- alkoxycarbonylheterocyclyl, (C3-C8)-Cycloalkoxycarbonylheterocyclyl, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxycarbonylheterocyclyl, Arylsulfonylaminoiminomethyl, heteroaryl- (C 1 -C 8) -alkyl, heterocyclyl- (C 1 -C 8) -alkyl, hydroxycarbonyl-heterocyclyl, (C 1 -C 8) -alkoxycarbonyl-heterocyclyl, (C 2 -C 8) -alkenyloxycarbonyl-heterocyclyl, (C 2 -C 8) -alkenyl- C 1 -C 8) -alkoxycarbonylheterocyclyl, aryl- (C 1 -C 8) -alkoxycarbonylheterocyclyl, (C 3 -C 8) -cycloalkoxycarbonylheterocyclyl, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkoxycarbonylheterocyclyl,
Aminocarbonylheterocyclyl, (Ci-C8)-Alkylaminocarbonylheterocyclyl, Bis-(Ci-C8)-Alkylaminocarbonylheterocyclyl, (C3-C8)- Cycloalkylaminocarbonylheterocyclyl, Aryl-(Ci-Cs)- alkylaminocarbonylheterocyclyl, (C2-C8)- Alkenylaminocarbonylheterocyclyl, Hydroxycarbonylheterocyclyl- (Ci-C8)-alkyl, (Ci-C8)-Alkoxycarbonylheterocyclyl-(Ci-C8)-alkyl, Hydroxycarbonyl-(C3-C8)-cycloalkyl-(Ci-C8)-alkyl, (Ci-Cs)- Alkoxycarbonyl-(C3-C8)-cycloalkyl-(Ci-C8)-alkyl steht, Aminocarbonylheterocyclyl, (C 1 -C 8) -alkylaminocarbonylheterocyclyl, bis (C 1 -C 8) -alkylaminocarbonylheterocyclyl, (C 3 -C 8) -cycloalkylaminocarbonylheterocyclyl, aryl- (C 1 -C 5) - alkylaminocarbonylheterocyclyl, (C 2 -C 8) -alkenylaminocarbonylheterocyclyl, hydroxycarbonylheterocyclyl- (C 1 -C 8) -alkyl, (C 1 -C 8) -alkoxycarbonylheterocyclyl- (C 1 -C 8) -alkyl, hydroxycarbonyl- (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkyl ) -alkyl, (C 1 -C 8) -alkoxycarbonyl- (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkyl,
R9 und R10 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C8)-Alkyl, (Ci-C8)-Alkoxy, (Ci-C8)-Haloalkyl, (Ci-C8)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C8)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, R 9 and R 10 independently of one another represent hydrogen, halogen, (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl , Aryl- (C 1 -C 8) -alkyl or together with the atom to which they are attached form a carbonyl group,
A4, A5 gleich oder verschieden sind und unabhängig voneinander für N-R11 , Sauerstoff, Schwefel oder die Gruppierung C-R11 stehen, wobei jedoch in keinem Fall mehr als ein Sauerstoffatom im Heterocyclus enthalten ist, und wobei R11 in den Gruppierungen N-R11 und C-R11 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, A 4 , A 5 are the same or different and are independently NR 11 , oxygen, sulfur or the group CR 11 , but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groups NR 11 and CR 11 has the same or different meanings as defined below,
R für Wasserstoff, (Ci-C8)-Alkyl, (C2-C8)-Alkenyl-(Ci-C8)-alkyl, (Ci-C8)- Alkoxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, Arylcarbonyl, R is hydrogen, (Ci-C 8) -alkyl, (C2-C8) alkenyl (Ci-C 8) alkyl, (Ci-C8) - alkoxy (Ci-C 8) alkyl, ( C 1 -C 8 -alkylcarbonyl, arylcarbonyl,
Heteroarylcarbonyl, (C3-C8)-Cycloalkylcarbonyl, (Ci-Cs)- Alkoxycarbonyl, (C2-C8)-Alkenyloxycarbonyl, (Ci-C6)-Alkoxycarbonyl- (Ci-C6)-alkyl, (Ci-C6)-Alkylaminocarbonyl-(Ci-C6)-alkyl, Heteroarylcarbonyl, (C 3 -C 8) -cycloalkylcarbonyl, (C 1 -C 8) -alkoxycarbonyl, (C 2 -C 8 -alkenyloxycarbonyl, (C 1 -C 6 ) -alkoxycarbonyl- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) - Alkylaminocarbonyl- (C 1 -C 6 ) -alkyl,
Arylaminocarbonyl-(Ci-C6)-alkyl, Aryloxyalkyl, Aryl-(Ci-C8)-alkyl, Heteroaryl-(Ci-C8)-alkyl, (Ci-C8)-Haloalkyl steht, Arylaminocarbonyl- (C 1 -C 6) -alkyl, aryloxyalkyl, aryl- (C 1 -C 8 ) -alkyl, heteroaryl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -haloalkyl,
R12 und R13 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C8)-Alkyl, (Ci-C8)-Alkoxy, (Ci-C8)-Haloalkyl, (Ci-C8)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C8)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, A6, A7, A8, A9 gleich oder verschieden sind und unabhängig voneinander für 0, S, N, NH, N-(Ci-Ce)-Alkyl, (Ci-C8)-Alkoxycarbonyl-N, (Ci-C8)- Alkoxy-(Ci-C8)-alkyl-N, N-Aryl, N-Heteroaryl, N-Heterocyclyl, R 12 and R 13 independently of one another are hydrogen, halogen, (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl , Aryl- (C 1 -C 8) -alkyl or together with the atom to which they are attached form a carbonyl group, A 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N- (C 1 -C 6) -alkyl, (C 1 -C 8 ) -alkoxycarbonyl-N, (Ci -C 8) - alkoxy (Ci-C 8) alkyl-N, N-aryl, N-heteroaryl, N-heterocyclyl,
Arylsulfonyl-N, (Ci-Ce)-Alkylsulfonyl-N, (C3-C8)-Cycloalkylsulfonyl-N oder die Gruppierung C-R15 stehen, wobei maximal zwei 0- oder S- Atome im Heterocyclus vorhanden sind sind, und wobei keine 0- oder S-Atome benachbart zueinander sind, und wobei R15 in der Arylsulfonyl-N, (Ci-Ce) alkylsulfonyl-N, (C 3 -C 8 ) -cycloalkylsulfonyl-N or the group CR 15 , wherein a maximum of two 0 or S atoms in the heterocycle are present, and wherein no 0 or S atoms are adjacent to each other, and wherein R 15 in the
Gruppierung C-R15 jeweils gleiche oder verschiedene Bedeutungen gemäß der vorstehenden Definition hat, Group CR 15 has the same or different meanings as defined above,
R16 und R17 unabhängig voneinander für Wasserstoff, Halogen, (Ci-Cs)-Alkyl, (Ci-Cs)-Alkoxy, (Ci-C8)-Haloalkyl, (Ci-Cs)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C8)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, R 16 and R 17 independently of one another are hydrogen, halogen, (C 1 -C 5) -alkyl, (C 1 -C 5 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl, aryl (C 1 -C 8 ) -alkyl or together with the atom to which they are attached form a carbonyl group,
A10 für N-R18, Sauerstoff oder die Gruppierung C-R18 steht und wobei R18 in den Gruppierungen N-R18 und C-R18 jeweils gleiche oder A 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or
verschiedene Bedeutungen gemäß der nachstehenden Definition hat,  has different meanings as defined below,
R 8 für Wasserstoff, (Ci-Cs)-Alkyl, (C2-C8)-Alkenyl-(Ci-C8)-alkyl, (Ci-C8)- Alkoxy-(Ci-C8)-alkyl, (Ci-Cs)-Alkylcarbonyl, Arylcarbonyl, R 8 is hydrogen, (Ci-Cs) alkyl, (C 2 -C 8) alkenyl (Ci-C 8) alkyl, (Ci-C8) - alkoxy (Ci-C 8) alkyl, (C 1 -C 5) -alkylcarbonyl, arylcarbonyl,
Heteroarylcarbonyl, (C3-C8)-Cycloalkylcarbonyl, (Ci-C8)- Alkoxycarbonyl, (C2-C8)-Allyloxycarbonyl, Aryloxy-(Ci-C8)-alkyl, Aryl- (Ci-Cs)-alkyl, (Ci-C8)-Haloalkyl, Aryl steht, Heteroarylcarbonyl, (C3-C8) cycloalkylcarbonyl, (Ci-C8) - alkoxycarbonyl, (C2-C8) -Allyloxycarbonyl, aryloxy (Ci-C8) alkyl, aryl (Ci-Cs) alkyl, (C 1 -C 8 ) -haloalkyl, aryl,
A11 für N oder die Gruppierung C-R21 steht und wobei R21 in der A 11 is N or the group CR 21 and R 21 is in the
Gruppierung C-R21 die Bedeutung gemäß der vorstehenden Definition hat, Grouping CR 21 has the meaning according to the above definition,
A12 für N-R18 oder die Gruppierung C(R19)R20 steht und wobei R19 und R20 in der Gruppierung C(R19)R20 die Bedeutung gemäß der A 12 stands for NR 18 or the group C (R 19 ) R 20 and where R 19 and R 20 in the group C (R 19 ) R 20 are as defined in the group
nachstehenden Definition haben, R19 und R20 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C8)-Alkyl, (Ci-Ce)-Alkoxy, (Ci-C8)-Haloalkyl, (Ci-C8)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C8)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, mit Ausnahme von 4-Hydroxy-4-{(E)-2-[2-(hydroxymethyl)phenyl]vinyl}-3,5,5- trimethylcyclohex-2-en-1 -on, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4- oxocyclohex-2-en-1 -yl)vinyl]benzaldehyd, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl- 4-oxocyclohex-2-en-1 -yl)vinyl]benzoesäure und Methyl-2-[(E)-2-(1 -hydroxy- 2,6,6-trimethyl-4-oxocyclohex-2-en-1 -yl)vinyl]benzoat. have the following definition, R 19 and R 20 independently of one another represent hydrogen, halogen, (C 1 -C 8 ) -alkyl, (C 1 -C 6 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy, aryl, heteroaryl, Aryl- (Ci-C8) -alkyl or together with the atom to which they are attached form a carbonyl group, with the exception of 4-hydroxy-4 - {(E) -2- [2- (hydroxymethyl) phenyl] vinyl} -3,5,5-trimethylcyclohex-2-en-1-one, 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1 -yl) vinyl] benzaldehyde, 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid and methyl 2- [ (E) -2- (1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoate.
3. Substituierte Vinyl- und Alkinyl-cyclohexenole der allgemeinen Formel (I) nach Anspruch 1 oder deren Salze, worin 3. Substituted vinyl and alkynylcyclohexenols of the general formula (I) according to claim 1 or their salts, in which
[X-Y] für die Gruppierungen [X-Y] for the groupings
[x-Y]1 und [X-Y]2 steht, für die carbocyclischen und heterocyclischen Gruppierungen Q-1 bis [xY] 1 and [XY] 2 , for the carbocyclic and heterocyclic moieties Q-1 to
Q-1 , Q-2 _ Q-3 und Q"4 steht, wobei die Gruppierungen R6 bis R21 und A1 bis A12 jeweils die Bedeutung gemäß der nachstehenden Definitionen haben und wobei der Pfeil für eine Bindung zur jeweiligen Gruppierung [X-Y] steht, Q-1, Q-2 _ Q-3 and Q " 4 where the groups R 6 to R 21 and A 1 to A 12 each have the meaning according to the definitions below and wherein the arrow represents a bond to the respective grouping [XY],
R1 für (Ci-C7)-Alkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, (C2-C7)-Alkenyl-R 1 is (Ci-C7) alkyl, (C 2 -C 7) alkenyl, (C 2 -C 7) -alkynyl, (C 2 -C 7) alkenyl
(Ci-C7)-alkyl, (C2-C7)-Alkinyl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, Hydroxy-(Ci-C7)-alkyl, (Ci-C7)-Alkylamino, Sulfonylamino, (Ci-C7)- Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy-(Ci-C7)-alkyl steht, (Ci-C7) alkyl, (C 2 -C 7) alkynyl (Ci-C7) alkyl, (Ci-C7) alkoxy (Ci-C7) alkyl, hydroxy (C -C 7 ) alkyl, (Ci-C 7 ) alkylamino, sulfonylamino, (Ci-C 7 ) - alkoxy, (Ci-C 7 ) haloalkyl, (Ci-C 7 ) -haloalkoxy- (Ci-C 7 ) -alkyl,
R2 für Wasserstoff, (Ci-C7)-Alkyl, Nitro-(Ci-C7)-alkyl, Hydroxy-(Ci-C7)- alkyl, (Ci-C7)-Haloalkyl, (Ci-C7)-Alkylamino, Sulfonylamino, (Ci-C7)- Alkoxy, Tris-[(Ci-C7)-alkylsilyl]- (Ci-C7)-alkyl, Cyano-(Ci-C7)-alkyl, Aryl- (Ci-C7)-alkyl, (Ci-C7)-Alkoxycarbonyl-(Ci-C7)-alkyl, (Ci-C7)- Haloalkoxycarbonyl-(Ci-C7)-alkyl, (Ci-C7)-Alkylthio-(Ci-C7)-alkyl, Arylthio-(Ci-C7)-alkyl steht, R 2 is hydrogen, (Ci-C 7) alkyl, nitro, (Ci-C7) alkyl, hydroxy (Ci-C7) - alkyl, (Ci-C7) haloalkyl, (Ci-C 7 ) -Alkylamino, sulfonylamino, (C 1 -C 7 ) -alkoxy, tris - [(C 1 -C 7 ) -alkylsilyl] - (C 1 -C 7 ) -alkyl, cyano- (C 1 -C 7 ) -alkyl, aryl- (Ci-C7) alkyl, (Ci-C 7) alkoxycarbonyl (Ci-C7) alkyl, (Ci-C7) - Haloalkoxycarbonyl- (Ci-C7) alkyl, (Ci-C 7 ) -Alkylthio (C 1 -C 7 ) -alkyl, arylthio (C 1 -C 7 ) -alkyl,
R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig R 1 and R 2 with the atoms to which they are attached, a complete
gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden,  form saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
R3 und R4 unabhängig voneinander für (Ci-C7)-Alkoxy, (Ci-C7)-Alkoxy-(Ci-C7)- alkoxy, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoxy, (Ci-C7)-Haloalkoxy, (Ci-C7)- Alkylthio, (Ci-C7)-Haloalkylthio stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, Hydroxyiminogruppe, R 3 and R 4 are each independently (Ci-C7) alkoxy, (Ci-C7) alkoxy (Ci-C7) - alkoxy, (C 3 -C 7) -cycloalkyl- (Ci-C 7 ) alkoxy, (Ci-C7) haloalkoxy, (Ci-C7) - alkylthio, (Ci-C 7) haloalkylthio, or together with the atom to which they are attached form an oxo group, hydroxyimino group,
(Ci-C7)-Alkoxyiminogruppe, (C3-C7)-Cycloalkoxyiminogruppe, (C3-C7)- Cycloalkyl-(Ci-C7)-alkoximinogruppe, (Ci-C7)-alkenyloximinogruppe, Aryl-(Ci-C7)-alkoxyiminogruppe oder einen 5-7-gliedrigen (Ci-C 7) -Alkoxyiminogruppe, (C3-C 7) -Cycloalkoxyiminogruppe, (C3-C7) - -alkenyloximinogruppe cycloalkyl- (Ci-C7) -alkoximinogruppe, (Ci-C 7), aryl (Ci- C 7 ) alkoxyimino group or a 5-7 membered one
heterocyclischen Ring, der gegebenenfalls weiter substituiert sein kann, bilden  heterocyclic ring, which may optionally be further substituted form
R5 für Wasserstoff, (Ci-C7)-Alkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkenyl-(Ci-C7)- alkyl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, (Ci-C7)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C7)-Cycloalkylcarbonyl, (C1-C7)- Alkoxycarbonyl, (C2-C7)-Alkenyloxycarbonyl, Aryloxy-(Ci-C7)-alkyl, Aryl-(Ci-C7)-alkyl, (Ci-C7)-Alkoxy-(Ci-C7)-alkoxy-(Ci-C7)-alkyl, (C1-C7)- Alkylthio-(Ci-C7)-alkyl, Tris-[(Ci-C7)-alkyl]silyl, (Ci-C7)-Alkyl-Bis- [(Ci-C7)-alkyl]silyl, (Ci-C7)-Alkyl-bis-Arylsilyl, Aryl-bis-[(Ci-C7)-alkyl]silyl,R 5 represents hydrogen, (Ci-C7) alkyl, (C 2 -C 7) alkenyl, (C 2 -C 7) alkenyl (Ci-C7) - alkyl, (Ci-C7) - Alkoxy- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkylcarbonyl, arylcarbonyl, Heteroarylcarbonyl, (C 3 -C 7 ) -cycloalkylcarbonyl, (C 1 -C 7 ) -alkoxycarbonyl, (C 2 -C 7 ) -alkenyloxycarbonyl, aryloxy- (C 1 -C 7 ) -alkyl, aryl- (C 1 -C 7 ) -alkyl, (C 1 -C 4 ) -cycloalkylcarbonyl, C7) -alkoxy- (C 1 -C 7 ) -alkoxy- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkylthio (C 1 -C 7 ) -alkyl, tris - [(C 1 -C 7 ) -alkyl ] silyl, (C 1 -C 7 ) -alkyl-bis- [(C 1 -C 7 ) -alkyl] silyl, (C 1 -C 7 ) -alkyl-bis-arylsilyl, aryl-bis - [(C 1 -C 7 ) alkyl] silyl,
(C3-C7)-Cycloalkyl-bis-[(Ci-C7)-alkyl]silyl, Halo-bis-[(Ci-C7)-alkyl]silyl, Tns-[(Ci-C7)-alkyl]silyl-(Ci-C7)-alkoxy-(Ci-C7)-alkyl steht, (C 3 -C 7 ) -cycloalkyl-bis - [(C 1 -C 7 ) -alkyl] silyl, halo-bis - [(C 1 -C 7 ) -alkyl] silyl, Tns - [(C 1 -C 7 ) -alkyl] silyl - (C 1 -C 7 ) -alkoxy- (C 1 -C 7 ) -alkyl,
R6 und R7 unabhängig voneinander für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-C7)-Alkyl, (C3-C7)-R 6 and R 7 independently of one another represent hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, (C 1 -C 7) -alkyl, (C 3 -C 7) -
Cycloalkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, Aryl, Aryl-(Ci-C7)-alkyl, (C2-C7)-Alkenyl-(Ci-C7)-alkyl, (C2-C7)-Alkinyl-(Ci-C7)-alkyl, Aryl-(Ci-C7)- alkoxy, Heteroaryl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, Hydroxy-(Ci-C7)-alkyl, (Ci-C7)-Haloalkyl, (C3-C7)-Halocycloalkyl, (Ci-C7)-Alkoxy, (C1-C7)- Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C7)-Cycloalkyloxy, Hydroxy,Cycloalkyl, (C2-C7) alkenyl, (C2-C7) alkynyl, aryl, aryl (Ci-C7) alkyl, (C2-C7) alkenyl (Ci-C7) alkyl , (C 2 -C 7 ) alkynyl (C 1 -C 7 ) -alkyl, aryl- (C 1 -C 7 ) -alkoxy, heteroaryl, (C 1 -C 7 ) -alkoxy- (C 1 -C 7 ) -alkyl, hydroxy (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -haloalkyl, (C 3 -C 7 ) -halocycloalkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkoxy, aryloxy, heteroaryloxy, ( C3-C7) cycloalkyloxy, hydroxy,
(C3-C7)-Cycloalkyl-(Ci-C7)-alkoxy, (Ci-C7)-Alkoxycarbonyl, (C 3 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -alkoxycarbonyl,
Hydroxycarbonyl, Aminocarbonyl, (Ci-C7)-Alkylaminocarbonyl, (C3-C7)- Cycloalkylaminocarbonyl, Cyano-(Ci-C7)-alkylaminocarbonyl, (C2-C7)- Alkenylaminocarbonyl, (C2-C7)-Alkinylaminocarbonyl, (C1-C7)- Alkylamino, (Ci-C7)-Alkylthio, (Ci-C7)-Haloalkylthio, Hydrothio, Bis-Hydroxycarbonyl, aminocarbonyl, (C 1 -C 7) -alkylaminocarbonyl, (C 3 -C 7) -cycloalkylaminocarbonyl, cyano- (C 1 -C 7) -alkylaminocarbonyl, (C 2 -C 7) -alkenylaminocarbonyl, (C 2 -C 7) -alkynylaminocarbonyl, (C 1 -C 7 ) - alkylamino, (C 1 -C 7 ) -alkylthio, (C 1 -C 7 ) -haloalkylthio, hydrothio, bis-
(Ci-C7)-alkylamino, (C3-C7)-Cycloalkylamino, (C1-C7)- Alkylcarbonylamino, (C3-C7)-Cycloalkylcarbonylamino, Formylamino, (Ci-C7)-Haloalkylcarbonylamino, (Ci-C7)-Alkoxycarbonylamino, (C 1 -C 7) -alkylamino, (C 3 -C 7) -cycloalkylamino, (C 1 -C 7) -alkylcarbonylamino, (C 3 -C 7) -cycloalkylcarbonylamino, formylamino, (C 1 -C 7) -haloalkylcarbonylamino, (C 1 -C 7) -alkoxycarbonylamino,
(Ci-C7)-Alkylaminocarbonylamino, (Ci-C7)-Alkyl-[(Ci-C7)-Alkyl]- aminocarbonylamino, (Ci-C7)-Alkylsulfonylamino, (C3-C7)-(C 1 -C 7 ) -alkylaminocarbonylamino, (C 1 -C 7 ) -alkyl - [(C 1 -C 7 ) -alkyl] -aminocarbonylamino, (C 1 -C 7 ) -alkylsulfonylamino, (C 3 -C 7 ) -
Cycloalkylsulfonylamino, Arylsulfonylamino, Hetarylsulfonylamino, Sulfonyl-(Ci-C7)-haloalkylamino, Aminosulfonyl, Amino-(Ci-C7)- alkylsulfonyl, Amino-(Ci-C7)-haloalkylsulfonyl, (C1-C7)- Alkylaminosulfonyl, Bis-[(Ci-C7)-alkyl]aminosulfonyl, (C3-C7)- Cycloalkylaminosulfonyl, (Ci-C7)-Haloalkylaminosulfonyl, Cycloalkylsulfonylamino, arylsulfonylamino, hetarylsulfonylamino, sulfonyl- (C 1 -C 7) -haloalkylamino, aminosulfonyl, amino- (C 1 -C 7) -alkylsulfonyl, amino- (C 1 -C 7) -haloalkylsulfonyl, (C 1 -C 7) -alkylaminosulfonyl, bis - [( C 1 -C 7) -alkyl] aminosulfonyl, (C 3 -C 7) -cycloalkylaminosulfonyl, (C 1 -C 7) -haloalkylaminosulfonyl,
Arylaminosulfonyl, Aryl-(Ci-C7)-alkylaminosulfonyl, (C1-C7)- Alkylsulfonyl, (C3-C7)-Cycloalkylsulfonyl, Arylsulfonyl, (C1-C7)- Alkylsulfinyl, (C3-C7)-Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-[(Ci-C7)- alkyl]sulfonimidoyl, S-(Ci-C7)-Alkylsulfonimidoyl, (C1-C7)- Alkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylaminosulfonyl, Aryl-(Ci-C7)-alkylcarbonylamino, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylcarbonylamino, Arylaminosulfonyl, aryl- (C 1 -C 7 ) -alkylaminosulfonyl, (C 1 -C 7 ) -alkylsulfonyl, (C 3 -C 7 ) -cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 7 ) - Alkylsulphinyl, (C 3 -C 7) cycloalkylsulfinyl, arylsulfinyl, N, S-bis - [(Ci-C7) - alkyl] sulfonimidoyl, S- (Ci-C7) -Alkylsulfonimidoyl, (C1-C7) - alkylsulfonylaminocarbonyl, (C 3 -C 7) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 7) -cycloalkylaminosulfonyl, aryl- (C 1 -C 7) -alkylcarbonylamino, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkylcarbonylamino,
Heteroarylcarbonylamino, (Ci-C7)-Alkoxy-(Ci-C7)-alkylcarbonylamino, Hydroxy-(Ci-C7)-alkylcarbonylamino, Tris-[(Ci-C7)-alkyl]silyl stehen,  Heteroarylcarbonylamino, (C 1 -C 7) -alkoxy- (C 1 -C 7) -alkylcarbonylamino, hydroxy- (C 1 -C 7) -alkylcarbonylamino, tris - [(C 1 -C 7) -alkyl] silyl,
A1 , A2, A3 gleich oder verschieden sind und unabhängig voneinander für NA 1 , A 2 , A 3 are the same or different and are independently N
(Stickstoff) oder die Gruppierung C-R8 stehen, wobei jedoch in keinem Fall mehr als zwei N-Atome benachbart sind, und wobei R8 in der Gruppierung C-R8 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat und (Nitrogen) or the group CR 8 , but in no case more than two N atoms are adjacent, and wherein R 8 in the group CR 8 each have the same or different meanings as defined below, and
A1 und A2, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6- gliedrigen Ring bilden, A 1 and A 2 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
A2 und A3, wenn beide für eine Gruppe C- R8 stehen, mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, teilgesättigten oder vollständig ungesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 5 bis 6- gliedrigen Ring bilden, A 2 and A 3 , when both represent a group C-R 8 , with the atoms to which they are attached, a fully saturated, partially saturated or fully unsaturated, optionally interrupted by heteroatoms and optionally further substituted 5 to 6-membered ring form,
R8, R14, R15 und R21 unabhängig voneinander jeweils für Wasserstoff, Nitro, Amino, Hydroxy, Hydrothio, Thiocyanato, Isothiocyanato, Halogen, (Ci-C7)-Alkyl, (C3-C7)-Cycloalkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, Aryl, Aryl-(Ci-C7)-alkyl, Aryl-(Ci-C7)-alkoxy, Heteroaryl, (Ci-C7)-Haloalkyl,R 8, R 14, R 15 and R 21 are each independently hydrogen, nitro, amino, hydroxy, Hydrothio, thiocyanato, isothiocyanato, halogen, (Ci-C7) alkyl, (C 3 -C 7) cycloalkyl, (C 2 -C 7) alkenyl, (C 2 -C 7) alkynyl, aryl, aryl (Ci-C7) alkyl, aryl (Ci-C7) alkoxy, heteroaryl, (Ci-C 7 ) -haloalkyl,
(Ci-C7)-Halocycloalkyl, (Ci-C7)-Alkoxy, (Ci-C7)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C7)-Cycloalkyloxy, (C3-C7)-Cycloalkyl-(Ci-C7)- alkoxy, Hydroxy-(Ci-C7)-alkyl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, Aryloxy- (Ci-C7)-alkyl, Heteroaryloxy-(Ci-C7)-alkyl, (C2-C7)- Alkenylaminocarbonyl, (Ci-C7)-Alkylamino, (Ci-C7)-Alkylthio, (Ci-C7)- Haloalkylthio, Bis-[(Ci-C7)-alkyl]amino, (C3-C7)-Cycloalkylamino, (C 1 -C 7 ) -halocycloalkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 7 ) -cycloalkyloxy, (C 3 -C 7 ) -cycloalkyl- (C 1 -C 4) -cycloalkyl C7) - alkoxy, hydroxy- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy- (C 1 -C 7 ) -alkyl, aryloxy- (C 1 -C 7 ) -alkyl, heteroaryloxy- (C 1 -C 7 ) alkyl, (C 2 -C 7) - alkenylaminocarbonyl, (Ci-C7) alkylamino, (Ci-C7) -alkylthio, (Ci-C7) - haloalkylthio, bis - [(Ci-C7) - alkyl] amino, (C 3 -C 7 ) -cycloalkylamino,
(Ci-C7)-Alkylcarbonylamino, (C3-C7)-Cycloalkylcarbonylamino, Formylamino, (Ci-C7)-Haloalkylcarbonylamino, (Ci-C7)- Alkoxycarbonylamino, (Ci-C7)-Alkylaminocarbonylamino, (Ci-C7)- Alkyl[(Ci-C7)-Alkyl]-aminocarbonylamino, (Ci-C7)-Alkylsulfonylamino, (C3-C7)-Cycloalkylsulfonylamino, Arylsulfonylamino, (Ci-C7) alkylcarbonylamino, (C3-C 7) -Cycloalkylcarbonylamino, formylamino, (Ci-C 7) -Haloalkylcarbonylamino, (Ci-C7) - alkoxycarbonylamino, (Ci-C 7) alkylaminocarbonylamino, (Ci- C 7 ) - alkyl [(C 1 -C 7 ) -alkyl] -aminocarbonylamino, (C 1 -C 7 ) -alkylsulfonylamino, (C 3 -C 7 ) -cycloalkylsulfonylamino, arylsulfonylamino,
Hetarylsulfonylamino, Sulfonyl-(Ci-C7)-haloalkylamino, Amino-(Ci-C7)- alkylsulfonyl, Amino-(Ci-C7)-haloalkylsulfonyl, (Ci-C7)- Alkylaminosulfonyl, Bis-(Ci-C7)-alkylaminosulfonyl, (C3-C7)- Cycloalkylaminosulfonyl, (Ci-C7)-Haloalkylaminosulfonyl, Hetarylsulfonylamino, sulfonyl (Ci-C 7) -haloalkylamino, amino (Ci-C7) - alkylsulfonyl, amino (Ci-C 7) haloalkylsulfonyl, (C 7) - alkylaminosulfonyl, bis (Ci-C 7 ) -alkylaminosulfonyl, (C 3 -C 7 ) -cycloalkylaminosulfonyl, (C 1 -C 7 ) -haloalkylaminosulfonyl,
Arylaminosulfonyl, Aryl-(Ci-C7)-alkylaminosulfonyl, (Ci-C7)- Alkylsulfonyl, (C3-C7)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C7)- Alkylsulfinyl, (C3-C7)-Cycloalkylsulfinyl, Arylsulfinyl, N,S-Bis-(Ci-C7)- alkylsulfonimidoyl, S-(Ci-C7)-Alkylsulfonimidoyl, (Ci-C7)- Alkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylaminosulfonyl, Aryl-(Ci-C7)-alkylcarbonylamino, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylcarbonylamino, Arylaminosulfonyl, aryl- (Ci-C7) alkylaminosulfonyl, (Ci-C7) - alkylsulfonyl, (C 3 -C 7) cycloalkylsulfonyl, arylsulfonyl, (Ci-C7) - alkylsulfinyl, (C 3 -C 7) cycloalkylsulfinyl, arylsulfinyl, N, S-bis (Ci-C7) - alkylsulfonimidoyl, S- (Ci-C7) -Alkylsulfonimidoyl, (Ci-C7) - alkylsulfonylaminocarbonyl, (C3-C 7) -Cycloalkylsulfonylaminocarbonyl, ( C 3 -C 7 -cycloalkylaminosulfonyl, aryl- (C 1 -C 7 ) -alkylcarbonylamino, (C 3 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkylcarbonylamino,
Heteroarylcarbonylamino, (Ci-C7)-Alkoxy-(Ci-C7)-alkylcarbonylamino, Hydroxy-(Ci-C7)-alkylcarbonylamino, Cyano, Cyano-(Ci-C7)-alkyl, Hydroxycarbonyl, (Ci-C7)-Alkoxycarbonyl, (C3-C7)- Cycloalkoxycarbonyl, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoxycarbonyl, Aryloxycarbonyl, Aryl-(Ci-C7)-alkoxycarbonyl, Aminocarbonyl, (Ci-C7)- Alkylaminocarbonyl, Bis-(Ci-C7)-alkylaminocarbonyl, (Ci-C7)- Alkyl[(Ci-C7)-Alkoxy]aminocarbonyl, (C3-C7)-Cycloalkylaminocarbonyl, Aryl-(Ci-C7)-alkylaminocarbonyl, Heteroaryl-(Ci-C7)- alkylaminocarbonyl, Cyano-(Ci-C7)-alkylaminocarbonyl, (Ci-C7)- Haloalkylaminocarbonyl, (C2-C7)-Alkinyl-(Ci-C7)-alkylaminocarbonyl, (Ci-C7)-Alkoxycarbonylaminocarbonyl, Aryl-(Ci-C7)- alkoxycarbonylaminocarbonyl, Hydroxycarbonyl-(Ci-C7)-alkyl, (Ci-C7)- Alkoxycarbonyl-(Ci-C7)-alkyl, (C3-C7)-Cycloalkoxycarbonyl-(Ci-C7)- alkyl, (Ci-C7)-Cycloalkyl-(Ci-C7)-alkoxycarbonyl-(Ci-C7)-alkyl, (C1-C7)- Alkylaminocarbonyl-(Ci-C7)-alkyl, Aminocarbonyl-(Ci-C7)-alkyl, Bis- (Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (C3-C7)- Cycloalkylaminocarbonyl-(Ci-C7)-alkyl, Aryl-(Ci-C7)- alkylaminocarbonyl-(Ci-C7)-alkyl, Heteroaryl-(Ci-C7)- alkylaminocarbonyl-(Ci-C7)-alkyl, Cyano-(Ci-C7)-alkylaminocarbonyl- (Ci-C7)-alkyl, (Ci-C7)-Haloalkylaminocarbonyl-(Ci-C7)-alkyl, (C2-C7)- Alkinyl-(Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (C3-C7)-Cycloalkyl- (Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (C1-C7)- Alkoxycarbonylaminocarbonyl-(Ci-C7)-alkyl, Aryl-(Ci-C7)- alkoxycarbonylaminocarbonyl-(Ci-C7)-alkyl, Heteroarylcarbonylamino, (C 1 -C 7 ) -alkoxy- (C 1 -C 7 ) -alkylcarbonylamino, hydroxy- (C 1 -C 7 ) -alkylcarbonylamino, cyano, cyano- (C 1 -C 7 ) -alkyl, hydroxycarbonyl, (C 1 -C 4 -alkyl) 7 ) -alkoxycarbonyl, (C 3 -C 7 ) -cycloalkoxycarbonyl, (C 3 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkoxycarbonyl, aryloxycarbonyl, aryl- (C 1 -C 7 ) -alkoxycarbonyl, aminocarbonyl, (alkylaminocarbonyl, bis Ci-C 7) alkylaminocarbonyl, (Ci-C 7) - - C 7) alkyl [(Ci-C7) alkoxy] aminocarbonyl, (C3-C 7) cycloalkylaminocarbonyl, aryl (C -C 7) alkylaminocarbonyl, heteroaryl (Ci-C7) - alkylaminocarbonyl, cyano (Ci-C 7) alkylaminocarbonyl, (Ci-C7) - Haloalkylaminocarbonyl, (C2-C7) alkynyl (Ci- C 7 ) -alkylaminocarbonyl, (C 1 -C 7 ) -alkoxycarbonylaminocarbonyl, aryl- (C 1 -C 7 ) -alkoxycarbonylaminocarbonyl, hydroxycarbonyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) - Alkoxycarbonyl- (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkoxycarbonyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkoxycarbonyl- (C 1 -C 7 ) -alkyl , (C 1 -C 7 ) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, aminocarbonyl- (C 1 -C 7 ) -alkyl, bis (C 1 -C 7 ) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) ) - cycloalkylaminocarbonyl- (C 1 -C 7) -alkyl, aryl- (C 1 -C 7) -alkylaminocarbonyl- (C 1 -C 7) -alkyl, heteroaryl- (C 1 -C 7) -alkylaminocarbonyl- (C 1 -C 7) -alkyl, cyano- (C 1 -C 7 ) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -haloalkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkynyl- (C 1 -C 7 ) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxycarbonylaminocarbonyl- (C 1 -C 7 ) -alkyl , Aryl- (C 1 -C 7) -alkoxycarbonylaminocarbonyl- (C 1 -C 7) -alkyl,
(Ci-C7)-Alkoxycarbonyl-(Ci-C7)-alkylaminocarbonyl, Hydroxycarbonyl- (Ci-C7)-alkylaminocarbonyl, Aminocarbonyl-(Ci-C7)- alkylaminocarbonyl, (Ci-C7)-Alkylaminocarbonyl-(C-i-C7)- alkylaminocarbonyl, (C3-C7)-Cycloalkylaminocarbonyl-(Ci-C7)- alkylaminocarbonyl, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylaminocarbonyl, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylaminocarbonyl-(Ci-C7)-alkyl, (C2-C7)- Alkenyloxycarbonyl, (C2-C7)-Alkenyloxycarbonyl-(Ci-C7)-alkyl, (C2-C7)- Alkenylaminocarbonyl, (C2-C7)-Alkenyl-(Ci-C7)-alkylaminocarbonyl, (C2-C7)-Alkenylaminocarbonyl-(Ci-C7)-alkyl, (C2-C7)-Alkenyl-(Ci-C7)- alkylaminocarbonyl-(Ci-C7)-alkyl, (Ci-C7)-Alkylcarbonyl, (C3-C7)- Cycloalkylcarbonyl, Formyl, Hydroxyiminomethyl, Aminoiminomethyl, (Ci-C7)-Alkoxyiminomethyl, (Ci-C7)-Alkylaminoiminomethyl, Bis- (Ci-C7)-alkylaminoiminomethyl, (C3-C7)-Cycloalkoxyiminomethyl, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoximinomethyl, Aryloximinomethyl, Aryl- (Ci-C7)-alkoxyiminomethyl, Aryl-(Ci-C7)-alkylaminoiminomethyl, (C2-C7)-Alkenyloxyiminomethyl, Arylaminoiminomethyl, (C 1 -C 7) -alkoxycarbonyl- (C 1 -C 7) -alkylaminocarbonyl, hydroxycarbonyl- (C 1 -C 7) -alkylaminocarbonyl, aminocarbonyl- (C 1 -C 7) -alkylaminocarbonyl, (C 1 -C 7) -alkylaminocarbonyl- (C 1 -C 7) - alkylaminocarbonyl, (C 3 -C 7) -cycloalkylaminocarbonyl- (C 1 -C 7) -alkylaminocarbonyl, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkylaminocarbonyl, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkenyloxycarbonyl, (C 2 -C 7 ) -alkenyloxycarbonyl- (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkenylaminocarbonyl, (C 2 -C 7 ) -alkenyl- C 1 -C 7 ) -alkylaminocarbonyl, (C 2 -C 7 ) -alkenylaminocarbonyl- (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkenyl- (C 1 -C 7 ) -alkylaminocarbonyl- (C 1 -C 7 ) -alkyl, ( C 1 -C 7) -alkylcarbonyl, (C 3 -C 7) -cycloalkylcarbonyl, formyl, hydroxyiminomethyl, aminoiminomethyl, (C 1 -C 7) -alkoxyiminomethyl, (C 1 -C 7) -alkylaminoiminomethyl, bis (C 1 -C 7) -alkylaminoiminomethyl, (C 3 -C 4) -alkylaminoiminomethyl C7) -cycloalkoxyiminomethyl, (C3-C7) -cycloalkyl- (Ci-C7) -alkoximinomethyl, aryloximinomethyl, aryl- (Ci-C7) -alkoxyiminomethyl, aryl- (Ci-C7) -alkylaminoiminomethyl, (C2-C7) -alkenyloxyiminom ethyl, arylaminoiminomethyl,
Arylsulfonylaminoiminomethyl, Heteroaryl-(Ci-C7)-alkyl, Heterocyclyl- (Ci-C7)-alkyl, Hydroxycarbonyl heterocyclyl, (C1-C7)- Alkoxycarbonylheterocyclyl, (C2-C7)-Alkenyloxycarbonylheterocyclyl, (C2-C7)-Alkenyl-(Ci-C7)-alkoxycarbonylheterocyclyl, Aryl-(Ci-C7)- alkoxycarbonylheterocyclyl, (C3-C7)-Cycloalkoxycarbonylheterocyclyl, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoxycarbonylheterocyclyl, Arylsulfonylaminoiminomethyl, heteroaryl- (C 1 -C 7) -alkyl, heterocyclyl- (C 1 -C 7) -alkyl, hydroxycarbonyl-heterocyclyl, (C 1 -C 7) -alkoxycarbonyl-heterocyclyl, (C 2 -C 7) -alkenyloxycarbonyl-heterocyclyl, (C 2 -C 7) -alkenyl- Ci-C7) -alkoxycarbonylheterocyclyl, aryl- (Ci-C7) - alkoxycarbonylheterocyclyl, (C 3 -C 7) -cycloalkoxycarbonylheterocyclyl, (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkoxycarbonylheterocyclyl,
Aminocarbonylheterocyclyl, (Ci-C7)-Alkylaminocarbonylheterocyclyl, Bis-(Ci-C7)-Alkylaminocarbonylheterocyclyl, (C3-C7)- Cycloalkylaminocarbonylheterocyclyl, Aryl-(Ci-C7)- alkylaminocarbonylheterocyclyl, (C2-C7)- Alkenylaminocarbonylheterocyclyl, Hydroxycarbonylheterocyclyl- (Ci-C7)-alkyl, (Ci-C7)-Alkoxycarbonylheterocyclyl-(Ci-C7)-alkyl, Hydroxycarbonyl-(C3-C7)-cycloalkyl-(Ci-C7)-alkyl, (C1-C7)- Alkoxycarbonyl-(C3-C7)-cycloalkyl-(Ci-C7)-alkyl steht,  Aminocarbonylheterocyclyl, (C 1 -C 7) -alkylaminocarbonylheterocyclyl, bis (C 1 -C 7) -alkylaminocarbonylheterocyclyl, (C 3 -C 7) -cycloalkylaminocarbonylheterocyclyl, aryl- (C 1 -C 7) -alkylaminocarbonylheterocyclyl, (C 2 -C 7) -alkenylaminocarbonylheterocyclyl, hydroxycarbonylheterocyclyl (Ci -C 7) alkyl, (C 1 -C 7) alkoxycarbonylheterocyclyl- (C 1 -C 7) -alkyl, hydroxycarbonyl- (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkyl, (C 1 -C 7) -alkoxycarbonyl- (C 3 -C 7) -cycloalkyl- (C 1 -C 7) -alkyl,
R9 und R10 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C7)-Alkyl, (Ci-C7)-Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C7)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, R 9 and R 10 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, heteroaryl , Aryl- (C 1 -C 7) -alkyl or together with the atom to which they are attached form a carbonyl group,
A4, A5 gleich oder verschieden sind und unabhängig voneinander für N-R11 , Sauerstoff, Schwefel oder die Gruppierung C-R11 stehen, wobei jedoch in keinem Fall mehr als ein Sauerstoffatom im Heterocyclus enthalten ist, und wobei R11 in den Gruppierungen N-R11 und C-R11 jeweils gleiche oder verschiedene Bedeutungen gemäß der nachstehenden Definition hat, A 4 , A 5 are the same or different and are independently NR 11 , oxygen, sulfur or the group CR 11 , but in no case more than one oxygen atom in the heterocycle is contained, and wherein R 11 in the groups NR 11 and CR 11 has the same or different meanings as defined below,
R11 für Wasserstoff, (Ci-C7)-Alkyl, (C2-C7)-Alkenyl-(Ci-C7)-alkyl, (C1-C7)- Alkoxy-(Ci-C7)-alkyl, (Ci-C7)-Alkylcarbonyl, Arylcarbonyl, R 11 is hydrogen, (C 1 -C 7 ) -alkyl, (C 2 -C 7 ) -alkenyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy- (C 1 -C 7 ) -alkyl, (Ci -C 7 ) -alkylcarbonyl, arylcarbonyl,
Heteroarylcarbonyl, (C3-C7)-Cycloalkylcarbonyl, (C1-C7)- Alkoxycarbonyl, (C2-C7)-Alkenyloxycarbonyl, (Ci-C7)-Alkoxycarbonyl- (Ci-C7)-alkyl, (Ci-C7)-Alkylaminocarbonyl-(Ci-C7)-alkyl, Heteroarylcarbonyl, (C 3 -C 7 ) -cycloalkylcarbonyl, (C 1 -C 7 ) -alkoxycarbonyl, (C 2 -C 7 ) -alkenyloxycarbonyl, (C 1 -C 7 ) -alkoxycarbonyl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkylaminocarbonyl - (C 1 -C 7 ) -alkyl,
Arylaminocarbonyl-(Ci-C7)-alkyl, Aryloxyalkyl, Aryl-(Ci-C7)-alkyl, Heteroaryl-(Ci-C7)-alkyl, (Ci-C7)-Haloalkyl steht, R12 und R13 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C7)-Alkyl, (Ci-C7)-Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C7)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, Arylaminocarbonyl- (C 1 -C 7 ) -alkyl, aryloxyalkyl, aryl- (C 1 -C 7 ) -alkyl, heteroaryl- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -haloalkyl, R 12 and R 13 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, heteroaryl , Aryl- (C 1 -C 7) -alkyl or together with the atom to which they are attached form a carbonyl group,
A6, A7, A8, A9 gleich oder verschieden sind und unabhängig voneinander für 0, S, N, NH, N-(Ci-C7)-Alkyl, (Ci-C7)-Alkoxycarbonyl-N, (Ci-C7)- Alkoxy-(Ci-C7)-alkyl-N, N-Aryl, N-Heteroaryl, N-Heterocyclyl, A 6 , A 7 , A 8 , A 9 are identical or different and are each independently 0, S, N, NH, N- (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxycarbonyl-N, ( Ci-C7) - alkoxy (Ci-C7) alkyl-N, N-aryl, N-heteroaryl, N-heterocyclyl,
Arylsulfonyl-N, (Ci-C7)-Alkylsulfonyl-N, (C3-C7)-Cycloalkylsulfonyl-N oder die Gruppierung C-R15 stehen, wobei maximal zwei 0- oder S- Atome im Heterocyclus vorhanden sind sind, und wobei keine 0- oder S-Atome benachbart zueinander sind, und wobei R15 in der Arylsulfonyl-N, (Ci-C 7 ) -alkylsulfonyl-N, (C 3 -C 7 ) -cycloalkylsulfonyl-N or the group CR 15 , wherein a maximum of two 0 or S atoms in the heterocycle are present, and wherein no O or S atoms are adjacent to each other, and wherein R 15 is in the
Gruppierung C-R15 jeweils gleiche oder verschiedene Bedeutungen gemäß der vorstehenden Definition hat und Group CR 15 has the same or different meanings as defined above, and
R16 und R17 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C7)-Alkyl, (Ci-C7)-Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C7)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, R 16 and R 17 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, Heteroaryl, aryl- (C 1 -C 7 ) -alkyl or together with the atom to which they are attached form a carbonyl group,
A10 für N-R18, Sauerstoff oder die Gruppierung C-R18 steht und wobei R18 in den Gruppierungen N-R18 und C-R18 jeweils gleiche oder A 10 is NR 18 , oxygen or the group CR 18 and wherein R 18 in the groupings NR 18 and CR 18 are each the same or
verschiedene Bedeutungen gemäß der nachstehenden Definition hat,  has different meanings as defined below,
R18 für Wasserstoff, (Ci-C7)-Alkyl, (C2-C7)-Alkenyl-(Ci-C7)-alkyl, (Ci-C7)- Alkoxy-(Ci-C7)-alkyl, (Ci-C7)-Alkylcarbonyl, Arylcarbonyl, R 18 is hydrogen, (Ci-C7) alkyl, (C 2 -C 7) alkenyl (Ci-C7) alkyl, (Ci-C7) - alkoxy (Ci-C7) alkyl , (C 1 -C 7 ) -alkylcarbonyl, arylcarbonyl,
Heteroarylcarbonyl, (C3-C7)-Cycloalkylcarbonyl, (Ci-C7)- Alkoxycarbonyl, (C2-C7)-Allyloxycarbonyl, Aryloxy-(Ci-C7)-alkyl, Aryl- (Ci-C7)-alkyl, (Ci-C7)-Haloalkyl, Aryl steht, A11 für N oder die Gruppierung C-R21 steht und wobei R21 in der Heteroarylcarbonyl, (C3-C7) cycloalkylcarbonyl, (C 7) - alkoxycarbonyl, (C2-C7) -Allyloxycarbonyl, aryloxy (Ci-C7) alkyl, aryl (Ci-C7) alkyl , (C 1 -C 7 ) -haloalkyl, aryl, A 11 is N or the group CR 21 and R 21 is in the
Gruppierung C-R21 die Bedeutung gemäß der vorstehenden Definition hat, Grouping CR 21 has the meaning according to the above definition,
A12 für N-R18 oder die Gruppierung C(R19)R20 steht und wobei R19 und R20 in de Gruppierung C(R19)R20 die Bedeutung gemäß der nachstehenden Definition haben, A 12 is NR 18 or the moiety C (R 19 ) R 20 and wherein R 19 and R 20 in the moiety C (R 19 ) R 20 are as defined below,
R19 und R20 unabhängig voneinander für Wasserstoff, Halogen, (Ci-C7)-Alkyl, (Ci-C7)-Alkoxy, (Ci-C7)-Haloalkyl, (Ci-C7)-Haloalkoxy, Aryl, Heteroaryl, Aryl-(Ci-C7)-alkyl stehen oder gemeinsam mit dem Atom, an das sie gebunden sind, eine Carbonylgruppe bilden, mit Ausnahme von 4-Hydroxy-4-{(E)-2-[2-(hydroxymethyl)phenyl]vinyl}-3,5,5- trimethylcyclohex-2-en-1 -on, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl-4- oxocyclohex-2-en-1 -yl)vinyl]benzaldehyd, 2-[(E)-2-(1 -Hydroxy-2,6,6-trimethyl- 4-oxocyclohex-2-en-1 -yl)vinyl]benzoesäure und Methyl-2-[(E)-2-(1 -hydroxy- 2,6,6-trimethyl-4-oxocyclohex-2-en-1 -yl)vinyl]benzoat. R 19 and R 20 independently of one another represent hydrogen, halogen, (C 1 -C 7 ) -alkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkyl, (C 1 -C 7 ) -haloalkoxy, aryl, heteroaryl , Aryl- (Ci-C7) -alkyl or form together with the atom to which they are attached, a carbonyl group, with the exception of 4-hydroxy-4 - {(E) -2- [2- (hydroxymethyl) phenyl vinyl} -3,5,5-trimethylcyclohex-2-en-1-one, 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-ene] 1 -yl) vinyl] benzaldehyde, 2 - [(E) -2- (1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoic acid and methyl 2- [(E) -2- (1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl) vinyl] benzoate.
Verwendung einer oder mehrerer Verbindungen der allgemeinen Formel (I) oder deren Salze gemäß einem der Ansprüche 1 bis 3 zur Toleranzerhöhung gegenüber abiotischem Stress in Pflanzen. Use of one or more compounds of the general formula (I) or salts thereof according to one of Claims 1 to 3 for increasing the tolerance to abiotic stress in plants.
Behandlung von Pflanzen, umfassend die Applikation einer zur Steigerung der Widerstandsfähigkeit von Pflanzen gegenüber abiotischen Stressfaktoren wirksamen, nicht-toxischen Menge einer oder mehrerer Verbindungen der allgemeinen Formel (I) oder deren Salze gemäß einem der Ansprüche 1 bis 3. Treatment of plants comprising the application of a non-toxic amount of one or more compounds of the general formula (I) or salts thereof according to one of Claims 1 to 3 which is effective for increasing the resistance of plants to abiotic stress factors.
Behandlung gemäß Anspruch 5, wobei die abiotischen Streßbedingungen einer oder mehrer Bedingungen ausgewählt aus der Gruppe von Hitze, Dürre, Kälte- und Trockenstress, osmotischer Streß, Staunässe, erhöhter Treatment according to claim 5, wherein the abiotic stress conditions of one or more conditions selected from the group of heat, drought, cold and dry stress, osmotic stress, waterlogging, increased
Bodensalzgehalt, erhöhtes Ausgesetztsein an Mineralien, Ozonbedingungen, Starklichtbedingungen, beschränkte Verfügbarkeit von Stickstoffnährstoffen, beschränkte Verfügbarkeit von Phosphornährstoffen entsprechen. Soil salt content, increased exposure to minerals, ozone conditions, High light conditions, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients.
7. Verwendung einer oder mehrerer Verbindungen der allgemeinen Formel (I) oder deren Salze gemäß einem der Ansprüche 1 bis 3 in der Sprühapplikation auf Pflanzen und Pflanzenteilen in Kombinationen mit einem oder mehrer Wirkstoffen ausgewählt aud der Gruppe der Insektizide, Lockstoffe, Akarizide, Fungizide, Nematizide, Herbizide, wachstumsregulatorische Stoffe, Safener, die Pflanzenreife beeinflussende Stoffe und Bakterizide. 7. Use of one or more compounds of the general formula (I) or salts thereof according to one of claims 1 to 3 in the spray application to plants and plant parts in combinations with one or more active substances selected from the group of insecticides, attractants, acaricides, fungicides, Nematicides, herbicides, growth regulators, safeners, plant maturity affecting substances and bactericides.
8. Verwendung einer oder mehrerer der Verbindungen der allgemeinen Formel (I) oder deren Salze gemäß einem der Ansprüche 1 bis 3 in der 8. Use of one or more of the compounds of general formula (I) or salts thereof according to one of claims 1 to 3 in the
Sprühapplikation auf Pflanzen und Pflanzenteilen in Kombinationen mit Düngemitteln.  Spray application on plants and plant parts in combinations with fertilizers.
9. Verwendung einer oder meherer der Verbindungen der allgemeinen Formel (I) oder deren Salze gemäß einem der Ansprüche 1 bis 3 zur Applikation auf gentechnisch veränderten Sorten, deren Saatgut, oder auf Anbauflächen auf denen diese Sorten wachsen. 9. Use of one or more of the compounds of the general formula (I) or salts thereof according to one of claims 1 to 3 for application to genetically modified varieties, their seeds, or on cultivated areas on which these varieties grow.
10 Sprühlösung zur Behandlung von Pflanzen, enthaltend eine zur Steigerung der Widerstandsfähigkeit von Pflanzen gegenüber abiotischen Stressfaktoren wirksame Menge einer oder meherer Verbindungen der allgemeinen Formel (I) gemäß einem der Ansprüche 1 bis 3 oder deren Salze. 10 spraying solution for the treatment of plants, containing an effective for increasing the resistance of plants to abiotic stress factors amount of one or more compounds of general formula (I) according to one of claims 1 to 3 or salts thereof.
1 1 Verwendung von Sprühlösungen, die eine oder mehrere der Verbindungen der allgemeinen Formel (I) gemäß einem der Ansprüche 1 bis 3 oder deren Salze enthalten, zur Steigerung der Widerstandsfähigkeit von Pflanzen gegenüber abiotischen Stressfaktoren. 1 1 Use of spray solutions containing one or more of the compounds of general formula (I) according to any one of claims 1 to 3 or salts thereof, for increasing the resistance of plants to abiotic stress factors.
12. Verfahren zur Erhöhung der Stresstoleranz bei Pflanzen ausgewählt aus der Gruppe der Nutzpflanzen, Zierpflanzen, Rasenarten, oder Bäumen, welches die Applikation einer ausreichenden, nicht-toxischen Menge einer oder mehrere Verbindungen der allgemeinen Formel (I) gemäß einem der 12. A method for increasing the stress tolerance in plants selected from the group of crops, ornamental plants, lawn species, or trees, which the application of a sufficient, non-toxic amount of one or more compounds of general formula (I) according to one of
Ansprüche 1 bis 3 oder deren Salze auf die Fläche, wo die entsprechende Wirkung gewünscht wird, umfasst, wobei die Applikation auf die Pflanzen, deren Saatgut oder auf die Fläche, auf der die Pflanzen wachsen, erfolgt.  Claims 1 to 3 or their salts on the surface where the corresponding effect is desired, wherein the application is carried out on the plants, their seeds or on the surface on which the plants grow.
13. Verfahren gemäß Anspruch 12, wobei die Widerstandsfähigkeit der so 13. The method according to claim 12, wherein the resistance of the so
behandelten Pflanzen gegenüber abiotischem Stress gegenüber nicht behandelten Pflanzen unter ansonsten gleichen physiologischen  treated plants against abiotic stress against untreated plants with otherwise the same physiological
Bedingungen um mindestens 3% erhöht ist.  Conditions is increased by at least 3%.
14. Verbindungen der allgemeinen Formel (II) oder ihrer Salze 14. Compounds of general formula (II) or their salts
R1 für (Ci-Ce)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C2-C8)-Alkenyl-R 1 is (C 1 -C 6 ) -alkyl, (C 2 -C 8 ) -alkenyl, (C 2 -C 8 ) -alkynyl, (C 2 -C 8 ) -alkenyl
(Ci-Ce)-alkyl, (C2-Ce)-Alkinyl-(Ci-Ce)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Hydroxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylamino, Sulfonylamino, (Ci-C8)- Alkoxy, (Ci-Cs)-Haloalkyl, (Ci-C8)-Haloalkoxy-(Ci-C8)-alkyl steht, (Ci-Ce) alkyl, (C2 -Ce) alkynyl (Ci-Ce) alkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, hydroxy (Ci-C 8 ) -alkyl, (C 1 -C 8 ) -alkylamino, sulfonylamino, (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -haloalkoxy- (C 1 -C 8 ) -alkyl .
R2 für Wasserstoff, (Ci-Cs)-Alkyl, Nitro-(Ci-C8)-alkyl, Hydroxy-(Ci-Cs)- alkyl, (Ci-Cs)-Haloalkyl, (Ci-Cs)-Alkylamino, Sulfonylamino, (Ci-C8)- Alkoxy, Tris-[(Ci-C8)-alkylsilyl]- (Ci-Cs)-alkyl, Cyano-(Ci-C8)-alkyl, Aryl- (Ci-Cs)-alkyl, (Ci-C8)-Alkoxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)- Haloalkoxycarbonyl-(Ci-C8)-alkyl, (Ci-C8)-Alkylthio-(Ci-C8)-alkyl, Arylthio-(Ci-C8)-alkyl steht, R1 und R2 mit den Atomen, an die sie gebunden sind, einen vollständig gesättigten, gegebenenfalls durch Heteroatome unterbrochenen und gegebenenfalls weiter substituierten 3 bis 6-gliedrigen Ring bilden, R 2 is hydrogen, (C 1 -C 5) -alkyl, nitro (C 1 -C 8 ) -alkyl, hydroxy (C 1 -C 5 ) -alkyl, (C 1 -C 8 ) -haloalkyl, (C 1 -C 8 ) -alkylamino, Sulfonylamino, (C 1 -C 8 ) -alkoxy, tris - [(C 1 -C 8 ) -alkylsilyl] - (C 1 -C 8 ) -alkyl, cyano- (C 1 -C 8 ) -alkyl, aryl- (C 1 -C 5) -alkyl, (C 1 -C 8 ) -alkoxycarbonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -haloalkoxycarbonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylthio (Ci -C 8) alkyl, arylthio (Ci-C 8) -alkyl, R 1 and R 2 with the atoms to which they are attached form a completely saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 6-membered ring,
R3 und R4 unabhängig voneinander für (Ci-C8)-Alkoxy, (Ci-C8)-Alkoxy-R 3 and R 4 independently of one another are (C 1 -C 8) -alkoxy, (C 1 -C 8) -alkoxy
(Ci-C8)-alkoxy, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxy, (Ci-C8)-Haloalkoxy, (Ci-C8)-Alkylthio, (Ci-C8)-Haloalkylthio stehen oder zusammen mit dem Atom, an das sie gebunden sind, eine Oxogruppe, (C 1 -C 8 ) -alkoxy, (C 3 -C 8 ) -cycloalkyl- (C 1 -C 8 ) -alkoxy, (C 1 -C 8 ) -haloalkoxy, (C 1 -C 8 ) -alkylthio, (C 1 -C 8 ) - Haloalkylthio or together with the atom to which they are attached, an oxo group,
Hydroxyiminogruppe, (Ci-C8)-Alkoxyiminogruppe, (C3-Cs)- Cycloalkoxyiminogruppe, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoximinogruppe, Aryl-(Ci-C8)-alkoxyiminogruppe oder einen 5-7-gliedrigen  Hydroxyimino group, (Ci-C8) -Alkoxyiminogruppe, (C3-Cs) - Cycloalkoxyiminogruppe, (C3-C8) -cycloalkyl (Ci-C8) -alkoximinogruppe, aryl (Ci-C8) -alkoxyiminogruppe or a 5-7-membered
heterocyclischen Ring, der gegebenenfalls weiter substituiert sein kann, bilden,  heterocyclic ring, which may optionally be further substituted form,
R5 für Wasserstoff, (Ci-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkenyl-(Ci-C8)- alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, (C3-C8)-Cycloalkylcarbonyl, (Ci-Cs)- Alkoxycarbonyl, (C2-C8)-Alkenyloxycarbonyl, Aryloxy-(Ci-C8)-alkyl, Aryl-(Ci-C8)-alkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkoxy-(Ci-C8)-alkyl, (Ci-C8)- Alkylthio-(Ci-C8)-alkyl, Tris-[(Ci-C8)-alkyl]silyl, (Ci-C8)-Alkyl-Bis- [(Ci-C8)-alkyl]silyl, (Ci-C8)-Alkyl-bis-Arylsilyl, Aryl-bis-[(Ci-C8)-alkyl]silyl, (C3-C8)-Cycloalkyl-bis-[(Ci-C8)-alkyl]silyl, Halo-bis-[(Ci-C8)-alkyl]silyl, Tns-[(Ci-C8)-alkyl]silyl-(Ci-C8)-alkoxy-(Ci-C8)-alkyl steht, und R 5 represents hydrogen, (Ci-C 8) alkyl, (C 2 -C 8) alkenyl, (C2-C8) alkenyl (Ci-C 8) - alkyl, (Ci-C 8) alkoxy (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, (C 3 -C 8 ) -cycloalkylcarbonyl, (C 1 -C 8 ) -alkoxycarbonyl, (C 2 -C 8 ) -alkenyloxycarbonyl, aryloxy- C 1 -C 8 ) -alkyl, aryl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) Alkylthio (C 1 -C 8 ) -alkyl, tris - [(C 1 -C 8 ) -alkyl] silyl, (C 1 -C 8 ) -alkyl-bis- [(C 1 -C 8 ) -alkyl] -silyl, ( C 1 -C 8 ) -alkyl-bis-arylsilyl, aryl-bis - [(C 1 -C 8 ) -alkyl] silyl, (C 3 -C 8 ) -cycloalkyl-bis - [(C 1 -C 8 ) -alkyl] -silyl , Halo-bis - [(Ci-C 8 ) alkyl] silyl, Tns - [(Ci-C 8 ) alkyl] silyl (Ci-C8) alkoxy (Ci-C 8 ) alkyl, and
X für Chlor, Brom, lod, (Ci-C9)-Haloalkylsulfonyloxy, (C1-C9)- Alkylsulfonyloxy steht. X is chloro, bromo, iodo, (C 1 -C 9 ) -haloalkylsulfonyloxy, (C 1 -C 9 ) -alkylsulfonyloxy.
EP12710948.6A 2011-04-15 2012-03-28 Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants Withdrawn EP2697214A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12710948.6A EP2697214A1 (en) 2011-04-15 2012-03-28 Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161475861P 2011-04-15 2011-04-15
EP11162599 2011-04-15
EP12710948.6A EP2697214A1 (en) 2011-04-15 2012-03-28 Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
PCT/EP2012/055479 WO2012139891A1 (en) 2011-04-15 2012-03-28 Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants

Publications (1)

Publication Number Publication Date
EP2697214A1 true EP2697214A1 (en) 2014-02-19

Family

ID=44227917

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12710948.6A Withdrawn EP2697214A1 (en) 2011-04-15 2012-03-28 Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants

Country Status (7)

Country Link
US (1) US20140080704A1 (en)
EP (1) EP2697214A1 (en)
JP (1) JP2014522384A (en)
CN (1) CN103764642A (en)
AR (1) AR085585A1 (en)
BR (1) BR112013026593A2 (en)
WO (1) WO2012139891A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014086723A1 (en) * 2012-12-05 2014-06-12 Bayer Cropscience Ag Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-bicycloalkanols as active agents against abiotic plant stress
CN105072903A (en) * 2012-12-05 2015-11-18 拜耳作物科学股份公司 Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress
EP2740720A1 (en) * 2012-12-05 2014-06-11 Bayer CropScience AG Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants
BR112017000694A2 (en) * 2014-07-18 2018-07-03 Bayer Cropscience Ag vinyl and alkynyl cyanocycloalkanols and substituted vinyl and alkynyl cyanoheterocycloalkanols as active agents against abiotic stress in plants
UA125245C2 (en) 2014-10-06 2022-02-09 Вертекс Фармасьютикалз Інкорпорейтед Modulators of cystic fibrosis transmembrane conductance regulator
JP2018512436A (en) * 2015-04-15 2018-05-17 バレント・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーＶａｌｅｎｔ ＢｉｏＳｃｉｅｎｃｅｓ ＬＬＣ (S) -2'-vinyl-abscisic acid derivative
WO2017173274A1 (en) 2016-03-31 2017-10-05 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
RS62670B1 (en) 2016-09-30 2021-12-31 Vertex Pharma Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
MD3551622T2 (en) 2016-12-09 2021-03-31 Vertex Pharma Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
EP3634402A1 (en) 2017-06-08 2020-04-15 Vertex Pharmaceuticals Incorporated Methods of treatment for cystic fibrosis
WO2019018395A1 (en) 2017-07-17 2019-01-24 Vertex Pharmaceuticals Incorporated Methods of treatment for cystic fibrosis
CA3071278A1 (en) 2017-08-02 2019-02-07 Vertex Pharmaceuticals Incorporated Processes for preparing pyrrolidine compounds
EP3697774A1 (en) 2017-10-19 2020-08-26 Vertex Pharmaceuticals Incorporated Crystalline forms and compositions of cftr modulators
JP7245834B2 (en) 2017-12-08 2023-03-24 バーテックス ファーマシューティカルズ インコーポレイテッド A process for creating modulators of cystic fibrosis transmembrane conductance regulators
TWI810243B (en) 2018-02-05 2023-08-01 美商維泰克斯製藥公司 Pharmaceutical compositions for treating cystic fibrosis
WO2019200246A1 (en) 2018-04-13 2019-10-17 Alexander Russell Abela Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
CN109287629A (en) * 2018-11-07 2019-02-01 华中农业大学 New uses of cis-3-hexenol and anti-stress agents including cis-3-hexenol
KR102385684B1 (en) * 2019-12-04 2022-04-12 대한민국 Composition for enhancing drought and osmotic Stress resistance, and their uses
CN114853713B (en) * 2022-06-21 2024-03-15 中国科学院西北高原生物研究所 Sesquiterpenoids in jellyfish herba Saussureae Involueratae, and extraction and separation method and application thereof

Family Cites Families (238)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164564A (en) 1967-08-21 1969-09-17 Shell Int Research Novel Cyclobexylpentadienone Acid Derivatives, the preparation thereof and Compositions containing the same
DE1905834C3 (en) 1969-02-06 1972-11-09 Basf Ag Procedure for avoiding dust and caking of salts or fertilizers
DE2906507A1 (en) 1979-02-20 1980-08-28 Bayer Ag Plant growth regulating compsn. - contg. alpha amino cyclo:alkanoic acid derivs., e.g. for dwarfing cereals
DE2948024A1 (en) 1979-11-29 1981-08-27 Bayer Ag, 5090 Leverkusen 1-AMINO-CYCLOPROPANCARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS PLANT GROWTH REGULATORS
ATE103902T1 (en) 1982-05-07 1994-04-15 Ciba Geigy Ag USE OF QUINOLINE DERIVATIVES TO PROTECT CROPS.
DE3335514A1 (en) 1983-09-30 1985-04-18 Bayer Ag, 5090 Leverkusen 1-METHYLAMINO-CYCLOPROPAN-1-CARBONIC ACID DERIVATIVES
US5304732A (en) 1984-03-06 1994-04-19 Mgi Pharma, Inc. Herbicide resistance in plants
US4761373A (en) 1984-03-06 1988-08-02 Molecular Genetics, Inc. Herbicide resistance in plants
US5331107A (en) 1984-03-06 1994-07-19 Mgi Pharma, Inc. Herbicide resistance in plants
US4581057A (en) 1984-03-15 1986-04-08 The Board Of Regents Of University Of Michigan, Corp. Of Michigan Abscisic acid containing foliar fertilizers and method of using same to enhance crop yields
DE3525205A1 (en) 1984-09-11 1986-03-20 Hoechst Ag, 6230 Frankfurt PLANT PROTECTIVE AGENTS BASED ON 1,2,4-TRIAZOLE DERIVATIVES AND NEW DERIVATIVES OF 1,2,4-TRIAZOLE
EP0191736B1 (en) 1985-02-14 1991-07-17 Ciba-Geigy Ag Use of quinoline derivatives for the protection of crop plants
DE3534948A1 (en) 1985-10-01 1987-04-09 Bayer Ag FUNGICIDES AND GROWTH REGULATORY AGENTS
EP0242236B2 (en) 1986-03-11 1996-08-21 Plant Genetic Systems N.V. Plant cells resistant to glutamine synthetase inhibitors, made by genetic engineering
GB8607749D0 (en) 1986-03-27 1986-04-30 Hetherington A M Compounds & pharmaceutical preparations
US5123951A (en) 1986-03-31 1992-06-23 Rhone-Poulenc Nederland B.V. Synergistic plant growth regulator compositions
US5637489A (en) 1986-08-23 1997-06-10 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
US5273894A (en) 1986-08-23 1993-12-28 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
US5276268A (en) 1986-08-23 1994-01-04 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
US5605011A (en) 1986-08-26 1997-02-25 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5378824A (en) 1986-08-26 1995-01-03 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5013659A (en) 1987-07-27 1991-05-07 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
DE3633840A1 (en) 1986-10-04 1988-04-14 Hoechst Ag PHENYLPYRAZOLIC CARBONIC ACID DERIVATIVES, THEIR PRODUCTION AND USE AS PLANT GROWTH REGULATORS AND SAFENERS
EP0268554B1 (en) 1986-10-22 1991-12-27 Ciba-Geigy Ag 1,5-diphenyl pyrazole-3-carbonic-acid derivatives for the protection of cultured plants
US5638637A (en) 1987-12-31 1997-06-17 Pioneer Hi-Bred International, Inc. Production of improved rapeseed exhibiting an enhanced oleic acid content
DE3808896A1 (en) 1988-03-17 1989-09-28 Hoechst Ag PLANT PROTECTION AGENTS BASED ON PYRAZOL CARBON SEA DERIVATIVES
GB8810120D0 (en) 1988-04-28 1988-06-02 Plant Genetic Systems Nv Transgenic nuclear male sterile plants
DE3817192A1 (en) 1988-05-20 1989-11-30 Hoechst Ag PLANT-PROTECTIVE AGENTS CONTAINING 1,2,4-TRIAZOLE DERIVATIVES AND NEW DERIVATIVES OF 1,2,4-TRIAZOLE
US5084082A (en) 1988-09-22 1992-01-28 E. I. Du Pont De Nemours And Company Soybean plants with dominant selectable trait for herbicide resistance
DE58903221D1 (en) 1988-10-20 1993-02-18 Ciba Geigy Ag Sulfamoylphenylharnstoffe.
US5518995A (en) 1988-12-01 1996-05-21 National Research Council Of Canada Use of compounds to enhance synchrony of germination and emergence in plants
EP0371882A3 (en) 1988-12-01 1991-04-24 Her Majesty In Right Of Canada As Represented By The National Research Council Of Canada Abscisic acid-related plant growth regulators - germination promoters
DD277832A1 (en) 1988-12-13 1990-04-18 Forschzent Bodenfruchtbarkeit MEANS FOR INCREASING THE STRESSTOLERANCE OF CULTURAL PLANTS
DD277835A1 (en) 1988-12-13 1990-04-18 Forschzent Bodenfruchtbarkeit MEANS FOR INCREASING THE STRESSTOLERANCE OF CULTURAL PLANTS
US6013861A (en) 1989-05-26 2000-01-11 Zeneca Limited Plants and processes for obtaining them
DE3921144A1 (en) 1989-06-28 1991-01-10 Hoechst Ag DEGRADABLE POLYMER BLOCKS
DE3922493A1 (en) 1989-07-08 1991-01-17 Bayer Ag PROCESS FOR PREPARING WAESSEN DISPERSIONS OF POLYURETHANES AND THEIR USE AS COATING AGENTS FOR ANY SUBSTRATE
ATE496135T1 (en) 1989-08-10 2011-02-15 Bayer Bioscience Nv PLANTS WITH MODIFIED FLOWERS
DE3939010A1 (en) 1989-11-25 1991-05-29 Hoechst Ag ISOXAZOLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PLANT PROTECTIVE AGENT
DE3939503A1 (en) 1989-11-30 1991-06-06 Hoechst Ag NEW PYRAZOLINE FOR THE PROTECTION OF CULTURAL PLANTS AGAINST HERBICIDES
US5739082A (en) 1990-02-02 1998-04-14 Hoechst Schering Agrevo Gmbh Method of improving the yield of herbicide-resistant crop plants
US5908810A (en) 1990-02-02 1999-06-01 Hoechst Schering Agrevo Gmbh Method of improving the growth of crop plants which are resistant to glutamine synthetase inhibitors
ATE152572T1 (en) 1990-04-04 1997-05-15 Pioneer Hi Bred Int PRODUCTION OF RAPE SEEDS WITH REDUCED SATURATED FATTY ACID CONTENT
US5198599A (en) 1990-06-05 1993-03-30 Idaho Resarch Foundation, Inc. Sulfonylurea herbicide resistance in plants
EP0536330B1 (en) 1990-06-25 2002-02-27 Monsanto Technology LLC Glyphosate tolerant plants
EP0539588A1 (en) 1990-07-05 1993-05-05 Nippon Soda Co., Ltd. Amine derivative
FR2667078B1 (en) 1990-09-21 1994-09-16 Agronomique Inst Nat Rech DNA SEQUENCE GIVING MALE CYTOPLASMIC STERILITY, MITOCHONDRIAL, MITOCHONDRIA AND PLANT CONTAINING THE SAME, AND PROCESS FOR THE PREPARATION OF HYBRIDS.
DE59108636D1 (en) 1990-12-21 1997-04-30 Hoechst Schering Agrevo Gmbh New 5-chloroquinoline-8-oxyalkanecarboxylic acid derivatives, process for their preparation and their use as antidots of herbicides
DE4103253C2 (en) 1991-02-04 2000-03-23 Aua Agrar Und Umweltanalytik G Means to increase the stress tolerance of agricultural and forestry crops
DE4104782B4 (en) 1991-02-13 2006-05-11 Bayer Cropscience Gmbh Novel plasmids containing DNA sequences that cause changes in carbohydrate concentration and carbohydrate composition in plants, as well as plants and plant cells containing these plasmids
US5731180A (en) 1991-07-31 1998-03-24 American Cyanamid Company Imidazolinone resistant AHAS mutants
WO1993003170A1 (en) 1991-08-05 1993-02-18 Bio-Technical Resources A fermentation process for producing natamycin
DE4128828A1 (en) 1991-08-30 1993-03-04 Basf Ag AMMONIUM OR UREA-CONTAINED DISPENSERS AND METHOD FOR THEIR PRODUCTION
US6270828B1 (en) 1993-11-12 2001-08-07 Cargrill Incorporated Canola variety producing a seed with reduced glucosinolates and linolenic acid yielding an oil with low sulfur, improved sensory characteristics and increased oxidative stability
US5305523A (en) 1992-12-24 1994-04-26 International Business Machines Corporation Method of direct transferring of electrically conductive elements into a substrate
TW259690B (en) 1992-08-01 1995-10-11 Hoechst Ag
DE4227061A1 (en) 1992-08-12 1994-02-17 Inst Genbiologische Forschung A polyfructane sucrase DNA sequence from Erwinia Amylovora
GB9218185D0 (en) 1992-08-26 1992-10-14 Ici Plc Novel plants and processes for obtaining them
DE69233352T2 (en) 1992-10-14 2004-10-07 Syngenta Ltd PLANTS AND METHOD FOR THEIR PRODUCTION
GB9223454D0 (en) 1992-11-09 1992-12-23 Ici Plc Novel plants and processes for obtaining them
WO1994015467A1 (en) 1993-01-07 1994-07-21 National Research Council Of Canada Use of compounds to confer low temperature tolerance to plants
SG71103A1 (en) 1993-01-21 2000-03-21 Matsushita Electric Ind Co Ltd Information recording medium and method of fabricating the same
EP0609022A3 (en) 1993-01-25 1995-08-23 Matsushita Electric Ind Co Ltd Image encoding apparatus.
BR9406484A (en) 1993-03-25 1996-01-09 Ciba Geigy Ag New proteins and pesticide strains
JP3527242B2 (en) 1993-04-27 2004-05-17 カージル，インコーポレーテッド Edible non-hydrogenated canola oil
DE4323804A1 (en) 1993-07-15 1995-01-19 Siemens Ag Method and device for controlling an m-pulse inverter arrangement, consisting of a master inverter and at least one slave inverter
WO1995004826A1 (en) 1993-08-09 1995-02-16 Institut Für Genbiologische Forschung Berlin Gmbh Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants
DE4330960C2 (en) 1993-09-09 2002-06-20 Aventis Cropscience Gmbh Combination of DNA sequences that enable the formation of highly amylose-containing starch in plant cells and plants, processes for producing these plants and the modified starch that can be obtained therefrom
DE4331448A1 (en) 1993-09-16 1995-03-23 Hoechst Schering Agrevo Gmbh Substituted isoxazolines, processes for their preparation, compositions containing them and their use as safeners
US5866782A (en) 1993-10-01 1999-02-02 Mitsubishi Corporation Gene which determines cytoplasmic sterility and a method of producing hybrid plants using said gene
AU692791B2 (en) 1993-10-12 1998-06-18 Agrigenetics, Inc. Brassica napus variety AG019
JPH09505467A (en) 1993-11-09 1997-06-03 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー Transgenic fructan accumulation crop and its production method
WO1995026407A1 (en) 1994-03-25 1995-10-05 National Starch And Chemical Investment Holding Corporation Method for producing altered starch from potato plants
ATE368118T1 (en) 1994-05-18 2007-08-15 Bayer Bioscience Gmbh FOR ENZYMES THAT HAVE THE ABILITY TO SYNTHESE LINEAR ALPHA 1,4-GLUCANS IN PLANTS, FUNGI AND MICROORGANISMS, DNA CODING SEQUENCES
US5824790A (en) 1994-06-21 1998-10-20 Zeneca Limited Modification of starch synthesis in plants
AU706849B2 (en) 1994-06-21 1999-06-24 Cerestar Usa, Inc. Novel plants and processes for obtaining them
NL1000064C1 (en) 1994-07-08 1996-01-08 Stichting Scheikundig Onderzoe Production of oligosaccharides in transgenic plants.
DE4441408A1 (en) 1994-11-10 1996-05-15 Inst Genbiologische Forschung DNA sequences from Solanum tuberosum encoding enzymes involved in starch synthesis, plasmids, bacteria, plant cells and transgenic plants containing these sequences
DE4447387A1 (en) 1994-12-22 1996-06-27 Inst Genbiologische Forschung Debranching enzymes from plants and DNA sequences encoding these enzymes
JP3840259B2 (en) 1995-01-06 2006-11-01 プラント リサーチ インターナショナル ベスローテン フェンノートシャップ DNA sequence encoding carbohydrate polymer synthase and method for producing transgenic plants
DE19509695A1 (en) 1995-03-08 1996-09-12 Inst Genbiologische Forschung Process for the preparation of a modified starch in plants, and the modified starch isolatable from the plants
ES2275275T3 (en) 1995-04-20 2007-06-01 Basf Aktiengesellschaft HERBICIDE RESISTANT PRODUCTS DESIGNED ON THE BASE OF THE STRUCTURE.
US5853973A (en) 1995-04-20 1998-12-29 American Cyanamid Company Structure based designed herbicide resistant products
DK0826061T3 (en) 1995-05-05 2007-09-24 Nat Starch Chem Invest Enhancements to or related to plant starch compositions
FR2734842B1 (en) 1995-06-02 1998-02-27 Rhone Poulenc Agrochimie DNA SEQUENCE OF A HYDROXY-PHENYL PYRUVATE DIOXYGENASE GENE AND OBTAINING PLANTS CONTAINING A HYDROXY-PHENYL PYRUVATE DIOXYGENASE GENE, TOLERANT TO CERTAIN HERBICIDES
US6284479B1 (en) 1995-06-07 2001-09-04 Pioneer Hi-Bred International, Inc. Substitutes for modified starch and latexes in paper manufacture
US5712107A (en) 1995-06-07 1998-01-27 Pioneer Hi-Bred International, Inc. Substitutes for modified starch and latexes in paper manufacture
GB9513881D0 (en) 1995-07-07 1995-09-06 Zeneca Ltd Improved plants
FR2736926B1 (en) 1995-07-19 1997-08-22 Rhone Poulenc Agrochimie 5-ENOL PYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE MUTEE, CODING GENE FOR THIS PROTEIN AND PROCESSED PLANTS CONTAINING THIS GENE
DK0851934T3 (en) 1995-09-19 2006-07-31 Bayer Bioscience Gmbh Plants which synthesize a modified starch, methods for their preparation and modified starch
GB9524938D0 (en) 1995-12-06 1996-02-07 Zeneca Ltd Modification of starch synthesis in plants
AU1089997A (en) 1995-12-21 1997-07-17 National Research Council Of Canada Hyperabas: biologically active abscisic acid analogs with unsaturated carbon substituents at the 8'-methyl or 9'-methyl carbon atoms
DE19601365A1 (en) 1996-01-16 1997-07-17 Planttec Biotechnologie Gmbh Nucleic acid molecules from plants encoding enzymes involved in starch synthesis
DE19608918A1 (en) 1996-03-07 1997-09-11 Planttec Biotechnologie Gmbh Nucleic Acid Molecules Encoding New Debranching Enzymes from Maize
US5773704A (en) 1996-04-29 1998-06-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Herbicide resistant rice
DE19618125A1 (en) 1996-05-06 1997-11-13 Planttec Biotechnologie Gmbh Nucleic acid molecules that encode new potato debranching enzymes
DE19619918A1 (en) 1996-05-17 1997-11-20 Planttec Biotechnologie Gmbh Nucleic acid molecules encoding soluble starch synthases from maize
DE19621522A1 (en) 1996-05-29 1997-12-04 Hoechst Schering Agrevo Gmbh New N-acylsulfonamides, new mixtures of herbicides and antidots and their use
DE69737448T2 (en) 1996-05-29 2007-11-15 Bayer Cropscience Ag NUCLEIC ACID MOLECULES CODING FOR ENZYMES FROM WHEAT INVOLVED IN STARCH SYNTHESIS
JP2001503607A (en) 1996-06-12 2001-03-21 パイオニア ハイ―ブレッド インターナショナル，インコーポレイテッド A substitute for modified starch in papermaking.
JP2000512349A (en) 1996-06-12 2000-09-19 パイオニア ハイ―ブレッド インターナショナル，インコーポレイテッド A substitute for modified starch in papermaking.
EP0904454A1 (en) 1996-06-12 1999-03-31 Pioneer Hi-Bred International, Inc. Substitutes for modified starch in paper manufacture
AUPO069996A0 (en) 1996-06-27 1996-07-18 Australian National University, The Manipulation of plant cellulose
US5850026A (en) 1996-07-03 1998-12-15 Cargill, Incorporated Canola oil having increased oleic acid and decreased linolenic acid content
US5773702A (en) 1996-07-17 1998-06-30 Board Of Trustees Operating Michigan State University Imidazolinone herbicide resistant sugar beet plants
DE19631764A1 (en) 1996-08-06 1998-02-12 Basf Ag Use of poly acids to treat mineral fertilisers - where the fertiliser contains nitrification inhibitor in mineral fertiliser, especially new or known pyrazole compound, to reduce volatility
GB9623095D0 (en) 1996-11-05 1997-01-08 Nat Starch Chem Invest Improvements in or relating to starch content of plants
US6232529B1 (en) 1996-11-20 2001-05-15 Pioneer Hi-Bred International, Inc. Methods of producing high-oil seed by modification of starch levels
DE19653176A1 (en) 1996-12-19 1998-06-25 Planttec Biotechnologie Gmbh New maize nucleic acid molecules and their use to produce a modified starch
CA2193938A1 (en) 1996-12-24 1998-06-24 David G. Charne Oilseed brassica containing an improved fertility restorer gene for ogura cytoplasmic male sterility
US5981840A (en) 1997-01-24 1999-11-09 Pioneer Hi-Bred International, Inc. Methods for agrobacterium-mediated transformation
DE19708774A1 (en) 1997-03-04 1998-09-17 Max Planck Gesellschaft Enzymes encoding nucleic acid molecules which have fructosyl polymerase activity
US6071856A (en) 1997-03-04 2000-06-06 Zeneca Limited Herbicidal compositions for acetochlor in rice
DE19709775A1 (en) 1997-03-10 1998-09-17 Planttec Biotechnologie Gmbh Nucleic acid molecules encoding corn starch phosphorylase
DE19727410A1 (en) 1997-06-27 1999-01-07 Hoechst Schering Agrevo Gmbh 3- (5-tetrazolylcarbonyl) -2-quinolones and crop protection agents containing them
GB9718863D0 (en) 1997-09-06 1997-11-12 Nat Starch Chem Invest Improvements in or relating to stability of plant starches
DE19742951A1 (en) 1997-09-29 1999-04-15 Hoechst Schering Agrevo Gmbh Acylsulfamoylbenzoic acid amides, crop protection agents containing them and process for their preparation
DE19749122A1 (en) 1997-11-06 1999-06-10 Max Planck Gesellschaft Enzymes encoding nucleic acid molecules that have fructosyl transferase activity
FR2770854B1 (en) 1997-11-07 2001-11-30 Rhone Poulenc Agrochimie DNA SEQUENCE OF A GENE OF HYDROXY-PHENYL PYRUVATE DIOXYGENASE AND PRODUCTION OF PLANTS CONTAINING SUCH A GENE, HERBICIDE TOLERANT
FR2772789B1 (en) 1997-12-24 2000-11-24 Rhone Poulenc Agrochimie PROCESS FOR THE ENZYMATIC PREPARATION OF HOMOGENTISATE
EP1068333A1 (en) 1998-04-09 2001-01-17 E.I. Du Pont De Nemours And Company Starch r1 phosphorylation protein homologs
DE19820607A1 (en) 1998-05-08 1999-11-11 Hoechst Schering Agrevo Gmbh New enzyme with starch synthase activity, useful for producing starch for foods and packaging materials
DE19820608A1 (en) 1998-05-08 1999-11-11 Hoechst Schering Agrevo Gmbh New nucleic acid encoding isoamylase from wheat and related transgenic plants producing starch with altered properties
EP1078088B1 (en) 1998-05-13 2006-07-26 Bayer BioScience GmbH Transgenic plants with a modified activity of a plastidial adp/atp translocator
DE19821614A1 (en) 1998-05-14 1999-11-18 Hoechst Schering Agrevo Gmbh Sugar beet mutants which are tolerant to sulfonylurea herbicides
US6635756B1 (en) 1998-06-15 2003-10-21 National Starch And Chemical Investment Holding Corporation Starch obtainable from modified plants
US6693185B2 (en) 1998-07-17 2004-02-17 Bayer Bioscience N.V. Methods and means to modulate programmed cell death in eukaryotic cells
DE19836098A1 (en) 1998-07-31 2000-02-03 Hoechst Schering Agrevo Gmbh Plants that synthesize a modified starch, process for producing the plants, their use and the modified starch
DE19836099A1 (en) 1998-07-31 2000-02-03 Hoechst Schering Agrevo Gmbh Nucleic acid molecules coding for a β-amylase, plants which synthesize a modified starch, process for the preparation of the plants, their use and the modified starch
EP1108040A2 (en) 1998-08-25 2001-06-20 Pioneer Hi-Bred International, Inc. Plant glutamine: fructose-6-phosphate amidotransferase nucleic acids
EP1109916A1 (en) 1998-09-02 2001-06-27 Planttec Biotechnologie GmbH Nucleic acid molecules encoding an amylosucrase
DE19924342A1 (en) 1999-05-27 2000-11-30 Planttec Biotechnologie Gmbh Genetically modified plant cells and plants with increased activity of an amylosucrase protein and a branching enzyme
BR9915026A (en) 1998-10-09 2001-07-17 Planttec Biotechnologie Gmbh Nucleic acid molecules encoding a branching enzyme from bacteria of the genus neisseria as well as methods for the production of alpha-1,4 glycans branched to alpha-1,6
US6624139B1 (en) 1998-11-05 2003-09-23 Eden Bioscience Corporation Hypersensitive response elicitor-induced stress resistance
JP2002529094A (en) 1998-11-09 2002-09-10 プランテック バイオテクノロジー ゲーエムベーハー Rice-derived nucleic acid molecule and its use for the production of modified starch
US6531648B1 (en) 1998-12-17 2003-03-11 Syngenta Participations Ag Grain processing method and transgenic plants useful therein
DE19905069A1 (en) 1999-02-08 2000-08-10 Planttec Biotechnologie Gmbh Alternansucrase encoding nucleic acid molecules
US6323392B1 (en) 1999-03-01 2001-11-27 Pioneer Hi-Bred International, Inc. Formation of brassica napus F1 hybrid seeds which exhibit a highly elevated oleic acid content and a reduced linolenic acid content in the endogenously formed oil of the seeds
BR0010069A (en) 1999-04-29 2002-01-22 Syngenta Ltd Isolated polynucellotide, vector, plant material, whole, fertile, morphologically normal plants, corn plants, methods for selectively controlling weeds in a field, and for producing vegetables that are substantially tolerant to the glyphosate herbicide, use of polynucleotide, and, methods to select transformed biological material, and to regenerate a fertile transformed plant to contain foreign DNA
EP1173580A1 (en) 1999-04-29 2002-01-23 Syngenta Limited Herbicide resistant plants
DE19926771A1 (en) 1999-06-11 2000-12-14 Aventis Cropscience Gmbh Nucleic acid molecules from wheat, transgenic plant cells and plants and their use for the production of modified starch
DE19937348A1 (en) 1999-08-11 2001-02-22 Aventis Cropscience Gmbh Nucleic acid molecules from plants encoding enzymes involved in starch synthesis
DE19937643A1 (en) 1999-08-12 2001-02-22 Aventis Cropscience Gmbh Transgenic cells and plants with altered activity of the GBSSI and BE proteins
AU7647000A (en) 1999-08-20 2001-03-19 Basf Plant Science Gmbh Increasing the polysaccharide content in plants
US6423886B1 (en) 1999-09-02 2002-07-23 Pioneer Hi-Bred International, Inc. Starch synthase polynucleotides and their use in the production of new starches
US6472588B1 (en) 1999-09-10 2002-10-29 Texas Tech University Transgenic cotton plants with altered fiber characteristics transformed with a sucrose phosphate synthase nucleic acid
GB9921830D0 (en) 1999-09-15 1999-11-17 Nat Starch Chem Invest Plants having reduced activity in two or more starch-modifying enzymes
AR025996A1 (en) 1999-10-07 2002-12-26 Valigen Us Inc NON-TRANSGENIC PLANTS RESISTANT TO HERBICIDES.
US6803501B2 (en) 2000-03-09 2004-10-12 Monsanto Technology, Llc Methods for making plants tolerant to glyphosate and compositions thereof using a DNA encoding an EPSPS enzyme from Eleusine indica
ES2414438T3 (en) 2000-03-09 2013-07-19 E.I. Du Pont De Nemours And Company Sunflower plants tolerant to sulfonylureas
US7169970B2 (en) 2000-09-29 2007-01-30 Syngenta Limited Herbicide resistant plants
AR031027A1 (en) 2000-10-23 2003-09-03 Syngenta Participations Ag AGROCHEMICAL COMPOSITIONS
US6734340B2 (en) 2000-10-23 2004-05-11 Bayer Cropscience Gmbh Monocotyledon plant cells and plants which synthesise modified starch
FR2815969B1 (en) 2000-10-30 2004-12-10 Aventis Cropscience Sa TOLERANT PLANTS WITH HERBICIDES BY METABOLIC BYPASS
CA2425956C (en) 2000-10-30 2014-12-23 Maxygen, Inc. Novel glyphosate n-acetyltransferase (gat) genes
EP1349446B1 (en) 2000-12-08 2013-01-23 Commonwealth Scientific And Industrial Research Organisation Modification of sucrose synthase gene expression in plant tissue and uses therefor
WO2002079410A2 (en) 2001-03-30 2002-10-10 Basf Plant Science Gmbh Glucan chain length domains
DE60226508D1 (en) 2001-06-12 2008-06-19 Bayer Cropscience Gmbh TRANSGENIC PLANTS MAKE THE STRENGTH OF HIGH AMYLOSE CONTENT
WO2003013226A2 (en) 2001-08-09 2003-02-20 Cibus Genetics Non-transgenic herbicide resistant plants
HUP0401861A2 (en) 2001-10-17 2004-12-28 Basf Plant Science Gmbh Starch
DE10208132A1 (en) 2002-02-26 2003-09-11 Planttec Biotechnologie Gmbh Process for the production of maize plants with an increased leaf starch content and their use for the production of maize silage
AR039501A1 (en) 2002-04-30 2005-02-23 Verdia Inc N-ACETIL TRANSFERASE GLYPHOSATE GENES (GAT)
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
FR2844142B1 (en) 2002-09-11 2007-08-17 Bayer Cropscience Sa TRANSFORMED PLANTS WITH ENHANCED PRENYLQUINON BIOSYNTHESIS
WO2004040012A2 (en) 2002-10-29 2004-05-13 Basf Plant Science Gmbh Compositions and methods for identifying plants having increased tolerance to imidazolinone herbicides
US20040110443A1 (en) 2002-12-05 2004-06-10 Pelham Matthew C. Abrasive webs and methods of making the same
DK1578973T3 (en) 2002-12-19 2008-11-24 Bayer Cropscience Ag Plant cells and plants that synthesize a starch with increased final viscosity
CA2517879A1 (en) 2003-03-07 2004-09-16 Basf Plant Science Gmbh Enhanced amylose production in plants
WO2004084631A1 (en) 2003-03-26 2004-10-07 Bayer Cropscience Gmbh Use of aromatic hydroxy compounds as safeners
CA2521729C (en) 2003-04-09 2013-12-03 Bayer Bioscience N.V. Methods and means for increasing the tolerance of plants to stress conditions
MXPA05011585A (en) 2003-04-29 2006-05-25 Pioneer Hi Bred Int Novel glyphosate-n-acetyltransferase (gat) genes.
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
CA2526480A1 (en) 2003-05-22 2005-01-13 Syngenta Participations Ag Modified starch, uses, methods for production thereof
EP1633875B1 (en) 2003-05-28 2012-05-02 Basf Se Wheat plants having increased tolerance to imidazolinone herbicides
EP1493328A1 (en) 2003-07-04 2005-01-05 Institut National De La Recherche Agronomique Method of producing double low restorer lines of brassica napus having a good agronomic value
CN1833026A (en) 2003-07-31 2006-09-13 东洋纺织株式会社 plants that produce hyaluronic acid
DE10335726A1 (en) 2003-08-05 2005-03-03 Bayer Cropscience Gmbh Use of hydroxyaromatics as safener
DE10335725A1 (en) 2003-08-05 2005-03-03 Bayer Cropscience Gmbh Safener based on aromatic-aliphatic carboxylic acid derivatives
CN100575490C (en) 2003-08-15 2009-12-30 联邦科学与工业研究组织 Method and means for altering fiber characteristics in fiber-producing plants
ES2743420T3 (en) 2003-08-29 2020-02-19 Instituto Nac De Tecnologia Agropecuaria Rice plants that have increased tolerance against imidazolinone herbicides
WO2005030942A1 (en) 2003-09-30 2005-04-07 Bayer Cropscience Gmbh Plants with reduced activity of a class 3 branching enzyme
EP1687416A1 (en) 2003-09-30 2006-08-09 Bayer CropScience GmbH Plants with increased activity of a class 3 branching enzyme
UA79404C2 (en) 2003-10-02 2007-06-11 Basf Ag 2-cyanobenzenesulfonamide for controlling pests
GB0329744D0 (en) 2003-12-23 2004-01-28 Koninkl Philips Electronics Nv A beverage maker incorporating multiple beverage collection chambers
WO2005077934A1 (en) 2004-02-18 2005-08-25 Ishihara Sangyo Kaisha, Ltd. Anthranilamides, process for the production thereof, and pest controllers containing the same
AR048024A1 (en) 2004-03-05 2006-03-22 Bayer Cropscience Gmbh PLANTS WITH INCREASED ACTIVITY OF DIFFERENT ENZYMES FOSFORILANTES DEL ALMIDON
ZA200607637B (en) 2004-03-05 2008-05-28 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide compound and noxious organism control agent
ATE541042T1 (en) 2004-03-05 2012-01-15 Bayer Cropscience Ag PLANTS WITH REDUCED ACTIVITY OF THE STARCH PHOSPHORYLATING ENZYME PHOSPHOGLUCAN-WATER DIKINASE
AR048025A1 (en) 2004-03-05 2006-03-22 Bayer Cropscience Gmbh PLANTS WITH INCREASED ACTIVITY OF AN ALMIDON FOSFORILING ENZYME
AR048026A1 (en) 2004-03-05 2006-03-22 Bayer Cropscience Gmbh PROCEDURES FOR THE IDENTIFICATION OF PROTEINS WITH ENZYMATIC ACTIVITY FOSFORILADORA DE ALMIDON
US7432082B2 (en) 2004-03-22 2008-10-07 Basf Ag Methods and compositions for analyzing AHASL genes
WO2005108345A1 (en) 2004-05-10 2005-11-17 National Research Council Of Canada Synthesis and biological activity or novel bicyclic aba analogs
DE102004023332A1 (en) 2004-05-12 2006-01-19 Bayer Cropscience Gmbh Quinoxaline-2-one derivatives, crop protection agents containing them, and processes for their preparation and their use
WO2006007373A2 (en) 2004-06-16 2006-01-19 Basf Plant Science Gmbh Polynucleotides encoding mature ahasl proteins for creating imidazolinone-tolerant plants
DE102004029763A1 (en) 2004-06-21 2006-01-05 Bayer Cropscience Gmbh Plants that produce amylopectin starch with new properties
BRPI0513981A (en) 2004-07-30 2008-05-20 Basf Agrochemical Products Bv plant, seed, methods for controlling weeds in the vicinity of a sunflower plant and a transformed plant, for increasing ahas activity in a plant, for producing a herbicide resistant plant, for enhancing herbicide tolerance in a tolerant plant the herbicide, to select a transformed plant cell, to increase the herbicide resistance of a plant, and to combat undesirable vegetation, isolated polynucleotide molecule, expression cassette, non-human host cell, transformation vector, plant cell transformed and isolated polypeptide
BRPI0514047A (en) 2004-08-04 2008-05-27 Basf Plant Science Gmbh isolated polynucleotide, plant expression vector, isolated polypeptide, transgenic plant cell, methods for enhancing ahas activity in a plant, for controlling weeds in the vicinity of a plant, and for producing a transgenic plants having increased ahas activity, transgenic plant and fusion polypeptide
DK1786908T3 (en) 2004-08-18 2010-06-07 Bayer Cropscience Ag Plants with increased plastidic activity of starch phosphorylating R3 enzyme
AU2005276075B2 (en) 2004-08-26 2010-08-26 National Dairy Development Board A novel cytoplasmic male sterility system for Brassica species and its use for hybrid seed production in Indian oilseed mustard Brassica juncea
DE102004044262A1 (en) 2004-09-10 2006-03-16 Basf Ag Process for the catalytic reduction of alkyne compounds
EP1805312B9 (en) 2004-09-23 2009-12-09 Bayer CropScience AG Methods and means for producing hyaluronan
US7872036B2 (en) 2004-10-20 2011-01-18 Kumiai Chemical Industry Co., Ltd. 3-triazolylphenyl sulfide derivative and insecticide, miticide and nematicide containing it as an active ingredient
CA2586520A1 (en) 2004-11-26 2006-06-01 Basf Aktiengesellschaft Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests
AR051690A1 (en) 2004-12-01 2007-01-31 Basf Agrochemical Products Bv MUTATION INVOLVED IN THE INCREASE OF TOLERANCE TO IMIDAZOLINONE HERBICIDES IN PLANTS
EP1672075A1 (en) 2004-12-17 2006-06-21 Bayer CropScience GmbH Transformed plant expressing a dextransucrase and synthesizing a modified starch
EP1679374A1 (en) 2005-01-10 2006-07-12 Bayer CropScience GmbH Transformed plant expressing a mutansucrase and synthesizing a modified starch
KR20070118133A (en) 2005-03-24 2007-12-13 바스프 악티엔게젤샤프트 2-cyanobenzenesulfonamide compound for seed treatment
JP2006304779A (en) 2005-03-30 2006-11-09 Toyobo Co Ltd Hexosamine high production plant
EP1707632A1 (en) 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylated waxy potato starch
EP1710315A1 (en) 2005-04-08 2006-10-11 Bayer CropScience GmbH High phosphate starch
TWI388282B (en) 2005-06-01 2013-03-11 Meiji Seika Pharma Co Ltd Pest control agents
WO2006133827A2 (en) 2005-06-15 2006-12-21 Bayer Bioscience N.V. Methods for increasing the resistance of plants to hypoxic conditions
KR101468830B1 (en) 2005-06-24 2014-12-03 바이엘 크롭사이언스 엔.브이. Methods for altering the reactivity of plant cell walls
AR054174A1 (en) 2005-07-22 2007-06-06 Bayer Cropscience Gmbh OVERPRINTING OF ALMIDON SYNTHEASE IN VEGETABLES
JPWO2007023719A1 (en) 2005-08-22 2009-02-26 クミアイ化学工業株式会社 Pesticide mitigation agent and herbicide composition with reduced phytotoxicity
EA200800622A1 (en) 2005-08-24 2008-08-29 Пайонир Хай-Бред Интернэшнл, Инк. COMPOSITIONS PROVIDING TOLERANCE TO SEVERAL HERBICIDES AND METHODS OF THEIR APPLICATION
JPWO2007023764A1 (en) 2005-08-26 2009-02-26 クミアイ化学工業株式会社 Pesticide mitigation agent and herbicide composition with reduced phytotoxicity
UA96421C2 (en) 2005-08-31 2011-11-10 Монсанто Текнолоджи Ллс Nucleotide sequence encoding insecticidal proteins
CN101297041A (en) 2005-10-05 2008-10-29 拜尔作物科学股份公司 Plants with an increased production of hyaluronan II
CA2624973C (en) 2005-10-05 2016-01-19 Bayer Cropscience Ag Production of hyaluronan from plants transgenic for hyaluronan synthase, gfat and udp-glucose dehydrogenase
CA2624592C (en) 2005-10-05 2016-07-19 Bayer Cropscience Ag Gfat-expressing plants with increased hyaluronan production
WO2007043677A1 (en) 2005-10-14 2007-04-19 Sumitomo Chemical Company, Limited Hydrazide compound and pesticidal use of the same
US20090069317A1 (en) 2005-11-21 2009-03-12 Basf Se Insecticidal Methods Using 3-Amino-1,2-Benzisothiazole Derivatives
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
DE102006015470A1 (en) 2006-03-31 2007-10-04 Bayer Cropscience Ag New cyclic enamine ketone derivatives useful for controlling pests, especially insects
DE102006015467A1 (en) 2006-03-31 2007-10-04 Bayer Cropscience Ag New cyclic enamine ketone derivatives useful for controlling pests, especially insects
DE102006015468A1 (en) 2006-03-31 2007-10-04 Bayer Cropscience Ag New cyclic enamine ketone derivatives useful for controlling pests, especially insects
TWI381811B (en) 2006-06-23 2013-01-11 Dow Agrosciences Llc A method to control insects resistant to common insecticides
JP5047588B2 (en) 2006-10-31 2012-10-10 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Quinoline derivatives and agricultural and horticultural insecticides comprising the same
BRPI0807371A2 (en) 2007-03-01 2014-05-06 Basf Se PESTICIDATED MIXTURES, COMPOUND, METHODS TO PROTECT PLANT ATTACK OR INFESTATION PLANTS, AACIDIA OR NEMATOIDS, TO CONTROL INSERTS, ARACHNIDS OR NEMATOIDS, TO PROTECT SEEDS, TO PROTECT ANIMAL INFECTIONS OR INFECTED INFECTIONS PARASITES, SEED, USE OF A MIX, AND, PESTICIDE OR PARASITIC COMPOSITION
EP1987717A1 (en) 2007-04-30 2008-11-05 Bayer CropScience AG Pyridon carboxamides, agents containing these but not impacting useful plants and method for their manufacture and application
EP1987718A1 (en) 2007-04-30 2008-11-05 Bayer CropScience AG Utilisation of pyridine-2-oxy-3-carbon amides as safener
GB0720126D0 (en) 2007-10-15 2007-11-28 Syngenta Participations Ag Chemical compounds
JP5268461B2 (en) 2008-07-14 2013-08-21 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 PF1364 substance, its production method, production strain, and agricultural and horticultural insecticide containing the same as an active ingredient
FR2934943B1 (en) 2008-08-12 2011-06-17 Algieplus USE OF APIOGALACTURONANES AND ITS DERIVATIVES FOR THE STIMULATION OF DEFENSE AND RESISTANCE REACTIONS OF PLANTS AGAINST BIOTIC AND ABIOTIC STRESS
CA2647900C (en) 2008-12-23 2017-05-16 National Research Council Of Canada Inhibitors of a 9-cis-epoxycarotenoid dioxygenase
WO2010122956A1 (en) 2009-04-20 2010-10-28 花王株式会社 Composition for imparting stress tolerance to plant
EP2248421A1 (en) 2009-05-07 2010-11-10 GMI - Gregor-Mendel-Institut für Molekulare Pflanzenbiologie GmbH Accumulation of biomass in plants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2012139891A1 *

Also Published As

Publication number Publication date
US20140080704A1 (en) 2014-03-20
JP2014522384A (en) 2014-09-04
BR112013026593A2 (en) 2016-07-26
CN103764642A (en) 2014-04-30
WO2012139891A1 (en) 2012-10-18
AR085585A1 (en) 2013-10-09

Similar Documents

Publication Publication Date Title
EP2697214A1 (en) Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
EP2611300B1 (en) Substituted annelated dihydropyrimidinone compounds
AU2012242124B2 (en) Substituted 5-(cyclohex-2-en-1-yl)-penta-2,4-dienes and 5-(cyclohex-2-en-1-yl)-pent-2-en-4-ynes as active agents against abiotic stress in plants
US9173395B2 (en) Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
EP2658376A1 (en) Use of substituted spirocyclic sulfonamidocarboxylic acids, carboxylic esters thereof, carboxamides thereof and carbonitriles thereof or salts thereof for enhancement of stress tolerance in plants
WO2014037340A1 (en) Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
EP2547204A2 (en) Aryl and hetaryl sulfonamides as active agents against abiotic plant stress
EP2757886A1 (en) Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
EP2928296A1 (en) Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress
WO2014086723A1 (en) Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-bicycloalkanols as active agents against abiotic plant stress
WO2014037313A1 (en) Use of substituted benzodiazepinones and benzazepinones or the salts thereof as active substances against abiotic plant stress
EP2542533B1 (en) Fluoralkyl-substituted 2-amidobenzimidazoles and their use for increasing stress tolerance in plants
EP2510786A1 (en) Substituted Prop-2-in-1-ol and Prop-2-en-1-ol derivatives
JP2014515746A (en) Substituted 5- (bicyclo [4.1.0] hept-3-en-2-yl) penta-2,4-dienes as active compounds against abiotic plant stress and 5- (bicyclo [4.1. 0] hept-3-en-2-yl) pent-2-en-4-ynes
WO2014037349A1 (en) Use of substituted 2,3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress
EP2740356A1 (en) Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives
EP2740720A1 (en) Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140611